Citrus Sinensis ID: 014359
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWC9 | 444 | CBL-interacting serine/th | yes | no | 0.983 | 0.943 | 0.681 | 1e-165 | |
| Q94C40 | 432 | CBL-interacting serine/th | no | no | 0.969 | 0.956 | 0.651 | 1e-160 | |
| Q9LGV5 | 461 | CBL-interacting protein k | yes | no | 0.990 | 0.915 | 0.634 | 1e-159 | |
| Q0D4B2 | 525 | CBL-interacting protein k | no | no | 0.964 | 0.782 | 0.647 | 1e-158 | |
| Q75L42 | 454 | CBL-interacting protein k | no | no | 0.962 | 0.903 | 0.623 | 1e-154 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.953 | 0.902 | 0.509 | 1e-121 | |
| Q2V452 | 441 | CBL-interacting serine/th | no | no | 0.938 | 0.907 | 0.497 | 1e-119 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.936 | 0.827 | 0.5 | 1e-119 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.924 | 0.897 | 0.490 | 1e-117 | |
| Q2QY53 | 438 | CBL-interacting protein k | no | no | 0.922 | 0.897 | 0.497 | 1e-117 |
| >sp|Q8RWC9|CIPK1_ARATH CBL-interacting serine/threonine-protein kinase 1 OS=Arabidopsis thaliana GN=CIPK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 582 bits (1500), Expect = e-165, Method: Compositional matrix adjust.
Identities = 297/436 (68%), Positives = 354/436 (81%), Gaps = 17/436 (3%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
+K ++GMRLG+YELGRTLGEGNFGKVKFA+D SG FAVKI++K+RI L + QIKRE
Sbjct: 9 KKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKRE 68
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQLI
Sbjct: 69 IRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLI 128
Query: 125 DG---------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
DG LEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYVA
Sbjct: 129 DGISYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVA 188
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229
PEVLANRGYDGA SDIWSCGVILYVILTG LPFDDRNLAVLYQKI +GD +P+WLSPGA
Sbjct: 189 PEVLANRGYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGA 248
Query: 230 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDG 288
+ +++++L+PNPV RIT+ GIKA EWF+ +Y P+ P DDDEE++ D++AFS+ E+ S+
Sbjct: 249 RTMIKRMLDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSEE 308
Query: 289 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEM 348
G+ SP +INAFQLIGMSS LDLSGFFE+E+VSER+IRFTSN SAKDLLE+IE VTEM
Sbjct: 309 GKGSDSPTIINAFQLIGMSSFLDLSGFFEQENVSERRIRFTSNSSAKDLLEKIETAVTEM 368
Query: 349 GFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 408
GF VQKK+ KL+ QE + QK LSV AEVFEI PSL VVELRKSYGD +YRQL +
Sbjct: 369 GFSVQKKHAKLRVKQEERNQKGQVGLSVTAEVFEIKPSLNVVELRKSYGDSCLYRQLYER 428
Query: 409 LSSDLGL-PPSQELLA 423
L D+G P QE++
Sbjct: 429 LLKDVGTSSPEQEIVT 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q94C40|CIPKH_ARATH CBL-interacting serine/threonine-protein kinase 17 OS=Arabidopsis thaliana GN=CIPK17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 565 bits (1456), Expect = e-160, Method: Compositional matrix adjust.
Identities = 281/431 (65%), Positives = 341/431 (79%), Gaps = 18/431 (4%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMR+G+YELGRTLGEGN KVKFA D +G FA+KI+EK+ I L ++ QIKREI TL
Sbjct: 4 KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG-- 126
K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDG
Sbjct: 64 KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123
Query: 127 -------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
LEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVL
Sbjct: 124 YCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVL 183
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233
AN GYDGA SDIWSCGVILYVILTG LPFDD NLAV+ +KIF+GD +P+W+S GA+ ++
Sbjct: 184 ANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMI 243
Query: 234 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 293
+++L+PNPV R+TIAGIKA +WF+ DYTP+N DDD++ + + F M E + ++P
Sbjct: 244 KRMLDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPD 301
Query: 294 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 353
SP +INAFQLIGMSS LDLSGFFE E +SER+IRFTSN AKDLLE IE I TEMGF +Q
Sbjct: 302 SPTIINAFQLIGMSSFLDLSGFFETEKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQ 361
Query: 354 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 413
KK+ KLKA +E QK LSV AEVFEISPSL VVELRKS+GD ++Y+QL +L ++L
Sbjct: 362 KKHAKLKAIKEESTQKRQCGLSVTAEVFEISPSLNVVELRKSHGDSSLYKQLYERLLNEL 421
Query: 414 GLPPS-QELLA 423
G QELLA
Sbjct: 422 GSSSQVQELLA 432
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LGV5|CIPK1_ORYSJ CBL-interacting protein kinase 1 OS=Oryza sativa subsp. japonica GN=CIPK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1446), Expect = e-159, Method: Compositional matrix adjust.
Identities = 283/446 (63%), Positives = 346/446 (77%), Gaps = 24/446 (5%)
Query: 1 MVIAEKKQEGMR---LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI 57
MV E + E R LGRYE+GRTLGEGNFGKVK+A+ L +G FA+KIL++N+I+ L+
Sbjct: 1 MVNGEAEAECTRASLLGRYEIGRTLGEGNFGKVKYARHLATGAHFAIKILDRNKILSLRF 60
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
DQI+REI TLKLLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGR
Sbjct: 61 DDQIRREIGTLKLLKHPNVVRLHEVAASKTKIYMVLEYVNGGELFDKIAVKGKLSEHEGR 120
Query: 118 KLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162
+LFQQLID + EN+L+D +GNIKISDFGLSALPQH +DGLLHTTC
Sbjct: 121 RLFQQLIDAVSYCHDKGVYHRDLKPENVLVDRRGNIKISDFGLSALPQHLGNDGLLHTTC 180
Query: 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 222
GSPNY+APEVL NRGYDG+ SDIWSCGVILYV+L GYLPFDDRNL VLYQKIF+GD ++P
Sbjct: 181 GSPNYIAPEVLQNRGYDGSLSDIWSCGVILYVMLVGYLPFDDRNLVVLYQKIFKGDTQIP 240
Query: 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 282
KWLSP A++LLR+ILEPNP+KRI IAGIK EWF++DYTP P DD++D ++D+ +
Sbjct: 241 KWLSPSARDLLRRILEPNPMKRINIAGIKEHEWFQKDYTPVVPYDDDDDNYLDS-VLPIK 299
Query: 283 EVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIE 342
E + + P INAFQLIGM+S LDLSGFFE+ED S+RKIRFTS HS KDL ++IE
Sbjct: 300 EQIDEAKQE--KPTHINAFQLIGMASALDLSGFFEEEDASQRKIRFTSTHSPKDLFDKIE 357
Query: 343 DIVTEMGFRVQKKNGKLKATQEHKPQKSL---GSLSVAAEVFEISPSLYVVELRKSYGDP 399
++VTEMGF+VQ+ N KLK + + K+L S V EV E+ PSLYVVEL+KS+GDP
Sbjct: 358 NVVTEMGFQVQRGNSKLKVMKNGRGSKNLRNPSSFLVCTEVVELGPSLYVVELKKSHGDP 417
Query: 400 TVYRQLCNKLSSDLGLPPSQELLATE 425
+YRQLC +LS +LG+ ++++ TE
Sbjct: 418 ILYRQLCERLSDELGVCKTEQIQRTE 443
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4B2|CIPKL_ORYSJ CBL-interacting protein kinase 21 OS=Oryza sativa subsp. japonica GN=CIPK21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 556 bits (1434), Expect = e-158, Method: Compositional matrix adjust.
Identities = 279/431 (64%), Positives = 336/431 (77%), Gaps = 20/431 (4%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
MR+G+YE+GR LGEG+FGKVK A+ D+G FA+KIL++ RI+ +KI +QIKREIATLK
Sbjct: 81 AMRMGKYEMGRALGEGHFGKVKLARHADTGAAFAIKILDRQRILAMKIDEQIKREIATLK 140
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-- 127
LLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGRKLFQQL+D +
Sbjct: 141 LLKHPNVVRLHEVSASKTKIYMVLEYVNGGELFDKIALKGKLSEKEGRKLFQQLMDAVSY 200
Query: 128 -------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
EN+L+D+KGNIK+SDFGLSALPQ+ R DGLLHTTCGSPNY+APEVL
Sbjct: 201 CHEKGVYHRDLKPENVLVDAKGNIKVSDFGLSALPQNQRKDGLLHTTCGSPNYIAPEVLL 260
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234
NRGYDG+ SDIWSCGVILYV+LTG LPFDD+N VLYQKI +GD ++PKWLSPGAQ++LR
Sbjct: 261 NRGYDGSLSDIWSCGVILYVMLTGNLPFDDQNTVVLYQKILKGDARIPKWLSPGAQDILR 320
Query: 235 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 294
KIL+PNP+ R+ I GI+A EWF QDYTPA P DD++D + + ++H + T +
Sbjct: 321 KILDPNPITRLDITGIRAHEWFRQDYTPAMPFDDDDDNNISDG--NLHMTENQDIETSPA 378
Query: 295 PPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 354
INAFQLIGMSSCLDLSGFFEKEDVSERKIRF SN+S L E+IE VTE GF+VQK
Sbjct: 379 ISQINAFQLIGMSSCLDLSGFFEKEDVSERKIRFVSNYSPTSLFEKIESTVTEKGFQVQK 438
Query: 355 KNGKLKATQ---EHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSS 411
+GKLK Q E + G+L ++AEVFEI+ SLYVVEL++S GD ++YRQLC LS
Sbjct: 439 NSGKLKVIQVCKEPANPRGHGNLLISAEVFEINESLYVVELKRSSGDCSLYRQLCASLSE 498
Query: 412 DLGLPPSQELL 422
DLG+ Q+LL
Sbjct: 499 DLGICKRQQLL 509
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75L42|CIPKH_ORYSJ CBL-interacting protein kinase 17 OS=Oryza sativa subsp. japonica GN=CIPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 544 bits (1401), Expect = e-154, Method: Compositional matrix adjust.
Identities = 267/428 (62%), Positives = 333/428 (77%), Gaps = 18/428 (4%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG YE+GRTLGEGNFGKVK+A+ L +G FAVKIL++ R++ L+ DQI+REIATLKLL+
Sbjct: 10 LGGYEMGRTLGEGNFGKVKYARHLATGGHFAVKILDRGRVVSLRAGDQIRREIATLKLLR 69
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
HP+VVRLHEV ASK+KIYMVLE+V GGELF++IA KG+L E EGR+LFQQLIDG+
Sbjct: 70 HPHVVRLHEVAASKTKIYMVLEFVNGGELFERIAVKGKLSEKEGRRLFQQLIDGVSYCHD 129
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
EN+L+D KGNIKISDFGLSALPQH +DGLLHTTCGSPNY+APEVL N+G
Sbjct: 130 RGVYHRDLKPENVLVDQKGNIKISDFGLSALPQHLGNDGLLHTTCGSPNYIAPEVLQNKG 189
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 237
YDG+ SDIWSCGVILYV+L GYLPFDDRN+ VLYQKIF+GD ++PKWLS AQNLLR+IL
Sbjct: 190 YDGSLSDIWSCGVILYVMLIGYLPFDDRNIVVLYQKIFKGDTQIPKWLSHSAQNLLRRIL 249
Query: 238 EPNPVKRITIAGIKADEWFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDGGRTPGSPP 296
EPNP+KRI +AGIK+ EWF++DY P P DDD+ED+ + ++ + G +
Sbjct: 250 EPNPMKRIDMAGIKSHEWFQKDYIPVLPYDDDDEDVQFGARLPAKEQINDEPGDK--NSH 307
Query: 297 LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN 356
INAFQLIGM+S LDLSGFFE E+VS+R+IRFTS H KD ++IE TE+GF+VQ+ +
Sbjct: 308 QINAFQLIGMASSLDLSGFFEDEEVSQRRIRFTSTHPPKDAFDKIESSATELGFQVQRGH 367
Query: 357 GKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLP 416
KLK + K K+ S V+AEVFE+ PS+ VVELRKS GDP +YRQLC ++SSD+G
Sbjct: 368 SKLKLMRNCKGSKNPESFMVSAEVFELGPSVNVVELRKSNGDPALYRQLCERISSDMGAR 427
Query: 417 PSQELLAT 424
++++ AT
Sbjct: 428 NTEQIFAT 435
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1123), Expect = e-121, Method: Compositional matrix adjust.
Identities = 223/438 (50%), Positives = 303/438 (69%), Gaps = 32/438 (7%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+GRYELGRTLGEG F KVKFA++ DSG A+KIL+K++++ K+ QIKREI+T+KL+
Sbjct: 9 RVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKREISTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
+HPNV+R+HEV+ASK+KIY+V+E VTGGELFDKIAS+GRL+E + RK FQQLI+ +
Sbjct: 69 RHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCH 128
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+LLD+ G +K+SDFGLSAL Q R+DGLLHTTCG+PNYVAPEV+ N+
Sbjct: 129 SRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNK 188
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236
GYDGA +D+WSCGVIL+V++ GYLPF+D NL LY+KIF+ DF P W S A+ L++KI
Sbjct: 189 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKI 248
Query: 237 LEPNPVKRITIAGIKADEWFEQDYTPANPD------DDEEDIFVDNEAFSMHEVPSDGGR 290
L+PNP RITIA + +EWF++ Y P + DD IF NE+ ++ + R
Sbjct: 249 LDPNPSTRITIAELINNEWFKKGYQPPRFETADVNLDDINSIF--NESGDQTQLVVE--R 304
Query: 291 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVS--ERKIRFTSNHSAKDLLERIEDIVTEM 348
P ++NAF+LI S L+L FEK+ +R+ RF S A ++L +IE M
Sbjct: 305 REERPSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEAAAGPM 364
Query: 349 GFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 408
GF VQK+N KLK E+ +K G L++A EVFE++PSLY+VELRKS GD + + +
Sbjct: 365 GFNVQKRNYKLKLQGENPGRK--GQLAIATEVFEVTPSLYMVELRKSNGDTLEFHKFYHN 422
Query: 409 LSS---DLGLPPSQELLA 423
+S+ D+ P ++A
Sbjct: 423 ISNGLKDVMWKPESSIIA 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 428 bits (1101), Expect = e-119, Method: Compositional matrix adjust.
Identities = 214/430 (49%), Positives = 299/430 (69%), Gaps = 30/430 (6%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++Q R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++ K+ +QI+REI
Sbjct: 4 RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 63
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI
Sbjct: 64 ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 123
Query: 126 GL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 170
+ EN+LLDS GN+KISDFGLSAL Q RDDGLLHT+CG+PNYVAP
Sbjct: 124 AVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAP 183
Query: 171 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 230
EVL +RGYDGAT+D+WSCGV+LYV+L GYLPFDD NL LY+KI G+F P WLS GA
Sbjct: 184 EVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAM 243
Query: 231 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPA-------NPDDDEEDIFVDNEAFSMHE 283
L+ +IL+PNP+ R+T + DEWF++DY P + DD + +F D+E + E
Sbjct: 244 KLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE 303
Query: 284 VPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIED 343
+ P INAF++I MS L+L F+ E +R+ R T A +++E+IE+
Sbjct: 304 ------KREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEE 357
Query: 344 IVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYR 403
+GF VQKKN K++ +K G+L+VA E+F+++PSL++V++ KS GD +
Sbjct: 358 AAKPLGFDVQKKNYKMRLENVKAGRK--GNLNVATEIFQVAPSLHMVQVSKSKGDTLEFH 415
Query: 404 QLCNKLSSDL 413
+ KLS+ L
Sbjct: 416 KFYKKLSNSL 425
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1100), Expect = e-119, Method: Compositional matrix adjust.
Identities = 211/422 (50%), Positives = 292/422 (69%), Gaps = 23/422 (5%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+G+YELGRTLGEG F KVKFA+++++G A+K+++K +++ K+ QIKREI+T+KL+K
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
HPNV+R+ EV+ASK+KIY VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ +
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
EN+LLD+ G +K+SDFGLSALPQ R+DGLLHTTCG+PNYVAPEV+ N+G
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 237
YDGA +D+WSCGVIL+V++ GYLPF+D NL LY+KIF+ +F P W S A+ L+++IL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267
Query: 238 EPNPVKRITIAGIKADEWFEQDYTP-----ANPDDDEEDIFVDNEAFSMHEVPSDGGRTP 292
+PNP RIT A + +EWF++ Y A+ D+ D D+ S + V
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEGL 327
Query: 293 GSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 351
+P +NAF+LI S L+L FEK+ + +RK RFTS SA +++ +IE MGF
Sbjct: 328 KTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGFD 387
Query: 352 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSS 411
V+ N K+K T E +K G L+VA EVF+++PSLY+VE+RKS GD + + L++
Sbjct: 388 VKTNNYKMKLTGEKSGRK--GQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTT 445
Query: 412 DL 413
L
Sbjct: 446 GL 447
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 423 bits (1087), Expect = e-117, Method: Compositional matrix adjust.
Identities = 208/424 (49%), Positives = 295/424 (69%), Gaps = 30/424 (7%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YE+G+TLG+G F KV+ A + ++G A+KIL+K +++ K+ +QI+REI T+KL+
Sbjct: 9 RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
HPNVVRL+EVLASK+KIY+VLE+ TGGELFDKI GRL+E RK FQQLI+ +
Sbjct: 69 NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+LLD++GN+K+SDFGLSAL + R DGLLHT CG+PNY APEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236
GYDGAT+D+WSCGVIL+V+L GYLPF+D NL LY+KI G++ P WLSPGA+NL+ +I
Sbjct: 189 GYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRI 248
Query: 237 LEPNPVKRITIAGIKADEWFEQDYTPANPD-------DDEEDIFVDNEAFSMHEVPSDGG 289
L+PNP+ RITI + D WF+++Y PA + DD + +F D+E + E +
Sbjct: 249 LDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEE-- 306
Query: 290 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 349
P +NAF+LI MS LDL FE+E+ +R+ RF + +A DL+++IE+ +G
Sbjct: 307 ----QPTSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKPLG 362
Query: 350 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKL 409
F +QKKN K++ +K G+L VA E+F++SPSL+++E+RK+ GD + + KL
Sbjct: 363 FDIQKKNYKMRLENVTAGRK--GNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKL 420
Query: 410 SSDL 413
S+ L
Sbjct: 421 STSL 424
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 420 bits (1080), Expect = e-117, Method: Compositional matrix adjust.
Identities = 211/424 (49%), Positives = 291/424 (68%), Gaps = 31/424 (7%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YELGRT+GEG F KVKFA+D ++G P A+KIL+K +++ K+ +QIKREI+T+KL+
Sbjct: 9 RVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
KHPNVVR++EV+ SK+KIY+VLEYVTGGELFD I + GR++E E R+ FQQLI+ +
Sbjct: 69 KHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDYCH 128
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+LLDS GN+K+SDFGLSAL Q +DDGLLHTTCG+PNYVAPEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLEDQ 188
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236
GYDGA +D+WSCGVIL+V+L GYLPF+D NL LY+KI +F P W S A+ LL +I
Sbjct: 189 GYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLTRI 248
Query: 237 LEPNPVKRITIAGIKADEWFEQDYTPANPD-------DDEEDIFVDNEAFSMHEVPSDGG 289
L+PNP+ R+TI I DEWF++ Y D DD +F D+E + E +
Sbjct: 249 LDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHVTEKKEE-- 306
Query: 290 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 349
P +NAF+LI MS+ L+L F+ E +R+ RFTS K+++ +IE+ +G
Sbjct: 307 -----PEALNAFELISMSAGLNLGNLFDSEQEFKRETRFTSKCPPKEIVRKIEEAAKPLG 361
Query: 350 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKL 409
F VQKKN KL+ + +K G+L+VA E+ +++PSL++VE+RK+ GD + + L
Sbjct: 362 FDVQKKNYKLRLEKVKAGRK--GNLNVATEILQVAPSLHMVEVRKAKGDTLEFHKFYKNL 419
Query: 410 SSDL 413
S L
Sbjct: 420 SRTL 423
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | ||||||
| 255556588 | 436 | CBL-interacting serine/threonine-protein | 0.976 | 0.954 | 0.777 | 0.0 | |
| 224110276 | 474 | predicted protein [Populus trichocarpa] | 0.974 | 0.875 | 0.777 | 0.0 | |
| 356548027 | 446 | PREDICTED: CBL-interacting serine/threon | 0.976 | 0.932 | 0.741 | 0.0 | |
| 363807952 | 448 | uncharacterized protein LOC100805710 [Gl | 0.976 | 0.928 | 0.723 | 0.0 | |
| 356530499 | 447 | PREDICTED: CBL-interacting serine/threon | 0.995 | 0.948 | 0.713 | 0.0 | |
| 357450323 | 465 | CBL-interacting protein kinase [Medicago | 0.964 | 0.883 | 0.740 | 1e-180 | |
| 359477295 | 392 | PREDICTED: CBL-interacting serine/threon | 0.849 | 0.923 | 0.811 | 1e-179 | |
| 297736814 | 391 | unnamed protein product [Vitis vinifera] | 0.847 | 0.923 | 0.809 | 1e-178 | |
| 356558505 | 437 | PREDICTED: CBL-interacting serine/threon | 0.953 | 0.929 | 0.730 | 1e-177 | |
| 357479181 | 446 | CBL-interacting protein kinase [Medicago | 0.957 | 0.914 | 0.702 | 1e-170 |
| >gi|255556588|ref|XP_002519328.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223541643|gb|EEF43192.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1800), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/436 (77%), Positives = 378/436 (86%), Gaps = 20/436 (4%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ + GMRLG YELGRTLGEGNFGKVK A+++DSGLPFAVKILEKNRIIHL I+DQI
Sbjct: 1 MVTHQHHNGMRLGNYELGRTLGEGNFGKVKLAKNIDSGLPFAVKILEKNRIIHLNISDQI 60
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV GGELFD+IASKG+L EA+GRKLFQ
Sbjct: 61 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVNGGELFDRIASKGKLPEAQGRKLFQ 120
Query: 122 QLIDG---------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166
QL+DG LEN+L+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN
Sbjct: 121 QLVDGVSYCHNKGVFHRDLKLENVLVDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 180
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 226
YVAPE+L+NRGYDGATSD WSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLS
Sbjct: 181 YVAPEILSNRGYDGATSDTWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQIPKWLS 240
Query: 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPS 286
GAQN++R+IL+PNPV RIT+A IK+DEWF+QDYTPA EEDI +DNE FSMHE+P
Sbjct: 241 SGAQNMIRRILDPNPVTRITMADIKSDEWFKQDYTPA-----EEDIHIDNEGFSMHELPP 295
Query: 287 DGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVT 346
+G SP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSN S KDLL++IE+ T
Sbjct: 296 EGESILRSPTLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNRSMKDLLQKIEETAT 355
Query: 347 EMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLC 406
EMGFR+QKKNGKLK QE K Q+SLGSLSVAAEVFEISPSL+VVEL+KS GDP+VYRQLC
Sbjct: 356 EMGFRIQKKNGKLKVVQERKEQRSLGSLSVAAEVFEISPSLHVVELQKSNGDPSVYRQLC 415
Query: 407 NKLSSDLGLPPSQELL 422
KLS+DL LP + LL
Sbjct: 416 KKLSNDLRLPSDEGLL 431
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110276|ref|XP_002315469.1| predicted protein [Populus trichocarpa] gi|116265922|gb|ABJ91209.1| CBL-interacting protein kinase 1 [Populus trichocarpa] gi|222864509|gb|EEF01640.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/431 (77%), Positives = 381/431 (88%), Gaps = 16/431 (3%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
GM+LG+YELGRTLGEGNFGKVK A+++++G PFAVKILEKNRII LKITDQIKREIATLK
Sbjct: 14 GMQLGKYELGRTLGEGNFGKVKLAKNIETGQPFAVKILEKNRIIDLKITDQIKREIATLK 73
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG--- 126
LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD+IASKG+L EAEGRK+FQQLIDG
Sbjct: 74 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDRIASKGKLPEAEGRKMFQQLIDGVSY 133
Query: 127 ------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
LEN+L+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+L+
Sbjct: 134 CHSKGVFHRDLKLENVLVDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILS 193
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234
NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLSPGA+N+++
Sbjct: 194 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQVPKWLSPGAKNMIK 253
Query: 235 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 294
+IL+PNPV RIT A IKADEWF+ DYTP + ++++D+++D+ AFS+ E PS+ G +P S
Sbjct: 254 RILDPNPVTRITTADIKADEWFKLDYTPMDSAEEQDDVYIDDAAFSIQEAPSEDG-SPKS 312
Query: 295 PPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 354
P LINAFQLIGMSSCLDLSG FEKEDVSERKIRFTSNHS DLLE+IEDIVTEMGFRVQK
Sbjct: 313 PNLINAFQLIGMSSCLDLSGLFEKEDVSERKIRFTSNHSMSDLLEKIEDIVTEMGFRVQK 372
Query: 355 KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLG 414
+NG+ + QEH+ +KS GSLSVA EVFEISPSLYVVELRKSYGD + YRQLC KLS+DLG
Sbjct: 373 RNGRFQVIQEHRGKKSSGSLSVATEVFEISPSLYVVELRKSYGDSSAYRQLCTKLSNDLG 432
Query: 415 LPPSQELLATE 425
+P S LL TE
Sbjct: 433 VPSSPGLLTTE 443
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548027|ref|XP_003542405.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/434 (74%), Positives = 368/434 (84%), Gaps = 18/434 (4%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++EGMRLG+YELGRTLGEGNFGKVKFA++ DSG FAVKI+EKN+I+ L IT+QIKREIA
Sbjct: 12 EREGMRLGKYELGRTLGEGNFGKVKFARNTDSGQAFAVKIIEKNKIVDLNITNQIKREIA 71
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
TLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+L E E RKLFQQLIDG
Sbjct: 72 TLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKLTEGECRKLFQQLIDG 131
Query: 127 ---------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
LEN+L+D+KGNIK++DFGLSALPQH R+DGLLHTTCGSPNYVAPE
Sbjct: 132 VSYCHTKGVFHRDLKLENVLVDNKGNIKVTDFGLSALPQHLREDGLLHTTCGSPNYVAPE 191
Query: 172 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231
VLAN+GYDGATSD WSCGVILYV LTGYLPFDDRNL VLYQKIF+GD ++PKWLSPGAQN
Sbjct: 192 VLANKGYDGATSDTWSCGVILYVSLTGYLPFDDRNLVVLYQKIFKGDAQIPKWLSPGAQN 251
Query: 232 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GR 290
++R+IL+PNP RIT+AGIK D WF++ Y PANP+D ED+ VDNEAFS HE P++ R
Sbjct: 252 MIRRILDPNPETRITMAGIKEDPWFKKGYIPANPED--EDVHVDNEAFSSHEEPNEAEQR 309
Query: 291 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGF 350
GSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRF S S KDL++RIED VTEM F
Sbjct: 310 NSGSPTLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFASILSVKDLIDRIEDTVTEMEF 369
Query: 351 RVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLS 410
RV+KKNGKLK +E+K K+LG LSV EVFEISPSLYVVELRKSYGD +VY+QLC KL
Sbjct: 370 RVEKKNGKLKVMRENKVHKTLGCLSVVVEVFEISPSLYVVELRKSYGDGSVYKQLCKKLL 429
Query: 411 SDLGLPPSQELLAT 424
+DLG+PP Q L+ +
Sbjct: 430 NDLGVPPKQGLVRS 443
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807952|ref|NP_001242199.1| uncharacterized protein LOC100805710 [Glycine max] gi|255644530|gb|ACU22768.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/434 (72%), Positives = 365/434 (84%), Gaps = 18/434 (4%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++EGMRLG+Y+LGRTLGEGNFGKVKFA++ DSG FAVKI++KN I+ + IT+QI REIA
Sbjct: 14 EREGMRLGKYDLGRTLGEGNFGKVKFARNTDSGQAFAVKIIDKNTIVDINITNQIIREIA 73
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
TLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+ E EGRKLFQQLIDG
Sbjct: 74 TLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKHIEGEGRKLFQQLIDG 133
Query: 127 ---------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
LEN+L+D+KGNIKI+DFGLSALPQH R+DGLLHTTCGSPNYVAPE
Sbjct: 134 VSYCHTKGVFHRDLKLENVLVDNKGNIKITDFGLSALPQHLREDGLLHTTCGSPNYVAPE 193
Query: 172 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231
VLAN+GYDGATSD WSCGVILYVIL G+LPFDDRNL VLYQKIF+GD ++PKWL+PGA+N
Sbjct: 194 VLANKGYDGATSDTWSCGVILYVILPGHLPFDDRNLVVLYQKIFKGDVQIPKWLTPGARN 253
Query: 232 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GR 290
++R+IL+PNP RIT+AGIK D WF++ Y P NP+D ED++VD EAFS+HE P++ R
Sbjct: 254 MIRRILDPNPETRITMAGIKEDPWFKKGYIPVNPED--EDVYVDQEAFSIHEQPNEAEQR 311
Query: 291 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGF 350
GSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRF SN S KDL+ERIED TEM F
Sbjct: 312 NSGSPSLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFASNLSVKDLIERIEDTATEMEF 371
Query: 351 RVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLS 410
RV+KKNGKLK +E+K K+LG LSV EVF IS SLYVVELRKSYGD +VY+QLCNKL
Sbjct: 372 RVEKKNGKLKVIRENKVHKTLGCLSVVVEVFGISSSLYVVELRKSYGDGSVYKQLCNKLL 431
Query: 411 SDLGLPPSQELLAT 424
+DLG+PP Q L+ +
Sbjct: 432 NDLGIPPKQPLVRS 445
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356530499|ref|XP_003533818.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/440 (71%), Positives = 372/440 (84%), Gaps = 16/440 (3%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ K+++G+RLG+YELG+TLGEGNFGKVK A+D SG FAVKIL+K++II L DQIK
Sbjct: 6 LGRKEEQGVRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNIDQIK 65
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI+TLKLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EAEGRK+FQQ
Sbjct: 66 REISTLKLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAEGRKIFQQ 125
Query: 123 LIDG---------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
LID LEN+L+D+KGNIKI+DF LSALPQHFR+DGLLHTTCGSPNY
Sbjct: 126 LIDCVSFCHNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHFREDGLLHTTCGSPNY 185
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227
VAPE+LAN+GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+G+ ++P+WLSP
Sbjct: 186 VAPEILANKGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGEVQIPRWLSP 245
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSD 287
G+QN+++++L+ NP RIT+A IK DEWF++ YTPANP+D+EE +++D+E FS+H+V +
Sbjct: 246 GSQNIIKRMLDANPKTRITMAMIKEDEWFKEGYTPANPEDEEESVYIDDEDFSIHDVSHE 305
Query: 288 GGR-TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVT 346
+ P SP LINAFQLI MSS LDLSG FE+EDVSERKIRFTS HS KDL+ERIEDIVT
Sbjct: 306 ADQGCPRSPTLINAFQLISMSSSLDLSGLFEQEDVSERKIRFTSIHSPKDLVERIEDIVT 365
Query: 347 EMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLC 406
EMGFRVQKKNG LK QE K QK GS SV AEVFEISPSLYVVEL KS GD ++YRQLC
Sbjct: 366 EMGFRVQKKNGMLKVIQEIKVQKCPGSFSVEAEVFEISPSLYVVELSKSCGDASLYRQLC 425
Query: 407 NKLSSDLGLPPSQELLATEV 426
KLS+DLG+ Q+L ++EV
Sbjct: 426 KKLSNDLGVHTRQQLGSSEV 445
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357450323|ref|XP_003595438.1| CBL-interacting protein kinase [Medicago truncatula] gi|355484486|gb|AES65689.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1639), Expect = e-180, Method: Compositional matrix adjust.
Identities = 317/428 (74%), Positives = 364/428 (85%), Gaps = 17/428 (3%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+RLG+YELG+TLGEGNFGKVK A+D D G FAVKILEKN+I+ L TDQIKREI+TLKL
Sbjct: 15 VRLGKYELGKTLGEGNFGKVKLARDTDCGQFFAVKILEKNKIVDLNNTDQIKREISTLKL 74
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG---- 126
LKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKI+SKG+L EA GRK+FQQLIDG
Sbjct: 75 LKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKISSKGKLTEAHGRKMFQQLIDGVSYC 134
Query: 127 -----------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 175
LEN+L+D+KGNIKI+DF LSALPQH R DGLLHTTCGSPNYVAPE+LAN
Sbjct: 135 HNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHCRADGLLHTTCGSPNYVAPEILAN 194
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 235
RGYDGA SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+ D ++P+WLSPGAQN+++K
Sbjct: 195 RGYDGAKSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKADVQIPRWLSPGAQNIIKK 254
Query: 236 ILEPNPVKRITIAGIKADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDGGRTPG 293
IL+PNP R+T+ IK DEWF++ Y PAN +++EED+F+D+EAFS+HEV DG ++P
Sbjct: 255 ILDPNPKTRVTMDMIKEDEWFKEGYNPANLEDEEEEEDVFIDDEAFSIHEVSLDGDQSPK 314
Query: 294 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 353
SP LINAFQLIGMSSCLDLSGFFE+EDVSERKIRFTSNHS KDL E+IEDIV EMGF+V
Sbjct: 315 SPALINAFQLIGMSSCLDLSGFFEQEDVSERKIRFTSNHSPKDLTEKIEDIVIEMGFKVH 374
Query: 354 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 413
KKNGKLK QE K KSL SLSVAAEVFE+ PSLYVVELRKSYGD +VYRQLC +LS+DL
Sbjct: 375 KKNGKLKVIQEDKAHKSLDSLSVAAEVFEVGPSLYVVELRKSYGDASVYRQLCKRLSNDL 434
Query: 414 GLPPSQEL 421
G+ E+
Sbjct: 435 GIAEVAEV 442
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477295|ref|XP_002275061.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Vitis vinifera] gi|229609839|gb|ACQ83535.1| CBL-interacting protein kinase 19 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1638), Expect = e-179, Method: Compositional matrix adjust.
Identities = 306/377 (81%), Positives = 338/377 (89%), Gaps = 15/377 (3%)
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14 IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73
Query: 121 QQLIDG---------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
QQLID LEN+L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP
Sbjct: 74 QQLIDAVSYCHNKGVFHRDLKLENVLVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 133
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 225
NYVAPE+LANRGYDG+TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWL
Sbjct: 134 NYVAPEILANRGYDGSTSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWL 193
Query: 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 285
S GA+N++++IL+P P RIT+AGIKADEWF+Q YTPA P+++EEDI VD+EAFS++EVP
Sbjct: 194 SSGAKNIIKRILDPKPETRITMAGIKADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYEVP 253
Query: 286 SDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIV 345
+ ++PGSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNH KDLLE+IEDIV
Sbjct: 254 MEAKKSPGSPNLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHCPKDLLEKIEDIV 313
Query: 346 TEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQL 405
TEMGFRV+KKNG+LK QEHK QKS GSLSVAAEVFEISPSLYVVELRKSYGD +VYRQL
Sbjct: 314 TEMGFRVEKKNGRLKVMQEHKCQKSFGSLSVAAEVFEISPSLYVVELRKSYGDSSVYRQL 373
Query: 406 CNKLSSDLGLPPSQELL 422
C KLSSDLG+P SQELL
Sbjct: 374 CKKLSSDLGVPTSQELL 390
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736814|emb|CBI26015.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 629 bits (1622), Expect = e-178, Method: Compositional matrix adjust.
Identities = 305/377 (80%), Positives = 337/377 (89%), Gaps = 16/377 (4%)
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14 IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73
Query: 121 QQLIDG---------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
QQLID LEN+L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP
Sbjct: 74 QQLIDAVSYCHNKGVFHRDLKLENVLVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 133
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 225
NYVAPE+LANRGYDG+TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWL
Sbjct: 134 NYVAPEILANRGYDGSTSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWL 193
Query: 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 285
S GA+N++++IL+P P RIT+AGIKADEWF+Q YTPA P+++EEDI VD+EAFS++E P
Sbjct: 194 SSGAKNIIKRILDPKPETRITMAGIKADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYE-P 252
Query: 286 SDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIV 345
+ ++PGSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNH KDLLE+IEDIV
Sbjct: 253 MEAKKSPGSPNLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHCPKDLLEKIEDIV 312
Query: 346 TEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQL 405
TEMGFRV+KKNG+LK QEHK QKS GSLSVAAEVFEISPSLYVVELRKSYGD +VYRQL
Sbjct: 313 TEMGFRVEKKNGRLKVMQEHKCQKSFGSLSVAAEVFEISPSLYVVELRKSYGDSSVYRQL 372
Query: 406 CNKLSSDLGLPPSQELL 422
C KLSSDLG+P SQELL
Sbjct: 373 CKKLSSDLGVPTSQELL 389
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558505|ref|XP_003547546.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 628 bits (1620), Expect = e-177, Method: Compositional matrix adjust.
Identities = 309/423 (73%), Positives = 360/423 (85%), Gaps = 17/423 (4%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMRLG+YELG+TLGEGNFGKVK A+D SG FAVKIL+K++II L TDQIKREI TL
Sbjct: 12 QGMRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNTDQIKREIFTL 71
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG-- 126
KLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EA GRK+FQQLID
Sbjct: 72 KLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAVGRKIFQQLIDCVS 131
Query: 127 -------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
LEN+L+D+KGNIKI+DF LSALPQHFR DGLLHTTCGSPNYVAPE+L
Sbjct: 132 FCHNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHFRADGLLHTTCGSPNYVAPEIL 191
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233
AN+GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI +G+ ++P+WLSPG+QN++
Sbjct: 192 ANKGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKILKGEVQIPRWLSPGSQNII 251
Query: 234 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGR-TP 292
+++L+ N RIT+A IK DEWF++ Y+PANP+D+EE +++D E FS+H+V + + +P
Sbjct: 252 KRMLDVNLKTRITMAMIKEDEWFKEGYSPANPEDEEESVYID-EDFSIHDVSLEADQGSP 310
Query: 293 GSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRV 352
SP LINAFQLI MSS LDLSG FE+EDVSERKIRFTS HS KDL+ER+EDIVTEMGFRV
Sbjct: 311 RSPTLINAFQLISMSSSLDLSGLFEQEDVSERKIRFTSIHSPKDLVERLEDIVTEMGFRV 370
Query: 353 QKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSD 412
QKKNG LK QE K QK LG+LSVAAEVFEISPSLYVVEL KS GD +VYRQLC KLS+D
Sbjct: 371 QKKNGMLKVVQEIKTQKCLGNLSVAAEVFEISPSLYVVELSKSCGDASVYRQLCKKLSND 430
Query: 413 LGL 415
LG+
Sbjct: 431 LGV 433
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479181|ref|XP_003609876.1| CBL-interacting protein kinase [Medicago truncatula] gi|355510931|gb|AES92073.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1558), Expect = e-170, Method: Compositional matrix adjust.
Identities = 298/424 (70%), Positives = 358/424 (84%), Gaps = 16/424 (3%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
EG+RLG+YELGR LGEGNFGKVKFA++ DSG P+A+KI++KN+II L IT+QIKREI L
Sbjct: 19 EGVRLGKYELGRILGEGNFGKVKFARNTDSGQPYAIKIIDKNKIIDLNITNQIKREICAL 78
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG-- 126
KLL+HPNVV+L+EVLASK+KIYMVLEYVTG ELFDKIASKG+L E EGRKLFQQLIDG
Sbjct: 79 KLLRHPNVVKLYEVLASKTKIYMVLEYVTGEELFDKIASKGKLPEGEGRKLFQQLIDGVS 138
Query: 127 -------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
LEN+L+D+KGN+KI+DFGLSALPQ FR DGLLHTTCGS NYVAPE+L
Sbjct: 139 YCHSKGVFHRDLKLENVLVDAKGNLKITDFGLSALPQQFRADGLLHTTCGSANYVAPEIL 198
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233
ANRGY+GA+SD+WSCGVILYV+LTG+LPFDDRNLAVLYQK+ +GDF+ PKWLS GAQN++
Sbjct: 199 ANRGYNGASSDVWSCGVILYVVLTGFLPFDDRNLAVLYQKVLKGDFQKPKWLSAGAQNII 258
Query: 234 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 293
++IL+PNP RIT+A IK D WF++ Y A +D+E+ ++VD++AF++HE+ + ++
Sbjct: 259 KRILDPNPKTRITMAEIKEDLWFKEGYNQAYHEDEEDGVYVDDQAFNIHELSHEEEKSSS 318
Query: 294 SPPL-INAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRV 352
P+ INAFQLIGMSSCLDLSGFFEKEDVSERKIRFT+N SAK L+E+IED VTEM FRV
Sbjct: 319 QSPIRINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTANLSAKVLMEKIEDSVTEMEFRV 378
Query: 353 QKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSD 412
QKKNGK+K QE+K K+LGSLSV EVFEIS SLYVVELRK YGD +VYRQLC KL +D
Sbjct: 379 QKKNGKMKVMQENKDHKTLGSLSVIIEVFEISSSLYVVELRKCYGDASVYRQLCKKLLND 438
Query: 413 LGLP 416
LG+P
Sbjct: 439 LGVP 442
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | ||||||
| TAIR|locus:2090537 | 444 | CIPK1 "CBL-interacting protein | 0.981 | 0.941 | 0.688 | 8.2e-154 | |
| TAIR|locus:2007685 | 432 | CIPK17 "CBL-interacting protei | 0.969 | 0.956 | 0.651 | 1.2e-143 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.953 | 0.900 | 0.5 | 6.3e-108 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.931 | 0.823 | 0.511 | 2.7e-107 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.938 | 0.911 | 0.497 | 4e-106 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.957 | 0.914 | 0.459 | 1.5e-97 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.910 | 0.921 | 0.459 | 3.1e-90 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.884 | 0.858 | 0.446 | 2.8e-89 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.908 | 0.877 | 0.437 | 5.9e-89 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.924 | 0.807 | 0.448 | 1.6e-88 |
| TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1500 (533.1 bits), Expect = 8.2e-154, P = 8.2e-154
Identities = 300/436 (68%), Positives = 354/436 (81%)
Query: 5 EKKQE-GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
EKK E GMRLG+YELGRTLGEGNFGKVKFA+D SG FAVKI++K+RI L + QIKR
Sbjct: 8 EKKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKR 67
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
EI TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQL
Sbjct: 68 EIRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQL 127
Query: 124 IDG---------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 168
IDG LEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYV
Sbjct: 128 IDGISYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYV 187
Query: 169 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 228
APEVLANRGYDGA SDIWSCGVILYVILTG LPFDDRNLAVLYQKI +GD +P+WLSPG
Sbjct: 188 APEVLANRGYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPG 247
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD-EEDIFVDNEAFSMHEVPSD 287
A+ +++++L+PNPV RIT+ GIKA EWF+ +Y P+ PDDD EE++ D++AFS+ E+ S+
Sbjct: 248 ARTMIKRMLDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSE 307
Query: 288 GGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTE 347
G+ SP +INAFQLIGMSS LDLSGFFE+E+VSER+IRFTSN SAKDLLE+IE VTE
Sbjct: 308 EGKGSDSPTIINAFQLIGMSSFLDLSGFFEQENVSERRIRFTSNSSAKDLLEKIETAVTE 367
Query: 348 MGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCN 407
MGF VQKK+ KL+ QE + QK LSV AEVFEI PSL VVELRKSYGD +YRQL
Sbjct: 368 MGFSVQKKHAKLRVKQEERNQKGQVGLSVTAEVFEIKPSLNVVELRKSYGDSCLYRQLYE 427
Query: 408 KLSSDLGLP-PSQELL 422
+L D+G P QE++
Sbjct: 428 RLLKDVGTSSPEQEIV 443
|
|
| TAIR|locus:2007685 CIPK17 "CBL-interacting protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1404 (499.3 bits), Expect = 1.2e-143, P = 1.2e-143
Identities = 281/431 (65%), Positives = 341/431 (79%)
Query: 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+GMR+G+YELGRTLGEGN KVKFA D +G FA+KI+EK+ I L ++ QIKREI TL
Sbjct: 4 KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG-- 126
K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDG
Sbjct: 64 KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123
Query: 127 -------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
LEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVL
Sbjct: 124 YCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVL 183
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233
AN GYDGA SDIWSCGVILYVILTG LPFDD NLAV+ +KIF+GD +P+W+S GA+ ++
Sbjct: 184 ANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMI 243
Query: 234 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 293
+++L+PNPV R+TIAGIKA +WF+ DYTP+N DDD++ + + F M E + ++P
Sbjct: 244 KRMLDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPD 301
Query: 294 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 353
SP +INAFQLIGMSS LDLSGFFE E +SER+IRFTSN AKDLLE IE I TEMGF +Q
Sbjct: 302 SPTIINAFQLIGMSSFLDLSGFFETEKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQ 361
Query: 354 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 413
KK+ KLKA +E QK LSV AEVFEISPSL VVELRKS+GD ++Y+QL +L ++L
Sbjct: 362 KKHAKLKAIKEESTQKRQCGLSVTAEVFEISPSLNVVELRKSHGDSSLYKQLYERLLNEL 421
Query: 414 GLPPS-QELLA 423
G QELLA
Sbjct: 422 GSSSQVQELLA 432
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1067 (380.7 bits), Expect = 6.3e-108, P = 6.3e-108
Identities = 212/424 (50%), Positives = 297/424 (70%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++Q R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++ K+ +QI+REI
Sbjct: 14 RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 73
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI
Sbjct: 74 ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 133
Query: 126 GL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 170
+ EN+LLDS GN+KISDFGLSAL Q RDDGLLHT+CG+PNYVAP
Sbjct: 134 AVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAP 193
Query: 171 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 230
EVL +RGYDGAT+D+WSCGV+LYV+L GYLPFDD NL LY+KI G+F P WLS GA
Sbjct: 194 EVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAM 253
Query: 231 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGG 289
L+ +IL+PNP+ R+T + DEWF++DY P ++ ++ D +A F E
Sbjct: 254 KLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE 313
Query: 290 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 349
+ P INAF++I MS L+L F+ E +R+ R T A +++E+IE+ +G
Sbjct: 314 KREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEEAAKPLG 373
Query: 350 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKL 409
F VQKKN K++ +K G+L+VA E+F+++PSL++V++ KS GD + + KL
Sbjct: 374 FDVQKKNYKMRLENVKAGRK--GNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKL 431
Query: 410 SSDL 413
S+ L
Sbjct: 432 SNSL 435
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
Identities = 218/426 (51%), Positives = 302/426 (70%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YELGRTLGEG F KVKFA+++++G A+K+++K +++ K+ QIKREI+T+KL+
Sbjct: 27 RVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLI 86
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
KHPNV+R+ EV+ASK+KIY VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ +
Sbjct: 87 KHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCH 146
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+LLD+ G +K+SDFGLSALPQ R+DGLLHTTCG+PNYVAPEV+ N+
Sbjct: 147 SRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNK 206
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236
GYDGA +D+WSCGVIL+V++ GYLPF+D NL LY+KIF+ +F P W S A+ L+++I
Sbjct: 207 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRI 266
Query: 237 LEPNPVKRITIAGIKADEWFEQDY-TPA--NPD---DDEEDIFVDN-EAFSMH-EVPSDG 288
L+PNP RIT A + +EWF++ Y P N D DD + IF D+ E+ ++ E +G
Sbjct: 267 LDPNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEG 326
Query: 289 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTE 347
+TP + +NAF+LI S L+L FEK+ + +RK RFTS SA +++ +IE
Sbjct: 327 LKTPVT---MNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAP 383
Query: 348 MGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCN 407
MGF V+ N K+K T E +K G L+VA EVF+++PSLY+VE+RKS GD + +
Sbjct: 384 MGFDVKTNNYKMKLTGEKSGRK--GQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYK 441
Query: 408 KLSSDL 413
L++ L
Sbjct: 442 NLTTGL 447
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1050 (374.7 bits), Expect = 4.0e-106, P = 4.0e-106
Identities = 208/418 (49%), Positives = 293/418 (70%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YE+G+TLG+G F KV+ A + ++G A+KIL+K +++ K+ +QI+REI T+KL+
Sbjct: 9 RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
HPNVVRL+EVLASK+KIY+VLE+ TGGELFDKI GRL+E RK FQQLI+ +
Sbjct: 69 NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+LLD++GN+K+SDFGLSAL + R DGLLHT CG+PNY APEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236
GYDGAT+D+WSCGVIL+V+L GYLPF+D NL LY+KI G++ P WLSPGA+NL+ +I
Sbjct: 189 GYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRI 248
Query: 237 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGGRTPGSP 295
L+PNP+ RITI + D WF+++Y PA ++ EE D +A F E + P
Sbjct: 249 LDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEEQP 308
Query: 296 PLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK 355
+NAF+LI MS LDL FE+E+ +R+ RF + +A DL+++IE+ +GF +QKK
Sbjct: 309 TSMNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKPLGFDIQKK 368
Query: 356 NGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 413
N K++ +K G+L VA E+F++SPSL+++E+RK+ GD + + KLS+ L
Sbjct: 369 NYKMRLENVTAGRK--GNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKLSTSL 424
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 1.5e-97, P = 1.5e-97
Identities = 203/442 (45%), Positives = 290/442 (65%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R+G+YE+GRT+GEG F KVKFA++ D+G A+KI+ K+ I+ ++ DQIKREI+ +K++
Sbjct: 7 RVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMKIV 66
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
+HPN+VRL+EVLAS SKIY+VLE+VTGGELFD+I KGRL+E+E RK FQQL+D +
Sbjct: 67 RHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAHCH 126
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+LLD+ GN+K+SDFGLSALPQ + LL TTCG+PNYVAPEVL+ +
Sbjct: 127 CKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQ 184
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236
GYDG+ +DIWSCGVIL+VIL GYLPF + +L LY+KI +F P W S + L+ +I
Sbjct: 185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRI 244
Query: 237 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE----DIFVDNEAFSMHEVPSDGGRTP 292
L+PNP RI I GIK D WF +Y P ++EE DI + V + R
Sbjct: 245 LDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENVERND 304
Query: 293 GSPPLINAFQLIGMSSCLDLSGFFEK-EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 351
P ++NAF++I +S L+LS F++ +D +R+ RF S +++ IE + MGF+
Sbjct: 305 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 364
Query: 352 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPT----VYRQLCN 407
+N K + E G L+V E++E++PSL++V++RK+ G+ Y++LC+
Sbjct: 365 SHTRNFKTRL--EGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCS 422
Query: 408 KLSSDL-----GLPPSQELLAT 424
KL + + G+P S E+L T
Sbjct: 423 KLENIIWRATEGIPKS-EILRT 443
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 900 (321.9 bits), Expect = 3.1e-90, P = 3.1e-90
Identities = 191/416 (45%), Positives = 270/416 (64%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
EKK + L RYE+G+ LG+G F KV A+ L +G A+K+++K RI+ + +T+QIKRE
Sbjct: 2 EKKGSVLML-RYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKRE 60
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I+ ++LL+HPN+V LHEV+A+KSKIY V+E+V GGELF+K+ S G+L+E RK FQQL+
Sbjct: 61 ISAMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKV-STGKLREDVARKYFQQLV 119
Query: 125 DGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
+ EN+LLD GN+KISDFGLSAL R DGLLHTTCG+P YVA
Sbjct: 120 RAVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVA 179
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229
PEV++ GYDG +D+WSCGVIL+V+L GYLPF D NL LY+KI + + K P WL+PGA
Sbjct: 180 PEVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGA 239
Query: 230 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGG 289
+ LL++IL+PNP R++ I WF + + EE+ VD EA +
Sbjct: 240 KRLLKRILDPNPNTRVSTEKIMKSSWFRKGLQEEVKESVEEETEVDAEAEGNASAEKEKK 299
Query: 290 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 349
R +NAF++I +S+ DLSG FEK + E ++RFTSN A ++ E++ +I ++
Sbjct: 300 RCIN----LNAFEIISLSTGFDLSGLFEKGEEKE-EMRFTSNREASEITEKLVEIGKDLK 354
Query: 350 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQL 405
+V+KK E + + S + V AEVFEI+PS ++V L+KS GD Y+++
Sbjct: 355 MKVRKKE------HEWRVKMSAEATVVEAEVFEIAPSYHMVVLKKSGGDTAEYKRV 404
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 891 (318.7 bits), Expect = 2.8e-89, P = 2.8e-89
Identities = 186/417 (44%), Positives = 270/417 (64%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+YELGR LG+G F KV A+++ +G A+K+++K ++ + + DQIKREI+ ++L++HP
Sbjct: 11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
+VV LHEV+ASK+KIY +EYV GGELFDK+ SKG+L+E RK FQQLI +
Sbjct: 71 HVVFLHEVMASKTKIYFAMEYVKGGELFDKV-SKGKLKENIARKYFQQLIGAIDYCHSRG 129
Query: 128 --------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 179
EN+LLD G++KISDFGLSAL + + DGLLHTTCG+P YVAPEV+ +GYD
Sbjct: 130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189
Query: 180 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 239
GA +D+WSCGV+LYV+L G+LPF ++NL +Y+KI +G+FK P W P + LL +IL+P
Sbjct: 190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249
Query: 240 NPVKRITIAGIKADEWFEQDY----TPANPDDDEEDIFVDN--EAFSMHEVPSDGGRTPG 293
NP RI I I + WF++ + TP +P+ + D + + AFS+
Sbjct: 250 NPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSV------------ 297
Query: 294 SPPLINAFQLIG-MSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG-FR 351
P NAF LI +S DLSG FEKE+ SE K FT+ AK+++ + E+I T F
Sbjct: 298 KPMSYNAFDLISSLSQGFDLSGLFEKEERSESK--FTTKKDAKEIVSKFEEIATSSERFN 355
Query: 352 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 408
+ K + +K + + +K G L++ E+FE++ S ++VE +KS GD Y+Q C++
Sbjct: 356 LTKSDVGVKMEDKREGRK--GHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDR 410
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 888 (317.7 bits), Expect = 5.9e-89, P = 5.9e-89
Identities = 183/418 (43%), Positives = 264/418 (63%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G+ GRYELGR LG G F KV A+++ +G A+K++ K +++ + + DQIKREI+ ++
Sbjct: 18 GLLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMR 77
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-- 127
++KHPN+V LHEV+ASKSKIY +E V GGELF K+A KGRL+E R FQQLI +
Sbjct: 78 MVKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVA-KGRLREDVARVYFQQLISAVDF 136
Query: 128 -------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
EN+LLD +GN+K++DFGLSA +H + DGLLHTTCG+P YVAPEV+
Sbjct: 137 CHSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVIL 196
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234
+GYDGA +D+WSCGVIL+V+L GYLPF D NL +Y+KI+RGDFK P WLS A+ L+
Sbjct: 197 KKGYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVT 256
Query: 235 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA--FSMHEVPSDGGRTP 292
K+L+PNP RITI + WF++ T + + I E F +H+ +
Sbjct: 257 KLLDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFLVHKSKEE----- 311
Query: 293 GSPPLINAFQLIGMSSCLDLSGFFEKEDVSE-RKIRFTSNHSAKDLLERIEDIVTEMG-- 349
+NAF +I +S DLS FE++ E R++RF ++ A ++ +E+ +G
Sbjct: 312 --TETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEE-AARVGNK 368
Query: 350 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCN 407
F V+K +++ + +K G L+V AE+F ++PS VVE++K +GD Y C+
Sbjct: 369 FDVRKSESRVRIEGKQNGRK--GKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCS 424
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 884 (316.2 bits), Expect = 1.6e-88, P = 1.6e-88
Identities = 190/424 (44%), Positives = 277/424 (65%)
Query: 5 EKKQEGMRL--GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
E++Q+ +R+ +YE+GR LG+G FGKV + +++ +G A+KI+ K+++ + +QIK
Sbjct: 30 EEEQQQLRVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIK 89
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI+ ++L++HPN+V L EV+A+K+KI+ ++EYV GGELF KI KG+L+E RK FQQ
Sbjct: 90 REISIMRLVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIV-KGKLKEDSARKYFQQ 148
Query: 123 LIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
LI + EN+L+D G++K+SDFGLSALP+ DGLLHT CG+P Y
Sbjct: 149 LISAVDFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAY 208
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227
VAPEVL +GYDGA DIWSCG+ILYV+L G+LPF D NL +Y+KIF+ +F+ P W SP
Sbjct: 209 VAPEVLRKKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSP 268
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANPDDDEEDIF-VDNEAFSMHEVP 285
++ L+ K+L +P KRI+I I WF ++ +P DE +I V++E +
Sbjct: 269 ESKRLISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVEDETPTTTATT 328
Query: 286 SDGGRTPGSPPLINAFQLIG-MSSCLDLSGFFEKEDVSERKIR--FTSNHSAKDLLERIE 342
+ TP SP NAF+ I MSS DLS FE S+RK+R FTS SA +++ ++E
Sbjct: 329 ATTTTTPVSPKFFNAFEFISSMSSGFDLSSLFE----SKRKLRSMFTSRWSASEIMGKLE 384
Query: 343 DIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 401
I EM +V++ K+ K+K + + +K G ++V AEVFE++P + VVEL KS GD
Sbjct: 385 GIGKEMNMKVKRTKDFKVKLFGKTEGRK--GQIAVTAEVFEVAPEVAVVELCKSAGDTLE 442
Query: 402 YRQL 405
Y +L
Sbjct: 443 YNRL 446
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RWC9 | CIPK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6811 | 0.9835 | 0.9436 | yes | no |
| Q9LGV5 | CIPK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6345 | 0.9906 | 0.9154 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 426 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-93 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-76 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-65 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-65 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-55 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-53 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-52 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-48 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-47 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-45 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-41 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-40 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-40 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-40 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 6e-40 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-38 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-37 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-37 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-37 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-37 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-37 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-37 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-37 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-37 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-36 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-36 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-35 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-35 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-35 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-35 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-35 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-35 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-34 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-34 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-33 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-33 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-33 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-32 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-32 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-32 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-32 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-30 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-30 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-30 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-29 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-29 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-28 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-28 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-27 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-27 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-26 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-25 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-25 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-23 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-22 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 1e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-22 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-22 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-21 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-21 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-21 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-20 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-18 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-17 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-14 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 4e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.002 | |
| cd12121 | 96 | cd12121, MARK_C_like, C-terminal kinase associated | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 279 bits (717), Expect = 8e-93
Identities = 107/260 (41%), Positives = 151/260 (58%), Gaps = 25/260 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE+ LGEG+FGKV A+D +G A+K+++K +I K ++I REI LK LKHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
+VRL++V + K+Y+V+EY GG+LFD + +GRL E E R +Q++ L
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
ENILLD G++K++DFGL+ L T G+P Y+APEVL +GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 181 ATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKI 236
A DIWS GVILY +LTG PF L L++KI + P +SP A++L+RK+
Sbjct: 176 A-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 237 LEPNPVKRITIAGIKADEWF 256
L +P KR+T +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 1e-76
Identities = 100/263 (38%), Positives = 137/263 (52%), Gaps = 25/263 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YEL R LG G+FG V A+ +G AVKIL+K K +REI L+ L HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
+VRL + K +Y+V+EY GG+LFD ++ G L E E +K+ Q++ GL
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
ENILLD G +KI+DFGL+ + + L T G+P Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 181 ATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIFRGDFKLPKW----LSPGAQNLL 233
D+WS GVILY +LTG PF N+ L ++I + + S A++L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 234 RKILEPNPVKRITIAGIKADEWF 256
+K L +P KR T I WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 2e-65
Identities = 95/253 (37%), Positives = 146/253 (57%), Gaps = 21/253 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G+FGKV + D+G +A+K+L+K +II K + E L + HP +V+LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------------- 127
++ K+Y+VLEY GGELF ++ +GR E R +++ L
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 128 -ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 186
ENILLD+ G+IK++DFGL+ + + +T CG+P Y+APEVL +GY G D W
Sbjct: 121 PENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 187 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 246
S GV+LY +LTG PF + +Y+KI + + P++LSP A++L+ +L+ +P KR+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 247 IAG---IKADEWF 256
G IKA +F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 4e-65
Identities = 95/262 (36%), Positives = 144/262 (54%), Gaps = 26/262 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E +TLG G+FG+V + SG +A+KIL K +I+ LK + + E L+ ++HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
+V L+ S +Y+V+EYV GGELF + GR E R Q++ L
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
EN+LLDS G IKI+DFG + R G +T CG+P Y+APE++ ++GY
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK 177
Query: 181 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240
A D W+ G+++Y +L GY PF D N +Y+KI G + P + SP A++L+R +L+ +
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 241 PVKRI-----TIAGIKADEWFE 257
KR+ + IK WF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 2e-57
Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 39/279 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
++ G+ +GEG+F V A++ ++ +A+KIL+K ++I K +K E L +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
+++L+ + +Y VLEY GEL I G L E R +++ L
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 128 --------ENILLDSKGNIKISDFGLS------ALPQHFRDDGLLHTT------------ 161
ENILLD +IKI+DFG + + P+ + D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 162 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 221
G+ YV+PE+L N G +SD+W+ G I+Y +LTG PF N + +QKI + ++
Sbjct: 183 VGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 222 PKWLSPGAQNLLRKILEPNPVKRITIAG----IKADEWF 256
P P A++L+ K+L +P R+ + +KA +F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 3e-55
Identities = 89/247 (36%), Positives = 126/247 (51%), Gaps = 52/247 (21%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LGEG FG V A+D +G A+KI++K L +++ REI LK L HPN+V+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL------------- 127
V ++ +Y+V+EY GG L D + G+L E E ++ Q+++GL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 128 --ENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 184
ENILLDS G +K++DFGLS D LL T G+P Y+APEVL +GY SD
Sbjct: 119 KPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 185 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 244
IWS GVILY + P ++L+RK+L+ +P KR
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 245 ITIAGIK 251
+ I
Sbjct: 206 PSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 5e-54
Identities = 85/260 (32%), Positives = 133/260 (51%), Gaps = 28/260 (10%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG G FG+V+ + FA+K ++K I+ + I E L+ HP +V+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------------- 127
K IYM++EY GGEL+ + +G E R ++
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 128 -ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 186
EN+LLDS G +K+ DFG + + + T CG+P YVAPE++ N+GYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176
Query: 187 SCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPV 242
S G++LY +LTG PF DD + +Y I +G+ KL P ++ A++L++++L NP
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 243 KRI-----TIAGIKADEWFE 257
+R+ I IK +WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 2e-53
Identities = 83/254 (32%), Positives = 129/254 (50%), Gaps = 22/254 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ G LG G+FG V A D D+G AVK +E + ++ + ++REI L L+HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59
Query: 75 NVVRL--HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
N+VR E K+ + + LEYV+GG L + G+L E RK +Q+++GL
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 129 -----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
NIL+DS G +K++DFG + + G+P ++APEV+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGE 178
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDF-KLPKWLSPGAQNLLR 234
G +DIWS G + + TG P+ + +A LY+ G+ ++P+ LS A++ LR
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 235 KILEPNPVKRITIA 248
K L +P KR T
Sbjct: 239 KCLRRDPKKRPTAD 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-52
Identities = 82/262 (31%), Positives = 129/262 (49%), Gaps = 36/262 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL------EKNRIIHLKITDQIKREIATL 68
+YE+ + +G+G+FGKV + G + +K + EK R + E+ L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-------EDALNEVKIL 53
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLI 124
K L HPN+++ +E K K+ +V+EY GG+L KI + + E + F QL
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 125 DGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
L+ NI L S G +K+ DFG+S + L T G+P Y++
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLS 171
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPG 228
PE+ N+ Y+ SDIWS G +LY + T PF+ NL L KI +G + +P S
Sbjct: 172 PELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230
Query: 229 AQNLLRKILEPNPVKRITIAGI 250
+NL+ +L+ +P +R +IA I
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-48
Identities = 81/258 (31%), Positives = 137/258 (53%), Gaps = 21/258 (8%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ +L +E+G TLG G+FG+V+ A+ +G +A+K L+K I+ +K +
Sbjct: 7 FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA 66
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
+E + L L HP +V + ++++Y +LE+V GGELF + GR + +
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126
Query: 123 LIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
L+ EN+LLD+KG++K++DFG + + T CG+P Y
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227
+APEV+ ++G+ A D W+ GV+LY + GY PF D +Y+KI G K P W
Sbjct: 182 LAPEVIQSKGHGKAV-DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
Query: 228 GAQNLLRKILEPNPVKRI 245
A++L++ +L+ + KR+
Sbjct: 241 RARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 5e-47
Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 26/262 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
E +T+G G FG+V +D S +A+K++ +I LK + E LK + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
++RL + +YM++EYV GGELF + + GR + G +++ L
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
ENILLD +G+IK++DFG + + RD T CG+P Y+APEV+ ++G++
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFA---KKLRDR--TWTLCGTPEYLAPEVIQSKGHNK 177
Query: 181 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240
A D W+ G+++Y +L GY PF D N +Y+KI G + P+ L A++L++K+L +
Sbjct: 178 AV-DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236
Query: 241 PVKRI-----TIAGIKADEWFE 257
+R+ +K WF+
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-45
Identities = 82/259 (31%), Positives = 132/259 (50%), Gaps = 27/259 (10%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
G +G+V A+ +G +A+K+++K +I DQ+ E L + P VV+L+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---------------N 129
K +Y+V+EY+ GG+L + + G L E R +++ LE N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 130 ILLDSKGNIKISDFGLSAL----PQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATS 183
IL+DS G++K++DFGLS + Q +D G+P+Y+APEV+ +G+ T
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--WLSPGAQNLLRKILEPNP 241
D WS G ILY L G PF ++Q I G + P+ +S A +L+ K+L P+P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242
Query: 242 VKRI---TIAGIKADEWFE 257
KR+ +I IK +F+
Sbjct: 243 EKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 86/245 (35%), Positives = 135/245 (55%), Gaps = 22/245 (8%)
Query: 20 RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPN 75
+ LG+G +GKV + + D+G FA+K+L+K I+ + K T K E L+ +KHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
+V L + K+Y++LEY++GGELF + +G E ++ L
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
ENILLD++G++K++DFGL + + + HT CG+ Y+APE+L G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 181 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240
D WS G ++Y +LTG PF N KI +G LP +L+P A++LL+K+L+ N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 241 PVKRI 245
P R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 5e-41
Identities = 77/253 (30%), Positives = 130/253 (51%), Gaps = 28/253 (11%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ +G+G FG+V A+ +G A+K+++ + ++I EI LK KHPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES---KEKKEKIINEIQILKKCKHPN 58
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGLE------ 128
+V+ + K ++++V+E+ +GG L D + S + L E++ + ++L+ GLE
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 179
NILL S G +K+ DFGLSA D +T G+P ++APEV+ + YD
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 180 GATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRK 235
+DIWS G+ + G P+ + + L+ KI + P+ S ++ L+K
Sbjct: 176 YK-ADIWSLGITAIELAEGKPPYSELPPMKALF-KIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 236 ILEPNPVKRITIA 248
L+ NP KR T
Sbjct: 234 CLQKNPEKRPTAE 246
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 91/292 (31%), Positives = 138/292 (47%), Gaps = 42/292 (14%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP- 74
Y + R LGEG+FG+V A+D A+K+L K K ++ REI L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFD---KIASKGRLQEAEGRKLFQQLIDGL---- 127
N+V+L++ + +Y+V+EYV GG L D KI KG L E+E + Q++ L
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 128 -----------ENILLDSKGN-IKISDFGLSAL----PQHFRDDGLLHTTCGSPNYVAPE 171
ENILLD G +K+ DFGL+ L L T+ G+P Y+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 172 VL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 217
VL + Y ++SDIWS G+ LY +LTG PF+ + + +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 218 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 268
P+ +S A +LL+K+L +P R++ + + + + D
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 102/324 (31%), Positives = 167/324 (51%), Gaps = 54/324 (16%)
Query: 20 RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLKLLKHP 74
+ LG+G+FGKV + + D+G +A+K+L+K LK+ D++ K E L + HP
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
+V+LH ++ K+Y++L+++ GG+LF +++ + E + + +L L
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 128 --------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 179
ENILLD +G+IK++DFGLS + ++ CG+ Y+APEV+ RG+
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 180 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 239
+ +D WS GV+++ +LTG LPF ++ I + +P++LSP AQ+LLR + +
Sbjct: 177 QS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235
Query: 240 NPVKRI-----TIAGIKADEWF-------------EQDYTPA--NPDDDEEDIFVDNEAF 279
NP R+ + IK +F + + PA PDD + D E
Sbjct: 236 NPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDD---TFYFDPEFT 292
Query: 280 SMHEVPSDGGRTPGSPPLINAFQL 303
S P D +PG PP NA QL
Sbjct: 293 S--RTPKD---SPGIPPSANAHQL 311
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 76/259 (29%), Positives = 121/259 (46%), Gaps = 22/259 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+LG +G G FG V +L++G A+K + +I + I +EI LK LKHP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
N+V+ + + +Y++LEY G L I G E+ Q++ GL
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGY 178
NIL G +K++DFG++ D + G+P ++APEV+ G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 179 DGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 237
A SDIWS G + +LTG P+ D N +A L++ + LP+ +SP ++ L +
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235
Query: 238 EPNPVKRITIAGIKADEWF 256
+ +P R T + W
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 6e-40
Identities = 53/116 (45%), Positives = 76/116 (65%), Gaps = 3/116 (2%)
Query: 299 NAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN-G 357
NAF LI +SS LDLSG FE+ED +R+ RFTS A++++E++E+ ++GFRV+KK G
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 358 KLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 413
+K E + G L+V+ EVFE++PSL VVE++KS GD Y + L L
Sbjct: 61 GVK--LEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPL 114
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-38
Identities = 84/242 (34%), Positives = 133/242 (54%), Gaps = 19/242 (7%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
+ LG+G+FGKV A+ + +AVK+L+K+ I+ + E L L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------- 127
LH +K +++ V+EYV GG+L I GR E R +++ GL
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
+N+LLDS+G+IKI+DFG+ + T CG+P+Y+APE+L+ + Y G
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
D W+ GV+LY +L G PF+ + L+Q I + + P+WLS A+++L+ L NP K
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 244 RI 245
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 8e-38
Identities = 91/267 (34%), Positives = 136/267 (50%), Gaps = 25/267 (9%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K I+ K + I E L K LKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------- 127
LH + K+Y VL+YV GGELF + + E R ++ +
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
ENILLDS+G++ ++DFGL + + T CG+P Y+APEVL YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
D W G +LY +L G PF R+++ +Y I +LP + A +LL +L + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 244 RITIAGIKADEWFEQD---YTPANPDD 267
R+ G KAD ++ ++P N DD
Sbjct: 238 RL---GAKADFLEIKNHVFFSPINWDD 261
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 77/262 (29%), Positives = 122/262 (46%), Gaps = 31/262 (11%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE+ T+G+G+FG V+ + G K ++ + K Q+ E+ L+ LKHPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPN 60
Query: 76 VVRL--HEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGL-- 127
+VR + S +Y+V+EY GG+L I + ++E ++ QL+ L
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 128 ------------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
NI LD+ N+K+ DFGL+ + H D T G+P Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYMS 178
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPG 228
PE L + YD SDIWS G ++Y + PF RN L KI G F ++P S
Sbjct: 179 PEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237
Query: 229 AQNLLRKILEPNPVKRITIAGI 250
+++ +L +P KR + +
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 86/255 (33%), Positives = 129/255 (50%), Gaps = 22/255 (8%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKRE 64
K++ M+ + RTLG G+FG+V A + P A+K EK++II K D + E
Sbjct: 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L + HP V L+ +S +Y+VLE+V GGE F + R G Q++
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141
Query: 125 ------DGL---------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
L EN+LLD G IK++DFG + + D +T CG+P Y+A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIA 196
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229
PE+L N G+ G +D W+ G+ +Y IL G PF ++YQKI G PK+L
Sbjct: 197 PEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNC 255
Query: 230 QNLLRKILEPNPVKR 244
++L++K+L + KR
Sbjct: 256 KHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 86/274 (31%), Positives = 148/274 (54%), Gaps = 37/274 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL R LG G +GKV + + D+G +A+K+L+K I+ K + + E L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG---- 126
+ P +V LH + +K++++L+YV GGELF + + E+E R +++
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 127 -----------LENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPEV 172
LENILLDS+G++ ++DFGLS + R ++ CG+ Y+APEV
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER----AYSFCGTIEYMAPEV 177
Query: 173 L--ANRGYDGATSDIWSCGVILYVILTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLS 226
+ + G+D A D WS GV+ + +LTG PF ++N + + ++I + PK +S
Sbjct: 178 IRGGSGGHDKAV-DWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236
Query: 227 PGAQNLLRKILEPNPVKRITIAG---IKADEWFE 257
A++ ++K+LE +P KR+ G IK +F+
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 86/255 (33%), Positives = 130/255 (50%), Gaps = 21/255 (8%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FGKV + D+ +A+K + K I+ E L + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------------- 127
S K+Y+VL ++ GGELF + +GR + R +L+ L
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 128 -ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 186
ENILLD +G+I + DFGL L + +DD +T CG+P Y+APE+L GY A D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV-DWW 177
Query: 187 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 246
+ GV+LY +LTG PF D N+ +Y+KI + + P A++LL +L +P +R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 247 IAG---IKADEWFEQ 258
G IK +F Q
Sbjct: 238 YNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 88/250 (35%), Positives = 127/250 (50%), Gaps = 22/250 (8%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K I+ K I E L K +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------- 127
LH + K+Y VL+YV GGELF + + E R ++ L
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
ENILLDS+G++ ++DFGL + T CG+P Y+APEVL + YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
D W G +LY +L G PF R+ A +Y I +L +S A++LL +L+ + K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 244 RITIAGIKAD 253
R+ G K D
Sbjct: 238 RL---GAKDD 244
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 5e-37
Identities = 72/248 (29%), Positives = 117/248 (47%), Gaps = 22/248 (8%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+EL R +G+G FGKV Q D+ FA+K + K + + + E L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
+V L + +Y+V++ + GG+L ++ K + E + + +++ L
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
+NILLD +G++ I+DF ++ D L +T G+P Y+APEVL +GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 181 ATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKIL 237
D WS GV Y L G P+ R + + D P S A + + K+L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 238 EPNPVKRI 245
E +P KR+
Sbjct: 238 ERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 7e-37
Identities = 98/306 (32%), Positives = 149/306 (48%), Gaps = 34/306 (11%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
+ +G+G+FGKV A+ +AVK+L+K I+ K I E LK +KHP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------- 127
LH + K+Y VL+Y+ GGELF + + E R ++ L
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
ENILLDS+G+I ++DFGL ++ +G T CG+P Y+APEVL + YD T
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
D W G +LY +L G PF RN A +Y I +L ++ A++LL +L+ + K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 244 RIT-------------IAGIKADEWFEQDYTPA-NPD-DDEEDIFVDNEAFSMHEVPSDG 288
R+ + I D+ + TP NP+ D+ + F+ VP+
Sbjct: 238 RLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSI 297
Query: 289 GRTPGS 294
G++P S
Sbjct: 298 GQSPDS 303
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 9e-37
Identities = 77/241 (31%), Positives = 126/241 (52%), Gaps = 18/241 (7%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL+K II E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------------ 127
+ ++ V+EY GGELF ++ + E R +++ L
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 128 ---ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 184
EN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 185 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 244
W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 245 I 245
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 4e-36
Identities = 78/251 (31%), Positives = 128/251 (50%), Gaps = 19/251 (7%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
+ LG+G+FGKV A+ + +A+K+L+K+ I+ D E L L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------- 127
LH +K +++ V+EYV GG+L +I + E R ++ L
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
+NILLD++G+ K++DFG+ + + T CG+P+Y+APE+L Y G +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
D W+ GV++Y ++ G PF+ N L++ I D P WLS A ++L+ + NP K
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 244 RITIAGIKADE 254
R+ + E
Sbjct: 238 RLGCVASQGGE 248
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 78/240 (32%), Positives = 127/240 (52%), Gaps = 19/240 (7%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLH 80
LG+G+FGKV A+ + +A+KIL+K+ II + E L L P + +LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------------- 127
+ ++Y V+EYV GG+L I G+ +E ++ GL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 128 --ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 185
+N++LD++G+IKI+DFG+ ++ T CG+P+Y+APE++A + Y G + D
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 186 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 245
W+ GV+LY +L G PFD + L+Q I + PK LS A ++ + +L +P KR+
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 9e-36
Identities = 80/266 (30%), Positives = 125/266 (46%), Gaps = 28/266 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
R++ G +G G FGKV A +LD+G AVK ++ N K +I E+ L+LLK
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLK 57
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
HPN+V+ + V + K+Y+ +EY +GG L + + L E R QL++GL
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 128 ----------ENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLAN 175
NI LD G IK+ DFG + + + G+P Y+APEV+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 176 RGYDG--ATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDFKLPK--WLSPGA 229
G +DIWS G ++ + TG P+ D +++ +P LSP
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237
Query: 230 QNLLRKILEPNPVKRITIAGIKADEW 255
++ L + LE +P KR T + + +
Sbjct: 238 KDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 83/241 (34%), Positives = 126/241 (52%), Gaps = 18/241 (7%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ SG +A+KIL+K II E LK +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG------------- 126
+K ++ V+EYV GGELF ++ + E R +++
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 127 --LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 184
LEN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 185 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 244
W GV++Y ++ G LPF +++ L++ I D K P+ LS A++LL +L +P KR
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 245 I 245
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 93/332 (28%), Positives = 164/332 (49%), Gaps = 46/332 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL + LG G +GKV + + D+G +A+K+L+K ++ K + + E L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE-- 128
+ P +V LH +++K++++L+YV+GGE+F + + E E R ++I LE
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 129 -------------NILLDSKGNIKISDFGLSALPQHF--RDDGLLHTTCGSPNYVAPEVL 173
NILLDS+G++ ++DFGLS + F + ++ CG+ Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLS---KEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPFD---DRNL-AVLYQKIFRGDFKLPKWLSPGA 229
+G G D WS G++++ +LTG PF +RN + + ++I + D P ++ P A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 230 QNLLRKILEPNPVKRITIAGIKADEWFEQDY---------------TPANPD-DDEEDIF 273
Q+LL K+L +P KR+ A E E + P P +E D+
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVG 298
Query: 274 VDNEAFS-MHEVPSDGGRTPGSPPLINAFQLI 304
E F+ + V S G P + + +
Sbjct: 299 NFAEEFTNLEPVYSPAGTPPSGARVFQGYSFV 330
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 75/258 (29%), Positives = 125/258 (48%), Gaps = 36/258 (13%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVL 83
G FG V A+ +G FA+K+L+K+ +I +K E A + + P V +L+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE--------------- 128
SK +Y+V+EY+ GG+ I + G L E ++ +++ G+E
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 129 NILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 185
N+L+D G++K++DFGLS + F G+P+Y+APE + G D SD
Sbjct: 127 NLLIDQTGHLKLTDFGLSRNGLENKKF---------VGTPDYLAPETILGVGDDKM-SDW 176
Query: 186 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNP 241
WS G +++ L GY PF ++ I P+ + SP A +L+ ++L +P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 242 VKRITIAG---IKADEWF 256
KR+ G IK+ +F
Sbjct: 237 AKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 83/253 (32%), Positives = 131/253 (51%), Gaps = 19/253 (7%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
+ LG+G+FGKV A+ + FA+K L+K+ ++ + E L L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---------- 128
L +K ++ V+EY+ GG+L I S GR EA R ++I GL+
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 129 -----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
N+LLD G+IKI+DFG+ ++ +G T CG+P+Y+APE+L + Y+ +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYNESV- 177
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
D WS GV+LY +L G PF + L+ I P+W+S A++ L K+ E +P K
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 244 RITIAGIKADEWF 256
R+ + G F
Sbjct: 238 RLGVDGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-35
Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 22/255 (8%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
R LG+G+FGKV A+ +SG +AVK+L+K+ I+ + E L L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------- 127
L+ + +++ V+E+V GG+L I R EA R ++ L
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
+N+LLD +G+ K++DFG+ + + T CG+P+Y+APE+L Y G +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
D W+ GV+LY +L G+ PF+ N L++ I + P WLS A ++L+ + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 244 R---ITIAGIKADEW 255
R +T+ G +A
Sbjct: 238 RLGSLTLGGEEAILR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 9e-35
Identities = 77/241 (31%), Positives = 125/241 (51%), Gaps = 18/241 (7%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL K II E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------------ 127
+ ++ V+EY GGELF ++ + E R +++ L
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 128 ---ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 184
EN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 185 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 244
W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 245 I 245
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 81/242 (33%), Positives = 133/242 (54%), Gaps = 23/242 (9%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLKHPNVVR 78
LG+G+FGKV A+ + +A+KIL+K+ +I ++ T KR +A K P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD--KPPFLTQ 65
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------- 127
LH + ++Y V+EYV GG+L I G+ +E + ++ GL
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125
Query: 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
+N++LDS+G+IKI+DFG+ +H D T CG+P+Y+APE++A + Y G +
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSV 182
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
D W+ GV+LY +L G PFD + L+Q I + PK LS A ++ + ++ +P K
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSK 242
Query: 244 RI 245
R+
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 40/258 (15%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLK 72
E + LG+G+ G V + +G +A+K IH+ + Q+ RE+ TL+ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKK------IHVDGDEEFRKQLLRELKTLRSCE 57
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
P VV+ + + +I +VLEY+ GG L D + G++ E + +Q++ GL+
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 129 ------------NILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLAN 175
N+L++SKG +KI+DFG+S L +T G+ Y++PE +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN---TLDQCNTFVGTVTYMSPERIQG 174
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKW----LSPG 228
+DIWS G+ L G PF L Q I G P SP
Sbjct: 175 E-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPE 231
Query: 229 AQNLLRKILEPNPVKRIT 246
++ + L+ +P KR +
Sbjct: 232 FRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-34
Identities = 78/244 (31%), Positives = 132/244 (54%), Gaps = 23/244 (9%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G FGKV ++ +G +A+KIL+K I+ E L+ +HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 80 HEVLASKSKIYMVLEYVTGGELF-----DKIASKGRLQ-------------EAEGRKLFQ 121
+ ++ V+EY GGELF +++ S+ R + +E +++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 122 QLIDGLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
L LEN++LD G+IKI+DFGL + +D + T CG+P Y+APEVL + Y G
Sbjct: 121 DL--KLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GR 175
Query: 182 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNP 241
D W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP 235
Query: 242 VKRI 245
+R+
Sbjct: 236 KQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (323), Expect = 4e-34
Identities = 87/297 (29%), Positives = 126/297 (42%), Gaps = 91/297 (30%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLL 71
YE LGEG +G V A+D +G A+K +I + I REI+ LK L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGE-----LFDKIASKGRLQEAEGRKLFQQLIDG 126
KHPN+V+L +V+ ++ K+Y+V EY + DK L + + QL+ G
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP--LSPNLIKSIMYQLLRG 110
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----- 166
L NIL++ G +K++DFGL+ G P
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-------------RAFGIPLRTYTH 157
Query: 167 ------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR-- 216
Y APE+L ++ Y A DIWS G I ++TG F D + L+ KIF+
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLF-KIFQIL 215
Query: 217 --------------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 246
D+K PK+ L P +LL K+L+ NP KRI+
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 78/250 (31%), Positives = 130/250 (52%), Gaps = 23/250 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL-KITDQIKREIATLKLLKH 73
+ G+ LG+G FG+V D+D+G AVK + + K + ++ EI LK L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----- 128
+V+ + L + + +EY+ GG + D++ + G L E RK +Q+++G+E
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRG 177
NIL DS GN+K+ DFG S Q G + + G+P +++PEV++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFR--GDFKLPKWLSPGAQNLLR 234
Y G +D+WS G + +LT P+ + +A ++ KI + +LP +SP A+N LR
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARNFLR 241
Query: 235 KILEPNPVKR 244
+ N KR
Sbjct: 242 RTFVENAKKR 251
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 80/256 (31%), Positives = 124/256 (48%), Gaps = 28/256 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
R+ G LG G+FG V +LD G FAVK L + + Q+++EIA L L+
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
HPN+V+ + +Y+ LE V GG L + G E R +Q++ GLE
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 129 -----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
NIL+D+ G +K++DFG++ + + + GSP ++APEV+A +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFK----LPKWLSPGAQNL 232
G +DIWS G + + TG P+ +F+ G K +P LS A++
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLE---GVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 233 LRKILEPNPVKRITIA 248
+ K L+ +P R T A
Sbjct: 235 ILKCLQRDPSLRPTAA 250
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 82/267 (30%), Positives = 151/267 (56%), Gaps = 32/267 (11%)
Query: 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
+EL + LG G +GKV + + DSG +A+K+L+K I+ K T+ + E L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 72 KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG---- 126
+ P +V LH + +K++++L+Y+ GGELF ++ + R +E E + +++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 127 -----------LENILLDSKGNIKISDFGLSALPQHFRDDGL--LHTTCGSPNYVAPEVL 173
LENILLDS G++ ++DFGLS + F +D + ++ CG+ Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLS---KEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 174 A--NRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSP 227
+ G+D A D WS GV++Y +LTG PF + + A + ++I + + P+ +S
Sbjct: 179 RGGDGGHDKAV-DWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADE 254
A+++++++L +P KR+ ADE
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADE 264
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 95/312 (30%), Positives = 149/312 (47%), Gaps = 35/312 (11%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
+ +G+G+FGKV A+ G +AVK+L+K +++ K I E LK +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------- 127
LH + K+Y VL++V GGELF + + E R ++ L
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
ENILLDS+G++ ++DFGL + T CG+P Y+APEV+ + YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TV 177
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
D W G +LY +L G PF R++A +Y I L S A ++L ++LE + +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 244 RI----TIAGIKADEWFEQ-DYT---------PANPD-DDEEDIFVDNEAFSMHEVPSDG 288
R+ I+ +FE +T P NP+ + +DI + F+ VP
Sbjct: 238 RLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSV 297
Query: 289 GRTPGSPPLINA 300
+ ++NA
Sbjct: 298 CFSSD-YSIVNA 308
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 77/243 (31%), Positives = 132/243 (54%), Gaps = 25/243 (10%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPNVV 77
LG+G+FGKV A+ + +A+KIL+K+ +I D ++ + ++L K P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSGKPPFLT 64
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------- 127
+LH + ++Y V+EYV GG+L +I GR +E ++ GL
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 128 -----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 182
+N++LDS+G+IKI+DFG+ ++ D T CG+P+Y+APE++A + Y G +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKS 181
Query: 183 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPV 242
D W+ GV+LY +L G PF+ + L+Q I + PK +S A + + ++ +P
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPG 241
Query: 243 KRI 245
KR+
Sbjct: 242 KRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 80/268 (29%), Positives = 124/268 (46%), Gaps = 46/268 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD-----QIKR-----E 64
+++ + LG+G++G V + VK L N+ LK D Q +R E
Sbjct: 1 DFKVLKKLGKGSYGSV-----------YKVKRLSDNQFYALKEVDLGSMSQKEREDAVNE 49
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLF 120
I L + HPN++ E +K+ +V+EY G+L I + + E E ++F
Sbjct: 50 IRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIF 109
Query: 121 QQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
QL+ GL+ NILL + +KI D G+S + + + T G+P
Sbjct: 110 IQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTP 165
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 224
+Y+APEV R Y SDIWS G +LY + T PF+ R++ L K+ RG + +P
Sbjct: 166 HYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI 224
Query: 225 LSPGAQNLLRKILEPNPVKRITIAGIKA 252
S QN +R +L+ P R I A
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 77/282 (27%), Positives = 127/282 (45%), Gaps = 53/282 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY++ +GEG G V A+D ++G A+K + R + I +Q REI L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGLE----- 128
VV+L +V S +V+EY+ L + + + R L EA+ + + L+ G+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL-ANR 176
N+L+ + G +KI+DFGL+ L ++ L++ + Y APE+L R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARL--FSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL---YQKIFRGDFKLPKW- 224
YD D+W+ G I +L G F N L ++ + G LP +
Sbjct: 177 KYDPGV-DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 225 ------------------LSPGAQNLLRKILEPNPVKRITIA 248
SP A +LL+ +L +P KR++ A
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA 277
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 83/291 (28%), Positives = 137/291 (47%), Gaps = 49/291 (16%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+E+ + +G G FG+V +D D+G +A+K+L K+ +I ++ E L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL---IDGL--- 127
P +V+L+ + +Y+V+EY+ GG+L + + K E R +L +D +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 128 ---------ENILLDSKGNIKISDFGLSA---------------LPQHFRDDGLLH---- 159
+NIL+D+ G+IK++DFGL FRD+ L+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 160 --------TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 211
+T G+P+Y+APEVL Y D WS GVILY +L G+ PF L Y
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 212 QKI--FRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIA-GIKADEWFE 257
KI ++ + P +SP A +L+ ++L P R+ IK+ +F+
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 28/224 (12%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
ELG+ LGEG FG+V + AVK L K + + E + +K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREE-FLEEASIMKKLS 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGLE--- 128
HPN+VRL V +Y+V EY+ GG+L D + +L + ++ Q+ G+E
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 129 ------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLA 174
N L+ +KISDFGLS + DD G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLS--RDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 175 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 217
+ + SD+WS GV+L+ I T G P+ + + + + G
Sbjct: 178 DGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-32
Identities = 76/249 (30%), Positives = 131/249 (52%), Gaps = 25/249 (10%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
+ LG+G+FGKV A+ + FA+K L+K+ ++ + D ++ + ++L +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPF 57
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------- 128
+ L+ +K ++ V+EY+ GG+L I S + ++I GL+
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 129 --------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
NILLD+ G+IKI+DFG+ ++ D T CG+P+Y+APE+L + Y
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY-N 174
Query: 181 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240
+ D WS GV+LY +L G PF + L+Q I + P+WL+ A+++L K+
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234
Query: 241 PVKRITIAG 249
P +R+ + G
Sbjct: 235 PERRLGVKG 243
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 8e-31
Identities = 76/258 (29%), Positives = 136/258 (52%), Gaps = 26/258 (10%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
+ LG+G+FGKV A+ G FAVK L+K+ ++ I D ++ + ++L ++P
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL---IDDDVECTMVEKRVLALAWENPF 57
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------- 128
+ L+ +K ++ V+E++ GG+L I KGR +++ GL+
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 129 --------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
N++LD G+IKI+DFG+ ++ D T CG+P+Y+APE+L Y
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 181 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240
+ D WS GV+LY +L G PF + L++ I P+W++ ++++L K+ E +
Sbjct: 176 SV-DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234
Query: 241 PVKRITIAG-IKADEWFE 257
P +R+ + G I+ +F+
Sbjct: 235 PTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 70/261 (26%), Positives = 111/261 (42%), Gaps = 47/261 (18%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
LG+ LGEG FG+V + AVK L+++ QI+ RE ++
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQIEEFLREARIMR 56
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID--- 125
L HPN+V+L V + + +V+EY+ GG+L L++ ++L L+
Sbjct: 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL------LDYLRKNRPKELSLSDLLSFAL 110
Query: 126 ----GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 165
G+E N L+ +KISDFGLS + DD P
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPI 168
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPK 223
++APE L + SD+WS GV+L+ I T G P+ + A + + + +G P
Sbjct: 169 RWMAPESLKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPP 227
Query: 224 WLSPGAQNLLRKILEPNPVKR 244
P L+ + +P R
Sbjct: 228 NCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 68/257 (26%), Positives = 109/257 (42%), Gaps = 40/257 (15%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG+ LGEG FG+V + + AVK L+++ ++ RE ++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
HPNVV+L V + +Y+V+EY+ GG+L L++ + L+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDL------LSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 126 GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVA 169
G+E N L+ +KISDFGLS + DD P ++A
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMA 171
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSP 227
PE L + SD+WS GV+L+ I T G P+ + + + + G P P
Sbjct: 172 PESLKEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP 230
Query: 228 GAQNLLRKILEPNPVKR 244
+L+ + +P R
Sbjct: 231 ELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 75/254 (29%), Positives = 129/254 (50%), Gaps = 22/254 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + +GEG+FGK + + G + +K + +++ K ++ ++E+A L +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRL-QEAEGRKLFQQLIDGL----- 127
N+V+ E +Y+V++Y GG+L+ KI A +G L E + F Q+ L
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
+NI L G IK+ DFG++ + + L T G+P Y++PE+ NR
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 236
Y+ SDIW+ G +LY + T F+ N+ L KI RG + + S +NL+ ++
Sbjct: 178 YNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 237 LEPNPVKRITIAGI 250
+ NP R ++ I
Sbjct: 237 FKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 78/244 (31%), Positives = 123/244 (50%), Gaps = 26/244 (10%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVR 78
LG G+FGKV A+ +G +A+K L+K II + + KR T +HP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---------QQLIDG--- 126
L ++ + V+EY GG+L I + +E R +F Q L +
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIV 123
Query: 127 -----LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
L+N+LLD++G +KI+DFGL F D T CG+P ++APEVL Y A
Sbjct: 124 YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRA 181
Query: 182 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNP 241
D W GV++Y +L G PF + ++ I + + P++LS A +++R++L NP
Sbjct: 182 V-DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNP 240
Query: 242 VKRI 245
+R+
Sbjct: 241 ERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 91/300 (30%), Positives = 133/300 (44%), Gaps = 72/300 (24%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLL 71
YE +GEG +G+V A++ +G A+K K R+ + K IT REI L+ L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPIT--AIREIKLLQKL 55
Query: 72 KHPNVVRLHEVLASKSK--IYMVLEYV----TGGELFDKIASKG-RLQEAEGRKLFQQLI 124
+HPN+VRL E++ SK K IYMV EY+ TG + S + E++ + +QL+
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLL 110
Query: 125 DGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
+GL+ NIL+++ G +K++DFGL A P R+ + Y
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRP 169
Query: 170 PEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------- 216
PE+L A R Y D+WS G IL + G F +KIF
Sbjct: 170 PELLLGATR-YGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 217 GDFKLP--------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256
G KLP + P A +LL K+L +P KRI+ E+F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G +G+V A+ D+G A+K ++K+ + L + E L K +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL---IDGL----------- 127
+Y+ +EYV GG+ + + G L E R ++ +D L
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 128 -ENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPNYVAPEVLANRGYDGATS 183
EN L+D+ G+IK++DFGLS G++ ++ GSP+Y+APEVL +GYD T
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKWLSPGA 229
D WS G +LY L G+ PF ++ + ++ + P + P
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF 227
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 78/244 (31%), Positives = 125/244 (51%), Gaps = 23/244 (9%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQI-KREIATLKLLKH-PNVVR 78
+G+G FG+V + D+ +A+K+L K I+ K + I +R I LL P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------- 127
L + S +Y+V +Y++GGELF + +GR E + +L+ L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGAT 182
ENILLD+ G+I + DFGLS + D+ +T CG+ Y+APEVL + +GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 183 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNP 241
D WS GV+++ + G+ PF + +Y+ I G + PK LS + ++ +L NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 242 VKRI 245
R+
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 73/263 (27%), Positives = 115/263 (43%), Gaps = 38/263 (14%)
Query: 20 RTLGEGNFGKVKFA---QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LGEG FG+V AVK L K + D +E +K L HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKD-FLKEARVMKKLGHPNV 58
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLID-------GL 127
VRL V + +Y+VLEY+ GG+L D + + + + + L+ G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 128 E---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN-YVAP 170
E N L+ +KISDFGLS + DD T G P ++AP
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--RDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 171 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSP 227
E L + + SD+WS GV+L+ I T G P+ + + + + +G ++L P++
Sbjct: 177 ESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKPEYCPD 234
Query: 228 GAQNLLRKILEPNPVKRITIAGI 250
L+ + +P R T + +
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 51/287 (17%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG+G+ G+V + +G FA+K+L+K +I ++ E L L HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGL---------- 127
+ +++ + +V++Y GGELF + L E R +++ L
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 128 -----ENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN------------- 166
ENILL G+I +SDF LS + L + S
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 167 -----------YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 215
Y+APEV++ G+ A D W+ G++LY +L G PF N + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 216 RGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG----IKADEWF 256
+ + P +S A++L+RK+L +P KR+ IK +F
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 83/263 (31%), Positives = 119/263 (45%), Gaps = 41/263 (15%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE------KNRIIHLKITDQIKREIATLKLLK 72
G +G G+FG V + SG AVK +E ++ + D + REIA LK L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
H N+V+ + + LEYV GG + + + G +E R +Q++ GL
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 129 -----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--------GSPNYVA 169
NIL+D+KG IKISDFG+S + L T GS ++A
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEA----NSLSTKTNGARPSLQGSVFWMA 180
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFKLPKW---L 225
PEV+ Y DIWS G ++ +LTG PF D Q IF+ G+ P+ +
Sbjct: 181 PEVVKQTSYTRKA-DIWSLGCLVVEMLTGKHPFPDCT---QLQAIFKIGENASPEIPSNI 236
Query: 226 SPGAQNLLRKILEPNPVKRITIA 248
S A + L K E + KR T A
Sbjct: 237 SSEAIDFLEKTFEIDHNKRPTAA 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 6e-28
Identities = 92/317 (29%), Positives = 130/317 (41%), Gaps = 85/317 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-DQIK----REIATLK 69
RYE G+ LGEG + V A+D ++G A+K K ++ K D I REI L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK---KIKLGERKEAKDGINFTALREIKLLQ 57
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGLE 128
LKHPN++ L +V KS I +V E++ +L I K L A+ + + GLE
Sbjct: 58 ELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 166
N+L+ S G +K++DFGL+ + GSPN
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQV 163
Query: 167 ----YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDD--RNLAVLYQKIFR-- 216
Y APE+L + G D+WS G I +L +LP D L KIF
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG----KIFEAL 219
Query: 217 ---------GDFKLPKWL----SPG-------------AQNLLRKILEPNPVKRITIAGI 250
G LP ++ P A +LL+++L NP KRIT
Sbjct: 220 GTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA 279
Query: 251 KADEWFEQDYTPANPDD 267
+F D P P
Sbjct: 280 LEHPYFSNDPAPTPPSQ 296
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 85/300 (28%), Positives = 142/300 (47%), Gaps = 60/300 (20%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+K L K+ ++ + ++ E L +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------- 128
VV+L+ ++ +Y+++EY+ GG++ + K E E R + I ++
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 129 --------NILLDSKGNIKISDFGLS-----------------ALPQHFRDD-------- 155
N+LLD+KG+IK+SDFGL ALP +F D
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 156 -----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 204
L ++T G+P+Y+APEV GY D WS GVI+Y +L GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 205 RNLAVLYQKI--FRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 257
N Y+KI ++ + P LSP A++L++++ +R+ G IK+ +F+
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 73/263 (27%), Positives = 134/263 (50%), Gaps = 33/263 (12%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG------------ 126
LH ++S+++ V+E+V+GG+L + + +L E R ++
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 127 ---LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GAT 182
L+N+LLD++G+IK++D+G+ + R T CG+PNY+APE+L RG D G +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEIL--RGEDYGFS 176
Query: 183 SDIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLL 233
D W+ GV+++ ++ G PFD D+N L+Q I ++P+ LS A ++L
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236
Query: 234 RKILEPNPVKRITIAGIKADEWF 256
+ L +P +R+ G F
Sbjct: 237 KGFLNKDPKERL---GCHPQTGF 256
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 77/254 (30%), Positives = 117/254 (46%), Gaps = 25/254 (9%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q +G +A K L+K R+ K E L+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGLE----------- 128
+K + +V+ + GG+L I + G E R +F Q+I GLE
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 129 ----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 184
N+LLD GN++ISD GL+ + + G+P Y+APEVL YD + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176
Query: 185 IWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240
++ G LY ++ G PF R V L ++ + P SP A++L +L+ +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 241 PVKRITIAGIKADE 254
P KR+ G ADE
Sbjct: 237 PEKRLGCRGGSADE 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 75/248 (30%), Positives = 120/248 (48%), Gaps = 23/248 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + R +GEG+FG+ Q ++S +A+K + + + ++E L +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS--AVEDSRKEAVLLAKMKHP 58
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGLE---- 128
N+V E + +Y+V+EY GG+L KI +G+L E + F Q+ G++
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 129 -----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
NI L G +K+ DFG + L T G+P YV PE+ N
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 236
Y+ SDIWS G ILY + T PF + L K+ +G +K LP S ++L++++
Sbjct: 177 YNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 237 LEPNPVKR 244
+ NP R
Sbjct: 236 FKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + + G +G V + ++ FA+K + K +I Q+ E L ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------- 128
VV + +K + MV+EYV GG+ + + G L R F + + LE
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 129 --------NILLDSKGNIKISDFGLSAL-----------------PQHFRDDGLLHTTCG 163
N+L+ S G+IK++DFGLS + + F D + CG
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV----CG 178
Query: 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK 223
+P Y+APEV+ +GY G D W+ G+ILY L G +PF L+ ++ D + P+
Sbjct: 179 TPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
Query: 224 W---LSPGAQNLLRKILEPNPVKRITIAG---IKADEWF 256
L AQ+L+ ++L NP++R+ G +K +F
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 67/248 (27%), Positives = 116/248 (46%), Gaps = 24/248 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ +G+G+FG V +A+K ++ +++ + + I E L L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGLE----- 128
++R +E K K+ +V+EY G+L + L E + + F Q++ GL
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLL-HTTCGSPNYVAPEVLANRG 177
N+ LD+ N+KI D G++ L D+ +T G+P Y++PE+ ++
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 236
Y+ SD+W+ GV+LY TG PFD N L KI RG F + + S L+ +
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236
Query: 237 LEPNPVKR 244
L + +R
Sbjct: 237 LTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 71/248 (28%), Positives = 119/248 (47%), Gaps = 34/248 (13%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+GEG G+V A D +G A+K L K + I EI +K KHPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK------ELIINEILIMKDCKHPNIVDY 80
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGLE---------- 128
++ ++++V+EY+ GG L D I + R+ E + + ++++ GLE
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140
Query: 129 -----NILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
NILL G++K++DFG +A + + ++ G+P ++APEV+ + Y
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR----NSVVGTPYWMAPEVIKRKDYGPK 196
Query: 182 TSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILE 238
DIWS G++ + G P + L L+ +G K P+ SP ++ L K L
Sbjct: 197 V-DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 239 PNPVKRIT 246
+P KR +
Sbjct: 256 KDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 72/253 (28%), Positives = 131/253 (51%), Gaps = 32/253 (12%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-----------------KLFQ 121
LH ++S+++ V+EYV GG+L + + +L E R +++
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 122 QLIDGLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
L L+N+LLDS+G+IK++D+G+ + R T CG+PNY+APE+L Y G
Sbjct: 121 DL--KLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GF 175
Query: 182 TSDIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNL 232
+ D W+ GV+++ ++ G PFD D+N L+Q I ++P+ LS A ++
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235
Query: 233 LRKILEPNPVKRI 245
L+ L +P +R+
Sbjct: 236 LKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 69/250 (27%), Positives = 118/250 (47%), Gaps = 31/250 (12%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ LGEG++G V A ++G A+K++ + +I +EI+ LK P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGLE----- 128
+V+ + + +++V+EY G + D KI +K L E E + Q + GLE
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
NILL+ +G K++DFG+S Q +T G+P ++APEV+ GY
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 179 DGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234
+ DIWS G+ + G P+ D R + ++ K P+ SP + ++
Sbjct: 177 NNKA-DIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDFVK 234
Query: 235 KILEPNPVKR 244
K L +P +R
Sbjct: 235 KCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 79/259 (30%), Positives = 132/259 (50%), Gaps = 31/259 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RYE+ + +GEG+FGK+ A+ +K ++ ++ +K + K+E+ L +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL--FQQLIDGL----- 127
N+V ++++V+EY GG+L +I + + +E + L F Q+ GL
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 128 ----------ENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLAN 175
+NI L G + K+ DFG++ + D L TC G+P Y++PE+ N
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG----AQN 231
R Y+ T DIWS G +LY + T PF+ NL L KI +G F P +SP ++
Sbjct: 177 RPYNNKT-DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-P--ISPNFSRDLRS 232
Query: 232 LLRKILEPNPVKRITIAGI 250
L+ ++ + +P R +I I
Sbjct: 233 LISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 80/300 (26%), Positives = 120/300 (40%), Gaps = 65/300 (21%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+T+G G FG+V + +D+ +A+K L K ++ +K E L + VV+L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----------- 128
+ K +Y V++Y+ GG++ + G +E R +L +E
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 129 ----NILLDSKGNIKISDFGLSA------------LPQHFRDDG---------------- 156
NIL+D G+IK++DFGL H R D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 157 -------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 203
L H+ G+PNY+APEVL GY D WS GVILY +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFL 245
Query: 204 DRNLAVLYQKI--FRGDFKLPKW--LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWF 256
A K+ + +P LS A +L+ + L R+ IKA +F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 72/258 (27%), Positives = 113/258 (43%), Gaps = 24/258 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+YE R +G G FG V + +K + ++ + E LKLL HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL----- 127
N++ +E + +V+EY GG L + I + L E F Q++ L
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 128 ----------ENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
+NILLD + KI DFG+S + +T G+P Y++PE+ +
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELCEGK 176
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRK 235
Y+ SDIW+ G +LY + + F+ NL L KI G F + SP + L+
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 236 ILEPNPVKRITIAGIKAD 253
+L +P KR ++ I A
Sbjct: 236 MLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 75/259 (28%), Positives = 122/259 (47%), Gaps = 33/259 (12%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLL 71
G +G+G +G+V A ++ +G AVK +E I + ++ EI TLK L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
H N+V+ ++ + + LEYV GG + + + GR +E R +Q+++GL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN- 175
+N+L+D+ G KISDFG+S D+ + GS ++APEV+ +
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 176 -RGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGDFKLP------KWLSP 227
+GY A DIWS G ++ + G P+ D+ +A ++ K+ P LSP
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-KLGNKRSAPPIPPDVSMNLSP 243
Query: 228 GAQNLLRKILEPNPVKRIT 246
A + L NP R T
Sbjct: 244 VALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 68/249 (27%), Positives = 127/249 (51%), Gaps = 26/249 (10%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
R +G G++ KV + + +A+K+++K + + D ++ E + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG------------ 126
LH + S++++V+EYV GG+L + + +L E R ++
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 127 ---LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
L+N+LLD+ G+IK++D+G+ + T CG+PNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 184 DIWSCGVILYVILTGYLPFD------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKI 236
D W+ GV+++ ++ G PFD D N L+Q I ++P++LS A ++L+
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 237 LEPNPVKRI 245
L +P +R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 76/262 (29%), Positives = 121/262 (46%), Gaps = 28/262 (10%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG +++ + +G+G F V A L G A+K ++ ++ K +EI LK L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGEL---FDKIASKGRL-QEAEGRKLFQQLIDGLE 128
HPNV++ +++ +VLE G+L + RL E K F QL LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 172
N+ + + G +K+ D GL + F H+ G+P Y++PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLG---RFFSSKTTAAHSLVGTPYYMSPER 177
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFK-LPK-WLSPG 228
+ GY+ SDIWS G +LY + PF D NL L +KI + D+ LP S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 229 AQNLLRKILEPNPVKRITIAGI 250
++L+ + + P+P KR I+ +
Sbjct: 237 LRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 65/252 (25%), Positives = 115/252 (45%), Gaps = 27/252 (10%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKLLKHPN 75
G+ LG G F A+D+ +G AVK + ++ + +++EI + L HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
++R+ S + +E++ GG + ++ G +EA +QL+ GL
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 128 -------ENILLDSKGN-IKISDFGLSA-LPQHFRDDGLLH-TTCGSPNYVAPEVLANRG 177
N+L+DS G ++I+DFG +A L G G+ ++APEVL
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----GDFKLPKWLSPGAQNL 232
Y G + D+WS G ++ + T P++ + IF+ +P+ LSPG +++
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 233 LRKILEPNPVKR 244
+ LE P R
Sbjct: 244 TLRCLELQPEDR 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 81/266 (30%), Positives = 124/266 (46%), Gaps = 46/266 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--------EKNRIIHLKITDQIKREIA 66
+Y + R LG G G V A+ + G PFAVK++ +KNR + E+
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA---------QAEVC 83
Query: 67 TLKLLKHPNVVRLHEVLASK--------SKIYMVLEYVTGGELFDKIASKGR----LQEA 114
L ++V+ HE A K I +VL+Y G+L +I S+ + +E
Sbjct: 84 CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH 143
Query: 115 EGRKLFQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLH 159
E LF Q++ + NILL S G +K+ DFG S + D +
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR 203
Query: 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 219
T CG+P YVAPE+ + Y +D++S GV+LY +LT PFD N+ + K G +
Sbjct: 204 TFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262
Query: 220 K-LPKWLSPGAQNLLRKILEPNPVKR 244
LP +SP Q ++ +L +P +R
Sbjct: 263 DPLPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 75/262 (28%), Positives = 124/262 (47%), Gaps = 36/262 (13%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLKHPNVVR 78
LG+G FGKV AQ ++GL A KI I ++ ++++ EI L KHPN+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKI------IQIESEEELEDFMVEIDILSECKHPNIVG 66
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGLE--------- 128
L+E ++K+++++E+ GG L + R L E + R + +Q+++ L
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 129 ------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRG 177
NILL G++K++DFG+SA + T G+P ++APEV+A +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLR 234
YD +DIWS G+ L + P + N + KI + + P S + L+
Sbjct: 185 YD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243
Query: 235 KILEPNPVKRITIAGIKADEWF 256
L +P R T A + +
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 85/318 (26%), Positives = 125/318 (39%), Gaps = 85/318 (26%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKL 70
+L YE+ LGEG FG+V A+ + +G A+K IL N IT REI LK
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL--REIKILKK 63
Query: 71 LKHPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKL 119
LKHPNVV L ++ + +YMV Y+ G L + +L E++ +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCY 120
Query: 120 FQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164
QL++G+ NIL+D++G +KI+DFGL+ + + G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA---RPYDGPPPNPKGGGG 177
Query: 165 PN------------YVAPE-VLANRGYDGATSDIWSCGVILYVILTG--YLP-FDDRNLA 208
Y PE +L R Y A DIW G + + T L D +
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 209 VLYQKIFR-----GDFKLPKWLS-PGAQN------------------------LLRKILE 238
IF+ + P W S PG + LL K+L
Sbjct: 237 ---HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293
Query: 239 PNPVKRITIAGIKADEWF 256
+P KR+T + +F
Sbjct: 294 LDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 70/283 (24%), Positives = 107/283 (37%), Gaps = 55/283 (19%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKL 70
+YE+ +GEG +G V ++ +G A+K E + + RE+ L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL--- 127
L+H N+V L E K ++Y+V EYV L AS G L R QL+ +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 128 ------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 175
ENIL+ G +K+ DFG A R L + Y APE+L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGF-ARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 176 RGYDGATSDIWSCGVI-------------------LYVILTGYLPFDDRNLAVLYQ-KIF 215
G D+W+ G I LY+I P + + F
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235
Query: 216 RG------------DFKLPKWLSPGAQNLLRKILEPNPVKRIT 246
G + + P +S A + L+ L +P +R+T
Sbjct: 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 79/263 (30%), Positives = 126/263 (47%), Gaps = 44/263 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
YEL + +G G +G V A+D+ +G A+K++ K+ I++EI+ LK
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI--------KLEPGDDFEIIQQEISMLK 55
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGLE 128
+HPN+V + K+++V+EY GG L D ++G L E + + ++ + GL
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
NILL G++K++DFG+SA Q + G+P ++APEV
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVA 173
Query: 174 ANR---GYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP------K 223
A GYDG DIW+ G+ + P FD + L+ I + +F P K
Sbjct: 174 AVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFL-ISKSNFPPPKLKDKEK 231
Query: 224 WLSPGAQNLLRKILEPNPVKRIT 246
W SP + ++K L +P KR T
Sbjct: 232 W-SPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 75/285 (26%), Positives = 113/285 (39%), Gaps = 66/285 (23%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
Y+ +GEG +G V A+D +G A+K K ++ REI LK L H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57
Query: 74 PNVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
PN+++L +V K +Y+V E++ T K +G L E+ + QL+ GL
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APE 171
EN+L++++G +K++DFGL+ F +T +YV APE
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARS---FGSPVRPYT-----HYVVTRWYRAPE 168
Query: 172 VLANRGYDGATSDIWSCGVILYVILTG--YLPFDD-----------------RNLAVLYQ 212
+L DIWS G I +L+ P
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228
Query: 213 KIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKRIT 246
F PK SP A +LL ++L +P KRIT
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 80/282 (28%), Positives = 136/282 (48%), Gaps = 44/282 (15%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----KREIA 66
M+ +++ + +G G FG+V+ + S +A+K+L K +I K +D +R+I
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDI- 96
Query: 67 TLKLLKHPN---VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
+ H N +V+LH +YMV+EY+ GG+L + + S + E R ++
Sbjct: 97 ----MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEV 151
Query: 124 IDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPN 166
+ L +N+LLD G++K++DFG +G++ T G+P+
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPD 208
Query: 167 YVAPEVLANRGYD---GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKL 221
Y++PEVL ++G D G D WS GV LY +L G PF +L Y KI +
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF 268
Query: 222 PK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 259
P +S A++L+ L V+ R + IK+ +F+ D
Sbjct: 269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 9e-23
Identities = 76/263 (28%), Positives = 121/263 (46%), Gaps = 40/263 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKH 73
YEL +G G V A L + A+K LEK + D++++E+ + H
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS----VDELRKEVQAMSQCNH 58
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGLE-- 128
PNVV+ + ++++V+ Y++GG L D + S G L EA + ++++ GLE
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 129 -------------NILLDSKGNIKISDFGLSALPQHFRDDG-----LLHTTCGSPNYVAP 170
NILL G++KI+DFG+SA D G + T G+P ++AP
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS---LADGGDRTRKVRKTFVGTPCWMAP 175
Query: 171 EVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLP-----K 223
EV+ GYD +DIWS G+ + TG P+ + VL + L K
Sbjct: 176 EVMEQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 224 WLSPGAQNLLRKILEPNPVKRIT 246
S + ++ L+ +P KR T
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 89/312 (28%), Positives = 125/312 (40%), Gaps = 83/312 (26%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+TLG G FG+V A+ +D+ +A+K L K ++ +K E L + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----------- 128
+ K +Y V++Y+ GG++ + G E R +L +E
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 129 ----NILLDSKGNIKISDFGL---------SALPQ---HFRDDG---------------- 156
NIL+D G+IK++DFGL S Q H R D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 157 -----------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 199
L H+ G+PNY+APEVL GY D WS GVILY +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 200 LPFDDRNLAVLYQKIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIA 248
PF L Q K+ W LSP A +L+ K+ P R+
Sbjct: 246 PPF-------LAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKN 297
Query: 249 G---IKADEWFE 257
G IKA +F+
Sbjct: 298 GADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-22
Identities = 29/58 (50%), Positives = 43/58 (74%), Gaps = 1/58 (1%)
Query: 298 INAFQLIGMSSCLDLSGFFEKEDVSERK-IRFTSNHSAKDLLERIEDIVTEMGFRVQK 354
+NAF LI +SS LDLSG FE+E S++K RFTS A +++ ++E+I E+GF+V+K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 31/210 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLK 69
+ L +G+G+FG+V A D + A+K+ I L+ I D I++EI L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV------IDLEEAEDEIED-IQQEIQFLS 54
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE- 128
+ P + + + SK+++++EY GG D + G+L E + ++++ GLE
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113
Query: 129 --------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
NILL +G++K++DFG+S Q +T G+P ++APEV+
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFDD 204
GYD +DIWS G+ + G P D
Sbjct: 172 QSGYDEK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-22
Identities = 70/241 (29%), Positives = 121/241 (50%), Gaps = 23/241 (9%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLKHPNV 76
G+ LG+G FG+V D+D+G A K ++ K ++ EI LK L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 77 VRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
V+ + L +++ + + +EY+ GG + D++ + G L E+ RK +Q+++G+
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGY 178
NIL DS GN+K+ DFG S Q G + + G+P +++PEV++ GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 179 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKI 236
G +D+WS G + +LT P+ + KI + +LP +S A++ L I
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCI 245
Query: 237 L 237
Sbjct: 246 F 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 65/257 (25%), Positives = 118/257 (45%), Gaps = 30/257 (11%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ L R LG G FG+V + + A+KIL+ + ++ ++E+ LK L+H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQ---QDFQKEVQALKRLRHKH 63
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDG---LE-- 128
++ L V + +Y++ E + G L + S +G+ L A + Q+ +G LE
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRG 177
NIL+ K++DFGL+ L ++D L + P + APE A+ G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEA-ASHG 179
Query: 178 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLS--PGAQNLLR 234
SD+WS G++LY + T G +P+ N +Y +I G +++P ++
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIML 238
Query: 235 KILEPNPVKRITIAGIK 251
+ P R + ++
Sbjct: 239 ECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 71/244 (29%), Positives = 120/244 (49%), Gaps = 23/244 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKH 73
+ LG+ LG G FG+V D D+G AVK + + + K + ++ EI LK L+H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE--- 128
+V+ + L + K+ + +EY+ GG + D++ + G L E R+ +Q++ G+
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 129 ------------NILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLAN 175
NIL DS GN+K+ DFG S Q G + + G+P +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLL 233
GY G +D+WS + +LT P+ + KI K LP +S ++ L
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242
Query: 234 RKIL 237
++I
Sbjct: 243 KQIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 71/247 (28%), Positives = 112/247 (45%), Gaps = 49/247 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+KIL K ++ + I+ E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL---IDGL----- 127
VV++ K +Y+++E++ GG++ + K L E E + + ID +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 128 -------ENILLDSKGNIKISDFGLS-----------------ALPQHFRDDG------- 156
+N+LLDSKG++K+SDFGL +LP F
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 157 ---------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 207
L +T G+P+Y+APEV GY+ D WS GVI+Y +L GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 208 AVLYQKI 214
Y+K+
Sbjct: 242 QETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 68/247 (27%), Positives = 113/247 (45%), Gaps = 49/247 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG+V+ Q D+G +A+KIL K ++ + I+ E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL---IDGL----- 127
VV++ K +Y+++E++ GG++ + K L E + + ID +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 128 -------ENILLDSKGNIKISDFGL-SALPQHFRDD------------------------ 155
+N+LLD+KG++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 156 --------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 207
L ++T G+P+Y+APEV GY+ D WS GVI+Y +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 208 AVLYQKI 214
Y+K+
Sbjct: 242 QETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 65/268 (24%), Positives = 127/268 (47%), Gaps = 31/268 (11%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ +G G+FG+V+ ++ +G +A+K+++K+ ++ + + E L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL------- 127
+ +L K +Y+V+EY GG+L + + + E + +L+ +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 128 --------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVL-ANR 176
EN+L+D G+IK++DFG +A + ++++ G+P+Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 177 GYDGATSDI----WSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKWL--SPG 228
G T + WS GVI Y ++ G PF + A Y I F+ K P+ S
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWF 256
+L++ +L +R+ G+ +F
Sbjct: 240 FLDLIQSLL-CGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-22
Identities = 71/244 (29%), Positives = 125/244 (51%), Gaps = 23/244 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN--RIIHLKITDQIKREIATLKLLKH 73
+ LG+ LG+G FG+V D D+G AVK ++ + K + ++ EI LK L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE--- 128
+V+ + L + + + +E++ GG + D++ S G L E RK +Q+++G+
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 129 ------------NILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLAN 175
NIL DS GN+K+ DFG S Q G + + G+P +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFR-GDFKLPKWLSPGAQNLL 233
GY G +DIWS G + +LT P+ + +A +++ + + LP +S ++ L
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 234 RKIL 237
++I
Sbjct: 243 KRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 78/256 (30%), Positives = 118/256 (46%), Gaps = 25/256 (9%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGLE--------- 128
+K + +VL + GG+L I G EGR +F ++ GLE
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 129 ------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 182
NILLD G+I+ISD GL+ H + + G+ Y+APEV+ N Y +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 181
Query: 183 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILE 238
D W+ G +LY ++ G PF R + +++ R + + SP A++L + +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 239 PNPVKRITIAGIKADE 254
+P +R+ G A E
Sbjct: 242 KDPKERLGCQGGGARE 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 30/284 (10%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ + ++ M+ Y++ + +G G FG+V+ + S +A+K+L K +I +
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E + P VV+L +YMV+EY+ GG+L + + S + E +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTA 149
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGS 164
+++ L +N+LLD G++K++DFG + G++ T G+
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVRCDTAVGT 206
Query: 165 PNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDF 219
P+Y++PEVL ++G Y G D WS GV L+ +L G PF +L Y KI +
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266
Query: 220 KLPK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 259
P+ +S A+NL+ L V+ R + IK +F+ D
Sbjct: 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 75/264 (28%), Positives = 115/264 (43%), Gaps = 33/264 (12%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GN G V +G AVK + I+ I QI RE+ L P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGLE--------- 128
+ + I + +EY+ GG L DKI +GR+ E K+ ++ GL
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 129 -------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
NIL++S+G IK+ DFG+S + L T G+ +Y+APE + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDY-SV 178
Query: 182 TSDIWSCGVILYVILTGYLPF---DDRNLAV--LYQKIFRGDF-KLPK-WLSPGAQNLLR 234
SDIWS G+ L + TG P+ +D + L Q I +LP SP Q+ +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238
Query: 235 KILEPNPVKRITIAGIKADEWFEQ 258
L +P +R + + + ++
Sbjct: 239 LCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-21
Identities = 75/256 (29%), Positives = 116/256 (45%), Gaps = 25/256 (9%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGL---------- 127
+K + +VL + GG+L I + G E R +F ++ GL
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 128 -----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 182
ENILLD G+I+ISD GL+ + + G+ Y+APEV+ N Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 183 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILE 238
D W G ++Y ++ G PF R V +++ R + + S A+++ R++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 239 PNPVKRITIAGIKADE 254
+P R+ G A+E
Sbjct: 242 KDPGFRLGCRGEGAEE 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 68/243 (27%), Positives = 100/243 (41%), Gaps = 61/243 (25%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+TLG G FG+V A +D+ +A+K L K +++ +K E L + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----------- 128
+ K +Y V++Y+ GG++ + E R +L +E
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 129 ----NILLDSKGNIKISDFGL----------------------SALPQHFRDD------- 155
NIL+D G+IK++DFGL S P DD
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 156 ----------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 199
L H+ G+PNY+APEVL +GY D WS GVIL+ +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 200 LPF 202
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 30/275 (10%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
M+ YE+ + +G G FG+V+ + + +A+K+L K +I + E +
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI---DGL 127
P VV+L +YMV+EY+ GG+L + + S + E R +++ D +
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 158
Query: 128 ------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 173
+N+LLD G++K++DFG +G++ T G+P+Y++PEVL
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 174 ANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLS 226
++G Y G D WS GV LY +L G PF +L Y KI + P +S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275
Query: 227 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 259
A+NL+ L V+ R + IK +F+ D
Sbjct: 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 70/282 (24%), Positives = 117/282 (41%), Gaps = 65/282 (23%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ +G+G FG+V+ Q D+G +A+K L K+ + +K E L P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----------- 128
+ +Y+++E++ GG+L + E R + + +E
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 129 ----NILLDSKGNIKISDFGL--------------------SALPQHFRDDGLL------ 158
NIL+D G+IK+SDFGL S + + +
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 159 -------------------HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 199
++T G+P+Y+APE+ +GY G D WS G I++ L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 200 LPFDDRNLAVLYQKI--FRGDFKLPK--WLSPGAQNLLRKIL 237
PF N Y+KI +R P LS A++L+R+++
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 80/301 (26%), Positives = 121/301 (40%), Gaps = 90/301 (29%)
Query: 24 EGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIATLKLLKHPNV 76
EG +G V A+D +G A+K LK+ + + REI L L+HPN+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLREINILLKLQHPNI 66
Query: 77 VRLHEVLASKS--KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGLE----- 128
V + EV+ + KIYMV+EYV +L + + K ++E + L QL+ G+
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------Y 167
N+LL+++G +KI DFGL+ R+ GSP Y
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWY 172
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------- 216
APE+L D+WS G I +LT F ++ KIF+
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232
Query: 217 GDFKLPKW---------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEW 255
G +LP LS +LL ++L +P KRI+ +
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
Query: 256 F 256
F
Sbjct: 293 F 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 81/283 (28%), Positives = 123/283 (43%), Gaps = 74/283 (26%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPN 75
+GEG +G V A+D +G A+K I L+ D+ I REI+ LK L HPN
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK------IRLETEDEGVPSTAI-REISLLKELNHPN 59
Query: 76 VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGL------ 127
+VRL +V+ S++K+Y+V E++ + D G L + QL+ G+
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSH 118
Query: 128 ---------ENILLDSKGNIKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVL 173
+N+L+D +G +K++DFGL+ R G+ H + Y APE+L
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLA------RAFGVPVRTYTHEVV-TLWYRAPEIL 171
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR---------------- 216
DIWS G I ++ F D + L+ +IFR
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSL 230
Query: 217 GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 246
D+K PKW L +LL K+L +P KRI+
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 3e-20
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 42/204 (20%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-REI-ATLKLLKH 73
Y++ + LG+G FG V A++ ++G A+K + K + + + + RE+ + KL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWE--ECMNLREVKSLRKLNEH 57
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGL---- 127
PN+V+L EV ++Y V EY+ G L+ + KG+ E+ R + Q++ GL
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYV------ 168
EN+L+ +KI+DFGL+ R P +YV
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLA------R-----EIRSRPPYTDYVSTRWYR 165
Query: 169 APEVLANRGYDGATSDIWSCGVIL 192
APE+L + DIW+ G I+
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIM 189
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 38/208 (18%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
G +EL +GEG +GKV A+ +G A+KI++ II + + IK E L K
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEE-IKEEYNILRKYSN 61
Query: 73 HPNVVRLHEVLASKS------KIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQ 122
HPN+ + K+ ++++V+E GG +L + KG RL+E + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 123 LIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
+ GL NILL +K+ DFG+SA Q G +T G+P +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYW 179
Query: 168 VAPEVLA-----NRGYDGATSDIWSCGV 190
+APEV+A + YD A SD+WS G+
Sbjct: 180 MAPEVIACDEQPDASYD-ARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 81/291 (27%), Positives = 128/291 (43%), Gaps = 70/291 (24%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
LGEG + V ++ +G A+K IHL + REI+ +K LKH N+V
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKE------IHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 78 RLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
RLH+V+ +++K+ +V EY+ + D +G L + QL+ G+
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVL-AN 175
+N+L++ +G +K++DFGL+ R G+ T + Y AP+VL +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 176 RGYDGATS-DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----------GDFKLPK 223
R Y +TS DIWS G I+ ++TG F N KIFR G +LP+
Sbjct: 176 RTY--STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233
Query: 224 W------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256
+ P +LL ++L+ NP RI+ WF
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 3e-20
Identities = 78/259 (30%), Positives = 123/259 (47%), Gaps = 28/259 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI--TDQIKREIATLKLLK 72
RY L + LG+G+FG V +D + +K+L++ + L T Q +E L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGL- 127
HP +V+ H + ++ EY G +L K+ + L E + + F QL+ G+
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 128 --------------ENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
+NI L K N+ KI DFG+S L D L T G+P Y++PE
Sbjct: 121 YMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEA 176
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 231
L ++GYD + SDIWS G ILY + F+ +N + +I G LP+ S +
Sbjct: 177 LKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235
Query: 232 LLRKILEPNPVKRITIAGI 250
+++ +L +P R + A I
Sbjct: 236 IMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 68/249 (27%), Positives = 124/249 (49%), Gaps = 30/249 (12%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + ++ FA+KIL K ++ T + E L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGLE------ 128
+ LH ++ +Y+V++Y GG+L ++ + RL E R +++ ++
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLA--- 174
NIL+D G+I+++DFG S L +DG + ++ G+P+Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 175 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKW---LSPG 228
+G G D WS GV +Y +L G PF +L Y KI + F+ P +S
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 229 AQNLLRKIL 237
A++L+R+++
Sbjct: 240 AKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 5e-20
Identities = 82/329 (24%), Positives = 125/329 (37%), Gaps = 82/329 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH 73
RYEL + +G G +G V A D +G A+K + + + L +I REI L+ L+H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 74 PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE 128
N++ L ++L S +Y+V E + +L I S L + + Q++ GL+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 129 ---------------NILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYV--- 168
NIL++S ++KI DFGL+ P L YV
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-------YVVTR 170
Query: 169 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 215
APE+ L++ Y A DIWS G I +LT F R+ I
Sbjct: 171 WYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229
Query: 216 ----------------RGDFKLPKW------LSPGAQNLLRKILEPNPVKRITIAGIKAD 253
SP A +LL K+L +P KRIT A
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289
Query: 254 EWFEQDYTPA----------NPDDDEEDI 272
+ Q + P D++++
Sbjct: 290 PYLAQLHDPEDEPVAKPPFDFDFFDDDEL 318
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-20
Identities = 89/269 (33%), Positives = 135/269 (50%), Gaps = 52/269 (19%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
LG+G +G V A+DL + + A+K I E++ + + EIA LKH N+V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQY- 70
Query: 81 EVLASKS-----KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGL----- 127
L S S KI+M E V GG L + SK G L++ E +F +Q+++GL
Sbjct: 71 --LGSDSENGFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 128 ----------ENILLDS-KGNIKISDFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL 173
+N+L+++ G +KISDFG S R G+ T G+ Y+APEV+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVI 181
Query: 174 --ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFK----LPKWLS 226
RGY GA +DIWS G + + TG PF + L +F+ G FK +P+ LS
Sbjct: 182 DKGPRGY-GAPADIWSLGCTIVEMATGKPPFIE--LGEPQAAMFKVGMFKIHPEIPESLS 238
Query: 227 PGAQNLLRKILEPNPVKRITIAGIKADEW 255
A+N + + EP+P KR + + D +
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-20
Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 29/235 (12%)
Query: 37 DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL-HEVLASKSKIYMVLEY 95
+G A+K+L + + +RE A L HPN+V L A ++ V EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---N 137
V G L + +A+ G L E +L Q++D L +NI++ G +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 138 IKISDFGLSALPQHFRDDGLLHTT-----CGSPNYVAPEVLANRGYDGATSDIWSCGVIL 192
K+ DFG+ L RD + T G+P Y APE L SD+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179
Query: 193 YVILTGYLPFDDRNLA-VLYQKIFRGDFKLPKWLS--PGAQNLLRKILEPNPVKR 244
LTG ++A +LYQ++ D LP W++ P Q +LRK L +P +R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQ-VLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 9e-20
Identities = 91/324 (28%), Positives = 124/324 (38%), Gaps = 105/324 (32%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------REIATLK 69
L R +GEG +G V A+D SG A+K K R D + REI L
Sbjct: 12 LNR-IGEGTYGIVYRARDTTSGEIVALK---KVR------MDNERDGIPISSLREITLLL 61
Query: 70 LLKHPNVVRLHEVLASKS--KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLID 125
L+HPN+V L EV+ K I++V+EY L D + + E++ + L QL+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLR 119
Query: 126 GLE---------------NILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN- 166
GL+ N+LL KG +KI+DFGL+ LP +P
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM----------TPKV 169
Query: 167 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLP------------------ 201
Y APE+L Y A D+W+ G IL +L LP
Sbjct: 170 VTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228
Query: 202 -------FDDRNLAVLYQKIFRGDFKLPK-----------WLSPGAQNLLRKILEPNPVK 243
F D L G F LPK WLS LL +L +P K
Sbjct: 229 NESIWPGFSDLPLV--------GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280
Query: 244 RITIAGIKADEWFEQDYTPANPDD 267
R T +F++ P P+
Sbjct: 281 RATAEEALESSYFKEKPLPCEPEM 304
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 74/257 (28%), Positives = 115/257 (44%), Gaps = 30/257 (11%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L + + + +G G F +V A L G+P A+K ++ ++ K +EI LK L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGLE 128
HPNV++ + +++ +VLE G+L I K + E K F QL LE
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
N+ + + G +K+ D GL H+ G+P Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231
GY+ SDIWS G +LY + PF D NL L +KI + D+ P S
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSE 235
Query: 232 LLRKILE----PNPVKR 244
LR+++ P+P KR
Sbjct: 236 ELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 76/275 (27%), Positives = 125/275 (45%), Gaps = 55/275 (20%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
L R LG G FG+V + + AVK L+ + + +E +K L+H +V
Sbjct: 10 LERKLGAGQFGEV-WMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLV 64
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GLE- 128
+L+ V + + IY+V EY++ G L D L+ EG+KL QL+D G+
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 129 --------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----VAP 170
NIL+ KI+DFGL+ L DD +T + AP
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFPIKWTAP 173
Query: 171 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229
E AN G SD+WS G++L I+T G +P+ + +++ RG +++P+ P
Sbjct: 174 EA-ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPR--PPNC 229
Query: 230 ----QNLLRKILEPNPVKRITIAGIKADEWFEQDY 260
+L+ + + +P +R T ++ F +DY
Sbjct: 230 PEELYDLMLQCWDKDPEERPTFEYLQ---SFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 76/284 (26%), Positives = 126/284 (44%), Gaps = 56/284 (19%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG +G V A++ +G A+K + + + I REI+ LK L HPN+V+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66
Query: 82 VLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGL------------- 127
V+ +++K+Y+V E++ + F + + + QL+ GL
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 128 --ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGA 181
+N+L++++G IK++DFGL+ R G+ T Y APE+L Y
Sbjct: 127 KPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 182 TSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LPK 223
DIWS G I ++T P D R L + ++ G D+K PK
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240
Query: 224 W-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256
W L ++LL ++L +P KRI+ A +F
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 29/206 (14%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E +G G G V +G +A+K++ N ++ QI REI L+ + HPNV
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR--QICREIEILRDVNHPNV 134
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGL-------- 127
V+ H++ +I ++LE++ GG L IA + L + + +Q++ G+
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHI 189
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL---ANRG 177
N+L++S N+KI+DFG+S + D +++ G+ Y++PE + N G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHG 247
Query: 178 -YDGATSDIWSCGVILYVILTGYLPF 202
YDG DIWS GV + G PF
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 84/322 (26%), Positives = 131/322 (40%), Gaps = 72/322 (22%)
Query: 15 RYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----------- 62
RY G LGEG +GKV+ A D +G A+K ++ I + D+
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE+ + +KH N++ L +V I +V++ + +L + K RL E++ + + Q
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQ 127
Query: 123 LIDGLE---------------NILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGS 164
+++GL NI ++SKG KI+DFGL+ P + T
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 165 PN---------YVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 213
Y APE+L A + Y A D+WS G I +LTG F N +
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEK-YHFAV-DMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 214 IF--RG-------------------DFKLPKWLSPGAQN-------LLRKILEPNPVKRI 245
IF G + PK L N LL+ +L+ NP++RI
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305
Query: 246 TIAGIKADEWFEQDYTPANPDD 267
+ E+F+ D P +P
Sbjct: 306 SAKEALKHEYFKSDPLPCDPSQ 327
|
Length = 335 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 69/259 (26%), Positives = 123/259 (47%), Gaps = 41/259 (15%)
Query: 15 RYELGR--TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IAT 67
R L +GEG+ G V A D +G AVK ++ + Q +RE +
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD--------LRKQQRRELLFNEVVI 69
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
++ +HPN+V ++ ++++V+E++ GG L D I + R+ E + + ++ L
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKAL 128
Query: 128 E---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
+ILL S G +K+SDFG A Q ++ + G+P ++APEV
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEV 186
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGD----FKLPKWLSP 227
++ Y G DIWS G+++ ++ G P F++ L + K R + K +SP
Sbjct: 187 ISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM--KRIRDNLPPKLKNLHKVSP 243
Query: 228 GAQNLLRKILEPNPVKRIT 246
++ L ++L +P +R T
Sbjct: 244 RLRSFLDRMLVRDPAQRAT 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 79/290 (27%), Positives = 128/290 (44%), Gaps = 72/290 (24%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
YE +GEG +G V A+DL++G A+K + + ++++ REIA LK
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKK------VRVPLSEEGIPLSTLREIALLKQ 54
Query: 71 LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
L+ HPN+VRL +V + K+ +V E+V K G L + L
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLM 113
Query: 121 QQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
+QL+ G++ NIL+ S G +KI+DFGL+ + + + L + +
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTL 170
Query: 166 NYVAPEVLANRGYDGATS-DIWSCGVILYVI---------------------LTGYLPFD 203
Y APEVL Y AT D+WS G I + + G +
Sbjct: 171 WYRAPEVLLQSSY--ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228
Query: 204 D--RNLAVL---YQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRIT 246
+ RN+++ + FK +P+ + +LL+K+L NP KRI+
Sbjct: 229 EWPRNVSLPRSSFPSYTPRSFKSFVPE-ICEEGLDLLKKMLTFNPHKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 79/293 (26%), Positives = 124/293 (42%), Gaps = 71/293 (24%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
+++ +GEG +G+V A+D D+G A+K K R+ + K I REI L+ L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 74 PNVVRLHEVLASKSK----------IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQ 122
N+V L E++ K Y+V EY+ +L + S E + +Q
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-HDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 123 LIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPN 166
L++GL NILL++KG IK++DFGL+ L + ++ +T +
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--YNSEESRPYTNKVITLW 182
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVL--------------- 210
Y PE+L G D+WSCG IL + T F ++ LA L
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 211 -----------------YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 246
Y++ R +F + A +LL +L +P KR T
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSF---IPTPALDLLDHMLTLDPSKRCT 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 73/248 (29%), Positives = 124/248 (50%), Gaps = 28/248 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RYE +G+G G V A D+ +G A+K + + ++ I EI +K LK+P
Sbjct: 23 RYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKNP 76
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
N+V + ++++V+EY+ GG L D + ++ + EA+ + ++ + LE
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 179
N+LL G++K++DFG A Q + T G+P ++APEV+ + Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 180 GATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKI 236
G DIWS G++ ++ G P+ + N L LY G +L P+ LSP ++ L +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252
Query: 237 LEPNPVKR 244
LE + KR
Sbjct: 253 LEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 78/257 (30%), Positives = 118/257 (45%), Gaps = 27/257 (10%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGLE--------- 128
+K + +VL + GG+L I + G E R +F +L GLE
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 129 ------NILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
NILLD +G+I+ISD GL+ +P+ G + G+ Y+APEV+ N Y
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKY-TF 180
Query: 182 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKIL 237
+ D W G ++Y ++ G PF R V +++ R + + S A+++ R +L
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 238 EPNPVKRITIAGIKADE 254
NP +R+ G A
Sbjct: 241 TKNPKERLGCRGNGAAG 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 78/257 (30%), Positives = 118/257 (45%), Gaps = 36/257 (14%)
Query: 15 RYELGRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR-----EIATL 68
Y R LG+G FG+ + + D L V E ++L + +R EI L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSL---VVWKE----VNLTRLSEKERRDALNEIVIL 53
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAE--GRKLFQ---- 121
LL+HPN++ + + + + +EY GG L+DKI KG+L E E LFQ
Sbjct: 54 SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113
Query: 122 ----QLIDGLE------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAP 170
L NI L G IK+ DFG+S + + + T G+P Y++P
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS---KILGSEYSMAETVVGTPYYMSP 170
Query: 171 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGA 229
E+ Y+ SDIW+ G +LY +LT FD N L KI +G++ + S
Sbjct: 171 ELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSEL 229
Query: 230 QNLLRKILEPNPVKRIT 246
+L+ +L+ +P KR T
Sbjct: 230 ISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 75/268 (27%), Positives = 116/268 (43%), Gaps = 52/268 (19%)
Query: 22 LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
LG+G+FG V+ + SG +P AVK L+ +++ I D +E A + L H N++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENLIR 60
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGR------------LQEAEGRKLFQQ--LI 124
L+ V+ + + MV E G L D++ +Q A G + + I
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 125 D---GLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV------------ 168
NILL S +KI DFGL ALPQ +YV
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQ------------NEDHYVMEEHLKVPFAWC 167
Query: 169 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 225
APE L R + A SD+W GV L+ + T G P+ + + + +KI + +L P+
Sbjct: 168 APESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEAC 226
Query: 226 SPGAQNLLRKILEPNPVKRITIAGIKAD 253
N++ + NP R T A ++
Sbjct: 227 PQDIYNVMLQCWAHNPADRPTFAALREF 254
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL------QEAE 115
+ E+ L H +V+ + S K+ +++EY +GG+L +I K RL QE E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYE 170
Query: 116 GRKLFQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLL-- 158
LF Q++ L+ NI L G IK+ DFG S + + D L
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS---KQYSDSVSLDV 227
Query: 159 -HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 217
+ CG+P Y+APE+ + Y +D+WS GVILY +LT + PF + + Q++ G
Sbjct: 228 ASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286
Query: 218 DFK-LPKWLSPGAQNLLRKILEPNPVKRIT 246
+ P +S G + LL +L NP R T
Sbjct: 287 KYDPFPCPVSSGMKALLDPLLSKNPALRPT 316
|
Length = 478 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 2e-18
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 41/202 (20%)
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG----- 126
+PN ++L+ + + ++++Y+ G+LFD + +G+L EAE +K+ +QL++
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 127 ----------LENILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEV 172
LEN+L D +K I + D+GL P + DG L +Y +PE
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--DGTL-------DYFSPEK 177
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVLYQKIFRGDFKLPKW 224
+ YD + D W+ GV+ Y +LTG PF + L QK K
Sbjct: 178 IKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKN 232
Query: 225 LSPGAQNLLRKILEPNPVKRIT 246
+S A + ++ +L+ N R+T
Sbjct: 233 VSKNANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 79/293 (26%), Positives = 126/293 (43%), Gaps = 80/293 (27%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIAT 67
+YE +GEG +G V A++ ++ A+K +++ D + REI
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREICL 52
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLID 125
LK LKH N+VRL++VL S K+ +V EY + FD + G + + QL+
Sbjct: 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLK 110
Query: 126 GL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN---- 166
GL +N+L++ G +K++DFGL+ R G + C S
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA------RAFG-IPVRCYSAEVVTL 163
Query: 167 -YVAPEVL-ANRGYDGATS-DIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFR------ 216
Y P+VL + Y TS D+WS G I + P F ++ ++IFR
Sbjct: 164 WYRPPDVLFGAKLYS--TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221
Query: 217 -----GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRIT 246
G KLP + L+ ++LL+ +L NPV+RI+
Sbjct: 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 33/209 (15%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKHP 74
EL R LGEG G V + ++G+ FA+K + + N + QI RE+ K K P
Sbjct: 5 ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ----KQILRELEINKSCKSP 59
Query: 75 NVVRLHE--VLASKSKIYMVLEYVTGGEL---FDKIASKG-RLQEAEGRKLFQQLIDGLE 128
+V+ + + S S I + +EY GG L + K+ +G R+ E K+ + ++ GL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
NILL KG +K+ DFG+S + L T G+ Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV----NSLAGTFTGTSFYMAPERI 175
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPF 202
+ Y TSD+WS G+ L + PF
Sbjct: 176 QGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 71/260 (27%), Positives = 121/260 (46%), Gaps = 25/260 (9%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
+G G FG+V + D+G +A+K L+K RI + E L L+ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---------- 128
+ + K+ +L+ + GG+L ++ G E E R ++I GLE
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 129 -----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 183
NILLD G+++ISD GL+ + H + G+ Y+APEVL +++
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSA 177
Query: 184 DIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240
D +S G +L+ +L G+ PF ++ + + + +LP SP ++LL +L+ +
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237
Query: 241 PVKRITIAGIKADEWFEQDY 260
KR+ G A E E +
Sbjct: 238 VSKRLGCLGRGAQEVKEHVF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-18
Identities = 73/259 (28%), Positives = 115/259 (44%), Gaps = 26/259 (10%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +++ + +G G F +V A L P A+K ++ ++ K +EI LK L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGLE 128
HPNV++ + +++ +VLE G+L I K + E K F QL +E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
N+ + + G +K+ D GL H+ G+P Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDF-KLPK-WLSPGA 229
GY+ SDIWS G +LY + PF D NL L QKI + D+ LP S
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 230 QNLLRKILEPNPVKRITIA 248
+ L+ + P+P +R I
Sbjct: 238 RELVSMCIYPDPDQRPDIG 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 7e-18
Identities = 69/253 (27%), Positives = 120/253 (47%), Gaps = 35/253 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLK 69
+Y +G+G G V A D+ +G A+K + + Q K+E I ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE- 128
KHPN+V + ++++V+EY+ GG L D + ++ + E + + ++ + LE
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 129 --------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
NILL G++K++DFG A Q + T G+P ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQN 231
+ Y G DIWS G++ ++ G P+ + N L LY G + + P+ LS ++
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247
Query: 232 LLRKILEPNPVKR 244
L + LE + KR
Sbjct: 248 FLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 76/272 (27%), Positives = 131/272 (48%), Gaps = 34/272 (12%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + ++G +A+KIL K ++ T + E L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQL---IDGL---- 127
+ LH ++ +Y+V++Y GG+L ++ RL E R ++ ID +
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 128 --------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLA--- 174
+N+LLD G+I+++DFG S L DG + + G+P+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 175 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLP---KWLSPG 228
+G G D WS GV +Y +L G PF +L Y KI + F+ P +S
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239
Query: 229 AQNLLRKILEPNPVKRITIAGI---KADEWFE 257
A++L+R+++ P R+ G+ K +FE
Sbjct: 240 AKDLIRRLICS-PETRLGRNGLQDFKDHPFFE 270
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 82/324 (25%), Positives = 133/324 (41%), Gaps = 65/324 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G+V A D +G A+K L + IH K T RE+ LK +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT---YRELRLLKHMD 72
Query: 73 HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V L +Y+V + G +L + + + +L + + L Q++ G
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRG 130
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
L+ NI ++ +KI DFGL+ D + + Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPE 185
Query: 172 VLANRGYDGATSDIWSCGVILYVILTGYLPF----------------------------- 202
++ N + T DIWS G I+ +LTG F
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 203 -DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260
RN ++ + DFK + +P A +LL K+L +P KRIT A A + + +
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305
Query: 261 TPAN-PDDDEEDIFVDNEAFSMHE 283
P + P D ++ ++ E
Sbjct: 306 DPEDEPVAPPYDQSFESRDLTVDE 329
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 62/202 (30%), Positives = 88/202 (43%), Gaps = 34/202 (16%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+G+GNFG V + L AVK LK + +E LK HPN+V+L
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKL 57
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLID---GLE------- 128
V K IY+V+E V GG L + K RL +KL Q +D G+E
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKNC 114
Query: 129 --------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANR 176
N L+ +KISDFG+S + G+ + G + APE L N
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEAL-NY 169
Query: 177 GYDGATSDIWSCGVILYVILTG 198
G + SD+WS G++L+ +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 82/322 (25%), Positives = 128/322 (39%), Gaps = 86/322 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+YE+ +G G +G+V A+ + G +A+K + ++ + I+ REIA L+ LK
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 73 HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
H NVV L EV + +Y++ +Y +L+ I A + + + + L Q+++
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 126 GL---------------ENILL----DSKGNIKISDFGL-----SALPQHFRDDGLLHTT 161
G+ NIL+ +G +KI D GL + L D ++ T
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 162 CGSPNYVAPEV-LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQ---- 212
Y APE+ L R Y A DIW+ G I +LT F + +Q
Sbjct: 180 W----YRAPELLLGARHYTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234
Query: 213 -KIFR-----------------------GDFK--------LPKW------LSPGAQNLLR 234
+IF DFK L KW +LLR
Sbjct: 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294
Query: 235 KILEPNPVKRITIAGIKADEWF 256
K+LE +P KRIT +F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 73/244 (29%), Positives = 114/244 (46%), Gaps = 27/244 (11%)
Query: 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILE---KNRIIHLKITDQIKREIATLKLLKHPN 75
G LG+G +G V + + G AVK +E N + K ++++ E+ LK LKH N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------- 128
+V+ + I + +E+V GG + + G L E K +Q++DG+
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 129 --------NILLDSKGNIKISDFG----LSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
N++L G IK+ DFG L+ + H +L + G+P ++APEV+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL 233
GY G SDIWS G ++ + TG P DR A+ Y RG +LP S A + +
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242
Query: 234 RKIL 237
L
Sbjct: 243 TSCL 246
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 73/261 (27%), Positives = 123/261 (47%), Gaps = 27/261 (10%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
+G G FG+V + D+G +A+K L+K RI + E L L+ P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---------- 128
+ + K+ +L+ + GG+L ++ G EAE R ++I GLE
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 129 -----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGAT 182
NILLD G+++ISD GL+ + H + G+ Y+APEVL YD ++
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-SS 176
Query: 183 SDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 239
+D +S G +L+ +L G+ PF ++ + + +LP SP ++LL +L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236
Query: 240 NPVKRITIAGIKADEWFEQDY 260
+ +R+ G A E E +
Sbjct: 237 DVNRRLGCLGRGAQEVKEHPF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 66/249 (26%), Positives = 121/249 (48%), Gaps = 30/249 (12%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ + +G G FG+V + + +A+KIL K ++ T + E L
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL------- 127
+ LH ++ +Y+V++Y GG+L ++ + RL E R +++ +
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 128 --------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLA--- 174
+N+LLD G+I+++DFG S L + DG + ++ G+P+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMN--QDGTVQSSVAVGTPDYISPEILQAME 179
Query: 175 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKWL---SPG 228
G G D WS GV +Y +L G PF +L Y KI + F+ P + S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 229 AQNLLRKIL 237
A++L+++++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 69/215 (32%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R LG+G FG+V Q +G +A K LEK RI K E L+ + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGL---------- 127
+K + +VL + GG+L I + G E R LF +++ GL
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 128 -----ENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
ENILLD G+I+ISD GL+ +P+ + G+ Y+APEVL N+ Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPE----GESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 182 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 216
+ D W G ++Y ++ G PF R V +++ R
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 73/254 (28%), Positives = 118/254 (46%), Gaps = 29/254 (11%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G GNFG+V + P AVK + LK + +E LK HPN+VRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGLE------------ 128
V K IY+V+E V GG+ + ++G RL+ E ++ + G+E
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 129 ---NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGA 181
N L+ K +KISDFG+S +DG+ +T G + APE L N G +
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEAL-NYGRYSS 175
Query: 182 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA-QNLLRKILEP 239
SD+WS G++L+ + G +P+ + + + I +G L P A L+ + E
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 240 NPVKRITIAGIKAD 253
+P +R + + + +
Sbjct: 236 DPGQRPSFSTVHQE 249
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 78/285 (27%), Positives = 122/285 (42%), Gaps = 63/285 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
+YE +GEG++G V ++ ++G A+K E + +I KI REI LK L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIA---LREIRMLKQL 57
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
KHPN+V L EV K K+++V EY L + + + E +K+ Q + +
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVLAN 175
ENIL+ +G IK+ DFG + + DD +T + Y APE+L
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVG 174
Query: 176 RGYDGATSDIWSCGVILYVILTG-------------YLPFDDRNLAVLY---QKIFR-GD 218
G D+W+ G + +LTG YL + L L Q+IF
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI--RKTLGDLIPRHQQIFSTNQ 232
Query: 219 F-----------------KLPKWLSPGAQNLLRKILEPNPVKRIT 246
F K P +S A + L+ L+ +P +R++
Sbjct: 233 FFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-17
Identities = 65/251 (25%), Positives = 114/251 (45%), Gaps = 35/251 (13%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+LG T+G+G FG V G AVK L+ E + + L+HPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHPNL 62
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ-QLIDGLE------ 128
V+L V+ + +Y+V EY+ G L D + S+GR + + F + +G+E
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 178
N+L+ K+SDFGL+ ++ + P + APE L + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEALREKKF 176
Query: 179 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRK 235
SD+WS G++L+ I + G +P+ L + + +G +++ P+ P +++
Sbjct: 177 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKD 234
Query: 236 ILEPNPVKRIT 246
E +P KR T
Sbjct: 235 CWELDPAKRPT 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 7e-17
Identities = 68/259 (26%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-----LKL 70
Y R +G+G++G+V + G + +K L +L+ + +R+ A L
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKL------NLRNASRRERKAAEQEAQLLSQ 55
Query: 71 LKHPNVVRLHEVLASKS-KIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGL 127
LKHPN+V E + +Y+V+ + GG+L+ K+ KG+L E + + F Q+ L
Sbjct: 56 LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 128 E---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
+ N+ L IK+ D G++ + ++ D + T G+P Y++PE+
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPEL 173
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 231
+N+ Y+ SD+W+ G +Y + T F+ +++ L +I G +PK SP
Sbjct: 174 FSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE 232
Query: 232 LLRKILEPNPVKRITIAGI 250
L+ +L P KR ++ I
Sbjct: 233 LIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-17
Identities = 80/260 (30%), Positives = 123/260 (47%), Gaps = 41/260 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ---IKREIATLKLLK 72
YEL + +G G +G V A++L +G AVKI I L+ D I++EI +K K
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKI------IKLEPGDDFSLIQQEIFMVKECK 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
H N+V S+ K+++ +EY GG L D G L E + + ++ + GL
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--- 174
NILL G++K++DFG++A + + G+P ++APEV A
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLP--FDDRNLAVLYQKIFRGDFKLP------KWLS 226
N GY+ DIW+ G I + L P FD + L+ + + +F+ P KW S
Sbjct: 183 NGGYN-QLCDIWAVG-ITAIELAELQPPMFDLHPMRALFL-MSKSNFQPPKLKDKTKW-S 238
Query: 227 PGAQNLLRKILEPNPVKRIT 246
N ++ L NP KR T
Sbjct: 239 STFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 26/201 (12%)
Query: 20 RTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LGEG+FGKV+ ++G AVK L + +D +REI L+ L H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSD-FEREIEILRTLDHEN 67
Query: 76 VVRLHEVL--ASKSKIYMVLEYVTGGELFD-------KIASKGRL----QEAEGRKLF-- 120
+V+ V + +++EY+ G L D +I K L Q +G
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 121 QQLID---GLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANR 176
Q+ I NIL++S+ +KISDFGL+ + +D + SP + APE L
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187
Query: 177 GYDGATSDIWSCGVILYVILT 197
+ A SD+WS GV LY + T
Sbjct: 188 KFSSA-SDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLKHPNVV 77
LG+GN+G V +G+ A+K I L++ + QI E+ L P +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKE------IRLELDESKFNQIIMELDILHKAVSPYIV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
+ + +YM +EY+ G +L+ + + E R++ ++ GL+
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
N+L++ G +K+ DFG+S L T G +Y+APE + + G
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGN----LVASLAKTNIGCQSYMAPERIKSGGP 178
Query: 179 DGA-----TSDIWSCGVILYVILTGYLPFDDRNLAVLY---QKIFRGD-FKLPKWLSPGA 229
+ SD+WS G+ + + G P+ A ++ I GD LP S A
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238
Query: 230 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 268
Q+ + K L P +R T A + W + N D D
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKY---KNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 76/282 (26%), Positives = 122/282 (43%), Gaps = 71/282 (25%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKLLKHPNV 76
+GEG +G V ++ +G A+K I L+ ++ REI+ LK L+HPN+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKK------IRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 77 VRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
V L +VL +S++Y++ E+++ + D + + + Q++ G+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 128 --------ENILLDSKGNIKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVLA 174
+N+L+D+KG IK++DFGL+ R G+ H + Y APEVL
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLA------RAFGIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFR----------------G 217
DIWS G I + T F D + L+ +IFR
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF-RIFRILGTPTEDVWPGVTSLP 233
Query: 218 DFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 246
D+K PKW L +LL K+L +P KRI+
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 70/258 (27%), Positives = 124/258 (48%), Gaps = 36/258 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLK 72
+E+ LG+G FGKV AQ+ ++G +L ++I K ++++ EI L
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETG------VLAAAKVIDTKSEEELEDYMVEIDILASCD 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGLE--- 128
HPN+V+L + ++ +++++E+ GG + + R L E + R + +Q ++ L
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 129 ------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--- 173
NIL G+IK++DFG+SA ++ R + G+P ++APEV+
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 174 --ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPG 228
+R YD +D+WS G+ L + P + N + KI + + P S
Sbjct: 179 TSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237
Query: 229 AQNLLRKILEPNPVKRIT 246
++ L+K LE N R T
Sbjct: 238 FKDFLKKCLEKNVDARWT 255
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 80/270 (29%), Positives = 129/270 (47%), Gaps = 44/270 (16%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP 74
+E+ T+G+G +GKV + +G AVKIL+ IH I ++I+ E LK L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP---IH-DIDEEIEAEYNILKALSDHP 75
Query: 75 NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRK------LFQQL 123
NVV+ + + K ++++VLE GG + D + KG L+ E + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133
Query: 124 IDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 168
+ GL+ NILL ++G +K+ DFG+SA R +T+ G+P ++
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 191
Query: 169 APEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFK 220
APEV+A + YD A D+WS G+ + G P D + KI R
Sbjct: 192 APEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250
Query: 221 LPKWLSPGAQNLLRKILEPNPVKRITIAGI 250
P+ S + +RK L + KR T++ +
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 35/268 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPF-AVK-------ILEKNRIIHLKITDQIKREIAT 67
Y + LG G FG V + ++G A+K K++ K I E+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 68 LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTG---GELFDKIASKG-RLQEAEGRKLFQQ 122
+K L+HPN+VR ++ ++Y+V++ + G GE F+ + K R E +F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 123 LIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166
++ L NI+L + I+DFGL+ Q + L + G+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESKLTSVVGTIL 178
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWL 225
Y PE++ N Y G +D+W+ G ILY + T PF N+ L KI ++ LP+ +
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 226 -SPGAQNLLRKILEPNPVKRITIAGIKA 252
S +++ L P+ R I + A
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 79/295 (26%), Positives = 125/295 (42%), Gaps = 63/295 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
+YE +GEG++G V + ++G A+K E ++++ KI REI LK L
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVK-KIA---MREIRMLKQL 57
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
+H N+V L EV K ++Y+V E+V L D L E+ RK Q++ G+
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 128 -----------ENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVL 173
ENIL+ G +K+ DFG + A P D + + Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELL 172
Query: 174 ANRGYDGATSDIWSCGVILYVILTG--YLPFDDR------------NLAVLYQKIFRG-- 217
G DIW+ G ++ +LTG P D NL +Q+IF+
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 218 ----------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256
+ + PK S +L ++ L +P R + + + E+F
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 37/204 (18%)
Query: 22 LGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LG+GNFG V+ QD ++G AVK L+ + HL+ +REI LK L+H N+
Sbjct: 12 LGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHSTAEHLR---DFEREIEILKSLQHDNI 67
Query: 77 VRLHEVLASKSK--IYMVLEYVTGGELFDK-IASKGRLQEAEGRKLFQ---QLIDGLE-- 128
V+ V S + + +V+EY+ G L D + RL + RKL Q+ G+E
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKGMEYL 124
Query: 129 -------------NILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNY-VAPEVL 173
NIL++S+ +KI DFGL+ LPQ ++ + SP + APE L
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESPIFWYAPESL 183
Query: 174 ANRGYDGATSDIWSCGVILYVILT 197
+ A SD+WS GV+LY + T
Sbjct: 184 TESKFSVA-SDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 75/267 (28%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q +G +A K L K R+ K + E L + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEA--EGRKLF--QQLIDGLE--------- 128
+K+ + +V+ + GG+L I + E R F Q+I GLE
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 129 ------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGYDG 180
N+LLD+ GN++ISD GL+ + DG T G+P ++APE+L YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELK----DGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 181 ATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKI 236
+ D ++ GV LY ++ PF R V L Q+I P SP +++ +
Sbjct: 177 SV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235
Query: 237 LEPNPVKRI-----TIAGIKADEWFEQ 258
L +P KR+ G++ F
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 34/259 (13%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E+ LG+G FGKV A++ ++G A K++E L + EI L HP
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPY 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGLE------ 128
+V+L K+++++E+ GG + + R L E + + + +Q+++ L+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 129 ---------NILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV----- 172
N+LL G+IK++DFG+SA + R D + G+P ++APEV
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCET 186
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGA 229
+ + YD +DIWS G+ L + P + N + KI + + P S
Sbjct: 187 MKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 230 QNLLRKILEPNPVKRITIA 248
++ L+ L+ +P R + A
Sbjct: 246 RDFLKTALDKHPETRPSAA 264
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 67/253 (26%), Positives = 121/253 (47%), Gaps = 35/253 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
+Y +G+G G V A D+ +G A+K + + Q K+E+ ++L
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71
Query: 72 --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-- 127
K+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + L
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 128 -------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
+NILL G++K++DFG A Q + T G+P ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQN 231
+ Y G DIWS G++ ++ G P+ + N L LY G +L P+ LS ++
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247
Query: 232 LLRKILEPNPVKR 244
L + LE + +R
Sbjct: 248 FLNRCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 38/264 (14%)
Query: 16 YELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
+E+ RT LG G +G+V L AVK L+++ + ++ +E A +
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 56
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
K +KHPN+V+L V + Y++ E++T G L D + R QE L Q+
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISS 115
Query: 126 GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVA 169
+E N L+ +K++DFGLS L D H P + A
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTA 173
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLS 226
PE LA + SD+W+ GV+L+ I T G P+ +L+ +Y+ + +G +++ P+
Sbjct: 174 PESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCP 231
Query: 227 PGAQNLLRKILEPNPVKRITIAGI 250
P L+R + NP R + A I
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 66/255 (25%), Positives = 123/255 (48%), Gaps = 39/255 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
+Y +G+G G V A D+ +G A++ + + Q K+E+ ++L
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72
Query: 72 --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE- 128
K+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + LE
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 129 --------------NILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 172
NILL G++K++DFG A P+ + ++ G+P ++APEV
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEV 187
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGA 229
+ + Y G DIWS G++ ++ G P+ + N L LY G +L P+ LS
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 230 QNLLRKILEPNPVKR 244
++ L + L+ + KR
Sbjct: 247 RDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 70/251 (27%), Positives = 124/251 (49%), Gaps = 41/251 (16%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLKLLKHPNV 76
+GEG+ G V A++ SG AVK+++ + Q +RE + ++ +H NV
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--------LRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL--------- 127
V +++ ++++++E++ GG L D I S+ RL E + + + ++ L
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVI 139
Query: 128 ------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
++ILL G +K+SDFG A Q +D + G+P ++APEV++ Y G
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GT 196
Query: 182 TSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRK 235
DIWS G+++ ++ G P F D + + K R D PK +SP ++ L +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--KRLR-DSPPPKLKNAHKISPVLRDFLER 253
Query: 236 ILEPNPVKRIT 246
+L P +R T
Sbjct: 254 MLTREPQERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 78/292 (26%), Positives = 120/292 (41%), Gaps = 81/292 (27%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLK- 72
Y++ +GEG F +V AQ +G +A+K ++K H K +Q+ REI L+ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 73 HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGL 127
HPN++RL EVL + ++ +V E + L++ I KGR L E + QL+ L
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSL 113
Query: 128 ---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---- 168
ENIL+ +K++DFG S P Y
Sbjct: 114 DHMHRNGIFHRDIKPENILIK-DDILKLADFG-SC-----------RGIYSKPPYTEYIS 160
Query: 169 -----APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----------------- 206
APE L GY G DIW+ G + + IL+ + F N
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220
Query: 207 -LAVLYQKIFRGDFKLPK-------WL----SPGAQNLLRKILEPNPVKRIT 246
+ ++K ++ P L S +LL+K+L +P +RIT
Sbjct: 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLK 72
+YE +G+G FG+V A+ + A+K +L +N IT REI L+LLK
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL--REIKILQLLK 69
Query: 73 HPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKLFQ 121
H NVV L E+ +K+ Y+V E+ G L +K + +E +K+ +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMK 126
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTT-CGS 164
L++GL NIL+ G +K++DFGL+ A +T +
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 165 PNYVAPEVLAN-RGYDGATSDIWSCGVIL 192
Y PE+L R Y G D+W G I+
Sbjct: 187 LWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 72/245 (29%), Positives = 113/245 (46%), Gaps = 46/245 (18%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-K 72
+E+ T+G+G +GKV + G AVKIL+ + ++I+ E L+ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 73 HPNVVRLHEVL-----ASKSKIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQL 123
HPNVV+ + + ++++VLE GG EL + G RL EA +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 124 IDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 168
+ GL+ NILL ++G +K+ DFG+SA R +T+ G+P ++
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 195
Query: 169 APEVLA-----NRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP 222
APEV+A + YD A D+WS G+ + G P FD + L FK+P
Sbjct: 196 APEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFDMHPVKTL--------FKIP 246
Query: 223 KWLSP 227
+ P
Sbjct: 247 RNPPP 251
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 7e-15
Identities = 40/137 (29%), Positives = 72/137 (52%), Gaps = 15/137 (10%)
Query: 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
G FGKV + ++ +AVK+++K +I+ + Q++ E L L K P +V L+ L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---------------N 129
S + +Y+V+EY+ GG++ + G E K ++ L+ N
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 130 ILLDSKGNIKISDFGLS 146
+L+ ++G+IK++DFGLS
Sbjct: 135 MLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 67/255 (26%), Positives = 121/255 (47%), Gaps = 31/255 (12%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+EL + +G G +G V A+++++G A+K++ ++ + +++EI +K KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
+V + K+++ +E+ GG L D G L E++ + ++ + GL
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--NRGY 178
NILL G++K++DFG+SA Q + G+P ++APEV A +G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 179 DGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP------KWLSPGAQN 231
DIW+ G+ + P FD + L+ + + +F+ P KW S +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MTKSNFQPPKLKDKMKW-SNSFHH 243
Query: 232 LLRKILEPNPVKRIT 246
++ L NP KR T
Sbjct: 244 FVKMALTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 37/255 (14%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLK 69
+ L + LG +GEG FG V + G AVK I +T Q E A +
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKN------IKCDVTAQAFLEETAVMT 54
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR------------LQEAEG- 116
L H N+VRL V+ +Y+V+E ++ G L + + ++GR L AEG
Sbjct: 55 KLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 117 -----RKLFQQLIDGLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
+KL + + NIL+ G K+SDFGL+ + D+ L + APE
Sbjct: 114 EYLESKKLVHRDLAA-RNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPE 167
Query: 172 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 229
L ++ + + SD+WS GV+L+ + + G P+ +L + + + +G + P+
Sbjct: 168 ALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADV 226
Query: 230 QNLLRKILEPNPVKR 244
L+ E P KR
Sbjct: 227 YVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 36/213 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKL 70
R EL +G G +G V + + +G A+KI I+L D I+RE+A L
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKI------INLDTPDDDVSDIQREVALLSQ 55
Query: 71 LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
L+ PN+ + + ++++++EY GG + + G + E + ++++ L
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL 114
Query: 128 E---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
+ NIL+ + GN+K+ DFG++AL T G+P ++APEV
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEV 172
Query: 173 LAN-RGYDGATSDIWSCGVILYVILTGYLPFDD 204
+ + YD +DIWS G+ +Y + TG P+ D
Sbjct: 173 ITEGKYYD-TKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LG GNFG V L + AVK L++ I K + RE + + L HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG---LE----- 128
VRL V + + +V+E G L + + + ++ ++L Q+ G LE
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 129 -------NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGY 178
N+LL ++ KISDFG+S AL D TT G P + APE + +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 179 DGATSDIWSCGVILYVILT-GYLPF 202
SD+WS GV L+ + G P+
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 23/199 (11%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P + R +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYITRYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------------- 128
+K+++++EY+ GG D + G L+E + ++++ GL+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 129 --NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 185
N+LL +G++K++DFG++ D + T G+P ++APEV+ YD +DI
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 186 WSCGVILYVILTGYLPFDD 204
WS G+ + G P D
Sbjct: 185 WSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 61/194 (31%), Positives = 94/194 (48%), Gaps = 33/194 (17%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+GNFG+V F L P AVK +++ LKI + E LK HPN+V+L
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIG 59
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG------LE------- 128
V + IY+V+E V GG+ + K E + ++L + +D LE
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 129 -----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYD 179
N L+ +KISDFG+S ++D ++++ G + APE L N G
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEAL-NYGRY 171
Query: 180 GATSDIWSCGVILY 193
+ SD+WS G++L+
Sbjct: 172 SSESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 77/296 (26%), Positives = 118/296 (39%), Gaps = 70/296 (23%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY R LG G+ G V A D D AVK + +K REI ++ L H
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDH 61
Query: 74 PNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
N+V+++EVL +Y+V EY+ + +G L E R
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLF 119
Query: 120 FQQLIDGL---------------ENILLDSKGNI-KISDFGLS-ALPQHFRDDGLLHTTC 162
QL+ GL N+ ++++ + KI DFGL+ + H+ G L
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 163 GSPNYVAPE-VLANRGYDGATSDIWSCGVILYVILTGYLPF------------------- 202
+ Y +P +L+ Y A D+W+ G I +LTG F
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 203 --DDRN--LAVLYQKIFRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRIT 246
+DRN L V+ + R D P+ ++P A + L +IL NP+ R+T
Sbjct: 239 REEDRNELLNVIPSFV-RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 33/201 (16%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKL------IHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL--------- 127
+ S +I + +E++ GG L D++ K GR+ E K+ ++ GL
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L Y
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHY-T 176
Query: 181 ATSDIWSCGVILYVILTGYLP 201
SDIWS G+ L + G P
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 61/256 (23%), Positives = 110/256 (42%), Gaps = 63/256 (24%)
Query: 29 KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88
KV D + F +K L K + + RE T+ PN+V LH+ + S+
Sbjct: 8 KVLLVMDTRTQQTFILKGLRK--------SSEYSRERLTIIPHCVPNMVCLHKYIVSEDS 59
Query: 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---------------NILLD 133
+++VL++ GG+L+ I+ + E ++ +++ L+ NILLD
Sbjct: 60 VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 134 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATS------ 183
+G+I+++ F + + + +C Y APEV G S
Sbjct: 120 DRGHIQLTYFS------RWSE---VEDSCDGEAVENMYCAPEV-------GGISEETEAC 163
Query: 184 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-----DFKLPKWLSPGAQNLLRKILE 238
D WS G IL+ +LTG L + G +P+W+S A++LL+++L+
Sbjct: 164 DWWSLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQ 214
Query: 239 PNPVKRITIAGIKADE 254
NP +R+ ++
Sbjct: 215 FNPTERLGAGVAGVED 230
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 56/218 (25%), Positives = 109/218 (50%), Gaps = 30/218 (13%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG G FG VK+ + A+K++++ + D+ E + L H +V+L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQL 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGLE---------- 128
+ V + IY+V EY++ G L + + G R Q ++ ++ + + +G+
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 129 -----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 180
N L+D +G +K+SDFGLS ++ DD ++ GS + PEVL +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS- 179
Query: 181 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 217
+ SD+W+ GV+++ + + G +P++ N + +K+ +G
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 48/274 (17%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----KITDQIKREIATLKLLKHPN 75
LG GN G V + + +G A K+ +H+ + QI RE+ + + P
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKV------VHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL------- 127
+V + +++ I M +E++ G L D+I K G + K+ +++GL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 128 ---------ENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
NIL++S+G IK+ DFG+S L D T G+ Y++PE +
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGK 178
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRN------------LAVLYQKIFRGDFKLPK-W 224
Y SD+WS G+ + + G PF N L +L Q + +LP
Sbjct: 179 YT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237
Query: 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
++ + L +P +R T + A F Q
Sbjct: 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 69/207 (33%), Positives = 99/207 (47%), Gaps = 40/207 (19%)
Query: 20 RTLGEGNFGKVKF-----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
R LGEG+FGKV A D +G AVK L++ T K+EI LK L H
Sbjct: 10 RVLGEGHFGKVSLYCYDPAND-GTGEMVAVKTLKRECGQQN--TSGWKKEINILKTLYHE 66
Query: 75 NVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
N+V+ + + + +++EYV G L D + K +L A+ QQ+ +G+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 129 -----------NILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNY-VAP 170
N+LLD+ +KI DFGL+ A+P+ R+DG SP + A
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAV 179
Query: 171 EVLANRGYDGATSDIWSCGVILYVILT 197
E L + A SD+WS GV LY +LT
Sbjct: 180 ECLKENKFSYA-SDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 89/310 (28%), Positives = 135/310 (43%), Gaps = 67/310 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D +GL AVK L + IIH K T RE+ LK +K
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 74
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +Y+V ++ G +L + I +L + + L Q++ G
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 132
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
L+ N+ ++ +KI DFGL+ +H D+ + + Y APE
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 187
Query: 172 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKIFR 216
++ N + T DIWS G I+ +LTG F D L A L +KI
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247
Query: 217 GDFK--------LPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260
+ +PK +P A +LL K+L + KRIT A A +F Q +
Sbjct: 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307
Query: 261 TPANPDDDEE 270
+PDD+
Sbjct: 308 ---DPDDEPV 314
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 35/205 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLK- 72
+YE +G G +G V A+D SG A+K + + L ++ RE+A LK L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLS--TVREVALLKRLEA 58
Query: 73 --HPNVVRLHEVLAS-----KSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQL 123
HPN+VRL +V A+ ++K+ +V E+V DK+ G L + L +Q
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117
Query: 124 IDGL---------------ENILLDSKGNIKISDFGLSALPQ-HFRDDGLLHTTCGSPNY 167
+ GL ENIL+ S G +K++DFGL+ + ++ T Y
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----Y 173
Query: 168 VAPEVLANRGYDGATSDIWSCGVIL 192
APEVL Y D+WS G I
Sbjct: 174 RAPEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 57/250 (22%), Positives = 107/250 (42%), Gaps = 35/250 (14%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
+ LG G FG V + + A+K++ + + D E + L HPN+V
Sbjct: 8 FLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLV 62
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGLE-------- 128
+L+ V + I++V EY+ G L + + KG+L + + + +E
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 129 -------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGY 178
N L+ +K+SDFGL+ ++ DD + G+ + PEV +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA---RYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYSR 177
Query: 179 DGATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGDFKL--PKWLSPGAQNLLR 234
+ SD+WS GV+++ + + G +P++ N V+ + + G ++L PK ++
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-ESVSAG-YRLYRPKLAPTEVYTIMY 235
Query: 235 KILEPNPVKR 244
P R
Sbjct: 236 SCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------- 127
+ S +I + +E++ GG L + GR+ E K+ +I GL
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126
Query: 128 ------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L Y
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 181
Query: 182 TSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGD 218
SDIWS G+ L + G P D + L +++ GD
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD 221
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 85/306 (27%), Positives = 128/306 (41%), Gaps = 77/306 (25%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
YE +GEG +GKV A+D ++G A+K K R L++ ++ REI+ L++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTR---LEMDEEGIPPTALREISLLQM 56
Query: 71 LKH-PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGR-----LQEAEGRKL 119
L +VRL +V + K +Y+V EY+ +L + S GR L +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 120 FQQLIDGL---------------ENILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHT 160
QL+ G+ +N+L+D KG +KI+D GL ++P H
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV----KSYTHE 171
Query: 161 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR--- 216
+ Y APEVL + DIWS G I + F D L L IF+
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLG 229
Query: 217 --------GDFKL------PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIK 251
G KL P+W LSP +LL+K+L +P KRI+
Sbjct: 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289
Query: 252 ADEWFE 257
+F+
Sbjct: 290 THPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
LG GN G V Q SGL A K+ IHL+I +QI RE+ L P +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------- 127
+ S +I + +E++ GG L + R+ E K+ ++ GL
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126
Query: 128 ------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L Y
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 181
Query: 182 TSDIWSCGVILYVILTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLSP 227
SDIWS G+ L + G P D + L A+ + + G+ P +SP
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 83/314 (26%), Positives = 127/314 (40%), Gaps = 65/314 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + +G G +G V A D +G A+K L + L + RE+ LK +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHE 74
Query: 75 NVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE 128
NV+ L +V + Y+V+ ++ G K+ +L E + L Q++ GL+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
N+ ++ +KI DFGL+ + D + + Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPF------------------------------D 203
N + T DIWS G I+ +LTG F D
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 204 DRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ---- 258
+N + + DF+ L +P A N+L K+L + RIT A A +FE+
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 259 -DYTPANPDDDEED 271
D T A P DD D
Sbjct: 308 EDETEAPPYDDSFD 321
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 80/304 (26%), Positives = 123/304 (40%), Gaps = 71/304 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY++ +G+G++G V A D +G A+K + + H+ +I REI L+LL+HP
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 59
Query: 75 NVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-- 127
++V + ++ S+ IY+V E + +L I + L + QL+ L
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 128 -------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------ 168
+NIL ++ +KI DFGL+ + F D T +YV
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTP---TAIFWTDYVATRWYR 173
Query: 169 APEVLANRGYDGATS--DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------- 219
APE L + T DIWS G I +LTG F +N V++Q D
Sbjct: 174 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLITDLLGTPSPE 230
Query: 220 -------------------KLPKWLS-------PGAQNLLRKILEPNPVKRITIAGIKAD 253
K P S P A LL ++L +P R T AD
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290
Query: 254 EWFE 257
+F+
Sbjct: 291 PYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 22/196 (11%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG+ G V A + +G AVK ++ + + + + E+ ++ H NVV ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------------- 127
++++V+E++ GG L D I + R+ E + + ++ L
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 128 -ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 186
++ILL S G IK+SDFG A Q ++ + G+P ++APEV++ Y G DIW
Sbjct: 146 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIW 202
Query: 187 SCGVILYVILTGYLPF 202
S G+++ ++ G P+
Sbjct: 203 SLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G +EL +G G +G+V + + +G A+K+++ + ++IK EI LK H
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 74 -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
N+ + KS ++++V+E+ G + D + +KG L+E + ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 125 DGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
GL +N+LL +K+ DFG+SA Q R G +T G+P ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 189
Query: 170 PEVLANRGYDGAT----SDIWSCGVILYVILTGYLPFDD 204
PEV+A AT SDIWS G+ + G P D
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 88/329 (26%), Positives = 136/329 (41%), Gaps = 80/329 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ +GEG +G V A +G+ A+K + H + REI L+ KH
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRRFKHE 63
Query: 75 NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE- 128
N++ + +++ S +Y+V E + +L+ I ++ L + Q++ GL+
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKY 121
Query: 129 --------------NILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGSPNYVAPEV 172
N+LL++ ++KI DFGL A P+H G L + Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-DHTGFLTEYVATRWYRAPEI 180
Query: 173 -LANRGYDGATSDIWSCGVILYVILTG--------Y------------------------ 199
L ++GY A DIWS G IL +L+ Y
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239
Query: 200 ---------LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 250
LPF + V + K+F P P A +LL K+L NP KRIT+
Sbjct: 240 LRARNYIKSLPFKPK---VPWNKLF------PN-ADPKALDLLDKMLTFNPHKRITVEEA 289
Query: 251 KADEWFEQDYTPANPDDDEEDIFVDNEAF 279
A + EQ + P++ EE D E F
Sbjct: 290 LAHPYLEQYHDPSDEPVAEEPFPFDFELF 318
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 53/199 (26%), Positives = 99/199 (49%), Gaps = 23/199 (11%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------------- 128
+K+++++EY+ GG D + + G E + + ++++ GL+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 129 --NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 185
N+LL +G++K++DFG++ D + T G+P ++APEV+ YD + +DI
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 184
Query: 186 WSCGVILYVILTGYLPFDD 204
WS G+ + G P D
Sbjct: 185 WSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 84/302 (27%), Positives = 131/302 (43%), Gaps = 75/302 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
+YE +GEG +G V A+D + A+K I L+ D+ REI+ LK
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKK------IRLEQEDEGVPSTAIREISLLK 56
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLID 125
++H N+VRL +V+ S+ ++Y+V EY+ +L K A+ +L + Q++
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 126 GL---------------ENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPN--- 166
G+ +N+L+D + N +K++DFGL+ R G+ T
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------RAFGIPVRTFTHEVVTL 167
Query: 167 -YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR-------- 216
Y APE+L + DIWS G I ++ F D + L+ KIFR
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEE 226
Query: 217 --------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEW 255
D+K PKW L P +LL K+L +P KRIT E+
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286
Query: 256 FE 257
F+
Sbjct: 287 FK 288
|
Length = 294 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 48/224 (21%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LG+G+FG V K + A+K + +N + +I + E + +K
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEF 66
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------KLFQ-- 121
+VVRL V+++ +V+E + G+L + S+ R + K Q
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMA 125
Query: 122 -QLIDGL---------------ENILLDSKGNIKISDFGLSAL---PQHFRDDG--LLHT 160
++ DG+ N ++ +KI DFG++ ++R G LL
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183
Query: 161 TCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 202
P ++APE L + G SD+WS GV+L+ + T P+
Sbjct: 184 ----PVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 53/275 (19%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L R LG G FG+V + ++ P AVK L+ + E +K L+HP +
Sbjct: 9 QLLRKLGAGQFGEV-WEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLIDG--------- 126
++L+ V + IY+V E + G L + LQ GR L QLID
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLE------YLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 127 -LE------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAP 170
LE N+L+ K++DFGL+ + ++D + G+ + AP
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARV---IKED-IYEAREGAKFPIKWTAP 173
Query: 171 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229
E A SD+WS G++L I+T G +P+ A + Q++ +G +++P PG
Sbjct: 174 EA-ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPC--PPGC 229
Query: 230 QNLLRKIL----EPNPVKRITIAGIKADEWFEQDY 260
L I+ + +P R T ++ W +D+
Sbjct: 230 PKELYDIMLDCWKEDPDDRPTFETLQ---WKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-12
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G+G+FG+V D + A+KI++ +I D I++EI L P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------------- 128
+K+++++EY+ GG D + G L E + + ++++ GL+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 129 --NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 185
N+LL G +K++DFG++ D + T G+P ++APEV+ YD + +DI
Sbjct: 129 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 184
Query: 186 WSCGVILYVILTGYLPFDD 204
WS G+ + G P +
Sbjct: 185 WSLGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 26/201 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + +G G FG V A+D +G A+K + K + + + RE+ LK L+H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHE 69
Query: 75 NVVRLHEVLASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----- 128
N++ L ++ S + IY V E + G ++ + L++ + Q++ GL+
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-LANRG 177
NIL++ ++KI DFGL A Q + G + T Y APE+ L +
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGL-ARIQDPQMTGYVSTR----YYRAPEIMLTWQK 182
Query: 178 YDGATSDIWSCGVILYVILTG 198
YD DIWS G I +L G
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 5e-12
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V Q ++G +A K L+K R+ E L+ + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGL------------ 127
SK+ + +V+ + GG+L I + G R + Q+ G+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 128 ---ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 184
EN+LLD +GN ++SD GL+ +D + G+ Y+APE+L Y D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV-D 176
Query: 185 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 216
++ G +Y ++ G PF D V +++ R
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 77/287 (26%), Positives = 121/287 (42%), Gaps = 59/287 (20%)
Query: 18 LGRTLGEGNFGKV--KFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLL 71
LG+TLGEG FGKV A L G AVK+L++N ++ D + E LK +
Sbjct: 4 LGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENAS-SSELRDLLS-EFNLLKQV 60
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK------GRLQEAEGRKLFQ-- 121
HP+V++L+ + + +++EY G L F + + K G L
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 122 --------------QLIDGLE---------------NILLDSKGNIKISDFGLSALPQHF 152
Q+ G++ N+L+ +KISDFGLS +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--DVY 178
Query: 153 RDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD---RN 206
+D + + G ++A E L + Y SD+WS GV+L+ I+T G P+
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 207 LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253
L L + +R + P+ S NL+ + P KR T A I +
Sbjct: 238 LFNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 52/226 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLP-----FAVKILEKNRIIHLKITDQIKREIATLK 69
R LG+ LGEG FG+V A+ + P AVK+L+ + ++D + E+ +K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVS-EMEMMK 70
Query: 70 LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------GRKLF 120
++ KH N++ L V + +Y+V+EY G L D + ++ E L
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 121 Q--------QLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRD--- 154
Q Q+ G+E N+L+ +KI+DFGL+ RD
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIHH 184
Query: 155 -DGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT 197
D TT G P ++APE L +R Y SD+WS GV+L+ I T
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 65/248 (26%), Positives = 121/248 (48%), Gaps = 31/248 (12%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+GEG+ G V A SG AVK ++ + + + + E+ ++ +H NVV ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------------- 127
++++V+E++ GG L D I + R+ E + + ++ L
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 128 -ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 186
++ILL G +K+SDFG A Q ++ + G+P ++APE+++ Y G DIW
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIW 200
Query: 187 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRKILEPN 240
S G+++ ++ G P F++ L + K+ R + PK +SP + L ++L +
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDNLP-PKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 241 PVKRITIA 248
P +R T A
Sbjct: 258 PAQRATAA 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 65/259 (25%), Positives = 108/259 (41%), Gaps = 42/259 (16%)
Query: 21 TLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
TLG G FG+V K ++ VK L+K + +L+ + +RE+ + L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKN 69
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGR-------LQEAEGRKLFQQLIDG 126
VVRL + YM+LEY G+L F + L + L Q+ G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAP 170
++ N L+ S+ +K+S LS + + P ++AP
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV--YNSEYYKLRNALIPLRWLAP 187
Query: 171 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229
E + + SD+WS GV+++ + T G LPF + + ++ G +LP + G
Sbjct: 188 EAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP--VPEGC 244
Query: 230 QNLLRKILE----PNPVKR 244
+ L K++ NP R
Sbjct: 245 PSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 65/270 (24%), Positives = 118/270 (43%), Gaps = 39/270 (14%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ + +L +T+G+G FG V G AVK ++ + + E + +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQ 55
Query: 71 LKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE- 128
L+H N+V+L V+ K +Y+V EY+ G L D + S+GR G L + +D E
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEA 114
Query: 129 -----------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
N+L+ K+SDFGL+ +D G L + APE
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 169
Query: 172 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 228
L + + SD+WS G++L+ I + G +P+ L + ++ +G +K+ P P
Sbjct: 170 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPV 227
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
+++++ + R + ++ E E
Sbjct: 228 VYDVMKQCWHLDAATRPSFLQLR--EQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 54/239 (22%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
+ +G G FG+V + G + A+K L +K R+ L E + +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-------TEASIMGQF 62
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
HPN++RL V+ + ++ EY+ G L DK L+E +G+ QL+ L
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116
Query: 128 ------------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SP-N 166
NIL++S K+SDFGLS + D +TT G P
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS---RRLEDSEATYTTKGGKIPIR 173
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 223
+ APE +A R + A SD+WS G++++ +++ G P+ D N V+ + + G ++LP
Sbjct: 174 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDG-YRLPP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 98/346 (28%), Positives = 138/346 (39%), Gaps = 98/346 (28%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---------R 63
L +YE+ + LG+G +G V A D + A+K KI D + R
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFR 55
Query: 64 EIATLK-LLKHPNVVRLHEVL-ASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
EI L+ L HPN+V+L V+ A K IY+V EY+ +L I L++ R +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIM 113
Query: 121 QQLIDGLE---------------NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS 164
QL+ L+ NILL+S +K++DFGL+ +L + + T
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT--- 170
Query: 165 PNYVA------PEVL-ANRGYDGATSDIWSCGVILYVILTG------------------- 198
+YVA PE+L + Y D+WS G IL +L G
Sbjct: 171 -DYVATRWYRAPEILLGSTRYTKGV-DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228
Query: 199 ------------YLPFDDRNLAVLYQ-KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 245
PF L L D LPK S A +LL+K+L NP KR+
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRL 287
Query: 246 TIAGIKADEWFEQDYTPA--NPDDDE---EDI---FVDNEAFSMHE 283
T A+E E Y NP D+ I DN S+ E
Sbjct: 288 T-----AEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAE 328
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 32/260 (12%)
Query: 17 ELGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LGR +GEG FG V + + + AVK + + ++ +E ++ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDH 66
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGL----- 127
P++V+L V+ +++ +++V+E GEL + +K L A QL L
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLAN 175
N+L+ S +K+ DFGLS ++ D+ + G P ++APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLS---RYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 176 RGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSPGAQNL 232
R + A SD+W GV ++ IL G PF +N V+ +I G+ +P P +L
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERLPMPPNCPPTLYSL 240
Query: 233 LRKILEPNPVKRITIAGIKA 252
+ K +P KR +KA
Sbjct: 241 MTKCWAYDPSKRPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 38/207 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFA----VKILEKNRIIHLKITDQIKREIATLKL 70
+YE +GEG +GKV A+DL +G F V++ + L RE+A L+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRH 57
Query: 71 LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
L+ HPNVVRL +V ++K+ +V E+V DK+ G E + +
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-KDMM 116
Query: 121 QQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
QL+ GL +NIL+ S G IK++DFGL+ + + L + +
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTL 173
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVIL 192
Y APEVL Y D+WS G I
Sbjct: 174 WYRAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 74/278 (26%), Positives = 127/278 (45%), Gaps = 50/278 (17%)
Query: 20 RTLGEGNFGKVKFA----QDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHP 74
R LGEG+FGKV+ + ++G AVK L+ ++ H+ +K+EI L+ L H
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI---ADLKKEIEILRNLYHE 66
Query: 75 NVVRLHEVLASK--SKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGLE--- 128
N+V+ + + I +++E++ G L + + +K ++ + K Q+ G++
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 129 ------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-VAPEVLAN 175
N+L++S+ +KI DFGL+ + ++ + SP + APE L
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDF---KLPKWLSPGAQ 230
+ A SD+WS GV LY +LT Y + + + + I G +L + L G +
Sbjct: 187 SKFYIA-SDVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 231 ------------NLLRKILEPNPVKRIT----IAGIKA 252
L+RK E P KR T I G +A
Sbjct: 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 35/199 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RIIHLKITDQIKREIATLKLLKH 73
+ R +G G+FG V FA+D+ + A+K + + + + K D IK E+ L+ L+H
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQQLRH 74
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGLE--- 128
PN + + ++V+EY G ++ + K LQE E + + GL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 129 ------------NILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEV-L 173
NILL G +K++DFG ++L P ++ G+P ++APEV L
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--------NSFVGTPYWMAPEVIL 184
Query: 174 A-NRG-YDGATSDIWSCGV 190
A + G YDG D+WS G+
Sbjct: 185 AMDEGQYDGKV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 28/226 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V ++ AVK L+ + E +K L+H +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL------- 127
VRL+ V+ + IY++ EY+ G L D + S G++ + Q+ +G+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 128 --------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 178
N+L+ KI+DFGL+ + + ++ P + APE + N G
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 180
Query: 179 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
SD+WS G++LY I+T G +P+ + + + + RG +++P+
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPR 225
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 53/254 (20%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
RL YE+ + +G G FG+V + + F K + R + + Q+ E+ ++ L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMREL 69
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLID 125
KH N+VR + +K+ K+Y+++E+ G+L I G+++E + +QL+
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 126 GL----------------------ENILLDSK----GNI-------------KISDFGLS 146
L +NI L + G I KI DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 204
++ + + H+ G+P Y +PE+L + + YD SD+W+ G I+Y + +G PF
Sbjct: 190 ---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFHK 245
Query: 205 -RNLAVLYQKIFRG 217
N + L ++ RG
Sbjct: 246 ANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 79/313 (25%), Positives = 128/313 (40%), Gaps = 66/313 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
RYEL + LG+G +G V A++ ++ V I + + KI KR + LKLL+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL--AKRALRELKLLRHF 58
Query: 73 --HPNVVRLHE---VLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N+ L++ V +++Y+ E + +L I S L +A + Q++ G
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 127 LE---------------NILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVA 169
L+ N+L+++ +KI DFGL+ + G + + Y A
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 170 PEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL---------- 210
PE+ L+ + Y A D+WS G IL +L F ++ L VL
Sbjct: 178 PEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 211 ------YQKIFRGDFKLPK---WLSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFE 257
I K + P A +LL K+L +P KRI++ +E E
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV-----EEALE 291
Query: 258 QDYTPANPDDDEE 270
Y D D+E
Sbjct: 292 HPYLAIWHDPDDE 304
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 2e-11
Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 34/219 (15%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G +EL +G G +G+V + + +G A+K+++ + ++IK+EI LK H
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 74 -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
N+ + K+ ++++V+E+ G + D I +KG L+E + ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 125 DGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
GL +N+LL +K+ DFG+SA Q R G +T G+P ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 179
Query: 170 PEVLANRGYDGAT----SDIWSCGVILYVILTGYLPFDD 204
PEV+A AT SD+WS G+ + G P D
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 41/208 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----LKITDQIKREIATLKL 70
RY+ +G G +G V A D SG A+K +I H + + RE+ L+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 71 LKHPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
KH N++ + ++L +Y+V++ + +L I S L E R QL+ G
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 168
L+ N+L++ ++I DFG++ + T YV
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT----EYVATR 175
Query: 169 ---APEVL-ANRGYDGATSDIWSCGVIL 192
APE+L + Y A D+WS G I
Sbjct: 176 WYRAPELLLSLPEYTTAI-DMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 30/233 (12%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLK 69
E + LG G FG V + G +P A+K+L + K +I E +
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELF-------DKIASKGRL----QEAEGRK 118
+ HP+VVRL + S S++ ++ + + G L D I S+ L Q A+G
Sbjct: 65 SVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 119 LFQQ--LID---GLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 171
++ L+ N+L+ + ++KI+DFGL+ L D+ H G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALE 181
Query: 172 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+ +R Y SD+WS GV ++ ++T G P++ + + +G+ +LP+
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 27/190 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVR 78
R +G G+FG V FA+D+ + A+K + + + K D IK E+ L+ L+HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQKLRHPNTIQ 79
Query: 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---------- 128
+ ++V+EY G K LQE E + + GL
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 129 -----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDG 180
NILL G +K+ DFG +++ + G+P ++APEV+ + G YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 181 ATSDIWSCGV 190
D+WS G+
Sbjct: 194 KV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 25/189 (13%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
R +G G+FG V FA+D+ + A+K + + + I +E+ L+ +KHPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----------- 128
+ ++V+EY G K LQE E + + GL
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 129 ----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGA 181
NILL G +K++DFG +++ ++ G+P ++APEV+ + G YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 182 TSDIWSCGV 190
D+WS G+
Sbjct: 205 V-DVWSLGI 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 27/188 (14%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
+G G+FG V FA + + AVK + + + K D IK E+ L+ LKHPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK-EVKFLQQLKHPNTIEYK 87
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------------ 128
+ ++V+EY G K LQE E + + GL
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 129 ---NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGAT 182
NILL G +K++DFG ++ ++ G+P ++APEV+ + G YDG
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 183 SDIWSCGV 190
D+WS G+
Sbjct: 202 -DVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 42/272 (15%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
LG+ LGEG FG V + +QD S L AVK ++ + + +I + + E A +K HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHP 61
Query: 75 NVVRLHEV---LASKSKI---YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID--- 125
NV++L V +S KI ++L ++ G+L + RL + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFMV 120
Query: 126 ----GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 165
G+E N +L + ++DFGLS + +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAKM 177
Query: 166 --NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKL 221
++A E LA+R Y + SD+W+ GV ++ I T G P+ +Y + G+ K
Sbjct: 178 PVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236
Query: 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253
P+ +L+ +P R T ++
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 69/238 (28%), Positives = 110/238 (46%), Gaps = 41/238 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ LGR LG+G FG V+ AQ + S AVK+L K I ++ RE A +K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 73 HPNVVRLHEV-LASKSK----IYMV-LEYVTGGELFDKIASKGRLQE----AEGRKLFQQ 122
HPNV++L V L S++K I MV L ++ G+L + R+ E + L +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS-RIGEEPFTLPLQTLVRF 118
Query: 123 LID---GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164
+ID G+E N +L+ + ++DFGLS + C S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCAS 175
Query: 165 P---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 218
++A E LA+ Y SD+W+ GV ++ I+T G P+ + +Y + +G+
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
LG GN G V A L + AVK++ + I +++ QI E+ L P ++ +
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 81 EVLASKSKIYMVLEYVTGGEL--FDKIASK--GRLQEAE--------GRKLFQQLIDGLE 128
+++I + E++ GG L + KI GR+ A K+ + +
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKP-S 124
Query: 129 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 188
N+L++++G +K+ DFG+S + + T G+ Y+APE ++ Y G SD+WS
Sbjct: 125 NMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQY-GIHSDVWSL 179
Query: 189 GVILYVILTGYLPF 202
G+ + G P+
Sbjct: 180 GISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+ LG G FG V + + + A+K + + + + E + L HP +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQL 64
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGLE---------- 128
+ V + +Y+V E++ G L + + + G+L + + Q + +G+E
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 129 -----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 180
N L+ S G +K+SDFG++ ++ DD ++ G+ + PEV Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMT---RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 181 ATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGD 218
+ SD+WS GV+++ + T G +PF+ + N V+ + I RG
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-EMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 90/328 (27%), Positives = 135/328 (41%), Gaps = 74/328 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATLKLLKH 73
RY + +G G +G V A D +G A+K L +R +I + RE+ LK ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 74 PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
NV+ L +V S Y+V+ Y+ KI L E + + L Q++ GL
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGL 130
Query: 128 E---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
+ N+ ++ +KI DFGL+ +H D + + Y APEV
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---RH--ADAEMTGYVVTRWYRAPEV 185
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQ------------------- 212
+ N + T DIWS G I+ +LTG F ++ L L Q
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245
Query: 213 ----------KIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ-- 258
K R DF PK SP A +LL K+LE + KR+T +F+
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPK-ASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 259 ---DYTPANPDDDEEDIFVDNEAFSMHE 283
+ T P DD ++NE S+ E
Sbjct: 305 DADEETEQQPYDDS----LENEKLSVDE 328
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 83/331 (25%), Positives = 138/331 (41%), Gaps = 79/331 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D AVK L + +IH + T RE+ LK +K
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHMK 72
Query: 73 HPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +++Y+V + G +L + I +L + + L QL+ G
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADL-NNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
L+ N+ ++ ++I DFGL+ + D + + Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPE 185
Query: 172 VLANRGYDGATSDIWSCGVILYVILTG--YLPFDD------RNLAVL------------- 210
++ N + T DIWS G I+ +L G P +D R + V+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 211 -----------------YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253
+KIFRG +P A +LL K+L + KRI+ + A
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRG-------ANPLAIDLLEKMLVLDSDKRISASEALAH 298
Query: 254 EWFEQDYTPAN-PDDDEEDIFVDNEAFSMHE 283
+F Q + P + P+ + D +N+ ++ E
Sbjct: 299 PYFSQYHDPEDEPEAEPYDESPENKERTIEE 329
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 25/173 (14%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE++ LK LKH N+V LH+++ ++ + +V EY+ +L + + G L K+F
Sbjct: 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMF 110
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 163
QL+ GL +N+L++ KG +K++DFGL+ ++P + ++
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----- 165
Query: 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 216
+ Y P+VL D+W G ILY + TG F + IFR
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 43/230 (18%)
Query: 13 LGRYELGRTLGEGNFGKV---------------KFAQDLDSGLPFAVKILEKNRIIHLKI 57
L + + L G FGK+ + + G P +++ K +
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV---LEYVTGGELFDK-IASKGRLQE 113
Q++ EI L L H N++++ E+L S++ YM+ ++ ++D+ K R
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 114 AEGRKLFQQLIDG---------------LENILLDSKGNIKISDFGLSAL---PQHFRDD 155
+ R + +QL+ LENI L+ G I + DFG + + D
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 204
G + T + +PE+LA GY T DIWSCG+IL +L+ + P D
Sbjct: 327 GWVGTVATN----SPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIA 66
++ + +G G FG+V + G +P A+K L EK R L E +
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-------SEAS 57
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------FDKIASKGRLQE-AE 115
+ HPN++ L V+ + +V EY+ G L F I G L+ A
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS 117
Query: 116 GRKLFQQLID-----GLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NY 167
G K + NIL++S K+SDFGLS + + D +TT G +
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRW 175
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 202
APE +A R + A SD+WS G++++ +++ G P+
Sbjct: 176 TAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 32/198 (16%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
Y + +TL G+ G+V A P +KI +K + E L+ + HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL------- 127
V+R+ + L S + MVL + + +L+ + + L + + +Q+++GL
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 128 --------ENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGY 178
ENI ++ + I D G + P GL G+ APEVLA Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233
Query: 179 DGATSDIWSCGVILYVIL 196
+ + +DIWS G++L+ +L
Sbjct: 234 N-SKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 69/279 (24%), Positives = 111/279 (39%), Gaps = 59/279 (21%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LGEG FGKV F + P AVK L++ + +RE L
Sbjct: 9 LKRELGEGAFGKV-FLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNF 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--------------KGRLQEAEGR 117
+H N+V+ + V MV EY+ G+L + S G L ++
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 118 KLFQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT- 161
++ Q+ G+ N L+ +KI DFG+S RD ++TT
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTTD 176
Query: 162 ----CGSP----NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 212
G ++ PE + R + SD+WS GV+L+ I T G P+ + + +
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235
Query: 213 KIFRGDFKL-PKWLSPGAQNLLRKILEPNPVKRITIAGI 250
I +G P+ +++ + +P +RI I I
Sbjct: 236 CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 41/126 (32%), Positives = 59/126 (46%), Gaps = 16/126 (12%)
Query: 129 NILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL----ANRGYDGATS 183
NILLD+ GN+K+ DFG+S D T + G Y+APE + N YD +
Sbjct: 145 NILLDASGNVKLCDFGISG----RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYD-IRA 199
Query: 184 DIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDF-KLP--KWLSPGAQNLLRKILE 238
D+WS G+ L + TG P+ VL KI + + LP + SP + + L
Sbjct: 200 DVWSLGISLVELATGQFPYKNCKTEFEVL-TKILQEEPPSLPPNEGFSPDFCSFVDLCLT 258
Query: 239 PNPVKR 244
+ KR
Sbjct: 259 KDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 55/275 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G+TLG G FGKV A D+ + AVK+L+ H + + E+ +
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT--AHSSEREALMSELKIMS 93
Query: 70 LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
L H N+V L I ++ EY G+L + + K R L Q+
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAK 152
Query: 126 GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 168
G+ N+LL +KI DFGL+ RD +++ + NYV
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS----NYVVK 200
Query: 169 ----------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 217
APE + N Y SD+WS G++L+ I + G P+ + + K+ +
Sbjct: 201 GNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 218 DFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 250
+++ P+ ++++ + +P+KR T I
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 65/250 (26%), Positives = 109/250 (43%), Gaps = 23/250 (9%)
Query: 22 LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG VK + S AVKIL KN + D++ RE ++ L +P +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----------- 128
+ ++S + +V+E G L + + E +L Q+ G++
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 129 ----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 183
N+LL ++ KISDFGLS + T P + APE + N + S
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFSSKS 179
Query: 184 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNP 241
D+WS GV+++ + G P+ + Q I G+ + P+ P +L++
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239
Query: 242 VKRITIAGIK 251
+R A ++
Sbjct: 240 DERPGFAVVE 249
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 41/232 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V + A+K L++ + + E +K L+HP +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GL- 127
VRL+ V+ ++ IY++ EY+ G L D L+ EG KL +LID G+
Sbjct: 64 VRLYAVV-TQEPIYIITEYMENGSLVD------FLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 128 --------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEV 172
NIL+ KI+DFGL+ L + ++ P + APE
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEA 174
Query: 173 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+ N G SD+WS G++L I+T G +P+ + Q + RG +++P+
Sbjct: 175 I-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
YE LGEG++ V + +G A+K++ T RE + LK LKH N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT--AIREASLLKGLKHAN 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGL------ 127
+V LH+++ +K + +V EYV + DK G L + QL+ GL
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 128 ---------ENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 175
+N+L+ G +K++DFGL+ ++P H + ++ + Y P+VL
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRPPDVLLG 177
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPF 202
D+W G I ++ G F
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 46/221 (20%)
Query: 22 LGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LGEG FGKV + + S A+K L++N K+ + ++E + L+HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNI 70
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLF 120
V L V + M+ EY+ G+L + + K L ++ +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 121 QQLIDGLE---------------NILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTC 162
Q+ G+E N L+ +KISDFGLS ++R + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR---VQSKSL 187
Query: 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 202
++ PE + G SDIWS GV+L+ I + G P+
Sbjct: 188 LPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 46/224 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ LD P AVK+L K+ ++D I E+
Sbjct: 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 76
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------GRLQE 113
+K++ KH N++ L +Y+++EY + G L + + ++ ++
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 114 AEGRKLFQ---QLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDD 155
+ L Q+ G+E N+L+ +KI+DFGL+ H D
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 194
Query: 156 GLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 197
TT G ++APE L +R Y SD+WS GV+L+ I T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 222
G+P+Y+APE+L + + A D W+ GV L+ LTG PF+D ++Q I D P
Sbjct: 542 GTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 223 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKAD------EWFEQDYTP----ANPDDD 268
+ LS AQN + +L +P KR + +K +W PDD+
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPDDE 659
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 32/80 (40%), Positives = 40/80 (50%), Gaps = 5/80 (6%)
Query: 129 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG--ATSDIW 186
NILLD GNIK+ DFG+S D G Y+APE + DG SD+W
Sbjct: 138 NILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVW 194
Query: 187 SCGVILYVILTGYLPFDDRN 206
S G+ LY + TG P+ N
Sbjct: 195 SLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 34/233 (14%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
+G G FGKV + G+ A V + E +E+ + L HPNV++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQL---------------- 123
+VLE+ G+L + + S +G + + + + Q++
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 124 --ID-GLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGY 178
D L N L + ++KI D+GL AL Q + +D + C + P ++APE++ RG
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGL-ALEQ-YPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 179 DGAT------SDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 223
D S+IWS GV ++ + T P+ D + VL Q + D KLPK
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 22 LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHP 74
+G G FG+V + G + A+K L+ T++ +R E + + HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG------YTEKQRRDFLSEASIMGQFDHP 65
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGEL----------FDKIASKGRLQE-AEGRKLFQQL 123
N++ L V+ + ++ E++ G L F I G L+ A G K ++
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 124 ID-----GLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 175
NIL++S K+SDFGLS + D ++ G + APE +A
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 176 RGYDGATSDIWSCGVILYVILT-GYLPF-DDRNLAVLYQKIFRGDFKLP 222
R + A SD+WS G++++ +++ G P+ D N V+ D++LP
Sbjct: 186 RKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVI--NAIEQDYRLP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G G FG V L+ A+K + + + + E + L HP +V+L+
Sbjct: 12 IGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------------- 128
V +S I +V E++ G L D + ++ E L +D E
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE--TLLGMCLDVCEGMAYLESSNVIHR 124
Query: 129 -----NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 180
N L+ +K+SDFG++ F D ++ G+ + +PEV + Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMT----RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS- 179
Query: 181 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+ SD+WS GV+++ + + G P+++R+ + + + I G F+L K
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYK 222
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE++ LK LKH N+V LH+++ ++ + +V EY+ +L + G KLF
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLF 111
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 163
QL+ GL +N+L++ +G +K++DFGL+ ++P + ++
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----- 166
Query: 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 216
+ Y P++L D+W G I Y + TG F + IFR
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 69/273 (25%), Positives = 105/273 (38%), Gaps = 50/273 (18%)
Query: 20 RTLGEGNFGKVKFAQDLD-----SG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LG G FG+V D SG + AVK L K K + +E + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG-----RKLFQQLID--- 125
PN+V+L V Y+++E + GG+L + R++ ++L +D
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAK 117
Query: 126 ---------------GLENILLDSKGN-----IKISDFGL-----SALPQHFRDDGLLHT 160
N L+ KG +KI DFGL + +GLL
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 161 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGD 218
++APE L + G SD+WS GV+++ ILT G P+ N VL G
Sbjct: 178 -----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231
Query: 219 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 251
+ P+ L+ +P +R T I+
Sbjct: 232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 70/262 (26%), Positives = 115/262 (43%), Gaps = 41/262 (15%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
LG+TLGEG FG V + QD DS L AVK ++ ++ D + E +K HP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQD-DSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60
Query: 75 NVVRLHEVL--ASKSKIY----MVLEYVTGGE-----LFDKIASKGRLQEAEGR-KLFQQ 122
NV+RL V +S+ Y ++L ++ G+ L+ ++ + + K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 123 LIDGLE---------------NILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGS 164
+ G+E N +L+ N+ ++DFGLS ++R +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-- 178
Query: 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLP 222
++A E LA+R Y SD+WS GV ++ I T G P+ + +Y + +G+ K P
Sbjct: 179 -KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236
Query: 223 KWLSPGAQNLLRKILEPNPVKR 244
G +L+ NP R
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDR 258
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 71/281 (25%), Positives = 108/281 (38%), Gaps = 68/281 (24%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
LGEG++ V +G A+K+ I +K + + RE + LK LKH N+V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------- 127
LH+++ +K + V EY+ I G L R QL+ GL
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 128 -----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGY 178
+N+L+ G +K++DFGL+ R + T S Y P+VL
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLA------RAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 179 DGATSDIWSCGVILYVILTGYLPFDDRN------------LAVLYQKIFRGDFKLPKW-- 224
+ DIW G I +L G F + L V + + G KLP +
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240
Query: 225 -----------------LS--PGAQNLLRKILEPNPVKRIT 246
LS P A++L ++L P RI+
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 66/234 (28%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ D + AVK+L+ N + D I E+
Sbjct: 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLIS-EMEL 70
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE------------- 113
+KL+ KH N++ L V + +Y+++EY A+KG L+E
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEY----------AAKGNLREFLRARRPPGPDYT 120
Query: 114 ------AEGRKLFQQLID-------GLE---------------NILLDSKGNIKISDFGL 145
E + F+ L+ G+E N+L+ +KI+DFGL
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL 180
Query: 146 SALPQHFRDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 197
+ D T+ G ++APE L +R Y SD+WS G++++ I T
Sbjct: 181 ARGVHDI--DYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 63/237 (26%), Positives = 103/237 (43%), Gaps = 51/237 (21%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
+ +G G FG+V G + A+K L EK R L E + +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-------EASIMGQF 63
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
H N++RL V+ ++ EY+ G L DK L++ +G QL+ L
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKY-----LRDHDGEFSSYQLVGMLRGIA 117
Query: 128 ------------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---N 166
NIL++S K+SDFGLS + + + +TT G
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIR 175
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 222
+ APE +A R + A SD+WS G++++ +++ G P+ D + + + I G F+LP
Sbjct: 176 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 82/330 (24%), Positives = 139/330 (42%), Gaps = 74/330 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ + + + AVK+L K+ ++D + E+
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVS-EMEM 70
Query: 68 LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK---------GRLQEAEGR 117
+K++ KH N++ L +Y+++EY + G L + + ++ + E +
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130
Query: 118 KLFQQLID-------GLE---------------NILLDSKGNIKISDFGLSALPQHFRD- 154
F+ L+ G+E N+L+ +KI+DFGL+ RD
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA------RDV 184
Query: 155 ---DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 208
D TT G ++APE L +R Y SD+WS GV+L+ I T G P+ +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243
Query: 209 VLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI-----------KADEW- 255
L++ + G P + ++R+ P +R T + DE+
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYL 303
Query: 256 -----FEQDYTPANPDDDEEDIFVDNEAFS 280
FEQ Y+P PD D+ F+
Sbjct: 304 DLSVPFEQ-YSPGCPDSPSSCSSGDDSVFA 332
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V A + AVK ++ + E +K L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGLE------ 128
V+LH V+ +K IY++ E++ G L D + S + + Q+ +G+
Sbjct: 64 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 178
NIL+ + KI+DFGL+ + + ++ P + APE + N G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 179
Query: 179 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
SD+WS G++L I+T G +P+ + + + + RG +++P+
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 224
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 54/225 (24%)
Query: 18 LGRTLGEGNFGKVKFAQDL--DSGLP-----FAVKILEKNRIIHLKITDQIKREIATLKL 70
LG+ LGEG FG+V A+ L D P AVK+L K+ ++D + E+ +K+
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 76
Query: 71 L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL---------QEAEGRKLF 120
+ KH N++ L +Y+++EY + G L + + ++ + + + F
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 121 QQLID-------GLE---------------NILLDSKGNIKISDFGLSALPQHFRD---- 154
+ L+ G+E N+L+ +KI+DFGL+ RD
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDVNNI 190
Query: 155 DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 197
D TT G ++APE L +R Y SD+WS GV+++ I T
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 48/272 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V + + AVK L+ + + E +K L+H +
Sbjct: 9 QLIKKLGNGQFGEV-WMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKL 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GL- 127
V+L+ V+ S+ IY+V EY++ G L D L++ EGR L L+D G+
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 128 --------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAP 170
NIL+ KI+DFGL+ L + D G+ + AP
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAP 172
Query: 171 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 228
E A G SD+WS G++L ++T G +P+ N + +++ RG P+
Sbjct: 173 EA-ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260
L+ + + +P +R T +++ F +DY
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQS---FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 73/257 (28%), Positives = 114/257 (44%), Gaps = 39/257 (15%)
Query: 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
R +G+G+FG V +DS + AVK L NRI L+ +Q +E +K HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 77 VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR-----------LQEAEG-----RKL 119
+ L + L S+ +VL Y+ G+L + I S+ LQ A+G K
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 120 FQQLIDGLENILLDSKGNIKISDFGLSALPQHFRD-------DGLLHTTCGSP-NYVAPE 171
F N +LD +K++DFGL+ RD HT P ++A E
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLA------RDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 172 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-PKWLSPGA 229
L + + SD+WS GV+L+ ++T G P+ D + + + +G L P++
Sbjct: 173 SLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPL 231
Query: 230 QNLLRKILEPNPVKRIT 246
++ P P R T
Sbjct: 232 YEVMLSCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 53/233 (22%), Positives = 96/233 (41%), Gaps = 45/233 (19%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ RY++ R +G+G G+V A D A+K + ++ + + + RE L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGEL-------FDKIASKGRLQEAEGRKLFQQLID 125
HP +V ++ + + +Y + Y+ G L + K + L E F +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 126 GL-------------------ENILLDSKGNIKISDFGLSALPQHFRDD---------GL 157
+ +NILL G + I D+G + + +D +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 158 LHTT-------CGSPNYVAPEVLANRGYDGATS-DIWSCGVILYVILTGYLPF 202
+++ G+P+Y+APE L G + S DI++ GVILY +LT P+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 70/272 (25%), Positives = 111/272 (40%), Gaps = 49/272 (18%)
Query: 22 LGEGNFGKVKFAQ------DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
LGEG FGKV A+ + D L AVK L++ +RE L +L+H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKML-VAVKALKE---ASESARQDFQREAELLTVLQHQH 68
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQ---------- 121
+VR + V + MV EY+ G+L + S G L E Q
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 122 -QLIDGL---------------ENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTC 162
Q+ G+ N L+ +KI DFG+S ++R G T
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTM 185
Query: 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK 220
++ PE + R + SDIWS GV+L+ I T G P+ + + I +G + +
Sbjct: 186 LPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244
Query: 221 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252
P+ P +++ + P +R+ I I +
Sbjct: 245 RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 43/173 (24%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-Q 121
RE++ LK LKH N+V LH+++ + + +V EY+ +L + G + K+F
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLY 111
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 163
Q++ GL +N+L++ +G +K++DFGL+ ++P + ++
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----- 166
Query: 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 216
+ Y P+VL D+W G I + + +G F + IFR
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 46/219 (21%)
Query: 18 LGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L R LGEG FGKV A+ + AVK L+ L +RE L L+
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ 65
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEG 116
H ++V+ + V + MV EY+ G+L +KG L ++
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 117 RKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA---LPQHFRDDGLL 158
+ Q+ G+ N L+ + +KI DFG+S ++R G
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 183
Query: 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 197
HT ++ PE + R + SD+WS GVIL+ I T
Sbjct: 184 HTML-PIRWMPPESIMYRKFT-TESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 49/167 (29%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
RE + LK LKH N+V LH+++ +K + +V EY+ +L + G +LF
Sbjct: 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLF 110
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLS---ALPQH----------FR 153
QL+ GL +N+L+ +G +K++DFGL+ ++P +R
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170
Query: 154 -DDGLLHTTCGSPNYVAPEVLANRGYDGATS-DIWSCGVILYVILTG 198
D LL GS Y +TS D+W G I Y + TG
Sbjct: 171 PPDVLL----GSTEY-------------STSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 52/270 (19%)
Query: 22 LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
+GEGNFG+V A GL A+K+L++ + H +++ KL HPN++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELE---VLCKLGHHPNII 66
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
L ++ +Y+ +EY G L D + K R+ E + ++L Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 124 ID------------------GLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS- 164
D N+L+ KI+DFGLS + + + T G
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-----VKKTMGRL 180
Query: 165 -PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL- 221
++A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G +++
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRME 238
Query: 222 -PKWLSPGAQNLLRKILEPNPVKRITIAGI 250
P+ L+R+ P +R A I
Sbjct: 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 69/269 (25%), Positives = 116/269 (43%), Gaps = 50/269 (18%)
Query: 22 LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
+GEGNFG+V A+ GL A+K +++ ++ H +++ KL HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPNII 59
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
L + +Y+ +EY G L D + K R+ E + ++L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 124 ID---GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS- 164
D G++ NIL+ KI+DFGLS + + + T G
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRL 173
Query: 165 -PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL 221
++A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G +
Sbjct: 174 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232
Query: 222 PKWLSPGAQNLLRKILEPNPVKRITIAGI 250
P +L+R+ P +R + A I
Sbjct: 233 PLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 39/214 (18%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHP 74
L R LGEG FGKV F + + P KIL + + + K RE L L+H
Sbjct: 9 LKRELGEGAFGKV-FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQ 121
++V+ + V + MV EY+ G+L + + G L +++ + Q
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCG 163
Q+ G+ N L+ +KI DFG+S ++R G HT
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTML- 184
Query: 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 197
++ PE + R + SD+WS GV+L+ I T
Sbjct: 185 PIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 56/236 (23%), Positives = 82/236 (34%), Gaps = 65/236 (27%)
Query: 14 GRYELGRTLGEGNFGKVKFA-----QDLDSGLP-----------FAVKILEKNRIIHLKI 57
LGEG FG+V QD AVK+L + + +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------FDKIASK 108
D +K E+ L L PN+ RL V + M++EY+ G+L +
Sbjct: 65 -DFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 109 GRL------------QEAEGRKLFQQL----ID-GLENILLDSKGNIKISDFGLSA---L 148
Q A G + + L D N L+ IKI+DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 149 PQHFRDDGLLHTTCGSPNYVAP-------EVLANRGYDGATSDIWSCGVILYVILT 197
++R G P VL + + SD+W+ GV L+ ILT
Sbjct: 183 SDYYRVQG---------RAPLPIRWMAWESVLLGK-FTTK-SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 70/267 (26%), Positives = 109/267 (40%), Gaps = 46/267 (17%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLH 80
+GEGNFG+V A+ GL I E+ L KL HPN++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE------------------------- 115
+ +Y+ +EY G L D + K R+ E +
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 116 -------GRKLFQQLIDGLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PN 166
+K F NIL+ KI+DFGLS + + + T G
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPVR 188
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWL 225
++A E L Y SD+WS GV+L+ I++ G P+ A LY+K+ +G ++L K L
Sbjct: 189 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPL 246
Query: 226 SPGAQ--NLLRKILEPNPVKRITIAGI 250
+ + +L+R+ P +R + A I
Sbjct: 247 NCDDEVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 11/137 (8%)
Query: 129 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE----VLANRGYDGATSD 184
N+L++ G +K+ DFG+S + D G Y+APE L +GYD SD
Sbjct: 134 NVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPELNQKGYD-VKSD 189
Query: 185 IWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNP 241
+WS G+ + + TG P+D L Q + +LP SP Q+ + K L+ N
Sbjct: 190 VWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNY 249
Query: 242 VKRITIAGIKADEWFEQ 258
+R + +FE
Sbjct: 250 KERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 22/195 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++E+ +GEG +G V + ++ A+K K+ + ++ + RE+ L+ LK
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
N+V L E + K+Y+V EYV EL +++ + G E + R QLI +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN-GVPPE-KVRSYIYQLIKAIHWCHK 118
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
EN+L+ +K+ DFG + + + Y +PE+L
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAP 177
Query: 178 YDGATSDIWSCGVIL 192
Y G D+WS G IL
Sbjct: 178 Y-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 33/213 (15%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D G+ AVK L + H K + RE+ LK
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK---RAYRELVLLKC 76
Query: 71 LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ H N++ L V + +Y+V+E + L I + L L Q++
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME--LDHERMSYLLYQML 133
Query: 125 DGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
G++ NI++ S +KI DFGL+ + ++ + Y A
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRA 190
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 202
PEV+ GY DIWS G I+ ++ G + F
Sbjct: 191 PEVILGMGYK-ENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E R +G G FG V D G A+K + N +L ++ RE+ L KH NV
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 77 VRLHEVLASK-----SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGLE-- 128
+ ++L +IY+V E + +L I S L ++ K+F Q++ GL+
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLS-SDHVKVFLYQILRGLKYL 119
Query: 129 -------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL-A 174
N+L++S +KI DFGL+ + + + + + Y APE+L
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPF 202
+R Y A DIWS G I +L + F
Sbjct: 179 SRHYTSAV-DIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 49/237 (20%)
Query: 18 LGRTLGEGNFGKV-KFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKR----EIATLKL 70
+ R LG G FG++ + L S LP A+ L +D+ +R E TL
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG------CSDKQRRGFLAEALTLGQ 62
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLENI 130
H N+VRL V+ + + +V EY++ G L L++ EG+ + QL+ L +
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGAL------DSFLRKHEGQLVAGQLMGMLPGL 116
Query: 131 ----------------------LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN- 166
L++S KIS F L + + + + T G SP
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQED-KSEAIYTTMSGKSPVL 173
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 222
+ APE + + A SD+WS G++++ +++ G P+ D + + + + G F+LP
Sbjct: 174 WAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 70/293 (23%), Positives = 115/293 (39%), Gaps = 87/293 (29%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEK---NRIIHLKITDQIKREIATLKLLKHPNVVR 78
+G G +G V A++ ++ A+K + NRI + REI L+ L H NV+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68
Query: 79 LHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----- 128
+ +++ + +Y+V E + +L I S L + + QL+ GL+
Sbjct: 69 IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----------YV 168
N+LL++ ++KI DFGL+ TT + Y
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKICDFGLA------------RTTSEKGDFMTEYVVTRWYR 175
Query: 169 APEVLANRGYDGATSDIWSCGVILYVILTG--------YL------------PFDD---- 204
APE+L N D+WS G I +L Y+ P ++
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235
Query: 205 ----------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 247
R+L ++ F F P +P A +LL K+L +P KRIT+
Sbjct: 236 IRNEKARRYIRSLPYTPRQSFARLF--PH-ANPLAIDLLEKMLVFDPSKRITV 285
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 9e-07
Identities = 70/267 (26%), Positives = 120/267 (44%), Gaps = 48/267 (17%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V + + A+K L+ ++ + +E +K L+H +V L+
Sbjct: 14 LGQGCFGEV-WMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--KLFQ------QLIDGL------ 127
V+ S+ IY+V E++ G L D L+E +G+ KL Q Q+ DG+
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLD------FLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 128 ---------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 175
NIL+ KI+DFGL+ L + D G+ + APE A
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-AL 176
Query: 176 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 233
G SD+WS G++L ++T G +P+ + +++ RG P+ L+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236
Query: 234 RKILEPNPVKRITIAGIKADEWFEQDY 260
+ + +P +R T I++ F +DY
Sbjct: 237 KLCWKKDPDERPTFEYIQS---FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 9e-07
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 40/218 (18%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
L YE G +G G +G V A+ D +A+K +E I+ REIA L+
Sbjct: 1 LFEYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRE 54
Query: 71 LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-------ASKGRLQEAEG--RKL 119
LKHPNV+ L +V S + K++++ +Y +L+ I A+K +Q G + L
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 120 FQQLIDGLE---------------NILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 159
Q++DG+ NIL+ +G +KI+D G + L + L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 197
+ Y APE+L + DIW+ G I +LT
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 54/225 (24%)
Query: 22 LGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
LGE FGKV + L P A+K L+ + ++ K E L+HPN
Sbjct: 13 LGEDRFGKV-YKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQHPN 69
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEGRKL 119
+V L V+ + + M+ Y + +L D K L+ A+ +
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 120 FQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRD------DGLL 158
Q+ G+E N+L+ K N+KISD GL FR+ L+
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL------FREVYAADYYKLM 183
Query: 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 202
+ +++PE + G SDIWS GV+L+ + + G P+
Sbjct: 184 GNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 40/218 (18%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
L YE G +G G +G V A+ D +A+K +E I+ REIA L+
Sbjct: 1 LFEYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRE 54
Query: 71 LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI----ASKG-----RLQEAEGRKL 119
LKHPNV+ L +V S S K++++ +Y +L+ I ASK +L + + L
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 120 FQQLIDGLE---------------NILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 159
Q++DG+ NIL+ +G +KI+D G + L + L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 197
+ Y APE+L + DIW+ G I +LT
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 52/194 (26%), Positives = 90/194 (46%), Gaps = 29/194 (14%)
Query: 22 LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG VK + + A+K+L+ + D++ RE + L +P +VR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGLE---------- 128
V +++ + +V+E +GG L ++ K + + +L Q+ G++
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 129 -----NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYD 179
N+LL ++ KISDFGLS AL DD + APE + R +
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 180 GATSDIWSCGVILY 193
+ SD+WS G+ ++
Sbjct: 177 -SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 60/234 (25%), Positives = 90/234 (38%), Gaps = 62/234 (26%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIA 66
L R LG G FG+V L AVK L E++ L E
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-------EAL 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------- 117
+ H N+VRL V + +++LE + GG+L K L+E R
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTM 115
Query: 118 ----KLFQQLIDG---LE------------NILLDSKGN---IKISDFGLSA---LPQHF 152
+ + G LE N LL KG KI+DFG++ ++
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175
Query: 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 205
R G ++ PE + G + +D+WS GV+L+ I + GY+P+ R
Sbjct: 176 RKGG---RAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 62/238 (26%)
Query: 15 RYELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLK 69
Y R +G+G FG+V A L PF AVK+L++ ++ Q RE A +
Sbjct: 8 EYV--RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ--REAALMA 63
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS---------------------- 107
HPN+V+L V A + ++ EY+ G+L + +
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 108 KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152
L E + +Q+ G+ N L+ +KI+DFGLS
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 177
Query: 153 RDDGLLHTTCGSPN------YVAPE-VLANRGYDGATSDIWSCGVILYVILT-GYLPF 202
R+ S N ++ PE + NR Y SD+W+ GV+L+ I + G P+
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNR-YT-TESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 47/162 (29%), Positives = 67/162 (41%), Gaps = 31/162 (19%)
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLE--------YVTGGE---LFDKIASKGRL 111
REI LK + H ++ L KS + MV+ YV L I + RL
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL 194
Query: 112 QEA----EGRKLFQQLIDGLENILLDSKGNIKISDFGLSA-------LPQHFRDDGLLHT 160
EA GR + + + ENI LD N + DFG + PQ + G L T
Sbjct: 195 LEALAYLHGRGIIHRDVK-TENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 161 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 202
+PE+LA Y A +DIWS G++L+ + +
Sbjct: 254 N-------SPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 39/212 (18%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+KIL N K + E + + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPH 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELF-------DKIAS-----------KGRLQEAEGR 117
+VRL V S + I +V + + G L D I S KG + E R
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 118 KLFQQLIDGLENILLDSKGNIKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPEV 172
+ + L N+L+ S ++KI+DFGL+ L ++ D G + ++A E
Sbjct: 130 LVHRDL--AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI-----KWMALEC 182
Query: 173 LANRGYDGATSDIWSCGVILYVILT-GYLPFD 203
+ R + SD+WS GV ++ ++T G P+D
Sbjct: 183 IHYRKFT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 60/266 (22%), Positives = 111/266 (41%), Gaps = 51/266 (19%)
Query: 22 LGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
LGE FGK+ + +D A+K L+ I + + + ++E + + L HPN+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIV 70
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKI-----------------ASKGRLQEAEGRKLF 120
L V+ + + M+ EY+ G+L + + K L + +
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 121 QQLIDGLE---------------NILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTC 162
Q+ G+E NIL+ + ++KISD GLS ++R + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR---VQPKSL 187
Query: 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVI----LTGYLPFDDRNLAVLYQKIFRGD 218
++ PE + + + SDIWS GV+L+ I L Y F ++ + + +K R
Sbjct: 188 LPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQL 244
Query: 219 FKLPKWLSPGAQNLLRKILEPNPVKR 244
+ P +L+ + + P +R
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 49/231 (21%), Positives = 91/231 (39%), Gaps = 36/231 (15%)
Query: 17 ELGRTLGEGNFGK--VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
EL +G+ V A+ + AVK + + + +++EI T + L+HP
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHP 59
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGLE---- 128
N++ S++Y+V + G D + + L E + + +++ L+
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 129 -----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--------NYVA 169
+ILL G + +S GL G +++
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYS-VSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 170 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY-QKIFRG 217
PEVL +GY+ SDI+S G+ + G++PF D + +K+ RG
Sbjct: 177 PEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-RG 225
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 31/208 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+K L + K +I E + + +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPH 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFD-------KIASKGRL----QEAEG------RK 118
V RL + + S + ++ + + G L D I S+ L Q A+G R+
Sbjct: 71 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 119 LFQQLIDGLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANR 176
L + + N+L+ + ++KI+DFGL+ L D+ H G ++A E + +R
Sbjct: 130 LVHRDL-AARNVLVKTPQHVKITDFGLAKLLG--ADEKEYHAEGGKVPIKWMALESILHR 186
Query: 177 GYDGATSDIWSCGVILYVILT-GYLPFD 203
Y SD+WS GV ++ ++T G P+D
Sbjct: 187 IYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 20 RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG V + G +P A+K+L +N K +I E + + P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPY 70
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGL------- 127
V RL + + S + +V + + G L D + +K R+ + Q+ G+
Sbjct: 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 128 --------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 177
N+L+ S ++KI+DFGL+ L D+ H G ++A E + +R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIKWMALESILHRR 187
Query: 178 YDGATSDIWSCGVILYVILT-GYLPFD 203
+ SD+WS GV ++ ++T G P+D
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-05
Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 2/92 (2%)
Query: 324 RKIRFTSNHSAKDLLERIEDIVTEMGFR--VQKKNGKLKATQEHKPQKSLGSLSVAAEVF 381
++ S ++ E I ++ G + N + + L S EV+
Sbjct: 4 WELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIEVY 63
Query: 382 EISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 413
E+ P L++V+ +K G + +L K+ L
Sbjct: 64 EVGPGLFMVDFKKKTGSTKTFTKLATKIQIKL 95
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 20/152 (13%)
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
E L+ + HP++++L ++L Y T +L+ +A+K + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190
Query: 123 LIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
++ + ENI ++ G++ + DFG + P + + G+
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY-YGWAGTIAT 249
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGY 199
APE+LA Y G DIWS G++L+ + T +
Sbjct: 250 NAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 43/173 (24%)
Query: 15 RYELGRTLGEGNFGKVKF------AQDLDSGLP--------FAVKILEKNRIIHLKITDQ 60
+ L LGEG FG+V A+ L G P AVK+L + + +
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARND 63
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG---------ELFDKIASKGRL 111
+EI + LK+PN++RL V S + M+ EY+ G E+ +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 112 QEAEGRKLFQ---QLIDGLE---------------NILLDSKGNIKISDFGLS 146
L Q+ G++ N L+ + IKI+DFG+S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 47/210 (22%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D +G A+K L + + H K + RE+ +KL
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMKL 71
Query: 71 LKHPNVVRLHEV------LASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQ 122
+ H N++ L V L +Y+V+E + ++ R+ L Q
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQ 126
Query: 123 LIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN- 166
++ G++ NI++ S +KI DFGL+ R G + +P
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG--TSFMMTPYV 178
Query: 167 ----YVAPEVLANRGYDGATSDIWSCGVIL 192
Y APEV+ GY DIWS G I+
Sbjct: 179 VTRYYRAPEVILGMGYK-ENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 69/284 (24%), Positives = 119/284 (41%), Gaps = 47/284 (16%)
Query: 20 RTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
R LG+G+FG V A+D+ G AVK + ++ + +I + E + +K
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQLI 124
+VVRL V++ +V+E + G+L + S + + GR ++ ++
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 125 DGL---------------ENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 164
DG+ N ++ +KI DFG++ ++R GLL
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 185
Query: 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLP 222
++APE L + G +SD+WS GV+L+ I + P+ N VL + G P
Sbjct: 186 -RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243
Query: 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 266
+L+R + NP R T I + D P+ P+
Sbjct: 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIV--NLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 32/202 (15%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG+G FG+V + + A+K L+ + + +E +K L+H +V+L+
Sbjct: 14 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 82 VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGL------------ 127
V+ S+ IY+V EY++ G L D K L+ + + Q+ G+
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 128 ---ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 181
NIL+ K++DFGL+ L + D G+ + APE A G
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFTI 182
Query: 182 TSDIWSCGVILYVILT-GYLPF 202
SD+WS G++L + T G +P+
Sbjct: 183 KSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 59/231 (25%), Positives = 91/231 (39%), Gaps = 71/231 (30%)
Query: 22 LGEGNFGKV---------KFAQD-------LDSGLPFAVKILEKNRIIHLKITDQIKREI 65
LGEG FG+V KF + + AVK+L ++ + + D +K EI
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR-NDFLK-EI 70
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG--------- 116
+ LK PN++RL V + + M+ EY+ G+L ++ S+ QEA
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTISY 129
Query: 117 ---RKLFQQLIDGLE---------------NILLDSKGNIKISDFGLSA---LPQHFRDD 155
+ Q+ G++ N L+ IKI+DFG+S ++R
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 156 GLLHTTCGSPNYVAPEVLANR---------GYDGATSDIWSCGVILYVILT 197
G VL R G SD+W+ GV L+ ILT
Sbjct: 190 G-------------RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 38/206 (18%)
Query: 19 GRTLGEGNFGKVK---FAQDLDS-GLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK 72
+ LG G FG V + + DS +P A+K ++ R +ITD + + L
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHM----LAMGSLD 67
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI------------------ASKGRLQEA 114
H +VRL + S + +V + G L D + +KG
Sbjct: 68 HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 115 EGRKLFQQLIDGLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSP-NYVAPE 171
E R + + L NILL S ++I+DFG++ L P D ++ +P ++A E
Sbjct: 127 EHRMVHRNL--AARNILLKSDSIVQIADFGVADLLYPD---DKKYFYSEHKTPIKWMALE 181
Query: 172 VLANRGYDGATSDIWSCGVILYVILT 197
+ Y SD+WS GV ++ +++
Sbjct: 182 SILFGRYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 45/241 (18%), Positives = 85/241 (35%), Gaps = 44/241 (18%)
Query: 41 PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH----EVLASKSKIYMVLEYV 96
++ +K H + D + EI L+ + N+++++ +++ ++ ++LEY
Sbjct: 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGLENI----------------LLDSKGNIKI 140
T G L + + + L + GL N+ L+ +KI
Sbjct: 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI 164
Query: 141 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT---------SDIWSCGVI 191
GL SP + + Y DI+S GV+
Sbjct: 165 ICHGL-------------EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211
Query: 192 LYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 249
L+ I TG +PF++ +Y I KLP + ++ + +KR I
Sbjct: 212 LWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271
Query: 250 I 250
I
Sbjct: 272 I 272
|
Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 61/229 (26%)
Query: 22 LGEGNFGKVKFA-----QDLDS-GLPF----------AVKILEKNRIIHLKITDQIKREI 65
LGEG FG+V QDL + PF AVKIL + + + D +K E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR-NDFLK-EV 70
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-------- 117
L LK PN++RL V + + M+ EY+ G+L ++ S L + E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129
Query: 118 ------------KLFQQLIDGLE---------------NILLDSKGNIKISDFGLSA--- 147
+ Q+ G++ N L+ IKI+DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 196
++R G ++A E + + A SD+W+ GV L+ IL
Sbjct: 190 AGDYYRIQG---RAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 20/66 (30%), Positives = 35/66 (53%), Gaps = 1/66 (1%)
Query: 128 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWS 187
EN+L++ +I + DFG + + + G+ + APEVLA Y + DIWS
Sbjct: 289 ENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWS 347
Query: 188 CGVILY 193
G++++
Sbjct: 348 AGLVIF 353
|
Length = 461 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 45/284 (15%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D A+K L + H K + RE+ +K
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 72
Query: 71 LKHPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ H N++ L V + +Y+V+E + L I + L L Q++
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQML 129
Query: 125 DGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 166
G++ NI++ S +KI DFGL+ R G ++ +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 183
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWL 225
Y APEV+ GY DIWS G I+ ++ + F R+ + K+ P+++
Sbjct: 184 YRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 269
Q +R +E P AG+ + F PA+ + ++
Sbjct: 243 KK-LQPTVRNYVENRP----KYAGLTFPKLFPDSLFPADSEHNK 281
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 33/225 (14%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
L RY+ + +G G G V A D A+K L + H K + RE+ +K
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGL 127
+ H N++ L V + + + EL D + E + + L Q++ G+
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 E---------------NILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 169
+ NI++ S +KI DFGL+ R G ++ + Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 214
PEV+ GY DIWS G I+ ++ G + F + + K+
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 52/236 (22%), Positives = 96/236 (40%), Gaps = 41/236 (17%)
Query: 22 LGEGNFGKVKFAQ-DLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
+G G FGKV ++ D+G+ VK L+ N K ++ ++ ++L+HPN+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDG--------- 126
+V EY G+L ++ + Q +++ ++ G
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 127 ------LENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGY 178
L N L S +K+ D+G+ P +++D + C ++APE++ +
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAPELVGEF-H 177
Query: 179 DGAT-------SDIWSCGVILYVILTG----YLPFDDRNLAVLYQKIFRGDFKLPK 223
G S++W+ GV L+ + Y DR VL I KL K
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHVIKDQQVKLFK 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|213377 cd12121, MARK_C_like, C-terminal kinase associated domain 1 (KA1), a phospholipid binding domain, of microtubule affinity-regulating kinases, and similar domains | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 20/103 (19%), Positives = 39/103 (37%), Gaps = 20/103 (19%)
Query: 324 RKIRF------TSNHSAKDLLERIEDIVTEMGFR-VQKKNGKLKATQEHKPQKSLGSLSV 376
R +R TS S ++++ I+ ++ G + L+ S
Sbjct: 1 RSLRGPFSVATTSTKSPEEIMNEIKRVLRSNGIDYEEVGGYLLECKHG-------DSSGG 53
Query: 377 AAEVFEI------SPSLYVVELRKSYGDPTVYRQLCNKLSSDL 413
+FEI L + ++ GD Y++LC K+ ++L
Sbjct: 54 EFVIFEIEICKLPRLGLNGIRFKRISGDSWQYKRLCKKILNEL 96
|
Microtubule-associated protein/microtubule affinity regulating kinases (MARKs), also called partition-defective (Par-1) kinases, are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Mammals contain four proteins, MARK1-4, encoded by distinct genes belonging to this subfamily, with additional isoforms arising from alternative splicing. In yeast, MARK/Par-1 homologs are called Kin1/2 kinases. Kin1 is a membrane-associated kinase that is involved in regulating cytokinesis and the cell surface. MARKs contain an N-terminal catalytic kinase domain, a ubiquitin-associated domain (UBA), and a C-terminal kinase associated domain (KA1). The KA1 domain binds anionic phospholipids and may be involved in membrane localization as well as in auto-inhibition of the kinase domain. Length = 96 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.69 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.66 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.59 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.55 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.52 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.49 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.48 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.46 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.43 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.38 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.32 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.24 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.06 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.6 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.53 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.45 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.39 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.27 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.08 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 98.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.88 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.73 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.61 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.37 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.21 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.1 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.02 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.75 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.68 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.23 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.19 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 96.13 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 95.74 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.55 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.46 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 93.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.42 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 92.74 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 91.7 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 91.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 90.89 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 89.54 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 88.21 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 88.15 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 87.25 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 86.89 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 85.4 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 84.02 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-55 Score=437.33 Aligned_cols=247 Identities=54% Similarity=1.002 Sum_probs=231.3
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc-c-hhHHHHHHHHHHHHhcCC-CCCccceeEEEEeC
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-H-LKITDQIKREIATLKLLK-HPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 86 (426)
....|+|++++.||+|+||+|++|.+..+++.||+|++++.... . ....+.+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 36789999999999999999999999999999999988775322 1 134677889999999999 99999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC-CCEEEeccCCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK-GNIKISDFGLSALPQ 150 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~-g~lKl~DFGla~~~~ 150 (426)
..+|+|||||.||+|+++|...+++.|.+++.+|+||++|+ ||||+|.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999999999999999999999999996 89999999 999999999999764
Q ss_pred cccCCCccccccCCCcccchhhhccCC-CCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCC-CHH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL-SPG 228 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~ 228 (426)
.......+.||||.|+|||++.+.+ |+|.++|||||||+||.|++|+.||++.+...++.++..+.+.+|.|+ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3467789999999999999999998 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
+.+||.+||.+||.+|+|+.+|++||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-56 Score=441.91 Aligned_cols=250 Identities=36% Similarity=0.674 Sum_probs=237.2
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
-+|..++.||+|||+.||.+++..+|+.||+|++.+....+....+.+.+||+|++.|+|||||+++++|++.+++|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
|+|+.++|..+++.++.++|.+|+.|++||+.|+ -||+|+++-+|||+|||||+.... ++...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 9999999999999999999999999999999996 599999999999999999997764 44567
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 238 (426)
.+.||||.|.|||++...++ +..+||||+|||+|.||+|++||+..+..+.|.+|...++.+|..+|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 89999999999999998887 59999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCChHHHhcCcCCccCCCCCCCC
Q 014359 239 PNPVKRITIAGIKADEWFEQDYTPANPD 266 (426)
Q Consensus 239 ~dP~~R~t~~~il~h~w~~~~~~~~~~~ 266 (426)
+||.+|||+++|+.|+||...+.|....
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 9999999999999999998888776543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-57 Score=448.08 Aligned_cols=247 Identities=47% Similarity=0.837 Sum_probs=233.8
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
-.+|-|+++++||.|+.|.|.+|+|..||+.+|||++.+...........+.+||.+|+.+.||||+++|+++++...+|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 45899999999999999999999999999999999998875445555678999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+|+||++||+||+++..++++++.+|.++|.||+.|+ ||+|||.++++||+|||+|.+- ..+
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPG 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cCC
Confidence 9999999999999999999999999999999999996 8999999999999999999853 246
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 235 (426)
..+.+.||+|.|.|||++.+.+|+|.++||||||||||.||||++||++.|...++.++.+|.+.+|..+|+++++||++
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCCChHHHhcCcCCccCC
Q 014359 236 ILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
||..||++|+|.+||++|||+....
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999997644
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=417.83 Aligned_cols=245 Identities=39% Similarity=0.710 Sum_probs=219.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchh----HHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
..+.|.+.++||+|+||.|.+|..+.+|+.||||++++....... ....+.+|++||++|+|||||+++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 557899999999999999999999999999999999876654322 2345789999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC---CCEEEeccCCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK---GNIKISDFGLSALP 149 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~---g~lKl~DFGla~~~ 149 (426)
..|+||||++||+|++++...+.+.+...+.+++||+.|+ ||||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 9999999999999999999999999999999999999996 89999877 68999999999965
Q ss_pred CcccCCCccccccCCCcccchhhhccCCC--CCchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHHhCCCCC--CCC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKL--PKW 224 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~~DIwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~--p~~ 224 (426)
. ......+.||||.|.|||++.+.++ ++.++|+||+|||||.+|+|.+||.+..... +.++|.+|.+.+ |.|
T Consensus 330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 4 4667889999999999999987664 3458999999999999999999999876655 889999998765 345
Q ss_pred --CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 225 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 225 --~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
++.++++||++||..||++|||++++|+||||+..
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 89999999999999999999999999999999863
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-53 Score=385.83 Aligned_cols=243 Identities=39% Similarity=0.757 Sum_probs=230.8
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
..+.+|+++++||.|+||.|.+++++.+|..+|+|++++...-+.+..+...+|.++|+.+.||+++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 77899999999999999999999999999999999999988877788899999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+||||++||+|+.++++.+++++..|+.|+.||+.|+ ||||+|.+|.+||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 9999999999999999999999999999999999996 79999999999999999999542
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 235 (426)
....+.||||.|+|||++..++|. .++|+|||||++|||++|.+||.+.+...+|++|..++..+|..+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 347789999999999999999985 9999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCC-----ChHHHhcCcCCccC
Q 014359 236 ILEPNPVKRI-----TIAGIKADEWFEQD 259 (426)
Q Consensus 236 ~L~~dP~~R~-----t~~~il~h~w~~~~ 259 (426)
+|+.|-.+|. ...+|..||||+..
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCcccccc
Confidence 9999999995 46799999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=394.97 Aligned_cols=246 Identities=37% Similarity=0.696 Sum_probs=229.2
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||+||.++.+++++.+|+|++++..+...+.......|..||..++||+||+++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999999999999999999998877777788999999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+|+||+.||+|+..|++.+.++|..|+.|+..|+.|| ||||||.+|+++|+|||+++..-. .
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--D 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--C
Confidence 99999999999999999999999999999999999996 899999999999999999995322 3
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 233 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li 233 (426)
+....+.|||+.|||||++.+.+|+ .++|+|||||++|+|++|.+||.+.+...++++|.+++ ...|..++.++++||
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 4556778999999999999999996 89999999999999999999999999999999999998 555666999999999
Q ss_pred HHccccCcCCCC----ChHHHhcCcCCcc
Q 014359 234 RKILEPNPVKRI----TIAGIKADEWFEQ 258 (426)
Q Consensus 234 ~~~L~~dP~~R~----t~~~il~h~w~~~ 258 (426)
+++|..||.+|. .+.+|.+||||..
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 999999999996 6899999999976
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=390.67 Aligned_cols=244 Identities=42% Similarity=0.761 Sum_probs=230.9
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
-+|++.++||+|+||+|.+|.....|+.||||.|+++.+.++...-.+++||+||+.|+||||+++|++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 48999999999999999999999999999999999999888888889999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+.+|+|+|+|..++.++|.+++++|+||.+|+ ||||||.|+++||+|||++.++. ....+
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DKKFL 209 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cccHH
Confidence 9999999999999999999999999999999994 89999999999999999999764 46678
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 238 (426)
.++||+|-|.+||++.+.+|.|+.+|-|||||+||.|+.|.+||++.+...+.++|..|.+.-|. -+.++.-||+.||.
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWMLM 288 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999887665 46789999999999
Q ss_pred cCcCCCCChHHHhcCcCCccCCC
Q 014359 239 PNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 239 ~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
.||.+|.|+.+|..|=|.+-.+.
T Consensus 289 VNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred cCcccchhHHHHhhhheeecccc
Confidence 99999999999999999876654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=382.09 Aligned_cols=247 Identities=39% Similarity=0.645 Sum_probs=225.3
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
....+|+|.+.+.||+|+||+||+|+++.++..||||.+.+..+ ..+..+.+..|+.+|+.++|||||.+++++.+++.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 34578999999999999999999999999999999999988765 45557889999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC------CCEEEeccCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK------GNIKISDFGLSA 147 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~------g~lKl~DFGla~ 147 (426)
+|+|||||.||||.++|+.+++++|..++.++.||+.|+ +||||+.+ -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999999999999999999999999999997 69999875 358999999999
Q ss_pred CCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC---CCCCCC
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKW 224 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~ 224 (426)
... ......+.||+|.|||||++..+.|+ .|+|+||+|+|||+|++|+.||+..+..+++..+.++. +.+|.+
T Consensus 164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred hCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhh
Confidence 765 45677899999999999999998897 89999999999999999999999999999998887775 345577
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
++....+|+...|..||..|.+..+-+.|+++....
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 899999999999999999999999999999987643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=390.45 Aligned_cols=249 Identities=35% Similarity=0.616 Sum_probs=229.9
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCe
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 88 (426)
.....+|.+++.||+|+|++|++|++..+++.||||++.+..+..++..+-+.+|-.+|.+| .||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 56678999999999999999999999999999999999988777777677889999999999 79999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+|+|+||+++|+|.++|.+.+.|++..++.|+.||+.|+ ||||||.||++||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999999999999999999999999999999999997 79999999999999999999765422
Q ss_pred CC-----------CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC
Q 014359 154 DD-----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 222 (426)
Q Consensus 154 ~~-----------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 222 (426)
.. ....+.+||..|++||++....- ++.+|||+||||||+|++|.+||.+.+..-++++|..-.+.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 11 11245799999999999987654 6999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 223 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+.+++.+.+||+++|..||.+|+|+.||.+||||...
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 9999999999999999999999999999999999763
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=382.81 Aligned_cols=251 Identities=33% Similarity=0.612 Sum_probs=224.4
Q ss_pred ccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
++....+++|++++.||+||||.||+|+.+.||+.+|+|++++......+....++.|-.+|...++|+||+||-.|++.
T Consensus 134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 44556789999999999999999999999999999999999998877777788999999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..+||||||++|||+..+|...+.+++..+++|+.+++.|+ +|+|||.+|++||+||||++.+..
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999999999999999999999999999996 799999999999999999974221
Q ss_pred c--------------------cCCC-------------------------ccccccCCCcccchhhhccCCCCCchhhHH
Q 014359 152 F--------------------RDDG-------------------------LLHTTCGSPNYVAPEVLANRGYDGATSDIW 186 (426)
Q Consensus 152 ~--------------------~~~~-------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIw 186 (426)
. ..+. ...+..|||.|||||++.+.+|. ..+|+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwW 372 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWW 372 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHH
Confidence 0 0000 11235799999999999999985 999999
Q ss_pred HHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCCCCC--CCHHHHHHHHHccccCcCCCCC---hHHHhcCcCCccC
Q 014359 187 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQD 259 (426)
Q Consensus 187 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~--~s~~~~~Li~~~L~~dP~~R~t---~~~il~h~w~~~~ 259 (426)
|||||+||||.|.+||.+.++.+.+++|...+ ..+|.. ++++++|||.+||. ||++|.. ++||.+||||...
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 99999999999999999999999999998765 555644 78999999999999 9999995 8999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=366.61 Aligned_cols=245 Identities=29% Similarity=0.482 Sum_probs=221.5
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe-
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK- 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 88 (426)
+...++.+.++.||+|..|+||+++|+.|++.+|+|++... .+....+++.+|+.+++.++|||||++|+.|.+++.
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 34556888999999999999999999999999999999543 355667899999999999999999999999999995
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
++|+||||.||+|.+.+...++++|.....++.+++.|| +|||++..|.+||||||.|+....
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn- 231 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN- 231 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh-
Confidence 999999999999999999889999999999999999997 699999999999999999986543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHHHHHHhCC-CCCCCC-C
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRGD-FKLPKW-L 225 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~ 225 (426)
....+..||..|||||.+.+..|. .++||||||+.++||++|+.||... +..+++..|..+. +.+|.. +
T Consensus 232 ---S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f 307 (364)
T KOG0581|consen 232 ---SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF 307 (364)
T ss_pred ---hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 366889999999999999999885 8899999999999999999999875 5678888888864 557776 9
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
|+++++||.+||++||.+|+|+.|+++|||+.+...
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 999999999999999999999999999999987543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=388.10 Aligned_cols=246 Identities=32% Similarity=0.607 Sum_probs=227.7
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCe
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 88 (426)
...+.+|.++++||+|+||+|++|..+.+++.+|||+++++.+...+..+..+.|.+|+.... ||.+++++.+|+++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 466789999999999999999999999999999999999998888888899999999999885 9999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+|+||||+.|||+.. +...+.|++..|+.|+..++.|| +|||||.+|++||+|||+++-. ..
T Consensus 444 l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MG 520 (694)
T ss_pred EEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CC
Confidence 999999999999544 44457899999999999999996 7999999999999999999942 23
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
......|.||||.|||||++.+..|. .++|+|||||+|||||+|+.||.+.+.++++..|...++.+|.|+|.++.+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 45578899999999999999999985 99999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCCC-----hHHHhcCcCCccC
Q 014359 234 RKILEPNPVKRIT-----IAGIKADEWFEQD 259 (426)
Q Consensus 234 ~~~L~~dP~~R~t-----~~~il~h~w~~~~ 259 (426)
+++|.+||.+|.. +.+|++||||...
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 9999999999996 4789999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=358.53 Aligned_cols=235 Identities=31% Similarity=0.519 Sum_probs=211.0
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEE-E-EeC
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV-L-ASK 86 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-~-~~~ 86 (426)
+...+.+|++.+.||+|+||.||++.+..+|..||.|.+..... +.+..+.+..|+.+|+.|+|||||++++. + ++.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 34456789999999999999999999999999999999986544 45557889999999999999999999983 4 444
Q ss_pred CeEEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH-------------------hheeeCCCCCEEEecc
Q 014359 87 SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL-------------------ENILLDSKGNIKISDF 143 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al-------------------eNILld~~g~lKl~DF 143 (426)
..++||||||.+|||...|+. .+.++|..+|+||.||+.|| .||+|+.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 459999999999999999963 45699999999999999997 5999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-CC
Q 014359 144 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP 222 (426)
Q Consensus 144 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p 222 (426)
|++++++. .....++..|||+||+||.+...+|+ .++||||+||++|||++-+.||.+.+...+..+|.+++++ +|
T Consensus 173 GL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 173 GLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 99998765 34456788999999999999999997 9999999999999999999999999999999999999876 67
Q ss_pred -CCCCHHHHHHHHHccccCcCCCCCh
Q 014359 223 -KWLSPGAQNLLRKILEPNPVKRITI 247 (426)
Q Consensus 223 -~~~s~~~~~Li~~~L~~dP~~R~t~ 247 (426)
..+|.++..||+.|+..||..||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 6699999999999999999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=374.27 Aligned_cols=250 Identities=36% Similarity=0.665 Sum_probs=230.7
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
+...|-|.+.++||+|-|+.|.+|++..+|+.||||++++....... ...+.+|++.|+.++|||||++|++..+...+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 56678899999999999999999999999999999999998765443 46788899999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheee-CCCCCEEEeccCCCCCCCcc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILL-DSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILl-d~~g~lKl~DFGla~~~~~~ 152 (426)
|+|+|+-.+|+|+|+|.+ ..++.|+.+++||.||+.|+ ||+.+ ..-|-+||+|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-- 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-- 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC--
Confidence 999999999999999965 46799999999999999996 78865 556899999999998654
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 232 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 232 (426)
+...+.+.||+..|.|||++.+..|+.+++||||||||||-|++|++||+..+..+.+..|++.++..|..++.++++|
T Consensus 171 -PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 171 -PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred -CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 4667899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCccCCCCC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPA 263 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~~~~~~ 263 (426)
|..||..||.+|.+.++|..|+|++....+.
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 9999999999999999999999998765543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=376.12 Aligned_cols=243 Identities=31% Similarity=0.577 Sum_probs=226.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+++.... .+..+.+.+|++|++.++|||||.++++|++..+.|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 46899999999999999999999999999999999987643 34478899999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
+|||.| +|+.++..++.++|+.++.+..|+++|| .|||++.+|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999977 9999999999999999999999999997 699999999999999999997554 4456
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcc
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 237 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 237 (426)
.+...|||.|||||++.+++|+ ..+|.||+|||||||++|++||...+...+.+.|.+....+|...+..+.+||+.+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 7788999999999999999987 889999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCChHHHhcCcCCccCC
Q 014359 238 EPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 238 ~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+||.+|+|..+++.|||.+...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999987644
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=363.91 Aligned_cols=246 Identities=34% Similarity=0.708 Sum_probs=223.4
Q ss_pred ccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
......+++|++.+.||+|+||.||+|++..+++.||||++.+.........+.+.+|+.+++.++||||+++++++.++
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 34566789999999999999999999999999999999999865444444467789999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
+..|+||||+++|+|.+++...+.+++..++.++.||+.|| +|||++.+|.+||+|||++.....
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999999999999888999999999999999997 699999999999999999985422
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 231 (426)
...+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..+..+.+.+|.+++..+.+
T Consensus 171 -----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 244 (329)
T PTZ00263 171 -----RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244 (329)
T ss_pred -----CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHH
Confidence 23356899999999999888774 899999999999999999999999888888899999999999999999999
Q ss_pred HHHHccccCcCCCCC-----hHHHhcCcCCcc
Q 014359 232 LLRKILEPNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 232 Li~~~L~~dP~~R~t-----~~~il~h~w~~~ 258 (426)
||.+||+.||.+|++ +++++.||||..
T Consensus 245 li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 245 LVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999999999997 799999999976
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=338.52 Aligned_cols=246 Identities=35% Similarity=0.674 Sum_probs=230.9
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
.....+++|++++.||+|-||.||+|+...++-.||+|++.+..+......+++.||++|.+.|+||||+++|++|-+..
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 34577899999999999999999999999999999999999887777777889999999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHH--hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~--~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
.+|+++||+.+|+|+..+. ...++++..++.|+.|++.|+ ||+|++..|.+||+|||.+...
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~- 174 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA- 174 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec-
Confidence 9999999999999999998 556799999999999999996 8999999999999999998742
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 230 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 230 (426)
+.....+.|||..|.|||...+.+++ ..+|+|++|++.||++.|.+||...+..+.|+.|.+-++.+|..++.++.
T Consensus 175 ---p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~ 250 (281)
T KOG0580|consen 175 ---PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAA 250 (281)
T ss_pred ---CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHH
Confidence 24556789999999999999999997 89999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 231 NLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
|||.+||..+|.+|.+..|++.|||...
T Consensus 251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=364.12 Aligned_cols=251 Identities=32% Similarity=0.506 Sum_probs=216.5
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC--Ce
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 88 (426)
...+.|+.++.||+|+||.||+|++..+|+.||+|.+..+.. +........|||.||++|+||||++|.++..+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 456789999999999999999999999999999999987653 334456788999999999999999999999876 68
Q ss_pred EEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
+|+|+|||+. ||.-++.. .-+|++.+++.|++||+.|| .|||||++|.+||+|||||+++...
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999977 99888876 45899999999999999998 4999999999999999999977653
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh--CCC--------CCC
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDF--------KLP 222 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~--------~~p 222 (426)
. ....+..+-|.+|.|||.+.+...++.++|+||+||||.||++|++.|++.+..+...+|.+ |.+ .+|
T Consensus 272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 2 33467778899999999999998888999999999999999999999999998888777764 111 111
Q ss_pred -------------------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCCC
Q 014359 223 -------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 264 (426)
Q Consensus 223 -------------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~~ 264 (426)
..+++.+.+|+.+||..||.+|.|+.++++|+||.....+..
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~ 411 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCD 411 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCC
Confidence 236899999999999999999999999999999965444433
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=346.21 Aligned_cols=245 Identities=38% Similarity=0.704 Sum_probs=221.3
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
..-+.|++.+.||+|+|+.||++.+..+|+.+|+|+++....... ..+.+.+|++|-+.|+||||+++++.+.+.+..|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 344789999999999999999999999999999999986655433 4688999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC---CEEEeccCCCCCCCcc
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---NIKISDFGLSALPQHF 152 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g---~lKl~DFGla~~~~~~ 152 (426)
+|+|++.|++|+.-|..+--++|..+..+++||+.|| +|+||.+.. -+||+|||+|..+.
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 9999999999998888777799999999999999997 699996543 59999999998554
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC--C--CCHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--W--LSPG 228 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s~~ 228 (426)
.......+.|||.|||||++...+| +.++||||||||||-||.|++||.+.+...+|++|..+.+.+|+ | ++++
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 4556778899999999999999988 58999999999999999999999999999999999999877763 4 8999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+++|+++||..||++|+|+.|+|+|||+.+..
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 99999999999999999999999999998643
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=352.26 Aligned_cols=239 Identities=34% Similarity=0.665 Sum_probs=217.4
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654333344567899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++|+|.+++...+.+++..++.++.|++.|| +|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 9999999999999888999999999999999996 699999999999999999985432 22
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 238 (426)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..+..+...+|..+++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 356899999999999888774 8999999999999999999999999888889999999999999999999999999999
Q ss_pred cCcCCCCC-----hHHHhcCcCCcc
Q 014359 239 PNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 239 ~dP~~R~t-----~~~il~h~w~~~ 258 (426)
.||.+|++ ++++++||||..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=369.74 Aligned_cols=250 Identities=41% Similarity=0.767 Sum_probs=234.5
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
.....+|.|.+.++||+|.|++|.+|++..++..||||++++..... .....+.+|+.+|+.++|||||+++.+.++..
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 45677899999999999999999999999999999999999876543 33556999999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|+||||+.+|++++++.+.+++.+..++.+|.|+.+|+ |||||+.+-++||+|||++..+.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence 9999999999999999999999999999999999999996 79999999999999999999765
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 232 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 232 (426)
......+.||+|.|.|||++.+..|+|+.+|+||+|++||.|+.|.+||++.+..........+.+.+|..++.++.+|
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL 285 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence 4677889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
|+++|..||.+|++++||+.|+|....+.
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhh
Confidence 99999999999999999999999876544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=356.53 Aligned_cols=254 Identities=39% Similarity=0.658 Sum_probs=220.1
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch-----------hHHHHHHHHHHHHhcCCCCCc
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------KITDQIKREIATLKLLKHPNV 76 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnI 76 (426)
.....+++|++++.||+|.||+|.+|++..+++.||||++++...... .-.+.+++||.||++|+||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 446778999999999999999999999999999999999986432211 113689999999999999999
Q ss_pred cceeEEEEeC--CeEEEEEcccCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHH---------------hheeeCCCCCE
Q 014359 77 VRLHEVLASK--SKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGL---------------ENILLDSKGNI 138 (426)
Q Consensus 77 v~l~~~~~~~--~~~~lVmEy~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~al---------------eNILld~~g~l 138 (426)
|+|+++..+. +.+|+|+|||..|.+.. ...+.+ +++.+|+.|++.++.|| .|+||+++|++
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 9999999764 67999999999998854 334455 99999999999999998 49999999999
Q ss_pred EEeccCCCCCCCcc---cCCCccccccCCCcccchhhhcc---CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH
Q 014359 139 KISDFGLSALPQHF---RDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ 212 (426)
Q Consensus 139 Kl~DFGla~~~~~~---~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~ 212 (426)
||+|||.+..+... +.+..+....|||.|+|||.+.+ ..+.|.+.||||+||+||.|+.|+.||.+....+++.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999999865322 12233445789999999999887 5677899999999999999999999999999999999
Q ss_pred HHHhCCCCCCCC--CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 213 KIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 213 ~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
+|....+.+|.. +.+.+++||.+||.+||.+|+++.+|..|||.......
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 999998888865 79999999999999999999999999999999876443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=341.56 Aligned_cols=241 Identities=27% Similarity=0.421 Sum_probs=205.9
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|+.+..+|+|+||.||+++++.||+.||||.+.... .+....+-..|||++|++++|||+|.++++|..+..+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 468999999999999999999999999999999986432 3444456678999999999999999999999999999999
Q ss_pred EcccCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
+|||+. ++.+.++ ...+++++.++.|++|++.|+ ||||++.+|.+||||||+|+.... +..
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 999987 4444554 456799999999999999995 899999999999999999997654 455
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh--------------CC----
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--------------GD---- 218 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------~~---- 218 (426)
..+....|.+|+|||.+.+...+|.++||||+||++.||++|.+.|++.+.-+....|.. ..
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 677889999999999999977778999999999999999999999999876555444332 10
Q ss_pred -CCCC------------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 219 -FKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 219 -~~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
..+| +.++.-+.+|+++||..||++|++.+|++.|+||.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1111 23678899999999999999999999999999994
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.54 Aligned_cols=246 Identities=33% Similarity=0.526 Sum_probs=208.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC--eEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--KIY 90 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 90 (426)
..+|..++.||+|+||.||++.+.++|+..|||.+..... .. .+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 4569999999999999999999999999999999876632 22 678999999999999999999999855444 699
Q ss_pred EEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCC-CCCEEEeccCCCCCCCcc-
Q 014359 91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDS-KGNIKISDFGLSALPQHF- 152 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~-~g~lKl~DFGla~~~~~~- 152 (426)
++|||+++|+|.+++.+.+ +++|..++.|.+|++.|| +|||++. +|.+||+|||+++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999877 799999999999999997 5999999 799999999999865531
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHHhC--CCCCCCCCCHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG--DFKLPKWLSPGA 229 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~ 229 (426)
..........|||.|||||++......+.++||||+||++.||+||+.||.. .......-.+... .+.+|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1123345678999999999998633333589999999999999999999997 3444433333333 367899999999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
++||.+||..||++|||++++|+|||......
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=356.37 Aligned_cols=242 Identities=39% Similarity=0.750 Sum_probs=220.8
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 91 (426)
-..|++++.||+|.||.||+++++.+|+.+|+|++.+.........+.+.+|+.+|++++ |||||++++++++.+.+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 357999999999999999999999999999999999877655545678999999999998 9999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC----CCEEEeccCCCCCCCcc
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK----GNIKISDFGLSALPQHF 152 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~----g~lKl~DFGla~~~~~~ 152 (426)
|||+|.||+|++.|... .++|..+..++.|++.|+ ||+|+... +.+|++|||+|.....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~- 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP- 191 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence 99999999999999887 599999999999999995 89999754 4799999999996543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC--CC--CCHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--KW--LSPG 228 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~~ 228 (426)
.......||||.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+....+.++..+.+.++ .| ++..
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred --CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 5578899999999999999988885 899999999999999999999999999999999999987654 34 7999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+++||++||..||.+|+|+.++++|||+...
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999998764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=355.13 Aligned_cols=245 Identities=35% Similarity=0.638 Sum_probs=220.0
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
.....+++|++.+.||+|+||.||+|.+..++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 34567789999999999999999999876554 68999999765444444467788999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
+..|+||||+++|+|.+++....++++..++.++.||+.|| +|||++.+|.+||+|||++.....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999999888999999999999999996 699999999999999999985432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 231 (426)
...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+..+...+|..+++.+.+
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 257 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKH 257 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 2346789999999999988776 4899999999999999999999999888888999998888889999999999
Q ss_pred HHHHccccCcCCCC-----ChHHHhcCcCCcc
Q 014359 232 LLRKILEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 232 Li~~~L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
+|++||+.||.+|+ |++++++||||..
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999996 8999999999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=352.22 Aligned_cols=237 Identities=33% Similarity=0.621 Sum_probs=212.9
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 99 (426)
+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998654433444567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCC
Q 014359 100 ELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164 (426)
Q Consensus 100 ~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt 164 (426)
+|.+++...+.+++..++.++.||+.|| +|||++.++.+||+|||+++.... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 9999999888999999999999999997 699999999999999999874322 22334567899
Q ss_pred CcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 014359 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 244 (426)
Q Consensus 165 ~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 244 (426)
+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+....+..+..+...+|..+++++.+||.+||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999888774 8999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----ChHHHhcCcCCccC
Q 014359 245 I-----TIAGIKADEWFEQD 259 (426)
Q Consensus 245 ~-----t~~~il~h~w~~~~ 259 (426)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=335.77 Aligned_cols=243 Identities=35% Similarity=0.685 Sum_probs=217.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHhcC-CCCCccceeEEEEe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 85 (426)
...+|+-.+.||.|..+.|.++.+..+|+.+|+|++...... -....+.-.+|+.||+++ .||||++++|++++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 357899999999999999999999999999999999743221 123456678899999999 59999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
+...++|+|+|+.|+|+|++.+...++|..++.+++||+.|+ ||||+|+|.++||+|||+|+...
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999999999999999999999999999999995 89999999999999999999654
Q ss_pred cccCCCccccccCCCcccchhhhccC------CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCC--C
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--P 222 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~------~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p 222 (426)
....+...||||+|+|||.+... +| +..+|+||||||+|.||.|.+||-.....-+++.|..|++.+ |
T Consensus 175 ---~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 175 ---PGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred ---CchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 45678889999999999998643 34 578999999999999999999999988889999999998765 6
Q ss_pred CC--CCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 223 KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 223 ~~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.| ++...++||.+||+.||.+|+|++|+|+||||.+
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 66 8899999999999999999999999999999965
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.42 Aligned_cols=244 Identities=29% Similarity=0.490 Sum_probs=211.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCC-e
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS-K 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-~ 88 (426)
...++|.+++.||.|+||.||+|+...+|+.||||.+++.... .+. -.-.||+..|++|+ |||||++++++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4568999999999999999999999999999999999765432 222 23458999999998 999999999998887 9
Q ss_pred EEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
+|+||||++. +|+++++.+ ..|++..++.|+.||+.|| ||||+..+..+||+|||+|+-...
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc-
Confidence 9999999965 999999865 4699999999999999997 899999999999999999995443
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh--C-------------
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--G------------- 217 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~------------- 217 (426)
....+.++.|.+|+|||++...++++.++|+||+|||++|+.+-++.|.|.+..+...+|.. |
T Consensus 163 --kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 --KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred --CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 44567789999999999999999999999999999999999999999999988777666643 1
Q ss_pred ----CCCCC-----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 218 ----DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 218 ----~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+.+| +.+++++.+||.+||.+||++|||++|+++||||+...
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 11222 22789999999999999999999999999999998654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=325.71 Aligned_cols=247 Identities=32% Similarity=0.436 Sum_probs=212.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
.+|...+.||+|+||.||+|++..+|+.||||.++.... .........|||..|+.++||||+.++|+|.+.+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 579999999999999999999999999999999986643 2333457889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||++. ||...|+.. ..++..+++.|+.|++.|+ .|+|++++|.+||+|||+|+.+.. .+..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~--p~~~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS--PNRI 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC--CCcc
Confidence 99976 999999864 4699999999999999997 599999999999999999998765 3344
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CC----------------
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF---------------- 219 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~---------------- 219 (426)
.....-|.+|.|||.+.|...+|..+||||.|||+.||+-|.+-|.+.+.-+....|... .+
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 445588999999999999887789999999999999999999999998876666665431 11
Q ss_pred ----CCC------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCCC
Q 014359 220 ----KLP------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 264 (426)
Q Consensus 220 ----~~p------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~~ 264 (426)
+.| +..+.++.||+.+||..||.+|+|+.|+++|+||.....|..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 111 125788999999999999999999999999999998554443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.81 Aligned_cols=235 Identities=36% Similarity=0.649 Sum_probs=211.2
Q ss_pred eeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCCh
Q 014359 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L 101 (426)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999765433444456788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCc
Q 014359 102 FDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166 (426)
Q Consensus 102 ~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~ 166 (426)
.+++...+++++..++.++.||+.|| +|||++.++.+||+|||+++.... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 99999888999999999999999997 699999999999999999985322 2233456789999
Q ss_pred ccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCC-
Q 014359 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI- 245 (426)
Q Consensus 167 Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~- 245 (426)
|+|||++.+..++ .++||||+||++|+|++|+.||.+.+....+..+..+...+|..+++++.+||.+||..||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999888775 88999999999999999999999988888889998888889999999999999999999999997
Q ss_pred --ChHHHhcCcCCccC
Q 014359 246 --TIAGIKADEWFEQD 259 (426)
Q Consensus 246 --t~~~il~h~w~~~~ 259 (426)
++.+++.||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=338.71 Aligned_cols=248 Identities=33% Similarity=0.623 Sum_probs=229.4
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
..+.+++|+.++.||+|+||+|-+++.+.+++.||||+++++.....+....-..|-++|+..+||.+..+.-.|++.+.
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 34678999999999999999999999999999999999998877666666777889999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+|+||||+.||+|+-.+.+...++|+.++.|-..|++|| ||+|||.+|++||+|||+.+- ...
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~ 320 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIK 320 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--ccc
Confidence 999999999999999999888899999999999999996 899999999999999999983 223
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
......+.||||.|+|||++....| |.++|+|.+||++|||++|++||...+...++..|...+..+|..++++++.|+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred ccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHH
Confidence 4456789999999999999999888 599999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCCC-----hHHHhcCcCCccC
Q 014359 234 RKILEPNPVKRIT-----IAGIKADEWFEQD 259 (426)
Q Consensus 234 ~~~L~~dP~~R~t-----~~~il~h~w~~~~ 259 (426)
..+|.+||.+|.. +.+|.+|+||...
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999999984 7899999999753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.63 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=219.1
Q ss_pred hhcccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEE
Q 014359 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (426)
Q Consensus 4 ~~~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 83 (426)
..+.+.....+.|++...||.|..++||+|+...+++.||||+++.+.+.+. .+.+++|+..|+.++||||++++..|
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 3444556677899999999999999999999999999999999998776443 68999999999999999999999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCC
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla 146 (426)
..+..+|+||.|+.+|++.+.+... ..++|..+..++++++.|| .||||+.+|.+||+|||.+
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence 9999999999999999999999863 4599999999999999998 4999999999999999988
Q ss_pred CCCCcccCCC--ccccccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC
Q 014359 147 ALPQHFRDDG--LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 222 (426)
Q Consensus 147 ~~~~~~~~~~--~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 222 (426)
..+...+... ...+..|||+|||||++.. .+|+ .|+||||||++..||.+|..||..-.+.+++..-.++.++.|
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL 252 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc
Confidence 7554433211 1256799999999999543 4676 999999999999999999999999888777766666766533
Q ss_pred C----------CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 223 K----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 223 ~----------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
. .++..++.+|..||+.||.+|||++++++|+||++.
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 2 267889999999999999999999999999999763
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=340.50 Aligned_cols=252 Identities=30% Similarity=0.485 Sum_probs=224.2
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
...+-+.+|++++.||+|.-|+||+++...++..+|+|++++......+...+.+.|-.||+.++||.++.||..++++.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 35566789999999999999999999999999999999999988777777788999999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
..|+|||||+||+|..+.+++ +.+++..|++|+..++.|| |||||.++|++-|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999999998764 4699999999999999997 79999999999999999875310
Q ss_pred c-----------------------------c---c-C---------------------CCccccccCCCcccchhhhccC
Q 014359 151 H-----------------------------F---R-D---------------------DGLLHTTCGSPNYVAPEVLANR 176 (426)
Q Consensus 151 ~-----------------------------~---~-~---------------------~~~~~~~~gt~~Y~APE~l~~~ 176 (426)
. . . . +....+.+||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 0 0112245799999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHccccCcCCCCC----hHHH
Q 014359 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IAGI 250 (426)
Q Consensus 177 ~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t----~~~i 250 (426)
++ +.++|+|+|||+|||||.|..||.+.+..+.+.++....+.+|.. ++..++|||+++|.+||.+|+. +++|
T Consensus 311 GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 311 GH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 98 489999999999999999999999999999999999988888854 7899999999999999999998 9999
Q ss_pred hcCcCCccCC
Q 014359 251 KADEWFEQDY 260 (426)
Q Consensus 251 l~h~w~~~~~ 260 (426)
.+||||+...
T Consensus 390 K~HpFF~gVn 399 (459)
T KOG0610|consen 390 KRHPFFEGVN 399 (459)
T ss_pred hcCccccCCC
Confidence 9999998754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=345.47 Aligned_cols=236 Identities=36% Similarity=0.636 Sum_probs=211.6
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 99 (426)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998654444444577889999999999999999999999999999999999999
Q ss_pred ChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCC
Q 014359 100 ELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164 (426)
Q Consensus 100 ~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt 164 (426)
+|.+++.....+++..++.++.||+.|| +|||++.++.+||+|||+++.... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 9999998888899999999999999996 699999999999999999874322 12234457899
Q ss_pred CcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 014359 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 244 (426)
Q Consensus 165 ~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 244 (426)
+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||++||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999988777 48999999999999999999999988888888888888888999999999999999999999999
Q ss_pred C-----ChHHHhcCcCCcc
Q 014359 245 I-----TIAGIKADEWFEQ 258 (426)
Q Consensus 245 ~-----t~~~il~h~w~~~ 258 (426)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=344.24 Aligned_cols=236 Identities=33% Similarity=0.624 Sum_probs=211.0
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||.||+|++..+++.||||++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999865443344456778898888876 699999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++....++++..++.++.|++.|| +|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 99999998888999999999999999997 699999999999999999874322 2233455689
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+....+..+..+....|.+++.++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887764 899999999999999999999999998899999998888999999999999999999999999
Q ss_pred CCCh------HHHhcCcCCcc
Q 014359 244 RITI------AGIKADEWFEQ 258 (426)
Q Consensus 244 R~t~------~~il~h~w~~~ 258 (426)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=347.98 Aligned_cols=244 Identities=30% Similarity=0.542 Sum_probs=209.3
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654434444577889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC----
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD---- 154 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~---- 154 (426)
||++||+|.+++...+++++..++.++.|++.|| +|||++.+|.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999999888999999999999999996 799999999999999999875432100
Q ss_pred -----------------------------CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc
Q 014359 155 -----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 205 (426)
Q Consensus 155 -----------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 205 (426)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346899999999999888875 8999999999999999999999998
Q ss_pred cHHHHHHHHHhC--CCCCCCC--CCHHHHHHHHHccccCcC---CCCChHHHhcCcCCccC
Q 014359 206 NLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPV---KRITIAGIKADEWFEQD 259 (426)
Q Consensus 206 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~~~L~~dP~---~R~t~~~il~h~w~~~~ 259 (426)
+....+.++... ...+|++ +++++++||.+|+. +|. .||++++|++||||...
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 888888887753 3445543 78999999999775 444 46899999999999763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=345.11 Aligned_cols=240 Identities=29% Similarity=0.521 Sum_probs=211.5
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998654433444567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||++||+|.+++...+.+++..++.++.||+.|+ +|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 9999999999999888899999999999999996 699999999999999999985432 34
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCCCC------CCCHHHH
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK------WLSPGAQ 230 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~ 230 (426)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+.... ...|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 567899999999999888775 89999999999999999999999988877776665432 22232 3589999
Q ss_pred HHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 231 NLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+||.+||..+|.+||++.++++||||...
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=343.73 Aligned_cols=237 Identities=32% Similarity=0.617 Sum_probs=211.6
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 99 (426)
+.||+|+||.||++++..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998654333344567788999999999999999999999999999999999999
Q ss_pred ChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCC
Q 014359 100 ELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164 (426)
Q Consensus 100 ~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt 164 (426)
+|..++...+.+++..++.++.||+.|| +|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 9999998888899999999999999997 699999999999999999874321 22233456899
Q ss_pred CcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 014359 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 244 (426)
Q Consensus 165 ~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 244 (426)
+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....+..+......+|..+++++.+||.+||..||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999887774 8999999999999999999999998888888888888888899999999999999999999999
Q ss_pred C-----ChHHHhcCcCCccC
Q 014359 245 I-----TIAGIKADEWFEQD 259 (426)
Q Consensus 245 ~-----t~~~il~h~w~~~~ 259 (426)
+ ++.++++||||...
T Consensus 238 ~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 8 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=341.85 Aligned_cols=241 Identities=33% Similarity=0.608 Sum_probs=214.8
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCccceeEEEEeCCeEEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lVm 93 (426)
+|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+..|+.++..++| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999986544334445678889999999976 46889999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++|+|.+++...+.+++..+..++.||+.|| +|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 9999999999999888899999999999999997 799999999999999999874221 22234
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 238 (426)
...+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+....+..+......+|..+++++.+||.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 567899999999999888774 8999999999999999999999999888889999888888899999999999999999
Q ss_pred cCcCCCCCh-----HHHhcCcCCcc
Q 014359 239 PNPVKRITI-----AGIKADEWFEQ 258 (426)
Q Consensus 239 ~dP~~R~t~-----~~il~h~w~~~ 258 (426)
.||.+|++. +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999987 89999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=347.94 Aligned_cols=244 Identities=32% Similarity=0.609 Sum_probs=210.4
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998654434444567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC---
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD--- 155 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~--- 155 (426)
||+++|+|.+++...+.+++..++.++.||+.|| +|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999999888899999999999999997 6999999999999999998753221100
Q ss_pred ---------------------------------CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCC
Q 014359 156 ---------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 202 (426)
Q Consensus 156 ---------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf 202 (426)
....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011245799999999999888775 8999999999999999999999
Q ss_pred CCccHHHHHHHHHhCC--CCCCC--CCCHHHHHHHHHccccCcCCCCC---hHHHhcCcCCccC
Q 014359 203 DDRNLAVLYQKIFRGD--FKLPK--WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQD 259 (426)
Q Consensus 203 ~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~~L~~dP~~R~t---~~~il~h~w~~~~ 259 (426)
.+.+....+..+.... +.+|. .+++++.+||.+||. +|.+|++ +.++++||||...
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9988877777776543 33444 368999999999997 9999998 9999999999763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=342.29 Aligned_cols=236 Identities=33% Similarity=0.622 Sum_probs=211.4
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||.||+|.+..+++.||||++.+...........+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999875443444456677899999866 799999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+.+...+.+++..++.++.||+.|| +|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 99999998888899999999999999997 699999999999999999874322 2233456789
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||...+....+..+..+....|.++++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999887775 899999999999999999999999999999999999888899999999999999999999999
Q ss_pred CC-------ChHHHhcCcCCcc
Q 014359 244 RI-------TIAGIKADEWFEQ 258 (426)
Q Consensus 244 R~-------t~~~il~h~w~~~ 258 (426)
|+ +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 8999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=332.31 Aligned_cols=248 Identities=29% Similarity=0.452 Sum_probs=209.3
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe-----CCe
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KSK 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 88 (426)
.+|..++.||+|+||.|..|.+..+|+.||||.+... ..+.-..++..||+.+|+.++|+||+.+.+++.. -..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3555579999999999999999999999999988632 3344557889999999999999999999999865 356
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+|+|+|++ +.||...|+.+..+++.+++.+++||+.|| .|+|++.++.+||+|||+|+......
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999999 559999999988899999999999999997 59999999999999999999765443
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh-----------------
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------------- 216 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~----------------- 216 (426)
.....+...-|.+|.|||++.....++.++||||+|||+.||++|++.|.+.+....+..|..
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 345567788999999999987765556999999999999999999999998776555544432
Q ss_pred ------CCCCCC--------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCC
Q 014359 217 ------GDFKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 263 (426)
Q Consensus 217 ------~~~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~ 263 (426)
..+..| +..++.+.+|+.+||..||.+|+|++|+++|||+.....|.
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 111111 34789999999999999999999999999999998866554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=352.38 Aligned_cols=241 Identities=27% Similarity=0.496 Sum_probs=212.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
-....|+....||+|+.|.||.|....+++.||||.++...... .+-+.+|+.+|+..+|+|||.+++.|.-.+.+|
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 34567999999999999999999999999999999998765333 467899999999999999999999999889999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+||||++||+|.|.+.. ..++|.++..++++++.|| +|||++.+|.+||+|||++..+.. ..
T Consensus 347 VVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~--~~ 423 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE--EQ 423 (550)
T ss_pred EEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc--cc
Confidence 99999999999998876 5699999999999999998 699999999999999999986654 23
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHHhCCC--CCCCCCCHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDF--KLPKWLSPGAQNL 232 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~--~~p~~~s~~~~~L 232 (426)
....+..|||+|||||++....| |+++||||||++++||+-|++||-..+.-. +|.--..|.+ ..|..+|+.+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 35678899999999999999888 599999999999999999999998766554 4444444544 4567799999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCcc
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
|.+||+.||.+|+++.++|+||||+.
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999999954
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.84 Aligned_cols=239 Identities=30% Similarity=0.571 Sum_probs=210.3
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH---hcCCCCCccceeEEEEeCCeEEEE
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL---KLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
|++.+.||+|+||.||+|.+..+++.||||++++.........+.+.+|+.++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999865433333456677777665 566799999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|||+++|+|...+.. +.+++..++.++.||+.|+ +|||++.++.+||+|||++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence 999999999988865 5799999999999999997 699999999999999999874322 2233
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcc
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 237 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L 237 (426)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+..+..+...+|..+++.+.+||.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 4567899999999999887774 899999999999999999999999988888888888888889999999999999999
Q ss_pred ccCcCCCC-----ChHHHhcCcCCcc
Q 014359 238 EPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 238 ~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
+.||++|| ++.++++||||..
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 99999999 6999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.66 Aligned_cols=251 Identities=31% Similarity=0.412 Sum_probs=213.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--CCe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSK 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 88 (426)
..++.|+.+..|++|+||.||+|+++.|++.||+|.++.+. .....--...|||.+|.+++|||||.+-++... -+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 45778999999999999999999999999999999997654 233334457799999999999999999999754 467
Q ss_pred EEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
+|+|||||+. ||...+..-+ +|...+++.++.|++.|+ .|+|+...|.+||+|||+|+.+..
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs- 229 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS- 229 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC-
Confidence 9999999976 9999998754 899999999999999997 599999999999999999997654
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh-----------CC---
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----------GD--- 218 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-----------~~--- 218 (426)
+....+...-|.+|.|||.+.+..-+++++|+||+|||+.||+++++.|.+....+...+|.+ |-
T Consensus 230 -p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 230 -PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred -CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 334456678899999999999988778999999999999999999999999887776666653 11
Q ss_pred -----CCCC-----------CC--CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCCCC
Q 014359 219 -----FKLP-----------KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 265 (426)
Q Consensus 219 -----~~~p-----------~~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~~~ 265 (426)
..+| .+ ++....+|++++|..||.+|+|+.|.|+|.||.+...|..|
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP 373 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence 1111 11 45889999999999999999999999999999987666544
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=347.38 Aligned_cols=245 Identities=31% Similarity=0.517 Sum_probs=207.8
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
..|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998765545555678999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC----
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD---- 154 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~---- 154 (426)
||++||+|.+++.....+++..++.++.||+.|| +|||++.+|++||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999999999888899999999999999996 699999999999999999864321000
Q ss_pred -----------------------------------------CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHH
Q 014359 155 -----------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 193 (426)
Q Consensus 155 -----------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ 193 (426)
.....+.+||+.|+|||++.+..++ .++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHH
Confidence 0012346899999999999888775 8999999999999
Q ss_pred HHhcCCCCCCCccHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHcc--ccCcCCCCChHHHhcCcCCccC
Q 014359 194 VILTGYLPFDDRNLAVLYQKIFR--GDFKLPK--WLSPGAQNLLRKIL--EPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 194 elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~Li~~~L--~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+|++|+.||...+.......+.. .....|. .+++++.+||.+|| ..+|..|++++++++||||...
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 99999999998777665555543 3344454 47999999999955 5566669999999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.42 Aligned_cols=237 Identities=32% Similarity=0.606 Sum_probs=208.5
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||.||+|.+..+++.||+|++++..............|..++... +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999865432223345677788888754 899999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++....++++..+..++.|++.|+ +|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 99999998888899999999999999997 699999999999999999874221 1233456789
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+....+.+|.+++.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999888775 899999999999999999999999888888888888888889999999999999999999999
Q ss_pred CCCh-HHHhcCcCCccC
Q 014359 244 RITI-AGIKADEWFEQD 259 (426)
Q Consensus 244 R~t~-~~il~h~w~~~~ 259 (426)
|+++ +++++||||...
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9998 589999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=332.12 Aligned_cols=240 Identities=24% Similarity=0.366 Sum_probs=199.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976432 2233567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||++++.|..+......+++..++.++.|++.|+ +||+++.++.+||+|||++...... .....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-ccccc
Confidence 9999887766655556799999999999999996 6999999999999999999865321 12223
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-------------------CC
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DF 219 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 219 (426)
...+||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+..+....+... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 356799999999999888774 8999999999999999999999876544332222110 00
Q ss_pred CCC-------------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 220 KLP-------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 220 ~~p-------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
..| ..+|.++.+||++||+.||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 111 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=340.32 Aligned_cols=236 Identities=29% Similarity=0.577 Sum_probs=205.9
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||.||+|.+..+++.||||++++...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544444456788999999998 699999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++...+++++..++.++.||+.|+ +|||++.++.+||+|||+++.... ......+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 99999998888999999999999999997 699999999999999999874211 2233456789
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc---------cHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---------NLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 234 (426)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||+.. .....+..+......+|.+++..+.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999888775 8999999999999999999999631 12234566777778889999999999999
Q ss_pred HccccCcCCCCC------hHHHhcCcCCcc
Q 014359 235 KILEPNPVKRIT------IAGIKADEWFEQ 258 (426)
Q Consensus 235 ~~L~~dP~~R~t------~~~il~h~w~~~ 258 (426)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=338.46 Aligned_cols=241 Identities=33% Similarity=0.604 Sum_probs=214.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVm 93 (426)
+|++.+.||+|+||.||+|++..+++.||||++.+..............|..++..+ +||+|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999875443333455677788888877 5899999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++|+|.+++...+.+++..+..++.||+.|| +|||++.++.+||+|||+++.... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 9999999999998888899999999999999997 699999999999999999874321 12234
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 238 (426)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..+......+|..++.++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 467899999999999988775 8999999999999999999999999888889999888888999999999999999999
Q ss_pred cCcCCCCCh-----HHHhcCcCCcc
Q 014359 239 PNPVKRITI-----AGIKADEWFEQ 258 (426)
Q Consensus 239 ~dP~~R~t~-----~~il~h~w~~~ 258 (426)
.||.+|++. .++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999984 89999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=342.89 Aligned_cols=236 Identities=33% Similarity=0.626 Sum_probs=211.2
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 99 (426)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998754444444567788999999999999999999999999999999999999
Q ss_pred ChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 100 ELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 100 ~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
+|.+++.....+++..++.++.||+.|| +|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 9999998888899999999999999996 699999999999999999874321 2223445689
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999887774 899999999999999999999999888888888888888889999999999999999999999
Q ss_pred CC-----ChHHHhcCcCCcc
Q 014359 244 RI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 244 R~-----t~~~il~h~w~~~ 258 (426)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=336.42 Aligned_cols=238 Identities=37% Similarity=0.672 Sum_probs=209.9
Q ss_pred eceeeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
++.||+|+||.||+|++. .+++.||||++.+.... .......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 47889999999864322 22334567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
|+++|+|.+++...+.+++..+..++.||+.|| +|||++.+|.+||+|||+++.... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 999999999999888899999999999999996 699999999999999999874322 223345
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcccc
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 239 (426)
..+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+..+...+|..+++++.+||.+||+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 56899999999999887764 89999999999999999999999988888888888888899999999999999999999
Q ss_pred CcCCCC-----ChHHHhcCcCCccC
Q 014359 240 NPVKRI-----TIAGIKADEWFEQD 259 (426)
Q Consensus 240 dP~~R~-----t~~~il~h~w~~~~ 259 (426)
||++|| +++++++||||...
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.82 Aligned_cols=237 Identities=36% Similarity=0.677 Sum_probs=211.3
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999875443444456778899999888 699999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++...+++++..+..++.||+.|| +|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 99999999888999999999999999996 699999999999999999874221 2223445689
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+....+..+......+|..++..+.+||++||+.||++
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999888775 899999999999999999999999888888888888888889999999999999999999999
Q ss_pred CCCh-----HHHhcCcCCccC
Q 014359 244 RITI-----AGIKADEWFEQD 259 (426)
Q Consensus 244 R~t~-----~~il~h~w~~~~ 259 (426)
|||+ .+++.||||...
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.60 Aligned_cols=237 Identities=35% Similarity=0.663 Sum_probs=207.8
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||.||+|.+..+++.||||++.+.........+.+..|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999865433333345666777777654 899999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++....++++..++.++.||+.|| +|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 99999998888999999999999999997 699999999999999999974322 1233456789
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+....+..+....+.+|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 899999999999999999999999888888888888888889999999999999999999999
Q ss_pred CCChH-HHhcCcCCccC
Q 014359 244 RITIA-GIKADEWFEQD 259 (426)
Q Consensus 244 R~t~~-~il~h~w~~~~ 259 (426)
||++. ++++||||...
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 238 RLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99875 88899999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.43 Aligned_cols=244 Identities=32% Similarity=0.602 Sum_probs=213.1
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998654434344677899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc-----
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR----- 153 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~----- 153 (426)
||+++|+|.+++...+.+++..++.++.||+.|| +|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 9999999999999888899999999999999996 69999999999999999998644321
Q ss_pred ----------------------CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHH
Q 014359 154 ----------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 211 (426)
Q Consensus 154 ----------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 211 (426)
.........||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 01123456799999999999888774 8999999999999999999999998877777
Q ss_pred HHHHh--CCCCCCCC--CCHHHHHHHHHccccCcCCCCC-hHHHhcCcCCccC
Q 014359 212 QKIFR--GDFKLPKW--LSPGAQNLLRKILEPNPVKRIT-IAGIKADEWFEQD 259 (426)
Q Consensus 212 ~~i~~--~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t-~~~il~h~w~~~~ 259 (426)
..+.. ....+|.. +++++.+||.+||. ||.+|++ ++++++||||...
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 77766 44445544 59999999999997 9999999 9999999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=335.45 Aligned_cols=244 Identities=33% Similarity=0.618 Sum_probs=208.4
Q ss_pred CEEEeceeeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 89 (426)
+|++++.||+|+||.||++++. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47899999999764322 223356788999999999 599999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+++|+|.+++.....+++..++.++.||+.|| +|||++.+|.+||+|||+++..... .
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-E 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc-C
Confidence 99999999999999998888899999999999999997 6999999999999999999854321 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc----cHHHHHHHHHhCCCCCCCCCCHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGAQ 230 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~ 230 (426)
.......+||+.|+|||++.+....+.++|||||||++|+|++|+.||... ........+......+|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 223345689999999999987654568999999999999999999999642 3345556666677788888999999
Q ss_pred HHHHHccccCcCCCC-----ChHHHhcCcCCccC
Q 014359 231 NLLRKILEPNPVKRI-----TIAGIKADEWFEQD 259 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~-----t~~~il~h~w~~~~ 259 (426)
+||.+||+.||++|| +++++++||||...
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 78899999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=332.74 Aligned_cols=240 Identities=30% Similarity=0.462 Sum_probs=205.3
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999986544333334567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|+++|+|.+.+.. ..++++..+..++.|++.|+ +|||+++++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 9999999988864 34699999999999999996 699999999999999999985422 222
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH----HHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
....+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+.. .....+......++..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 3456899999999999888775 8999999999999999999999875432 3333444455567778999999999
Q ss_pred HHccccCcCCCCC-----hHHHhcCcCCcc
Q 014359 234 RKILEPNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 234 ~~~L~~dP~~R~t-----~~~il~h~w~~~ 258 (426)
++||+.||.+||+ ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=346.14 Aligned_cols=244 Identities=33% Similarity=0.540 Sum_probs=208.2
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998654444445678899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc-----
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR----- 153 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~----- 153 (426)
||+++|+|.+++...+.+++..++.++.||+.|+ +|||++.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999999998888899999999999999996 79999999999999999986332100
Q ss_pred ----------------------------------------CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHH
Q 014359 154 ----------------------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 193 (426)
Q Consensus 154 ----------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ 193 (426)
......+.+||+.|+|||++.+.+|+ .++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00012345799999999999988875 8999999999999
Q ss_pred HHhcCCCCCCCccHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHccccCcCCCCC---hHHHhcCcCCccC
Q 014359 194 VILTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQD 259 (426)
Q Consensus 194 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t---~~~il~h~w~~~~ 259 (426)
+|++|+.||.+.+..+...++... ....| ..+++++.+||.+|+ .||.+|++ ++++++||||...
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999988777666666543 23344 358999999999976 59999997 9999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=336.27 Aligned_cols=237 Identities=33% Similarity=0.595 Sum_probs=207.9
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||+||+|.+..+++.||||++................|..+++.. +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999865432223345667788888764 899999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++....++++..+..++.|++.|+ +|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 99999998888899999999999999997 699999999999999999874221 1223456689
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+....+.+|.+++.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999888775 899999999999999999999999888888888877778888999999999999999999999
Q ss_pred CCChH-HHhcCcCCccC
Q 014359 244 RITIA-GIKADEWFEQD 259 (426)
Q Consensus 244 R~t~~-~il~h~w~~~~ 259 (426)
||++. ++++||||...
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 238 RLGVKGDIRQHPFFREI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99996 89999999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=346.28 Aligned_cols=243 Identities=30% Similarity=0.538 Sum_probs=207.4
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997654434444677899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC---
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD--- 155 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~--- 155 (426)
||++||+|.+++...+.+++..++.++.|++.|| +|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999999888899999999999999997 6999999999999999999632210000
Q ss_pred ------------------------------------------CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHH
Q 014359 156 ------------------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 193 (426)
Q Consensus 156 ------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ 193 (426)
......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 001135799999999999888774 8999999999999
Q ss_pred HHhcCCCCCCCccHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHccccCcCCC---CChHHHhcCcCCcc
Q 014359 194 VILTGYLPFDDRNLAVLYQKIFRG--DFKLPK--WLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ 258 (426)
Q Consensus 194 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~Li~~~L~~dP~~R---~t~~~il~h~w~~~ 258 (426)
+|++|.+||.+.+....+..+... ...+|. .++.++.+||.+||. +|.+| +|+.+++.||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777777643 344554 378999999999998 77665 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=330.56 Aligned_cols=240 Identities=26% Similarity=0.391 Sum_probs=199.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++.+.||+|+||.||+|.+..+++.||+|+++.... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 46889999999999999999999999999999999975432 2223567899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
||||+.+ +|.+++...+ .+++..++.++.||+.|| +|||++.++.+||+|||+++.... ..
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~ 157 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PT 157 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CC
Confidence 9999975 9999887644 589999999999999997 799999999999999999975432 12
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-----------------
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------- 218 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------- 218 (426)
.......||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 233456789999999998765444689999999999999999999998877655444332210
Q ss_pred --CCCC-----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 --FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 --~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
..+| ..+++++.+||.+||+.||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0111 2367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=335.06 Aligned_cols=242 Identities=33% Similarity=0.599 Sum_probs=213.7
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lVm 93 (426)
+|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+..|+.+++.+. ||+|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998654333344567788999998886 578889999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||++||+|.+++...+.+++..++.++.|++.|+ +|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 9999999999999888999999999999999997 699999999999999999874322 12234
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 238 (426)
...+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+....+..+.......|..++.++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456899999999999887774 8999999999999999999999998888888889888888999999999999999999
Q ss_pred cCcCCCCC-----hHHHhcCcCCccC
Q 014359 239 PNPVKRIT-----IAGIKADEWFEQD 259 (426)
Q Consensus 239 ~dP~~R~t-----~~~il~h~w~~~~ 259 (426)
.||.+|++ .+++++||||...
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 99999997 4789999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.27 Aligned_cols=243 Identities=31% Similarity=0.525 Sum_probs=206.7
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654333334567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC----
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD---- 154 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~---- 154 (426)
||+++|+|.+++...+.+++..++.++.||+.|| +|||++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999999888899999999999999997 699999999999999999853321000
Q ss_pred -------------------------------------CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc
Q 014359 155 -------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 197 (426)
Q Consensus 155 -------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt 197 (426)
.......+||+.|+|||++.+..++ .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 0011245899999999999888775 89999999999999999
Q ss_pred CCCCCCCccHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHccccCcCCCC---ChHHHhcCcCCcc
Q 014359 198 GYLPFDDRNLAVLYQKIFRG--DFKLP--KWLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 258 (426)
Q Consensus 198 G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~R~---t~~~il~h~w~~~ 258 (426)
|+.||.+.+.......+... ....| ..+++++.+||.+|+ .+|.+|+ |+.++++||||..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988876665555443 23333 358999999999976 5999999 9999999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=342.20 Aligned_cols=249 Identities=29% Similarity=0.513 Sum_probs=213.3
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34567899999999999999999999999999999999976543333334568899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
.|+||||++||+|.+++.. ..+++..+..++.||+.|| +|||++.+|.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999999998875 4699999999999999997 69999999999999999998543211
Q ss_pred CCCccccccCCCcccchhhhccCC---CCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCCCC--CCC
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLS 226 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~---~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s 226 (426)
.......+||+.|+|||++.+.. +.+.++|||||||++|+|++|+.||.+.+....+.++.... ..+|. .+|
T Consensus 197 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred -cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 11234568999999999987643 34589999999999999999999999988888888887643 44554 479
Q ss_pred HHHHHHHHHccccCcCC--CCChHHHhcCcCCccC
Q 014359 227 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 259 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~--R~t~~~il~h~w~~~~ 259 (426)
.++.+||.+||..+|.+ |+|++++++||||...
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=336.27 Aligned_cols=236 Identities=37% Similarity=0.635 Sum_probs=206.9
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHhcCCCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||+||+|.+..+++.||||++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998654333333345555555 56889999999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++...+.+++..++.++.||+.|| +|||++.+|.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 99999999888999999999999999997 699999999999999999874322 2233445689
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+..+...+++.+++.+.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999888775 899999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCh----HHHhcCcCCcc
Q 014359 244 RITI----AGIKADEWFEQ 258 (426)
Q Consensus 244 R~t~----~~il~h~w~~~ 258 (426)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9997 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=335.03 Aligned_cols=237 Identities=34% Similarity=0.660 Sum_probs=209.1
Q ss_pred eceeeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
++.||+|+||.||++++. .+|+.||+|++.+.... ......+.+|+.++++++||||+++++++.+.+.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999863 57899999999865432 22245677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcccc
Q 014359 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 160 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~ 160 (426)
+++|+|.+++.....+++..++.++.||+.|| +|||++.++.+||+|||++..... .......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYS 157 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceec
Confidence 99999999998888899999999999999997 699999999999999999985432 2233446
Q ss_pred ccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccC
Q 014359 161 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240 (426)
Q Consensus 161 ~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 240 (426)
.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+.......+......+|..+++.+.+||++||+.|
T Consensus 158 ~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred ccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 7899999999999887774 899999999999999999999999888888888888888899999999999999999999
Q ss_pred cCCCCC-----hHHHhcCcCCccC
Q 014359 241 PVKRIT-----IAGIKADEWFEQD 259 (426)
Q Consensus 241 P~~R~t-----~~~il~h~w~~~~ 259 (426)
|.+||| +.+++.||||...
T Consensus 237 P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 237 PANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999999 7789999999763
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=335.78 Aligned_cols=236 Identities=30% Similarity=0.585 Sum_probs=205.0
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544444566788999998877 799999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++...+++++..++.++.||+.|+ +|||++.++.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 99999998888999999999999999996 699999999999999999874322 2223446789
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC---------ccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 234 (426)
|+.|+|||++.+..++ .++|||||||++|+|++|+.||.. ......+..+......+|..++..+.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999888775 899999999999999999999952 122334566677778889999999999999
Q ss_pred HccccCcCCCCC------hHHHhcCcCCcc
Q 014359 235 KILEPNPVKRIT------IAGIKADEWFEQ 258 (426)
Q Consensus 235 ~~L~~dP~~R~t------~~~il~h~w~~~ 258 (426)
+||+.||++||| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=343.96 Aligned_cols=240 Identities=26% Similarity=0.435 Sum_probs=212.8
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
..|+..+.||+|+||.||+|.+..+++.||+|+++.+.. ....+.+++|+.+|..+++|||.++|+.+..+..+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 357888999999999999999999999999999987653 333688999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
|||.||++.+.++....++|..+..++++++.|+ .|||+..+|.+||+|||.+...... ....
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--hhcc
Confidence 9999999999999987789999999999999997 4999999999999999999865442 2334
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHcc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKIL 237 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L 237 (426)
.+..|||.|||||++.+.+|+ .++||||||++.+||++|.+||.+.++......|-+.. +.+...+++.+++|+..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 789999999999999988887 89999999999999999999999888765544444433 3334568999999999999
Q ss_pred ccCcCCCCChHHHhcCcCCcc
Q 014359 238 EPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 238 ~~dP~~R~t~~~il~h~w~~~ 258 (426)
++||+.||++.++++|+|++.
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHh
Confidence 999999999999999999976
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=340.25 Aligned_cols=244 Identities=30% Similarity=0.568 Sum_probs=209.8
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654434444678889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC----
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD---- 154 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~---- 154 (426)
||++||+|.+++...+++++..++.++.|++.|| +|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999999888999999999999999996 799999999999999999874321100
Q ss_pred -----------------------------CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc
Q 014359 155 -----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 205 (426)
Q Consensus 155 -----------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 205 (426)
.....+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0112246899999999999988875 8999999999999999999999998
Q ss_pred cHHHHHHHHHhC--CCCCCCC--CCHHHHHHHHHccccCcCCCC---ChHHHhcCcCCccC
Q 014359 206 NLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQD 259 (426)
Q Consensus 206 ~~~~~~~~i~~~--~~~~p~~--~s~~~~~Li~~~L~~dP~~R~---t~~~il~h~w~~~~ 259 (426)
+....+.++... ...+|+. +++++++||.+|+. ||.+|+ ++.++++||||...
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 888887777653 3444543 78999999999874 999998 47999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=328.34 Aligned_cols=242 Identities=26% Similarity=0.400 Sum_probs=196.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 47899999999999999999999989999999999754321 1234677899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+. ++|.+++.. .+.+++..++.++.|++.|| +|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 99995 588888765 35699999999999999997 699999999999999999874322 122
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHHh--CCC---------C----
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFR--GDF---------K---- 220 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~--~~~---------~---- 220 (426)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+... ......+.. +.+ .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 334567899999999987655456899999999999999999999987432 222222211 000 0
Q ss_pred --------CC---------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 221 --------LP---------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 221 --------~p---------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.| ...++.+.+||.+||+.||++|||+.|+++||||.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 0135788999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.72 Aligned_cols=248 Identities=30% Similarity=0.529 Sum_probs=211.2
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 45568999999999999999999999999999999999764433333456688999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+++|+|.+++.. .++++..++.++.||+.|| +|||++.++.+||+|||+|.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~- 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG- 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-
Confidence 999999999999999975 4699999999999999997 69999999999999999998543211
Q ss_pred CCccccccCCCcccchhhhccCC---CCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCCCC--CCCH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLSP 227 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~---~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~ 227 (426)
.....+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|+.||.+.+....+..+.... +.+|. .++.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 11234678999999999997653 34589999999999999999999999988888888877643 45555 3699
Q ss_pred HHHHHHHHccccCcCC--CCChHHHhcCcCCccC
Q 014359 228 GAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 259 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~--R~t~~~il~h~w~~~~ 259 (426)
.++++|.+||..+|.+ |+|+.++++||||...
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999999999866654 8999999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=336.20 Aligned_cols=243 Identities=27% Similarity=0.523 Sum_probs=208.2
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998754433444677889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||+++|+|.+++... ..+++..++.++.|++.|| +|||++.+|.+||+|||++....... ...
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence 999999999999875 6799999999999999997 69999999999999999998543311 112
Q ss_pred cccccCCCcccchhhhcc-----CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCCC--CCCCHH
Q 014359 158 LHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSPG 228 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~ 228 (426)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+..+.... ..+| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 334589999999999873 2223588999999999999999999999888777777766542 2333 357999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
+.+||++||. ||++|||++++++||||..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=330.41 Aligned_cols=241 Identities=29% Similarity=0.420 Sum_probs=204.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|++..++..||+|++.... .....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999997542 23345789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
||||+++|+|.+++.....+++..+..++.|++.|+ +|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 999999999999998888899999999999999996 699999999999999999875422
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHH--------------------
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-------------------- 215 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------------------- 215 (426)
......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+..++...+.
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 233456799999999999887764 89999999999999999999998765443322111
Q ss_pred --------------------------hCC-CCCC-CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 216 --------------------------RGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 216 --------------------------~~~-~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
... ...+ ..+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 110 1111 2368899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=331.18 Aligned_cols=236 Identities=36% Similarity=0.626 Sum_probs=206.4
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHhcCCCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998654333333445555654 67889999999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|...+.....+++..++.++.||+.|| +|||++.+|.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 99999998888899999999999999997 699999999999999999874321 2233456689
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+......+|...+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999887775 889999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCh----HHHhcCcCCcc
Q 014359 244 RITI----AGIKADEWFEQ 258 (426)
Q Consensus 244 R~t~----~~il~h~w~~~ 258 (426)
|+++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.03 Aligned_cols=236 Identities=36% Similarity=0.606 Sum_probs=206.6
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHhcCCCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999999999999999998654333333455566655 56789999999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|..++...+++++..++.++.||+.|| +|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 99999999888999999999999999997 699999999999999999874321 2223456789
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+.......++..+..+.++|++||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999888775 899999999999999999999999888888888888887777889999999999999999999
Q ss_pred CCCh----HHHhcCcCCcc
Q 014359 244 RITI----AGIKADEWFEQ 258 (426)
Q Consensus 244 R~t~----~~il~h~w~~~ 258 (426)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9987 58999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=331.05 Aligned_cols=237 Identities=29% Similarity=0.571 Sum_probs=206.2
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544444567788999999888 699999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++...+++++..++.++.||+.|+ +|||++.++.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 99999998888899999999999999996 699999999999999999874221 2233456789
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc-------cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-------NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 236 (426)
|+.|+|||++.+..++ .++|||||||++|+|++|..||... .....+..+......+|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999888774 8999999999999999999999531 2334566666777788889999999999999
Q ss_pred cccCcCCCCC------hHHHhcCcCCccC
Q 014359 237 LEPNPVKRIT------IAGIKADEWFEQD 259 (426)
Q Consensus 237 L~~dP~~R~t------~~~il~h~w~~~~ 259 (426)
|+.||.+|++ +++++.||||...
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999999998 5799999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=322.97 Aligned_cols=240 Identities=30% Similarity=0.449 Sum_probs=205.0
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
.|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999988999999999976543333334567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|+++|+|.+++... .++++..+..++.|++.|+ +||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 99999999888653 4699999999999999996 699999999999999999985432 222
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH----HHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
....+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+... ....+......+|..++..+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 3456899999999999887764 88999999999999999999998765432 233344445566677999999999
Q ss_pred HHccccCcCCCC-----ChHHHhcCcCCcc
Q 014359 234 RKILEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 234 ~~~L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
.+||+.||++|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=333.86 Aligned_cols=235 Identities=32% Similarity=0.578 Sum_probs=204.1
Q ss_pred eeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
||+|+||+||+|++..+++.||||++.+.............+|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765433333344556677777665 699999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++...+.+++..++.++.||+.|+ +|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 99999999888999999999999999997 699999999999999999875322 2233456789
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHccccCcC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNPV 242 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~Li~~~L~~dP~ 242 (426)
|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+..+...+|. .+++++.+||++||..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999976554468999999999999999999999999888888888888777775 4799999999999999999
Q ss_pred CCC----ChHHHhcCcCCcc
Q 014359 243 KRI----TIAGIKADEWFEQ 258 (426)
Q Consensus 243 ~R~----t~~~il~h~w~~~ 258 (426)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7899999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=328.66 Aligned_cols=242 Identities=29% Similarity=0.454 Sum_probs=195.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----CeE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 89 (426)
+|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999874322 222345788999999999999999999988543 358
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+. ++|.+++.....+++..++.++.||+.|| +|||++.++.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 69999998888899999999999999997 699999999999999999985432111
Q ss_pred -CCccccccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh---------------
Q 014359 155 -DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--------------- 216 (426)
Q Consensus 155 -~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------- 216 (426)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 122345689999999999865 344 5899999999999999999999987654322211110
Q ss_pred -----------CCCCCC-----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 217 -----------GDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 217 -----------~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
...+.+ +.+++.+.+||.+||+.||++|||++++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 001111 2367889999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=329.48 Aligned_cols=236 Identities=37% Similarity=0.636 Sum_probs=205.0
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHhcCCCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998654322222334444544 56889999999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
|+|.+++...+.+++..++.++.||+.|| +|||++.++.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 99999999888899999999999999997 699999999999999999974322 2233456789
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+.+..+......+++.+++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999888775 899999999999999999999999888888888888877778889999999999999999999
Q ss_pred CCChH----HHhcCcCCcc
Q 014359 244 RITIA----GIKADEWFEQ 258 (426)
Q Consensus 244 R~t~~----~il~h~w~~~ 258 (426)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=331.13 Aligned_cols=236 Identities=29% Similarity=0.474 Sum_probs=201.1
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCce-EEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC-e
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-K 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~ 88 (426)
.......+.+.||+|+||+||+|.+. |+. ||||++......... .+.+.+|+.+|++++|||||+++|++.... .
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 34556677788999999999999974 445 999999876544443 779999999999999999999999998887 7
Q ss_pred EEEEEcccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH----------------hheeeCCCC-CEEEeccCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL----------------ENILLDSKG-NIKISDFGLSALP 149 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al----------------eNILld~~g-~lKl~DFGla~~~ 149 (426)
.++||||+++|+|.+++.. ...++...+..++.||+.|+ +|||++.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999999987 67899999999999999996 699999998 9999999999854
Q ss_pred CcccCCCccccccCCCcccchhhhc--cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHH-hC-CCCCCCCC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RG-DFKLPKWL 225 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~--~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~ 225 (426)
.... .......||+.|||||++. ...|+ .|+|||||||+||||+||+.||.+.........+. .+ ++.+|..+
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 3311 2233478999999999999 55775 99999999999999999999999877654444443 33 56678889
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
++.+..|+.+||+.||.+||++.+|+.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999999999999999865
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.54 Aligned_cols=249 Identities=34% Similarity=0.604 Sum_probs=226.6
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 86 (426)
+..++..+|..+..||+|+||+|.+|..+.+.+.+|||+++++-....+..+--..|-++|... +.|.+++++.+|++-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 3356678999999999999999999999999999999999988776666667777788888877 578999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
+.+|+||||+.||+|--.|+.-+++.|..|..|+..|+-|| +|||||.+|++||+|||+++- .
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--n 500 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--N 500 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--c
Confidence 99999999999999999999999999999999999999996 799999999999999999983 2
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 231 (426)
.-......+.||||.|+|||++.-++| |..+|+||+||+|||||+|++||++.+..++++.|......+|..+|.++.+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ 579 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVA 579 (683)
T ss_pred ccCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHH
Confidence 223456778999999999999999988 5999999999999999999999999999999999999999999999999999
Q ss_pred HHHHccccCcCCCCCh-----HHHhcCcCCccC
Q 014359 232 LLRKILEPNPVKRITI-----AGIKADEWFEQD 259 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~-----~~il~h~w~~~~ 259 (426)
+.+..|.+.|.+|... .+|..||||...
T Consensus 580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 9999999999999864 689999999753
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=321.46 Aligned_cols=234 Identities=29% Similarity=0.493 Sum_probs=199.4
Q ss_pred eeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCCh
Q 014359 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L 101 (426)
||+|+||+||++.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++++++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999765443333456778899999999999999999999999999999999999999
Q ss_pred HHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcccccc
Q 014359 102 FDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162 (426)
Q Consensus 102 ~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~ 162 (426)
.+.+.. ...+++..+..++.||+.|+ +||+++.++.+||+|||++..... .........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC--CCccccccC
Confidence 888743 34699999999999999997 699999999999999999975432 122234568
Q ss_pred CCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH----HHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 014359 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 163 gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 238 (426)
||+.|+|||++.+..++ .++||||+||++|+|++|+.||..... ......+.......|..+++.+.+|+.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999988775 899999999999999999999976432 2334444455566677899999999999999
Q ss_pred cCcCCCC-----ChHHHhcCcCCcc
Q 014359 239 PNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 239 ~dP~~R~-----t~~~il~h~w~~~ 258 (426)
.||++|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=333.35 Aligned_cols=249 Identities=31% Similarity=0.523 Sum_probs=210.7
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34556899999999999999999999999999999999976443333345668899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
.|+||||++||+|.+++.. .++++..++.++.||+.|| +|||++.+|.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~- 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE- 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-
Confidence 9999999999999999876 4699999999999999996 6999999999999999999854321
Q ss_pred CCCccccccCCCcccchhhhccCC---CCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCCCC--CCC
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLS 226 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~---~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s 226 (426)
......+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+....+..+.... ..+|. .++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 112234678999999999987643 24589999999999999999999999988888888887643 34443 589
Q ss_pred HHHHHHHHHccccCcCC--CCChHHHhcCcCCccC
Q 014359 227 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 259 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~--R~t~~~il~h~w~~~~ 259 (426)
..+++||.+||..++.+ |+++++|++|+||.+.
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.20 Aligned_cols=240 Identities=39% Similarity=0.750 Sum_probs=216.4
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998655444445678899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++++|.+++....++++..+..++.|++.|+ .|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 9999999999999888999999999999999997 5999999999999999999854321 3
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~ 238 (426)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+....+..+..+...+|..+++.+.++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 45679999999999987765 48899999999999999999999988877778888888888898999999999999999
Q ss_pred cCcCCCC-----ChHHHhcCcCCccC
Q 014359 239 PNPVKRI-----TIAGIKADEWFEQD 259 (426)
Q Consensus 239 ~dP~~R~-----t~~~il~h~w~~~~ 259 (426)
.||.+|+ +++++++||||...
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccC
Confidence 9999999 89999999999763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=325.90 Aligned_cols=245 Identities=28% Similarity=0.521 Sum_probs=204.9
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998644333344567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||++||+|.+++.. ...+++..++.++.||+.|+ +|||++.++.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999976 45799999999999999997 69999999999999999987443211 111
Q ss_pred cccccCCCcccchhhhcc----CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCCC---CCCCHH
Q 014359 158 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP---KWLSPG 228 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 228 (426)
....+||+.|+|||++.. ....+.++||||+||++|+|++|+.||.+.+..+.+..+.... ..+| ..++..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 233579999999999863 2334588999999999999999999999888777777776532 3333 347999
Q ss_pred HHHHHHHccccCcCC--CCChHHHhcCcCCccC
Q 014359 229 AQNLLRKILEPNPVK--RITIAGIKADEWFEQD 259 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~--R~t~~~il~h~w~~~~ 259 (426)
+++||++||..++++ |+++.++++||||...
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999998765544 8899999999999763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.10 Aligned_cols=243 Identities=28% Similarity=0.493 Sum_probs=221.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe-EE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-IY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~ 90 (426)
.+++|+.++.+|+|+||.+++.+++..++.|++|.+......... .....+|+.++++++|||||.+.+.|..++. .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 368999999999999999999999999999999999877654433 4578899999999999999999999998888 99
Q ss_pred EEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|||+||+||+|.+.|..++ -++|+.+..||.|++.|+ .||+++.++.+||+|||+|+....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~-- 158 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP-- 158 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--
Confidence 9999999999999997654 599999999999999997 599999999999999999997654
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 232 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 232 (426)
......+..|||.||+||++.+.+|. .|+|||||||++|||++-+.+|.+.+...+..++..+. .+.|...+.+++.|
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 33467789999999999999999985 99999999999999999999999999999999998886 67888899999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCcc
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
|+.||..+|..||++.+++.+|.+..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999999988763
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.96 Aligned_cols=245 Identities=32% Similarity=0.531 Sum_probs=211.9
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 87 (426)
.-++|++.+.||+|+||+||+|++..+++.||||++..... .......+.+|+.++..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34799999999999999999999999999999999976543 2334567889999999999999999998775432
Q ss_pred ----eEEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccC
Q 014359 88 ----KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFG 144 (426)
Q Consensus 88 ----~~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFG 144 (426)
.+++||||+++|+|.+++.. ...+++..+..++.|++.|| +|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 37899999999999999864 24699999999999999997 69999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCC
Q 014359 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPK 223 (426)
Q Consensus 145 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~ 223 (426)
+++............+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..+..+.. ++|.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 267 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 99865433233344567899999999999888775 899999999999999999999999888887777776643 4677
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.+++++.+|+.+||+.||.+||++.++++|||++.
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 89999999999999999999999999999999865
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=319.40 Aligned_cols=244 Identities=23% Similarity=0.376 Sum_probs=200.4
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++.+.||+|+||.||+|.+..+++.||+|.++..... .....+.+|+.++++++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 467899999999999999999999999999999999754322 223467789999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
||||+.+ +|.+++... ..+++..++.++.||+.|| +|||++.++.+||+|||++..... ..
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--PT 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC--Cc
Confidence 9999975 888888654 4589999999999999996 699999999999999999975332 12
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC------------------
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------ 217 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 217 (426)
.......+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22334578999999999876554468999999999999999999999887655443333210
Q ss_pred -CCCCC-----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 218 -DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 218 -~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
....| +.+++++.+||.+||..||.+|||++++++||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00111 23688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=324.00 Aligned_cols=241 Identities=29% Similarity=0.421 Sum_probs=202.5
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
-++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 478999999999999999999999999999999987542 233356789999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+++|+|.+++...+.+++..+..++.|++.|+ +|||++.++.+||+|||++..... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----h
Confidence 99999999999999888899999999999999986 699999999999999999874422 2
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH-----------------------
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK----------------------- 213 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~----------------------- 213 (426)
.....+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...+.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 23345799999999999887664 899999999999999999999986554322111
Q ss_pred ---------------------HHhC-CCCCC-CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 214 ---------------------IFRG-DFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 214 ---------------------i~~~-~~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+... ....+ ..++.++.+||.+||+.||++|||+.+++.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 1111 11111 23678999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=338.89 Aligned_cols=242 Identities=28% Similarity=0.428 Sum_probs=209.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCC-CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+|+.++||||+++++++...+..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998777 788999977543 23334677889999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
||||++||+|.+++.. ..++++..+..++.|++.|| +|||++.++.+||+|||+++.+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999987753 45699999999999999997 6999999999999999999865432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 231 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 231 (426)
.......+.+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+..+.+..+..+.. +.|..+++++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 222334567899999999999887774 899999999999999999999999888887777776654 456678999999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
||.+||..||++|||+++++.|+|+..
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=327.32 Aligned_cols=243 Identities=27% Similarity=0.423 Sum_probs=200.6
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 345678999999999999999999999999999999996543 233457789999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+++|+|.+. ...++..+..++.||+.|| +|||++.++.+||+|||++......
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-- 221 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--
Confidence 999999999998653 3467888899999999997 6999999999999999999864321
Q ss_pred CCccccccCCCcccchhhhcc----CCCCCchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHHH-hCCCCCCCCCC
Q 014359 155 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIF-RGDFKLPKWLS 226 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---~~~~~~i~-~~~~~~p~~~s 226 (426)
........||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+. ......+..++
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence 122345689999999998753 23456789999999999999999999974332 22222222 23345566789
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.++.+||.+||+.||++|||+.|+++||||....
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999999999999999998753
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=328.88 Aligned_cols=240 Identities=19% Similarity=0.320 Sum_probs=195.9
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
+...++|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 4556789999999999999999999999999999996432 3467899999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+|||++. ++|..++....++++..++.++.||+.|| +|||++.++.+||+|||+|...... .
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~ 236 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N 236 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence 99999995 69999998888899999999999999997 6999999999999999999753321 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHH---------------
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQ--------------- 212 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-------~~~~~~--------------- 212 (426)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||-..+ ......
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 223345689999999999988777 489999999999999999998764321 011111
Q ss_pred -----------HHHhCCC----CCCCC-----CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 213 -----------KIFRGDF----KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 213 -----------~i~~~~~----~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
....... ..|.| ++.++.+||.+||+.||.+|||+.|+++||||.....
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 1111110 11112 4678999999999999999999999999999987543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=328.78 Aligned_cols=243 Identities=27% Similarity=0.386 Sum_probs=201.2
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----eE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 89 (426)
+|++++.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4789999999999999999999999999999986532 22233567889999999999999999999998776 79
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+. ++|.+.+.....+++..++.++.||+.|| +|||++.++.+||+|||+++..... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999996 58999998888899999999999999997 6999999999999999999854321 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh------------------
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------ 216 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------------ 216 (426)
........+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 22233457899999999998765556899999999999999999999988765544433321
Q ss_pred -----CCC---------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 217 -----GDF---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 217 -----~~~---------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
... ......++++.+||.+||+.||.+|||+.++++||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 111 12234688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=309.15 Aligned_cols=242 Identities=31% Similarity=0.525 Sum_probs=206.4
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
+.|++.+.||+|++|.||+|.+..+++.||+|.+....... ......+.+|+.++++++||||+++++++......|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 1234678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC-
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD- 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~- 155 (426)
||||+++++|.+.+...+.+++..++.++.|++.|+ +||++++++.++|+|||+++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 999999999999998888899999999999999996 6999999999999999999754322111
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLL 233 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li 233 (426)
......+|+..|+|||++.+..+ +.++||||+||++|+|++|+.||...+......++... ....|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 11134578899999999988775 48999999999999999999999877665544444333 3456777899999999
Q ss_pred HHccccCcCCCCChHHHhcCcCC
Q 014359 234 RKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
++||..||.+|||+.++++|+||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=335.80 Aligned_cols=237 Identities=24% Similarity=0.352 Sum_probs=192.5
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC------
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 86 (426)
.++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 468999999999999999999999999999999886432 2345799999999999999999987432
Q ss_pred --CeEEEEEcccCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccC
Q 014359 87 --SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFG 144 (426)
Q Consensus 87 --~~~~lVmEy~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFG 144 (426)
..+|+||||+++ +|.+++. ....+++..++.++.||+.|| +|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 247799999975 7777764 346799999999999999997 799999765 79999999
Q ss_pred CCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-------
Q 014359 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------- 217 (426)
Q Consensus 145 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------- 217 (426)
+|+.... .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 217 la~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9985432 222345688999999999877644468999999999999999999999987655444333220
Q ss_pred ----------CC------------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 218 ----------DF------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 218 ----------~~------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.. .+|...++++.+||.+||..||.+|||+.|+++||||....
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00 12345788999999999999999999999999999997643
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=322.36 Aligned_cols=244 Identities=27% Similarity=0.512 Sum_probs=205.3
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997643333333456888999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||+++|+|.+++.. ...+++..++.++.||+.|+ +|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999976 46799999999999999996 6999999999999999998743221 1112
Q ss_pred cccccCCCcccchhhhcc----CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCCC---CCCCHH
Q 014359 158 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP---KWLSPG 228 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 228 (426)
....+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||...+....+.++.... ..+| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234689999999999863 2333589999999999999999999999988888888776543 2333 347999
Q ss_pred HHHHHHHccccCcCC--CCChHHHhcCcCCcc
Q 014359 229 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 258 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~--R~t~~~il~h~w~~~ 258 (426)
+.+||++||..+|.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999766555 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=323.57 Aligned_cols=243 Identities=28% Similarity=0.430 Sum_probs=196.9
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC---
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 87 (426)
..+++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 457899999999999999999999999999999999975432 2333567889999999999999999999986543
Q ss_pred ---eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 88 ---~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
..|+||||+.+ +|.+.+. ..+++..+..++.|++.|| +|||++.+|.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999965 6777764 3589999999999999996 7999999999999999999743
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHH--------------
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-------------- 215 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------------- 215 (426)
.. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 174 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 174 CT---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cc---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 22 2234456899999999999888775 88999999999999999999998765433222111
Q ss_pred --------hCCCC---------CCC-----------CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 216 --------RGDFK---------LPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 216 --------~~~~~---------~p~-----------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
..... +|. ..++.+.+||.+||+.||++|||+.|+++||||...+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 11111 111 13678999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=322.11 Aligned_cols=244 Identities=27% Similarity=0.497 Sum_probs=205.3
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997643333334566888999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||++||+|.+++.. ...+++..++.++.|++.|| +|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999986 46799999999999999997 69999999999999999997543211 112
Q ss_pred cccccCCCcccchhhhccC----CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCCCC---CCCHH
Q 014359 158 LHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK---WLSPG 228 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 228 (426)
....+||+.|+|||++.+. +..+.++||||+||++|+|++|+.||...+..+.+..+.... +++|. .++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2346899999999998752 223588999999999999999999999888877777776543 33443 36899
Q ss_pred HHHHHHHccccCcCC--CCChHHHhcCcCCcc
Q 014359 229 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ 258 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~--R~t~~~il~h~w~~~ 258 (426)
+.+||.+||..++.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999976655 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=313.71 Aligned_cols=244 Identities=25% Similarity=0.384 Sum_probs=201.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
..+++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++......|
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 3578999999999999999999999999999999998754322 22356778999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+||||+. ++|.+++.. ...+++..++.++.|++.|+ +|||++.++.+||+|||++..... .
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~ 157 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--P 157 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--C
Confidence 9999997 589888875 35689999999999999997 699999999999999999975332 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-----------------
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------------- 217 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 217 (426)
........+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 222334567999999999877655568999999999999999999999887665443332210
Q ss_pred --CCCCC-----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 218 --DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 218 --~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
....| ..+++.+.+||.+||+.||.+|||++++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 01111 2468899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=326.80 Aligned_cols=229 Identities=28% Similarity=0.447 Sum_probs=197.2
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
+.+++.||+|-||.||+|.+. ....||+|.++..... .+.+.+|+.+|++|+|+|||++++++.....+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 456789999999999999984 3447999999765332 36778999999999999999999999998899999999
Q ss_pred cCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 96 VTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 96 ~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
++.|+|.++++. ...++..+...++.||++|+ .||||++++.+||+|||||+..... .-...
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~ 361 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTAS 361 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeec
Confidence 999999999986 45699999999999999997 4999999999999999999943221 11111
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~ 236 (426)
....-...|.|||.+....++ .++|||||||+||||+| |+.||.+.+..+..+.+.+| +.+.|..+|+++.+++..|
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 111224589999999988885 89999999999999999 99999999999999999888 5788999999999999999
Q ss_pred cccCcCCCCChHHHh
Q 014359 237 LEPNPVKRITIAGIK 251 (426)
Q Consensus 237 L~~dP~~R~t~~~il 251 (426)
|..+|++|||++.+.
T Consensus 441 W~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLR 455 (468)
T ss_pred hhCCcccCCCHHHHH
Confidence 999999999998664
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=310.21 Aligned_cols=238 Identities=36% Similarity=0.624 Sum_probs=199.5
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
|++++.||+|+||+||++.+..+++.||+|++......... .....+|+.++++++||||+++++++.+....|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999876533222 23445699999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcccc
Q 014359 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 160 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~ 160 (426)
+.+++|.+++...+.+++..+..++.|++.|| +||+++.++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 99999999999778899999999999999997 7999999999999999999743 122344566
Q ss_pred ccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc---HHHHHHHHHhCCCCCC----CCCCHHHHHHH
Q 014359 161 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLP----KWLSPGAQNLL 233 (426)
Q Consensus 161 ~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p----~~~s~~~~~Li 233 (426)
.++|+.|+|||++......+.++||||||+++|+|++|..||...+ ...............+ ...++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 7899999999998833344599999999999999999999999873 3333333333222111 11248999999
Q ss_pred HHccccCcCCCCChHHHhcCcCC
Q 014359 234 RKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=311.93 Aligned_cols=237 Identities=31% Similarity=0.416 Sum_probs=192.6
Q ss_pred cCEEEeceeeecCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCccceeEEEE-----
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA----- 84 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~----- 84 (426)
.+|++.+.||+|+||.||+|++.. +++.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999864 56889999987543222 2234566788777766 6999999999985
Q ss_pred eCCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~ 147 (426)
....+|+||||+. ++|.+++... ..+++..++.++.|++.|| +|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999996 5999998753 4589999999999999996 69999999999999999998
Q ss_pred CCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-C------
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-K------ 220 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~------ 220 (426)
.... .......+||+.|+|||++.+..+. .++||||+||++|+|++|++||.+.+..+.+..+..... +
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 5432 2334566899999999999887765 899999999999999999999998776665555543210 0
Q ss_pred --------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 221 --------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 221 --------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+.+.+++.+.+||.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.82 Aligned_cols=240 Identities=30% Similarity=0.454 Sum_probs=201.5
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+++++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999976544444444667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|++|++|.+++... .++++..+..++.|++.|+ +||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 99999999988643 3599999999999999996 699999999999999999875432 222
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH---HHHHHH-HhCCCCCCCCCCHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKI-FRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---~~~~~i-~~~~~~~p~~~s~~~~~Li 233 (426)
....+||+.|+|||++.+..++ .++||||+||++|+|++|+.||...... ...... .......+..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 3345799999999999887764 8999999999999999999999864321 112222 2223345667899999999
Q ss_pred HHccccCcCCCCC-----hHHHhcCcCCcc
Q 014359 234 RKILEPNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 234 ~~~L~~dP~~R~t-----~~~il~h~w~~~ 258 (426)
.+||+.||.+||| ++++++||||..
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=321.65 Aligned_cols=242 Identities=26% Similarity=0.393 Sum_probs=197.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 86 (426)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 46899999999999999999999999999999999975432 233356788999999999999999999987543
Q ss_pred -CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
..+|+||||+.+ +|.+.+.. .+++..++.++.|++.|| +|||++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 358999999965 78777753 489999999999999996 69999999999999999998542
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-------------
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 217 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 217 (426)
. ........||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+.++...
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 2233456899999999999888775 8999999999999999999999887765554443321
Q ss_pred ---------CCCC--------------------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 218 ---------DFKL--------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 218 ---------~~~~--------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
.+.. +...+..+++||.+||+.||.+|||+.++++||||...+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 0000 0113467899999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=310.44 Aligned_cols=245 Identities=31% Similarity=0.456 Sum_probs=208.0
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC-ccceeEEEEeCC----
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKS---- 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~---- 87 (426)
+..|+.++.||+|+||+||+|++..+|+.||+|.+..+... +..-....||+.+|+.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56688889999999999999999999999999999765432 334466789999999999999 999999998877
Q ss_pred --eEEEEEcccCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCC
Q 014359 88 --KIYMVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 88 --~~~lVmEy~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla 146 (426)
..|+|+||+.. +|..++.... .++...++.+++||+.|+ +|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 9999998654 588899999999999997 6999999999999999999
Q ss_pred CCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC---------
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------- 217 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------- 217 (426)
+.+.- +........+|.+|.|||++.+...+++.+||||+|||++||++++..|++.+..+....|..-
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 95542 3344667789999999999999877779999999999999999999999998876666655431
Q ss_pred ---------CCCCCCC------------CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 218 ---------DFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 218 ---------~~~~p~~------------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
...+|.| .+++..+++.+||+.+|.+|+|+..++.||||.+...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 1122322 2358999999999999999999999999999987543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=304.71 Aligned_cols=241 Identities=33% Similarity=0.491 Sum_probs=205.1
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc------hhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
+|.+++.||+|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999998899999999887543322 1234678899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
.++||||+++++|.+++...+.+++..++.++.|++.|+ +||++++++.+||+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 999999999999999998888899999999999999996 69999999999999999998654211
Q ss_pred C----CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-CCCCCCCCCHH
Q 014359 154 D----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 228 (426)
Q Consensus 154 ~----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 228 (426)
. ........|++.|+|||.+.+..++ .++|+||+||++|+|++|+.||.+.+.......+... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 1112245689999999999887764 8899999999999999999999887655444444333 44566778999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+.++|++||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=312.43 Aligned_cols=239 Identities=29% Similarity=0.427 Sum_probs=201.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..++..||+|.+.... ......++.+|+.++++++||||+++++++.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999987542 2334567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||+++++|.+++...+++++..+..++.|++.|+ +|||+++++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 9999999999998888899999999999999986 699999999999999999874322 22
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--------------------
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------- 217 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------- 217 (426)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345689999999999887766 48899999999999999999999765543322221110
Q ss_pred -----------------CCCCC-CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 218 -----------------DFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 218 -----------------~~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+..| ..++.++.+||.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 11111 1267889999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=302.03 Aligned_cols=238 Identities=26% Similarity=0.523 Sum_probs=204.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe-CCeEEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lVm 93 (426)
+|++.+.||+|++|.||++.+..+++.||+|.+..... .....+.+.+|+.++++++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 59999999999999999999998999999999975433 22335678899999999999999999998864 45689999
Q ss_pred cccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 94 EYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 94 Ey~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||+++++|.+++.. ...+++.+++.++.|++.|+ +||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 99999999999976 34589999999999999996 699999999999999999986533 222
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRK 235 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~ 235 (426)
......|++.|+|||++.+..++ .++||||+||++++|++|+.||...+.......+..+.. ..|..+++++.++|.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 34456789999999999887765 889999999999999999999998777666666655544 4566789999999999
Q ss_pred ccccCcCCCCChHHHhcCcCC
Q 014359 236 ILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~ 256 (426)
||+.||.+|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=318.63 Aligned_cols=243 Identities=26% Similarity=0.402 Sum_probs=197.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC----
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK---- 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 86 (426)
..+++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 457899999999999999999999989999999999875432 233356788999999999999999999998643
Q ss_pred --CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 87 --SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 87 --~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
...|+||||+.+ +|.+.+.. .+++..++.++.|++.|| +|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999965 77777754 589999999999999996 7999999999999999999853
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh-------------
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------- 216 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------- 216 (426)
.. .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 170 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 170 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CC---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 22 2234456899999999999888775 899999999999999999999988765433322211
Q ss_pred ---------CCC-----C---------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 217 ---------GDF-----K---------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 217 ---------~~~-----~---------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
... . .+...+.++.+||.+||+.||++|||+.|+++||||...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 000 0 01123567899999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=308.13 Aligned_cols=241 Identities=29% Similarity=0.457 Sum_probs=204.9
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
.|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+++++.+..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999976544444444567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|+++++|.+.+... .++++..+..++.|++.|+ +||++++++.+||+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 99999999888643 3699999999999999997 699999999999999999874322 222
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH----HHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
.....|++.|+|||++.+..++ .++|+||+||++|+|++|..||.+..... ....+.......+..+++++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 3456899999999999887764 88999999999999999999998765433 233334444556667899999999
Q ss_pred HHccccCcCCCCC-----hHHHhcCcCCccC
Q 014359 234 RKILEPNPVKRIT-----IAGIKADEWFEQD 259 (426)
Q Consensus 234 ~~~L~~dP~~R~t-----~~~il~h~w~~~~ 259 (426)
.+||+.||++||| +.+++.|+||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=308.77 Aligned_cols=233 Identities=26% Similarity=0.446 Sum_probs=193.8
Q ss_pred eeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCCh
Q 014359 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L 101 (426)
||+|+||.||++.+..+|+.||+|.+.............+..|+.+++.++||||+++++++.++...|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999764433333344566799999999999999999999999999999999999999
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCC
Q 014359 102 FDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164 (426)
Q Consensus 102 ~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt 164 (426)
.+.+... ..+++..+..++.|++.|+ +||++++++.+||+|||++..... ........||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 9888643 3589999999999999997 699999999999999999875432 2223456799
Q ss_pred CcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH----HHHHHHHHhCCCCCC-CCCCHHHHHHHHHcccc
Q 014359 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLP-KWLSPGAQNLLRKILEP 239 (426)
Q Consensus 165 ~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~ 239 (426)
+.|+|||++.+..+ +.++||||+||++|+|++|+.||..... ..............+ ..+++++.+||.+||+.
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999988876 4899999999999999999999976432 233344443333332 45899999999999999
Q ss_pred CcCCCCCh----HHHhcCcCCcc
Q 014359 240 NPVKRITI----AGIKADEWFEQ 258 (426)
Q Consensus 240 dP~~R~t~----~~il~h~w~~~ 258 (426)
||.+||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=306.37 Aligned_cols=237 Identities=33% Similarity=0.647 Sum_probs=207.4
Q ss_pred ccccCEEEec-eeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe---
Q 014359 11 MRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS--- 85 (426)
Q Consensus 11 ~~~~~y~i~~-~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--- 85 (426)
...++|.+-. .||-|-.|+|..+.++.||+.+|+|++... ...+||++++-+. .|||||.++++|+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 3567888865 699999999999999999999999988532 5678899988777 59999999999854
Q ss_pred -CCeEEEEEcccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHH---------------hheeeCCC---CCEEEeccC
Q 014359 86 -KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL---------------ENILLDSK---GNIKISDFG 144 (426)
Q Consensus 86 -~~~~~lVmEy~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~al---------------eNILld~~---g~lKl~DFG 144 (426)
...+.+|||.++||+|+..|+.++. ++|.+|..+++||..|+ ||+|.+.+ ..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 4678999999999999999998765 99999999999999995 89999765 479999999
Q ss_pred CCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc----HHHHHHHHHhCCCC
Q 014359 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFK 220 (426)
Q Consensus 145 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~ 220 (426)
+|+... ....+.+.|-||+|.|||++....|+ ..+|+||+|||+|.||+|++||.... ...+..+|..|.+.
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 999543 24567899999999999999999886 88999999999999999999997643 24677889999888
Q ss_pred CC--CC--CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 221 LP--KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 221 ~p--~~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+| +| +|..++++|+++|..+|.+|.|+++++.|||..+.
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 77 45 89999999999999999999999999999999764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=308.28 Aligned_cols=236 Identities=32% Similarity=0.430 Sum_probs=191.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCccceeEEEEe-----C
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS-----K 86 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~ 86 (426)
+|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987543221 1234556778777766 69999999999864 3
Q ss_pred CeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
..++++|||+.+ +|.+++... ..+++..++.++.|++.|+ +|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999975 898888753 3589999999999999996 6999999999999999999865
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-----------C
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-----------D 218 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------~ 218 (426)
.. ........||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+....+.++... .
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 2223456789999999999887764 8999999999999999999999877665544443321 0
Q ss_pred C----------------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 F----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 ~----------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
. .+.+.++..+.+||.+||+.||++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.35 Aligned_cols=238 Identities=27% Similarity=0.476 Sum_probs=207.2
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999998765432 3345778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|+++++|.+++... ..+++..+..++.|++.|+ +||+++.++.+||+|||++..... ....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~--~~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccC--ccch
Confidence 99999999999764 5799999999999999996 699999999999999999885433 1222
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHc
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 236 (426)
....+|++.|+|||++.+..++ .++|+|||||++++|++|+.||...+.......+..+.. +++..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999999887765 899999999999999999999998887776777666544 34456889999999999
Q ss_pred cccCcCCCCChHHHhcCcCC
Q 014359 237 LEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h~w~ 256 (426)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=304.52 Aligned_cols=238 Identities=31% Similarity=0.534 Sum_probs=208.7
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999988999999999987654444556789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
|+.|++|.+++....++++..+..++.||+.|+ +||++++++.++|+|||++..... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence 999999999998877899999999999999997 699999999999999999985433 22334
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 236 (426)
...|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+. ..............|..++..+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678999999999988775 4899999999999999999999987663 33333333355667778899999999999
Q ss_pred cccCcCCCCCh--HHHhcCcCC
Q 014359 237 LEPNPVKRITI--AGIKADEWF 256 (426)
Q Consensus 237 L~~dP~~R~t~--~~il~h~w~ 256 (426)
|..||.+||++ .++++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=318.71 Aligned_cols=241 Identities=28% Similarity=0.399 Sum_probs=196.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 86 (426)
..++|++++.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34789999999999999999999999999999999875432 222345678999999999999999999988543
Q ss_pred -CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
...|++||++ +++|.+++.. .++++..++.++.||+.|| +|||++.++.+||+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3579999998 7899887754 5799999999999999997 69999999999999999998542
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC------------
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------ 218 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------ 218 (426)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 23456799999999999875545689999999999999999999998766544433332110
Q ss_pred -----------CCCC--------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 219 -----------FKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 219 -----------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
...| ...++.+.+||.+||..||.+|||+.++++||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0011 23567789999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=330.25 Aligned_cols=238 Identities=24% Similarity=0.348 Sum_probs=190.3
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC------CCccceeEEEEeC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH------PNVVRLHEVLASK 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~ 86 (426)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996432 123445667777776654 4588999988764
Q ss_pred -CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCC-------------
Q 014359 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKG------------- 136 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g------------- 136 (426)
..+|+|||++ |++|.+++...+.+++..++.++.||+.|| +|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999998 789999998888999999999999999996 699998776
Q ss_pred ---CEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH
Q 014359 137 ---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 213 (426)
Q Consensus 137 ---~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 213 (426)
.+||+|||++... .......+||+.|+|||++.+..|. .++|||||||++|+|++|++||++.+..+....
T Consensus 283 ~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999988632 2223467899999999999988875 899999999999999999999987665443322
Q ss_pred HHhCCCCCC----------------------------C--------------CCCHHHHHHHHHccccCcCCCCChHHHh
Q 014359 214 IFRGDFKLP----------------------------K--------------WLSPGAQNLLRKILEPNPVKRITIAGIK 251 (426)
Q Consensus 214 i~~~~~~~p----------------------------~--------------~~s~~~~~Li~~~L~~dP~~R~t~~~il 251 (426)
+......+| . ..++.+.+||.+||..||.+|||++|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 211100000 0 0135678999999999999999999999
Q ss_pred cCcCCccCCC
Q 014359 252 ADEWFEQDYT 261 (426)
Q Consensus 252 ~h~w~~~~~~ 261 (426)
+||||.+.+.
T Consensus 437 ~Hp~~~~~~~ 446 (467)
T PTZ00284 437 THPYVLKYYP 446 (467)
T ss_pred cCccccccCC
Confidence 9999987543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=308.46 Aligned_cols=225 Identities=20% Similarity=0.288 Sum_probs=194.7
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe----CCeEEEEEcc
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKIYMVLEY 95 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lVmEy 95 (426)
..||+|++|.||+|.. +|+.||||.+...........+.+.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999996 788999999986544444445788899999999999999999999876 4578999999
Q ss_pred cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
+++|+|.+++.....+++.....++.|++.|+ +|||++.++.+||+|||+++.... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence 99999999999888899999999999999986 699999999999999999885432 123
Q ss_pred cccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Q 014359 160 TTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~ 235 (426)
...||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+..+.+..+..+ .++.|..+++.+.+||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4578999999999876 455 48999999999999999999999998887877777544 455566789999999999
Q ss_pred ccccCcCCCCChHHHhc
Q 014359 236 ILEPNPVKRITIAGIKA 252 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~ 252 (426)
||+.||++|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999975
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.94 Aligned_cols=238 Identities=29% Similarity=0.411 Sum_probs=194.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999988999999999875432 22234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 95 y~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|++ ++|.+++... ..+++..++.++.||+.|| +|||++++|.+||+|||++..... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC--Ccc
Confidence 997 5898888642 4699999999999999997 699999999999999999975432 122
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC------------------C
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------D 218 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~ 218 (426)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2334567899999999876554458999999999999999999999876543222111100 0
Q ss_pred C-----------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 F-----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 ~-----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
. .....+++++.+||++||+.||++|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 0122378999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.23 Aligned_cols=249 Identities=29% Similarity=0.495 Sum_probs=218.7
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.+..++|++++.||+|+||.|.+++++.+++.||+|++.+-..........|..|-.+|..-+.+-|++++-.|.++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 45568999999999999999999999999999999999874444344457789999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||++||||..++.+..++|++.|++|+..|+.|| +|||||.+|++||+|||.+-.....+
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG- 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG- 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-
Confidence 99999999999999999888999999999999999996 79999999999999999887544322
Q ss_pred CCccccccCCCcccchhhhcc----CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCC--CCCC
Q 014359 155 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLS 226 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s 226 (426)
.-.....+|||.|++||++.. .+.+|+.+|+||+||++|||+.|..||...+..+.|.+|... .+.+| ..+|
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 123456789999999999863 256689999999999999999999999999999999999987 57788 4599
Q ss_pred HHHHHHHHHccccCcCCCCC---hHHHhcCcCCccCC
Q 014359 227 PGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQDY 260 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t---~~~il~h~w~~~~~ 260 (426)
+++++||.+++. +|..|.. +++|..||||....
T Consensus 310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 999999999887 4668887 99999999997643
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=304.39 Aligned_cols=237 Identities=30% Similarity=0.425 Sum_probs=197.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 468999999999999999999999999999999987542 12245688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|||+++++|.+++...+++++..+..++.|++.|+ +||+++.++.+||+|||++..... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~--~~~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA--TIAK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc--cccc
Confidence 99999999999998878899999999999999996 699999999999999999985432 1112
Q ss_pred cccccCCCcccchhhhcc---CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC-----CCCCHHH
Q 014359 158 LHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPGA 229 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 229 (426)
.....|++.|+|||.+.. ..+ +.++||||+||++|+|++|+.||...+.......+....+..| ..++..+
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred cCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 234578999999999853 234 4789999999999999999999976554433333322222222 2368899
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w 255 (426)
.+||++||+.||++|||+++|++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=308.23 Aligned_cols=244 Identities=30% Similarity=0.559 Sum_probs=208.5
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987654333344567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc-----
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR----- 153 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~----- 153 (426)
||++|++|.+++...+.+++..+..++.|++.|+ +||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999998888899999999999999996 69999999999999999987321100
Q ss_pred --------CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC--
Q 014359 154 --------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 223 (426)
Q Consensus 154 --------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 223 (426)
.........|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+..+.+..+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0001123468899999999887766 58999999999999999999999988887777777766544432
Q ss_pred -CCCHHHHHHHHHccccCcCCCCC---hHHHhcCcCCcc
Q 014359 224 -WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ 258 (426)
Q Consensus 224 -~~s~~~~~Li~~~L~~dP~~R~t---~~~il~h~w~~~ 258 (426)
.++.++.++|.+||+.||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47899999999999999999998 789999999966
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.32 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=205.5
Q ss_pred ccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe-
Q 014359 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS- 85 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~- 85 (426)
..+...+++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|+.++||||+++++++.+
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3456778999999999999999999999999999999999976543 23335778999999999999999999998854
Q ss_pred -CCeEEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH----------------------hheeeCC----
Q 014359 86 -KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL----------------------ENILLDS---- 134 (426)
Q Consensus 86 -~~~~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al----------------------eNILld~---- 134 (426)
...+|+||||+++|+|.++|.. ...+++..++.++.||+.|| +||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4579999999999999999865 35799999999999999986 5899964
Q ss_pred -------------CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccC-CCCCchhhHHHHHHHHHHHhcCCC
Q 014359 135 -------------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYL 200 (426)
Q Consensus 135 -------------~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~ 200 (426)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 23589999999985432 2234456899999999998643 233589999999999999999999
Q ss_pred CCCCccHH-HHHHHHHhCCCCCC-CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 201 PFDDRNLA-VLYQKIFRGDFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 201 Pf~~~~~~-~~~~~i~~~~~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
||...+.. .+...+..+ +.+| ...+.++.+||.+||..+|.+||++.|++.|+|+.....+
T Consensus 242 PF~~~~~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred CCCcCCcHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 99865543 344444333 3333 4578999999999999999999999999999999865443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.24 Aligned_cols=235 Identities=31% Similarity=0.441 Sum_probs=200.1
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-C-----CCccceeEEEEeCC
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H-----PNVVRLHEVLASKS 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~~~~ 87 (426)
.+|++.+.||+|+||.|-+|.+..|++.||||+++... ....+...|+.+|..|+ | -|+|+++|+|..++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 48999999999999999999999999999999998653 33577888999999997 4 38999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCC--CEEEeccCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKG--NIKISDFGLSAL 148 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g--~lKl~DFGla~~ 148 (426)
+.|||+|++. -+|+++|+.+ .+++...++.+++||+.|| |||||.+-+ .+||+|||.|+.
T Consensus 262 HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999999995 5999999864 4699999999999999996 899998654 799999999995
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh------------
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------ 216 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------ 216 (426)
.. ....+.+-+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|..
T Consensus 341 ~~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 341 ES-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cC-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 43 234488999999999999999996 899999999999999999999999887776655431
Q ss_pred ---------C-------------------------------CCCCCCC-----------CCHHHHHHHHHccccCcCCCC
Q 014359 217 ---------G-------------------------------DFKLPKW-----------LSPGAQNLLRKILEPNPVKRI 245 (426)
Q Consensus 217 ---------~-------------------------------~~~~p~~-----------~s~~~~~Li~~~L~~dP~~R~ 245 (426)
. ....|+. -...+.+||++||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0 0001100 134678999999999999999
Q ss_pred ChHHHhcCcCCccC
Q 014359 246 TIAGIKADEWFEQD 259 (426)
Q Consensus 246 t~~~il~h~w~~~~ 259 (426)
|+.|+++|||+...
T Consensus 495 tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 495 TPAQALNHPFLTGT 508 (586)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999853
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.15 Aligned_cols=240 Identities=27% Similarity=0.435 Sum_probs=201.8
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc---chhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
+|++++.||+|+||.||+|.+ .+++.+|+|.+...... .......+.+|+.+++.++||||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999987 57889999998754321 12234678999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc---
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR--- 153 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~--- 153 (426)
+|||+++++|.+++.+..++++..++.++.|++.|+ +||++++++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999998878899999999999999996 69999999999999999987542211
Q ss_pred -CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC---CCCCCCCCCHHH
Q 014359 154 -DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGA 229 (426)
Q Consensus 154 -~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 229 (426)
.........|+..|+|||++.+..++ .++|||||||++|+|++|..||...+.......+... ....|..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11223345789999999999887764 8999999999999999999999876654443333332 234566789999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
.++|++||+.||++|||+.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.41 Aligned_cols=240 Identities=25% Similarity=0.436 Sum_probs=206.8
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+....|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47999999999999999999999999999999987543 2233567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++++|.+++... ++++..++.++.|++.|+ +||++++++.++|+|||+++..... ....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST--MSKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc--cccc
Confidence 999999999999875 899999999999999996 6999999999999999999865432 1223
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCCCCC-CCHHHHHHHHHc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKW-LSPGAQNLLRKI 236 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~~~ 236 (426)
....|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......+.... ...+.. +++.+.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 445789999999999887764 89999999999999999999998776655555554443 334445 789999999999
Q ss_pred cccCcCCCCChHHHhcCcCCccC
Q 014359 237 LEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
|..||++|||++++++||||...
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=306.76 Aligned_cols=242 Identities=30% Similarity=0.427 Sum_probs=205.8
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.++...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998654 333456788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+++++|.+++.. ...+++..++.++.|++.|+ +||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence 999999999999876 35699999999999999996 6999999999999999998754321 22
Q ss_pred ccccccCCCcccchhhhccCC----CCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC---CCCCCCCHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGA 229 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~----~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 229 (426)
......||+.|+|||++.... ..+.++||||+||++|+|++|+.||...+.......+..+.. ..|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 233457899999999985321 224789999999999999999999998777666666665532 3456689999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.++|.+||+.||.+|||+.++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.64 Aligned_cols=233 Identities=35% Similarity=0.682 Sum_probs=205.4
Q ss_pred eeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCCh
Q 014359 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L 101 (426)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.++...|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999889999999999876544444567899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCc
Q 014359 102 FDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166 (426)
Q Consensus 102 ~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~ 166 (426)
.+++.+...+++..+..++.||+.|+ +||+++.++.++|+|||++...... ......+|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---cccccccCCcC
Confidence 99998878899999999999999997 6999999999999999999865332 12344578999
Q ss_pred ccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc--HHHHHHHHH--hCCCCCCCCCCHHHHHHHHHccccCcC
Q 014359 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIF--RGDFKLPKWLSPGAQNLLRKILEPNPV 242 (426)
Q Consensus 167 Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~Li~~~L~~dP~ 242 (426)
|+|||.+.+..++ .++|+||+|+++|+|++|..||...+ ....+..+. ......|...++++.++|.+||..||+
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998877765 88999999999999999999998766 666666666 345667777899999999999999999
Q ss_pred CCCC-----hHHHhcCcCCcc
Q 014359 243 KRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 243 ~R~t-----~~~il~h~w~~~ 258 (426)
+||| ++|+++||||..
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=304.24 Aligned_cols=238 Identities=26% Similarity=0.422 Sum_probs=198.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3468999999999999999999999999999999987542 2224567889999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||||+++++|.+++...+.+++..++.++.|++.|+ +||+++.++.+||+|||++..... ...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~ 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIA 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--ccc
Confidence 999999999999998888999999999999999996 699999999999999999875432 112
Q ss_pred ccccccCCCcccchhhhc---cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC-----CCCCHH
Q 014359 157 LLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPG 228 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~---~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~ 228 (426)
......||+.|+|||++. ...+ +.++|+||+||++|+|++|..||...................+ ..++..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred ccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 233457999999999974 3334 4899999999999999999999976554333333333332222 236788
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w 255 (426)
+.++|.+||+.||++|||++++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=299.26 Aligned_cols=238 Identities=30% Similarity=0.589 Sum_probs=206.1
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999998754332 2335678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|+.+++|.+.+.... .+++..+..++.|++.|+ +|||++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VEL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--hhh
Confidence 999999999997543 589999999999999996 6999999999999999999854331 112
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHc
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 236 (426)
.....|++.|+|||++.+..++ .++|+|||||++++|++|..||...+..+....+..+.. +.|..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 2345689999999999887764 889999999999999999999998877777776666554 45667899999999999
Q ss_pred cccCcCCCCChHHHhcCcCC
Q 014359 237 LEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h~w~ 256 (426)
|+.+|++||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=304.11 Aligned_cols=242 Identities=33% Similarity=0.615 Sum_probs=214.1
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 92 (426)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999899999999998755444444577889999999998 99999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC--
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD-- 155 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~-- 155 (426)
|||+++++|.+++...+.+++..++.++.|++.|+ +||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888899999999999999996 6999999999999999999865432211
Q ss_pred ----------------CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC
Q 014359 156 ----------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 219 (426)
Q Consensus 156 ----------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 219 (426)
.......|+..|+|||++.+..+ +.++||||+|++++++++|+.||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 22234467899999999887665 4889999999999999999999998887777777777778
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCCh----HHHhcCcCC
Q 014359 220 KLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWF 256 (426)
Q Consensus 220 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~----~~il~h~w~ 256 (426)
.+|..+++.+.+||.+||+.||.+|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=330.83 Aligned_cols=239 Identities=28% Similarity=0.430 Sum_probs=211.7
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
+.|+|+..||.|+||+||+|.++.++-..|-|+|... .....+.+.-||.||..++||+||++++.|...+.+|+++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4689999999999999999999999988899999754 3444788899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|||.||-....+-. ...+++.+++.+++|++.|| -|||++-+|.++|+|||.+..... ....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence 99999999887755 45799999999999999998 499999999999999999874322 2334
Q ss_pred cccccCCCcccchhhhc-----cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC---CCCCCCHHH
Q 014359 158 LHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGA 229 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~-----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~ 229 (426)
..++.|||+|||||++. ..+|+ .++||||||++|.+|..+.+|...-++....-++.+..++ .|..++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 56789999999999975 45676 8999999999999999999999999999888888877654 467789999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.|++.+||.+||..||+++|+++|||+..
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999999999999999999999999985
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=308.13 Aligned_cols=245 Identities=30% Similarity=0.524 Sum_probs=211.1
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999899999999998765443344677899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC--
Q 014359 94 EYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD-- 154 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~-- 154 (426)
||+.+++|.+++... ..+++..++.++.|++.|| +||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998753 5699999999999999996 699999999999999999875422110
Q ss_pred -------------------------CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH
Q 014359 155 -------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 209 (426)
Q Consensus 155 -------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 209 (426)
........||..|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 001123468999999999988776 489999999999999999999999888877
Q ss_pred HHHHHHhCCCCCCCC--CCHHHHHHHHHccccCcCCCCC----hHHHhcCcCCccC
Q 014359 210 LYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IAGIKADEWFEQD 259 (426)
Q Consensus 210 ~~~~i~~~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t----~~~il~h~w~~~~ 259 (426)
.+..+......+|.. ++..+.++|.+||..||++||| +++++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 777777666655544 6999999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=316.34 Aligned_cols=237 Identities=26% Similarity=0.396 Sum_probs=191.1
Q ss_pred ccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 86 (426)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999752 345789999987542 223356789999999999 899999999988754
Q ss_pred -CeEEEEEcccCCCChHHHHHhC---------------------------------------------------------
Q 014359 87 -SKIYMVLEYVTGGELFDKIASK--------------------------------------------------------- 108 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~~~--------------------------------------------------------- 108 (426)
..+|+||||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999998742
Q ss_pred -----CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCccc
Q 014359 109 -----GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 168 (426)
Q Consensus 109 -----~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~ 168 (426)
.++++..+..++.||+.|| +|||++.++.+||+|||+++...............+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 2477888999999999997 69999999999999999998543211111222345678999
Q ss_pred chhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHH-HHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCC
Q 014359 169 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRI 245 (426)
Q Consensus 169 APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~ 245 (426)
|||++.+..++ .++|||||||++|+|++ |..||.+..... ....+..+ ....|..+++.+.+||.+||+.||++||
T Consensus 244 aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999887775 89999999999999997 999998765433 33333333 3445677899999999999999999999
Q ss_pred ChHHHhc
Q 014359 246 TIAGIKA 252 (426)
Q Consensus 246 t~~~il~ 252 (426)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=300.60 Aligned_cols=241 Identities=28% Similarity=0.453 Sum_probs=204.6
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++++.||.|+||.||+|.+..++..||+|++....... ....+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997554322 4678999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
||+++++|.+++... ..+++..++.++.|++.|+ +||++++++.+||+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999763 4599999999999999997 6999999999999999998865442221
Q ss_pred --CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-CC-----CCCCH
Q 014359 156 --GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-----KWLSP 227 (426)
Q Consensus 156 --~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~~s~ 227 (426)
......+|++.|+|||++......+.++|+|||||++|+|++|+.||...+....+........+ ++ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12344578999999999887634458999999999999999999999887766666555444321 21 24678
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
.+.+++.+||..||++|||+.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=302.49 Aligned_cols=240 Identities=27% Similarity=0.406 Sum_probs=198.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999998999999999875432 2222356789999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||++++.|..++.....+++..++.++.||+.|+ +||+++.++.+||+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP--GDDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC--cccc
Confidence 9999998888877767899999999999999997 6999999999999999999865432 1123
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-------------------CC
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DF 219 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 219 (426)
....++..|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34568899999999877554468999999999999999999999876544332222110 00
Q ss_pred CCC------------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 220 KLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 220 ~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
..| +.++..+.+||.+||++||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 2367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.10 Aligned_cols=242 Identities=26% Similarity=0.445 Sum_probs=205.9
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
....+|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.....+|
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 34467999999999999999999999999999999987543 223567889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+|+||+++++|.+++.. ..+++.++..++.|++.|+ +||+++.++.+||+|||++...... .
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--~ 169 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--Q 169 (296)
T ss_pred EEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc--c
Confidence 99999999999998875 4699999999999999986 6999999999999999998854331 1
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNL 232 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~L 232 (426)
......+|++.|+|||.+.+..+. .++|||||||++|+|++|+.||.+.+.......+.... ...|..+++.+.+|
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 223345789999999999887764 89999999999999999999999877654444443332 23455689999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCccC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
|.+||..||.+|||+.+++.||||...
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.63 Aligned_cols=240 Identities=28% Similarity=0.391 Sum_probs=199.5
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999998899999999987543322 33567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||++++.|..++.....+++..+..++.|++.|+ +||++++++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 9999999988877766799999999999999986 6999999999999999998864332 2233
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-------------------CC
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DF 219 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 219 (426)
....++..|+|||++.+....+.++||||+||++|+|++|++||...+..+....+... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 44568999999999877555568899999999999999999999876543332222210 00
Q ss_pred C------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 220 K------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 220 ~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
. .++.++..+.+|+.+||+.||++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=304.47 Aligned_cols=243 Identities=25% Similarity=0.439 Sum_probs=205.3
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
+-...+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+......
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 44557999999999999999999999899999999998765422 246788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+++++|.+++.. ..+++.++..++.|++.|+ +|||++.++.+||+|||++..... .
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~--~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--E 169 (296)
T ss_pred EEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc--c
Confidence 999999999999999865 5689999999999999996 699999999999999999885432 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh-CC--CCCCCCCCHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GD--FKLPKWLSPGAQN 231 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~ 231 (426)
........|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......+.. +. ...|..++..+.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence 1223345799999999999877664 899999999999999999999987765433333322 22 2335568899999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
||.+||..||++|||+.++++||||...
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=306.09 Aligned_cols=238 Identities=28% Similarity=0.437 Sum_probs=194.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999975432 22224567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 95 y~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
|+. ++|.+++.. .+++++..++.++.||+.|+ +||+++.++.+||+|||++..... .....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~--~~~~~ 156 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVRCY 156 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC--CCCCc
Confidence 996 588887764 56799999999999999997 699999999999999999985432 12223
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCC-CCccHHHHHHHHHhCC-------------------
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGD------------------- 218 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~------------------- 218 (426)
....+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+..+.+..+....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 44567899999999877655568999999999999999988885 4444444433332100
Q ss_pred C----------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 F----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 ~----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
. ...+.+++++.+||.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=300.89 Aligned_cols=242 Identities=30% Similarity=0.463 Sum_probs=200.2
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc-------hhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-------LKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
+|.+.+.||+|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6899999999999999999998899999999886432111 112456889999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
..|+||||+++++|.+++...+++++..++.++.|++.|+ +||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 9999999999999999998888899999999999999996 6999999999999999999854332
Q ss_pred cCCCccccccCCCcccchhhhccCC-CCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCCC----CC
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPK----WL 225 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~ 225 (426)
..........|+..|+|||.+.... ..+.++|+||||+++|+|++|..||...+.......+... ...+|. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222234557899999999987654 2358899999999999999999999766554433333222 223333 35
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+..+.++|.+||.++|++|||++++++|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=304.56 Aligned_cols=247 Identities=31% Similarity=0.409 Sum_probs=203.7
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+|++.+.||+|+||.||+|.+..+++.||||.+...... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999889999999999765432 122345677899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+ +|+|.+++.... .+++..+..++.||+.|| +||+++.++.+||+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 899999998765 799999999999999997 6999999999999999999854331 12
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC------------------
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------------ 218 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 218 (426)
......+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+....+.++....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 23344678899999998765545689999999999999999999998766554444433210
Q ss_pred -----CC-----CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCCC
Q 014359 219 -----FK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 264 (426)
Q Consensus 219 -----~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~~ 264 (426)
.. .....+..+.+||.+||..||++|||+.+++.|+||.+...+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 00 01235788999999999999999999999999999998776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=298.52 Aligned_cols=241 Identities=28% Similarity=0.486 Sum_probs=200.6
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIY 90 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 90 (426)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+ ....|
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 689999999999999999999999999999998754322 22335678899999999999999999999875 36789
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc-C
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR-D 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~-~ 154 (426)
++|||+++++|.+++.....+++...+.++.|++.|+ +||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 9999999999999998878899999999999999996 69999999999999999987543211 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~L 232 (426)
........++..|+|||.+.+..++ .++||||+||++|+|++|+.||...+......+.... .+.+|..+++.+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 1222345689999999999887664 8999999999999999999999876654444333322 345567789999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCc
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
| +||..+|++|||++++++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=299.81 Aligned_cols=237 Identities=27% Similarity=0.415 Sum_probs=196.0
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC-----
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK----- 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~----- 86 (426)
-|.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 3679999999999999999999999999999999875421 235788999999998 699999999998653
Q ss_pred -CeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 87 -SKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
..+|++|||+.+|+|.+++... ..+++..+..++.|++.|+ +||++++++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999999863 4689999999999999996 699999999999999999985
Q ss_pred CCcccCCCccccccCCCcccchhhhcc-----CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCC
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKL 221 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~ 221 (426)
... ........+|++.|+|||++.+ ..+ +.++||||+||++|+|++|..||................ ...
T Consensus 161 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 161 LDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred ccc--ccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 432 1223445689999999999863 234 478999999999999999999998765544433333222 122
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 222 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+..++..+.+||.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 34578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=310.57 Aligned_cols=236 Identities=28% Similarity=0.454 Sum_probs=205.3
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
|.++.+||+|+||.||+|.++.+|+.||||.+..+. ..+.+.+|+.||++++.|++|++|+.+.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 678899999999999999999999999999887543 268899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHh---------------heeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 96 ~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~ale---------------NILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
|-.|+..|.++- +.+++|.++..+++..+.||+ ||||+.+|..||+|||.|..+.. .-....
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence 999999999974 567999999999999999983 99999999999999999985433 233456
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHc
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~ 236 (426)
+..|||.|||||++..-+|+ .++||||||++..||..|++||.+..+....-.|-... +.-|...|.++.+++++|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 78999999999999999997 89999999999999999999998876654332232222 223455799999999999
Q ss_pred cccCcCCCCChHHHhcCcCCccC
Q 014359 237 LEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
|.++|++|-|+.++++|||.+..
T Consensus 267 LiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hcCCHHHHHHHHHHhhhhhhcCC
Confidence 99999999999999999998763
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=301.00 Aligned_cols=243 Identities=30% Similarity=0.588 Sum_probs=209.2
Q ss_pred CEEE-eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEEE
Q 014359 15 RYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 15 ~y~i-~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 92 (426)
-|.+ .+.||+|+|+.|--+.+..+|..||||++++.. .....++.||++++..++ |+||++++++|++++..|+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 3444 357999999999999999999999999999873 223678999999999995 99999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC---CEEEeccCCCCCCCccc-
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---NIKISDFGLSALPQHFR- 153 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g---~lKl~DFGla~~~~~~~- 153 (426)
||-+.||.|...|..+..|+|.+|.++.+.|++|| ||||-..-. -+|||||.++.......
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999999999999999999999999999999997 799987654 48999999987533221
Q ss_pred ----CCCccccccCCCcccchhhhc----cCCCCCchhhHHHHHHHHHHHhcCCCCCCCc---------------cHHHH
Q 014359 154 ----DDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDR---------------NLAVL 210 (426)
Q Consensus 154 ----~~~~~~~~~gt~~Y~APE~l~----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---------------~~~~~ 210 (426)
....+.+.||+..|||||+.. ...++..++|.||||||||.||+|++||.+. ....+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 233456789999999999863 2233448999999999999999999999652 23568
Q ss_pred HHHHHhCCCCCCC--C--CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 211 YQKIFRGDFKLPK--W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 211 ~~~i~~~~~~~p~--~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
|..|..|.+++|+ | +|.++++||..+|..|+.+|.++.++++|||++...
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 8999999999994 4 899999999999999999999999999999998643
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=303.27 Aligned_cols=242 Identities=27% Similarity=0.429 Sum_probs=203.6
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++.+...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999998899999999987542 2333567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
||+++++|..++... ..+++..++.++.|++.|+ +||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999999988763 3799999999999999986 699999999999999999875422
Q ss_pred CCccccccCCCcccchhhhccCCC-----CCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH---HHHhC-CCCCCCCC
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ---KIFRG-DFKLPKWL 225 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~-----~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~-~~~~p~~~ 225 (426)
.......|++.|+|||.+.+... .+.++||||+||++|+|++|+.||...+....+. .+..+ ....|..+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 23345678999999999865432 2478999999999999999999998765544333 23333 24566678
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
+.++.+||.+||+.+|++||++.+++.||||.....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=300.42 Aligned_cols=240 Identities=30% Similarity=0.448 Sum_probs=200.0
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999889999999999765432 2335678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 95 y~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
|+ +++|.+++.. ...+++..++.++.|++.|+ +||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-CCcc
Confidence 99 9999999864 45699999999999999996 69999999999999999998654321 1223
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-------------------C
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------F 219 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 219 (426)
....|+..|+|||.+.+....+.++||||+||++|+|++|.+||.+.+....+..+...- .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 456799999999998766555689999999999999999999998766544443332210 0
Q ss_pred C-----------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 220 K-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 220 ~-----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
. ..+..+..+.+||.+||..||.+|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0123578899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=301.92 Aligned_cols=238 Identities=28% Similarity=0.452 Sum_probs=201.7
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788899999999999999999999999999986542 33356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 96 ~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
+++++|...+.. ..++++..+..++.|++.|| +|||++.++.+||+|||++..... ......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--cccccc
Confidence 999999988764 56799999999999999997 699999999999999999875322 122234
Q ss_pred cccCCCcccchhhhcc-----CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHH
Q 014359 160 TTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 231 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~ 231 (426)
...||+.|+|||++.. ..+ +.++||||+||++|+|++|+.||...+.......+.... ...|..++.++.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 5678999999999842 223 478999999999999999999998877666555554432 2345568899999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
||.+||+.||.+|||++++++||||...
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 9999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=317.16 Aligned_cols=238 Identities=24% Similarity=0.343 Sum_probs=193.8
Q ss_pred cccCEEEeceeeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
...+|++++.||+|+||.||+|... .+++.||+|.+... ....+|+.+|+.++||||+++++++......
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3457999999999999999999754 35678999987643 2346899999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+|||++. ++|.+++....++++..++.++.||+.|| +|||++.++.+||+|||++........
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99999995 69999998778899999999999999997 699999999999999999975543222
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHHHh---------------
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFR--------------- 216 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~--------------- 216 (426)
........||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+... ...+..+.+
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 2233456799999999999888775 899999999999999999999965431 111111110
Q ss_pred --------------CCCCCCC-----CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 217 --------------GDFKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 217 --------------~~~~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
..+..|. .++.++.+||.+||..||.+|||+.+++.||||.+.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0111121 246788999999999999999999999999999863
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=299.51 Aligned_cols=242 Identities=26% Similarity=0.454 Sum_probs=201.8
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc---chhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
+|+.++.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999999999999999999754321 12245789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccCCCCCCCcccC-
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFGLSALPQHFRD- 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFGla~~~~~~~~- 154 (426)
||||+++++|.+++...+++++..+..++.|++.|+ +||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999997 699998876 599999999875433211
Q ss_pred -CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH---H--hCCCCCCCCCCHH
Q 014359 155 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---F--RGDFKLPKWLSPG 228 (426)
Q Consensus 155 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i---~--~~~~~~p~~~s~~ 228 (426)
........||..|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+ . ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1112345689999999999877664 8899999999999999999999764432222222 1 2234566778999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
+.+++.+||..||++|||+.++++||||.
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=302.86 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=203.6
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCC-----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
..+++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34678999999999999999999876554 679999987543 23345678999999999999999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHH---------------hheeeCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGL---------------ENILLDS 134 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~al---------------eNILld~ 134 (426)
....|++|||+++|+|.+++... ..+++..+..++.|++.|+ +||++++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 4588899999999999997 6999999
Q ss_pred CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHH
Q 014359 135 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 213 (426)
Q Consensus 135 ~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 213 (426)
++.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999854332222233445678999999998877764 89999999999999998 9999998888887777
Q ss_pred HHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 214 IFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 214 i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+..+. ...|..+++++.+|+.+||+.||++|||+.+|+++
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 76554 34567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=302.64 Aligned_cols=241 Identities=26% Similarity=0.406 Sum_probs=203.1
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
-++|++++.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 36799999999999999999999999999999998654 333467788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+++++|..++.. ...+++..++.++.|++.|+ +||+++.++++||+|||++..... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--ccc
Confidence 999999999888754 45799999999999999997 699999999999999999874322 112
Q ss_pred ccccccCCCcccchhhhcc-----CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC---CCCCCCCHH
Q 014359 157 LLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPG 228 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~ 228 (426)
......+++.|+|||++.+ ..+ +.++|||||||++|+|++|..||...+....+.++..... ..|..++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred ccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 2234578999999999853 223 4789999999999999999999988776655555544432 234567899
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+.++|.+||..||++||+++++++||||...
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 9999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=303.98 Aligned_cols=244 Identities=26% Similarity=0.447 Sum_probs=204.8
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
+-..++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 3445899999999999999999999989999999999875432 2246788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+++++|.+++.+ ..+++..+..++.|++.|+ +|||++.++.+||+|||++..... .
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~--~ 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--E 168 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC--C
Confidence 999999999999999865 5689999999999999996 699999999999999999875432 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh-CC--CCCCCCCCHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GD--FKLPKWLSPGAQN 231 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~ 231 (426)
........+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.+.......+.. +. ...|..++..+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 222345578999999999988776 4899999999999999999999987665333222222 21 2245568899999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
||.+||..||++|||+.++++||||....
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 99999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=295.20 Aligned_cols=237 Identities=30% Similarity=0.469 Sum_probs=201.8
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.+....|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 3689999999999999999999988999999999975532 2357899999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+.+++|.+++... .++++..++.++.|++.|+ +||+++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence 9999999999999775 7899999999999999996 6999999999999999999854331 11
Q ss_pred ccccccCCCcccchhhhccC---CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCC-----CCCCCHH
Q 014359 157 LLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-----PKWLSPG 228 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~~ 228 (426)
......++..|+|||.+.+. .++ .++|||||||++|+|++|+.||.+.+.......+....+.. +..++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 23445789999999998766 564 78999999999999999999998876554444444332221 2335788
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w 255 (426)
+.+||++||..||.+|||+.+++.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.09 Aligned_cols=248 Identities=30% Similarity=0.427 Sum_probs=201.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 89 (426)
.+++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++... +..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 578999999999999999999999999999999998754322 22233566899999999999999999998754 568
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+.+ +|.+++.. ...+++..++.++.|++.|+ +||++++++.+||+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~- 161 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP- 161 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc-
Confidence 999999964 88888875 46799999999999999996 6999999999999999999865431
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC----------------
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---------------- 217 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------- 217 (426)
........+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 -AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred -cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 122233456889999999876554468999999999999999999999988776665554331
Q ss_pred ---CCCCC-----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCC
Q 014359 218 ---DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 263 (426)
Q Consensus 218 ---~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~ 263 (426)
.+..+ .+.++.+.+||.+||+.||++|||+.++++||||.....+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 11111 23588999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=313.44 Aligned_cols=247 Identities=30% Similarity=0.470 Sum_probs=218.1
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
..+..+.|+.-+.||+|+||.|+-++.+.||+.||.|.+.+.+...........+|-.+|.+++.|.||.+--.|++++.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34567789999999999999999999999999999999988777666666778899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 89 IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
+++||..|+||||.-.|...+ .|++..++.|+.+|+.|| ||||||+.|+++|+|.|+|.-+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~- 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP- 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC-
Confidence 999999999999988887655 799999999999999997 79999999999999999999543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH----HHHHHHHHhCCCCCCCCCCH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSP 227 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~ 227 (426)
.........||.+|||||++.+..|+ ..+|+||+||+||+|+.|+.||..... +++-+.+......+|..+|+
T Consensus 339 --~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 339 --EGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred --CCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 33445566999999999999999876 889999999999999999999976432 34455566667778899999
Q ss_pred HHHHHHHHccccCcCCCC-----ChHHHhcCcCCccC
Q 014359 228 GAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQD 259 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~-----t~~~il~h~w~~~~ 259 (426)
++++|.+.+|++||++|. +++++.+||||+..
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 999999999999999998 46799999999874
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=294.97 Aligned_cols=242 Identities=30% Similarity=0.489 Sum_probs=201.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 89 (426)
.+|++++.||+|+||.||+|.+..+++.||||.+...... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999999999999999988643221 223356889999999999999999999998763 568
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc-
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR- 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~- 153 (426)
|++|||+++++|.+++.+...+++..+..++.|++.|+ +||+++.++.+||+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998878899999999999999997 69999999999999999998543211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQN 231 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 231 (426)
........+|+..|+|||++.+..+ +.++|||||||++|+|++|+.||...+........... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 1112344579999999999988776 48999999999999999999999876554444443322 23456668889999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCCc
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
+|.+||. +|++||+++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=293.54 Aligned_cols=238 Identities=32% Similarity=0.549 Sum_probs=204.7
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYMV 92 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV 92 (426)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999976543 23335678899999999999999999998754 4568999
Q ss_pred EcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH--------------------hheeeCCCCCEEEeccCCCCC
Q 014359 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL--------------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 93 mEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al--------------------eNILld~~g~lKl~DFGla~~ 148 (426)
|||+++++|.+++.. ..++++..++.++.||+.|+ +||++++++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999975 35799999999999999875 599999999999999999986
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCCCCCH
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSP 227 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 227 (426)
.... ........|++.|+|||++.+..++ .++|+||||+++|+|++|+.||...+.......+..+.. .+|..++.
T Consensus 160 ~~~~--~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHD--SSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCC--cccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 5432 1123456789999999999877664 889999999999999999999998887777777766654 45667899
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
.+.+++.+||+.+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=305.90 Aligned_cols=232 Identities=31% Similarity=0.450 Sum_probs=180.0
Q ss_pred eceeeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeEEEEEc
Q 014359 19 GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYMVLE 94 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lVmE 94 (426)
++.||+|+||.||+|++. .+++.||+|.+..... ...+.+|+.++++++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 568999999999999975 4678999999865432 3457789999999999999999999854 457899999
Q ss_pred ccCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHH---------------hheee----CCCCCEEEeccCCC
Q 014359 95 YVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGL---------------ENILL----DSKGNIKISDFGLS 146 (426)
Q Consensus 95 y~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~al---------------eNILl----d~~g~lKl~DFGla 146 (426)
|+. ++|.+++... ..+++..++.++.||+.|| +|||+ +.++.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 5898887532 2589999999999999997 79999 45679999999999
Q ss_pred CCCCccc-CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH---------HHHHHHHHh
Q 014359 147 ALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---------AVLYQKIFR 216 (426)
Q Consensus 147 ~~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---------~~~~~~i~~ 216 (426)
+...... ........+||+.|+|||++.+...++.++||||+||++|+|++|++||...+. ...+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 8654321 112334568999999999998765556899999999999999999999964321 111111110
Q ss_pred C----------------------------CCC----------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 217 G----------------------------DFK----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 217 ~----------------------------~~~----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
. ... .....+..+.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 000 001135678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=300.15 Aligned_cols=241 Identities=28% Similarity=0.426 Sum_probs=200.8
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 589999999999999999999998999999999875432 2333578899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||++++.|..++.....+++..+..++.|++.|+ +||++++++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 9999887877777767799999999999999997 699999999999999999986543221 133
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC---------------------
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------------------- 217 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--------------------- 217 (426)
....+++.|+|||++.+....+.++||||+|+++|+|++|+.||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 45678999999999988734458999999999999999999999876554333222110
Q ss_pred CC-----------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 218 DF-----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 218 ~~-----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
.+ .+|..+++++.+||++||..||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1233458999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=292.92 Aligned_cols=239 Identities=33% Similarity=0.498 Sum_probs=203.6
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+|+..+.||+|+||+||+|.+..+++.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+....|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58889999999999999999988999999999875432 1233457889999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|||+++++|.+++.+...+++..+..++.|++.|+ +||+++.++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~---~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---cc
Confidence 99999999999998877899999999999999996 6999999999999999998854332 12
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh--CCCCCCCCCCHHHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~Li~~ 235 (426)
.....|++.|+|||.+......+.++|+||+||++|+|++|+.||...........+.. ....+|..+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987665235899999999999999999999987664444333333 2345567789999999999
Q ss_pred ccccCcCCCCChHHHhcCcCC
Q 014359 236 ILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~ 256 (426)
||+.||++|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=293.07 Aligned_cols=238 Identities=29% Similarity=0.464 Sum_probs=207.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++++.||+|+||.||.+++..+++.|++|.+...... ......+.+|+.++++++||||+++++++.+....+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 699999999999999999999999999999998765432 3335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|+++|+|.+++... ..+++..+..++.|++.|+ +||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 99999999999764 4689999999999999996 69999999999999999998543321 13
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHc
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 236 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~ 236 (426)
.....|++.|+|||.+.+..++ .++||||+||++|+|++|..||...+..+....+..+.+. .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456799999999999877664 7899999999999999999999988877777777666443 3456899999999999
Q ss_pred cccCcCCCCChHHHhcCcCC
Q 014359 237 LEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h~w~ 256 (426)
|..||.+|||+.++++|+|+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=300.60 Aligned_cols=242 Identities=26% Similarity=0.413 Sum_probs=203.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.....+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4578999999999999999999999899999999987543 23345788999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
||||+++++|.+++...+.+++..++.++.|++.|+ +||++++++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---- 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---- 156 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence 999999999999998878899999999999999885 699999999999999999874322
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH-----------HHHHHHHhCC-CCCCC
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-----------VLYQKIFRGD-FKLPK 223 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~ 223 (426)
......+||..|+|||++.+..+ +.++||||+||++|+|++|..||...+.. .....+.... ..++.
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 12235679999999999877765 48899999999999999999999864431 2233333322 23333
Q ss_pred C-CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 224 W-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 224 ~-~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
. ++.++.+||.+||+.||++|||+.++++|+||.+..
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 3 788999999999999999999999999999997754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=322.19 Aligned_cols=236 Identities=29% Similarity=0.501 Sum_probs=204.7
Q ss_pred eeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCC
Q 014359 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE 100 (426)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~ 100 (426)
.||+|+||+||-|++..+...+|||-+.... ....+-+..||.++++|+|.|||+++|.+..++.+-|+||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999987543 3336778999999999999999999999999999999999999999
Q ss_pred hHHHHHhC-CCC--CHHHHHHHHHHHHHHH---------------hheeeCC-CCCEEEeccCCCCCCCcccCCCccccc
Q 014359 101 LFDKIASK-GRL--QEAEGRKLFQQLIDGL---------------ENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTT 161 (426)
Q Consensus 101 L~~~i~~~-~~l--~e~~~~~~~~ql~~al---------------eNILld~-~g~lKl~DFGla~~~~~~~~~~~~~~~ 161 (426)
|.+++++. +++ +|..+..|.+||+.|| +|+|++. .|.+||+|||-++.+.. -+....+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 99999864 677 8999999999999998 6999964 69999999999986543 45567789
Q ss_pred cCCCcccchhhhccC-CCCCchhhHHHHHHHHHHHhcCCCCCCCc-c-HHHHHHH-HHhCCCCCCCCCCHHHHHHHHHcc
Q 014359 162 CGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDR-N-LAVLYQK-IFRGDFKLPKWLSPGAQNLLRKIL 237 (426)
Q Consensus 162 ~gt~~Y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~-~-~~~~~~~-i~~~~~~~p~~~s~~~~~Li~~~L 237 (426)
.||..|||||++... .-+|.++|||||||+..||.||++||... + ...+|+- +.+-.+++|..++.+++.+|.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 999999999999653 23479999999999999999999999753 2 2344443 455678899999999999999999
Q ss_pred ccCcCCCCChHHHhcCcCCccCCC
Q 014359 238 EPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 238 ~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
.+||..||++.++|++||++....
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred CCCcccCccHHHhccCcccccCCC
Confidence 999999999999999999987643
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=292.11 Aligned_cols=237 Identities=30% Similarity=0.502 Sum_probs=204.9
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999865433 2335789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccCCCCCCCcccCCC
Q 014359 95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 95 y~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFGla~~~~~~~~~~ 156 (426)
|+++++|.+++... ..+++..+..++.|++.|+ +||++++++ .+||+|||++..... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~---~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC---Cc
Confidence 99999999999763 3589999999999999996 699998665 589999999985432 22
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 235 (426)
......|++.|+|||.+.+..++ .++||||+|+++|+|++|..||...+.......+..+. .++|..+++++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 23345789999999999877664 88999999999999999999999888776666665543 45667789999999999
Q ss_pred ccccCcCCCCChHHHhcCcCC
Q 014359 236 ILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~ 256 (426)
||..||++|||+.++++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=302.72 Aligned_cols=237 Identities=31% Similarity=0.464 Sum_probs=199.2
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----eE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 89 (426)
.|+-.+.+|+|+||.||.|....+++.||||.+-.+.. --.+|+.+|+.++|||||++.-+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 58889999999999999999999999999998765432 2236999999999999999999885432 34
Q ss_pred EEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCC-CCEEEeccCCCCCC
Q 014359 90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSK-GNIKISDFGLSALP 149 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~-g~lKl~DFGla~~~ 149 (426)
.+||||++. +|.+.++. +.+++.-.++-|..||+.|+ .|||+|.+ |.+||||||.|+..
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 589999987 99999984 57899999999999999997 69999987 99999999999976
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh--C----------
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--G---------- 217 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~---------- 217 (426)
.. .....+...|..|+|||.+.+...++.+.||||+|||+.||+-|++-|.+.+..+....|.+ |
T Consensus 177 ~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred cc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 54 23345677899999999999988778999999999999999999999999877665554432 0
Q ss_pred -----CCCC------------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 218 -----DFKL------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 218 -----~~~~------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
...+ ....++++.+|+.++|..+|.+|.++.|++.||||.....+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111 12368999999999999999999999999999999876544
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=300.14 Aligned_cols=238 Identities=28% Similarity=0.423 Sum_probs=195.1
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||.|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999875432 22234578899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|+. ++|.+++.. ...+++..+..++.|++.|+ +||+++.++.+||+|||++..... ....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~--~~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhccc--Cccc
Confidence 996 589988865 35689999999999999996 699999999999999999875432 1122
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-C-----------------C
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-D-----------------F 219 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~-----------------~ 219 (426)
.....+++.|+|||++.+....+.++|||||||++|+|+||+.||.+.+......++... . .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 334567899999999877665568899999999999999999999876544332222110 0 0
Q ss_pred CC-----------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 220 KL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 220 ~~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
.+ .+.+++++.++|.+||+.||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=299.19 Aligned_cols=235 Identities=28% Similarity=0.451 Sum_probs=194.6
Q ss_pred eeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHH---HHHhcCCCCCccceeEEEEeCCeEEEEEcccC
Q 014359 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI---ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei---~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
.||+|+||.||+|.+..+++.||+|.+.+..............|. ..++...||||+++++++.+.+..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999865433222222233343 34555689999999999999999999999999
Q ss_pred CCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcccccc
Q 014359 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162 (426)
Q Consensus 98 gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~ 162 (426)
||+|.+++...+.+++..++.++.|++.|+ +||+++.++.+||+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 999999998888899999999999999997 699999999999999999875432 2234568
Q ss_pred CCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc---cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcccc
Q 014359 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 163 gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 239 (426)
|+..|+|||++.+....+.++||||+||++|+|++|+.||.+. ...............+|..++.++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875533358899999999999999999999876 3334444444456677777899999999999999
Q ss_pred CcCCCC-----ChHHHhcCcCCccC
Q 014359 240 NPVKRI-----TIAGIKADEWFEQD 259 (426)
Q Consensus 240 dP~~R~-----t~~~il~h~w~~~~ 259 (426)
||.+|| ++.++++||||...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.98 Aligned_cols=234 Identities=29% Similarity=0.463 Sum_probs=190.9
Q ss_pred eeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHh---cCCCCCccceeEEEEeCCeEEEEEcccC
Q 014359 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK---LLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~---~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
.||+|+||.||+|.+..+++.||+|.+.+.............+|..+++ ..+||||+++++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654332222233445554444 3479999999999999999999999999
Q ss_pred CCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcccccc
Q 014359 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162 (426)
Q Consensus 98 gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~ 162 (426)
+|+|.+++...+.+++..+..++.|++.|+ +|||+++++.+||+|||++..... .......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----cCccCcC
Confidence 999999998888899999999999999997 699999999999999999874432 1223457
Q ss_pred CCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc---HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcccc
Q 014359 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 163 gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 239 (426)
||+.|+|||.+.+....+.++||||+||++|+|++|..||.... ..............+|..+++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643333589999999999999999999997532 222222233344566778999999999999999
Q ss_pred CcCCCC-----ChHHHhcCcCCcc
Q 014359 240 NPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 240 dP~~R~-----t~~~il~h~w~~~ 258 (426)
||++|+ |++++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.16 Aligned_cols=235 Identities=23% Similarity=0.376 Sum_probs=196.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++......++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987543 2333567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++++|..+ ..+++..+..++.|++.|+ +|||++.++.+||+|||++..... ...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence 99999999654 3589999999999999996 699999999999999999975432 223
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHHHHhCC-CCC-CCCCCHHH
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-------AVLYQKIFRGD-FKL-PKWLSPGA 229 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~-~~~-p~~~s~~~ 229 (426)
...+||+.|+|||++.+..+. .++|+||+||++|+|++|+.||..... ......+.... ... ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 456899999999999887764 899999999999999999999965321 12222222222 222 23478899
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.++|.+||+.||++||++++++.||||...
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=295.79 Aligned_cols=236 Identities=33% Similarity=0.610 Sum_probs=206.9
Q ss_pred eeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCCh
Q 014359 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L 101 (426)
||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999889999999999765443344567899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC------CCcccc
Q 014359 102 FDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD------DGLLHT 160 (426)
Q Consensus 102 ~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~------~~~~~~ 160 (426)
.+++.+.+.+++..+..++.|++.|| +||++++++.+||+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998877899999999999999997 699999999999999999885432211 112334
Q ss_pred ccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHccc
Q 014359 161 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--SPGAQNLLRKILE 238 (426)
Q Consensus 161 ~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~Li~~~L~ 238 (426)
..+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....+..+..+....|... +..+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 578899999999887765 4899999999999999999999998888888888877777777665 9999999999999
Q ss_pred cCcCCCCCh---HHHhcCcCCcc
Q 014359 239 PNPVKRITI---AGIKADEWFEQ 258 (426)
Q Consensus 239 ~dP~~R~t~---~~il~h~w~~~ 258 (426)
.+|++|||+ .++++||||.+
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=299.89 Aligned_cols=233 Identities=30% Similarity=0.496 Sum_probs=197.8
Q ss_pred eeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCCh
Q 014359 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L 101 (426)
||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765433333355677899999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCC
Q 014359 102 FDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164 (426)
Q Consensus 102 ~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt 164 (426)
.+++.... .+++..+..++.|++.|+ +||++++++.+||+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 99997655 799999999999999996 699999999999999999875432 2223445688
Q ss_pred CcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH----HHHHHHHHhCCCCCCCCCCHHHHHHHHHccccC
Q 014359 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240 (426)
Q Consensus 165 ~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~d 240 (426)
..|+|||++.+..+ +.++||||+||++|+|++|+.||..... ......+.......|..+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 99999999987775 4889999999999999999999977543 233333444455667778999999999999999
Q ss_pred cCCCC-----ChHHHhcCcCCcc
Q 014359 241 PVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 241 P~~R~-----t~~~il~h~w~~~ 258 (426)
|.+|| ++.+++.||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=296.50 Aligned_cols=238 Identities=29% Similarity=0.430 Sum_probs=197.4
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC----
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS---- 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~---- 87 (426)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5899999999999999999999988999999999875432 246789999999999 6999999999997644
Q ss_pred --eEEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCC
Q 014359 88 --KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 88 --~~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla 146 (426)
.+|+||||+++++|.+++.. ...+++..++.++.|++.|+ +||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 48999999999999998864 35799999999999999997 6999999999999999998
Q ss_pred CCCCcccCCCccccccCCCcccchhhhccCC----CCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC---
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--- 219 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--- 219 (426)
..... .........|++.|+|||++.... ..+.++|||||||++|+|++|+.||...+.......+.....
T Consensus 161 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 75432 122234567899999999985432 224789999999999999999999987665554444444322
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 220 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 220 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
..+..++..+.+||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2223367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=292.20 Aligned_cols=241 Identities=32% Similarity=0.521 Sum_probs=202.6
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999889999999999865432 3456889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC-c-
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG-L- 157 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~-~- 157 (426)
|+++++|.+++.....+++..++.++.|++.|+ +||++++++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999998877799999999999999997 69999999999999999998654322111 1
Q ss_pred cccccCCCcccchhhhccCC--CCCchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHHHH-hCCCCCCCCC--CHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIF-RGDFKLPKWL--SPGAQN 231 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~--~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~-~~~~~~p~~~--s~~~~~ 231 (426)
....++++.|+|||++.+.. ..+.++||||+|+++|+|++|+.||...+ .......+. .....+|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22467899999999987665 13488999999999999999999997653 222222222 2334556554 899999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCC
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+|.+||+.||.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=294.76 Aligned_cols=235 Identities=27% Similarity=0.446 Sum_probs=200.9
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .+.+.+|+.+++.++||||+++++++.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 679999999999999999999988899999999865421 578999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||+++++|.+++.. ...+++..++.++.|++.|+ +||++++++.+||+|||++...... ...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~--~~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC--ccc
Confidence 99999999999975 45789999999999999997 5999999999999999999865432 112
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC---CCCCCCCCCHHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~ 234 (426)
.....|+..|+|||++.+..++ .++||||+||++|+|++|+.||...+.......+... ....+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 3345689999999999888764 8999999999999999999999876655443333222 12234457889999999
Q ss_pred HccccCcCCCCChHHHhcCcCC
Q 014359 235 KILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+||+.||++|||+.++++||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=298.71 Aligned_cols=240 Identities=24% Similarity=0.417 Sum_probs=204.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
+.|+..+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468889999999999999999988999999999875432 233578899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++|+|.+++.. +++++..+..++.|++.|+ +||+++.++.++|+|||++...... ....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--cccc
Confidence 99999999999875 5799999999999999986 6999999999999999999754331 1122
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKIL 237 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L 237 (426)
....++..|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+..+ ....+..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 345688999999999877664 8999999999999999999999877665554444333 23344557889999999999
Q ss_pred ccCcCCCCChHHHhcCcCCccC
Q 014359 238 EPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 238 ~~dP~~R~t~~~il~h~w~~~~ 259 (426)
..||++||++.++++|+||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=299.65 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=194.1
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC--
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 87 (426)
...+++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 4567899999999999999999999999999999999865432 2222345678999999999999999999986543
Q ss_pred ------eEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 88 ------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 88 ------~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
..|+||||+. ++|.+.+... ..+++..++.++.|++.|+ +||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4699999996 4888887654 3699999999999999997 699999999999999999
Q ss_pred CCCCCcccCC--CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh--CC---
Q 014359 146 SALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GD--- 218 (426)
Q Consensus 146 a~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~--- 218 (426)
+......... .......++..|+|||.+.+....+.++||||+|+++|+|++|+.||.+.+.......+.. +.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9855332111 1223456789999999987655445899999999999999999999987665433222211 10
Q ss_pred --------------CCCC-------------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 --------------FKLP-------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 --------------~~~p-------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
...| ...+..+.+||.+||..||.+|||++++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011 1135778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=291.99 Aligned_cols=234 Identities=31% Similarity=0.560 Sum_probs=202.3
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||++.+..+++.||+|.++... .....+.+.+|+.+++.++||||+++++.+.+.+..|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999987543 22335778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|+++|+|.+++.. ...+++..+..++.|++.|+ +||++++++.++|+|||++...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 9999999999865 34589999999999999997 6999999999999999999754331 222
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHc
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~ 236 (426)
.....|++.|+|||++.+..++ .++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 2345789999999999887764 899999999999999999999998887777776666544 45667899999999999
Q ss_pred cccCcCCCCChHHHhcC
Q 014359 237 LEPNPVKRITIAGIKAD 253 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h 253 (426)
|+.||++|||+.+++..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=296.26 Aligned_cols=242 Identities=28% Similarity=0.407 Sum_probs=198.8
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC--
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK-- 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-- 86 (426)
+...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 345788999999999999999999999999999999986532 1245678899999999 799999999998653
Q ss_pred ---CeEEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccC
Q 014359 87 ---SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFG 144 (426)
Q Consensus 87 ---~~~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFG 144 (426)
...|+||||+++|+|.+++.. ...+++..++.++.|++.|+ +||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 368999999999999998853 45799999999999999996 69999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCcccchhhhccCCC----CCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-
Q 014359 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY----DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF- 219 (426)
Q Consensus 145 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~----~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~- 219 (426)
++...... ........|++.|+|||++..... .+.++||||+||++|+|++|+.||...+.......+.....
T Consensus 174 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 174 VSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred cchhcccc--cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 98854321 112234578999999999865331 24889999999999999999999987766555445444322
Q ss_pred --CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 220 --KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 220 --~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
..|..++..+.+||.+||+.||++||++.++++||||+
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 22445778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=296.89 Aligned_cols=240 Identities=29% Similarity=0.443 Sum_probs=192.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++.+.||+|+||.||+|.+..+++.||||.+....... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 3688999999999999999999998899999999987543211 13456789999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
||||+.+ +|.+++... ..+++..++.++.|++.|+ +||+++.++.+||+|||++..... ..
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--~~ 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV--PS 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC--CC
Confidence 9999975 999988753 4689999999999999997 699999999999999999874322 11
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHHHHhC-----------------
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG----------------- 217 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~----------------- 217 (426)
.......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+ ..+....+.+.
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 122334578999999998765434589999999999999999999997655 22222221110
Q ss_pred --C--CCC---------CCCCC--HHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 218 --D--FKL---------PKWLS--PGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 218 --~--~~~---------p~~~s--~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
. ... ...++ .++.++|.+||+.||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 01234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=313.52 Aligned_cols=239 Identities=25% Similarity=0.409 Sum_probs=193.4
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3356899999999999999999986443 3579999997543 223356788999999999 8999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhC--------------------------------------------------------
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~-------------------------------------------------------- 108 (426)
..+..|+||||+++|+|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999998542
Q ss_pred --------------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 109 --------------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 109 --------------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
.++++..++.++.|++.|| +|||+++++.+||+|||+++............
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 2478889999999999996 69999999999999999998543211111122
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHc
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~ 236 (426)
...+++.|+|||++.+..++ .++||||+||++|+|++ |+.||........+...... ....|.++++++.++|.+|
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred CCCCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 23456789999999877764 89999999999999997 99999876544333333332 3456677899999999999
Q ss_pred cccCcCCCCChHHHhc
Q 014359 237 LEPNPVKRITIAGIKA 252 (426)
Q Consensus 237 L~~dP~~R~t~~~il~ 252 (426)
|+.||++|||+.++++
T Consensus 352 l~~dp~~RPs~~~l~~ 367 (374)
T cd05106 352 WNLEPTERPTFSQISQ 367 (374)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=296.23 Aligned_cols=241 Identities=25% Similarity=0.465 Sum_probs=202.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC---CCCccceeEEEEeCCeEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 91 (426)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999987543 2233567889999999996 9999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||||+++++|.+++.. +.+++..+..++.|++.|+ +||+++.++.++|+|||++...... ..
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SS 156 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC--cc
Confidence 9999999999999876 4799999999999999996 6999999999999999999865432 22
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCCCCC-CCHHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKW-LSPGAQNLLR 234 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~ 234 (426)
......|++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+.......+.... ..++.. ++.++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 23445799999999998765544689999999999999999999998876654444333322 223332 7889999999
Q ss_pred HccccCcCCCCChHHHhcCcCCccCC
Q 014359 235 KILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+||..||++|||+.+++.|+||++..
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=294.91 Aligned_cols=238 Identities=30% Similarity=0.452 Sum_probs=202.9
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++......|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478999999999999999999998999999999876532 234567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||+.+++|.+++... ..+++..+..++.|++.|+ +||++++++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 999999999999875 7899999999999999996 6999999999999999998754321
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHHHHHHhC-CCCCCCC-CCHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRG-DFKLPKW-LSPGA 229 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~ 229 (426)
......++..|+|||.+.+..++ .++||||+||++|+|++|..||... ........+... .+..|.. ++.++
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred HhhcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 11227789999999999887764 8999999999999999999999754 233344444433 2344444 88999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.++|.+||..||++|||+.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.75 Aligned_cols=239 Identities=21% Similarity=0.371 Sum_probs=191.8
Q ss_pred Eeceeeec--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 18 LGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 18 i~~~LG~G--~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
++++||+| +|++||++.+..+|+.||+|.++.... .......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56889999 789999999999999999999976543 233456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC----
Q 014359 96 VTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD---- 154 (426)
Q Consensus 96 ~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~---- 154 (426)
+++|+|.+++.. ...+++..++.++.|++.|| +|||++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999965 34599999999999999997 699999999999999987553221111
Q ss_pred -CCccccccCCCcccchhhhccC--CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-----------
Q 014359 155 -DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----------- 220 (426)
Q Consensus 155 -~~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------- 220 (426)
........++..|+|||++.+. .+ +.++||||+||++|+|++|+.||..............+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 0111234678889999998763 35 58999999999999999999999865543332222211110
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 221 -----------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 221 -----------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
....+++.+.+||.+||+.||++|||++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 01125678999999999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=300.12 Aligned_cols=238 Identities=24% Similarity=0.335 Sum_probs=191.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECC----------------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn 75 (426)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35789999999999999999998532 34479999987543 2333567899999999999999
Q ss_pred ccceeEEEEeCCeEEEEEcccCCCChHHHHHhCC-------------------CCCHHHHHHHHHHHHHHH---------
Q 014359 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------------RLQEAEGRKLFQQLIDGL--------- 127 (426)
Q Consensus 76 Iv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~-------------------~l~e~~~~~~~~ql~~al--------- 127 (426)
|+++++++.+.+..|+||||+++|+|.+++.... .++...+..++.||+.|+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 367788899999999996
Q ss_pred ------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc--CC
Q 014359 128 ------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GY 199 (426)
Q Consensus 128 ------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt--G~ 199 (426)
+|||++.++.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence 699999999999999999985433211122234456889999999887776 489999999999999986 67
Q ss_pred CCCCCccHHHHHHHHHh--------CCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 200 LPFDDRNLAVLYQKIFR--------GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 200 ~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.||.+.+.......... .....|+.++..+.+||.+||+.||++|||+.+|.+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 88887665544433221 112335568899999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.62 Aligned_cols=232 Identities=31% Similarity=0.571 Sum_probs=195.6
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-hcCCCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+||||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999889999999999765432222233445555544 455899999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 99 GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 99 g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
++|.+++...+.+++..+..++.|++.|| +||++++++.+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 99999998888899999999999999997 699999999999999999874322 234568
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHcccc
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL----PKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~Li~~~L~~ 239 (426)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+..+.... +..+++.+.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999988775 589999999999999999999999888777777766554332 335789999999999999
Q ss_pred CcCCCCC---hHHHhcCcCCcc
Q 014359 240 NPVKRIT---IAGIKADEWFEQ 258 (426)
Q Consensus 240 dP~~R~t---~~~il~h~w~~~ 258 (426)
||++||| ++|++.||||.+
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 9999995 579999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=292.59 Aligned_cols=237 Identities=22% Similarity=0.310 Sum_probs=197.8
Q ss_pred cccCEEEeceeeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
...+|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 3467999999999999999999864 456789999987643 22334678899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.|+||||+++|+|.+++... ..+++..++.++.|++.|+ +|||++.++.+|++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999999764 5799999999999999997 6999999999999999987643211
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 230 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 230 (426)
. ........+++.|+|||++.+..++ .++||||+||++|++++ |..||.+.+.......+..+ ..+.|..++..+.
T Consensus 161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 161 A-IYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238 (266)
T ss_pred c-hhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 1 1111223456789999999887764 89999999999999775 99999988877777766655 3456677899999
Q ss_pred HHHHHccccCcCCCCChHHHhc
Q 014359 231 NLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+++.+||+.+|.+|||+.+|++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=295.00 Aligned_cols=237 Identities=29% Similarity=0.450 Sum_probs=196.5
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|++|.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999999765321 224567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 95 y~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|+++ +|.+++... .++++..+..++.|++.|+ +||++++++.+||+|||++..... ...
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~--~~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI--PVN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC--Ccc
Confidence 9975 898888653 3589999999999999996 699999999999999999975432 112
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC------------------
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------------ 218 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 218 (426)
......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 23345678999999998776555689999999999999999999998877655444432210
Q ss_pred CC-----------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 ~~-----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
.. +.+.+++.+.++|.+||+.||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=314.79 Aligned_cols=235 Identities=23% Similarity=0.298 Sum_probs=190.3
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++++||||+++++++...+..|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999995321 3456899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||++. ++|.+++... ..+++..++.++.|++.|| +|||++.++.+||+|||+++.........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99995 6999888754 4699999999999999997 69999999999999999998654322222
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC--------ccHHHHHHHHHhCCC---------
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVLYQKIFRGDF--------- 219 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~--------- 219 (426)
.....+||+.|+|||++.+..++ .++|||||||+||||++|..|+-. .....+.+.+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 23356799999999999888775 899999999999999998765422 112222222222111
Q ss_pred --------------------CCCCC-----CCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 220 --------------------KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 220 --------------------~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
..+.| ++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11112 4568999999999999999999999999999975
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=293.93 Aligned_cols=240 Identities=24% Similarity=0.409 Sum_probs=204.0
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
-|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++..+...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37788999999999999999988999999998864432 2335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
|+++++|.+++.. ..+++..+..++.|++.|+ +||+++.++.++|+|||++...... .....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~ 159 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRN 159 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hhhhc
Confidence 9999999999875 5799999999999999996 6999999999999999998754321 11223
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccc
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~ 238 (426)
...|+..|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+..+ ...++..++.++.++|.+||.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 45789999999998876664 8899999999999999999999877665555555443 334566789999999999999
Q ss_pred cCcCCCCChHHHhcCcCCccCC
Q 014359 239 PNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 239 ~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+|.+||++.++++||||....
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhhh
Confidence 9999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=296.09 Aligned_cols=238 Identities=26% Similarity=0.374 Sum_probs=200.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..++|.+.+.||+|+||.||+|.+.. +++.||||.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 45789999999999999999998743 46789999987543 222357899999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhC--------------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN 137 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~--------------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~ 137 (426)
...|+||||+++|+|.+++... ..+++..+..++.|++.|+ +||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999999999999999754 2478999999999999996 6999999999
Q ss_pred EEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHh
Q 014359 138 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 216 (426)
Q Consensus 138 lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 216 (426)
+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 999999999753221111122344567899999999887775 88999999999999998 9999988887777777776
Q ss_pred CCCC-CCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 217 GDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 217 ~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+... .|..++..+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6543 45668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=289.10 Aligned_cols=238 Identities=31% Similarity=0.571 Sum_probs=202.7
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||++.+..++..||+|.+...... ....+.+.+|+.+++.++||||+++++.+.+....|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 689999999999999999999999999999999765332 2234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccCCCCCCCcccCCC
Q 014359 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 95 y~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFGla~~~~~~~~~~ 156 (426)
|+++++|.+++.... .+++..+..++.|++.|+ +||++++++ .+||+|||.+..... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence 999999999997643 479999999999999996 699999886 469999999986533 122
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRK 235 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~ 235 (426)
......|++.|+|||++.+..++ .++|+||+||++++|++|..||...+.......+..+.. +.++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 23345689999999998877664 899999999999999999999998777666665555433 3445678999999999
Q ss_pred ccccCcCCCCChHHHhcCcCC
Q 014359 236 ILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~ 256 (426)
||..+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=310.96 Aligned_cols=238 Identities=28% Similarity=0.430 Sum_probs=193.2
Q ss_pred ccCEEEeceeeecCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 86 (426)
.++|++++.||+|+||.||+|.+ ..++..||||+++... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999974 3467789999997543 223356788999999999 899999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCC---------------------------------------------------------
Q 014359 87 SKIYMVLEYVTGGELFDKIASKG--------------------------------------------------------- 109 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~--------------------------------------------------------- 109 (426)
+..|+||||+++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999986422
Q ss_pred ------------------CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 110 ------------------RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 110 ------------------~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
.+++..+..++.||+.|+ +|||++.++.+||+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 478888999999999997 69999999999999999998543321111
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHH-HHHHHHHhC-CCCCCCCCCHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VLYQKIFRG-DFKLPKWLSPGAQNLL 233 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~Li 233 (426)
......+++.|+|||++.+..++ .++|||||||++|+|++ |..||...... .....+..+ ....|...+.++.+||
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 12233456789999999887775 89999999999999998 99999876543 334444433 2344667889999999
Q ss_pred HHccccCcCCCCChHHHhcC
Q 014359 234 RKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h 253 (426)
.+||+.||++|||+.++++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.85 Aligned_cols=237 Identities=27% Similarity=0.396 Sum_probs=203.6
Q ss_pred cccCEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
...+.+..+.||+|+||+||+|+... ....||||.++... +.....+|+||++++..++|||||+|+|+|..+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 34567888999999999999998542 34689999998654 444578999999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCC--------------CCCHHHHHHHHHHHHHHH---------------hheeeCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKG--------------RLQEAEGRKLFQQLIDGL---------------ENILLDSKGN 137 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~--------------~l~e~~~~~~~~ql~~al---------------eNILld~~g~ 137 (426)
+.+|+|+||+..|||.+++.... +++..+...++.||+.|+ .|+|+.++-.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 99999999999999999996432 278889999999999997 4999999999
Q ss_pred EEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHh
Q 014359 138 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 216 (426)
Q Consensus 138 lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 216 (426)
|||+||||++..-..+--.......-..+|||||.+....|+ +++||||+||+|||+.+ |..||.+.+.++..+.+..
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 999999999954322222222223345799999999998886 89999999999999999 9999999999999998888
Q ss_pred CC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHh
Q 014359 217 GD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 251 (426)
Q Consensus 217 ~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il 251 (426)
+. .+.|+.+|.++.+|+..||+.+|++||++.||-
T Consensus 721 g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 721 GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 76 678899999999999999999999999999983
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=298.05 Aligned_cols=241 Identities=31% Similarity=0.424 Sum_probs=198.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 89 (426)
.+++|++.+.||+|+||.||+|.+..+++.||+|.++..... ......+.+|+.++++++||||+++++++... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 357899999999999999999999889999999999754332 22345677899999999999999999998877 889
Q ss_pred EEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+.+ +|.+++.... .+++..++.++.|++.|| +||+++.++.+||+|||++......
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 159 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP- 159 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC-
Confidence 999999974 9999887643 599999999999999997 6999999999999999999854431
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC---------------
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------- 218 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------- 218 (426)
........+++.|+|||.+.+....+.++|+||+||++|+|++|..||...+....+.++....
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 -LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred -ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 1223445678999999998776555689999999999999999999998776555444332210
Q ss_pred ----------------CCCCCC-CCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 ----------------FKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 ----------------~~~p~~-~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
..+|.. +++.+.+||++||+.||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=295.36 Aligned_cols=240 Identities=30% Similarity=0.404 Sum_probs=193.4
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCe----
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK---- 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~---- 88 (426)
++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 579999999999999999999999999999999875432 2223467888999999995 6999999999977665
Q ss_pred -EEEEEcccCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHH---------------hheeeCC-CCCEEEeccCCC
Q 014359 89 -IYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGL---------------ENILLDS-KGNIKISDFGLS 146 (426)
Q Consensus 89 -~~lVmEy~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~al---------------eNILld~-~g~lKl~DFGla 146 (426)
.|+||||+++ +|.+++... ..+++..++.++.||+.|| +||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999985 898888642 3589999999999999997 6999999 889999999998
Q ss_pred CCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--C-----
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F----- 219 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~----- 219 (426)
..... .........+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+..+.... +
T Consensus 159 ~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSI--PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCC--CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 75422 11222334678999999998765444589999999999999999999998766544433332210 0
Q ss_pred ----------CCC-----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 220 ----------KLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 220 ----------~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
..| +.+++++.+||.+||.+||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 001 23788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=296.05 Aligned_cols=238 Identities=26% Similarity=0.409 Sum_probs=195.2
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe-----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS----- 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----- 85 (426)
..|.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4589999999999999999999999999999999986542 2245688899999998 69999999999853
Q ss_pred -CCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCC
Q 014359 86 -KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 86 -~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~ 147 (426)
...+|++|||+.+|+|.+++... ..+++..+..++.||+.|+ +||++++++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 46789999999999999999753 4589999999999999996 69999999999999999987
Q ss_pred CCCcccCCCccccccCCCcccchhhhcc-----CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CC-
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FK- 220 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~- 220 (426)
.... .........|++.|+|||++.. ..+ +.++|||||||++|+|++|..||...........+.... ..
T Consensus 170 ~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhc--cccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 5432 1122345679999999999863 334 478999999999999999999997765443333333221 11
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 221 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 221 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
.+..++.++.+||++||+.||.+|||+.++++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=290.31 Aligned_cols=238 Identities=29% Similarity=0.474 Sum_probs=199.1
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999988764444455566788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 93 mEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|||+++|+|.+++.. ...+++..+..++.|++.|+ +||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~- 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence 999999999988853 34589999999999999997 6999999999999999998865331
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc--HHHHHHHHHhCC-CCCC-CCCCHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD-FKLP-KWLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~-~~~p-~~~s~~~ 229 (426)
........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.... .......+.... ++.+ ..++..+
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred -hHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1223345789999999999887764 88999999999999999999996543 234444444332 2222 3578899
Q ss_pred HHHHHHccccCcCCCCChHHHhcC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.++|.+||+.+|++|||+.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=295.15 Aligned_cols=239 Identities=31% Similarity=0.472 Sum_probs=195.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEE-----
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA----- 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~----- 84 (426)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 35679999999999999999999999999999999876432 1135678899999999 6999999999873
Q ss_pred eCCeEEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
.....|+||||+++++|.+++.. ...+++..++.++.|++.|+ +||+++.++.+||+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 34679999999999999998753 35689999999999999986 699999999999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhcc-----CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-- 218 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-- 218 (426)
+..... .........|++.|+|||++.. ..+ +.++||||+||++|+|++|+.||...+.......+....
T Consensus 171 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 171 SAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred eeeccc--CCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 875432 1122344579999999999853 234 478999999999999999999998766544433333222
Q ss_pred -CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
...|..++..+.+||.+||+.||++|||+.++++|+||
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22345578899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.00 Aligned_cols=250 Identities=30% Similarity=0.589 Sum_probs=225.4
Q ss_pred cccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEE
Q 014359 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 84 (426)
+.+.++.+.+|.+++.||+|+|++|-+++.++|.+.||+|+++++...+....+.++.|-.+...- +||.+|-++.+|.
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 345567788999999999999999999999999999999999998887777788999999998777 6999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
++..+++|.||++||+|--.++.+++++|++|+.|-..|+.|| +|+|+|..|++||+|+|+.+-
T Consensus 322 tesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke- 400 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE- 400 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc-
Confidence 9999999999999999988888889999999999999999996 799999999999999999983
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC-------cc-HHHHHHHHHhCCCCC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-------RN-LAVLYQKIFRGDFKL 221 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-------~~-~~~~~~~i~~~~~~~ 221 (426)
...+.....+.||||.|.|||++.+..| |..+|+|+|||+++||++|+.||+- .+ ..-+++-|......+
T Consensus 401 -~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 401 -GLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred -CCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 3345566789999999999999999988 6999999999999999999999952 22 344677788889999
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCC------hHHHhcCcCCcc
Q 014359 222 PKWLSPGAQNLLRKILEPNPVKRIT------IAGIKADEWFEQ 258 (426)
Q Consensus 222 p~~~s~~~~~Li~~~L~~dP~~R~t------~~~il~h~w~~~ 258 (426)
|..+|..+..+++..|++||.+|.. +.++..|+||..
T Consensus 479 prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 9999999999999999999999874 789999999974
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=293.83 Aligned_cols=234 Identities=31% Similarity=0.468 Sum_probs=190.8
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeC--CeEEEE
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SKIYMV 92 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV 92 (426)
|++.+.||+|+||.||+|.+..+++.||+|.+....... . .....+|+.+++++. ||||+++++++.+. +..|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999987543221 1 223457888998885 99999999999887 889999
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+. |+|.+.+.. ...+++..++.++.|++.|| +||+++. +.+||+|||++..... ..
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---KP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---CC
Confidence 99997 588888875 35789999999999999997 6999999 9999999999985432 12
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC------------------C
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------D 218 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~ 218 (426)
......+++.|+|||++....+.+.++||||+||++|+|++|..||.+.+..+.+..+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2234568999999998766555568999999999999999999999887665544433210 1
Q ss_pred CCCC-----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 ~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
..+| ..++..+.+||.+||++||++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=300.77 Aligned_cols=245 Identities=29% Similarity=0.447 Sum_probs=195.5
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----C
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----S 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 87 (426)
-++|++.+.||+|+||.||+|.+..+|+.||||.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 368999999999999999999999999999999986422 223356788899999999999999999987654 3
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
..|++|||+. ++|.+.+.. .++++..++.++.|++.|| +|||++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5899999996 489888754 5799999999999999997 6999999999999999999854332
Q ss_pred cC-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh---------------
Q 014359 153 RD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--------------- 216 (426)
Q Consensus 153 ~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------- 216 (426)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 11223467899999999976644446899999999999999999999987654332221110
Q ss_pred --------C---CCC-----CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 217 --------G---DFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 217 --------~---~~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
. ... ..+..++++.+||.+||+.||++|||+.++++||||.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 000 01235788999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=288.38 Aligned_cols=240 Identities=29% Similarity=0.474 Sum_probs=206.5
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
.+|++.+.||+|++|.||+|.+..+++.||||.+...... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765422 34578999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||+++++|.+++.....+++..+..++.|++.|+ +||+++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT--LDQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC--CCc
Confidence 9999999999998878899999999999999996 6999999999999999999865331 122
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc---cHHHHHHHHHhC-CCCCCCC-CCHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRG-DFKLPKW-LSPGAQNL 232 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~L 232 (426)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...+....+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 235578999999999887755 48999999999999999999999876 344455554433 3344555 88999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCcc
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
|.+||.++|++|||+.++++|||++.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=293.71 Aligned_cols=237 Identities=30% Similarity=0.414 Sum_probs=194.7
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
|++.+.||.|++|.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999988999999999976532 222345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 96 VTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 96 ~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
+. ++|.+++.... .+++..+..++.|++.|| +||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 69999997755 799999999999999997 6999999999999999999754321 1222
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--------------------
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------- 218 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------- 218 (426)
....+++.|+|||++.+....+.++||||+||++|+|++|++||...+.......+.+..
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334678999999998765544588999999999999999999998766543332222110
Q ss_pred ---------CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 ---------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 ---------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
....+.++..+.++|.+||++||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=293.71 Aligned_cols=239 Identities=27% Similarity=0.373 Sum_probs=190.9
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999875432 22234677899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+. ++|.+.+.. ...+++..++.++.|++.|| +|||++.++.+||+|||+++..... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQ 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CC
Confidence 99995 678777654 45688999999999999996 6999999999999999999854321 22
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHHh--CC------------C--
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFR--GD------------F-- 219 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~--~~------------~-- 219 (426)
......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+.. +....+.. +. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2344568999999999876543457899999999999999999999865432 22221110 00 0
Q ss_pred -------CCC---------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 220 -------KLP---------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 220 -------~~p---------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
..+ ...++.+.+++.+||..||++|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 0125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=298.68 Aligned_cols=239 Identities=24% Similarity=0.413 Sum_probs=201.7
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
..|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.++++++||||+++++++......|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 357778899999999999999988999999999875432 233567899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++++|.+++.. +++++..++.++.|++.|+ +||++++++.+||+|||++...... ....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence 99999999998865 5799999999999999996 6999999999999999999854331 1122
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKIL 237 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L 237 (426)
....|+..|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+..+ ....+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 345689999999999887764 8999999999999999999999876555444444333 23344557889999999999
Q ss_pred ccCcCCCCChHHHhcCcCCcc
Q 014359 238 EPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 238 ~~dP~~R~t~~~il~h~w~~~ 258 (426)
+.+|++|||+.++++||||..
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHH
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=297.91 Aligned_cols=242 Identities=24% Similarity=0.404 Sum_probs=203.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
..|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45666788999999999999998899999999986532 233567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++++|.+++.. +++++..+..++.||+.|+ +||++++++.+||+|||++..... .....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~--~~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKR 175 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc--ccccC
Confidence 99999999998854 5699999999999999996 699999999999999999875432 12223
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHHHHHH
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~ 235 (426)
....|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+....+..+.... ...+..++..+.++|.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 456789999999999877764 89999999999999999999998877665555444322 12223478899999999
Q ss_pred ccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 236 ILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
||..||++|||++++++||||.....|
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999875444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.62 Aligned_cols=238 Identities=26% Similarity=0.400 Sum_probs=207.5
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
|.-++.||.|+||.||.|++..+.+.||||.+...........+.+.+|+..|+.++|||+|.+-++|.-+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56678999999999999999999999999999876655555578899999999999999999999999999999999999
Q ss_pred cCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 96 VTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 96 ~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
|- |+-.|++. ...++.+.++..++.+.+.|| -||||++.|.|||+|||.|.+..+ ..
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 95 58888886 356899999999999999997 499999999999999999986543 45
Q ss_pred cccCCCcccchhhhc---cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-CC-CCCCHHHHHHHH
Q 014359 160 TTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-KWLSPGAQNLLR 234 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~---~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~Li~ 234 (426)
+++|||+|||||++. ...|+ -++||||||++..||.-.++|+-..|....+..|..+..+ ++ +.+|..+++|+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 789999999999974 23465 6899999999999999999999888887777777766543 33 347899999999
Q ss_pred HccccCcCCCCChHHHhcCcCCccCCC
Q 014359 235 KILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
.||++-|..|||.++++.|+|......
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccCCC
Confidence 999999999999999999999876543
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=284.98 Aligned_cols=240 Identities=33% Similarity=0.518 Sum_probs=205.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMV 92 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 92 (426)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ..+|++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999889999999999765432 33467899999999999999999999999988 899999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|||+++++|.+++.....+++..+..++.|++.|+ +||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998877999999999999999996 699999999999999999986544222112
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHHHH--hCCCCCCCCCCHHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIF--RGDFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~Li~ 234 (426)
.....++..|+|||.+.+..+ +.++||||+|+++|+|++|..||...+ .......+. ......|..++..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999887765 489999999999999999999998765 223333333 2334566778999999999
Q ss_pred HccccCcCCCCChHHHhcCcCC
Q 014359 235 KILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+||+.||++||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=306.16 Aligned_cols=232 Identities=27% Similarity=0.379 Sum_probs=185.8
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
..+|++.+.||+|+||.||+|.+..+++.||+|+.... ...+|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 45799999999999999999999999999999975432 234699999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+. ++|.+++.. ..++++..++.++.||+.|| +|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 99995 588888865 45799999999999999997 699999999999999999974322 22
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcC-CCCCCCccHH----------HHHHHHHh---CCCCCC
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLA----------VLYQKIFR---GDFKLP 222 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~----------~~~~~i~~---~~~~~p 222 (426)
......||+.|+|||++.+..+. .++||||+||++|+|+++ ..+|...... .+...+.. ....+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 23456799999999999888775 899999999999999985 4444432110 11111110 000011
Q ss_pred ------------------------------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 223 ------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 223 ------------------------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 125677888999999999999999999999999975
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=293.76 Aligned_cols=233 Identities=27% Similarity=0.460 Sum_probs=191.8
Q ss_pred ccccCEEEecee--eecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 11 MRLGRYELGRTL--GEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~L--G~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
...++|++.+.+ |+|+||.||++.+..++..+|+|++....... .|+.....+ +||||+++++.+...+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 346788888877 99999999999999999999999987543211 122222222 7999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFGla~~~~~ 151 (426)
..|+||||+++|+|.+++....++++..++.++.|++.|+ +||+++.++ .++|+|||++.....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999999999999998877999999999999999996 699999998 999999999874322
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH----HHHHHHhCCCCCCCCCCH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSP 227 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~ 227 (426)
.....|++.|+|||++.+..++ .++||||+||++|+|++|+.||....... ..........+.++.+++
T Consensus 163 ------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T PHA03390 163 ------PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSK 235 (267)
T ss_pred ------CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCH
Confidence 2234689999999999887775 89999999999999999999998654322 122222334455667999
Q ss_pred HHHHHHHHccccCcCCCCC-hHHHhcCcCCcc
Q 014359 228 GAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ 258 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t-~~~il~h~w~~~ 258 (426)
.+.+||.+||+.||.+||+ ++++++||||..
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 9999999999999999996 699999999963
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=287.30 Aligned_cols=232 Identities=41% Similarity=0.757 Sum_probs=207.6
Q ss_pred eeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCCh
Q 014359 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L 101 (426)
||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.++...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999876554444567899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCc
Q 014359 102 FDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166 (426)
Q Consensus 102 ~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~ 166 (426)
.+++.....+++..+..++.|++.|+ +||+++.++.++|+|||++...... ........++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--GSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--CCcccCCcCCcc
Confidence 99999887899999999999999997 6999999999999999999854331 123445678999
Q ss_pred ccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCC
Q 014359 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 246 (426)
Q Consensus 167 Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t 246 (426)
|+|||.+.+... +.++|+||||+++|++++|..||...+....+..+.....++|..++..+.++|++||..||++|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999887765 4889999999999999999999988887777777777788888889999999999999999999999
Q ss_pred h---HHHhcCcCC
Q 014359 247 I---AGIKADEWF 256 (426)
Q Consensus 247 ~---~~il~h~w~ 256 (426)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.97 Aligned_cols=238 Identities=34% Similarity=0.580 Sum_probs=208.1
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++|||++++++.+......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 68999999999999999999988999999999976543 22345778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 95 YVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 95 y~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|+++++|.+++... ..+++..+..++.|++.|+ +||+++.+++++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999764 6799999999999999996 69999999999999999998654321
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLR 234 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~ 234 (426)
......+|++.|+|||.+.+..+. .++|+||+|+++++|++|..||...+............ .++|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 234456899999999998887764 88999999999999999999999887777666665543 4456678999999999
Q ss_pred HccccCcCCCCChHHHhcCcCC
Q 014359 235 KILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+||..||++|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=291.49 Aligned_cols=240 Identities=22% Similarity=0.386 Sum_probs=192.5
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HhcCCCCCccceeEEEEeCCeEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
++|++.+.||+|+||.||+|.+..+|+.||+|.++...... ....+..|+.+ ++.++||||+++++++..++..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987653222 23455556665 6677899999999999999999999
Q ss_pred EcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 93 mEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
|||++ |+|.+++.. ...+++..++.++.|++.|+ +|||++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99996 588777753 34699999999999999986 699999999999999999985432
Q ss_pred cCCCccccccCCCcccchhhhcc----CCCCCchhhHHHHHHHHHHHhcCCCCCCCc-cHHHHHHHHHhC-CCCCC-CCC
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRG-DFKLP-KWL 225 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~-~~~~p-~~~ 225 (426)
........|+..|+|||++.+ ..+ +.++|+||+||++|+|++|+.||... +..+.......+ ....| ..+
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 157 --SVAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred --ccccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 112233578999999999865 233 47899999999999999999999753 222223333332 33344 347
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
|.++.++|.+||..+|++|||+.++++||||....
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 89999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.24 Aligned_cols=242 Identities=28% Similarity=0.439 Sum_probs=196.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 86 (426)
..++|++.+.||+|+||.||+|.+..+++.||||.+.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45789999999999999999999999999999999865432 233346778899999999999999999998643
Q ss_pred -CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
...|+||||+. ++|.+.+... +++..+..++.|++.|| +||+++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 35799999995 5898888654 99999999999999997 69999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-------------
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 217 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 217 (426)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+....+..+...
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 2223456789999999999888775 8999999999999999999999876644333332110
Q ss_pred ---------CCC--------------C-------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 218 ---------DFK--------------L-------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 218 ---------~~~--------------~-------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
... . +...+..+.+||.+||+.||++|||+.+++.||||...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 000 0 1123567899999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=300.96 Aligned_cols=243 Identities=26% Similarity=0.382 Sum_probs=197.7
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----C
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----S 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 87 (426)
..+|.+.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3589999999999999999999999999999999875432 222245677899999999999999999988644 3
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
..|+||||+. ++|.+++...+++++..+..++.|++.|+ +||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999995 69999998888899999999999999997 6999999999999999999854331
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh----------------
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------- 216 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------- 216 (426)
........+|..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+....+..+..
T Consensus 162 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 162 --GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred --cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 12334557899999999987644446899999999999999999999987654322221110
Q ss_pred -------C-----CC---CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 217 -------G-----DF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 217 -------~-----~~---~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
. .. ...+.+++++.+||++||+.||++|||++++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00 0123578999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.15 Aligned_cols=231 Identities=31% Similarity=0.540 Sum_probs=191.9
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEE-EEe---C---
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV-LAS---K--- 86 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~---~--- 86 (426)
+++|.+.|.+|||+.||+|.+...|..||+|++-.. ++...+.+++||.+|+.|+ |||||.++|. ... .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 578899999999999999999888899999988654 5666889999999999997 9999999993 221 1
Q ss_pred CeEEEEEcccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH-----------------hheeeCCCCCEEEeccCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL-----------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al-----------------eNILld~~g~lKl~DFGla~ 147 (426)
-.++|.||||.||.|-|++.. +.+|+|.++.+||+|++.|+ |||||..+|+.||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 258899999999999999974 45799999999999999995 89999999999999999998
Q ss_pred CCCcccCC--C-----ccccccCCCcccchhhhc---cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC
Q 014359 148 LPQHFRDD--G-----LLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 217 (426)
Q Consensus 148 ~~~~~~~~--~-----~~~~~~gt~~Y~APE~l~---~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 217 (426)
-....... + ..-....|+.|+|||.+. +.+. +.|+|||+|||+||.|+....||++... -.|..+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEec
Confidence 42221100 0 001235799999999863 4455 5999999999999999999999987532 246678
Q ss_pred CCCCCC--CCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 218 DFKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 218 ~~~~p~--~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+.+|+ .++..+.+||+.||+.||++||++.|++.+
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 888775 589999999999999999999999998764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=313.55 Aligned_cols=247 Identities=31% Similarity=0.595 Sum_probs=227.9
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
..+.+.+.+++.+||-|+||.|=++........+|+|++++...-+.+..+.+..|-+||..++.|.||++|..|.+...
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 34667889999999999999999988755555699999998877777778889999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+|++||-|-||+|...+..++.|++..+++|+.-++.|+ ||+|||.+|.+||.|||+|+...
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--- 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--- 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---
Confidence 999999999999999999999999999999999999995 89999999999999999999654
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQN 231 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 231 (426)
.....-+.||||.|+|||++.+++++ .++|.||||+++||||+|.+||.+.++...|..|++| ...+|..++..+.+
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD 650 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence 46677899999999999999999997 8999999999999999999999999999999999998 57889999999999
Q ss_pred HHHHccccCcCCCCC-----hHHHhcCcCCccC
Q 014359 232 LLRKILEPNPVKRIT-----IAGIKADEWFEQD 259 (426)
Q Consensus 232 Li~~~L~~dP~~R~t-----~~~il~h~w~~~~ 259 (426)
||+++...+|.+|.. +.+|.+|.||...
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 999999999999996 8999999999763
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=295.68 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=204.1
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
+...++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 445689999999999999999999998899999999986432 22246788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+|+||+++++|.+++.+ ..+++..+..++.|++.|+ +||+++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~-- 168 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 168 (293)
T ss_pred EEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--
Confidence 999999999999999875 4689999999999999996 6999999999999999998754332
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh-CCC--CCCCCCCHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDF--KLPKWLSPGAQN 231 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~--~~p~~~s~~~~~ 231 (426)
........|++.|+|||.+.+..+ +.++|+|||||++|++++|+.||...+.......+.. +.. ..+..++..+.+
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence 222334578999999999987766 4899999999999999999999987665443333322 222 223447889999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+|++||+.+|++||++.+++.|+||....
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=292.09 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=199.3
Q ss_pred ccccCEEEeceeeecCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..+..|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 35678999999999999999999853 356789999987432 233346788999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhC-----------------CCCCHHHHHHHHHHHHHHH---------------hheeeCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASK-----------------GRLQEAEGRKLFQQLIDGL---------------ENILLDS 134 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~-----------------~~l~e~~~~~~~~ql~~al---------------eNILld~ 134 (426)
...|+||||+++|+|.+++... ..+++..+..++.|++.|+ +|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999998532 2478889999999999997 6999999
Q ss_pred CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHH
Q 014359 135 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 213 (426)
Q Consensus 135 ~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 213 (426)
++.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999985433222222344556788999999987766 489999999999999998 9999988776666655
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 214 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 214 i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+... .++.|..+++.+.+++.+||+.||++||++.+|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5544 345667799999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=296.25 Aligned_cols=242 Identities=25% Similarity=0.377 Sum_probs=200.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
...+|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34679999999999999999999988999999999875544444445678999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
||||+. |+|.+.+.. ..++++..+..++.|++.|+ +||+++.++.+||+|||++.....
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---- 167 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence 999997 577777653 45799999999999999997 699999999999999999874322
Q ss_pred CccccccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCC-CCCCCHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKL-PKWLSPGAQN 231 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~s~~~~~ 231 (426)
.....|++.|+|||++.+ ....+.++||||+|+++|+|++|+.||.+.+.......+.... +.. +..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred --CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 234578899999998742 2223589999999999999999999998877655444444332 222 2346889999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+|.+||..||++||++.+++.||||....
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=296.43 Aligned_cols=241 Identities=30% Similarity=0.452 Sum_probs=192.0
Q ss_pred CEEEeceeeecCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIY 90 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 90 (426)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ...|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999999864322333456788999999999999999999999888 8899
Q ss_pred EEEcccCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHH---------------hheeeCC----CCCEEEeccCCC
Q 014359 91 MVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGL---------------ENILLDS----KGNIKISDFGLS 146 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~al---------------eNILld~----~g~lKl~DFGla 146 (426)
+||||+.+ +|.+.+... ..+++..++.++.|++.|+ +|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999965 777776432 3689999999999999997 6999999 899999999999
Q ss_pred CCCCcccC-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH---------HHHHHH-
Q 014359 147 ALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---------LYQKIF- 215 (426)
Q Consensus 147 ~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~---------~~~~i~- 215 (426)
........ .......++|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543221 1123345789999999998775544589999999999999999999997543221 000000
Q ss_pred -------------------------hCCCCCC-----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 216 -------------------------RGDFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 216 -------------------------~~~~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
......+ ...+..+.++|.+||+.||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0001111 1467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=293.01 Aligned_cols=243 Identities=28% Similarity=0.411 Sum_probs=196.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4789999999999999999999988999999999865432 222346788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHH---------------hheeeCC-CCCEEEeccCCCCCCCcccC
Q 014359 93 LEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL---------------ENILLDS-KGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~al---------------eNILld~-~g~lKl~DFGla~~~~~~~~ 154 (426)
|||+. ++|.+.+..... +++..++.++.||+.|| +||+++. ++.+||+|||++..... .
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~--~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--P 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC--C
Confidence 99995 588888865443 58889999999999997 6999985 45799999999975432 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CC-------------
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF------------- 219 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~------------- 219 (426)
........+++.|+|||++.+....+.++||||+||++|+|++|+.||...+..+...++... .+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 122234567899999999877554458999999999999999999999876654444333210 00
Q ss_pred ------C--------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 220 ------K--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 220 ------~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
. ..+.+++.+.++|.+||+.||.+||++.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 012468889999999999999999999999999999864
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=298.37 Aligned_cols=232 Identities=31% Similarity=0.450 Sum_probs=178.4
Q ss_pred eceeeecCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE--eCCeEEEEEc
Q 014359 19 GRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMVLE 94 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lVmE 94 (426)
+..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .....|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999653 668899998865432 345778999999999999999999985 3567899999
Q ss_pred ccCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHH---------------hheee----CCCCCEEEeccCCC
Q 014359 95 YVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGL---------------ENILL----DSKGNIKISDFGLS 146 (426)
Q Consensus 95 y~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~al---------------eNILl----d~~g~lKl~DFGla 146 (426)
|+. ++|.+++... ..+++..++.++.||+.|| +|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 996 4888887521 2489999999999999997 79999 56679999999999
Q ss_pred CCCCcccC-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH---------HHHHHHHh
Q 014359 147 ALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------VLYQKIFR 216 (426)
Q Consensus 147 ~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---------~~~~~i~~ 216 (426)
+....... ........||+.|+|||++.+....+.++||||+||++|+|+||++||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 86543211 122345678999999999987655568999999999999999999999653211 00100000
Q ss_pred ----------------------------CCC----------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 217 ----------------------------GDF----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 217 ----------------------------~~~----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
... ......+..+.+||.+||..||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=296.09 Aligned_cols=242 Identities=25% Similarity=0.439 Sum_probs=202.8
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
.-|+....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 345566789999999999999988999999999865432 22466889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++++|.+++.. ..+++..++.++.|++.|+ +||+++.++.+||+|||++...... ....
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~ 174 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKR 174 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccc
Confidence 99999999987755 5799999999999999997 6999999999999999998754321 1223
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC---CCCCCCCHHHHHHHHH
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLRK 235 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~ 235 (426)
...+|++.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+..... ..+..++..+.++|.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 45679999999999987776 4899999999999999999999987776655555544322 2234578899999999
Q ss_pred ccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 236 ILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
||+.+|.+||++.++++||||.+...+
T Consensus 254 ~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 254 MLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred HhcCCcccCcCHHHHhhChhhccCCCc
Confidence 999999999999999999999875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=282.47 Aligned_cols=238 Identities=31% Similarity=0.507 Sum_probs=206.6
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.++++++|||++++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999889999999999866432 2345789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
|+++++|.+++....++++..++.++.|++.|+ +||+++.++.++|+|||++...... .....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC--ccccc
Confidence 999999999998888899999999999999996 6999999999999999999865432 22234
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHH-hCCCCCCCCCCHHHHHHHHHccc
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~Li~~~L~ 238 (426)
...++..|+|||.+.+..+ +.++||||+|+++|+|++|..||...+......... .....+|..++..+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 5678999999999877765 589999999999999999999998766544333333 34455677789999999999999
Q ss_pred cCcCCCCChHHHhcCcCC
Q 014359 239 PNPVKRITIAGIKADEWF 256 (426)
Q Consensus 239 ~dP~~R~t~~~il~h~w~ 256 (426)
.||++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=290.41 Aligned_cols=240 Identities=25% Similarity=0.428 Sum_probs=203.0
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
.|.-.+.||+|++|.||+|.+..+++.||+|.++... ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4555679999999999999998899999999886432 2234668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
|+++++|.+++.. .++++..+..++.|++.|+ +||+++.++.++|+|||++..... ......
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~--~~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK--EVPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc--CCcccc
Confidence 9999999999987 6799999999999999997 699999999999999998874432 112223
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCC---CCCCCHHHHHHHHHc
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGAQNLLRKI 236 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~Li~~~ 236 (426)
...|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......+.....+. +..++..+.++|++|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 45789999999999887764 89999999999999999999998877666666665543222 223788999999999
Q ss_pred cccCcCCCCChHHHhcCcCCccCCC
Q 014359 237 LEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
|+.||++|||+.++++||||.+...
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred cccChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=289.81 Aligned_cols=239 Identities=29% Similarity=0.430 Sum_probs=196.4
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYM 91 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 91 (426)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++.+ .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999998999999999875432 2345778999999999999999999998854 447899
Q ss_pred EEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
||||+++++|.+++.. ...+++..+..++.||+.|+ +||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999887653 34689999999999999996 699999999999999999875432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHHHHHHhCC-CCCC----
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRGD-FKLP---- 222 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~-~~~p---- 222 (426)
.......++..|+|||.+.+..++ .++|||||||++|+|++|..||... ...+....+.... ..++
T Consensus 158 ---~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 158 ---SLAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ---cccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 122345688999999999887775 8999999999999999999999865 2233444433321 1111
Q ss_pred --CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 223 --KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 223 --~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
...++.+.++|.+||..||++|||+.|++.||||...
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1246789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.35 Aligned_cols=239 Identities=21% Similarity=0.293 Sum_probs=196.4
Q ss_pred cccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
.-++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3468999999999999999999864 245679999886432 223346688999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEe
Q 014359 87 SKIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKIS 141 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~ 141 (426)
...++||||+++|+|.+++.... .++...+..++.|++.|+ +|||+++++.+||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999997532 356778889999999996 69999999999999
Q ss_pred ccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-C
Q 014359 142 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-F 219 (426)
Q Consensus 142 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~ 219 (426)
|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999875432111111223456789999999987766 489999999999999999 799999888777766665543 4
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 220 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 220 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..|..++..+.+++.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5667789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=308.96 Aligned_cols=233 Identities=33% Similarity=0.655 Sum_probs=203.2
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
-++||+|-||+||-|+++++|+.||||+|++.+..... ..++++|+.||+.+.||.||.+--.|++.+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 36899999999999999999999999999988776544 58899999999999999999999999999999999999965
Q ss_pred CChHHHHH--hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC---CEEEeccCCCCCCCcccCCCcc
Q 014359 99 GELFDKIA--SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---NIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 99 g~L~~~i~--~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g---~lKl~DFGla~~~~~~~~~~~~ 158 (426)
|..+.|- ..+++++...++++.||+.|| ||+||.+.. ++||||||+|++... ....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFR 723 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSFR 723 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhhh
Confidence 6666653 467899999999999999997 899997664 799999999997543 4456
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC--CC--CCHHHHHHHH
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--KW--LSPGAQNLLR 234 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~s~~~~~Li~ 234 (426)
.+..|||.|+|||++.+++|+ ..-|+||.|||+|.-|.|..||... +++-.+|.+..+-+| +| +++++.+||+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred hhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 788999999999999999997 8899999999999999999999753 244455655554444 45 8999999999
Q ss_pred HccccCcCCCCChHHHhcCcCCccC
Q 014359 235 KILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+|+..-.+|.|.++.+.|||++..
T Consensus 801 ~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999863
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=290.86 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=199.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 35789999999999999999997642 35589999886443 222345678899999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEe
Q 014359 87 SKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKIS 141 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~----------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~ 141 (426)
...|+||||+++|+|.+++... ...+...+..++.|++.|+ +|||++.++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999999753 2346678889999999986 69999999999999
Q ss_pred ccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CC
Q 014359 142 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF 219 (426)
Q Consensus 142 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~ 219 (426)
|||+++...............++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99998854321111112233457789999999877664 89999999999999998 89999988877777666554 34
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCChHHHhc------CcCCcc
Q 014359 220 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA------DEWFEQ 258 (426)
Q Consensus 220 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~------h~w~~~ 258 (426)
..|..+++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 556778899999999999999999999999986 888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=291.23 Aligned_cols=233 Identities=34% Similarity=0.522 Sum_probs=192.0
Q ss_pred EEeceeeecCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 17 ELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.+.+.||.|+||.||+|... ..+..|+||++... ......+.+.+|+..+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 57889999999999999987 35678999999543 2333468899999999999999999999999988889999
Q ss_pred EcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|||+++|+|.+++... ..+++.....++.|++.|| .|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 6799999999999999997 6999999999999999999855221111
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 233 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li 233 (426)
.......+...|+|||.+.+..+ +.++||||||+++||+++ |+.||.+.+..+...++.++. .+.|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 22334457789999999988776 499999999999999999 789999988888777776654 455677999999999
Q ss_pred HHccccCcCCCCChHHHhc
Q 014359 234 RKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~ 252 (426)
.+||..||.+|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=300.23 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=199.2
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe----CCeE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 89 (426)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875432 22335677889999999999999999998753 3568
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+. |+|.+++.....+++..++.++.|++.|| +||+++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 69999998878899999999999999997 699999999999999999975432211
Q ss_pred --CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh----------------
Q 014359 155 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------- 216 (426)
Q Consensus 155 --~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~---------------- 216 (426)
........|+..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 11223457899999999987644446899999999999999999999987654332221111
Q ss_pred ----------CCCCC-----CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 217 ----------GDFKL-----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 217 ----------~~~~~-----p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
..... .+..+.++.++|.+||+.||.+|||+.+++.||||.+...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 00111 13368999999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=284.29 Aligned_cols=241 Identities=29% Similarity=0.474 Sum_probs=201.9
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 89 (426)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999998864321 1233456889999999999999999999998764 568
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+++|||+++++|.+++...+.+++..++.++.|++.|+ +||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999996 699999999999999999985432111
Q ss_pred -CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHH
Q 014359 155 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQN 231 (426)
Q Consensus 155 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 231 (426)
........|+..|+|||.+.+..++ .++|+|||||++|+|++|+.||..........++... ...+|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1122345789999999999887764 8899999999999999999999877655544444432 34567789999999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCC
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+|.+||. +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=285.16 Aligned_cols=237 Identities=30% Similarity=0.503 Sum_probs=199.7
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++.+.||+|+||.||+|.+..+++.||+|.++..........+.+.+|+.++++++|+||+++++++...+..|+|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 47899999999999999999999889999999998754444444467899999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 93 mEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|||+++|+|.+++.. ...+++..+..++.|++.|+ +||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~- 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC-
Confidence 999999999999864 34589999999999999996 6999999999999999998754331
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc--HHHHHHHHHhCCC-CCCC-CCCHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDF-KLPK-WLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~ 229 (426)
........|++.|+|||.+.+..++ .++||||+||++|+|++|+.||.... .......+..+.. +.|. .++..+
T Consensus 160 -~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred -CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 2223456789999999999887775 88999999999999999999996543 3344455444432 3444 688899
Q ss_pred HHHHHHccccCcCCCCChHHHhc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.++|.+||..+|++|||+.+|++
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=286.96 Aligned_cols=233 Identities=30% Similarity=0.482 Sum_probs=192.4
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
-..||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+|+||+++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 458999999999999998899999999886542 23356789999999999999999999999999999999999999
Q ss_pred CChHHHHHhC-CCC--CHHHHHHHHHHHHHHH---------------hheeeCC-CCCEEEeccCCCCCCCcccCCCccc
Q 014359 99 GELFDKIASK-GRL--QEAEGRKLFQQLIDGL---------------ENILLDS-KGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 99 g~L~~~i~~~-~~l--~e~~~~~~~~ql~~al---------------eNILld~-~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
++|.+++... ..+ ++..+..++.|++.|+ +||+++. ++.+||+|||++...... .....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 167 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTE 167 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCccc
Confidence 9999999764 455 8889999999999997 6999986 679999999998754321 22233
Q ss_pred cccCCCcccchhhhccCC-CCCchhhHHHHHHHHHHHhcCCCCCCCccHH--HHHHH-HHhCCCCCCCCCCHHHHHHHHH
Q 014359 160 TTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQK-IFRGDFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~~~~~Li~~ 235 (426)
...|++.|+|||++.+.. ..+.++||||+|+++|+|++|+.||...... ..+.. .......+|..+++++.+|+.+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 456899999999986543 2358999999999999999999999754322 22221 2233455677899999999999
Q ss_pred ccccCcCCCCChHHHhcCcCC
Q 014359 236 ILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~ 256 (426)
||+.+|.+|||+.+++.||||
T Consensus 248 ~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=291.17 Aligned_cols=236 Identities=27% Similarity=0.398 Sum_probs=198.1
Q ss_pred ccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
..+|.+.+.||+|+||+||++.+. .++..||+|.+... .....+.+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 357999999999999999999852 34567999988643 2334567899999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCC-------------CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEE
Q 014359 88 KIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIK 139 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~-------------~l~e~~~~~~~~ql~~al---------------eNILld~~g~lK 139 (426)
..|+||||+++++|.+++...+ .+++..+..++.|++.|+ +|||+++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999997543 489999999999999997 699999999999
Q ss_pred EeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC
Q 014359 140 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 218 (426)
Q Consensus 140 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 218 (426)
|+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999854322111222334467889999999877664 89999999999999998 999999888777777777765
Q ss_pred -CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 219 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 219 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
...+..+++++.+|+.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3455668999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=289.96 Aligned_cols=239 Identities=24% Similarity=0.327 Sum_probs=197.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34689999999999999999999876 77889999886443 222345688999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHH---------------hheeeCCCC---CEEEe
Q 014359 87 SKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGL---------------ENILLDSKG---NIKIS 141 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~-------~l~e~~~~~~~~ql~~al---------------eNILld~~g---~lKl~ 141 (426)
...|+||||++|++|.+++...+ .+++..+..++.||+.|+ +|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999997643 489999999999999996 699998765 59999
Q ss_pred ccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CC
Q 014359 142 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF 219 (426)
Q Consensus 142 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~ 219 (426)
|||+++...............+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999854221111111122345689999999877764 89999999999999997 99999987776666655443 45
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 220 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 220 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..|..++..+.+++.+||+.||++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5667789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=297.63 Aligned_cols=249 Identities=30% Similarity=0.397 Sum_probs=200.7
Q ss_pred ccCEEE-eceeeecCceEEEEEEECCCCceEEEEEeecccccchh-----------HHHHHHHHHHHHhcCCCCCcccee
Q 014359 13 LGRYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------ITDQIKREIATLKLLKHPNVVRLH 80 (426)
Q Consensus 13 ~~~y~i-~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~HpnIv~l~ 80 (426)
-++|.. .+.||+|+||.||+|.+..+++.||||.+......... ....+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 467875 57799999999999999989999999998654322100 112577899999999999999999
Q ss_pred EEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 81 ~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
+++......|+||||+. |+|.+++.....+++..+..++.|++.|+ +||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999999996 59999998888899999999999999996 699999999999999999
Q ss_pred CCCCCccc------------CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH
Q 014359 146 SALPQHFR------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 213 (426)
Q Consensus 146 a~~~~~~~------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 213 (426)
+....... .........+++.|+|||.+.+....+.++||||+||++|+|++|..||.+.+....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 97543110 111223446788999999987765556899999999999999999999988776554443
Q ss_pred HHhC--CCC--------------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 214 IFRG--DFK--------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 214 i~~~--~~~--------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
+... .+. .....+..+.++|.+||+.||++|||+++++.||||+....+
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 3220 000 012357889999999999999999999999999999876444
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=288.55 Aligned_cols=237 Identities=30% Similarity=0.497 Sum_probs=198.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.++||||+++++++..++..|++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 47899999999999999999999889999999988764443444457888999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 93 mEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|||+++++|.+++.. ...+++..++.++.|++.|+ +||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 999999999998863 34689999999999999996 6999999999999999998865331
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH--HHHHHHHHhCCCC-C-CCCCCHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL--AVLYQKIFRGDFK-L-PKWLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~-~-p~~~s~~~ 229 (426)
.......+|++.|+|||.+.+..++ .++|+||||+++|+|++|..||.+... ......+.....+ . +..+++.+
T Consensus 160 -~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred -CcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 2223456799999999999887775 889999999999999999999976443 3444444433322 2 24588999
Q ss_pred HHHHHHccccCcCCCCChHHHhc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.++|.+||+.||++|||+.+|++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=290.37 Aligned_cols=244 Identities=32% Similarity=0.593 Sum_probs=204.3
Q ss_pred CEEEeceeeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 89 (426)
+|++.+.||+|+||.||+|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ +||||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 47899999999754322 223346788999999999 599999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+++++|.+++....++++..+..++.|++.|+ +|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 99999999999999998888899999999999999996 69999999999999999998543311
Q ss_pred CCccccccCCCcccchhhhccC-CCCCchhhHHHHHHHHHHHhcCCCCCCCc----cHHHHHHHHHhCCCCCCCCCCHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGA 229 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~ 229 (426)
.......+|+..|+|||.+.+. ...+.++||||+|+++|+|++|..||... ........+.....+.|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1223456799999999998653 23357899999999999999999999743 234445555556667777899999
Q ss_pred HHHHHHccccCcCCCC-----ChHHHhcCcCCccC
Q 014359 230 QNLLRKILEPNPVKRI-----TIAGIKADEWFEQD 259 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~-----t~~~il~h~w~~~~ 259 (426)
.+++.+||+.||++|| ++.+++.||||...
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=286.88 Aligned_cols=238 Identities=22% Similarity=0.350 Sum_probs=198.9
Q ss_pred ccCEEEeceeeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.++|++.+.||+|+||.||+|.+..+ ...||||.++... .......+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46799999999999999999998644 4579999987543 233356788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|++|||+++++|.+++.. .+.+++..+..++.|++.|+ +|||++.++.+||+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999976 34799999999999999997 69999999999999999998654211
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 231 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 231 (426)
.........+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...........+..+ ..+.|..++..+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11112223456789999999877764 89999999999999998 99999877766666666554 34556678999999
Q ss_pred HHHHccccCcCCCCChHHHhcC
Q 014359 232 LLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h 253 (426)
|+.+||+.||++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=294.94 Aligned_cols=238 Identities=26% Similarity=0.402 Sum_probs=196.1
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCce--EEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 86 (426)
...+++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 35678999999999999999999998777764 466665432 2333456788999999999 899999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hheeeCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENILLDSK 135 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNILld~~ 135 (426)
+.+|+||||+++|+|.+++...+ .+++..++.++.|++.|+ +|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997532 478999999999999996 69999999
Q ss_pred CCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHH
Q 014359 136 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 214 (426)
Q Consensus 136 g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 214 (426)
+.+||+|||++...... .......++..|+|||++.+..+ +.++|||||||++|+|+| |..||.+.+..+.+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 161 YVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred CcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 99999999998732211 11112234678999999877765 489999999999999998 99999888777777666
Q ss_pred HhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 215 FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 215 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..+ ....|..+++++.+||.+||+.||++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 544 234455688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.25 Aligned_cols=242 Identities=29% Similarity=0.452 Sum_probs=205.5
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
.+|.-.++||+|+||+||+|++..+++.||+|.+..+.. ++..-....|||.+|+.++|.|||+++++..++...-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 356777899999999999999999999999999976542 3444567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|||.. +|..+..+ ++.++.+.++.++.|++.|+ .|+|++.||.+|++|||+|+.+.- +.+.
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--pvrc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC--ceEe
Confidence 99955 89888876 56799999999999999997 699999999999999999996643 2333
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC--CC---------C-----
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DF---------K----- 220 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~---------~----- 220 (426)
......|.+|.+|.++.+...+++..|+||.|||+.|+.. |++.|++.+..+...+|... .+ .
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 4455779999999999998888899999999999999987 99999999888777776531 11 0
Q ss_pred ----CC---------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 221 ----LP---------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 221 ----~p---------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+| +.++..-++|++++|.-+|.+|++++.+++||||.+.
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 11 1145667899999999999999999999999999764
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=285.99 Aligned_cols=236 Identities=27% Similarity=0.405 Sum_probs=200.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
...+|++.+.||+|+||.||+|.+..+++.||+|.+..+. .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 4567999999999999999999998899999999986532 124678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+|||+++++|.+++... ..+++..++.++.|++.|+ +|||+++++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999999999753 3589999999999999997 699999999999999999985432111
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
.......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+.+..+..+ ....|..+++++.++
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (263)
T cd05052 160 -TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL 237 (263)
T ss_pred -eccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 111122346789999999887775 88999999999999998 99999988887777777654 455677789999999
Q ss_pred HHHccccCcCCCCChHHHhcC
Q 014359 233 LRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h 253 (426)
|.+||+.||++|||+.++++.
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHccCCcccCCCHHHHHHH
Confidence 999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=288.53 Aligned_cols=238 Identities=23% Similarity=0.311 Sum_probs=199.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 356899999999999999999987643 4789999986442 223346788999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEe
Q 014359 87 SKIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKIS 141 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~ 141 (426)
...|+||||+++|+|.+++.... .+++..+..++.|++.|+ +|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999999996532 367889999999999996 69999999999999
Q ss_pred ccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CC
Q 014359 142 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF 219 (426)
Q Consensus 142 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~ 219 (426)
|||+++...............+|..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999985433222222334567889999999877766 489999999999999998 99999988877777666654 34
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 220 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 220 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..|..++..+.++|.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567778999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=296.49 Aligned_cols=242 Identities=29% Similarity=0.374 Sum_probs=198.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 87 (426)
.-++|++.+.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3478999999999999999999999999999999986542 22333467889999999999999999999987653
Q ss_pred --eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 88 --~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
.+|+||||+ +++|.+++.. .++++..++.++.|++.|+ +||+++.++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 468999999 7799888764 5799999999999999996 69999999999999999998542
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-----------
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF----------- 219 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 219 (426)
. ......+++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+....+..+.....
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 2 223456899999999987644446899999999999999999999987665444433322111
Q ss_pred --------------------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 220 --------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 220 --------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
.....+++.+.++|.+||+.||++|||+.+++.||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 012357888999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=284.33 Aligned_cols=231 Identities=28% Similarity=0.407 Sum_probs=200.4
Q ss_pred ceeeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEccc
Q 014359 20 RTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~ 96 (426)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+.+++.++||||+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999998765 8899999997654322 4678999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 97 TGGELFDKIASK---------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 97 ~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
++++|.+++... ..+++..++.++.|++.|+ +||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 7799999999999999997 6999999999999999999865442
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 230 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 230 (426)
..........+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+ ....|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 22223445678899999999988766 489999999999999999 69999998887777777654 4566788999999
Q ss_pred HHHHHccccCcCCCCChHHHhcC
Q 014359 231 NLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+++.+||..||.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=298.61 Aligned_cols=241 Identities=29% Similarity=0.382 Sum_probs=199.4
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe---
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK--- 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--- 88 (426)
.-++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45789999999999999999999999999999999865422 22334677889999999999999999998866554
Q ss_pred ---EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 89 ---IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 89 ---~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
.|+|+||+ +++|.+++.. .++++..++.++.|++.|+ +||++++++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799998876 5799999999999999996 69999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC----------
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---------- 220 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------- 220 (426)
. ......+|+.|+|||.+.+....+.++||||+||++|+|++|+.||.+.+....+..+......
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred c-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 2 2345578999999999876544568999999999999999999999877665554443321100
Q ss_pred ---------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 221 ---------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 221 ---------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
....+++.+.+||.+||+.||++|||+.++++||||.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0123588999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=297.04 Aligned_cols=242 Identities=29% Similarity=0.399 Sum_probs=193.9
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC------
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 86 (426)
-++|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 3799999999999999999999999999999999875432 3356788999999999999999999876543
Q ss_pred --------CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCC-CCCEEEec
Q 014359 87 --------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDS-KGNIKISD 142 (426)
Q Consensus 87 --------~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~-~g~lKl~D 142 (426)
...|+||||+. ++|.+++.. +++++..++.++.||+.|+ +||+++. ++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999997 599888764 5799999999999999997 6999985 56799999
Q ss_pred cCCCCCCCcccC-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC---
Q 014359 143 FGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--- 218 (426)
Q Consensus 143 FGla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--- 218 (426)
||++........ ........|+..|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999975432111 1122334689999999987664445689999999999999999999998766544433332210
Q ss_pred ----------------------CC-----CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 219 ----------------------FK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 219 ----------------------~~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.. +.+.++.++.+||.+||+.||.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 113477889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=284.36 Aligned_cols=230 Identities=27% Similarity=0.429 Sum_probs=189.8
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 99 (426)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999998899999999886432 2334577899999999999999999999999999999999999999
Q ss_pred ChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 100 ELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 100 ~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
+|.+++... ..+++..++.++.|++.|| +|||++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 999999764 3689999999999999996 699999999999999999875332110100111123
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccccCc
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 241 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 241 (426)
+..|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+... ....|..++..+.+|+.+||+.||
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 4579999999877764 88999999999999998 99999876665555555443 445666789999999999999999
Q ss_pred CCCCChHHHhc
Q 014359 242 VKRITIAGIKA 252 (426)
Q Consensus 242 ~~R~t~~~il~ 252 (426)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=284.83 Aligned_cols=233 Identities=24% Similarity=0.421 Sum_probs=195.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 467999999999999999999874 4567999988644321 35688899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+++|+|.+++.. .+.+++..+..++.|++.|+ +||+++.++.+||+|||+++...... ..
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-ee
Confidence 999999999999975 35689999999999999997 69999999999999999988542211 11
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLR 234 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~ 234 (426)
......++..|+|||++.+..+. .++||||+|+++|+|++ |+.||...+..+....+..+. ...|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11122355689999999877764 89999999999999999 999999888877777777653 3446668899999999
Q ss_pred HccccCcCCCCChHHHhc
Q 014359 235 KILEPNPVKRITIAGIKA 252 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~ 252 (426)
+||+.||++|||++++++
T Consensus 236 ~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 SCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.89 Aligned_cols=243 Identities=24% Similarity=0.367 Sum_probs=196.3
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 92 (426)
..|++++.||+||.++||++..- ..+.||+|.+.... .+......+.+|+..|.+|+ |.+||+|+||-..++.+|+|
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 36999999999999999999863 44567777665433 25556789999999999995 99999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCH-HHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIASKGRLQE-AEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e-~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||=+ .||...|.......+ -..+.|.+|++.|+ .|.|+ -.|.+||+|||+|.........-
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccce
Confidence 99885 499999987665444 57888999999996 47766 36899999999999765544444
Q ss_pred ccccccCCCcccchhhhccCCCC----------CchhhHHHHHHHHHHHhcCCCCCCCc-cHHHHHHHHHhCC--CCCCC
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGD--FKLPK 223 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~----------~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~--~~~p~ 223 (426)
...+.+||+.||+||.+....+. +.++||||||||||+|+.|++||..- +...-+..|.... .++|.
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~ 596 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPD 596 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccC
Confidence 55678999999999998654332 67899999999999999999999763 3445555666543 45665
Q ss_pred CCCHH-HHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 224 WLSPG-AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 224 ~~s~~-~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.-+.. +.++++.||+.||++|||+.++|+|||++-..
T Consensus 597 ~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 597 IPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred CCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 54444 99999999999999999999999999987643
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=292.59 Aligned_cols=241 Identities=27% Similarity=0.434 Sum_probs=198.9
Q ss_pred CccccCEEEeceeeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 81 (426)
....++|.+++.||+|+||.||+|.+.. +...||+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3445899999999999999999998643 23569999997542 223356788899999999 7999999999
Q ss_pred EEEeCCeEEEEEcccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hhe
Q 014359 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENI 130 (426)
Q Consensus 82 ~~~~~~~~~lVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNI 130 (426)
++...+..|+||||+++|+|.+++.... .++...+..++.|++.|+ +||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997542 478899999999999996 699
Q ss_pred eeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHH
Q 014359 131 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 209 (426)
Q Consensus 131 Lld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 209 (426)
|++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999998754321111111222345789999999887664 89999999999999998 999999888777
Q ss_pred HHHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 210 LYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 210 ~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+..+..+. ...|..++.++.+||.+||..+|.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 777666554 45667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.78 Aligned_cols=239 Identities=26% Similarity=0.396 Sum_probs=193.3
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3457899999999999999999987533 3469999996543 2333567899999999996 999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhC--------------------------------------------------------
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~-------------------------------------------------------- 108 (426)
..+..|+||||+++|+|.+++...
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999988542
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHH---------------hheeeC
Q 014359 109 ----------------------------------------GRLQEAEGRKLFQQLIDGL---------------ENILLD 133 (426)
Q Consensus 109 ----------------------------------------~~l~e~~~~~~~~ql~~al---------------eNILld 133 (426)
..+++..+..++.|++.|+ +|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 2377888899999999996 699999
Q ss_pred CCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHH-HHH
Q 014359 134 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VLY 211 (426)
Q Consensus 134 ~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~-~~~ 211 (426)
.++.+||+|||+++...............+++.|+|||++.+..++ .++|||||||++|+|++ |..||...... ..+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999999854332221222344577899999999887764 89999999999999997 99999875543 333
Q ss_pred HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 212 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 212 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..+..+ ..+.|..++..+.+++.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 444433 34456678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=309.01 Aligned_cols=222 Identities=25% Similarity=0.400 Sum_probs=194.7
Q ss_pred EEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEccc
Q 014359 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~ 96 (426)
.-++-||+|+.|.||+|+. .++.||||.++. .-..+|+.|++|+|||||.+.++|.....+|||||||
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 3456799999999999985 678899996632 2235788999999999999999999999999999999
Q ss_pred CCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccc
Q 014359 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 161 (426)
Q Consensus 97 ~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~ 161 (426)
..|.|...++..+.+.......|..+|+.|+ -||||..+..+||+|||-++.... ....-.+
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh---hhhhhhh
Confidence 9999999999999999999999999999997 399999999999999999985433 2445678
Q ss_pred cCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHcccc
Q 014359 162 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 162 ~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~ 239 (426)
|||..|||||++.+.+.. .|+|||||||||||||||..||.+.+...+..-+-.+ .++.|..++..++=||+.||+-
T Consensus 272 aGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 999999999999998875 9999999999999999999999987776665554443 3577889999999999999999
Q ss_pred CcCCCCChHHHhcCc
Q 014359 240 NPVKRITIAGIKADE 254 (426)
Q Consensus 240 dP~~R~t~~~il~h~ 254 (426)
.|.+||++.||+.|-
T Consensus 351 KpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHL 365 (904)
T ss_pred CCCCCccHHHHHHHH
Confidence 999999999999884
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=288.26 Aligned_cols=238 Identities=32% Similarity=0.473 Sum_probs=196.6
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeEEEEE
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMVL 93 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lVm 93 (426)
|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++|||++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999899999999998654 2333356788999999999999999999999888 8999999
Q ss_pred cccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||+++ +|.+++... ..+++..++.++.|++.|+ +||++++++.+||+|||++....... ...
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~-~~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN-SAD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC-ccc
Confidence 99975 899888765 5799999999999999997 69999999999999999998654321 112
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--C----------------
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F---------------- 219 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~---------------- 219 (426)
.....++..|+|||.+.+....+.++||||+|+++|+|++|+.||...+.......+.... +
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 3345678899999987765444689999999999999999999998877655544443210 0
Q ss_pred -----CC-------CCC-CCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 220 -----KL-------PKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 220 -----~~-------p~~-~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
.. ... +++.+.++|++||..||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=294.13 Aligned_cols=238 Identities=21% Similarity=0.306 Sum_probs=195.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
...+|++.+.||+|+||.||+|.+..+++. ||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 346799999999999999999997666554 8999986432 233456788999999999999999999998764
Q ss_pred eEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..++++||+++|+|.+++... ..+++..+..++.|++.|| +|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 578999999999999999864 4689999999999999997 699999999999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 229 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 229 (426)
...........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+....+....+..+ ..+.|..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2211112233456789999999887775 89999999999999998 99999987766554444333 345567789999
Q ss_pred HHHHHHccccCcCCCCChHHHhcC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+++.+||..||++|||+.+++.+
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=291.29 Aligned_cols=243 Identities=29% Similarity=0.431 Sum_probs=193.2
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 86 (426)
.+++|++.+.||+|+||.||+|.+..+++.||||.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 4799999999999999999999999999999999987543222 1234567899999999999999999987443
Q ss_pred ---CeEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCC
Q 014359 87 ---SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 87 ---~~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~ 147 (426)
..+|+||||+.+ +|...+.. ...+++..++.++.|++.|| +||++++++.+||+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 357999999965 77777764 45799999999999999997 69999999999999999998
Q ss_pred CCCcccCC---------CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC
Q 014359 148 LPQHFRDD---------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 218 (426)
Q Consensus 148 ~~~~~~~~---------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 218 (426)
........ .......|++.|+|||.+.+....+.++||||+||++|+|++|++||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54332111 112234678899999998765444689999999999999999999999877665544433210
Q ss_pred --C---------------------CCC-------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 --F---------------------KLP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 --~---------------------~~p-------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+ ..| ..+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 000 1245788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=296.57 Aligned_cols=246 Identities=33% Similarity=0.418 Sum_probs=203.9
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----eE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 89 (426)
+|++.+.||+|+||.||+|.+..+++.||||.+..... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 69999999999999999999988999999999875431 2333577899999999999999999999987765 78
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|++|||+. ++|.+.+....++++..++.++.||+.|+ +|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 58999998877899999999999999997 699999999999999999986543211
Q ss_pred -CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-------------
Q 014359 155 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------- 220 (426)
Q Consensus 155 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------- 220 (426)
........+|+.|+|||++.+....+.++|+||+||++|+|++|++||.+.+..+.+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 022344568999999999988733458999999999999999999999987766655554431100
Q ss_pred ------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 221 ------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 221 ------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
..+.+++++.+||.+||+.||.+|||+++++.||||+....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 112367889999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=286.30 Aligned_cols=236 Identities=26% Similarity=0.352 Sum_probs=194.6
Q ss_pred EEEeceeeecCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe----
Q 014359 16 YELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK---- 88 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 88 (426)
|++++.||+|+||.||+|.... ++..||||.+..+.. .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5788999999999999998754 347899999875433 23335678999999999999999999998865443
Q ss_pred --EEEEEcccCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 89 --IYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 89 --~~lVmEy~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
.+++|||+++|+|..++... ..+++..+..++.|++.|| +||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988532 3689999999999999997 699999999999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCC
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 223 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 223 (426)
++...............++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+.+..+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 985433211112223345778999999877766 489999999999999999 99999988777777666654 455677
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.++..+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=338.47 Aligned_cols=244 Identities=32% Similarity=0.502 Sum_probs=212.0
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|.-+..||.|.||+||.|.+..+|+..|+|-+...... ......+.+|..++..++|||+|++|++-.+++..||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 678889999999999999999999999999988765443 4446789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc--CCCc
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR--DDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~--~~~~ 157 (426)
||+||+|.+.++..+-.+|...+.|..|++.|+ +||+|+.+|.+|++|||.|......- -.+.
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999999999999877789999999999999997 69999999999999999998654321 1234
Q ss_pred cccccCCCcccchhhhccCC--CCCchhhHHHHHHHHHHHhcCCCCCCCcc--HHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~--~~~~~~DIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
+....|||.|||||++.+.. -++.++||||+|||..||+||+.||..-+ ..-+|.--....+++|..+|++.++||
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence 55678999999999997653 23578999999999999999999998643 345555555557889999999999999
Q ss_pred HHccccCcCCCCChHHHhcCcCCccC
Q 014359 234 RKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+||..||++|.++.|+++|.|-+..
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHhcCchhhhHHHHHHHhhccccc
Confidence 99999999999999999999987654
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.12 Aligned_cols=240 Identities=22% Similarity=0.359 Sum_probs=193.9
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+|+|++.+.||+|+||.||+|.+..+++.||||++...........+++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999999765444444567899999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhC-----------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCC
Q 014359 93 LEYVTGGELFDKIASK-----------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~-----------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla 146 (426)
|||++||+|.+++... .+++...+..++.||+.|| +|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988641 2355667888999999996 7999999999999999999
Q ss_pred CCCCcccC----------------CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHH
Q 014359 147 ALPQHFRD----------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL 210 (426)
Q Consensus 147 ~~~~~~~~----------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~ 210 (426)
........ .......+||+.|+|||++.+..++ .++||||+||++|+|++|..||...+....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 86521100 0111235799999999999888774 899999999999999999999987654433
Q ss_pred HHH-HHhCCCCC--CCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 211 YQK-IFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 211 ~~~-i~~~~~~~--p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
... ........ ...+++.+.+++.+||+.||++|++..+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222 11111111 23578999999999999999999886665543
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=277.37 Aligned_cols=234 Identities=32% Similarity=0.509 Sum_probs=199.2
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++||||+++++++......|+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999988999999999976532 335789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 95 YVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 95 y~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
|+++++|.+++... ..+++..+..++.|++.|+ +||++++++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999999875 5799999999999999997 699999999999999999985433111 3
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh-CCCCCCCC--CCHHHHHHHHH
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFKLPKW--LSPGAQNLLRK 235 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~~~p~~--~s~~~~~Li~~ 235 (426)
....|+..|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...+.......... .....+.. ++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999987765 4889999999999999999999988754433333322 22223322 48999999999
Q ss_pred ccccCcCCCCChHHHhcCcC
Q 014359 236 ILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w 255 (426)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=288.18 Aligned_cols=240 Identities=28% Similarity=0.449 Sum_probs=205.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999988899999999975432 35678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
++||+++++|.+++.... .+++..+..++.|++.|+ +||+++.++.++|+|||++...... .
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--~ 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--K 170 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--h
Confidence 999999999999998866 899999999999999996 6999999999999999998754321 1
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCC--CCCCCHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKL--PKWLSPGAQNL 232 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~--p~~~s~~~~~L 232 (426)
.......+++.|+|||++.+..++ .++|+||+||++|+|++|+.||...+.......+.... ... +..++..+.++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 122345688999999999887764 89999999999999999999998876655444444332 222 23378999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCcc
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
|.+||+.+|.+|||+.++++|+||.+
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=289.33 Aligned_cols=244 Identities=29% Similarity=0.448 Sum_probs=196.5
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC--
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 87 (426)
...+++|++.+.||+|+||.||+|.+..+++.||+|.++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3567899999999999999999999998999999999975432 1222356788999999999999999999987654
Q ss_pred --------eEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEecc
Q 014359 88 --------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDF 143 (426)
Q Consensus 88 --------~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DF 143 (426)
.+|+|+||+++ +|.+.+... ..+++..++.++.|++.|| +||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999976 777777653 4699999999999999996 6999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCC-
Q 014359 144 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK- 220 (426)
Q Consensus 144 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~- 220 (426)
|++........ .......+++.|+|||.+.+....+.++||||+||++|+|++|++||...+....+..+... ...
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99986533211 12223456889999999876544468999999999999999999999877655544443321 000
Q ss_pred ---------------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 221 ---------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 221 ---------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
....++..+.++|.+||..||++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 012368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=288.69 Aligned_cols=240 Identities=23% Similarity=0.356 Sum_probs=201.1
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
+.+.+|++.+.||+|+||.||+|.+..+ ++.||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456789999999999999999987543 5789999997543 23345678899999999999999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHH---------------hheeeCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGL---------------ENILLDS 134 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~al---------------eNILld~ 134 (426)
....++++||+.+++|.+++... ..+++..+..++.|++.|+ +|||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999998532 3488899999999999997 6999999
Q ss_pred CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHH
Q 014359 135 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 213 (426)
Q Consensus 135 ~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 213 (426)
++.+||+|||+++...............+++.|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+....
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999885433222222334456789999999987766 488999999999999998 9999998888777777
Q ss_pred HHhCCC-CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 214 IFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 214 i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+..+.. +.|..++..+.+|+.+||+.+|.+||++++|+..
T Consensus 239 i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 776653 4577799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=287.86 Aligned_cols=238 Identities=27% Similarity=0.399 Sum_probs=198.1
Q ss_pred ccccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
...++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 34678999999999999999999854 345679999886432 2334678899999999999999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hheeeCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENILLDS 134 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNILld~ 134 (426)
....++||||+++++|.+++.... .+++..++.++.||+.|+ +|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999997532 388999999999999997 6999999
Q ss_pred CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHH
Q 014359 135 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 213 (426)
Q Consensus 135 ~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 213 (426)
++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999754322111222344578899999999887764 88999999999999999 9999988777777776
Q ss_pred HHhCCC-CCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 214 IFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 214 i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+..+.. ..+..++..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 666543 345568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=289.34 Aligned_cols=240 Identities=28% Similarity=0.454 Sum_probs=199.7
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 84 (426)
...++|++.+.||+|+||.||+|.+... ...||+|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3457899999999999999999987643 3789999987543 223356788999999999 7999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHh----------------CCCCCHHHHHHHHHHHHHHH---------------hheeeC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLFQQLIDGL---------------ENILLD 133 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~----------------~~~l~e~~~~~~~~ql~~al---------------eNILld 133 (426)
..+..|++|||+++|+|.+++.. ...+++..+..++.|++.|+ +|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 99999999999999999999964 24589999999999999997 699999
Q ss_pred CCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHH
Q 014359 134 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 212 (426)
Q Consensus 134 ~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~ 212 (426)
.++.+||+|||+++...............++..|+|||++.+..++ .++||||+||++|+|++ |..||.+.+..+.+.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999865432111112223456789999998877764 88999999999999998 999999888777777
Q ss_pred HHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 213 KIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 213 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+..+. ...|..++..+.+|+.+||..||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 766553 35566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=284.89 Aligned_cols=233 Identities=26% Similarity=0.426 Sum_probs=198.8
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
-.+|++++.||+|+||.||+|.+.. ++.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4579999999999999999999876 8899999987653 22246788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|||+++|+|.+++.+. ..+++..++.++.||+.|+ +||++++++.+||+|||++..... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~--~~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE--DV 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC--cc
Confidence 9999999999999753 4689999999999999997 699999999999999999975432 11
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 233 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 233 (426)
.......++..|+|||++.+..+. .++||||||+++|+|++ |+.||...+..+.+..+..+ ..+.|..+++.+.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 112234467789999999877664 88999999999999998 89999988777777776654 3455677899999999
Q ss_pred HHccccCcCCCCChHHHhc
Q 014359 234 RKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~ 252 (426)
.+||+.||.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=296.07 Aligned_cols=248 Identities=30% Similarity=0.403 Sum_probs=198.9
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC--
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK-- 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-- 86 (426)
....++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 3456899999999999999999999988999999998865322 222245677899999999 999999999998643
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
...|+||||+. ++|.+++... .+++..++.++.|++.|| +||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 46899999997 5999998775 789999999999999996 699999999999999999986533
Q ss_pred ccCC---CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-----------
Q 014359 152 FRDD---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------- 217 (426)
Q Consensus 152 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------- 217 (426)
.... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 23344578999999999876555568999999999999999999999876544332222111
Q ss_pred ----------------C-C---CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 218 ----------------D-F---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 218 ----------------~-~---~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
. . ...+.++.++.++|.+||+.||++|||+.++++|||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0 0 01123688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=280.53 Aligned_cols=236 Identities=32% Similarity=0.526 Sum_probs=205.3
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999899999999999765432 2335677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 95 YVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 95 y~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|+++++|.+++.. ...+++..++.++.|++.|+ +||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999866 35689999999999999996 6999999999999999999865432
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLR 234 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~ 234 (426)
......|++.|+|||.+.+..++ .++|+||+|+++|+|++|+.||...+.......+..+.+ +.+..++.++.++|.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 33456789999999999887764 789999999999999999999998887776666665543 355668899999999
Q ss_pred HccccCcCCCCChHHHhcCcCC
Q 014359 235 KILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=288.21 Aligned_cols=239 Identities=25% Similarity=0.377 Sum_probs=198.3
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
+.|...+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34777888999999999999999999999999997654444444567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||+. |+|.+.+.. ..++++..+..++.|++.|+ +||+++.++.+||+|||++.... .
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~ 173 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------P 173 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence 9996 578887764 45799999999999999996 69999999999999999987322 2
Q ss_pred cccccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CC-CCCCCHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL-PKWLSPGAQNLL 233 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~Li 233 (426)
.....|+..|+|||++.. ....+.++|||||||++|+|++|..||...+.......+..... .. ...++..+.+|+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 235678999999999842 22234789999999999999999999988766554444443322 22 234678899999
Q ss_pred HHccccCcCCCCChHHHhcCcCCccC
Q 014359 234 RKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+||+.+|.+||++.+++.||||...
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=281.90 Aligned_cols=235 Identities=23% Similarity=0.403 Sum_probs=195.2
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.++++++||||+++++++......|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 3568999999999999999999874 3456999988754321 3568899999999999999999999998889999
Q ss_pred EEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+|||+.+|+|.+++... ..+++..++.++.|++.|+ +||+++.++.+||+|||+++...... .
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~ 155 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-Y 155 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-e
Confidence 99999999999999763 4689999999999999997 69999999999999999987543211 1
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 233 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li 233 (426)
.......++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+.......+..+. ...+...+..+.+++
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIM 234 (256)
T ss_pred eecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 111122355789999999877764 89999999999999998 999999877777767666653 334566789999999
Q ss_pred HHccccCcCCCCChHHHhcC
Q 014359 234 RKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h 253 (426)
.+||+.||.+|||+.+++.+
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=288.12 Aligned_cols=239 Identities=22% Similarity=0.284 Sum_probs=196.9
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCC----------------ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG----------------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp 74 (426)
...++|++++.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.+++.++||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCC
Confidence 34679999999999999999999876543 468999987553 224467889999999999999
Q ss_pred CccceeEEEEeCCeEEEEEcccCCCChHHHHHhCC-----------CCCHHHHHHHHHHHHHHH---------------h
Q 014359 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGL---------------E 128 (426)
Q Consensus 75 nIv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~-----------~l~e~~~~~~~~ql~~al---------------e 128 (426)
||+++++++..++..+++|||+.+++|.+++.... .+++..++.++.|++.|+ +
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999999999999999999999997655 689999999999999996 6
Q ss_pred heeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc--CCCCCCCcc
Q 014359 129 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRN 206 (426)
Q Consensus 129 NILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~ 206 (426)
||+++.++.++|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999999985433222222334567889999999887666 489999999999999998 788998766
Q ss_pred HHHHHHHHHhC--------CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 207 LAVLYQKIFRG--------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 207 ~~~~~~~i~~~--------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
....+...... ..+.|..++.++.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 66555544322 12334567899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.36 Aligned_cols=135 Identities=30% Similarity=0.553 Sum_probs=125.7
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 68999999999999999999999999999999999876555555567899999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCC
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~ 147 (426)
|||+.|++|.+++...+.+++..++.++.||+.|| +|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999998878899999999999999997 69999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.82 Aligned_cols=240 Identities=25% Similarity=0.401 Sum_probs=196.1
Q ss_pred CccccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 83 (426)
....++|++.+.||+|+||.||+|.+. .++..||+|.++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 455678999999999999999999752 355689999987543 233356789999999999 799999999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCC
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla 146 (426)
...+..|+||||+.+|+|.+++.... .+++..+..++.|++.|+ +|||++.++.+||+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997543 389999999999999996 6999999999999999999
Q ss_pred CCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC--CCCCCC
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPK 223 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~ 223 (426)
................+++.|+|||.+.+..++ .++||||+||++|+|++ |..||.+.+....+...... ....|.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 854332111112233467889999999887764 89999999999999998 99999887655444443333 234456
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..++.+.+|+.+||+++|++|||+.++++
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 78999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=293.37 Aligned_cols=241 Identities=30% Similarity=0.420 Sum_probs=194.7
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC------
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 86 (426)
-++|++.+.||+|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3799999999999999999999989999999999875432 222346788899999999999999999988643
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
...|++++++ +++|.+.+.. .++++..++.++.|++.|+ +||++++++.+||+|||++.....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3478899887 7899888765 4699999999999999996 699999999999999999885321
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-------------
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------- 218 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------- 218 (426)
......||+.|+|||++.+....+.++||||+||++|+|++|+.||...+....+..+....
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 173 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred -----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 23345789999999998764444589999999999999999999998765443333222110
Q ss_pred ----------CCCC--------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 219 ----------FKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 219 ----------~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
...| ...++++.+||.+||+.||.+|||+.+++.||||.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0001 125788999999999999999999999999999987443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.92 Aligned_cols=238 Identities=24% Similarity=0.348 Sum_probs=200.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
....-++.+.||+|+||.||.|....... .||||.+.+.. +......|.+|..+|+.++|||||+++|++.+.
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 34567889999999999999998764322 48888887543 555578999999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccC
Q 014359 87 SKIYMVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFG 144 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~-------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFG 144 (426)
...+|++|||+||||..+|++. ..++..+...++.|++.|. .|+||+....+||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999999865 3488999999999999996 59999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHH-HHHhCCCCCC
Q 014359 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ-KIFRGDFKLP 222 (426)
Q Consensus 145 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~-~i~~~~~~~p 222 (426)
+|+........+......-...|||||.+....+ +.|+|||||||+|||++| |..||.+.+..+++. ....++++.|
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P 926 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP 926 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence 9993222111111111123368999999998776 489999999999999999 999999988877776 4555688999
Q ss_pred CCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 223 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..++..+.+++..||+.+|++||++..|++
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 999999999999999999999999999987
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.94 Aligned_cols=234 Identities=22% Similarity=0.402 Sum_probs=194.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
..+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 346899999999999999999875 5668999998654321 35678899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+++++|.+++.. ...+++..+..++.|++.|+ +||++++++.+||+|||+++...... ..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~ 156 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YT 156 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc-cc
Confidence 999999999999975 34689999999999999996 69999999999999999987542210 01
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~ 234 (426)
......++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+..+....+..+ ....|..+++.+.+++.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 11112234579999999887764 89999999999999999 89999887776666666554 34556678999999999
Q ss_pred HccccCcCCCCChHHHhcC
Q 014359 235 KILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h 253 (426)
+||..+|++|||+.++++.
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHhcCChhhCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=280.49 Aligned_cols=230 Identities=26% Similarity=0.364 Sum_probs=191.2
Q ss_pred ceeeecCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccC
Q 014359 20 RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
+.||+|+||.||+|.+ ..++..||+|++.... ......+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence 3689999999999965 4578899999987543 233446788999999999999999999998854 46789999999
Q ss_pred CCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC-Cccccc
Q 014359 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTT 161 (426)
Q Consensus 98 gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~-~~~~~~ 161 (426)
+|+|.+++.....+++..+..++.|++.|+ .||+++.++.+||+|||++......... ......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 999999998878899999999999999997 5999999999999999999854332111 011223
Q ss_pred cCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHcccc
Q 014359 162 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 162 ~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~ 239 (426)
.+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+. ++.|..+++++.+||.+||+.
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 45689999999877665 489999999999999998 999999877777777666553 566778999999999999999
Q ss_pred CcCCCCChHHHhc
Q 014359 240 NPVKRITIAGIKA 252 (426)
Q Consensus 240 dP~~R~t~~~il~ 252 (426)
||++||++++|..
T Consensus 238 ~p~~Rp~~~~i~~ 250 (257)
T cd05116 238 GVDERPGFAVVEL 250 (257)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=288.65 Aligned_cols=240 Identities=25% Similarity=0.380 Sum_probs=200.4
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
..|+..+.||+|+||.||+|++..++..||+|.+.............+.+|+.+++.++|||++++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888999999999999999998899999999997654444455678899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||+.| +|.+.+.. ..++++..+..++.|++.|+ +||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99975 78777754 56799999999999999996 699999999999999999874322
Q ss_pred cccccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CC-CCCCCHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL-PKWLSPGAQNLL 233 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~Li 233 (426)
.....|++.|+|||++.. .+..+.++||||+||++|+|++|+.||...+.......+..+.. .. +..+++.+.+||
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 234578999999999742 22235889999999999999999999988766555555554432 22 234788999999
Q ss_pred HHccccCcCCCCChHHHhcCcCCccCC
Q 014359 234 RKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+||+.+|.+||++.++++|+|+....
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhhccC
Confidence 999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=280.40 Aligned_cols=234 Identities=24% Similarity=0.385 Sum_probs=194.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++......|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 4578999999999999999999874 566799998764321 24678999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+|||+++|+|.+++... ..++......++.|++.|+ +||+++.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 157 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE- 157 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc-
Confidence 99999999999999753 4688999999999999996 69999999999999999998643211
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ..+.+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1111223456789999998877664 88999999999999998 99999887776666666544 233445688999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
+.+||..||++|||++++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=296.16 Aligned_cols=238 Identities=27% Similarity=0.405 Sum_probs=191.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe-
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS- 85 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~- 85 (426)
-++|++.+.||+|+||.||+|.+.. +++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3589999999999999999997543 45789999987433 223346788899999999 89999999998864
Q ss_pred CCeEEEEEcccCCCChHHHHHhC---------------------------------------------------------
Q 014359 86 KSKIYMVLEYVTGGELFDKIASK--------------------------------------------------------- 108 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~--------------------------------------------------------- 108 (426)
...+|++|||+++|+|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 46789999999999999998642
Q ss_pred ----CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccc
Q 014359 109 ----GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169 (426)
Q Consensus 109 ----~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~A 169 (426)
.++++..+..++.|++.|+ +|||++.++.+||+|||++................++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578999999999999997 699999999999999999986432211112233456778999
Q ss_pred hhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHH-HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCC
Q 014359 170 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY-QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRIT 246 (426)
Q Consensus 170 PE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~-~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t 246 (426)
||++.+..++ .++||||+||++|+|++ |..||.+....+.+ ..+..+ ....|...++++.+++.+||+.+|++||+
T Consensus 244 PE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 9999888875 89999999999999998 99999875543333 333332 23445668899999999999999999999
Q ss_pred hHHHhcC
Q 014359 247 IAGIKAD 253 (426)
Q Consensus 247 ~~~il~h 253 (426)
+.++++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=284.36 Aligned_cols=236 Identities=28% Similarity=0.407 Sum_probs=196.0
Q ss_pred ccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
..+|++.++||+|+||.||++... .++..+|+|.+... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 467899999999999999999743 35678999987643 2334578999999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCC---------------CCCHHHHHHHHHHHHHHH---------------hheeeCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKG---------------RLQEAEGRKLFQQLIDGL---------------ENILLDSKGN 137 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~---------------~l~e~~~~~~~~ql~~al---------------eNILld~~g~ 137 (426)
..|++|||+++|+|.+++.... .+++..+..++.|++.|+ +|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999997643 488999999999999996 6999999999
Q ss_pred EEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHh
Q 014359 138 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 216 (426)
Q Consensus 138 lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 216 (426)
+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...+.......+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999998743221111112233457889999999887775 89999999999999998 9999988776666666655
Q ss_pred C-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 217 G-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 217 ~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+ ....|..+++.+.+||.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4 34556778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=284.50 Aligned_cols=244 Identities=33% Similarity=0.591 Sum_probs=202.1
Q ss_pred CEEEeceeeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 89 (426)
+|++.+.||+|+||.||+|.+. .+++.||||++.+.... .....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46788999999754322 223346788999999999 599999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+.+|+|.+++.....+++..++.++.|++.|+ .||+++.++.++|+|||++..+... .
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-E 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc-c
Confidence 99999999999999998877899999999999999997 6999999999999999998864332 1
Q ss_pred CCccccccCCCcccchhhhccCC-CCCchhhHHHHHHHHHHHhcCCCCCCCcc----HHHHHHHHHhCCCCCCCCCCHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGA 229 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 229 (426)
.......+|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||.... .......+.....+.|..++..+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 12223457899999999987654 23578999999999999999999996432 23444455556677788899999
Q ss_pred HHHHHHccccCcCCCCC---hHHHhcCcCCccC
Q 014359 230 QNLLRKILEPNPVKRIT---IAGIKADEWFEQD 259 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t---~~~il~h~w~~~~ 259 (426)
.++|.+||+.||++||| +.++++||||+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5677999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.29 Aligned_cols=238 Identities=25% Similarity=0.428 Sum_probs=198.8
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccC
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
-...||+|+||.||+|.+..+++.||||.+.... ......+.+|+.+++.++||||+++++++...+..|+||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3467999999999999998999999999885432 2235678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcccccc
Q 014359 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162 (426)
Q Consensus 98 gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~ 162 (426)
+++|.+++.. .++++..++.++.|++.|+ +||+++.++.++|+|||++..... .........
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLV 177 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc--ccccccccc
Confidence 9999987754 5799999999999999996 699999999999999999874432 112223457
Q ss_pred CCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHHHHHHcccc
Q 014359 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 163 gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~~L~~ 239 (426)
|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.+.......+.... ......+++.+.+++.+||+.
T Consensus 178 ~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 178 GTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred cCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 8999999999877666 489999999999999999999998876655544443322 222344789999999999999
Q ss_pred CcCCCCChHHHhcCcCCccCCCC
Q 014359 240 NPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 240 dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
||.+||++.++++||||.+...|
T Consensus 257 ~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 257 DPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred CcccCcCHHHHhcChHHhccCCC
Confidence 99999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=282.46 Aligned_cols=236 Identities=26% Similarity=0.367 Sum_probs=192.6
Q ss_pred EEEeceeeecCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC------C
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------S 87 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 87 (426)
|.+++.||+|+||.||+|.+..++. .||+|.++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3578899999999999999877665 699998875432 333357788999999999999999999987432 2
Q ss_pred eEEEEEcccCCCChHHHHHh------CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCC
Q 014359 88 KIYMVLEYVTGGELFDKIAS------KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~------~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla 146 (426)
..+++|||+++|+|.+++.. ...+++..+..++.|++.|+ +|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 47899999999999988742 23489999999999999996 7999999999999999999
Q ss_pred CCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCC
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKW 224 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 224 (426)
+...............+++.|+|||++.+..+ +.++||||+||++|+|++ |+.||.+.+....+..+..+. .+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 86533211111223456788999999988776 489999999999999999 899999877777777776654 345667
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
++..+.++|.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.60 Aligned_cols=235 Identities=27% Similarity=0.409 Sum_probs=194.9
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 89 (426)
+++|++.+.||+|+||.||+|....++. .+|+|.++... .....+.+.+|+.+++++ +||||+++++++...+.+
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 3689999999999999999999877664 46888776322 233356788999999999 799999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCE
Q 014359 90 YMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNI 138 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNILld~~g~l 138 (426)
|+||||+++|+|.+++.... .+++..++.++.|++.|+ +|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999999999999997532 488999999999999997 69999999999
Q ss_pred EEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC
Q 014359 139 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 217 (426)
Q Consensus 139 Kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 217 (426)
||+|||++...... ........+..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+....+..+..+
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 99999998732211 011112335579999999877764 89999999999999997 99999988887777777655
Q ss_pred C-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 218 D-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 218 ~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
. ...|..++..+.+||.+||..||.+|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 34566789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=285.01 Aligned_cols=235 Identities=29% Similarity=0.386 Sum_probs=194.8
Q ss_pred CEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 23568999886543 223356788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhC------------------------CCCCHHHHHHHHHHHHHHH---------------hhe
Q 014359 90 YMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGL---------------ENI 130 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql~~al---------------eNI 130 (426)
|++|||+.+|+|.+++... .++++..+..++.|++.|+ +||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2478899999999999996 699
Q ss_pred eeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHH
Q 014359 131 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 209 (426)
Q Consensus 131 Lld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 209 (426)
|+++++.+||+|||+++..............+++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999854332221122334567899999998877664 89999999999999998 999999888777
Q ss_pred HHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 210 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 210 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
....+..+ ..+.|..++.++.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66665543 34456778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=288.30 Aligned_cols=239 Identities=27% Similarity=0.428 Sum_probs=197.1
Q ss_pred cccCEEEeceeeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 83 (426)
..++|.+++.||+|+||.||+|.+.. ....||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 45789999999999999999998632 34579999987542 233356788999999999 699999999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHH---------------hheee
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGL---------------ENILL 132 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~al---------------eNILl 132 (426)
...+.+|++|||+++|+|.+++... ..++...+..++.|++.|+ +|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9999999999999999999999753 2488889999999999997 69999
Q ss_pred CCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHH
Q 014359 133 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 211 (426)
Q Consensus 133 d~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~ 211 (426)
+.++.+||+|||+++...............+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+....+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999854332111112223345689999999877664 89999999999999999 99999988877777
Q ss_pred HHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 212 QKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 212 ~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..+..+. ...|..++.++.+||.+||..||++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7766553 45566788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=287.20 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=193.0
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 91 (426)
.++|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...|+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 45678889999999999999999999999999998754322 33567889999999996 9999999999999999999
Q ss_pred EEcccCCCChHHHH---H--hCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 92 VLEYVTGGELFDKI---A--SKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 92 VmEy~~gg~L~~~i---~--~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
+|||+.. +|.++. . ....+++..+..++.|++.|+ +||+++.++.+||+|||++....
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999854 554433 2 236799999999999999986 69999999999999999987432
Q ss_pred cccCCCccccccCCCcccchhhhccC--CCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHHhCC-CCCC----
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGD-FKLP---- 222 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~p---- 222 (426)
. ........||+.|+|||++.+. ...+.++||||+||++|+|++|+.||...+. ......+..+. +..+
T Consensus 160 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 160 D---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred c---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 2 1222345789999999999776 2335899999999999999999999976542 12222332222 2222
Q ss_pred CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 223 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
..++.++.+||.+||+.||++|||++++++||||...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 2378999999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=286.81 Aligned_cols=244 Identities=25% Similarity=0.429 Sum_probs=201.7
Q ss_pred ccCCccccCEEEeceeeecCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccc
Q 014359 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 78 (426)
++-....++|++++.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.+++.+ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchh
Confidence 344566689999999999999999999753 234579999887542 223356789999999999 8999999
Q ss_pred eeEEEEeCCeEEEEEcccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHH---------------
Q 014359 79 LHEVLASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGL--------------- 127 (426)
Q Consensus 79 l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~al--------------- 127 (426)
+++++......|++|||+++|+|.+++... ..++...+..++.|++.|+
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999999753 2477888899999999997
Q ss_pred hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCcc
Q 014359 128 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 206 (426)
Q Consensus 128 eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~ 206 (426)
+|||++.++.+||+|||+++...............+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 6999999999999999999855332222223334567889999999887775 88999999999999998 899999888
Q ss_pred HHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 207 LAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 207 ~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..+....+..+. ...|..++..+.+||.+||..+|++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 887777766543 34566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=280.98 Aligned_cols=239 Identities=21% Similarity=0.357 Sum_probs=197.4
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.++.|++.+.||+|+||.||+|.+..+++ .||||++.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 35789999999999999999999876654 69999987542 33345789999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.|+||||+++|+|.+++.. .+.+++..++.++.|++.|+ +||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999999975 35689999999999999996 6999999999999999998754332
Q ss_pred cCCCcccccc---CCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCH
Q 014359 153 RDDGLLHTTC---GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 227 (426)
Q Consensus 153 ~~~~~~~~~~---gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 227 (426)
.......... .+..|+|||.+.+..++ .++||||+||++|+|++ |..||...+.......+... ..+.|..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence 2111111112 24579999999887775 89999999999999886 99999887777666666443 3344566889
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+.+++.+||..||++||++.+++..
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=284.35 Aligned_cols=238 Identities=25% Similarity=0.362 Sum_probs=197.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45789999999999999999998743 67889999987543 233356788999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhC----------------------CCCCHHHHHHHHHHHHHHH---------------hh
Q 014359 87 SKIYMVLEYVTGGELFDKIASK----------------------GRLQEAEGRKLFQQLIDGL---------------EN 129 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~----------------------~~l~e~~~~~~~~ql~~al---------------eN 129 (426)
...|++|||+++|+|.+++... ..+++..+..++.|++.|| +|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 9999999999999999999743 2378888999999999997 69
Q ss_pred eeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHH
Q 014359 130 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 208 (426)
Q Consensus 130 ILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 208 (426)
|+++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998754321111112233456789999999887764 89999999999999998 88999887777
Q ss_pred HHHHHHHhCCC-CCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 209 VLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 209 ~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+....+..+.. +.|..++.++.+||.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77777766543 456778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=301.48 Aligned_cols=235 Identities=28% Similarity=0.429 Sum_probs=198.9
Q ss_pred cCEEEeceeeecCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
++-.+.+.||+|+||.||+|.....+ ..||||..+............+.+|+++|+.++|||||++||+......+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34566789999999999999876432 23899998864434555678899999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+|||+|.||+|.++++..+ .++..+...++.+.+.|| +|+|++.++.+||+|||+++.-..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-- 314 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-- 314 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc--
Confidence 99999999999999999876 499999999999999997 599999999999999999984321
Q ss_pred CCCcccccc-CCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC--CCCCCCCCHHH
Q 014359 154 DDGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~-gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~ 229 (426)
.......+ -...|+|||.+....|+ .++||||+||++||+.+ |..||.+....+...++.... .+.|...+..+
T Consensus 315 -~~~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 315 -YVMKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred -eeeccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence 11111122 45699999999888664 99999999999999999 899999999999999985543 45566788899
Q ss_pred HHHHHHccccCcCCCCChHHHhc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..++.+||..||++|||+.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999855
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=279.82 Aligned_cols=233 Identities=24% Similarity=0.355 Sum_probs=194.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999974 457899999875432 146688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|||+++++|.+++.... .+++..+..++.|++.|+ +||+++.++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999999997644 699999999999999996 699999999999999999986532111
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 233 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 233 (426)
........+..|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+.......+... ..+.+..++..+.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred cccCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 111112234579999998877664 89999999999999999 99999988777777666544 3345566899999999
Q ss_pred HHccccCcCCCCChHHHhc
Q 014359 234 RKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~ 252 (426)
.+||+.||.+||++.++.+
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=282.82 Aligned_cols=237 Identities=20% Similarity=0.301 Sum_probs=193.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
..++|++++.||+|+||.||+|.+..+++. ||+|.+.... .......+..|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 457899999999999999999998777764 6667664321 2233467888899999999999999999875 45
Q ss_pred eEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..++++||+++|+|.+++.. .+.+++..+..++.|++.|+ +|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 57899999999999999975 45689999999999999997 699999999999999999985433
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGA 229 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 229 (426)
...........++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.........+..+. ++.|..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 2222223345677899999999877764 89999999999999998 999999877666555555543 34455678899
Q ss_pred HHHHHHccccCcCCCCChHHHhc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.+++.+||..||++|||+.++++
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=283.34 Aligned_cols=235 Identities=32% Similarity=0.441 Sum_probs=192.1
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCccceeEEEEeCCe----
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSK---- 88 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~---- 88 (426)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999988899999999975432 222245566788877666 59999999999988776
Q ss_pred -EEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 89 -IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 89 -~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
+|++|||+.+ +|.+++.... .+++..++.++.|++.|+ +||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887643 599999999999999997 69999999999999999998643
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-----CC-----
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----FK----- 220 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~----- 220 (426)
. ........+++.|+|||++.+..+. .++|+||+||++|+|++|++||.+.+..+.+.++.... ..
T Consensus 159 ~---~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 F---EMALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred C---CcccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 2 2223344688999999999887764 89999999999999999999999877666555544310 00
Q ss_pred ------C-----------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 221 ------L-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 221 ------~-----------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+ .+.+++.+.++|.+||+.||++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01246788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=281.41 Aligned_cols=238 Identities=31% Similarity=0.502 Sum_probs=198.8
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888777888877643221 122245677899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 93 mEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|||+++++|.+.+.. ...+++..++.++.|++.|+ +||++++ +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999998853 35699999999999999996 6999975 6799999999875432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 232 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 232 (426)
.........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..+. +..|..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 22233456789999999998877765 78999999999999999999998877666666665543 34566688999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.71 Aligned_cols=241 Identities=27% Similarity=0.371 Sum_probs=194.6
Q ss_pred CccccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVL 83 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~ 83 (426)
....++|.+++.||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.+|.++. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 344568999999999999999999864 355689999997543 2223457889999999997 99999999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhCC------------------------------------------------------
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASKG------------------------------------------------------ 109 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~~------------------------------------------------------ 109 (426)
...+..|+||||+++|+|.+++...+
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999996431
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHH---------------hhe
Q 014359 110 --------------------------------------------RLQEAEGRKLFQQLIDGL---------------ENI 130 (426)
Q Consensus 110 --------------------------------------------~l~e~~~~~~~~ql~~al---------------eNI 130 (426)
.++...+..++.||+.|+ +||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256677888999999997 699
Q ss_pred eeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHH
Q 014359 131 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 209 (426)
Q Consensus 131 Lld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 209 (426)
|++.++.+||+|||+++...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999999985432111112234467889999999987766 489999999999999998 999998755444
Q ss_pred HH-HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 210 LY-QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 210 ~~-~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.. ..+..+ .+..|..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33 333333 345677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=287.17 Aligned_cols=242 Identities=29% Similarity=0.431 Sum_probs=195.5
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe-CCeEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~l 91 (426)
-++|++.+.||.|+||.||+|.+..+++.||||.+.+... .....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4689999999999999999999999999999998865432 22335678899999999999999999999865 567899
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
+|||+ +++|.+++.. .++++..+..++.|++.|+ .|||++.++.+||+|||++.....
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 99998 6689887764 5689999999999999997 699999999999999999874321
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh--------------------
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-------------------- 216 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 216 (426)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||...+....+..+.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 223456789999999986644345899999999999999999999987654322211110
Q ss_pred ------CCCCCC-----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 217 ------GDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 217 ------~~~~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
.....| +.++..+.++|.+||+.||++|||+++++.||||.....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 000111 3467899999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=279.23 Aligned_cols=233 Identities=24% Similarity=0.375 Sum_probs=192.4
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.+++.++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 347899999999999999999988655 4599999875432 1356889999999999999999999875 456899
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
||||+++|+|.+++... ..+++..+..++.|++.|+ +||++++++.+||+|||.+.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~- 156 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 156 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence 99999999999999753 3589999999999999997 69999999999999999997543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........++..|+|||++.+..++ .++||||+||++|+|++ |..||.+.+.......+..+ ..+.+..++..+.+|
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 1112234467789999998877764 89999999999999999 99999887776666666544 244456689999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
|.+||++||++|||+.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=283.36 Aligned_cols=235 Identities=29% Similarity=0.463 Sum_probs=192.7
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEEEEc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lVmE 94 (426)
|++.+.||+|+||.||+|....+++.||||.+...... . ......+|+..+++++ ||||+++++++.+.+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-W-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-h-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999889999999998654321 1 1234567999999999 9999999999999999999999
Q ss_pred ccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|+ +|+|.+.+.... .+++..+..++.|++.++ +||++++++.++|+|||++..... ...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence 99 789999987754 789999999999999997 699999999999999999985432 222
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--C-----------------
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D----------------- 218 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~----------------- 218 (426)
.....++..|+|||++.+....+.++|+||||+++++|++|+.||...+..+.+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 334568999999999865544458999999999999999999999877655444333210 0
Q ss_pred CC-----------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 ~~-----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
.. ..+..+..+.++|++||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=286.35 Aligned_cols=240 Identities=25% Similarity=0.365 Sum_probs=198.3
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
-..|+..+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++|||++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34588889999999999999999989999999998754333344456788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+. |+|.+.+.. ..++++..+..++.|++.|+ +||+++.++.+||+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 99996 588777753 45689999999999999996 699999999999999999875322
Q ss_pred ccccccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CC-CCCCCHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL-PKWLSPGAQNL 232 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~L 232 (426)
.....|++.|+|||++.+ ....+.++|||||||++|+|++|..||...+.......+..+.. .. +..++..+.+|
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 234578999999999753 22234789999999999999999999987665544444444332 22 33578899999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCccC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
|++||+.+|.+||++.++++|||+...
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCcccccc
Confidence 999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=279.09 Aligned_cols=237 Identities=22% Similarity=0.384 Sum_probs=195.5
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.++|++.+.||+|+||.||+|.+..++ ..||+|.++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 468999999999999999999986544 379999986543 233356889999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+++++|.+++... ..+++..+..++.|++.|+ +|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 4689999999999999996 69999999999999999998654321
Q ss_pred CCC-ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 014359 154 DDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 230 (426)
Q Consensus 154 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 230 (426)
... ......++..|+|||.+.+..+ +.++|+|||||++|++++ |..||.+.+..+....+.++ ..+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 111 1111233568999999987776 489999999999999887 99999887766666666554 2344456789999
Q ss_pred HHHHHccccCcCCCCChHHHhc
Q 014359 231 NLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+++.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=280.64 Aligned_cols=237 Identities=23% Similarity=0.331 Sum_probs=195.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
...+|++.+.||+|+||.||+|.+..+++ .||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 45689999999999999999999876666 48999986543 233356788999999999999999999998754
Q ss_pred eEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..+++|||+++|+|.+++.. .+.+++..+..++.|++.|+ +|||+++++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999976 45699999999999999997 699999999999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 229 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 229 (426)
...........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..+ ..+.+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 2111111223356789999999887775 89999999999999998 99999887766666555554 344566789999
Q ss_pred HHHHHHccccCcCCCCChHHHhc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.+++.+||..||++||++.+++.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=283.14 Aligned_cols=247 Identities=22% Similarity=0.334 Sum_probs=197.6
Q ss_pred ccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe
Q 014359 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 85 (426)
......+++|++.+.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.++.+. .||||+++++++.+
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 3445678999999999999999999999988899999999975432 22245566777766666 49999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~ 148 (426)
....|++|||+. ++|.+.+.. ...+++..+..++.|++.|+ +||++++++.+||+|||++..
T Consensus 86 ~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 86 DSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred CCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 999999999985 477777755 45799999999999999986 699999999999999999875
Q ss_pred CCcccCCCccccccCCCcccchhhhccCC---CCCchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHHhCC-CCCCC
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGD-FKLPK 223 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~p~ 223 (426)
... ........+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... .+.+..+.... ...+.
T Consensus 165 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 165 LVD---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241 (296)
T ss_pred ccC---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence 432 11223346888999999987553 124789999999999999999999976432 34444444433 22332
Q ss_pred --CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 224 --WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 224 --~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.++.++.+||.+||..||.+|||+.++++||||...
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 368899999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=289.09 Aligned_cols=238 Identities=30% Similarity=0.409 Sum_probs=193.0
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC------
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 86 (426)
.++|.+.+.||+|+||.||+|.+..+++.||||.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3799999999999999999999988999999999875432 222345688999999999999999999998654
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..+|+||||+.. +|.+.+. ..+++..+..++.|++.|+ +|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999964 7776652 4699999999999999997 699999999999999999875321
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--------------
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 217 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------- 217 (426)
......+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2234578899999999876443458999999999999999999999987655444333221
Q ss_pred ---------CCCCC--------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 218 ---------DFKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 218 ---------~~~~p--------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
....+ +..++.+.+||.+||+.||.+|||+++++.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00011 2367889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=282.18 Aligned_cols=237 Identities=33% Similarity=0.475 Sum_probs=196.4
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999998653 2233346778899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 96 ~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
+. ++|.+++... ..+++..+..++.|++.|+ +||++++++.+||+|||++...... .....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 97 5999999875 5799999999999999997 6999999999999999999865331 22233
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC------------------CCCC
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------DFKL 221 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~~~~ 221 (426)
...++..|+|||.+.+....+.++||||+||++|+|++|..||...+....+.++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4567889999999877634468999999999999999999999887655444333210 0011
Q ss_pred C-----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 222 P-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 222 p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+ +.++..+.++|++||..||++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1247889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=274.13 Aligned_cols=237 Identities=27% Similarity=0.423 Sum_probs=192.1
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe-----CCe
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KSK 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 88 (426)
.||++.+.||+|||+.||++++..+++.||+|.+.... .+..+...+|++..++++|||+++++++... ...
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 58999999999999999999999999999999986543 3447889999999999999999999988632 345
Q ss_pred EEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH-----------------hheeeCCCCCEEEeccCCCC
Q 014359 89 IYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL-----------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al-----------------eNILld~~g~lKl~DFGla~ 147 (426)
.|++++|...|+|.+.|+. ...++|.++.+||.++++|| .|||+.+++.++|.|||.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999974 23699999999999999997 49999999999999999998
Q ss_pred CCCcccCCC-------ccccccCCCcccchhhhccCCCC--CchhhHHHHHHHHHHHhcCCCCCCCccHH--HHHHHHHh
Q 014359 148 LPQHFRDDG-------LLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQKIFR 216 (426)
Q Consensus 148 ~~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~--~~~~DIwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~ 216 (426)
...-.-..+ .......|..|.|||.+.-+.+. +.++|||||||+||+|+.|..||+..-.. .+.-.+..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n 257 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN 257 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence 543211111 11123568999999998755433 58999999999999999999999642111 11112334
Q ss_pred CCCCCCCC--CCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 217 GDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 217 ~~~~~p~~--~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+.+.+|.. +|..+.+||+.||+.||.+||++.+++.+
T Consensus 258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 55566643 89999999999999999999999999875
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=277.02 Aligned_cols=229 Identities=25% Similarity=0.382 Sum_probs=190.2
Q ss_pred ceeeecCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEccc
Q 014359 20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~ 96 (426)
+.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 47999999999999876544 78999998765432 345678999999999999999999998764 4689999999
Q ss_pred CCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC-cccc
Q 014359 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG-LLHT 160 (426)
Q Consensus 97 ~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~-~~~~ 160 (426)
++|+|.+++.....+++..+..++.|++.|+ +|||++.++.+||+|||+++......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 9999999998877899999999999999997 69999999999999999998653321110 0111
Q ss_pred ccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccc
Q 014359 161 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILE 238 (426)
Q Consensus 161 ~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~ 238 (426)
..++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+..+....+..+. .+.|..++..+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 2235689999999877764 89999999999999998 999999887777666665553 45677799999999999999
Q ss_pred cCcCCCCChHHHhc
Q 014359 239 PNPVKRITIAGIKA 252 (426)
Q Consensus 239 ~dP~~R~t~~~il~ 252 (426)
.||++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.51 Aligned_cols=239 Identities=26% Similarity=0.489 Sum_probs=205.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe--
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-- 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 88 (426)
++++|. ..||+|+|-+||+|.|..+|-.||.--++.... ......+++..|+++|+.|+|||||++|++|.+...
T Consensus 40 Ry~k~~--evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 40 RYLKFD--EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred ceeehh--hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 444443 589999999999999999999999765543222 244456899999999999999999999999987655
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------hheeeCCC-CCEEEeccCCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------ENILLDSK-GNIKISDFGLSALPQ 150 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------eNILld~~-g~lKl~DFGla~~~~ 150 (426)
+-+|+|++.+|+|..|+++.++++...++.|++||+.|| +||+|+.+ |.|||+|.|||+...
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 889999999999999999999999999999999999997 69999876 899999999999754
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHHhCCCC--CCCCCCH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK--LPKWLSP 227 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~ 227 (426)
. .......|||.|||||.+. ..|+ ..+||||||+++.||+|+..||.. .+..++|+++..|..+ +..--.+
T Consensus 198 ~----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 198 K----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred c----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 3 2344578999999999987 5676 999999999999999999999987 4677999999988543 2333579
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
++++||.+||.. .+.|+|+.++|.||||...
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999999 9999999999999999875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=286.44 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=193.8
Q ss_pred CEEEeceeeecCceEEEEEEECCC--CceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC----C
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK----S 87 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~----~ 87 (426)
+|++.+.||+|+||.||++.+..+ +..||+|.+..... .....+.+.+|+.+++++ +||||+++++..... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999877 89999999864321 222346778899999999 599999999975432 4
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|++|||+. ++|.+.+....++++..++.++.||+.|| +|||++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5889999995 69999998888899999999999999997 6999999999999999999854321
Q ss_pred cC--CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-------------
Q 014359 153 RD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 217 (426)
Q Consensus 153 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 217 (426)
.. ........||+.|+|||++.+....+.++||||+||++|+|++|++||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112334579999999998866433358999999999999999999999876543332221110
Q ss_pred ---------------CCCC---CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 218 ---------------DFKL---PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 218 ---------------~~~~---p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
...+ .+..+..+.+|+.+||+.||.+|||+.+++.|||+.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 0001 1225789999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=292.15 Aligned_cols=239 Identities=26% Similarity=0.382 Sum_probs=191.0
Q ss_pred cccCEEEeceeeecCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 85 (426)
..++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.++.++ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 357899999999999999999984 3467899999997543 222356788999999999 68999999998865
Q ss_pred -CCeEEEEEcccCCCChHHHHHhC--------------------------------------------------------
Q 014359 86 -KSKIYMVLEYVTGGELFDKIASK-------------------------------------------------------- 108 (426)
Q Consensus 86 -~~~~~lVmEy~~gg~L~~~i~~~-------------------------------------------------------- 108 (426)
....|+||||+++|+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 45689999999999999998642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcccccc
Q 014359 109 -----------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162 (426)
Q Consensus 109 -----------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~ 162 (426)
..++...+..++.|++.|+ +|||++.++.+||+|||++................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1367778888999999997 69999999999999999998543211111222344
Q ss_pred CCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHH-HHHHHHHhC-CCCCCCCCCHHHHHHHHHcccc
Q 014359 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 163 gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 239 (426)
+++.|+|||++.+..++ .++|||||||++|+|++ |..||...... .....+..+ ....|.+.++++.+++.+||+.
T Consensus 243 ~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 243 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 56789999999887774 89999999999999997 99999875433 223333333 3456777899999999999999
Q ss_pred CcCCCCChHHHhcC
Q 014359 240 NPVKRITIAGIKAD 253 (426)
Q Consensus 240 dP~~R~t~~~il~h 253 (426)
||++|||+.++++|
T Consensus 322 ~p~~Rps~~eil~~ 335 (343)
T cd05103 322 EPSQRPTFSELVEH 335 (343)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=279.08 Aligned_cols=237 Identities=24% Similarity=0.345 Sum_probs=197.9
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
..++|++.+.||+|+||.||+|.+..+++ .||+|.+..... ......+.+|+.++++++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45789999999999999999999876654 589998865532 3345678899999999999999999999987 7
Q ss_pred eEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..++||||+++|+|.+++... ..+++..+..++.|++.|+ +|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 899999999999999999764 4699999999999999997 699999999999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGA 229 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 229 (426)
...........++..|+|||.+....++ .++|+|||||++|++++ |..||.+.+..+....+..+. .+.|...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2111111222346789999998777665 89999999999999999 999999988777777776653 45567788999
Q ss_pred HHHHHHccccCcCCCCChHHHhc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.+++.+||..||+.|||+.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.52 Aligned_cols=229 Identities=34% Similarity=0.571 Sum_probs=199.9
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 90 (426)
....|++...+|.|+|+.|..+.+..+++..++|++.+.. ....+|+.++... +||||+++++++.+....|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 4678999999999999999999999999999999998762 2234577666666 7999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheee-CCCCCEEEeccCCCCCCCcccC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILL-DSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILl-d~~g~lKl~DFGla~~~~~~~~ 154 (426)
+|||++.|+.|.+.|.....+. .++..|+.||+.|+ +|||+ ++.|+++|+|||.++....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~--- 468 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER--- 468 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch---
Confidence 9999999999999998866555 88889999999996 69999 5889999999999985433
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
...+.|-|..|.|||++...+|+ .++||||||++||+||+|+.||..... .++...+..+.+. .++|..+++||
T Consensus 469 --~~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 469 --SCDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred --hhcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 25677889999999999999886 999999999999999999999986544 3666666554444 89999999999
Q ss_pred HHccccCcCCCCChHHHhcCcCC
Q 014359 234 RKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
++||+.||.+|+++.+++.|||+
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=283.95 Aligned_cols=237 Identities=23% Similarity=0.311 Sum_probs=190.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCC--------------CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccc
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDS--------------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~--------------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 78 (426)
.++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 46899999999999999999987543 2358999987543 2334567899999999999999999
Q ss_pred eeEEEEeCCeEEEEEcccCCCChHHHHHhCC------------CCCHHHHHHHHHHHHHHH---------------hhee
Q 014359 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKG------------RLQEAEGRKLFQQLIDGL---------------ENIL 131 (426)
Q Consensus 79 l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~------------~l~e~~~~~~~~ql~~al---------------eNIL 131 (426)
+++++......|+||||+.+++|.+++.... .+++..+..++.|++.|+ +||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986432 368888999999999996 6999
Q ss_pred eCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc--CCCCCCCccHHH
Q 014359 132 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAV 209 (426)
Q Consensus 132 ld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~~~~ 209 (426)
+++++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999975432111112233455779999999887776 489999999999999988 778998766555
Q ss_pred HHHHHHh-----C---CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 210 LYQKIFR-----G---DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 210 ~~~~i~~-----~---~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
....+.. . ....++.+++.+.+|+.+||+.||++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4433221 1 12234557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=275.49 Aligned_cols=234 Identities=26% Similarity=0.393 Sum_probs=196.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+. .++.||||.+..... ..+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 4578999999999999999999975 557799999875432 14678899999999999999999999999899999
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
||||+++++|.+++... ..+++..+..++.|++.|+ +||++++++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 99999999999999764 3689999999999999996 69999999999999999988543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........++..|+|||.+.+..+ +.++||||+||++|+|++ |+.||.+.+.......+..+ ..+.|...+..+.++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111112234578999999987766 489999999999999998 99999988777777776654 345566688999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
+.+||..||.+||+++++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=275.52 Aligned_cols=229 Identities=27% Similarity=0.496 Sum_probs=196.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.. .++.||+|.+..... ..+++.+|+.+++.++||||+++++++.+.+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 457899999999999999999986 478899999975532 35788999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
||||+++++|.+++.... .+++..+..++.|++.|+ +||+++.++.+||+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~--- 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ--- 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc---
Confidence 999999999999998655 699999999999999996 699999999999999999985422
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
......++..|+|||.+....+. .++||||||+++|+|++ |..||...+.......+..+ ....|..+++.+.++
T Consensus 155 --~~~~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 155 --GQDSGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV 231 (256)
T ss_pred --ccccCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence 11133456789999998776664 89999999999999997 99999988777766665544 345567789999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
|.+||..||++|||+.++++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=277.85 Aligned_cols=233 Identities=25% Similarity=0.384 Sum_probs=193.4
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.++++++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 4578999999999999999999875 5667999998754321 356889999999999999999999885 456899
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+|||+++++|.+++... ..+++..++.++.|++.|+ +||++++++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-
Confidence 99999999999999753 3589999999999999997 69999999999999999998543311
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........++..|+|||.+.+..++ .++||||||+++|+|++ |.+||.+.+..+....+..+ .++.|...+..+.+|
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 1111222356689999998777664 89999999999999999 99999887777777766654 455677789999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
+.+||.+||++|||++++.+
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=278.42 Aligned_cols=238 Identities=21% Similarity=0.265 Sum_probs=196.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECC----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe-C
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-K 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~ 86 (426)
.-++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 35789999999999999999999865 36889999886432 33446778999999999999999999998765 5
Q ss_pred CeEEEEEcccCCCChHHHHHhC--------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEecc
Q 014359 87 SKIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDF 143 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~--------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DF 143 (426)
...++++||+.+|+|.+++... ..+++..+..++.|++.|+ +||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 7789999999999999998653 4589999999999999997 6999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCC
Q 014359 144 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKL 221 (426)
Q Consensus 144 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~ 221 (426)
|+++.+.............++..|+|||++.+..++ .++|||||||++|++++ |++||...+..+....+..+. +..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 999854321111111233567789999999887764 89999999999999999 999999887777666655542 344
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 222 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+..+++++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5667899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=275.29 Aligned_cols=229 Identities=25% Similarity=0.464 Sum_probs=193.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEE-EeCCeE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~ 89 (426)
....+|++.+.||+|+||.||++.. .+..||+|.+.... ..+.+.+|+.++++++|||++++++++ ...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 3457899999999999999999985 47889999886432 246788999999999999999999976 455679
Q ss_pred EEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
|++|||+++++|.+++.... .+++..+..++.|++.|+ +||++++++.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 99999999999999997643 488999999999999996 699999999999999999874322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 230 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 230 (426)
......++..|+|||++.+..++ .++|||||||++|+|++ |+.||...+.......+..+ ....+..+++.+.
T Consensus 155 ----~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 155 ----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229 (256)
T ss_pred ----cCCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 12234556789999999887765 88999999999999998 99999988877776666554 3445667899999
Q ss_pred HHHHHccccCcCCCCChHHHhc
Q 014359 231 NLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~ 252 (426)
++|.+||..||++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=275.69 Aligned_cols=237 Identities=22% Similarity=0.354 Sum_probs=195.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.++|+..+.||+|+||.||+|.+..+++ .+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4579999999999999999999876554 79999886542 233356788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+++++|.+++.. .+.+++..+..++.|++.|+ +||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999975 35789999999999999996 69999999999999999998553321
Q ss_pred CCCc-cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 014359 154 DDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 230 (426)
Q Consensus 154 ~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 230 (426)
.... ......++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+ ..+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1111 1112234579999999887764 89999999999999997 99999887777776666554 2334455889999
Q ss_pred HHHHHccccCcCCCCChHHHhc
Q 014359 231 NLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+++.+||+.+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=287.22 Aligned_cols=240 Identities=26% Similarity=0.434 Sum_probs=197.4
Q ss_pred cccCEEEeceeeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 83 (426)
.-.+|++++.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 34589999999999999999998643 22368999887432 233357889999999999 799999999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hheee
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENILL 132 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNILl 132 (426)
...+..|++|||+++|+|.+++.... .++...+..++.|++.|+ +|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 99999999999999999999997532 377788889999999997 69999
Q ss_pred CCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHH
Q 014359 133 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 211 (426)
Q Consensus 133 d~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~ 211 (426)
+.++.+||+|||+++...............++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+.+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999854332111112223445789999999887775 88999999999999998 99999988888777
Q ss_pred HHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCc
Q 014359 212 QKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 254 (426)
Q Consensus 212 ~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~ 254 (426)
..+..+. ...|..++.++.+|+.+||+.+|.+|||+.+++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 7766543 455667889999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=282.11 Aligned_cols=237 Identities=23% Similarity=0.328 Sum_probs=190.1
Q ss_pred ccCEEEeceeeecCceEEEEEEECC----------------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 76 (426)
.++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999986432 34579999987542 23345788999999999999999
Q ss_pred cceeEEEEeCCeEEEEEcccCCCChHHHHHhCC-----------CCCHHHHHHHHHHHHHHH---------------hhe
Q 014359 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGL---------------ENI 130 (426)
Q Consensus 77 v~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~-----------~l~e~~~~~~~~ql~~al---------------eNI 130 (426)
+++++++...+..|+||||+++|+|.+++.... .+++..+..++.|++.|+ +||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997532 367788999999999996 699
Q ss_pred eeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc--CCCCCCCccHH
Q 014359 131 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLA 208 (426)
Q Consensus 131 Lld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~~~ 208 (426)
|++.++.+||+|||+++...............+++.|+|||+..+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999985432111112223345678999999877766 489999999999999998 78999876655
Q ss_pred HHHHHHH--------hCCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 209 VLYQKIF--------RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 209 ~~~~~i~--------~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+...... ....+.|..+++.+.+|+.+||+.||.+|||+.+|.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4433221 1123445668899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.90 Aligned_cols=233 Identities=25% Similarity=0.384 Sum_probs=191.6
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 347899999999999999999987554 4599998865432 2357889999999999999999999885 456899
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+|||+.+|+|.+++... ..+++..+..++.|++.|+ +||++++++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-
Confidence 99999999999999753 3488999999999999997 69999999999999999997543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+.+..+....+..+ ..+.|..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 111122345678999999887766 489999999999999999 99999987777766666554 344566789999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
+.+||.+||++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=280.27 Aligned_cols=237 Identities=32% Similarity=0.455 Sum_probs=195.6
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
|++.+.||+|++|.||+|.+..+++.+|+|.+..... .......+.+|+.++++++||||+++++++.+....|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6778999999999999999988999999999875432 223356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 96 ~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
+++ +|.+.+.. ...+++..+..++.|++.|+ +||+++.++.+||+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 975 88888866 35799999999999999997 69999999999999999997554321 1223
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-------------------CCC
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DFK 220 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~~ 220 (426)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+.+..+... ...
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 3568889999999887633458999999999999999999999887655444333211 000
Q ss_pred -----------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 221 -----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 221 -----------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
..+.++.++.++|.+||++||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.75 Aligned_cols=232 Identities=26% Similarity=0.416 Sum_probs=192.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
-++|++++.||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.++++++||||+++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 46899999999999999999986 46778999998754321 357889999999999999999999874 4568999
Q ss_pred EcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|||+.+|+|.+++... ..+++..+..++.|++.|+ +||++++++.++|+|||++...... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-~~ 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN-EY 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC-Cc
Confidence 9999999999998653 4689999999999999997 6999999999999999999754321 11
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 233 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 233 (426)
.......++..|+|||++....+ +.++|||||||++|+|++ |++||.+.+.......+..+ ..+.|...+.++.++|
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11123345678999999987766 489999999999999999 99999988777666665544 3455666889999999
Q ss_pred HHccccCcCCCCChHHHhc
Q 014359 234 RKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~ 252 (426)
.+||..||++|||+++++.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHccCChhhCCCHHHHHH
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=273.32 Aligned_cols=233 Identities=27% Similarity=0.423 Sum_probs=196.7
Q ss_pred EEEeceeeecCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
+++++.||.|+||.||+|.+...+ ..||+|++.... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357889999999999999998766 899999996543 22246789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+|||+++++|.+++..... +++..+..++.|++.|+ +||++++++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 99999999999999997 699999999999999999986543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 232 (426)
.. .....+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+..+. ...+..++.++.++
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred cc-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 11 111237789999999866655 589999999999999998 899999888777777766553 44566789999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
+.+||..||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=304.30 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=182.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCC-CceEEEEE--------------eecccccchhHHHHHHHHHHHHhcCCCCC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKI--------------LEKNRIIHLKITDQIKREIATLKLLKHPN 75 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~-~~~vAvK~--------------i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn 75 (426)
..+++|++++.||+|+||+||++..... +..++.|. +.+...........+.+|+.+|+.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 4467999999999999999999876432 22222221 11111112233567889999999999999
Q ss_pred ccceeEEEEeCCeEEEEEcccCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHH---------------hheeeCCC
Q 014359 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGL---------------ENILLDSK 135 (426)
Q Consensus 76 Iv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~al---------------eNILld~~ 135 (426)
|+++++++.+.+..|+|||++. ++|.+++... .......++.++.||+.|| +|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999999999999999995 5888877542 2345677889999999997 69999999
Q ss_pred CCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCC-CCCCc--cHHHHHH
Q 014359 136 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL-PFDDR--NLAVLYQ 212 (426)
Q Consensus 136 g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~-Pf~~~--~~~~~~~ 212 (426)
|.+||+|||++..+... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|.. ||... +....+.
T Consensus 304 ~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999865431 11223356899999999999988875 89999999999999999875 44322 1211111
Q ss_pred HHHhC----------------------CC-----CCC-----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 213 KIFRG----------------------DF-----KLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 213 ~i~~~----------------------~~-----~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
++... .+ .++ ..++.++.++|.+||+.||.+|||+.|++.||||...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11110 00 000 1256678889999999999999999999999999764
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.79 Aligned_cols=228 Identities=25% Similarity=0.378 Sum_probs=187.6
Q ss_pred eeeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCC
Q 014359 21 TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 21 ~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999865 445679999987542 23345679999999999999999999998864 568999999999
Q ss_pred CChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC-ccccc
Q 014359 99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTT 161 (426)
Q Consensus 99 g~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~-~~~~~ 161 (426)
|+|.+++.. ...+++..+..++.|++.|+ +|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999975 45799999999999999997 69999999999999999998543221111 11112
Q ss_pred cCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcccc
Q 014359 162 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 162 ~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 239 (426)
.+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.........+..+ ....|...++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 335789999998877764 89999999999999996 99999988777766666554 3566778899999999999999
Q ss_pred CcCCCCChHHHhc
Q 014359 240 NPVKRITIAGIKA 252 (426)
Q Consensus 240 dP~~R~t~~~il~ 252 (426)
||++||++.+|.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=288.01 Aligned_cols=240 Identities=20% Similarity=0.315 Sum_probs=189.1
Q ss_pred ceeeec--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccC
Q 014359 20 RTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G--~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
..||+| +||+||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999998765432 3345789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC----
Q 014359 98 GGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG---- 156 (426)
Q Consensus 98 gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~---- 156 (426)
+|+|.+++... ..+++..+..++.|++.|| +|||++.++.+|++|||.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998763 3589999999999999997 69999999999999998654321111100
Q ss_pred -ccccccCCCcccchhhhccCC-CCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC--------------
Q 014359 157 -LLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-------------- 220 (426)
Q Consensus 157 -~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------- 220 (426)
......++..|+|||++.+.. ..+.++||||+||++|+|++|+.||.+................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011224567899999987642 2358999999999999999999999876554443332221110
Q ss_pred ---------------------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 221 ---------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 221 ---------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+..+++.+.+||++||+.||++|||+.++++||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 1122567899999999999999999999999999997644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=274.13 Aligned_cols=229 Identities=28% Similarity=0.455 Sum_probs=191.2
Q ss_pred ceeeecCceEEEEEEECC-CC--ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEccc
Q 014359 20 RTLGEGNFGKVKFAQDLD-SG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~ 96 (426)
+.||+|++|.||+|.+.. .+ ..||||.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999765 33 36999999766532 456789999999999999999999999988 8899999999
Q ss_pred CCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC-Ccc
Q 014359 97 TGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD-GLL 158 (426)
Q Consensus 97 ~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~-~~~ 158 (426)
++|+|.+.+.... .+++..++.++.|++.|| +||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999998754 689999999999999997 6999999999999999999865332111 112
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~ 235 (426)
....++..|+|||.+.+..++ .++||||+||++|+|++ |..||...+..+....+... ....|..++..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234678899999999887775 88999999999999998 99999887777666665532 233455688999999999
Q ss_pred ccccCcCCCCChHHHhc
Q 014359 236 ILEPNPVKRITIAGIKA 252 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~ 252 (426)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=272.71 Aligned_cols=234 Identities=23% Similarity=0.402 Sum_probs=195.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++.+.||+|+||.||+|.+. .++.+|+|.+...... ...+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 468999999999999999999874 4678999988654321 35688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+++++|.+++... +.+++..++.++.|++.|+ +||+++.++.+||+|||++....... ..
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence 9999999999999763 5689999999999999986 69999999999999999987432211 11
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~ 234 (426)
......++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+..+ ....|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 11223356789999999877664 89999999999999998 99999988877777776655 33445668899999999
Q ss_pred HccccCcCCCCChHHHhcC
Q 014359 235 KILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h 253 (426)
+||+.+|++|||+.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=280.06 Aligned_cols=250 Identities=31% Similarity=0.462 Sum_probs=199.0
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe-CC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~ 87 (426)
+..|++...||+|+||.||+|...+++ +.+|||.++.+.. .........||+.+++.++||||+.+..++.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 468999999999999999999655443 3789999976532 22345678899999999999999999999876 88
Q ss_pred eEEEEEcccCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCC----CCEEEecc
Q 014359 88 KIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSK----GNIKISDF 143 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~-----~~~l~e~~~~~~~~ql~~al---------------eNILld~~----g~lKl~DF 143 (426)
.+|+++||++. ||...|+- ...++...++.++.||++|+ .|||+..+ |.+||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999977 99999863 23599999999999999996 69999988 89999999
Q ss_pred CCCCCCCcccC-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH---------HHHHHH
Q 014359 144 GLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---------AVLYQK 213 (426)
Q Consensus 144 Gla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---------~~~~~~ 213 (426)
|+|+.+...-. -......+.|.+|.|||.+.+...++++.||||.|||+.||+|-++.|.+... .+....
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99998754221 22344567899999999999999888999999999999999998888854221 122222
Q ss_pred HHh--CCC---------CCCCC--------------------------CCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 214 IFR--GDF---------KLPKW--------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 214 i~~--~~~---------~~p~~--------------------------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
|.. |.+ .+|.| -++.+.+|+.+||..||.+|+|++|+++|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 221 111 11211 25668999999999999999999999999999
Q ss_pred ccCCCCCC
Q 014359 257 EQDYTPAN 264 (426)
Q Consensus 257 ~~~~~~~~ 264 (426)
.....|..
T Consensus 341 ~~d~lpp~ 348 (438)
T KOG0666|consen 341 TEDPLPPL 348 (438)
T ss_pred ccCCCCCC
Confidence 98766633
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=270.24 Aligned_cols=229 Identities=25% Similarity=0.409 Sum_probs=189.3
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 99 (426)
+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4689999999999986 467889999987543 2333457889999999999999999999999999999999999999
Q ss_pred ChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 100 ~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
+|.+++.. ...+++..+..++.|++.|+ +||+++.++.+||+|||++...... .........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc-ccccCCCCCC
Confidence 99999875 34689999999999999986 6999999999999999998743221 1111122345
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccccCc
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 241 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 241 (426)
++.|+|||++.+..+. .++||||+|+++|++++ |..||.+.+.......+..+ ....|..++..+.+++.+||+.||
T Consensus 157 ~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 6789999999877664 89999999999999998 99999887776666666554 345567789999999999999999
Q ss_pred CCCCChHHHhcC
Q 014359 242 VKRITIAGIKAD 253 (426)
Q Consensus 242 ~~R~t~~~il~h 253 (426)
++|||+.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=274.91 Aligned_cols=236 Identities=26% Similarity=0.394 Sum_probs=194.0
Q ss_pred ccCEEEeceeeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
-.+|++.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 35799999999999999999987543 3568999886543 23345788999999999999999999999875 457
Q ss_pred EEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+++|+|.+++.... .+++..+..++.|++.|+ +|||++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999999999999997643 589999999999999997 69999999999999999987543311
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 231 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 231 (426)
........+++.|+|||.+....+. .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..++..+.+
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 162 -YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred -ceecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 1111123345689999998877664 89999999999999986 99999988777666666554 34566778999999
Q ss_pred HHHHccccCcCCCCChHHHhcC
Q 014359 232 LLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h 253 (426)
+|.+||..+|++|||+.+++..
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=275.01 Aligned_cols=228 Identities=28% Similarity=0.421 Sum_probs=187.8
Q ss_pred ceeeecCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEccc
Q 014359 20 RTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~ 96 (426)
+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999887775 46888776432 233356788999999999 7999999999999999999999999
Q ss_pred CCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 97 TGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 97 ~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
++|+|.+++.... .+++..+..++.|++.|+ +|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997532 478999999999999997 699999999999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCC
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 223 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 223 (426)
+...... ......+.++.|+|||++....++ .++|||||||++|+|++ |..||.+.+....+..+..+ ....|.
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchh---hhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 8632211 111123346679999999877664 89999999999999997 99999888777777766554 334566
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.++.++.+|+.+||..||.+|||+.+++..
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=270.98 Aligned_cols=229 Identities=26% Similarity=0.364 Sum_probs=190.8
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg 99 (426)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999877 999999988754322 34568899999999999999999999999999999999999999
Q ss_pred ChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccC
Q 014359 100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 163 (426)
Q Consensus 100 ~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~g 163 (426)
+|.+++.. ...+++..+..++.|++.|+ +|||++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999965 35689999999999999886 699999999999999999985432111111122334
Q ss_pred CCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHccccCc
Q 014359 164 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 241 (426)
Q Consensus 164 t~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP 241 (426)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|..++..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 667999999887766 489999999999999999 89999887766666665544 345566789999999999999999
Q ss_pred CCCCChHHHhc
Q 014359 242 VKRITIAGIKA 252 (426)
Q Consensus 242 ~~R~t~~~il~ 252 (426)
.+|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=271.11 Aligned_cols=243 Identities=23% Similarity=0.368 Sum_probs=201.4
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCe
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 88 (426)
...+++.+.+..||+|+.|.|++++.+.+|...|||.+.+.. +....+++.+.+.++.... .|+||+.+|+|..+..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 445667788889999999999999999999999999998664 3444678888888876664 8999999999999999
Q ss_pred EEEEEcccCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 89 IYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
+++.||.+.. -+..++. ..++++|..+-++...+++|| .|||+|..|++|+||||++..+-.
T Consensus 166 V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 166 VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999999843 3443333 357899999999999999997 599999999999999999975432
Q ss_pred ccCCCccccccCCCcccchhhhcc---CCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHHhCCCCC-C--CC
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKL-P--KW 224 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~-p--~~ 224 (426)
........|.+.|||||-+.- ..|+ ..+||||||+.|+||.||+.||.+.+. .+++.++.+..++. | ..
T Consensus 245 ---SkAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g 320 (391)
T KOG0983|consen 245 ---SKAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG 320 (391)
T ss_pred ---ccccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence 222345579999999999864 3565 789999999999999999999998654 47777887765543 3 23
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+|+++.+|+..||.+|+.+||...++++|||....
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 89999999999999999999999999999998764
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=274.57 Aligned_cols=237 Identities=25% Similarity=0.398 Sum_probs=198.1
Q ss_pred ccCEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
..+|++.+.||+|+||.||+|++.. ..+.||+|.+.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999999753 35679999886532 2234578999999999999999999999999989
Q ss_pred eEEEEEcccCCCChHHHHHhCC---------CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEecc
Q 014359 88 KIYMVLEYVTGGELFDKIASKG---------RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDF 143 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~---------~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DF 143 (426)
..|+||||+++|+|.+++.... .+++..+..++.|++.|+ +|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999998655 699999999999999997 6999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCCCC--
Q 014359 144 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK-- 220 (426)
Q Consensus 144 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~-- 220 (426)
|++...... .........+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+...
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 998743221 1112234456788999999887765 488999999999999999 89999887776777766655433
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 221 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 221 ~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+..++..+.+++.+||..||.+|||+.+++.+
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 355688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=276.32 Aligned_cols=224 Identities=23% Similarity=0.294 Sum_probs=183.7
Q ss_pred ceeeecCceEEEEEEECCCCc-------eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 20 RTLGEGNFGKVKFAQDLDSGL-------PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~-------~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+.||+|+||.||+|.+...+. .||+|.+.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999999865443 48888876432 33356788899999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCC--------EEEeccCCCCC
Q 014359 93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGN--------IKISDFGLSAL 148 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~--------lKl~DFGla~~ 148 (426)
|||+.+|+|.+++...+ .+++..+..++.||+.|+ +|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997644 589999999999999997 6999988765 69999999874
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcC-CCCCCCccHHHHHHHHHhCCCCCCCCCCH
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 227 (426)
... .....+++.|+|||++.+....+.++||||+||++|+|++| ..||...+..... ........+|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 322 23457889999999998754445899999999999999998 5777665544333 233445667777889
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
++.+||.+||+.||++|||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=295.82 Aligned_cols=235 Identities=23% Similarity=0.388 Sum_probs=200.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..+...++..||+|.||+||+|++- | .||||+++.+.... ...+.|++|+.++++-+|.||+-+.|++..+.. .|
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred CHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 3456788999999999999999974 3 49999998776544 468999999999999999999999999988776 99
Q ss_pred EEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|+.+|+|-+|+.+|+- +.+|.....+.|++|++.|+ .||+|.+++.|||+|||+++.-......
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 9999999999999974 45799999999999999997 4999999999999999999875544444
Q ss_pred CccccccCCCcccchhhhccC---CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-----CCCCCCH
Q 014359 156 GLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSP 227 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~ 227 (426)
.......|...|||||++..+ +| +..+||||||||+|||+||.+||...+.+.+...+..|... .-..++.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 556667789999999998643 45 58999999999999999999999988877777666666322 1234677
Q ss_pred HHHHHHHHccccCcCCCCChHHHhc
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
++++|+..||..++++||++.+|+.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999999987
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=274.80 Aligned_cols=230 Identities=27% Similarity=0.385 Sum_probs=188.4
Q ss_pred ceeeecCceEEEEEEECCCC------ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 20 RTLGEGNFGKVKFAQDLDSG------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
+.||+|+||.||+|.+.... +.||||.+.... .......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46999999999999876433 689999886542 1223567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCC-----CEEEeccCCC
Q 014359 94 EYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKG-----NIKISDFGLS 146 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-------~~l~e~~~~~~~~ql~~al---------------eNILld~~g-----~lKl~DFGla 146 (426)
||+++++|.+++... ..+++..+..++.|++.|+ +||+++.++ .+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999642 3478899999999999986 699999988 8999999999
Q ss_pred CCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCC
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKW 224 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 224 (426)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75432111112223456789999999987766 589999999999999998 99999887766666665443 3456677
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
++..+.+||.+||..+|.+||++.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=277.62 Aligned_cols=238 Identities=24% Similarity=0.332 Sum_probs=193.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
..++|+..+.||+|+||.||+|.+..+++ .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45789999999999999999999877776 46888876432 223345688999999999999999999998754
Q ss_pred eEEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..++++||+++|+|.+++.... .+++..+..++.|++.|+ +|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4679999999999999997643 689999999999999997 699999999999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 229 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 229 (426)
...........++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.........+..+ .++.+...+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 2221122334567899999999877764 89999999999999997 99999887665555544443 244456688999
Q ss_pred HHHHHHccccCcCCCCChHHHhcC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+++.+||..||++||++.++++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=274.51 Aligned_cols=249 Identities=28% Similarity=0.428 Sum_probs=203.6
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe------
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 85 (426)
..+.|+-..++|+|+||.||+|+...+|+.||+|.+-.+.. .+..-....+|+.+|..++|+|++.++++|.+
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 45789999999999999999999999999999986543221 22334567789999999999999999998843
Q ss_pred --CCeEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCC
Q 014359 86 --KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 86 --~~~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~ 147 (426)
+..+|+|+.+|+. ||+-++... .+++..+++.+++++++|| +|+|++.+|.+||+|||+++
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 3459999999976 999988765 6899999999999999997 79999999999999999998
Q ss_pred CCCcccC--CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh--CCC----
Q 014359 148 LPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDF---- 219 (426)
Q Consensus 148 ~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~---- 219 (426)
.+..... ....+.+..|.+|.+||.+.+...+|++.|||..|||+.+|.||.+-+++.+.......|.. |..
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 7654322 12244556799999999999988889999999999999999999999998776655544321 111
Q ss_pred ----------------CCCCC-------------CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 220 ----------------KLPKW-------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 220 ----------------~~p~~-------------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
++|.. -++++.+|+.++|..||.+|+++.+++.|.||.++..|
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 11111 25689999999999999999999999999999987655
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=280.85 Aligned_cols=239 Identities=21% Similarity=0.327 Sum_probs=185.4
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccC
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
+++.+|.| |.||.+++..+++.||||++..... .......+.+|+.+++.++||||+++++++...+..|++|||++
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 44444444 5556666667999999999976532 23346789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC-----C
Q 014359 98 GGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD-----D 155 (426)
Q Consensus 98 gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~-----~ 155 (426)
+|+|.+++... ..+++..+..++.|++.|+ +||+++.+|.+||+|||.+........ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999999753 4689999999999999997 699999999999999998874322111 1
Q ss_pred CccccccCCCcccchhhhccC--CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-HHHHhCC--------------
Q 014359 156 GLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY-QKIFRGD-------------- 218 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~~-------------- 218 (426)
.......++..|+|||++.+. .+ +.++||||+||++|+|++|+.||...+..... .++....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 122344678899999998763 34 48899999999999999999999875543322 2221100
Q ss_pred -------------------CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 219 -------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 219 -------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
...+..++.++.+|+.+||..||++|||+.++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000112456789999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=270.16 Aligned_cols=235 Identities=29% Similarity=0.482 Sum_probs=195.5
Q ss_pred CEEEeceeeecCceEEEEEEECC-CCceEEEEEeecccc-------cchhHHHHHHHHHHHHhc-CCCCCccceeEEEEe
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI-------IHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS 85 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 85 (426)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999877 788999998864321 122234567788888865 799999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGl 145 (426)
.+..|++|||+++++|.+++.. ...+++..++.++.|++.|+ +||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 35699999999999999986 699999999999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-CC-C
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-K 223 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~ 223 (426)
+...... .......|+..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+..+... .+ .
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 9864331 13455678999999999987766 58999999999999999999999887776666666555433 22 2
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+++.+.++|.+||+.||++||++.++.++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=270.72 Aligned_cols=214 Identities=28% Similarity=0.444 Sum_probs=179.8
Q ss_pred cCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCChHHH
Q 014359 25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDK 104 (426)
Q Consensus 25 G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L~~~ 104 (426)
|+||+||++++..+++.||+|.+.... ...+|...+....||||+++++++.+....|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997642 223445555566799999999999999999999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccc
Q 014359 105 IASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169 (426)
Q Consensus 105 i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~A 169 (426)
+.+..++++..+..++.|++.|+ +||+++.++.++++|||++..... ......++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 98877899999999999999996 699999999999999998764332 1234566788999
Q ss_pred hhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCCh--
Q 014359 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI-- 247 (426)
Q Consensus 170 PE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~-- 247 (426)
||.+.+..++ .++||||+||++|+|++|+.||....... .......+|.++++.+.+||.+||+.||++|||+
T Consensus 151 PE~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEET-EACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 9998777664 88999999999999999999876432110 0112345778899999999999999999999996
Q ss_pred ---HHHhcCcCC
Q 014359 248 ---AGIKADEWF 256 (426)
Q Consensus 248 ---~~il~h~w~ 256 (426)
++++.||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=269.70 Aligned_cols=227 Identities=26% Similarity=0.476 Sum_probs=190.6
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++.+.||+|+||.||++. .+++.||+|.+.... ..+.+.+|+.+++.++||||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 45789999999999999999987 478889999886432 146788999999999999999999998654 4799
Q ss_pred EEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+|||+.+++|.+++.... .+++..+..++.|++.|+ +||+++.++.+||+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence 999999999999997643 589999999999999996 699999999999999999874321
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 232 (426)
.......+..|+|||.+.+..+ +.++|+||+||++|+|++ |+.||...+.......+..+. +..+..++..+.++
T Consensus 153 --~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 153 --GVDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred --cCCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 1122334578999999887766 489999999999999998 999999888777666665543 34455688999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
+.+||+.+|++||++++++.
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=273.87 Aligned_cols=235 Identities=29% Similarity=0.369 Sum_probs=185.6
Q ss_pred cCE-EEeceeeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC--
Q 014359 14 GRY-ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-- 86 (426)
Q Consensus 14 ~~y-~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-- 86 (426)
++| ++.+.||+|+||+||++. ...+++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 566 999999999999998765 33577899999987542 222356788999999999999999999987653
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
...|++|||+++|+|.+++.. ..+++..++.++.|++.|+ +|||+++++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 468999999999999999976 4699999999999999996 699999999999999999985433
Q ss_pred ccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH--HHH-------------HHHH
Q 014359 152 FRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLY-------------QKIF 215 (426)
Q Consensus 152 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--~~~-------------~~i~ 215 (426)
.... .......++..|+|||++.+..++ .++|||||||++|+|++|..||...... ... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 1111 112233566789999998877664 8999999999999999999998653311 111 0111
Q ss_pred h-CCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 216 R-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 216 ~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
. ...+.|..++..+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 123345668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=268.93 Aligned_cols=231 Identities=25% Similarity=0.363 Sum_probs=185.1
Q ss_pred ceeeecCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE-eCCeEEEEEcc
Q 014359 20 RTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKIYMVLEY 95 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lVmEy 95 (426)
+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 34579999875432 2333577889999999999999999999765 45668999999
Q ss_pred cCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC--CCc
Q 014359 96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD--DGL 157 (426)
Q Consensus 96 ~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~--~~~ 157 (426)
+.+|+|.+++... ...++.....++.|++.|+ +|||+++++.+||+|||+++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999999764 3467788888999999996 699999999999999999975432110 011
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~ 235 (426)
.....+++.|+|||.+.+..+. .++|||||||++|+|++ |.+||...+.......+..+. +..|..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1233567789999999877764 89999999999999999 677888777766666665553 34456688999999999
Q ss_pred ccccCcCCCCChHHHhcC
Q 014359 236 ILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h 253 (426)
||..+|++||++.+++..
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=271.33 Aligned_cols=230 Identities=20% Similarity=0.249 Sum_probs=178.2
Q ss_pred ceeeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccC
Q 014359 20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46999999999999864 3556799998865432 2223578889999999999999999999999999999999999
Q ss_pred CCChHHHHHhCC-----CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 98 gg~L~~~i~~~~-----~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
+|+|.+++.... ..++..++.++.|++.|+ +||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999997532 356778889999999996 699999999999999999974322111111
Q ss_pred cccccCCCcccchhhhccCC------CCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHH-hCCCCC-----CCC
Q 014359 158 LHTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF-RGDFKL-----PKW 224 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~------~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~-~~~~~~-----p~~ 224 (426)
....+|++.|+|||++.+.. ..+.++||||+||++|+|++ |+.||...+..+...... ...... +..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 23456788999999986432 12578999999999999996 999998766554433322 222221 223
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.++.+.+++.+|| .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999999 68999999999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=273.56 Aligned_cols=223 Identities=25% Similarity=0.310 Sum_probs=179.7
Q ss_pred eeeecCceEEEEEEECC------------------------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc
Q 014359 21 TLGEGNFGKVKFAQDLD------------------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76 (426)
Q Consensus 21 ~LG~G~fg~V~~a~~~~------------------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 76 (426)
.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999997432 12458999886432 2334678889999999999999
Q ss_pred cceeEEEEeCCeEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC----
Q 014359 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---- 136 (426)
Q Consensus 77 v~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g---- 136 (426)
+++++++......|+||||+++|+|..++.. .+++++..+..++.|++.|+ +|||++.++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 56799999999999999997 699998654
Q ss_pred ---CEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHh-cCCCCCCCccHHHHHH
Q 014359 137 ---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQ 212 (426)
Q Consensus 137 ---~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ell-tG~~Pf~~~~~~~~~~ 212 (426)
.+|++|||++..... .....+++.|+|||.+.+....+.++|||||||++|+|+ +|+.||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998863221 123467889999999876444468999999999999985 6999998766544333
Q ss_pred HHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 213 KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 213 ~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
........|...++.+.++|.+||+.+|++|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2233445555677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=267.81 Aligned_cols=233 Identities=25% Similarity=0.395 Sum_probs=191.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 4578999999999999999999864 55669999886432 124678899999999999999999999887 77899
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+|||+++|+|.+++... ..++...+..++.|++.|+ +||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 156 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE- 156 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-
Confidence 99999999999999763 3578888999999999997 69999999999999999997543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........++..|+|||++....+ +.++|+|||||++|++++ |..||.+.+.......+..+ ..+.+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 235 (260)
T ss_pred cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence 111122345678999999987665 488999999999999999 99999987776666665544 234456688999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
+.+||+.||++||++.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=292.12 Aligned_cols=246 Identities=32% Similarity=0.528 Sum_probs=206.9
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
+.=.-|..++.||=|+||+|.++...+|...||+|.+.+......+....++.|-.||..-+.+-||+||-.|.+++++|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34456889999999999999999999999999999999887777777788999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC-
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD- 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~- 154 (426)
+||+|++|||+-.++.+.+-|+|+.|++|+..|..|+ +|||||.+|++||+||||++-+.-...
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999999999999889999999999999999997 599999999999999999875422100
Q ss_pred ---------------------------------------CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHH
Q 014359 155 ---------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI 195 (426)
Q Consensus 155 ---------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~el 195 (426)
....+..+||+.|+|||++...+|. .-+|+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHH
Confidence 0012234799999999999999996 889999999999999
Q ss_pred hcCCCCCCCccHHHHHHHHH--hCCCCCC--CCCCHHHHHHHHHccccCcCCCC---ChHHHhcCcCCcc
Q 014359 196 LTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ 258 (426)
Q Consensus 196 ltG~~Pf~~~~~~~~~~~i~--~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~---t~~~il~h~w~~~ 258 (426)
+.|++||...+.-+...++. ...+.+| ..+|+++.+||.++.. +++.|. .++|+..||||+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 99999998766544433322 2223333 4589999999988553 566777 4778999999975
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=269.10 Aligned_cols=230 Identities=23% Similarity=0.280 Sum_probs=177.7
Q ss_pred ceeeecCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccC
Q 014359 20 RTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999996532 44578888775432 23334678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhCC-----CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 98 gg~L~~~i~~~~-----~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
+|+|.+++.... ..++..+..++.||+.|+ +|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999997643 246788899999999996 699999999999999999874322111111
Q ss_pred cccccCCCcccchhhhccC------CCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHH-HhCCCC-----CCCC
Q 014359 158 LHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI-FRGDFK-----LPKW 224 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~------~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i-~~~~~~-----~p~~ 224 (426)
.....+++.|+|||++... ...+.++||||+||++|+|++ |..||......+..... ...... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 2233467789999997532 223578999999999999999 89999877655544443 333222 2345
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+++.+.+++..|| .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999999 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=269.47 Aligned_cols=224 Identities=23% Similarity=0.293 Sum_probs=180.3
Q ss_pred ceeeecCceEEEEEEECC------------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 20 RTLGEGNFGKVKFAQDLD------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 22358889876532 333567888999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC-------EEEeccC
Q 014359 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN-------IKISDFG 144 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~-------lKl~DFG 144 (426)
..++||||+++|+|..++.. ...+++..+..++.||+.|+ +|||++.++. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999988875 35699999999999999997 6999987764 8999999
Q ss_pred CCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHh-cCCCCCCCccHHHHHHHHHhCCCCCCC
Q 014359 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFRGDFKLPK 223 (426)
Q Consensus 145 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~ 223 (426)
++..... .....++..|+|||++......+.++||||+||++|+|+ +|..||......+.. ....+......
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 9874321 223568899999999875444468999999999999998 599999876654432 23334444444
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..+.++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=272.30 Aligned_cols=236 Identities=27% Similarity=0.397 Sum_probs=187.4
Q ss_pred CEEEeceeeecCceEEEEEEE----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC--Ce
Q 014359 15 RYELGRTLGEGNFGKVKFAQD----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK 88 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 88 (426)
-|++.+.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 368899999999999999974 3578899999986543 233356799999999999999999999998775 56
Q ss_pred EEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.|+||||++|++|.+++... ..+++..+..++.|++.|+ +||+++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999999764 3589999999999999996 6999999999999999999865332
Q ss_pred cCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc---------------HHHHHHHHHh
Q 014359 153 RDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---------------LAVLYQKIFR 216 (426)
Q Consensus 153 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---------------~~~~~~~i~~ 216 (426)
... .......++..|+|||++.+..++ .++||||+||++|+|+++..|+.... .......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 111 122345677889999998877664 89999999999999999877653211 1111111222
Q ss_pred C-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 217 G-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 217 ~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+ ..+.+..++..+.+||.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2 234456689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=286.06 Aligned_cols=249 Identities=30% Similarity=0.436 Sum_probs=204.0
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc----hhHHHHHHHHHHHHhcCCCCCccceeEEEE-e
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----LKITDQIKREIATLKLLKHPNVVRLHEVLA-S 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~ 85 (426)
..-++|-++.+||+|+|+.||+|.+...++.||||+-.....+. ++..+...+|.+|++.|+||.||++|+++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 44578999999999999999999999999999999876544332 234466789999999999999999999996 5
Q ss_pred CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------hheeeCC---CCCEEEeccCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------ENILLDS---KGNIKISDFGL 145 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------eNILld~---~g~lKl~DFGl 145 (426)
.+.+|-|+|||+|.+|.-+++...-++|.+|+.|+.||++|| .||||-+ .|.+||+|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 567899999999999999999888999999999999999997 4999954 47899999999
Q ss_pred CCCCCcccCC-----CccccccCCCcccchhhhccC---CCCCchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHH--H
Q 014359 146 SALPQHFRDD-----GLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQK--I 214 (426)
Q Consensus 146 a~~~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~--i 214 (426)
++..+....+ .......||.+|++||.+.-. +-.+.++||||+|||+|.++.|+-||.... ..++++. |
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9987653322 233445799999999987533 223578999999999999999999997643 3344332 3
Q ss_pred HhC-CCCCC--CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 215 FRG-DFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 215 ~~~-~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+. +..+| +.+++++++||++||+..-+.|+...++..||||...
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 332 34444 5599999999999999999999999999999998753
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=268.78 Aligned_cols=236 Identities=25% Similarity=0.378 Sum_probs=191.7
Q ss_pred EEEeceeeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----
Q 014359 16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 87 (426)
|++.++||+|+||.||+|... .+++.||||++..+.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 3578999999976443 3333577889999999999999999999886432
Q ss_pred -eEEEEEcccCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 88 -KIYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 88 -~~~lVmEy~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
..++++||+.+|+|.+++... ..+++..++.++.|++.|+ +||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 357899999999999887532 2478999999999999996 699999999999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCC
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 223 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 223 (426)
++...............+++.|++||.+.+..++ .++|||||||++|+|++ |+.||.+.+....+..+..+ ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 9854321111112233456789999999877765 89999999999999999 99999888777777766554 345566
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+++..+.+++.+||+.+|++|||+.+++++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=269.22 Aligned_cols=236 Identities=26% Similarity=0.403 Sum_probs=185.2
Q ss_pred cCEEEeceeeecCceEEEEEEE----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--CC
Q 014359 14 GRYELGRTLGEGNFGKVKFAQD----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 87 (426)
.+|++.+.||+|+||.||+|.. ..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4799999999999999999973 457889999998654 23335678999999999999999999998743 35
Q ss_pred eEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
.+|+||||+++|+|.+++... ..+++..+..++.|++.|| +||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999754 4689999999999999997 699999999999999999986533
Q ss_pred ccCCC-ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH----------------HHHHH
Q 014359 152 FRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----------------LYQKI 214 (426)
Q Consensus 152 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~----------------~~~~i 214 (426)
..... ......++..|+|||++.+..+ +.++||||+||++|+|++|..|+....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 11111 1112233456999999987766 489999999999999999887765432110 11111
Q ss_pred Hh-CCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 215 FR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 215 ~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.. ..++.+..++.++.+||.+||..+|++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 11 1234456688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=279.36 Aligned_cols=232 Identities=30% Similarity=0.396 Sum_probs=181.5
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC-eEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV 92 (426)
++|.-...||+|+||.||+|... ++..||||.+....... ..+|.+|+.++.+++|||+|+|+|||.+.+ ..++|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 46777789999999999999874 45889999876543221 345999999999999999999999999988 59999
Q ss_pred EcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH------------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL------------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al------------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
+||+++|+|.+.+.... ++++....+|+.+++.|| .|||||++++.||+|||+|+.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999998654 899999999999999997 5999999999999999999743221
Q ss_pred cCCCccccc-cCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHH-HHHhCC------
Q 014359 153 RDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN------LAVLYQ-KIFRGD------ 218 (426)
Q Consensus 153 ~~~~~~~~~-~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~------~~~~~~-~i~~~~------ 218 (426)
.....+. .||.+|+|||++..... +.++|||||||+|.||+||+.|.+... ..+... .+.++.
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred --ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 2222233 89999999999977555 589999999999999999998887432 112111 122211
Q ss_pred CCCC-CCCC--HH---HHHHHHHccccCcCCCCChHHHhc
Q 014359 219 FKLP-KWLS--PG---AQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 219 ~~~p-~~~s--~~---~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+.+. ...+ .. +..+..+|++.+|..||++.|+.+
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1222 22 456779999999999999999754
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=265.82 Aligned_cols=230 Identities=20% Similarity=0.293 Sum_probs=178.3
Q ss_pred ceeeecCceEEEEEEECCC--CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccC
Q 014359 20 RTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
+.||+|+||.||+|..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975432 2346667665432 22335789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhC----CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 98 GGELFDKIASK----GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 98 gg~L~~~i~~~----~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
+|+|.+++... ...++..++.++.|++.|+ +|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999999753 2467778889999999997 6999999999999999998642211111222
Q ss_pred ccccCCCcccchhhhccCC------CCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC------CCCCCCC
Q 014359 159 HTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD------FKLPKWL 225 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~------~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~ 225 (426)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+..+. +..+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3567899999999975321 12478999999999999997 688998777666665544332 2233457
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
++.+.+++.+|| .+|++|||++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 68999999999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=267.52 Aligned_cols=237 Identities=27% Similarity=0.401 Sum_probs=189.5
Q ss_pred ccCEEEeceeeecCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--C
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~ 86 (426)
-.+|++.+.||+|+||.||+|... .+++.||||++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357889999999999999999864 34789999999765422 346789999999999999999999999877 5
Q ss_pred CeEEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
...|++|||+++++|.+++.... .+++..+..++.|++.|| +||+++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 67999999999999999997644 699999999999999997 69999999999999999998654
Q ss_pred cccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH---------------HHHHH
Q 014359 151 HFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---------------LYQKI 214 (426)
Q Consensus 151 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~---------------~~~~i 214 (426)
..... .......++..|+|||.+.+..+. .++|||||||++|+|++|..||....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 21111 111123455679999998877664 88999999999999999999986542211 11222
Q ss_pred HhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 215 FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 215 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..+ ..+.|..++.++.+|+.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 221 23445667899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=291.70 Aligned_cols=244 Identities=26% Similarity=0.410 Sum_probs=207.2
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe--
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS-- 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-- 85 (426)
-.-.-+.|++.+++|.|.+|+||+++++.+++.+|+|+.+.+.. ..+.+..|.++|+.+ .|||++.+++++.-
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34456789999999999999999999999999999999876532 246788899999988 59999999999854
Q ss_pred ---CCeEEEEEcccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 86 ---KSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 86 ---~~~~~lVmEy~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
++.+|+|||||.||+.-|+++. ..++.|+.+..+++.++.|+ .|||++.+|.|||+|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 4679999999999999999975 45799999999999999997 599999999999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccC-----CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 220 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 220 (426)
+..... ..+...+..|||.|||||++... .|+ ..+|+||||++..||..|.+|+-+..+...+-.|-.+.++
T Consensus 170 SaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP 246 (953)
T KOG0587|consen 170 SAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 246 (953)
T ss_pred eeeeec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc
Confidence 986544 34556788999999999998653 344 6899999999999999999999988877655555443322
Q ss_pred ---CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 221 ---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 221 ---~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
-|...+.++.++|..||.+|-.+||+..++++|||..+.
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 234478999999999999999999999999999999743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=287.02 Aligned_cols=239 Identities=29% Similarity=0.409 Sum_probs=202.5
Q ss_pred ccCEEEeceeeecCceEEEEEEECC-CC--ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLD-SG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.++..+.++||+|+||.|+.|.+.. +| -.||||.+..+.... ....|.+|+.+|.+|+|||+|+|||+..+ ...
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 3567778999999999999999875 33 368999998665432 46889999999999999999999999987 678
Q ss_pred EEEEcccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 90 YMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|||+++.|+|.+.+.+ +..|.......|+.||+.|+ .||||..-..+||+||||.+.+...
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 899999999999999986 34588888999999999997 5999999999999999999976543
Q ss_pred cCCCc-cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 014359 153 RDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 229 (426)
Q Consensus 153 ~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 229 (426)
..... .....-...|.|||.+....+. .++|||++||++|||++ |+.||.+.....+++++.++ .++-|+.++.++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedI 344 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDI 344 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHH
Confidence 22111 1112234589999999998885 89999999999999999 99999999999999988866 467889999999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w 255 (426)
.+++..||..+|++|||+..|.+.-+
T Consensus 345 Y~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHhHH
Confidence 99999999999999999999975543
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=262.94 Aligned_cols=221 Identities=23% Similarity=0.253 Sum_probs=178.9
Q ss_pred ceeeecCceEEEEEEECCCC----------ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 20 RTLGEGNFGKVKFAQDLDSG----------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
+.||+|+||.||+|.+..++ ..|++|++..... . ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---D-SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---h-HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999987766 3578887754321 1 4678899999999999999999999988 778
Q ss_pred EEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCC-------CEEEeccCCC
Q 014359 90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKG-------NIKISDFGLS 146 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g-------~lKl~DFGla 146 (426)
|+||||+++|+|.+++.... .++...+..++.||+.|+ +|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998755 799999999999999996 699999888 7999999999
Q ss_pred CCCCcccCCCccccccCCCcccchhhhccC-CCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCCCCCCCC
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW 224 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 224 (426)
..... .....++..|+|||++.+. ...+.++|||||||++|+|++ |..||...+......... .....|..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 85322 2234577889999998776 233589999999999999999 688997765433332222 22222333
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
....+.++|.+||..||.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3489999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=276.63 Aligned_cols=237 Identities=30% Similarity=0.461 Sum_probs=192.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-C-CC----ccceeEEEEe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H-PN----VVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-H-pn----Iv~l~~~~~~ 85 (426)
.-++|++.++||+|+||+|-.+.+..++..||||+++.-. ...+..+-|+.+|.++. + |+ +|++.++|.-
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 4579999999999999999999999999999999997432 23456677999999994 2 33 7888899999
Q ss_pred CCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCC--------------
Q 014359 86 KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDS-------------- 134 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~-------------- 134 (426)
.++++||+|.+ |-++++++..+ .+++..+++.+.+||+.++ ||||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999999 77999999864 3799999999999999995 8999853
Q ss_pred ------CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH
Q 014359 135 ------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 208 (426)
Q Consensus 135 ------~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~ 208 (426)
+-.+||+|||.|+.-. ..-.+...|..|.|||++.+-++. .++||||+||||+||.+|...|+..+..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred eeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcH
Confidence 2358999999998532 223677889999999999999996 8999999999999999999999876532
Q ss_pred ---HHHHHHHh------------------CCCCCCCC-------------------------CCHHHHHHHHHccccCcC
Q 014359 209 ---VLYQKIFR------------------GDFKLPKW-------------------------LSPGAQNLLRKILEPNPV 242 (426)
Q Consensus 209 ---~~~~~i~~------------------~~~~~p~~-------------------------~s~~~~~Li~~~L~~dP~ 242 (426)
.+++.+.. +...+|+. -..++.|||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 24444332 11111111 124678999999999999
Q ss_pred CCCChHHHhcCcCCccC
Q 014359 243 KRITIAGIKADEWFEQD 259 (426)
Q Consensus 243 ~R~t~~~il~h~w~~~~ 259 (426)
+|+|+.|++.||||...
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=280.79 Aligned_cols=228 Identities=27% Similarity=0.452 Sum_probs=199.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+.++..+||-|-||.||.|.+++-.-.||||.++.+.. ..+.|++|+.+|+.++|||+|+|+++|..+..+|||+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 45677899999999999999999888999999976532 26889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 95 y~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||..|+|.++++... -++.-....++.||.+|+ .|+|+.++..+||+|||+++++.. ..
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DT 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DT 419 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----Cc
Confidence 999999999998654 377777788999999997 499999999999999999997543 11
Q ss_pred cccccC---CCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 158 LHTTCG---SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 158 ~~~~~g---t~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
.+...| ...|.|||-+.-+.+. .|+|||+|||+|||+.| |-.||.+.+....|..+.++ +..-|..+++...+|
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeL 498 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYEL 498 (1157)
T ss_pred eecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHH
Confidence 222233 4589999999888875 89999999999999999 99999999999999888776 466789999999999
Q ss_pred HHHccccCcCCCCChHHHh
Q 014359 233 LRKILEPNPVKRITIAGIK 251 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il 251 (426)
++.||+.+|++||++++|-
T Consensus 499 MraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 499 MRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHhcCCcccCccHHHHH
Confidence 9999999999999999983
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=281.28 Aligned_cols=232 Identities=28% Similarity=0.441 Sum_probs=195.3
Q ss_pred cCEEEeceeeecCceEEEEEEECCC--C--ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDS--G--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~--~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
...++.+.||.|-||.||.|..... | -.||||..+.+.. .+..+.|..|..+|+.++|||||+++|+|.+ ...
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 3456677899999999999986532 2 3589999887543 3337899999999999999999999999965 468
Q ss_pred EEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|||||+++-|+|..+++.+ ..++......|+.||..|| .|||+.+...+||+|||+++..+.
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed-- 543 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED-- 543 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc--
Confidence 9999999999999999864 4689999999999999997 599999999999999999997654
Q ss_pred CCCccccccC--CCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 014359 154 DDGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~g--t~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 229 (426)
+...+...| ...|||||.+.-..++ .++|||-|||++||++. |.-||.+-...+....+.+| ++++|+.+|+.+
T Consensus 544 -~~yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 544 -DAYYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred -cchhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence 222222233 4689999999888775 89999999999999988 99999997777776667666 588999999999
Q ss_pred HHHHHHccccCcCCCCChHHHhc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..|+.+||+.+|.+||++.+|..
T Consensus 622 YslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHHH
Confidence 99999999999999999887643
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=261.53 Aligned_cols=238 Identities=13% Similarity=0.114 Sum_probs=178.6
Q ss_pred cccCEEEeceeeecCceEEEEEEECCC---CceEEEEEeecccccc--hhH------HHHHHHHHHHHhcCCCCCcccee
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIH--LKI------TDQIKREIATLKLLKHPNVVRLH 80 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~--~~~------~~~~~~Ei~il~~l~HpnIv~l~ 80 (426)
.-++|++.+.||+|+||+||+|.+..+ +..+|+|+........ +.. ......+...+..++|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 336899999999999999999998777 6678888654322110 000 01122334456677899999999
Q ss_pred EEEEeCC----eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEe
Q 014359 81 EVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKIS 141 (426)
Q Consensus 81 ~~~~~~~----~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~ 141 (426)
+++.... ..|++||++. .++.+.+......++..++.++.|++.|+ +|||++.++.+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 9875543 4578899884 47777776655678999999999999997 69999999999999
Q ss_pred ccCCCCCCCcccC-----CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HH------
Q 014359 142 DFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AV------ 209 (426)
Q Consensus 142 DFGla~~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~------ 209 (426)
|||+|+.+..... ........||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+... ..
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 9999986532111 112233579999999999988877 4899999999999999999999987532 11
Q ss_pred --HHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 210 --LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 210 --~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
....+..+...+ +..++.+.++++.||..+|.+||+++++++
T Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 CDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223333344333 346899999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=251.13 Aligned_cols=225 Identities=44% Similarity=0.773 Sum_probs=194.1
Q ss_pred CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCChHHHH
Q 014359 26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI 105 (426)
Q Consensus 26 ~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L~~~i 105 (426)
+||.||+|.+..+++.||+|++........ .+.+.+|+..+++++|+||+++++++......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999988899999999976543221 578899999999999999999999999999999999999999999999
Q ss_pred HhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccch
Q 014359 106 ASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 170 (426)
Q Consensus 106 ~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP 170 (426)
.....++...+..++.|++.++ .||++++++.++|+|||.+..... ........++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP---GGLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecc---ccccccccCCcCCCCH
Confidence 8766699999999999999986 699999999999999999986433 1234566789999999
Q ss_pred hhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHccccCcCCCCC
Q 014359 171 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRIT 246 (426)
Q Consensus 171 E~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~Li~~~L~~dP~~R~t 246 (426)
|.+.+..++ .++||||+|+++++|++|..||.. .+.......+..+....+.. ++..+.+++.+||..||++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999877775 799999999999999999999987 55666666666555443322 8899999999999999999999
Q ss_pred hHHHhcCcCC
Q 014359 247 IAGIKADEWF 256 (426)
Q Consensus 247 ~~~il~h~w~ 256 (426)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.72 Aligned_cols=240 Identities=32% Similarity=0.516 Sum_probs=194.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe------
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 85 (426)
-+.+|+.++.||+||||.||+++++-+|+.||||.|.... .......+.+|+..|.+|+|||||++|..|..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3567899999999999999999999999999999998654 34446789999999999999999999763310
Q ss_pred --------------------------------------------------------------------------------
Q 014359 86 -------------------------------------------------------------------------------- 85 (426)
Q Consensus 86 -------------------------------------------------------------------------------- 85 (426)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEcccCCCChHHHHHhCCCC-CHHHHHHHHHHHHHHH----
Q 014359 86 -------------------------K--------SKIYMVLEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGL---- 127 (426)
Q Consensus 86 -------------------------~--------~~~~lVmEy~~gg~L~~~i~~~~~l-~e~~~~~~~~ql~~al---- 127 (426)
+ ..+||-||||+...|.++|..+... ....+|++|+||+.||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 2379999999997777777664433 4888999999999997
Q ss_pred -----------hheeeCCCCCEEEeccCCCCCCC----c------------ccCCCccccccCCCcccchhhhccCC---
Q 014359 128 -----------ENILLDSKGNIKISDFGLSALPQ----H------------FRDDGLLHTTCGSPNYVAPEVLANRG--- 177 (426)
Q Consensus 128 -----------eNILld~~g~lKl~DFGla~~~~----~------------~~~~~~~~~~~gt~~Y~APE~l~~~~--- 177 (426)
-||+||++++|||+|||+|+... . .......+...||.-|+|||++.+..
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 59999999999999999998621 0 01123456778999999999998776
Q ss_pred CCCchhhHHHHHHHHHHHhcCCCCCCCc-cHHHHHHHHHhCCCCCCCC----CCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 178 YDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDFKLPKW----LSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 178 ~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~p~~----~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
|+ .|+|+||||||||||+ .||... ........+.++.++.|.. --+.-..+|++||+.||++|||+.|+|+
T Consensus 795 Yn-~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 795 YN-SKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cc-chhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 54 9999999999999998 456542 3345666777777776633 2356778999999999999999999999
Q ss_pred CcCCc
Q 014359 253 DEWFE 257 (426)
Q Consensus 253 h~w~~ 257 (426)
+.||.
T Consensus 871 s~llp 875 (1351)
T KOG1035|consen 871 SELLP 875 (1351)
T ss_pred ccCCC
Confidence 99986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=274.74 Aligned_cols=240 Identities=24% Similarity=0.374 Sum_probs=196.3
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
-.+..+++.||+|-||.|.++.- ..+..||||.++.... ......|.+||++|.+|+||||+.++++|..++.++++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 35678899999999999999985 4568999999987653 33468899999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 93 LEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|||++.|+|.+++..... ..-.....++.||++|+ .|+|+|.++++||+|||+++.+-.....
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999999987532 23445567999999997 5999999999999999999954332222
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc--CCCCCCCccHHHHHHHHH---hC-----CCCCCCCC
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIF---RG-----DFKLPKWL 225 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt--G~~Pf~~~~~~~~~~~i~---~~-----~~~~p~~~ 225 (426)
+......-..+|||||.+...+++ +++|+|++|+++||+++ ...||...+.++..+... .. .+..|.-+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 333344556899999999888885 89999999999999765 889998877665554432 21 24567789
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
+..+.+|+.+||..|-.+||+++++ |.+|++
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~l--h~~lq~ 803 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQL--HLFLQE 803 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence 9999999999999999999999999 444543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=284.71 Aligned_cols=237 Identities=24% Similarity=0.405 Sum_probs=207.3
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.....|.+.||.|.||.|++|+.+..| ..||||.++... .++....|+.|+.||-+++||||++|.|+......+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 345678899999999999999987655 479999998654 455578899999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
.||+|||++|+|..+++. ++.|+..+...+++.|++|+ .|||++.|-.+|++|||+++..+...
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999999999974 57799999999999999996 59999999999999999999775532
Q ss_pred CCCccccccCC--CcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 014359 154 DDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~gt--~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 229 (426)
+....+..|. .+|.|||.+...+++ .++||||+||++||.++ |..||-+.+.++....|.++ +++.|-++|..+
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred -CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence 3334444443 589999999999886 89999999999999887 99999888888888888877 577788899999
Q ss_pred HHHHHHccccCcCCCCChHHHhcC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+|+..||++|-++||+++||+.+
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=271.24 Aligned_cols=235 Identities=28% Similarity=0.411 Sum_probs=196.9
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC------CCCccceeEEEEeCC
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK------HPNVVRLHEVLASKS 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~~ 87 (426)
++|.+....|+|-|++|-.|.+...|..||||+|..+. -+.+.=++|+.||++|+ --|+++|+-.|...+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 58999999999999999999999999999999997653 33456678999999996 248999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFGLSAL 148 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFGla~~ 148 (426)
++|+|+|-+. -+|.+.++..+ ++....++.|.+||..|| +|||++++. .+||||||.|..
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 9999999994 59999998654 589999999999999997 699999875 689999999985
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC------
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP------ 222 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------ 222 (426)
.. ....+.+..+..|.|||++.|-+|+ .+.|+||+||+||||.||+..|++.+...++...+.-.-++|
T Consensus 587 ~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 587 AS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 43 2345566778899999999999997 889999999999999999999999877766654432111111
Q ss_pred ---------------------------------------------------CC---CCHHHHHHHHHccccCcCCCCChH
Q 014359 223 ---------------------------------------------------KW---LSPGAQNLLRKILEPNPVKRITIA 248 (426)
Q Consensus 223 ---------------------------------------------------~~---~s~~~~~Li~~~L~~dP~~R~t~~ 248 (426)
.. +-.++++||.+||..||++|+|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 00 124678999999999999999999
Q ss_pred HHhcCcCCcc
Q 014359 249 GIKADEWFEQ 258 (426)
Q Consensus 249 ~il~h~w~~~ 258 (426)
|+|+||||..
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=278.60 Aligned_cols=244 Identities=20% Similarity=0.265 Sum_probs=168.2
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCC----CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEE-
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDS----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV- 82 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~- 82 (426)
+.....++|++.+.||+|+||.||+|.+..+ +..||||.+..... .+....| .++...+.++..++..
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGF 198 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhh
Confidence 4566789999999999999999999999888 89999998764321 1111111 1122222333322221
Q ss_pred -----EEeCCeEEEEEcccCCCChHHHHHhCCC--------------------CCHHHHHHHHHHHHHHH----------
Q 014359 83 -----LASKSKIYMVLEYVTGGELFDKIASKGR--------------------LQEAEGRKLFQQLIDGL---------- 127 (426)
Q Consensus 83 -----~~~~~~~~lVmEy~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~ql~~al---------- 127 (426)
......+|+||||+.+++|.+++..... ..+..++.++.||+.||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456679999999999999999875321 12345678999999996
Q ss_pred -----hheeeCC-CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCC---------------------C
Q 014359 128 -----ENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD---------------------G 180 (426)
Q Consensus 128 -----eNILld~-~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~---------------------~ 180 (426)
+|||++. ++.+||+|||+|+..... ........+||+.|+|||.+...... +
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 7999996 589999999999854321 12334567899999999976432211 2
Q ss_pred chhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCC---------------------CCCCCHHHHHHHHHcccc
Q 014359 181 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---------------------PKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 181 ~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------p~~~s~~~~~Li~~~L~~ 239 (426)
.++||||+||+||+|+++..|++.. .......+....... ....+....+||.+||+.
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 4569999999999999988776532 112222221111110 111233456899999999
Q ss_pred CcCCCCChHHHhcCcCCccCC
Q 014359 240 NPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 240 dP~~R~t~~~il~h~w~~~~~ 260 (426)
||.+|||+.++++||||....
T Consensus 437 dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred CcccCCCHHHHhCCcCcCCCC
Confidence 999999999999999998743
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=272.96 Aligned_cols=227 Identities=35% Similarity=0.532 Sum_probs=183.1
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC------
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS------ 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 87 (426)
+-|..-+.||+||||.||+++++.+|+.||||.++... .....+...+|+++|++++|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 67888999999999999999999999999999998755 3333678889999999999999999999865543
Q ss_pred eEEEEEcccCCCChHHHHHh---CCCCCHHHHHHHHHHHHHHH---------------hheeeCCC--C--CEEEeccCC
Q 014359 88 KIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGL---------------ENILLDSK--G--NIKISDFGL 145 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~al---------------eNILld~~--g--~lKl~DFGl 145 (426)
...+|||||.||||+..+++ ..+++|.+...++..+..|+ +||++-.. | .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 47899999999999999974 45799999999999999997 69987433 3 479999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHHHHHHh----
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFR---- 216 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~---- 216 (426)
|+-.+ ++....+..||+.|.+||.+..+++++..+|.||+||++|++.||..||... +.+.++..+.+
T Consensus 171 Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99654 4557889999999999999997666679999999999999999999999542 22233333322
Q ss_pred ----------------CCCCCCCCCCHH----HHHHHHHccccCcCCCC
Q 014359 217 ----------------GDFKLPKWLSPG----AQNLLRKILEPNPVKRI 245 (426)
Q Consensus 217 ----------------~~~~~p~~~s~~----~~~Li~~~L~~dP~~R~ 245 (426)
..+++|..+++. +...+..+|..||.+|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 112334444443 34567888999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=265.27 Aligned_cols=249 Identities=18% Similarity=0.209 Sum_probs=176.2
Q ss_pred CccccCEEEeceeeecCceEEEEEEEC----------------CCCceEEEEEeecccccch-----------hHHHHHH
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDL----------------DSGLPFAVKILEKNRIIHL-----------KITDQIK 62 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~----------------~~~~~vAvK~i~~~~~~~~-----------~~~~~~~ 62 (426)
....++|++.+.||+|+||.||+|... ..++.||||.+........ ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 456789999999999999999999752 2356799999864321100 0012233
Q ss_pred HHHHHHhcCCCCCc-----cceeEEEEe--------CCeEEEEEcccCCCChHHHHHhCC--------------------
Q 014359 63 REIATLKLLKHPNV-----VRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASKG-------------------- 109 (426)
Q Consensus 63 ~Ei~il~~l~HpnI-----v~l~~~~~~--------~~~~~lVmEy~~gg~L~~~i~~~~-------------------- 109 (426)
.|+.++.+++|.++ +++++++.. .+..|+||||+++|+|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 47777777766554 677777643 356899999999999999886421
Q ss_pred ----CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccch
Q 014359 110 ----RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 170 (426)
Q Consensus 110 ----~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP 170 (426)
.+++..++.++.|++.|+ +|||++.++.+||+|||++...... .........+|+.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeCh
Confidence 235677888999999996 6999999999999999999754321 11111223458999999
Q ss_pred hhhccCCC--------------------C-CchhhHHHHHHHHHHHhcCCC-CCCCccHH-----------HHHHHHHhC
Q 014359 171 EVLANRGY--------------------D-GATSDIWSCGVILYVILTGYL-PFDDRNLA-----------VLYQKIFRG 217 (426)
Q Consensus 171 E~l~~~~~--------------------~-~~~~DIwSlGvil~elltG~~-Pf~~~~~~-----------~~~~~i~~~ 217 (426)
|++..... . ..+.||||+||++|+|++|.+ ||.+.... ..++.+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 99764321 1 124799999999999999986 77542211 111222223
Q ss_pred CCCCC--CCCCHHHHHHHHHccccCc---CCCCChHHHhcCcCCccC
Q 014359 218 DFKLP--KWLSPGAQNLLRKILEPNP---VKRITIAGIKADEWFEQD 259 (426)
Q Consensus 218 ~~~~p--~~~s~~~~~Li~~~L~~dP---~~R~t~~~il~h~w~~~~ 259 (426)
.+.++ ...++.+++|+.+||..+| .+|+|++|+|+||||...
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 34444 3478999999999999866 689999999999999653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=247.79 Aligned_cols=238 Identities=26% Similarity=0.379 Sum_probs=190.9
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVm 93 (426)
+.+-+..||.|+||+|++-.++.+|+..|||.|..... .....+++.|.....+- +.||||++||.+..++..|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 44446689999999999999999999999999987653 33457788888765554 6899999999999999999999
Q ss_pred cccCCCChHHHH-----HhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 94 EYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 94 Ey~~gg~L~~~i-----~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
|++.- +|..+- ..+.+++|...-.+..-.+.|| .|||||..|.+||||||.+..+..
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~- 220 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD- 220 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence 99943 664432 2346788888777777677775 599999999999999999874432
Q ss_pred cCCCccccccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHHHHhCCCCC---CCC--
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL---PKW-- 224 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~---p~~-- 224 (426)
.-..+.-.|..+|||||-+.. .+|+ .++||||||++|||+.||..||.+-+ ..+...++..|.++. +..
T Consensus 221 --SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 221 --SIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred --HHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 222334579999999999864 3566 89999999999999999999998754 345556666676553 222
Q ss_pred -CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 225 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 225 -~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
++..+..+|.-||.+|-+.||...+++++||+...
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 78999999999999999999999999999998764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=272.19 Aligned_cols=233 Identities=29% Similarity=0.473 Sum_probs=193.0
Q ss_pred EEEeceeeecCceEEEEEEEC----C---CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 16 YELGRTLGEGNFGKVKFAQDL----D---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~----~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
..+.+.||+|+||.|++|.-. . ....||||.++..... ...+.+..|+.+|+.+ .||||+.+++++..++
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 356679999999999999743 1 1457999998765433 4468899999999999 5999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hheeeCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENILLDSKG 136 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNILld~~g 136 (426)
..++|+||+..|+|.++++..+ .++..+...+..||+.|+ .|||+..+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 9999999999999999998754 388889999999999997 499999999
Q ss_pred CEEEeccCCCCCCCcccCCCccccccCCC--cccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCcc-HHHHHH
Q 014359 137 NIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN-LAVLYQ 212 (426)
Q Consensus 137 ~lKl~DFGla~~~~~~~~~~~~~~~~gt~--~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~-~~~~~~ 212 (426)
.+||+|||+|+........ ......||. .|||||.+....|+ .++||||+||+|||+.+ |..||.+.. ..+.++
T Consensus 456 ~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred EEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 9999999999843321111 111122223 49999999997775 89999999999999999 999999854 556677
Q ss_pred HHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 213 KIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 213 ~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.+..|. ...|..+++++.++++.||+.+|++||++.++.+
T Consensus 534 ~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 777774 5889999999999999999999999999999865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=270.10 Aligned_cols=241 Identities=29% Similarity=0.429 Sum_probs=207.6
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
-.++|+++..+|+|+||.||+|+++.+++..|+|+++...-.+ ..-+++|+-+++.++|||||.+++.+..++..|+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 3578999999999999999999999999999999998764322 5678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
.||||.||+|.+.-.-.++++|.++...++..+.|+ .|||+++.|.+|++|||.+..... .-.
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~ 167 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIA 167 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hhh
Confidence 999999999999888888999999999999999997 499999999999999999885433 233
Q ss_pred ccccccCCCcccchhhhc---cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC-----CCCCHH
Q 014359 157 LLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPG 228 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~---~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~ 228 (426)
...++.|||+|||||+-. ..+| ...+|||++|+...|+---++|..+..+........+..+..| ...++.
T Consensus 168 KrksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 456789999999999852 3345 5899999999999999888888777666666555555555544 236889
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
+.+|++.+|..||++|||++.++.|||...
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 999999999999999999999999999865
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=259.39 Aligned_cols=191 Identities=32% Similarity=0.586 Sum_probs=170.8
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHhcCC---CCCccceeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLK---HPNVVRLHE 81 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~---HpnIv~l~~ 81 (426)
...+..|+.++.||+|+||+|++|.++.+...|+||.|.+++..-.. ..-.+-.||.||..++ |+||+|+++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 45677899999999999999999999999999999999887654221 1123567999999997 999999999
Q ss_pred EEEeCCeEEEEEccc-CCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 82 VLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 82 ~~~~~~~~~lVmEy~-~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
+|++++.+|++||-- +|-|||++|+-+.+++|.+|+.+|+|++.|+ ||+.++.+|.+||+|||.
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 999999999999974 6789999999999999999999999999997 799999999999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 204 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 204 (426)
|.+. ..+......||..|.|||++.+.+|-|.+-|||++|++||.++....||..
T Consensus 717 aa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9864 346678899999999999999999999999999999999999999999863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=288.03 Aligned_cols=221 Identities=24% Similarity=0.338 Sum_probs=172.7
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
.|...+.||+|+||.||+|.+..++..||||.+..... ...+|+.++++++|||||++++++.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 45666789999999999999988999999998864321 12346889999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH------------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al------------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|+++|+|.+++.. +++..+..++.|++.|+ +||+++.++..++. ||.+....
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 9999999999963 89999999999999996 59999999988876 66654321
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc-----HHHHHHHHHhC-------CCCC---
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-----LAVLYQKIFRG-------DFKL--- 221 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~-------~~~~--- 221 (426)
......||+.|+|||++.+..++ .++||||+||++|||++|+.||+... ..+..+..... ++..
T Consensus 834 ~~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 834 TDTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred cCCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 11234689999999999887775 89999999999999999999996421 11111111100 0111
Q ss_pred ---CCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 222 ---PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 222 ---p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+.....++.+++.+||+.||++|||+.|+++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11112356789999999999999999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=262.24 Aligned_cols=232 Identities=24% Similarity=0.346 Sum_probs=197.4
Q ss_pred EEeceeeecCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 17 ELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
...++||+|+||+||+|.+.-.|+ +||||++.... ..+....+..|+-+|.+++|||+++|++++.... +.||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 345689999999999999865454 68999887554 3334678999999999999999999999998766 8899
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
++|+++|.|.|+++. +.++.......|..||++|+ .|+|+..-..+||.|||+|+.......+-
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999999975 56799999999999999997 59999999999999999999876543332
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~ 234 (426)
......-.+.|||-|.+....|. .++||||+||.+||++| |..||++....++-..+..+ +++.|+.++-++.-++-
T Consensus 856 ~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV 934 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence 22223335789999999998886 89999999999999999 99999998888877776666 57889999999999999
Q ss_pred HccccCcCCCCChHHHhc
Q 014359 235 KILEPNPVKRITIAGIKA 252 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~ 252 (426)
+||..|+..||++.++..
T Consensus 935 kCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 935 KCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhccCcccCccHHHHHH
Confidence 999999999999988643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=231.84 Aligned_cols=236 Identities=24% Similarity=0.430 Sum_probs=191.4
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeC--Ce
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~ 88 (426)
.+++|++.+.+|+|-|+.||.|.+..+++.++||+++.-. .+.++||+.||..|. ||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4578999999999999999999999999999999997553 478999999999997 99999999999765 35
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC-CCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK-GNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~-g~lKl~DFGla~~~~~~ 152 (426)
..+++||+.+.+...+- ..++..+++.|+.||+.|| .|+++|.. ..++|+|+|+|.+...
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp- 185 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 185 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-
Confidence 77999999987776554 3488999999999999998 49999976 4799999999997654
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCC-CCccHHHHHHHHHh---------------
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR--------------- 216 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~--------------- 216 (426)
.....-+..+..|--||.+.....+...-|+|||||+|..|+..+.|| .+.+..+...+|.+
T Consensus 186 --~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 --GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred --CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 233445677888999999887665568899999999999999988887 34443333322211
Q ss_pred -----------CCCCCCCC-----------CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 217 -----------GDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 217 -----------~~~~~p~~-----------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+..+--+| .++++.|||.++|..|..+|+|+.|++.||||...
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 01111112 57999999999999999999999999999999754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=242.19 Aligned_cols=243 Identities=28% Similarity=0.400 Sum_probs=198.7
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----e
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----K 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~ 88 (426)
-+.+--+.||.|+||.||.+.+..+|+.||+|.+..- ..+-...+.+.+|+.+|..++|.|++..+++..... .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3456678999999999999999999999999987642 223333578899999999999999999999987654 4
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+|+++|++.. ||...|.+...++.+.++-+++||+.|| .|+|+++|..+||||||+|+.-+..
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d- 209 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR- 209 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-
Confidence 8899999955 9999999889999999999999999997 4999999999999999999965432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHH------------------
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF------------------ 215 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~------------------ 215 (426)
.....+....|-+|.|||++.+...++.++||||.|||+.||+..+..|+..++.+..+.|.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 22334445678999999999998888899999999999999999999998776654443332
Q ss_pred -----hCCCCCCC-----------CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 216 -----RGDFKLPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 216 -----~~~~~~p~-----------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
++....|. .-..+..+++.++|.+||.+|++.++.+.|++....
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 22222221 234577889999999999999999999999998664
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=238.59 Aligned_cols=237 Identities=27% Similarity=0.428 Sum_probs=195.9
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 86 (426)
.-.||.-++.+|.|+- .|-.|.+.-++++||+|.+... ..+....++..+|..++..++|+||++++.++...
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 3457888899999998 7888989889999999988665 33444567889999999999999999999998554
Q ss_pred -CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
...|+||||+. ++|...+. -.++-..+..++.|++.|+ +||++..++.+||.|||+|+.-.
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 35899999995 59999887 3488889999999999995 79999999999999999998422
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-------------
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------- 217 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------- 217 (426)
..-..+....|..|.|||++.+.+|. +.+||||+||++.||++|+..|.+.+.-+.+.++...
T Consensus 170 ---~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 ---TDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ---cccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 23356678899999999999999874 8999999999999999999999987766555444320
Q ss_pred ---------C-----CC----CCCC-----------CCHHHHHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 218 ---------D-----FK----LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 218 ---------~-----~~----~p~~-----------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
. .. +|.+ -+..+++|+.+||..||++|++++++|+|||++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 11 1211 245689999999999999999999999999998
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=243.42 Aligned_cols=235 Identities=23% Similarity=0.341 Sum_probs=187.4
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhc--CCCCCccceeEEEEeC
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASK 86 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~ 86 (426)
+...+...++.+.+|+|.||.||+|.. +++.||||++.... .+.+++|-+|.+. ++|+||+++++.-...
T Consensus 205 pl~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 205 PLLELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred ccccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 345567788899999999999999985 56899999997543 4566677666655 4799999999986544
Q ss_pred C----eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH------------------------hheeeCCCCCE
Q 014359 87 S----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------------------------ENILLDSKGNI 138 (426)
Q Consensus 87 ~----~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al------------------------eNILld~~g~l 138 (426)
+ .++||+||.+.|+|.+++.. ..++.....+++..++.|| .||||.+|++.
T Consensus 277 t~~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 277 TADRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred CccccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 4 79999999999999999987 4599999999999999997 49999999999
Q ss_pred EEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCC-----chhhHHHHHHHHHHHhcCC------------CC
Q 014359 139 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG-----ATSDIWSCGVILYVILTGY------------LP 201 (426)
Q Consensus 139 Kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-----~~~DIwSlGvil~elltG~------------~P 201 (426)
-|+|||+|-.+......+......||.+|||||++.+.--.. .+.||||+|.||||+++.. +|
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp 435 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP 435 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence 999999999887766666777799999999999997753221 3689999999999999842 34
Q ss_pred CC-----CccHHHHHHHHH--hCCCCCCCC-----CCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 202 FD-----DRNLAVLYQKIF--RGDFKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 202 f~-----~~~~~~~~~~i~--~~~~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
|. .++.+++...+. +.++.+|.. -...+++.+..||+.||+-|+|+.-+.+
T Consensus 436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 43 244455544433 345666643 2456889999999999999999875543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=239.41 Aligned_cols=231 Identities=26% Similarity=0.414 Sum_probs=178.3
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH--hcCCCCCccceeEEEEeC----
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL--KLLKHPNVVRLHEVLASK---- 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il--~~l~HpnIv~l~~~~~~~---- 86 (426)
-.+.++.+.||+|.||.||+|.+ .|+.||||++.... .....||.+|. ..|+|+||+.+++.-..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 45789999999999999999997 58899999997542 23445555555 456999999998874322
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------------hheeeCCCCCEEEecc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------------ENILLDSKGNIKISDF 143 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------------eNILld~~g~lKl~DF 143 (426)
..+|+|++|.+.|+|+|++.. ..++.....+++..+++|| .|||+..||.+-|+|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 359999999999999999988 6799999999999999997 4999999999999999
Q ss_pred CCCCCCCccc--CCCccccccCCCcccchhhhccCC----CCC-chhhHHHHHHHHHHHhcC----------CCCCCC--
Q 014359 144 GLSALPQHFR--DDGLLHTTCGSPNYVAPEVLANRG----YDG-ATSDIWSCGVILYVILTG----------YLPFDD-- 204 (426)
Q Consensus 144 Gla~~~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~----~~~-~~~DIwSlGvil~elltG----------~~Pf~~-- 204 (426)
|||-...... -+-.....+||.+|||||++...- +.+ ..+||||||.|+||++.. ++||.+
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9998654421 123456789999999999986532 111 468999999999999852 678854
Q ss_pred ---ccHHHHHHHHHh--CCCCCC-CCCCH----HHHHHHHHccccCcCCCCChHHHhc
Q 014359 205 ---RNLAVLYQKIFR--GDFKLP-KWLSP----GAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 205 ---~~~~~~~~~i~~--~~~~~p-~~~s~----~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
++.+++..-+.- -++.+| .|-+. .+..|++.||..||+-|.|+--|.+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 455566554433 344555 45443 3456899999999999999877654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=239.93 Aligned_cols=238 Identities=27% Similarity=0.447 Sum_probs=184.6
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----C---CCccceeEEEEe
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----H---PNVVRLHEVLAS 85 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~~ 85 (426)
|||.+.++||.|-|++||+|.+..+.+.||+|+.+... ...+....||.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 79999999999999999999999999999999997543 23567778999999884 3 369999999965
Q ss_pred ----CCeEEEEEcccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH----------------h---------------
Q 014359 86 ----KSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL----------------E--------------- 128 (426)
Q Consensus 86 ----~~~~~lVmEy~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al----------------e--------------- 128 (426)
..++++|+|++ |.+|..+|.. .++++...++.|++|++.|| |
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 45799999999 8899999975 45799999999999999995 0
Q ss_pred --------------------------------------------------------------------------------
Q 014359 129 -------------------------------------------------------------------------------- 128 (426)
Q Consensus 129 -------------------------------------------------------------------------------- 128 (426)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred --------------------he--------------------------------------------eeC-------CCCC
Q 014359 129 --------------------NI--------------------------------------------LLD-------SKGN 137 (426)
Q Consensus 129 --------------------NI--------------------------------------------Lld-------~~g~ 137 (426)
|. ++. .+-.
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 00 000 0114
Q ss_pred EEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc-------HH--
Q 014359 138 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LA-- 208 (426)
Q Consensus 138 lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-------~~-- 208 (426)
+||+|||.|+-+ ....+.-.-|..|+||||+.+.+|. +.+||||++|++|||+||...|+..+ ..
T Consensus 393 vKIaDlGNACW~-----~khFT~DIQTRQYRapEVllGsgY~-~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 393 VKIADLGNACWV-----HKHFTEDIQTRQYRAPEVLLGSGYS-TSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred EEEeeccchhhh-----hhhhchhhhhhhccCcceeecCCCC-CchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 799999999853 2345556789999999999999995 88999999999999999999885321 11
Q ss_pred -HHHH-------HH-HhCC------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCChHH
Q 014359 209 -VLYQ-------KI-FRGD------------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAG 249 (426)
Q Consensus 209 -~~~~-------~i-~~~~------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~ 249 (426)
.+.+ ++ ..|+ +.++..-..++.+||.-||+.+|++|||+.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 1111 11 1111 1111112456789999999999999999999
Q ss_pred HhcCcCCccCCCC
Q 014359 250 IKADEWFEQDYTP 262 (426)
Q Consensus 250 il~h~w~~~~~~~ 262 (426)
+++|||+.....+
T Consensus 547 cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 547 CLKHPWLNPVAGP 559 (590)
T ss_pred HhcCccccCCCCC
Confidence 9999999976554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=212.19 Aligned_cols=205 Identities=45% Similarity=0.732 Sum_probs=173.2
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
|++.+.||+|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++......|+++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999888999999999765432 2467899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 96 VTGGELFDKIASKGR-LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
+.+++|.+++..... +++.....++.|++.++ .||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 999999999988666 89999999999999986 69999999999999999998654321 11334
Q ss_pred cccCCCcccchhhh-ccCCCCCchhhHHHHHHHHHHHhcCCCCCCC--ccHHHHHHHHHhCCCCCCCC
Q 014359 160 TTCGSPNYVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPFDD--RNLAVLYQKIFRGDFKLPKW 224 (426)
Q Consensus 160 ~~~gt~~Y~APE~l-~~~~~~~~~~DIwSlGvil~elltG~~Pf~~--~~~~~~~~~i~~~~~~~p~~ 224 (426)
...++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+...+.+.+..+.+...+|
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWEW 224 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccccc
Confidence 56788999999998 555554 699999999999999999999987 44457788888777555444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=249.96 Aligned_cols=229 Identities=31% Similarity=0.429 Sum_probs=179.9
Q ss_pred eceeeecCceE-EEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEEEccc
Q 014359 19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 19 ~~~LG~G~fg~-V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lVmEy~ 96 (426)
.+.+|.|+-|+ ||+|.. .|+.||||.+-.+. .....|||..|+.- +|||||++|+.-.+++..||..|+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35789999874 689884 78899999775432 45788999999998 5999999999999999999999999
Q ss_pred CCCChHHHHHhCCC---C-CHHHHHHHHHHHHHHH---------------hheeeCC---CC--CEEEeccCCCCCCCcc
Q 014359 97 TGGELFDKIASKGR---L-QEAEGRKLFQQLIDGL---------------ENILLDS---KG--NIKISDFGLSALPQHF 152 (426)
Q Consensus 97 ~gg~L~~~i~~~~~---l-~e~~~~~~~~ql~~al---------------eNILld~---~g--~lKl~DFGla~~~~~~ 152 (426)
.. +|.++++..+. . .....+..+.|+++|+ .||||+. ++ .++|+|||+++.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 65 99999987421 1 1144578899999986 6999987 34 6899999999966543
Q ss_pred cC-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCCCCCC---CCCCH
Q 014359 153 RD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP---KWLSP 227 (426)
Q Consensus 153 ~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~ 227 (426)
.. -....+..||-+|+|||++....-. .++||+|+|||+|+.++ |..||.+.-.. ..+|..+.+.+- +.-..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCchH
Confidence 22 2234566899999999999887654 78999999999999999 59999864322 234555554332 11122
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
++.+||.+|++++|..||++.+++.||+|-..
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 89999999999999999999999999999763
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=203.18 Aligned_cols=198 Identities=44% Similarity=0.773 Sum_probs=171.2
Q ss_pred eeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccCCCCh
Q 014359 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL 101 (426)
Q Consensus 22 LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L 101 (426)
||+|++|.||++.+..+++.+++|++....... ..+.+.+|+..++.++|++|+++++++......+++|||+.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998789999999997654221 346799999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCC-CCCEEEeccCCCCCCCcccCCCccccccCC
Q 014359 102 FDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGS 164 (426)
Q Consensus 102 ~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~-~g~lKl~DFGla~~~~~~~~~~~~~~~~gt 164 (426)
.+++... ..++...++.++.+++.++ .||+++. ++.++|+|||.+....... .......++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--SLLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc--chhhcccCC
Confidence 9999875 5799999999999999986 6999999 8999999999998543311 123445688
Q ss_pred CcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 014359 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 244 (426)
Q Consensus 165 ~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 244 (426)
..|++||.+......+.++|+||+|+++++| ..+.+++.+||+.||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 9999999987762345889999999999998 788899999999999999
Q ss_pred CChHHHhcCc
Q 014359 245 ITIAGIKADE 254 (426)
Q Consensus 245 ~t~~~il~h~ 254 (426)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=215.51 Aligned_cols=239 Identities=26% Similarity=0.424 Sum_probs=187.5
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEE-EEeCCe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV-LASKSK 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~-~~~~~~ 88 (426)
...+.|.|.+.||+|.||++.+++++.+++.+++|.+++... ....|.+|...--.| .|.||+.-|++ |++.+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 445789999999999999999999999999999999986532 256788998776666 48999999887 577788
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeC-CC-CCEEEeccCCCCCCCc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLD-SK-GNIKISDFGLSALPQH 151 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld-~~-g~lKl~DFGla~~~~~ 151 (426)
+.++|||++.|||.+-+.. .++.|...+.++.|+++|+ ||||+- .| -++||||||+.+...
T Consensus 97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g- 174 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG- 174 (378)
T ss_pred EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC-
Confidence 8899999999999998877 5699999999999999997 799984 33 379999999988432
Q ss_pred ccCCCccccccCCCcccchhhhccCC---C-CCchhhHHHHHHHHHHHhcCCCCCCCccHH----HHHHHHHhC-CCCCC
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRG---Y-DGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRG-DFKLP 222 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~---~-~~~~~DIwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~-~~~~p 222 (426)
...+..--+-.|.|||++.... + ..+.+|||.||+|+|.+|||.+||+..... ..+.++..+ .+..|
T Consensus 175 ----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 175 ----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred ----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 2333445567899999865321 1 136789999999999999999999854322 233344333 34455
Q ss_pred C---CCCHHHHHHHHHccccCcCCC---CChHHHhcCcCCccC
Q 014359 223 K---WLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQD 259 (426)
Q Consensus 223 ~---~~s~~~~~Li~~~L~~dP~~R---~t~~~il~h~w~~~~ 259 (426)
. -+++.+..+.++-|.++|++| -++...+...|....
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 3 389999999999999999999 556666677786543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-28 Score=250.78 Aligned_cols=246 Identities=29% Similarity=0.503 Sum_probs=198.5
Q ss_pred cCE-EEeceeeecCceEEEEEEECCCCceEEEEEeec---ccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK---NRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 14 ~~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~---~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.+| .....+|.|++|.|+.+......+.++.|.... ...........+..|..+-..+.|||++.....+.+...+
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 456789999999999888877777677775542 1111222233377888899999999999888888777767
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+-+||||++ ||+.++...+++...++..++.||+.|+ ||++++.+|.+||+|||.+..+.....
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 777999999 9999999988999999999999999986 799999999999999999998776554
Q ss_pred C--CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHH--HHHHH-------hCCCCCCC
Q 014359 155 D--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL--YQKIF-------RGDFKLPK 223 (426)
Q Consensus 155 ~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~--~~~i~-------~~~~~~p~ 223 (426)
. ......+|+.+|+|||++.+..|+...+||||+|++++.|.+|+.||..+...+. +.... .+...+-.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 4 5567789999999999999999999999999999999999999999976544322 11111 11112223
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.++...+.+|.+||++||.+|+|+++|++.+||+...
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 4788999999999999999999999999999998754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=201.63 Aligned_cols=196 Identities=22% Similarity=0.387 Sum_probs=160.7
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 92 (426)
+....+..||+|+||.|-+-++..+|...|+|.+...- ..+..+++.+|+.+..+. ..|.+|++|+.+.....+|+.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 45556778999999999999999999999999997543 233457788999887776 699999999999999999999
Q ss_pred EcccCCCChHHHH----HhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 93 LEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 93 mEy~~gg~L~~~i----~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
||.+.. +|..+- ...+.++|...-+++..++.|| .|||++.+|++|+||||.+..+..
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d- 201 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD- 201 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh-
Confidence 999954 775543 4466799999999999999997 499999999999999999986532
Q ss_pred cCCCcccc-ccCCCcccchhhhcc----CCCCCchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHHhC
Q 014359 153 RDDGLLHT-TCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG 217 (426)
Q Consensus 153 ~~~~~~~~-~~gt~~Y~APE~l~~----~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~ 217 (426)
....+ ..|...|||||.+.. .+|+ .++||||||+.++||.+++.||+. .++.+.+.++...
T Consensus 202 ---SiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 202 ---SIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred ---hhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 33333 678899999998753 3565 899999999999999999999975 4555666666544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=215.08 Aligned_cols=237 Identities=19% Similarity=0.212 Sum_probs=197.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE-eC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SK 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~ 86 (426)
..|+++...+-+|+||.||.|.++. +.+.|-+|.++... ++-....+..|...+..+.|||+..+.+++. +.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 3578888899999999999997653 23456677765433 2334678889999999999999999999975 55
Q ss_pred CeEEEEEcccCCCChHHHHHhC--------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEecc
Q 014359 87 SKIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDF 143 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~--------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DF 143 (426)
...++++.+..-|+|..++... +.++..+...+..|++.|+ .|.++|+.-++||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 6788999999999999999721 2367777788999999997 4999999999999999
Q ss_pred CCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCC
Q 014359 144 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL 221 (426)
Q Consensus 144 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~ 221 (426)
.+++...+.+-...-........||+||.+.+..|. .++|+|||||+||||+| |+.||...++.+++..+++| +...
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 999965544333333444556789999999998885 89999999999999999 99999999999999999988 4677
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 222 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
|..+|.++..++..||..+|++||+++|+..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 8889999999999999999999999999854
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-26 Score=201.38 Aligned_cols=150 Identities=24% Similarity=0.301 Sum_probs=120.8
Q ss_pred CChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCccc
Q 014359 99 GELFDKIASK-GRLQEAEGRKLFQQLIDGL---------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 168 (426)
Q Consensus 99 g~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~ 168 (426)
|+|.+++..+ .++++..++.++.|++.|| +|||++.++.+|+ ||++..... ....||+.||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~g~~~y~ 71 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQAKSGNILLTWDGLLKL--DGSVAFKTP-------EQSRVDPYFM 71 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccEeEcCccceee--ccceEeecc-------ccCCCccccc
Confidence 6899999864 4699999999999999997 6999999999999 999885432 1236899999
Q ss_pred chhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHHhCCCCC-------CCCCCH--HHHHHHHHccc
Q 014359 169 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKL-------PKWLSP--GAQNLLRKILE 238 (426)
Q Consensus 169 APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~Li~~~L~ 238 (426)
|||++.+..|+ .++||||+||++|+|++|+.||..... ...+..+....... +..++. .+.++|.+||.
T Consensus 72 aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~ 150 (176)
T smart00750 72 APEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCAS 150 (176)
T ss_pred ChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHh
Confidence 99999988875 899999999999999999999976543 23333333322111 222344 69999999999
Q ss_pred cCcCCCCChHHHhcCcCCcc
Q 014359 239 PNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 239 ~dP~~R~t~~~il~h~w~~~ 258 (426)
.||.+|||+.++++|+|+..
T Consensus 151 ~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 151 RLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cccccccCHHHHHHHHHHHH
Confidence 99999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=217.35 Aligned_cols=240 Identities=28% Similarity=0.423 Sum_probs=187.5
Q ss_pred ccccCEEEeceeeecCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 86 (426)
.....|.+.++||+|+|+.||+|.+.. ..+.||+|.+..... ..++.+|+++|..+. +.||+++.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 345679999999999999999999877 788999999875432 467999999999995 99999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC-CCEEEeccCCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK-GNIKISDFGLSALPQ 150 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~-g~lKl~DFGla~~~~ 150 (426)
+...+||||++..+..++... ++-.+++.|++.++.|| .|+|.+.. +.-.|+|||+|...+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999999888887755 78999999999999997 48888765 678899999997211
Q ss_pred ccc-------------------------------CCC-----------ccccccCCCcccchhhhccCCCCCchhhHHHH
Q 014359 151 HFR-------------------------------DDG-----------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSC 188 (426)
Q Consensus 151 ~~~-------------------------------~~~-----------~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSl 188 (426)
... +.+ ......||++|.|||++.+.+-.++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 000 00123599999999999988777889999999
Q ss_pred HHHHHHHhcCCCCCCCcc-----HHHHH--------HH----------------------------H-----HhCCC---
Q 014359 189 GVILYVILTGYLPFDDRN-----LAVLY--------QK----------------------------I-----FRGDF--- 219 (426)
Q Consensus 189 Gvil~elltG~~Pf~~~~-----~~~~~--------~~----------------------------i-----~~~~~--- 219 (426)
|||+.-+++++.||-... ..++. ++ + .+.+.
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999983211 00000 00 0 00000
Q ss_pred C---CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 220 K---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 220 ~---~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
. ..+.++..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0 00125668999999999999999999999999999984
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-26 Score=227.86 Aligned_cols=225 Identities=32% Similarity=0.629 Sum_probs=193.8
Q ss_pred eeeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEEEEccc
Q 014359 21 TLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 21 ~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lVmEy~ 96 (426)
++|+|+||+|++++.. +.+..+|+|+..+........ .....|-.++..++ ||.+++++..++.++..|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 4799999999986532 567889999998655433222 25566778888886 999999999999999999999999
Q ss_pred CCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccc
Q 014359 97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 161 (426)
Q Consensus 97 ~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~ 161 (426)
.||+|+..+.....+.+...+.+...++-|+ +||+++.+|++++.|||+++..-. ....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~------~~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK------EKIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh------hhhc
Confidence 9999999999888899999999999888885 799999999999999999985322 1222
Q ss_pred cCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCc
Q 014359 162 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNP 241 (426)
Q Consensus 162 ~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP 241 (426)
|||..|||||++. ++. ..+|.||+|++.|+|+||..||.. +....|.+..+.+|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999998 444 789999999999999999999998 777888888999999999999999999999999
Q ss_pred CCCCC-----hHHHhcCcCCccC
Q 014359 242 VKRIT-----IAGIKADEWFEQD 259 (426)
Q Consensus 242 ~~R~t-----~~~il~h~w~~~~ 259 (426)
.+|.- ..+|++|++|+..
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHhccCcchhHHHhccchheee
Confidence 99986 4799999999763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=233.84 Aligned_cols=186 Identities=16% Similarity=0.181 Sum_probs=133.5
Q ss_pred cCCC-CCccceeEEE-------EeCCeEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH-------------
Q 014359 70 LLKH-PNVVRLHEVL-------ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL------------- 127 (426)
Q Consensus 70 ~l~H-pnIv~l~~~~-------~~~~~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al------------- 127 (426)
.++| +||.++++++ .....++.+|||+ +++|.+++.. ...+++.+++.++.||+.||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5788888876 2334678888987 6699999975 45699999999999999997
Q ss_pred --hheeeCCC-------------------CCEEEeccCCCCCCCcccC--------------CCccccccCCCcccchhh
Q 014359 128 --ENILLDSK-------------------GNIKISDFGLSALPQHFRD--------------DGLLHTTCGSPNYVAPEV 172 (426)
Q Consensus 128 --eNILld~~-------------------g~lKl~DFGla~~~~~~~~--------------~~~~~~~~gt~~Y~APE~ 172 (426)
+||||+.. +.+||+|||+++....... .......+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 79999654 4556666666653211000 000112468999999999
Q ss_pred hccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHccccCcCCCCChHHHh
Q 014359 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIK 251 (426)
Q Consensus 173 l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il 251 (426)
+.+..| +.++|||||||+||||++|..|+..... ....+.....+ .+....+...+++.+||++||.+|||+.|++
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 988887 4899999999999999999998764321 12222111111 1111346678999999999999999999999
Q ss_pred cCcCCccC
Q 014359 252 ADEWFEQD 259 (426)
Q Consensus 252 ~h~w~~~~ 259 (426)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-21 Score=185.49 Aligned_cols=241 Identities=37% Similarity=0.604 Sum_probs=197.8
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC-CccceeEEEEeCCeEEEEEc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lVmE 94 (426)
|.+.+.||.|+||.||++.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999986 78999999876554433567899999999999988 79999999988888899999
Q ss_pred ccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccCCCCCCCcccCC
Q 014359 95 YVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 95 y~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFGla~~~~~~~~~ 155 (426)
|+.+++|.+.+.... .+++..+..++.|++.++ +||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887664 799999999999999984 799999999 7999999999854432221
Q ss_pred ----CccccccCCCcccchhhhccC--CCCCchhhHHHHHHHHHHHhcCCCCCCCcc----HHHHHHHHHhCCCC-CCCC
Q 014359 156 ----GLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFK-LPKW 224 (426)
Q Consensus 156 ----~~~~~~~gt~~Y~APE~l~~~--~~~~~~~DIwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~-~p~~ 224 (426)
......+||+.|+|||.+.+. .+.....|+||+|++++++++|..||.... .......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 135678999999999999874 345689999999999999999999998766 34555555544433 2222
Q ss_pred CC--------HHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 225 LS--------PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 225 ~s--------~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 22 478999999999999999999999888666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=182.52 Aligned_cols=157 Identities=20% Similarity=0.139 Sum_probs=119.3
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECC-CCceEEEEEeecccc--cchhHHHHHHHHHHHHhcCCCCCccc-eeEEEE
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVR-LHEVLA 84 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~ 84 (426)
.....++|++.+.||+|+||+||+|.+.. +++.||||.+..... ........+.+|+.+|+.++|+||+. +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34566899999999999999999999876 678889998753311 12234567999999999999999985 4442
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~ 148 (426)
+..|+||||++|++|.. +.. .. ...++.|++.|| +|||++.++.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 45899999999999973 221 11 145778888875 699999999999999999997
Q ss_pred CCcccCCC------ccccccCCCcccchhhhccC
Q 014359 149 PQHFRDDG------LLHTTCGSPNYVAPEVLANR 176 (426)
Q Consensus 149 ~~~~~~~~------~~~~~~gt~~Y~APE~l~~~ 176 (426)
+....... .....++++.|+|||.+...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 65433222 23467899999999998643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-22 Score=209.08 Aligned_cols=245 Identities=32% Similarity=0.521 Sum_probs=207.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 90 (426)
...|.+.+.||+|+|+.|-++.+.. +...+|+|.+.... ........+..|..+-+.+. |+|++++++...+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5679999999999999999888743 45567777765443 23344567788999999997 999999999999999999
Q ss_pred EEEcccCCCChHHHH-HhCC-CCCHHHHHHHHHHHHHHH----------------hheeeCCCC-CEEEeccCCCCCCCc
Q 014359 91 MVLEYVTGGELFDKI-ASKG-RLQEAEGRKLFQQLIDGL----------------ENILLDSKG-NIKISDFGLSALPQH 151 (426)
Q Consensus 91 lVmEy~~gg~L~~~i-~~~~-~l~e~~~~~~~~ql~~al----------------eNILld~~g-~lKl~DFGla~~~~~ 151 (426)
++++|..|+++++.+ .... .++...+..++.|+.+++ +|.+++.++ .+|++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 7666 799999999999999985 799999999 999999999998877
Q ss_pred -ccCCCccccccC-CCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHHhC--C--CCCCCC
Q 014359 152 -FRDDGLLHTTCG-SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRG--D--FKLPKW 224 (426)
Q Consensus 152 -~~~~~~~~~~~g-t~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~--~--~~~p~~ 224 (426)
.+........|| ++.|+|||...+..|.++..|+||+|+++..+++|..||....... .+..+... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 566777888899 9999999999998888999999999999999999999998765432 22222222 2 223344
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
++....+++.++|..+|..|.+.+++..++|+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8999999999999999999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.3e-21 Score=173.37 Aligned_cols=231 Identities=21% Similarity=0.361 Sum_probs=184.6
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.+..++...++.+|.+.-.|..|+|++.. ..++.|++..... .......|..|.-.|+.+.||||+.+++.|.+..+
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred cCcchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 35667777888899999999999999853 3466788865443 33345678899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHH-----------------hheeeCCCCCEEEe--ccCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL-----------------ENILLDSKGNIKIS--DFGLSA 147 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~al-----------------eNILld~~g~lKl~--DFGla~ 147 (426)
..++..|++.|+|+..+..... ++..++.++..+++.|+ ..+++|++-+.+|+ |--++.
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence 9999999999999999987554 67888899999999885 37788888766653 322221
Q ss_pred CCCcccCCCccccccCCCcccchhhhccCCCC--CchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHH-hC-CCCCCC
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RG-DFKLPK 223 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~--~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~-~~~~p~ 223 (426)
......-.|.||+||.+...+.+ -.++|+|||.++||||.|...||.+-...+.-.++. .| +..+|+
T Consensus 342 ---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp 412 (448)
T KOG0195|consen 342 ---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP 412 (448)
T ss_pred ---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC
Confidence 01123457999999999887654 357999999999999999999999877766555543 22 577899
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHh
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIK 251 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il 251 (426)
.+++....|++-|+..||.+||.+.+|.
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999999999988763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=198.38 Aligned_cols=214 Identities=29% Similarity=0.530 Sum_probs=162.1
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
-.+|..++++..|+||.||+.+|+.+.+++|+| ++++.+ +.|- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------hhhc--cccccCCccee---------------
Confidence 357999999999999999999999999999995 444321 1211 44444555555
Q ss_pred EcccCCCChHHHHHhCCCCCHHH--HHHHHHHHHH---H--HhheeeCCCCCEEEeccCCCCCCCcccC-----------
Q 014359 93 LEYVTGGELFDKIASKGRLQEAE--GRKLFQQLID---G--LENILLDSKGNIKISDFGLSALPQHFRD----------- 154 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~--~~~~~~ql~~---a--leNILld~~g~lKl~DFGla~~~~~~~~----------- 154 (426)
||=...++.-++++.+. +..|++..-. . .+|+|++.-|++|++|||+++..-....
T Consensus 136 ------gDc~tllk~~g~lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~ 209 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKD 209 (1205)
T ss_pred ------chhhhhcccCCCCcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHH
Confidence 45555565555555554 2222221110 0 2799999999999999999874211100
Q ss_pred --CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCC---CCHHH
Q 014359 155 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW---LSPGA 229 (426)
Q Consensus 155 --~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~---~s~~~ 229 (426)
.-.....||||.|.|||++..++| |.++|+|++|+|+|+.+.|..||.+.+.++++.+.......+|+. +++++
T Consensus 210 t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea 288 (1205)
T KOG0606|consen 210 THEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEA 288 (1205)
T ss_pred HHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHH
Confidence 011234599999999999999998 699999999999999999999999999999999988877777744 78999
Q ss_pred HHHHHHccccCcCCCC---ChHHHhcCcCCccC
Q 014359 230 QNLLRKILEPNPVKRI---TIAGIKADEWFEQD 259 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~---t~~~il~h~w~~~~ 259 (426)
+++|.++|..+|..|. .+-++.+|+||+..
T Consensus 289 ~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 289 QDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred HHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 9999999999999997 46789999999753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-18 Score=166.51 Aligned_cols=234 Identities=22% Similarity=0.280 Sum_probs=179.7
Q ss_pred CEEEeceeeecCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHhcCCC----CCccceeEEE-EeCCe
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----PNVVRLHEVL-ASKSK 88 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~ 88 (426)
+|.+.+.||+|+||.||++.+..++ ..+|+|+-........ ..+..|+.++..+.+ +++.++++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 6789998765432211 267889999999873 6999999999 57888
Q ss_pred EEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCC-----CCEEEeccCCC
Q 014359 89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSK-----GNIKISDFGLS 146 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~-----g~lKl~DFGla 146 (426)
.|+||+.+ |.+|.++.... ++++...+.++..|++.+| +|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 88999988543 5799999999999999997 59999765 36999999999
Q ss_pred CCCCcccCCC-------c-cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH---HHHHHHH
Q 014359 147 ALPQHFRDDG-------L-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIF 215 (426)
Q Consensus 147 ~~~~~~~~~~-------~-~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---~~~~~i~ 215 (426)
+.+....... . .....||..|.++.+..+... +.+.|+||++.++.+++.|.+||.+.... ..+....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 9433211111 1 123459999999999888776 59999999999999999999999775532 2222222
Q ss_pred hCC-CC-CCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 216 RGD-FK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 216 ~~~-~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
... .. .....+.++..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 221 11 234456778888887777899999998877654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-19 Score=191.57 Aligned_cols=231 Identities=26% Similarity=0.360 Sum_probs=172.6
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeeccc-ccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR-IIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
+|...+.||++.|=+|.+|++. .|. |+||++-+.. ...-....+..+|++ ....+|||++.+.-+.+.....|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 7888999999999999999973 454 9999997654 222222344445566 66679999999999988888899999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc--ccCC-
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH--FRDD- 155 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~--~~~~- 155 (426)
+|+.. +|+|+|..+.-+...+-++|+.||+.|+ ||||+++-+.+.|+||..-+..-- .++.
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99966 9999999888899999999999999997 899999999999999987653211 1111
Q ss_pred --CccccccCCCcccchhhhccCC----------CCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCCCCCC
Q 014359 156 --GLLHTTCGSPNYVAPEVLANRG----------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 222 (426)
Q Consensus 156 --~~~~~~~gt~~Y~APE~l~~~~----------~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 222 (426)
-...+...-.+|.|||-+.... .-.++.||||+||+++||++ |++||.-...-.+. .+.-..|
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr----~~~~~~~ 255 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYR----SGNADDP 255 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHh----ccCccCH
Confidence 1223334456899999876522 12478999999999999999 89999532211111 1100000
Q ss_pred -----CCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 223 -----KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 223 -----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.--+..+++||..|++.||++|.++++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1124578999999999999999999999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.7e-18 Score=154.79 Aligned_cols=159 Identities=14% Similarity=0.173 Sum_probs=117.9
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHH------HHHHHHHHhcCCCCCccceeEEEEe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
.-++|++.+.||.|+||.||++.. ++..+|||++.......+..... +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 458999999999999999999754 46689999997654444443334 6899999999999999999998664
Q ss_pred C--------CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEec
Q 014359 86 K--------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISD 142 (426)
Q Consensus 86 ~--------~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~D 142 (426)
. +..+++|||++|.+|.+... +++.. ..+++.++ .||+++++| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~~~----~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISEDV----KAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccHHH----HHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3 35899999999999988732 34433 23444443 799999999 99999
Q ss_pred cCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHh
Q 014359 143 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 196 (426)
Q Consensus 143 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ell 196 (426)
||.+..... ... ...++....|. .++|+||||+++..+.
T Consensus 178 fg~~~~~~e---~~a-----------~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQ---RKA-----------KDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccc---hhh-----------HHHHHHHhHhc-ccccccceeEeehHHH
Confidence 998874421 110 01144555676 7899999999987653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-17 Score=152.62 Aligned_cols=213 Identities=22% Similarity=0.340 Sum_probs=169.8
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lVm 93 (426)
+|+++++||+|+||..+.|.+.-++++||||.=.... ...++.-|-+..+.|. .++|...|-+....-+-.+||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 8999999999999999999999999999999654332 1457778888888885 699999999988888888999
Q ss_pred cccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC-----CEEEeccCCCCCCCcc
Q 014359 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG-----NIKISDFGLSALPQHF 152 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g-----~lKl~DFGla~~~~~~ 152 (426)
|++ |-+|.|+..- .++|+...+..++.|++.-+ +|.||..-+ .+-|+|||+|+.+...
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 999 8899988874 45799999999999999875 699997544 4889999999976543
Q ss_pred cCC-----CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC---ccHHHHHHHHHhCCCCCC--
Q 014359 153 RDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLP-- 222 (426)
Q Consensus 153 ~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p-- 222 (426)
... +...+..||.+||+--...+..- +..-|+=|||=++.+.|-|.+||++ .+..+-|++|-..+...|
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 221 12335579999999988888765 4889999999999999999999987 456677888866554433
Q ss_pred ---CCCCHHHHHHHH
Q 014359 223 ---KWLSPGAQNLLR 234 (426)
Q Consensus 223 ---~~~s~~~~~Li~ 234 (426)
..+|.++..-++
T Consensus 262 ~Lc~g~P~efa~Yl~ 276 (449)
T KOG1165|consen 262 VLCEGFPEEFATYLR 276 (449)
T ss_pred HHHhcCHHHHHHHHH
Confidence 235555554443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-17 Score=147.47 Aligned_cols=234 Identities=20% Similarity=0.260 Sum_probs=182.1
Q ss_pred ccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCccceeEEEEe
Q 014359 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLAS 85 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~ 85 (426)
..+-.+.|+|.+++.||+|+||.+|+|.+..+|+.||||+=.... . -.++..|..+.+.|+| ..|..+..+..+
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhccc
Confidence 344567899999999999999999999999999999999765432 1 2457789999999975 778888888888
Q ss_pred CCeEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCC---CCEEEeccCCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSK---GNIKISDFGLS 146 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~---g~lKl~DFGla 146 (426)
+..-.+||+++ |-+|.++..- .++++...+.-.+-|++.-+ +|.|..-+ ..+-++|||+|
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 88889999999 8899988863 45699999999999999886 57776543 36899999999
Q ss_pred CCCCcccCC-----CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc---HHHHHHHHHhCC
Q 014359 147 ALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGD 218 (426)
Q Consensus 147 ~~~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~ 218 (426)
+.+...... +......||..|.+--...+... +..-|+=|+|.+|..+.-|.+||++-. ..+.+++|...+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 966543322 12234579999998777665543 477899999999999999999999853 346677787776
Q ss_pred CCCC-----CCCCHHHHHHHHHccccCcCCCCCh
Q 014359 219 FKLP-----KWLSPGAQNLLRKILEPNPVKRITI 247 (426)
Q Consensus 219 ~~~p-----~~~s~~~~~Li~~~L~~dP~~R~t~ 247 (426)
...| ..+|.++.-.+.-|-..-=++-|.-
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 6655 4478888888887766555555653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=155.82 Aligned_cols=219 Identities=24% Similarity=0.329 Sum_probs=137.7
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC----------CCccceeEEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----------PNVVRLHEVLA 84 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H----------pnIv~l~~~~~ 84 (426)
.+..++.||.|+++.||.+.+..|++.+|||++...........+.+++|.-....+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778899999999999999999999999999876554444557888888766655432 23333344332
Q ss_pred e---------C---C-----eEEEEEcccCCCChHHHHH---hCCCC--C-HHHHH-HHHHHHHHHH-------------
Q 014359 85 S---------K---S-----KIYMVLEYVTGGELFDKIA---SKGRL--Q-EAEGR-KLFQQLIDGL------------- 127 (426)
Q Consensus 85 ~---------~---~-----~~~lVmEy~~gg~L~~~i~---~~~~l--~-e~~~~-~~~~ql~~al------------- 127 (426)
- . + +.+++|+-+. +||.+.+. ..... . ...|+ .+..|++..+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 2477888884 59988764 22222 1 12232 2336666553
Q ss_pred --hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccC--------CCCCchhhHHHHHHHHHHHhc
Q 014359 128 --ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR--------GYDGATSDIWSCGVILYVILT 197 (426)
Q Consensus 128 --eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--------~~~~~~~DIwSlGvil~ellt 197 (426)
+|++++.+|.++|+||+...... ........+..|.+||..... .+ +.+.|.|+||+++|.|.|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g-----~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~-t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAG-----TRYRCSEFPVAFTPPELESCAGQFGQNNAPY-TFATDAWQLGITLYSLWC 245 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETT-----EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE--HHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecC-----ceeeccCCCcccCChhhhhhhcccCccccee-eeccCHHHHHHHHHHHHH
Confidence 79999999999999998766321 112224456789999987543 23 478999999999999999
Q ss_pred CCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 014359 198 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 244 (426)
Q Consensus 198 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 244 (426)
|..||............ --.+. .+|..++.||+++|++||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~~---f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEWD---FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGGG---GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccccc---chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999865433211110 11233 688999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.3e-17 Score=156.64 Aligned_cols=241 Identities=23% Similarity=0.391 Sum_probs=165.3
Q ss_pred cccCCccccCEEEeceeeecCceEEEEEEECCCC-----------------------------------ceEEEEEeecc
Q 014359 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSG-----------------------------------LPFAVKILEKN 50 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-----------------------------------~~vAvK~i~~~ 50 (426)
..-..+.+++|+++..||+|.-+.||.|.....| -+.|||.+-.-
T Consensus 149 r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~ 228 (598)
T KOG4158|consen 149 RIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNF 228 (598)
T ss_pred hhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccc
Confidence 3345678899999999999999999998643211 13566654321
Q ss_pred cc--cchhHHHHHHHHHH------HH--------hc--------CCCCCccceeEEEEe---------------------
Q 014359 51 RI--IHLKITDQIKREIA------TL--------KL--------LKHPNVVRLHEVLAS--------------------- 85 (426)
Q Consensus 51 ~~--~~~~~~~~~~~Ei~------il--------~~--------l~HpnIv~l~~~~~~--------------------- 85 (426)
.. .+....+.+-+|.. .+ +. -+|||||+++..|.+
T Consensus 229 ~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~ 308 (598)
T KOG4158|consen 229 EHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWY 308 (598)
T ss_pred ccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceec
Confidence 11 12222333333321 11 11 259999999887633
Q ss_pred ------CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeC--CCC--CEEE
Q 014359 86 ------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLD--SKG--NIKI 140 (426)
Q Consensus 86 ------~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld--~~g--~lKl 140 (426)
....|+||.-++. +|..++-.+ ..+....+-++.|++.|. +|||+. +|+ .+.|
T Consensus 309 p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 309 PSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred ccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence 2359999999865 999999764 467888899999999996 699984 444 5889
Q ss_pred eccCCCCCCCcc----cCCCccccccCCCcccchhhhccCC-----CCCchhhHHHHHHHHHHHhcCCCCCCCccHHH--
Q 014359 141 SDFGLSALPQHF----RDDGLLHTTCGSPNYVAPEVLANRG-----YDGATSDIWSCGVILYVILTGYLPFDDRNLAV-- 209 (426)
Q Consensus 141 ~DFGla~~~~~~----~~~~~~~~~~gt~~Y~APE~l~~~~-----~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~-- 209 (426)
+|||++-.-+.. .-....-...|...-||||+....+ .+-.++|.|++|.+.||++....||.+.....
T Consensus 387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~ 466 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD 466 (598)
T ss_pred cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec
Confidence 999987521110 0011122346778899999975432 12358999999999999999999998743221
Q ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCChH
Q 014359 210 LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIA 248 (426)
Q Consensus 210 ~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~ 248 (426)
....-...-+.+|+.+++.+++|+..+|++||++|++..
T Consensus 467 ~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 467 TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 111112234677888999999999999999999999853
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=144.48 Aligned_cols=127 Identities=20% Similarity=0.285 Sum_probs=98.2
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccccchh-----------------------HHHHHHHHHHHHhcCCCCC
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------------------ITDQIKREIATLKLLKHPN 75 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~Hpn 75 (426)
...||+|+||.||+|.+. +|+.||||+++........ ......+|+.++.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999764321111 0123456999999999888
Q ss_pred ccceeEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEE
Q 014359 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIK 139 (426)
Q Consensus 76 Iv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lK 139 (426)
+.....+... ..|+||||++|++|...+....++++..+..++.|++.++ +|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7554443322 2389999999988876655557899999999999988885 699998 58899
Q ss_pred EeccCCCCCC
Q 014359 140 ISDFGLSALP 149 (426)
Q Consensus 140 l~DFGla~~~ 149 (426)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999999843
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=138.07 Aligned_cols=129 Identities=22% Similarity=0.266 Sum_probs=100.1
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEeecccccch-----------------------hHHHHHHHHHHHHhcCCCC
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------------------KITDQIKREIATLKLLKHP 74 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~Hp 74 (426)
+.+.||+|+||.||+|.+. +|+.||||+++....... -......+|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 899999999986521100 0023356899999999999
Q ss_pred CccceeEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCE
Q 014359 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNI 138 (426)
Q Consensus 75 nIv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~l 138 (426)
+|.....+.... .|+||||++|+++........++++..+..++.|++.++ +|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 986555544333 489999999886655433456789999999999999885 699999 8999
Q ss_pred EEeccCCCCCCC
Q 014359 139 KISDFGLSALPQ 150 (426)
Q Consensus 139 Kl~DFGla~~~~ 150 (426)
+|+|||+|....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.4e-16 Score=155.61 Aligned_cols=185 Identities=28% Similarity=0.401 Sum_probs=143.5
Q ss_pred HhcCCCCCccceeEEEEeCCeEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH----------------hhe
Q 014359 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL----------------ENI 130 (426)
Q Consensus 68 l~~l~HpnIv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al----------------eNI 130 (426)
|+.+.|.|+.++++.+.+....++|.+||..|+|.|.+.. ...++.--...+.+.|+.|+ .|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999986 45678778888899999997 499
Q ss_pred eeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCC------CCchhhHHHHHHHHHHHhcCCCCCCC
Q 014359 131 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY------DGATSDIWSCGVILYVILTGYLPFDD 204 (426)
Q Consensus 131 Lld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~------~~~~~DIwSlGvil~elltG~~Pf~~ 204 (426)
++|.+..+||+|||+.............+...-..-|.|||.+..... -+.+.||||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999886542111111222234457899999987422 24679999999999999999999976
Q ss_pred cc----HHHHHHHHHh-CCCCC-CC-----CCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 205 RN----LAVLYQKIFR-GDFKL-PK-----WLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 205 ~~----~~~~~~~i~~-~~~~~-p~-----~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.. ..+....+.+ +...+ |. .+++++..++++||..+|..||++++|..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2345555555 33222 21 24567999999999999999999999865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6e-17 Score=160.46 Aligned_cols=236 Identities=20% Similarity=0.260 Sum_probs=157.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeE-------EE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE-------VL 83 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-------~~ 83 (426)
+-+.+.+..+.++++.+....-..+ .+-++-+..+.+. ........+++-.+....|-+..-+.+ .+
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS 320 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence 4455556666666666654432222 2333334333222 122344455666665555544443433 11
Q ss_pred -----EeCCeEEEEEcccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHh------------heeeCCCCCEEEecc
Q 014359 84 -----ASKSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGLE------------NILLDSKGNIKISDF 143 (426)
Q Consensus 84 -----~~~~~~~lVmEy~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~ale------------NILld~~g~lKl~DF 143 (426)
......||.|++|...+|.++|..+. ..+......++.|+..|++ ||....++.+||.||
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhh
Confidence 11235899999999999999997543 3667778899999998764 999999999999999
Q ss_pred CCCCCCCccc----CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC
Q 014359 144 GLSALPQHFR----DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 218 (426)
Q Consensus 144 Gla~~~~~~~----~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 218 (426)
|+.+...... .....+...||..||+||.+.++.|. .++||||||+||+||+. =..+| .....+..+.++.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ 476 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGI 476 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCC
Confidence 9998554322 11234456899999999999999885 99999999999999996 22222 1223344555555
Q ss_pred CCCCCCC-CHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 219 FKLPKWL-SPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 219 ~~~p~~~-s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
++.-.+. -+.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 477 ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 477 IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 4422222 2455689999999999999988887777775
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-14 Score=131.15 Aligned_cols=175 Identities=17% Similarity=0.183 Sum_probs=124.3
Q ss_pred EEeceeeecCceEEEEEEECCCCceEEEEEeecccccchh-HHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEEEEc
Q 014359 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lVmE 94 (426)
.+...|++|+||+||++.. .+.+++.+.+......... ....+.+|+++|++|. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999998764 6778887777654332111 1235889999999995 5889999886 34799999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCC---
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDD--- 155 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~--- 155 (426)
|+.|.+|...+.. + ...++.|++.++ +|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~-~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPR-G------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhh-h------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9999999765422 1 123566666654 5999999999999999999855432210
Q ss_pred -C-------ccccccCCCcccchhhhccCCCCC-chhhHHHHHHHHHHHhcCCCCCCC
Q 014359 156 -G-------LLHTTCGSPNYVAPEVLANRGYDG-ATSDIWSCGVILYVILTGYLPFDD 204 (426)
Q Consensus 156 -~-------~~~~~~gt~~Y~APE~l~~~~~~~-~~~DIwSlGvil~elltG~~Pf~~ 204 (426)
. .......++.|++|+.-.--.-.+ ...++++-|+-+|.++|+..|+-+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 011234788999998643221111 567899999999999999888644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.5e-14 Score=127.92 Aligned_cols=120 Identities=18% Similarity=0.204 Sum_probs=91.6
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-----CCCCccceeEEEEeCC---eEE
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-----KHPNVVRLHEVLASKS---KIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~~ 90 (426)
.+.||+|+||.||. ++.++.. +||++..... ...+.+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 7667665 6998876432 2346799999999999 5799999999998873 434
Q ss_pred -EEEcc--cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCC----CCEEEeccCCCC
Q 014359 91 -MVLEY--VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSK----GNIKISDFGLSA 147 (426)
Q Consensus 91 -lVmEy--~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~----g~lKl~DFGla~ 147 (426)
+|||| +.+|+|.+++.. +.+++. ..++.|++.++ +|||++.+ ++++|+||+.+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 667999999976 457766 24566666553 79999743 389999955444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.5e-15 Score=157.77 Aligned_cols=250 Identities=25% Similarity=0.411 Sum_probs=199.6
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...+.+.+.+-+-+|+++.++.+.-..+|...++|+............+.+.++-.++-...||-++...-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 46788999999999999999999888888878888776554433333455555555555556677776666666778899
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc---
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF--- 152 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~--- 152 (426)
++|+|+.+++|...++.-+..+++.++.++..+..+. .|+|...+|..+++|||........
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999999999999999888888888888777776664 4888889999999999843321100
Q ss_pred --------------------------cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc
Q 014359 153 --------------------------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 206 (426)
Q Consensus 153 --------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 206 (426)
+.........||+.|.+||.+.+... +..+|+|+.|+++++.++|.+||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00012334579999999999998876 588999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCC---CCCHHHHHHHHHccccCcCCCCChH---HHhcCcCCccCCC
Q 014359 207 LAVLYQKIFRGDFKLPK---WLSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQDYT 261 (426)
Q Consensus 207 ~~~~~~~i~~~~~~~p~---~~s~~~~~Li~~~L~~dP~~R~t~~---~il~h~w~~~~~~ 261 (426)
.+..++.+..+..++|. ..+.++++++.++|..+|.+|..+. +...|++|+....
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 99999999988877764 4799999999999999999999987 8999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.6e-13 Score=123.52 Aligned_cols=122 Identities=22% Similarity=0.333 Sum_probs=99.2
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+.||+|++|.||+|.+ .|..|++|+.......... ....+.+|+.++..+.|+||.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999986 6778999987543322111 12467889999999999999888888777888999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
|++|++|.+.+..... ....++.+++.++ .|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999875432 6778888888875 699999 88999999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-13 Score=129.22 Aligned_cols=129 Identities=22% Similarity=0.240 Sum_probs=99.4
Q ss_pred CEEEeceeeecCceEEEEEE-ECCCCceEEEEEeecccccch---------------------hHHHHHHHHHHHHhcCC
Q 014359 15 RYELGRTLGEGNFGKVKFAQ-DLDSGLPFAVKILEKNRIIHL---------------------KITDQIKREIATLKLLK 72 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~-~~~~~~~vAvK~i~~~~~~~~---------------------~~~~~~~~Ei~il~~l~ 72 (426)
-|++.+.||+|+||.||+|. +..+|+.||||+++....... .....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47899999999999999998 667999999999975431100 01134678999999997
Q ss_pred CC--CccceeEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCC
Q 014359 73 HP--NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDS 134 (426)
Q Consensus 73 Hp--nIv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~ 134 (426)
+. .+.++++. ...|+||||+.|++|.........+....+..++.|++.++ +||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 23444432 23589999999988877664555677777889999999986 699999
Q ss_pred CCCEEEeccCCCCC
Q 014359 135 KGNIKISDFGLSAL 148 (426)
Q Consensus 135 ~g~lKl~DFGla~~ 148 (426)
++.++|+|||+|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999884
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=148.06 Aligned_cols=219 Identities=19% Similarity=0.284 Sum_probs=164.7
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC---CCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~ 89 (426)
-.+|.|.+.||+|+||+||+|.+.+ |+.||+|+=+......-....++ +.+|+ -+.|.++...+.-.+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~------~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQV------MERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHH------HHhhchhhhcchHHHHHHHccCCcc
Confidence 3589999999999999999999866 99999998776654443333333 33443 35566666666666778
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCC-------CCCEEEeccCCCC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDS-------KGNIKISDFGLSA 147 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~-------~g~lKl~DFGla~ 147 (426)
++|+||.+.|+|.+++...+.+++..+..+..|++.-+ +|.||.. +--++|+|||.|-
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 99999999999999999888899999999999998875 5888843 2359999999998
Q ss_pred CCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-----CCCC
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----FKLP 222 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~p 222 (426)
-+........+...++|-.+-.+|...|.++. ..+|.|.++-+++.||.|+.- +...+. ..+|
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~-----------q~~~g~~~~~~~~~~ 917 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM-----------EVKNGSSWMVKTNFP 917 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH-----------HhcCCcceeccccch
Confidence 66665556677888999999999999999986 899999999999999998631 122221 1133
Q ss_pred CCCCHH-HHHHHHHccccCcCCCCChHHH
Q 014359 223 KWLSPG-AQNLLRKILEPNPVKRITIAGI 250 (426)
Q Consensus 223 ~~~s~~-~~~Li~~~L~~dP~~R~t~~~i 250 (426)
..+..+ .-+++..+|+.|-..=|...++
T Consensus 918 Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 918 RYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred hhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 333333 4467788888554444444444
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.5e-14 Score=101.04 Aligned_cols=60 Identities=47% Similarity=0.866 Sum_probs=48.3
Q ss_pred CCcccccceeeccCcCCCCCCcccccc--cccceeeEecCCHHHHHHHHHHHHHHcCcEEEe
Q 014359 295 PPLINAFQLIGMSSCLDLSGFFEKEDV--SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 354 (426)
Q Consensus 295 p~~~~~~~~~~~s~~~~~~~~~~~~~~--~~~~~~f~s~~~~~~~~~~l~~~~~~~~~~~~~ 354 (426)
|..+|||++|++|+|+|||+||+.... .++.+||+|..++++|+++||++++.+|++|++
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 667999999999999999999986533 467899999999999999999999999999875
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.5e-12 Score=118.34 Aligned_cols=118 Identities=19% Similarity=0.235 Sum_probs=91.5
Q ss_pred eeeecCceEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
.||+|+||.||+|.. ++..|++|+......... ....++.+|+.+++.++|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 678899998654322111 1135678899999999998876666566667778999999
Q ss_pred cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
++|++|.+.+..... .++.|++.++ +||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 5667777765 699999 89999999999885
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=2e-12 Score=117.75 Aligned_cols=124 Identities=25% Similarity=0.345 Sum_probs=90.8
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch-------------------hHHHHHHHHHHHHhcCCCCC-
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-------------------KITDQIKREIATLKLLKHPN- 75 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~Hpn- 75 (426)
|.+.+.||+|+||.||+|.+ .+|+.||||++........ .......+|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88899999999999999987 4799999999865321000 01123678999999998874
Q ss_pred -ccceeEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEE
Q 014359 76 -VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIK 139 (426)
Q Consensus 76 -Iv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lK 139 (426)
+++.++ ....++||||++|++|...... ..+..++.+++.++ +||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 2456899999999999765431 23445556666653 799999999999
Q ss_pred EeccCCCCCCC
Q 014359 140 ISDFGLSALPQ 150 (426)
Q Consensus 140 l~DFGla~~~~ 150 (426)
|+|||++....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999997443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-11 Score=128.47 Aligned_cols=123 Identities=19% Similarity=0.226 Sum_probs=95.1
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.|...+.||+|+||.||++.+.. ..+++|+........ ....+.+.+|+.+++.++|++|+....+..+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34567899999999999998643 345555432211111 11235688999999999999999888887777788
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
++||||++|++|.+++. ....++.|++.++ +|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999885 3466778888875 69999 678999999999984
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.8e-11 Score=107.87 Aligned_cols=124 Identities=27% Similarity=0.399 Sum_probs=83.4
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHH---------------------HHHHHHHHHhcCCCCC-
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------------QIKREIATLKLLKHPN- 75 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~Hpn- 75 (426)
+++.||+|+||.||+|.+. +++.||||++............ ....|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999986 7899999998754322111111 1135666666664433
Q ss_pred -ccceeEEEEeCCeEEEEEcccCCCChHHH-HHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCC
Q 014359 76 -VVRLHEVLASKSKIYMVLEYVTGGELFDK-IASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGN 137 (426)
Q Consensus 76 -Iv~l~~~~~~~~~~~lVmEy~~gg~L~~~-i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~ 137 (426)
+.+.+++ ...++||||++++.+... +... ... ..++.++.|++.++ +||+++ ++.
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4455543 236899999999544221 1111 111 66778888888875 699999 999
Q ss_pred EEEeccCCCCCC
Q 014359 138 IKISDFGLSALP 149 (426)
Q Consensus 138 lKl~DFGla~~~ 149 (426)
++|+|||++...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.7e-11 Score=102.81 Aligned_cols=117 Identities=24% Similarity=0.288 Sum_probs=92.5
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--CCccceeEEEEeCCeEEEEEcc
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lVmEy 95 (426)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| +++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999974 36799998865432 3578899999999976 5899999988888889999999
Q ss_pred cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH------------------hheeeCCCCCEEEeccCCCCC
Q 014359 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al------------------eNILld~~g~lKl~DFGla~~ 148 (426)
+.|+.+... +......++.+++.++ +||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877643 3334444555555443 699999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.3e-11 Score=125.61 Aligned_cols=138 Identities=22% Similarity=0.329 Sum_probs=95.2
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc--------------------------c-h----hHHHH
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--------------------------H-L----KITDQ 60 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--------------------------~-~----~~~~~ 60 (426)
.+..|+. +.||+|++|.||+|+...+|+.||||+++..... + . +..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3556777 8999999999999999878999999999754210 0 0 11122
Q ss_pred H------HHHHHHHhcCC----CCCccceeEEEEe-CCeEEEEEcccCCCChHHH--HHhCC----CCCHHHHHHHHHHH
Q 014359 61 I------KREIATLKLLK----HPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDK--IASKG----RLQEAEGRKLFQQL 123 (426)
Q Consensus 61 ~------~~Ei~il~~l~----HpnIv~l~~~~~~-~~~~~lVmEy~~gg~L~~~--i~~~~----~l~e~~~~~~~~ql 123 (426)
+ .+|+..+.++. +.+.+.+-.++.+ .+..++||||+.|+.+.+. +...+ .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 3 33443333332 3333443344332 3456799999999999874 33333 36777788888998
Q ss_pred HHH--------HhheeeCCCC----CEEEeccCCCCCCC
Q 014359 124 IDG--------LENILLDSKG----NIKISDFGLSALPQ 150 (426)
Q Consensus 124 ~~a--------leNILld~~g----~lKl~DFGla~~~~ 150 (426)
+.- +.||+++.+| .++++|||++....
T Consensus 277 f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 864 4899999998 99999999998553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-11 Score=122.24 Aligned_cols=240 Identities=19% Similarity=0.178 Sum_probs=176.9
Q ss_pred cCEEEeceeee--cCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCe
Q 014359 14 GRYELGRTLGE--GNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (426)
Q Consensus 14 ~~y~i~~~LG~--G~fg~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 88 (426)
..+.+...+|. |.+|.||.+.. ..++..+|+|.=+.... ......+-.+|+.-.+.+ .|+|.++.+..++..+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCCc
Confidence 35667788999 99999999988 78899999997332211 111123445677777777 49999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCC-CCHHHHHHHHHHHHH----HH---------------hheeeCCC-CCEEEeccCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID----GL---------------ENILLDSK-GNIKISDFGLSA 147 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~----al---------------eNILld~~-g~lKl~DFGla~ 147 (426)
.|+-+|+| +.+|..+...... +++..++.++.+... |+ +||+...+ ...+++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999999 5688888876555 999999999999999 75 68888888 789999999988
Q ss_pred CCCcccCCC---ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc--cHHHHHHHHHhCCCCCC
Q 014359 148 LPQHFRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRGDFKLP 222 (426)
Q Consensus 148 ~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~p 222 (426)
......-.. .....-|...|++||...+. .+...|++|+|.+..+-.+|..+.... +.-...+++. -..++-
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~~ 348 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEFC 348 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchhhh
Confidence 655432111 11223678899999998654 358899999999999988876554332 1111111111 011112
Q ss_pred CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 223 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
...+..+...+..|++.+|-.|++.+.+++|++...
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 234667777999999999999999999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-09 Score=110.76 Aligned_cols=170 Identities=19% Similarity=0.319 Sum_probs=121.4
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
|++ ...+-++.+..-.|..+.++.+|.|.+.+.... .....+.+-+.-|+.++||||+++++.++..+..|+|+|-
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 555 333333333222345557888999998876542 3356788889999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
+. -|..+++..+ ......-+.||+.|| .-++++..|..||++|-++........ ...
T Consensus 91 V~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~ 163 (690)
T KOG1243|consen 91 VR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAK 163 (690)
T ss_pred cc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccc
Confidence 84 6777777643 677777889999997 246888999999999988864333221 111
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCC
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 199 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~ 199 (426)
...---.|..|+.+.... -..|.|-|||++++++.|.
T Consensus 164 ~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcc
Confidence 112222456777654433 2479999999999999993
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.3e-09 Score=100.58 Aligned_cols=122 Identities=20% Similarity=0.284 Sum_probs=87.7
Q ss_pred ceee-ecCceEEEEEEECCCCceEEEEEeecccc----------cchhHHHHHHHHHHHHhcCCCCCc--cceeEEEEeC
Q 014359 20 RTLG-EGNFGKVKFAQDLDSGLPFAVKILEKNRI----------IHLKITDQIKREIATLKLLKHPNV--VRLHEVLASK 86 (426)
Q Consensus 20 ~~LG-~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----------~~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~ 86 (426)
..|| .|+.|+||.+.. .+..++||.+..... ........+.+|+.++..++|++| ++.+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 778888888775 477899998864321 011123568899999999998875 6777764432
Q ss_pred -Ce---EEEEEcccCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCC
Q 014359 87 -SK---IYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 87 -~~---~~lVmEy~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla 146 (426)
.. .++||||++| .+|.+++.. .++++... .|++.++ +|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~~----~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQW----QAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHHH----HHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999997 689888865 45676654 4455543 7999999999999999998
Q ss_pred CC
Q 014359 147 AL 148 (426)
Q Consensus 147 ~~ 148 (426)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 73
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.6e-11 Score=112.49 Aligned_cols=187 Identities=19% Similarity=0.236 Sum_probs=125.1
Q ss_pred HhcCCCCCccceeEEEEeC-----CeEEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH-----------
Q 014359 68 LKLLKHPNVVRLHEVLASK-----SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL----------- 127 (426)
Q Consensus 68 l~~l~HpnIv~l~~~~~~~-----~~~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al----------- 127 (426)
|-.+.|.||++++.++.+. ....+++||++.|+|..++++ +..+.....++|+.||++||
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 3445699999999998654 458899999999999999975 34588889999999999997
Q ss_pred ------hheeeCCCCCEEEeccCCCCCCCcccCC--CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCC
Q 014359 128 ------ENILLDSKGNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 199 (426)
Q Consensus 128 ------eNILld~~g~lKl~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~ 199 (426)
+-|++..+|-+|+.--.-.......... .......+-++|.|||.=....- ..++|||++|....+|..|.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHhe
Confidence 4677788888887532221111111100 11112345688999986333333 36799999999999999887
Q ss_pred CCCC-CccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 200 LPFD-DRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 200 ~Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.--. +.+....-..+..--+-. -..--+++|.+||+..|..||++..++.||.+-+
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 5422 222111111221111111 1122356899999999999999999999998654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.2e-09 Score=111.14 Aligned_cols=130 Identities=25% Similarity=0.317 Sum_probs=81.7
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccch---------------------------hH----HH------HHH
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---------------------------KI----TD------QIK 62 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---------------------------~~----~~------~~~ 62 (426)
+.||.|++|.||+|+. .+|+.||||+.+......- .. .. .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 5789999999864321000 00 00 244
Q ss_pred HHHHHHhcCC----CCCccceeEEE-EeCCeEEEEEcccCCCChHHHHHhC-CCCC-----HHHHHHHHHHHHHH-----
Q 014359 63 REIATLKLLK----HPNVVRLHEVL-ASKSKIYMVLEYVTGGELFDKIASK-GRLQ-----EAEGRKLFQQLIDG----- 126 (426)
Q Consensus 63 ~Ei~il~~l~----HpnIv~l~~~~-~~~~~~~lVmEy~~gg~L~~~i~~~-~~l~-----e~~~~~~~~ql~~a----- 126 (426)
+|+..+.++. |.+-+.+-.++ ...+..++||||++|++|.+..... ...+ ...+..++.|+...
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~ 281 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHA 281 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeC
Confidence 4555555542 32222222222 2234579999999999998876432 1222 22233344454432
Q ss_pred ---HhheeeCCCCCEEEeccCCCCCCC
Q 014359 127 ---LENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 127 ---leNILld~~g~lKl~DFGla~~~~ 150 (426)
+.||+++.+|.++++|||++....
T Consensus 282 D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 282 DLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCCcccEEECCCCcEEEEeCCCeeECC
Confidence 379999999999999999998554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-09 Score=110.64 Aligned_cols=239 Identities=20% Similarity=0.176 Sum_probs=176.9
Q ss_pred CCccccCEEEeceeeecCceEEEEEEEC-CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 86 (426)
.....++|..+..||.|.|+.|+..... .++..|++|.+......... ...-..|+.+...+ .|.|++.++..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-DIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-hhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 3445788999999999999999987755 67888999987655433322 22334577777777 599999999998888
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC-CCEEEeccCCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK-GNIKISDFGLSALPQ 150 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~-g~lKl~DFGla~~~~ 150 (426)
...|+-.|||+++++...+.-...+++...++...|++.++ +||++.++ +..++.|||.++.+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 88889999999999988886666789999999999999985 69999887 789999999987321
Q ss_pred cccCCCccccccCCCccc-chhhhccCCCCCchhhHHHHHHHHHHHhcCCCC-CCCccHHHHHHHHHhCCCCCCCCCCHH
Q 014359 151 HFRDDGLLHTTCGSPNYV-APEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWLSPG 228 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~-APE~l~~~~~~~~~~DIwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~ 228 (426)
. ......++-++. .+|++.....+..++|++|||.-..+.++|... +.+. ....+..+..+..+....+
T Consensus 419 ~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 F-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred e-----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHh
Confidence 1 011122333444 245544444445899999999999999998643 2221 1223445555555556688
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
+..+.+.+..+++..|+.+.+...|.=|.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 99999999999999999999888776544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1e-06 Score=88.25 Aligned_cols=197 Identities=21% Similarity=0.208 Sum_probs=141.9
Q ss_pred CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe----CCeEEEEEcccCC-CC
Q 014359 26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKIYMVLEYVTG-GE 100 (426)
Q Consensus 26 ~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lVmEy~~g-g~ 100 (426)
--.+.|++....+|..|++|.++..+.... .....-+++++++.|+|||++.+++.+ +..+.+|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 345789999989999999999965544332 223345788999999999999999863 4568999999876 67
Q ss_pred hHHHHH---------------hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 101 LFDKIA---------------SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 101 L~~~i~---------------~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
|.++-- ...+.+|...|.|+.||..|| .+||++.+-+++|+..|...+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 766542 122488999999999999997 59999999899999888776543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc-HHHH-HHHHHhCCCCCCCCCCHH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVL-YQKIFRGDFKLPKWLSPG 228 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~-~~~i~~~~~~~p~~~s~~ 228 (426)
... + |.+.++ .+-|.=.||.+++.|.||..--...+ .... ...+. ..++.+
T Consensus 445 ~d~---------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------~~yS~D 497 (655)
T KOG3741|consen 445 EDP---------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------TTYSTD 497 (655)
T ss_pred CCC---------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------hhhhHH
Confidence 311 1 112222 45688999999999999965421111 1111 22222 347889
Q ss_pred HHHHHHHccccCcCCCCChHHHhcC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
++++|.-+...++.. -++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999999999999886 677777665
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.6e-07 Score=81.31 Aligned_cols=112 Identities=18% Similarity=0.212 Sum_probs=76.7
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-cceeEEEEeCCeEEEEEcccC
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lVmEy~~ 97 (426)
.+.|+.|.++.||++.. .++.|++|+...... ....+.+|+.+++.+.+.++ .+++.+.. +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999985 477899998754321 12346789999999865554 45555433 34589999999
Q ss_pred CCChHHHHHhCCCCCHHHHHHHHHHHHHHH--------------------hheeeCCCCCEEEeccCCCC
Q 014359 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGL--------------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 98 gg~L~~~i~~~~~l~e~~~~~~~~ql~~al--------------------eNILld~~g~lKl~DFGla~ 147 (426)
|.++.+. ...... .+.+++.++ .||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~----~~~~~~----~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE----DFSDPE----NLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc----cccCHH----HHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9888643 011112 222333322 599999 6789999999887
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.3e-06 Score=76.36 Aligned_cols=126 Identities=16% Similarity=0.216 Sum_probs=85.3
Q ss_pred eceeeecCceEEEEEEECC------CCceEEEEEeecccc-------------------cchhHHHH----HHHHHHHHh
Q 014359 19 GRTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRI-------------------IHLKITDQ----IKREIATLK 69 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~------~~~~vAvK~i~~~~~-------------------~~~~~~~~----~~~Ei~il~ 69 (426)
...||.|-=+.||.|.... .+..+|||+.+.... ...+-... .++|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 357899998753110 00111223 348999999
Q ss_pred cCC--CCCccceeEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hhee
Q 014359 70 LLK--HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENIL 131 (426)
Q Consensus 70 ~l~--HpnIv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNIL 131 (426)
++. .-++.+.+++ ...++||||+.++.+..-.-.+..+++..+..++.|++.++ .|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 995 3567777765 45689999997654532222233456666666667776665 5999
Q ss_pred eCCCCCEEEeccCCCCCC
Q 014359 132 LDSKGNIKISDFGLSALP 149 (426)
Q Consensus 132 ld~~g~lKl~DFGla~~~ 149 (426)
++ ++.+.|+|||.|...
T Consensus 158 ~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EE-CCcEEEEECCCceeC
Confidence 97 578999999988743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.5e-06 Score=79.71 Aligned_cols=82 Identities=18% Similarity=0.245 Sum_probs=61.6
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--CCccceeEEEEeC---CeEEEEEc
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASK---SKIYMVLE 94 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lVmE 94 (426)
+.||.|..+.||++... .|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999864 3678999987654321 124578899999999975 4567788877654 36789999
Q ss_pred ccCCCChHHH
Q 014359 95 YVTGGELFDK 104 (426)
Q Consensus 95 y~~gg~L~~~ 104 (426)
|++|.++.+.
T Consensus 81 ~i~G~~l~~~ 90 (223)
T cd05154 81 RVDGRVLRDR 90 (223)
T ss_pred EeCCEecCCC
Confidence 9999877553
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.3e-08 Score=99.52 Aligned_cols=229 Identities=19% Similarity=0.170 Sum_probs=146.4
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC-ccceeEEEEeCCeEEEEEc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lVmE 94 (426)
|.....+++|+++++++++...+...+ .+++... ....-++++|.+++||| .+..++-++.+...+++|+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 556677899999999999876555544 5655432 34556889999999999 7777777778888999999
Q ss_pred ccCCC-ChHHHH-HhCCCCCHHHHHHHHHHHHHHH-----------hheeeCCCCCEEEeccCCCCCCCcccCCCccccc
Q 014359 95 YVTGG-ELFDKI-ASKGRLQEAEGRKLFQQLIDGL-----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 161 (426)
Q Consensus 95 y~~gg-~L~~~i-~~~~~l~e~~~~~~~~ql~~al-----------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~ 161 (426)
++.++ +-.... ...-.+.+-+.....+.-..++ +|||..+ +..|..||+....+... -...+.
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~-~~~~~~~~~v~~~L~~~---~~~~t~ 390 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRDNILGSE-EEVKLLDFAVPPQLTRT---MKPRTA 390 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcccccccc-cccccccccCCcccCcc---cccccC
Confidence 99887 221111 0000111111111222222222 3555544 67899999998755432 145677
Q ss_pred cCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCC---CCCCCHHHHHHHHHc
Q 014359 162 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKL---PKWLSPGAQNLLRKI 236 (426)
Q Consensus 162 ~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~---p~~~s~~~~~Li~~~ 236 (426)
.+|+.++|||+.....++ .+.|.||+|+--.++.-|-+|-..+-.. ...+-.+. +.+ ..|-+..-.++...|
T Consensus 391 ~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~ 467 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGPNSPMLTDKSAWSPVFHRDFPAPC 467 (829)
T ss_pred CCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCCCccccchhhhcCcccccCCcccc
Confidence 899999999999888887 7889999998777887787775431100 00000000 000 112222222467889
Q ss_pred cccCcCCCCChHHHhcCcCCccCC
Q 014359 237 LEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+..-|..|++...++.|.+|....
T Consensus 468 ~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 468 LNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred cCCCCCCCcchhhHHHHHHhccCc
Confidence 999999999999988888886543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.2e-05 Score=73.68 Aligned_cols=220 Identities=19% Similarity=0.228 Sum_probs=134.0
Q ss_pred EEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEE------EEeCCe-
Q 014359 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV------LASKSK- 88 (426)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~------~~~~~~- 88 (426)
..++.||+|+-+.+|-.- .-+..|| |+........ +-+ -+..|... .||-+-.-+.+ ..+++.
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VA-KIYh~Pppa~-----~aq-k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVA-KIYHAPPPAA-----QAQ-KVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhh-eeecCCCchH-----HHH-HHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 346789999999999543 2233355 8887653211 111 12233333 56654331111 122233
Q ss_pred EEEEEcccCCCChHHHH-Hh---C---CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCC
Q 014359 89 IYMVLEYVTGGELFDKI-AS---K---GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i-~~---~---~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla 146 (426)
+.+.|..++|..=-..+ .. + .....+-+.+..+.|+.+. +|+|+.+++.+.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 78899999885322222 11 1 2366677778888888884 6999999999999885543
Q ss_pred CCCCcccCCCccccccCCCcccchhhhccCCCC----CchhhHHHHHHHHHHHhcC-CCCCCCccHH----HHHH-HHHh
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD----GATSDIWSCGVILYVILTG-YLPFDDRNLA----VLYQ-KIFR 216 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~----~~~~DIwSlGvil~elltG-~~Pf~~~~~~----~~~~-~i~~ 216 (426)
.+- ..+.......|.+.|.+||.-.-..+. ....|-|.|||++|++|.| +.||.+.... .-++ .|..
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 321 233444556799999999975422111 3668999999999999996 9999752110 0011 1211
Q ss_pred -----------CCCCCC---CC--CCHHHHHHHHHcccc--CcCCCCChH
Q 014359 217 -----------GDFKLP---KW--LSPGAQNLLRKILEP--NPVKRITIA 248 (426)
Q Consensus 217 -----------~~~~~p---~~--~s~~~~~Li~~~L~~--dP~~R~t~~ 248 (426)
+..+.| +| +++++..|..+|+.. ++.-|||++
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 111222 22 789999999999875 466899974
|
|
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.6e-05 Score=54.26 Aligned_cols=43 Identities=28% Similarity=0.554 Sum_probs=38.3
Q ss_pred cceEEEEEEEEEe-CceEEEEEEecCCCchHHHHHHHHHHhhcC
Q 014359 372 GSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLG 414 (426)
Q Consensus 372 ~~l~~~~~i~~~~-~~~~~v~~~~~~gd~~e~~~~~~~~~~~l~ 414 (426)
..+.+.+||+++. .+.+.|+|+|.+||.+.|+++|.+|...|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence 5689999999998 899999999999999999999999988775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00015 Score=64.22 Aligned_cols=123 Identities=22% Similarity=0.239 Sum_probs=84.5
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhH-----HHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-----TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
..+++|+=+.+|.+.+ -|..+++|.-.+...-++.. ..+..+|+.++.++.--.|..-+-+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4678999999999865 45557777544333223222 2457789999999875555444444556677789999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHH-----------HhheeeCCCCCEEEeccCCCCC
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDG-----------LENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~a-----------leNILld~~g~lKl~DFGla~~ 148 (426)
|++|-.|.+.+... .....+.+-.++..- ..||++..++ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~---~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888775 344444444444332 1699997665 99999999984
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.7e-06 Score=86.36 Aligned_cols=133 Identities=22% Similarity=0.301 Sum_probs=96.2
Q ss_pred hheeeCCCCCEEEeccCCCCCCCcccC-------CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHh-cCC
Q 014359 128 ENILLDSKGNIKISDFGLSALPQHFRD-------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGY 199 (426)
Q Consensus 128 eNILld~~g~lKl~DFGla~~~~~~~~-------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ell-tG~ 199 (426)
++|.++.+|..||+.|+.+........ ........-...|.|||++.+. ..++++|++|+||++|.+. .|+
T Consensus 129 ~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~~~~~sd~fSlG~li~~i~~~gk 207 (700)
T KOG2137|consen 129 EAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-TNTPASDVFSLGVLIYTIYNGGK 207 (700)
T ss_pred hheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-cccccccceeeeeEEEEEecCCc
Confidence 799999999999999998764322000 0111111235689999999884 4468999999999999998 566
Q ss_pred CCCCCccHHHHHHHHH----hCCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 200 LPFDDRNLAVLYQKIF----RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 200 ~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
.-+...+....+..-. .+.+..+..+++++++=|.++|..++..||++..+...|||.+...
T Consensus 208 ~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 208 SIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGL 273 (700)
T ss_pred chhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCchh
Confidence 6665543333322211 1223445779999999999999999999999999999999987543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00017 Score=63.77 Aligned_cols=129 Identities=23% Similarity=0.237 Sum_probs=87.0
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
....+-||+=+.|+++.+ .|+.+.||.-.....-++. ...+.++|+++|.++.--.|.--.-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567889999999999984 7888888854332222222 235688999999998755665555556666677899
Q ss_pred EcccCC-CChHHHHHhCC-CCCHHHH-HHHHHHHHHHH---------------hheeeCCCC---CEEEeccCCCCC
Q 014359 93 LEYVTG-GELFDKIASKG-RLQEAEG-RKLFQQLIDGL---------------ENILLDSKG---NIKISDFGLSAL 148 (426)
Q Consensus 93 mEy~~g-g~L~~~i~~~~-~l~e~~~-~~~~~ql~~al---------------eNILld~~g---~lKl~DFGla~~ 148 (426)
|||++| .++.+++.... .-.++.. ..++++|-..+ .||+|.++| .+-++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999977 47788876422 1222222 34444443332 699998776 358999999974
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00021 Score=78.31 Aligned_cols=189 Identities=19% Similarity=0.234 Sum_probs=133.9
Q ss_pred HHHHHHHHHHhcCCCCCccceeEEEEeCCe----EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-------
Q 014359 59 DQIKREIATLKLLKHPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127 (426)
Q Consensus 59 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al------- 127 (426)
.....|...+..+.|+|++.++.+-..+.. ..+..++|+.-++...+..-+..+....+.+..+++.|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 445557778888899999999999755433 345568999999999999989999999999999999997
Q ss_pred -hheee----------CCCCCEEEe--ccCCCCCCCcccCCCccccccCCCcccchhhhccCCCC-CchhhHHHHHHHHH
Q 014359 128 -ENILL----------DSKGNIKIS--DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILY 193 (426)
Q Consensus 128 -eNILl----------d~~g~lKl~--DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~~DIwSlGvil~ 193 (426)
+|..+ +..+...++ ||+.+..+.. ........-+..|.|||....+.+. +...|+|.+|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 34444 233456666 8888775433 2222334456678888887766554 22369999999999
Q ss_pred HHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 194 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 194 elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+..|..+-.. ........ +........+++.+|+..++++|+++.+++.|+|....
T Consensus 384 ~~~~~~~i~~~---~~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 384 QLSQGEDISEK---SAVPVSLL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhcCccccc---ccchhhhh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 99887644211 11111111 11122267889999999999999999999999998653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00019 Score=63.12 Aligned_cols=116 Identities=16% Similarity=0.279 Sum_probs=77.9
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcc-ceeEEEEeCCeEEEEEccc
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSKIYMVLEYV 96 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lVmEy~ 96 (426)
+.+.||+|++|.||++.+ .|..+|+|+-..+.. ...+..|+++|..+...++. ++|.+-.+ ++.|||+
T Consensus 26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeec--cCceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 456799999999999996 566899998765432 56789999999999876664 55555433 4569999
Q ss_pred CCCChHHHHHhCCCCCHHHHHHHHHH--HH----------HHH-hheeeCCCCCEEEeccCCCCC
Q 014359 97 TGGELFDKIASKGRLQEAEGRKLFQQ--LI----------DGL-ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 97 ~gg~L~~~i~~~~~l~e~~~~~~~~q--l~----------~al-eNILld~~g~lKl~DFGla~~ 148 (426)
.|-.|.+.-... +..+...++.. .+ +++ .||++.+ +.+.|+||..|++
T Consensus 95 ~G~~L~~~~~~~---~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG---DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc---cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 998887654421 22222222221 11 111 2555544 4899999999984
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00018 Score=67.40 Aligned_cols=126 Identities=23% Similarity=0.271 Sum_probs=85.6
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc-----------------c--hhHHHHHHHHHHHHhcCCCC--
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----------------H--LKITDQIKREIATLKLLKHP-- 74 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----------------~--~~~~~~~~~Ei~il~~l~Hp-- 74 (426)
+.++..||-|-=|.||.|.+. .|.++|||.-+....+ + .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356789999999999999974 7888999965321110 0 01123577899999999754
Q ss_pred CccceeEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------hheeeCCCCCEEEecc
Q 014359 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------ENILLDSKGNIKISDF 143 (426)
Q Consensus 75 nIv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------eNILld~~g~lKl~DF 143 (426)
.+.+.+++ +...+||||++|-.|...-- ...=++.....++.++..+. =||+++++|.+.++||
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDw 246 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL-DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC-cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeC
Confidence 77777765 45679999999977754321 11112223334455555553 2999999999999999
Q ss_pred CCCC
Q 014359 144 GLSA 147 (426)
Q Consensus 144 Gla~ 147 (426)
--+.
T Consensus 247 PQ~v 250 (304)
T COG0478 247 PQAV 250 (304)
T ss_pred cccc
Confidence 7655
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00025 Score=63.87 Aligned_cols=114 Identities=27% Similarity=0.300 Sum_probs=66.3
Q ss_pred EEEEEEECCCCceEEEEEeecccc-----------------------cchhHHHHHHHHHHHHhcCCCC--CccceeEEE
Q 014359 29 KVKFAQDLDSGLPFAVKILEKNRI-----------------------IHLKITDQIKREIATLKLLKHP--NVVRLHEVL 83 (426)
Q Consensus 29 ~V~~a~~~~~~~~vAvK~i~~~~~-----------------------~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~ 83 (426)
.||.|.. ..|..+|||+...... ...-.....++|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899987 5677999998753210 0011234678899999999755 567777653
Q ss_pred EeCCeEEEEEcccC--CCChHHHHHhC--CCCCHHHHHHHHHHHHHHH------------hheeeCCCCCEEEeccCCCC
Q 014359 84 ASKSKIYMVLEYVT--GGELFDKIASK--GRLQEAEGRKLFQQLIDGL------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 84 ~~~~~~~lVmEy~~--gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al------------eNILld~~g~lKl~DFGla~ 147 (426)
...+||||+. |..+..+.... ..-.......++.++...+ -|||++++ .+.|+|||.+.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav 154 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAV 154 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred ----CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcce
Confidence 2479999998 65554433322 1122233333333343343 49999887 99999999887
Q ss_pred C
Q 014359 148 L 148 (426)
Q Consensus 148 ~ 148 (426)
.
T Consensus 155 ~ 155 (188)
T PF01163_consen 155 D 155 (188)
T ss_dssp E
T ss_pred e
Confidence 3
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=6.9e-06 Score=91.37 Aligned_cols=240 Identities=16% Similarity=0.076 Sum_probs=147.2
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEee---cccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--C
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE---KNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~---~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~ 86 (426)
.+..|++.-.+|.|.+++-..-+.+..+ +-+|+.+ ..... +...+....|..-++...|+++.....-... .
T Consensus 1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~Ls-ePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLS-EPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred HhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHh-hHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 3456666666666665543322211222 2334332 22211 1123445556666777789999887776543 3
Q ss_pred CeEEEEEcccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHH--------------------hheeeCCCCCEEEec
Q 014359 87 SKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGL--------------------ENILLDSKGNIKISD 142 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~al--------------------eNILld~~g~lKl~D 142 (426)
...|.+++|+.+|++++.|-+. .+..+..+....++.+.+. -|.++..+-++|+.+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 4579999999999999998642 3355555555555534442 377888889999999
Q ss_pred cCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCC
Q 014359 143 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKL 221 (426)
Q Consensus 143 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~ 221 (426)
+|+.+...+ .........+++.|++|++...-.+. .++|+|+.|+.+|++..|..+|-......+...+.++. ..+
T Consensus 1384 ~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sI 1460 (2724)
T KOG1826|consen 1384 GGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSI 1460 (2724)
T ss_pred cccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccc
Confidence 999983222 23344566788999999998877775 66999999999999998887764332222222222222 223
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 222 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
+.-.|.++-.+...+|-..-..||.-..++.-+.+.
T Consensus 1461 e~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1461 EKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred cccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 333344444455555555555777776666655553
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00015 Score=74.98 Aligned_cols=129 Identities=22% Similarity=0.319 Sum_probs=84.8
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccc---------------------------hhH----HH------HHH
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---------------------------LKI----TD------QIK 62 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~---------------------------~~~----~~------~~~ 62 (426)
..|+.++-|.||+|+. .+|+.||||+.+..-... ... .+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5788999999999997 469999999886432100 000 01 134
Q ss_pred HHHHHHhcCC-----CCCccceeEEEEeCCeEEEEEcccCCCChHHHH--HhCCCC-----CHHHHHHHHHHHHHH----
Q 014359 63 REIATLKLLK-----HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI--ASKGRL-----QEAEGRKLFQQLIDG---- 126 (426)
Q Consensus 63 ~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lVmEy~~gg~L~~~i--~~~~~l-----~e~~~~~~~~ql~~a---- 126 (426)
+|..-+.++. .|+|.--.=+++-.+.-.++|||++|-.+.+.. +. .++ .+.-++.++.|++.-
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~dgffH 288 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLRDGFFH 288 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHhcCccc
Confidence 4555555542 344332222333345568999999999888874 44 333 444555667776653
Q ss_pred ----HhheeeCCCCCEEEeccCCCCCCC
Q 014359 127 ----LENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 127 ----leNILld~~g~lKl~DFGla~~~~ 150 (426)
+-||+++.+|.+-+.|||+.....
T Consensus 289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 289 ADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cCCCccceEEecCCcEEEEcCcceecCC
Confidence 369999999999999999987543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00025 Score=71.71 Aligned_cols=162 Identities=22% Similarity=0.252 Sum_probs=105.5
Q ss_pred HHHHHHHHHHhcCCCCCccceeEEEEeC-CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHhheeeCCCCC
Q 014359 59 DQIKREIATLKLLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLENILLDSKGN 137 (426)
Q Consensus 59 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aleNILld~~g~ 137 (426)
.++.--...++.+.|+|...++++.... ....+|||++ +.+|.+....+. +-..... +.+ ++ .-+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------~~~---~~--~~~~ 93 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------AHG---VL--HLNI 93 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------ccc---cc--eehh
Confidence 4555667889999999999999988654 4578999999 569999887643 2111110 110 00 0112
Q ss_pred EEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC
Q 014359 138 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 217 (426)
Q Consensus 138 lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 217 (426)
++++| -+++ .| | ...++|+||||+|.++.++.-|...|......+....+.+-
T Consensus 94 ~~~td-~~~t------------------~~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~ 146 (725)
T KOG1093|consen 94 IYITD-HFLT------------------KY--P------SPIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY 146 (725)
T ss_pred hhccc-cccc------------------cC--C------CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh
Confidence 23333 1110 00 1 11235999999999999999998888766555555444332
Q ss_pred CCCC------------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 218 DFKL------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 218 ~~~~------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.... --.++.....+..+|+-..|..||...++++++-|.+.+
T Consensus 147 ~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 147 YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY 201 (725)
T ss_pred ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence 1110 011567778899999999999999999999999887653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0013 Score=61.00 Aligned_cols=72 Identities=15% Similarity=0.226 Sum_probs=55.0
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC--CccceeEEEEeCCeEEEEEcccC
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..- .+.+.+++.++.+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999973 24567889876432 134578999999998643 35788888888888899999999
Q ss_pred CCC
Q 014359 98 GGE 100 (426)
Q Consensus 98 gg~ 100 (426)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0086 Score=57.08 Aligned_cols=117 Identities=13% Similarity=0.048 Sum_probs=76.8
Q ss_pred EEEEEEECCCCceEEEEEeecccccc---h-----hHHHHHHHHHHHHhcCCCCCc--cceeEEEEe-----CCeEEEEE
Q 014359 29 KVKFAQDLDSGLPFAVKILEKNRIIH---L-----KITDQIKREIATLKLLKHPNV--VRLHEVLAS-----KSKIYMVL 93 (426)
Q Consensus 29 ~V~~a~~~~~~~~vAvK~i~~~~~~~---~-----~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~-----~~~~~lVm 93 (426)
.|.+.. -.|+.|.||......... . .-.....+|...+.+|..-+| ++.+.+.+. ....|+||
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 355544 356789999664322100 0 001147789998888853333 344445443 23578999
Q ss_pred cccCCC-ChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCC-------CCCEEEeccCCCC
Q 014359 94 EYVTGG-ELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDS-------KGNIKISDFGLSA 147 (426)
Q Consensus 94 Ey~~gg-~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~-------~g~lKl~DFGla~ 147 (426)
|++++. +|.+++.. ..+.++.....++.+++..+ .|||++. ++.+.++||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999886 79888863 34566777778888877764 6999985 4579999999886
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0065 Score=56.53 Aligned_cols=122 Identities=19% Similarity=0.232 Sum_probs=79.5
Q ss_pred eeeecCceEEEEEEECCCCceEEEEEeecccccchh---------------------HHHHHHHHHHHHhcCC--CCCcc
Q 014359 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---------------------ITDQIKREIATLKLLK--HPNVV 77 (426)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~---------------------~~~~~~~Ei~il~~l~--HpnIv 77 (426)
.|++|--+.||+|.. ..+..||||++......-.. ......+|..-|+++. +=.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 667788889999985 56889999998643211110 1123566888888874 44555
Q ss_pred ceeEEEEeCCeEEEEEcccCCCC-hHHHHHhCCCCCHHHHHHHHHHHHHHHh----------------heeeCCCCCEEE
Q 014359 78 RLHEVLASKSKIYMVLEYVTGGE-LFDKIASKGRLQEAEGRKLFQQLIDGLE----------------NILLDSKGNIKI 140 (426)
Q Consensus 78 ~l~~~~~~~~~~~lVmEy~~gg~-L~~~i~~~~~l~e~~~~~~~~ql~~ale----------------NILld~~g~lKl 140 (426)
+-+.+.. -.+||||+.... -.-.+. +.++...++..++.+++..++ |||+. +|.+.|
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 5565543 368999994421 111111 223444467777777777751 99999 889999
Q ss_pred eccCCCCCC
Q 014359 141 SDFGLSALP 149 (426)
Q Consensus 141 ~DFGla~~~ 149 (426)
+|||-|...
T Consensus 208 ID~~QaV~~ 216 (268)
T COG1718 208 IDVSQAVTI 216 (268)
T ss_pred EECcccccc
Confidence 999988744
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0082 Score=54.99 Aligned_cols=78 Identities=24% Similarity=0.313 Sum_probs=56.7
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC--CccceeEEEE---eCCeEEEEE
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEVLA---SKSKIYMVL 93 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~---~~~~~~lVm 93 (426)
++.|+.|..+.||+..... ..+++|+.... .....+.+|..+++.+... .+.+++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999998644 58999986543 2356788999999888533 3567776443 334579999
Q ss_pred cccCCCChHH
Q 014359 94 EYVTGGELFD 103 (426)
Q Consensus 94 Ey~~gg~L~~ 103 (426)
++++|..+..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999987776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.016 Score=54.23 Aligned_cols=75 Identities=17% Similarity=0.185 Sum_probs=53.5
Q ss_pred eeeecCc-eEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEEEEcccCC
Q 014359 21 TLGEGNF-GKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 21 ~LG~G~f-g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
.|..|.. +.||+... .+..+.||+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444554 88998864 34678889875432 245678999988884 44466888887777778999999999
Q ss_pred CChHH
Q 014359 99 GELFD 103 (426)
Q Consensus 99 g~L~~ 103 (426)
..|..
T Consensus 77 ~~l~~ 81 (244)
T cd05150 77 VPAAA 81 (244)
T ss_pred ccHhH
Confidence 77653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.021 Score=51.83 Aligned_cols=122 Identities=20% Similarity=0.190 Sum_probs=80.1
Q ss_pred cCEEEeceeeecCc-eEEEEEEECCCCceEEEEEeec---ccc-------cc-h-------hHHHHHHHHHHHHhcCC--
Q 014359 14 GRYELGRTLGEGNF-GKVKFAQDLDSGLPFAVKILEK---NRI-------IH-L-------KITDQIKREIATLKLLK-- 72 (426)
Q Consensus 14 ~~y~i~~~LG~G~f-g~V~~a~~~~~~~~vAvK~i~~---~~~-------~~-~-------~~~~~~~~Ei~il~~l~-- 72 (426)
.+++.++.||.|+- |.||+++. .|+.||+|++.. ... .. . .....+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999984 788999999421 100 00 0 12345778888777774
Q ss_pred -CCCc--cceeEEEEeC------------------CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHhhee
Q 014359 73 -HPNV--VRLHEVLASK------------------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLENIL 131 (426)
Q Consensus 73 -HpnI--v~l~~~~~~~------------------~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aleNIL 131 (426)
+.++ |+.+|++.-. ....||.||++... .++...+.++...+...=..-+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~~~~~~dl~~~~k~gI 185 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDIPQMLRDLKILHKLGI 185 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHHHHHHHHHHHHHHCCe
Confidence 5566 9999997322 12468888886643 4566677777766654422111
Q ss_pred e------CCCCCEEEeccCCC
Q 014359 132 L------DSKGNIKISDFGLS 146 (426)
Q Consensus 132 l------d~~g~lKl~DFGla 146 (426)
+ .+--.-||+|||.+
T Consensus 186 ~~~Dv~~~ny~~G~lvDfs~~ 206 (207)
T PF13095_consen 186 VPRDVKPRNYRGGKLVDFSSS 206 (207)
T ss_pred eeccCccccccCCEEEecccC
Confidence 1 12225689999965
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.013 Score=60.82 Aligned_cols=126 Identities=21% Similarity=0.252 Sum_probs=77.7
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccc----------------------------hhHHHH------HHHHH
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----------------------------LKITDQ------IKREI 65 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~----------------------------~~~~~~------~~~Ei 65 (426)
+.||..+.|.||+|+-+ +|+.||||+-+..-... .+..+. +.+|+
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 57899999999999975 49999999875422100 000111 23343
Q ss_pred HHH----hcCCCCC------ccceeEEEEeCCeEEEEEcccCCCChHHH--HHhCCCCCHHHH-----HHHHHHHHHH--
Q 014359 66 ATL----KLLKHPN------VVRLHEVLASKSKIYMVLEYVTGGELFDK--IASKGRLQEAEG-----RKLFQQLIDG-- 126 (426)
Q Consensus 66 ~il----~~l~Hpn------Iv~l~~~~~~~~~~~lVmEy~~gg~L~~~--i~~~~~l~e~~~-----~~~~~ql~~a-- 126 (426)
+-. +.+.|-+ |.++|--+ .+...++|||++|.-+.|. |.+. .++...+ ..+..||+.-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~qIf~~Gf 322 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQIFKTGF 322 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHHHHhcCC
Confidence 322 3334544 44443333 3456899999999877654 4443 3444443 3344555443
Q ss_pred ------HhheeeCC----CCCEEEeccCCCCCC
Q 014359 127 ------LENILLDS----KGNIKISDFGLSALP 149 (426)
Q Consensus 127 ------leNILld~----~g~lKl~DFGla~~~ 149 (426)
+-||+++. ++.+.+-|||+....
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 36999994 568999999998854
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.056 Score=49.06 Aligned_cols=123 Identities=20% Similarity=0.269 Sum_probs=84.9
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccc-------------cchhHHHHHHHHHHHHhcCC------CCCcccee
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-------------IHLKITDQIKREIATLKLLK------HPNVVRLH 80 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------HpnIv~l~ 80 (426)
..||+|+.-.||. |+.+ ....||+...... .......+..+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--CCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5799999999994 4333 3467899876550 00112456777777666665 88999999
Q ss_pred EEEEeCCeEEEEEcccCC------CChHHHHHhCCCCCHHHHHHHHHHHHHHH------------hheeeCCCC----CE
Q 014359 81 EVLASKSKIYMVLEYVTG------GELFDKIASKGRLQEAEGRKLFQQLIDGL------------ENILLDSKG----NI 138 (426)
Q Consensus 81 ~~~~~~~~~~lVmEy~~g------g~L~~~i~~~~~l~e~~~~~~~~ql~~al------------eNILld~~g----~l 138 (426)
|+.+++.-..+|+|.+.. -+|.+++.. +.+++ .....+.++...+ .||++..+. .+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~l 161 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRL 161 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEE
Confidence 999999999999998743 357788754 45777 5555555555553 699986543 47
Q ss_pred EEec-cCCCC
Q 014359 139 KISD-FGLSA 147 (426)
Q Consensus 139 Kl~D-FGla~ 147 (426)
.|+| ||...
T Consensus 162 vlIDG~G~~~ 171 (199)
T PF10707_consen 162 VLIDGLGEKE 171 (199)
T ss_pred EEEeCCCCcc
Confidence 7888 56544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.044 Score=50.40 Aligned_cols=129 Identities=17% Similarity=0.173 Sum_probs=77.4
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHH------HHHHHHHHHhcCCCC---CccceeEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------QIKREIATLKLLKHP---NVVRLHEVL 83 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~------~~~~Ei~il~~l~Hp---nIv~l~~~~ 83 (426)
-++|.+.+.+-......|.+.. ..|+.+++|.........+.... ...+++..+.++... .+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4678888888888888887765 46788999987643321111111 123444444444332 233333322
Q ss_pred Ee-----CCeEEEEEcccCCCChHHHHHhCCCCCHHH---HHHHHHHHHHH--------HhheeeCCCCCEEEeccCCCC
Q 014359 84 AS-----KSKIYMVLEYVTGGELFDKIASKGRLQEAE---GRKLFQQLIDG--------LENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 84 ~~-----~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~---~~~~~~ql~~a--------leNILld~~g~lKl~DFGla~ 147 (426)
+- ....+++|||++|..|.+... +++.. +...+.|+-.. +.|+++++++ ++++||+..+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 21 234668999999988876532 33322 33444555443 3699998655 9999998776
Q ss_pred C
Q 014359 148 L 148 (426)
Q Consensus 148 ~ 148 (426)
.
T Consensus 183 ~ 183 (229)
T PF06176_consen 183 M 183 (229)
T ss_pred c
Confidence 3
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.023 Score=62.87 Aligned_cols=108 Identities=14% Similarity=0.289 Sum_probs=74.3
Q ss_pred eceeeecCceEEEEEEECCCC--ceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCc--cceeEEEEeC---CeEE
Q 014359 19 GRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNV--VRLHEVLASK---SKIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~~~ 90 (426)
.+.|+.|.+..+|+......+ ..+++|+........ ....+.+|..+|+.+. |+++ .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577899999999998764332 467788765432111 1357889999999995 6765 7888887664 4689
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHhhe
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLENI 130 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~aleNI 130 (426)
+||||++|..+.+.. -..+++.+...+..+++.+|..|
T Consensus 121 lVME~v~G~~~~~~~--~~~~~~~~r~~l~~~l~~~La~L 158 (822)
T PLN02876 121 YIMEYLEGRIFVDPK--LPGVAPERRRAIYRATAKVLAAL 158 (822)
T ss_pred EEEEecCCcccCCcc--CCCCCHHHHHHHHHHHHHHHHHH
Confidence 999999885543211 12356777777888888877433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.092 Score=48.03 Aligned_cols=123 Identities=17% Similarity=0.173 Sum_probs=81.5
Q ss_pred eecCceEEEEEEECCCCceEEEEEeecccc---cchhHHHHHHHHHHHHhcCCCC--CccceeEEEEe----CCeEEEEE
Q 014359 23 GEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IHLKITDQIKREIATLKLLKHP--NVVRLHEVLAS----KSKIYMVL 93 (426)
Q Consensus 23 G~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~----~~~~~lVm 93 (426)
|+||.+.|+.... .|+.+=+|.-..... ........+.+|...|..|..- .+.+....... .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 4588899998664 344678886541111 0122356799999999998532 24444422111 12478999
Q ss_pred cccCC-CChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC--EEEeccCCCC
Q 014359 94 EYVTG-GELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN--IKISDFGLSA 147 (426)
Q Consensus 94 Ey~~g-g~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~--lKl~DFGla~ 147 (426)
|-+.| -+|.+++... .+.++..-..++.+++..+ .|||++.+|. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97753 6888887652 3457777777888887775 6999997777 9999998765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.086 Score=48.08 Aligned_cols=90 Identities=21% Similarity=0.316 Sum_probs=67.4
Q ss_pred HHHHHHHHHHhcCCCC--CccceeEEEEeC----CeEEEEEcccCCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHH----
Q 014359 59 DQIKREIATLKLLKHP--NVVRLHEVLASK----SKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127 (426)
Q Consensus 59 ~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~----~~~~lVmEy~~gg-~L~~~i~~~~~l~e~~~~~~~~ql~~al---- 127 (426)
....+|...+..|..- .+.+.+.+.+.. ...|+|+|++++. +|.+++......+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4678888888887533 345666665543 2468999999884 7999988744467777777777777764
Q ss_pred -----------hheeeCCCC---CEEEeccCCCCC
Q 014359 128 -----------ENILLDSKG---NIKISDFGLSAL 148 (426)
Q Consensus 128 -----------eNILld~~g---~lKl~DFGla~~ 148 (426)
.|||++.++ .+.++||+.++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 599999988 899999998773
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.041 Score=49.52 Aligned_cols=84 Identities=23% Similarity=0.303 Sum_probs=65.1
Q ss_pred HHHHHHHhcCCC-CCccceeEEEEeCCeEEEEEcccCCCChHHH---HHhCCCCCHHHHHHHHHHHHHHH----------
Q 014359 62 KREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGL---------- 127 (426)
Q Consensus 62 ~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lVmEy~~gg~L~~~---i~~~~~l~e~~~~~~~~ql~~al---------- 127 (426)
..|.-+++.+++ +++++++|+|- .++|.||...+++... +..-...++....+++.|++..+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999976 79999999983 2678899987766421 11223468888889999999886
Q ss_pred --------hheeeCCCCCEEEeccCCCCCC
Q 014359 128 --------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 128 --------eNILld~~g~lKl~DFGla~~~ 149 (426)
+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.11 Score=50.20 Aligned_cols=99 Identities=14% Similarity=0.087 Sum_probs=66.9
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC---CCccceeEEEEe---CCeEEE
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVRLHEVLAS---KSKIYM 91 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~~l 91 (426)
-.+.||.|..+.||.... .+..+.+|..+... . ...+.+|...|+.+.- -.+.++++++.. .+..|+
T Consensus 18 ~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~--~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYD--SQGNPMPLMARSFS--T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEc--CCCCEEEEEecccc--c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 356799999999998863 23357778753311 1 3578899999998853 467888888754 366899
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHh
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE 128 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~ale 128 (426)
|||+++|+++.+. ..+......+..+++.++.
T Consensus 91 VmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La 122 (297)
T PRK10593 91 LLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLL 122 (297)
T ss_pred EEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHH
Confidence 9999999888651 1233334445555555543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.49 Score=47.76 Aligned_cols=87 Identities=20% Similarity=0.180 Sum_probs=59.2
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccc---cc-hhHHHHHHHHHHHHhcCC---CCCccceeEEEEeCCeEEE
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IH-LKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~-~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 91 (426)
.+.||.|.+..||++.....++.|+||.-..... .. .-..++...|...|+.+. ..++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999999854446899997531110 00 112467788888888863 3567788877 4455789
Q ss_pred EEcccCCCC-hHHHHHh
Q 014359 92 VLEYVTGGE-LFDKIAS 107 (426)
Q Consensus 92 VmEy~~gg~-L~~~i~~ 107 (426)
||||+++.. +.+.+..
T Consensus 109 VME~L~~~~~lr~~Ll~ 125 (401)
T PRK09550 109 VMEDLSDHKILRKGLID 125 (401)
T ss_pred EEecCCCccHHHHHHhc
Confidence 999998754 4444444
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=93.96 E-value=0.38 Score=44.60 Aligned_cols=72 Identities=14% Similarity=0.099 Sum_probs=45.8
Q ss_pred ceeeecCce-EEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC---CccceeEEEEeC---CeEEEE
Q 014359 20 RTLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLASK---SKIYMV 92 (426)
Q Consensus 20 ~~LG~G~fg-~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~---~~~~lV 92 (426)
+.++.|+.. .||+. +..+++|+..... ....+.+|..+++.+... -+.++++..... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457766666 58865 2347778654321 135788999999888532 345555544332 245889
Q ss_pred EcccCCCCh
Q 014359 93 LEYVTGGEL 101 (426)
Q Consensus 93 mEy~~gg~L 101 (426)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999666
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.4 Score=46.02 Aligned_cols=79 Identities=16% Similarity=0.145 Sum_probs=52.1
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC--CccceeEE------EEeC
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEV------LASK 86 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~------~~~~ 86 (426)
+..-.+.|..|....+|+... .+..+++|+.... . ...+..|+.++..+.+. .+.+++.. ....
T Consensus 15 ~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~ 86 (296)
T cd05153 15 ELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA 86 (296)
T ss_pred chhheecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence 333356788888889998864 3457899987541 1 35677788888877432 24444432 2334
Q ss_pred CeEEEEEcccCCCCh
Q 014359 87 SKIYMVLEYVTGGEL 101 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L 101 (426)
+..++|++|++|..+
T Consensus 87 ~~~~~l~~~i~G~~~ 101 (296)
T cd05153 87 GKPAALVEFLAGEHL 101 (296)
T ss_pred CceEEEEEeCCCCCC
Confidence 567899999998665
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.016 Score=58.75 Aligned_cols=74 Identities=26% Similarity=0.404 Sum_probs=61.0
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
......++.+..+|.|+||+|+.+.+...+-.+|||.|.... ......+..+|+.-+..+.|++++++...|..
T Consensus 45 sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn--~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~ 118 (516)
T KOG1033|consen 45 SREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN--REESRSRVLREVSSLAEFEHPGIKRYFHAWYE 118 (516)
T ss_pred hhhhccccccccccccCccccCCccccccchhhHHHHhcccc--hhhhhhhhhccccchhhhcccchhhheeceec
Confidence 345678999999999999999999988777789999887544 23335678899999999999999999887754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=92.74 E-value=0.12 Score=50.22 Aligned_cols=124 Identities=21% Similarity=0.209 Sum_probs=78.6
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc-----------------chhH--HHHHHHHHHHHhcCC-C-
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----------------HLKI--TDQIKREIATLKLLK-H- 73 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----------------~~~~--~~~~~~Ei~il~~l~-H- 73 (426)
-|.+++.||=|-=+-||.+.+ ..|++.++|.-...+.+ .+-. .-...+|...|+.|. |
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367889999999999999987 56788899854321110 0111 123567888888884 3
Q ss_pred CCccceeEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH------------hheeeCCCCCEEEe
Q 014359 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------------ENILLDSKGNIKIS 141 (426)
Q Consensus 74 pnIv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al------------eNILld~~g~lKl~ 141 (426)
=-+.+.+++ +..++|||++.|-.|...-+- -+...+..-+..++--| =||++++++.++++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vI 244 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV---EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVI 244 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec---CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEe
Confidence 234555554 457899999999777543211 22222222222222222 29999999999999
Q ss_pred ccCCC
Q 014359 142 DFGLS 146 (426)
Q Consensus 142 DFGla 146 (426)
||--.
T Consensus 245 DFPQm 249 (465)
T KOG2268|consen 245 DFPQM 249 (465)
T ss_pred echHh
Confidence 99643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=91.70 E-value=0.86 Score=42.80 Aligned_cols=72 Identities=17% Similarity=0.195 Sum_probs=45.9
Q ss_pred eeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-cceeEEEEeCCeEEEEEcccCCC
Q 014359 21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 21 ~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lVmEy~~gg 99 (426)
.+..|-.+.+|+.. .+++.+++|+...... ...-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45668888999886 4567788997543211 100135678899988864333 44444432 36899999986
Q ss_pred Ch
Q 014359 100 EL 101 (426)
Q Consensus 100 ~L 101 (426)
.+
T Consensus 74 ~~ 75 (256)
T TIGR02721 74 VI 75 (256)
T ss_pred cc
Confidence 65
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=91.35 E-value=1.7 Score=42.09 Aligned_cols=81 Identities=15% Similarity=0.121 Sum_probs=50.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC--CccceeEE------EEe
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEV------LAS 85 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~------~~~ 85 (426)
+...-++.++.|....+|+... . +..+++|+..... . .+.+..|..++..|... .+.+++.. ...
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEe-C-CCcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 4444467788888889998863 3 4468889875421 1 23455677777776422 23444332 122
Q ss_pred CCeEEEEEcccCCCCh
Q 014359 86 KSKIYMVLEYVTGGEL 101 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L 101 (426)
.+..+++++|++|..+
T Consensus 95 ~g~~~~l~e~i~G~~~ 110 (307)
T TIGR00938 95 AGKPACLVEFLQGLSV 110 (307)
T ss_pred CCeEEEEEEeCCCCCC
Confidence 4568999999988553
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.89 E-value=2.1 Score=42.50 Aligned_cols=125 Identities=23% Similarity=0.372 Sum_probs=79.4
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccc-------------------cch---hH-HHHHHHHHHHHhcCCCCC
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-------------------IHL---KI-TDQIKREIATLKLLKHPN 75 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-------------------~~~---~~-~~~~~~Ei~il~~l~Hpn 75 (426)
-..|..|-=+-||.|.. ..|..+|||+++...+ ... ++ .-...+|++-|+++....
T Consensus 149 nGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34677888899999985 5778899998753211 000 11 123567888888887655
Q ss_pred ccceeEEEEeCCeEEEEEcccCCCCh-HHHHHhCCCCCHHHHHHHHHHHHHHH---------------h-heeeCCCCCE
Q 014359 76 VVRLHEVLASKSKIYMVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLIDGL---------------E-NILLDSKGNI 138 (426)
Q Consensus 76 Iv~l~~~~~~~~~~~lVmEy~~gg~L-~~~i~~~~~l~e~~~~~~~~ql~~al---------------e-NILld~~g~l 138 (426)
|..---+..- ...|||+++-...- .-.+ .+..++...+..+.+|++.-+ | |+|+ .+|.+
T Consensus 228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCceeee--cceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 4432222221 24689999943211 1122 235688888888888877765 2 7776 56889
Q ss_pred EEeccCCCCC
Q 014359 139 KISDFGLSAL 148 (426)
Q Consensus 139 Kl~DFGla~~ 148 (426)
.|+|-+-|.-
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999987763
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=89.54 E-value=0.14 Score=42.38 Aligned_cols=44 Identities=23% Similarity=0.298 Sum_probs=32.9
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhc
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~ 70 (426)
+.||.|+.|.||+|+.. +|+.||||+.+..- .+.+...+.+|+.
T Consensus 17 ~PlasASiaQVh~a~l~-~g~~VaVKV~rP~i------~~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 17 EPLASASIAQVHRARLK-DGEEVAVKVQRPGI------EEQIEADLRILRR 60 (119)
T ss_pred chhhheehhhheeeeec-ccchhhhhhcchHH------HHHHHHHHHHHHH
Confidence 57999999999999864 59999999986542 3455555555544
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=88.21 E-value=3 Score=42.18 Aligned_cols=104 Identities=13% Similarity=0.036 Sum_probs=65.4
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEeecccc-cch---hHHHHHHHHHHHHhcCC---CCCccceeEEEEeCCeEE
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL---KITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~ 90 (426)
-.+.||.|....||+..+ .++.|+||.-..... ... -...+...|...|+.+. ..++.+++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 367889999999999886 345699997542111 011 12455566777777664 357888988887 3457
Q ss_pred EEEcccCC--CChHHHHHhCCCCCHHHHHHHHHHHHHH
Q 014359 91 MVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDG 126 (426)
Q Consensus 91 lVmEy~~g--g~L~~~i~~~~~l~e~~~~~~~~ql~~a 126 (426)
++|||+++ ..+.+.+-.. ...+..+..+...++..
T Consensus 112 lvME~L~~~~~ilr~~Ll~G-~~~p~~a~~ig~~la~t 148 (418)
T PLN02756 112 IGMRYLEPPHIILRKGLIAG-IEYPLLAEHMSDYMAKT 148 (418)
T ss_pred EEEeecCCcceehhhhhccC-CCCHHHHHHHHHHHHHH
Confidence 89999977 3455555442 23355555555555444
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.15 E-value=7.7 Score=37.54 Aligned_cols=75 Identities=11% Similarity=0.085 Sum_probs=44.8
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC--CccceeE------EEEeCCeEE
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHE------VLASKSKIY 90 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~------~~~~~~~~~ 90 (426)
.+.|+.|....+|+... . +..+++|++... . .+.+..|+.+++.|... .+.+.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~~~---~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFERL---T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe-C-CCcEEEEEeccC---C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 45677788889998874 2 336899987521 1 23344455555555311 1333332 123356789
Q ss_pred EEEcccCCCCh
Q 014359 91 MVLEYVTGGEL 101 (426)
Q Consensus 91 lVmEy~~gg~L 101 (426)
++++|++|..+
T Consensus 99 ~l~~~l~G~~~ 109 (319)
T PRK05231 99 AIVTFLEGKWP 109 (319)
T ss_pred EEEEecCCCCC
Confidence 99999998643
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=87.25 E-value=1.2 Score=44.13 Aligned_cols=70 Identities=29% Similarity=0.363 Sum_probs=46.1
Q ss_pred CCCccceeEEEEeC-CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCC
Q 014359 73 HPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSK 135 (426)
Q Consensus 73 HpnIv~l~~~~~~~-~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~ 135 (426)
.++..+.+-+-.++ -..|++|++- |+.|. .+. .-..+++..++.+.++-+ .|||++ +
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 34444444444233 3467888876 65663 222 234566777777766654 599999 9
Q ss_pred CCEEEeccCCCCC
Q 014359 136 GNIKISDFGLSAL 148 (426)
Q Consensus 136 g~lKl~DFGla~~ 148 (426)
|++-|+||-+++.
T Consensus 358 GnvtLIDfklsRl 370 (488)
T COG5072 358 GNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEeeeeec
Confidence 9999999999984
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.89 E-value=5.3 Score=39.06 Aligned_cols=82 Identities=17% Similarity=0.177 Sum_probs=50.4
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--CCccceeEEEEeCC--eEEE
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKS--KIYM 91 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~--~~~l 91 (426)
..+.+....|..-.+|.... +++.+++. ... ............+|..+++.+.- --+...+++|.++. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 34445554454455565553 37778888 332 12223335778888888888743 33445566666555 7899
Q ss_pred EEcccCCCCh
Q 014359 92 VLEYVTGGEL 101 (426)
Q Consensus 92 VmEy~~gg~L 101 (426)
||+|++|..+
T Consensus 103 v~~~veGe~~ 112 (321)
T COG3173 103 VMEWVEGEVV 112 (321)
T ss_pred EEEEecceec
Confidence 9999998433
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=85.40 E-value=4.4 Score=40.30 Aligned_cols=97 Identities=19% Similarity=0.135 Sum_probs=59.2
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecc-c---ccchhHHHHHHHHHHHHhcCC--CC-CccceeEEEEeCCeEEEE
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKN-R---IIHLKITDQIKREIATLKLLK--HP-NVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~---~~~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lV 92 (426)
+.+|.|....||++.+...++.|+||.-..- + ..-.-..++...|...|+... -| ++.++|.+ ++....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 3579999999999997544468999954311 1 011122456677888887764 24 45666554 45556799
Q ss_pred EcccCCC-ChHHHHHhCCCCCHHHHHHH
Q 014359 93 LEYVTGG-ELFDKIASKGRLQEAEGRKL 119 (426)
Q Consensus 93 mEy~~gg-~L~~~i~~~~~l~e~~~~~~ 119 (426)
||+++.. .|...+.. +...+..+..+
T Consensus 79 MEdL~~~~ilR~~Li~-g~~~p~~A~~i 105 (370)
T TIGR01767 79 MEDLSHHKIARKGLIE-GENYPHLARHI 105 (370)
T ss_pred HhhCccchHHHHHHHc-CCCChHHHHHH
Confidence 9999553 34455544 34444544433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=84.02 E-value=3.4 Score=39.83 Aligned_cols=75 Identities=17% Similarity=0.226 Sum_probs=49.1
Q ss_pred EEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC---CCCccceeEEEEeCCeEEEEE
Q 014359 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lVm 93 (426)
+-.+.++.|....+|... .+++.+.||+-.... ...+..|..-|+.|. .-.+.+.+.+....+..|+||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345678999999999877 678889999876322 356778888888883 446789999988877789999
Q ss_pred cccCCC
Q 014359 94 EYVTGG 99 (426)
Q Consensus 94 Ey~~gg 99 (426)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999764
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 426 | ||||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-66 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-65 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-65 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-63 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-63 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-62 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-62 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-58 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-56 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-56 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-55 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-55 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-55 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-55 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-54 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-54 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-54 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-52 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-51 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-48 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-48 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-47 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-47 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-47 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-43 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-40 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-40 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-40 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-40 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-39 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-39 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-39 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-39 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-39 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-38 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-38 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-38 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-38 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-38 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-38 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-38 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-38 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-38 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-38 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-38 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-38 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-38 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-38 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-38 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-38 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-38 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-38 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-38 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-37 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-37 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-37 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-37 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-37 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-37 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-37 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-37 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-37 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-37 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-37 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-36 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-36 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-36 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-36 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-36 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-36 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-36 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-36 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-36 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-36 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-36 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-36 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-36 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-36 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-36 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-36 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-36 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-36 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-36 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-36 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-36 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-36 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-36 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-36 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-36 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-36 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-36 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-36 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-36 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-36 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-36 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-36 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-36 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-36 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-36 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-36 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-36 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-36 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-36 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-36 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-36 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-36 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-36 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-36 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-36 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-36 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-36 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-36 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-36 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-36 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-36 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-36 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-36 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-36 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-36 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-35 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-35 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-35 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-35 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-35 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-35 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-35 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-35 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-35 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-35 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-35 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-35 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-35 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-35 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-35 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-35 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-35 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-35 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-34 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-34 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-34 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-34 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-34 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-34 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-34 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-34 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-34 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-34 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-34 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-34 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-34 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-34 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-34 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-34 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-34 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-34 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-34 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-33 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-33 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-33 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-33 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-33 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-33 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-33 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-33 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-33 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-33 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-33 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-33 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-33 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-33 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-33 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-33 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-33 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-33 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-33 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-32 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-32 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-32 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-32 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-32 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-31 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-31 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-31 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-31 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-31 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-31 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-31 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-31 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-31 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-31 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-31 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-31 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-31 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-30 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-30 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-30 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-30 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-30 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-30 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-30 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-30 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-30 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-30 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-30 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-30 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-30 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-30 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-30 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-30 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-30 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-30 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-30 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-30 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-30 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-29 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-29 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-29 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-29 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-29 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-29 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-29 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-29 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-29 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-29 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-29 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-29 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-29 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-29 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-28 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-28 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-28 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-28 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-28 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-28 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-28 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-28 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-28 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-28 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-28 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-28 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-28 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-28 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-28 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-28 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-28 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-28 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-28 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-28 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-28 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-28 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-27 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-27 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-27 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-27 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-27 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-27 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-27 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-26 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-26 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-26 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-26 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-26 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-25 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-25 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-25 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-25 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-24 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-24 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-24 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-23 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-22 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-22 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-21 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-20 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-20 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-20 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-20 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-20 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-20 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-20 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-20 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-20 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-20 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-20 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-20 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-20 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-20 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-20 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-20 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-20 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-20 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-20 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-20 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-19 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-19 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-19 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-19 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-19 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-19 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-19 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-19 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-17 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-16 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-16 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-06 | ||
| 2zfd_B | 123 | The Crystal Structure Of Plant Specific Calcium Bin | 6e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-04 |
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ZFD|B Chain B, The Crystal Structure Of Plant Specific Calcium Binding Protein Atcbl2 In Complex With The Regulatory Domain Of Atcipk14 Length = 123 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 443 bits (1141), Expect = e-154
Identities = 142/474 (29%), Positives = 225/474 (47%), Gaps = 81/474 (17%)
Query: 1 MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
M +K +++G Y LG TLG G FGKVK + +G AVKIL + +I L + +
Sbjct: 3 MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
I+REI LKL +HP++++L++V+++ S I+MV+EYV+GGELFD I GRL E E R+LF
Sbjct: 63 IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122
Query: 121 QQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
QQ++ G+ EN+LLD+ N KI+DFGLS + D L T+CGSP
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSP 179
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 225
NY APEV++ R Y G DIWS GVILY +L G LPFDD ++ L++KI G F P++L
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239
Query: 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWF-----------EQDYTPANPDDD------ 268
+P +LL+ +L+ +P+KR TI I+ EWF + Y+ DD+
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVC 299
Query: 269 ------EEDI----------------------------------FVDNEAFSMHEVPSDG 288
EE++ + S +
Sbjct: 300 EKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLT 359
Query: 289 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIR---FTSNHSAKDLLERIEDIV 345
P P + A + +L+ K + S D++ + +
Sbjct: 360 RPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAI 419
Query: 346 TEMGFRVQKKNG-KLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD 398
++ + + N L+ K + ++ +++++ Y+++ R +
Sbjct: 420 KQLDYEWKVVNPYYLRV--RRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDE 471
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 430 bits (1108), Expect = e-152
Identities = 122/274 (44%), Positives = 173/274 (63%), Gaps = 18/274 (6%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K +++G Y LG TLG G FGKVK + +G AVKIL + +I L + +IKR
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
EI LKL +HP++++L++V+++ + +MV+EYV+GGELFD I GR++E E R+LFQQ+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 124 IDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 168
+ + EN+LLD+ N KI+DFGLS + D L T+CGSPNY
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYA 177
Query: 169 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 228
APEV++ R Y G DIWSCGVILY +L G LPFDD ++ L++KI G F +P++L+
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262
LL +L+ +P+KR TI I+ EWF+QD
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 431 bits (1110), Expect = e-151
Identities = 107/345 (31%), Positives = 162/345 (46%), Gaps = 33/345 (9%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
RY+ + +G GNFG + +D + AVK +E+ I + ++REI + L
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSL 73
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG----- 126
+HPN+VR EV+ + + + +++EY +GGEL+++I + GR E E R FQQL+ G
Sbjct: 74 RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 127 ----------LENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
LEN LLD +KI DFG S +T G+P Y+APEVL
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLL 190
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK----IFRGDFKLPK--WLSPG 228
+ YDG +D+WSCGV LYV+L G PF+D Y+K I + +P +SP
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP--ANPDDDEEDIFVDNEAFSMHEVPS 286
+L+ +I +P RI+I IK WF ++ N + + +
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIM 310
Query: 287 DGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSN 331
P + N M+ LDL + D SE +I S+
Sbjct: 311 QIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFD-SESEIDIDSS 354
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 425 bits (1094), Expect = e-149
Identities = 114/290 (39%), Positives = 175/290 (60%), Gaps = 20/290 (6%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+G Y + TLGEG+FGKVK A + A+K + + + + +++REI+
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
LKLL+HP++++L++V+ + + I MV+EY GGELFD I K R+ E EGR+ FQQ+I
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 127 L---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
+ EN+LLD N+KI+DFGLS + D L T+CGSPNY APE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPE 177
Query: 172 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231
V+ + Y G D+WSCG++LYV+L G LPFDD + L++K+ + +P +LSPGAQ+
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237
Query: 232 LLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDEEDIFVDNEAFS 280
L+R+++ +P++RITI I+ D WF + P ++ + + D+ S
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVS 287
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 420 bits (1083), Expect = e-147
Identities = 99/289 (34%), Positives = 148/289 (51%), Gaps = 28/289 (9%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKL 70
+G+Y +G LGEG++GKVK D ++ AVKIL+K ++ + +K+EI L+
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 71 LKHPNVVRLHEVL--ASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
L+H NV++L +VL K K+YMV+EY G E+ D + + R + F QLIDG
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDG 121
Query: 127 L---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
L N+LL + G +KIS G++ F D T+ GSP + PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 172 VLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 230
+ + G DIWS GV LY I TG PF+ N+ L++ I +G + +P P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 231 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN------PDDDEEDIF 273
+LL+ +LE P KR +I I+ WF + + PA P D +D +
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRW 290
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 421 bits (1084), Expect = e-147
Identities = 100/309 (32%), Positives = 154/309 (49%), Gaps = 29/309 (9%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ G+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
EN+LLD + N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 234
+ D+WSCG++L +L G LP+D + Y L W + LL
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 235 KILEPNPVKRITIAGIKADEWFEQDYTP--------ANPDDDEEDIFVDNEAFSMHEVPS 286
KIL NP RITI IK D W+ + + + F + ++ P
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPV 303
Query: 287 DGG-RTPGS 294
+ RTPGS
Sbjct: 304 NSASRTPGS 312
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-147
Identities = 93/266 (34%), Positives = 141/266 (53%), Gaps = 20/266 (7%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ G+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
EN+LLD + N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 234
+ D+WSCG++L +L G LP+D + Y L W + LL
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 235 KILEPNPVKRITIAGIKADEWFEQDY 260
KIL NP RITI IK D W+ +
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPL 269
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 405 bits (1044), Expect = e-142
Identities = 86/276 (31%), Positives = 137/276 (49%), Gaps = 18/276 (6%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I E + RY GR LG+G F K D D+ FA KI+ K+ ++ +++
Sbjct: 4 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 63
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
EI+ + L H +VV H +++VLE L + + L E E R +Q
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 123
Query: 123 LIDG---------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
++ G L N+ L+ +KI DFGL+ ++ D CG+PNY
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNY 181
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227
+APEVL+ +G+ D+WS G I+Y +L G PF+ L Y +I + ++ +PK ++P
Sbjct: 182 IAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 263
A +L++K+L+ +P R TI + DE+F Y PA
Sbjct: 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 403 bits (1038), Expect = e-140
Identities = 86/276 (31%), Positives = 137/276 (49%), Gaps = 18/276 (6%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I E + RY GR LG+G F K D D+ FA KI+ K+ ++ +++
Sbjct: 30 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 89
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
EI+ + L H +VV H +++VLE L + + L E E R +Q
Sbjct: 90 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 149
Query: 123 LIDG---------------LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
++ G L N+ L+ +KI DFGL+ ++ D CG+PNY
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNY 207
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227
+APEVL+ +G+ D+WS G I+Y +L G PF+ L Y +I + ++ +PK ++P
Sbjct: 208 IAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 266
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 263
A +L++K+L+ +P R TI + DE+F Y PA
Sbjct: 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 399 bits (1028), Expect = e-139
Identities = 105/283 (37%), Positives = 167/283 (59%), Gaps = 19/283 (6%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
IA E +G Y L +T+G+GNF KVK A+ + +G A+KI++K ++ + ++
Sbjct: 4 IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLF 62
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE+ +K+L HPN+V+L EV+ ++ +Y+++EY +GGE+FD + + GR++E E R F+Q
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 123 LIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
++ + EN+LLD+ NIKI+DFG S F G L CG+P Y
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE---FTVGGKLDAFCGAPPY 179
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227
APE+ + YDG D+WS GVILY +++G LPFD +NL L +++ RG +++P ++S
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 270
+NLL++ L NP+KR T+ I D W + E
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVE 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-137
Identities = 74/274 (27%), Positives = 142/274 (51%), Gaps = 19/274 (6%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G ++ +++G LG+G+F V A+ + +GL A+K+++K + + +++ E+
Sbjct: 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL- 127
LKHP+++ L+ + +Y+VLE GE+ + ++ E E R Q+I G+
Sbjct: 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 128 --------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
N+LL NIKI+DFGL+ + +T CG+PNY++PE+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIA 184
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233
+ G SD+WS G + Y +L G PFD + K+ D+++P +LS A++L+
Sbjct: 185 TRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243
Query: 234 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 267
++L NP R++++ + + ++ + + D+
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 389 bits (1002), Expect = e-135
Identities = 88/298 (29%), Positives = 144/298 (48%), Gaps = 47/298 (15%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------ 58
+ ++L +Y L +G+G++G VK A + + +A+K+L K ++I
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 59 -----------------DQIKREIATLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGG 99
+Q+ +EIA LK L HPNVV+L EVL ++ +YMV E V G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 100 ELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFG 144
+ + + + L E + R FQ LI G+ N+L+ G+IKI+DFG
Sbjct: 124 PVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPF 202
+S + D LL T G+P ++APE L+ + + G D+W+ GV LY + G PF
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 203 DDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
D + L+ KI + P ++ ++L+ ++L+ NP RI + IK W +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 387 bits (996), Expect = e-135
Identities = 81/278 (29%), Positives = 144/278 (51%), Gaps = 20/278 (7%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+AE + + +++GR LG+G FG V A++ + A+K+L K+++ + Q++
Sbjct: 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
REI L+HPN++R++ + +IY++LE+ GEL+ ++ GR E ++
Sbjct: 63 REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 123 LIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
L D L EN+L+ KG +KI+DFG S R T CG+ +Y
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDY 178
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227
+ PE++ + +D D+W GV+ Y L G PFD + +++I D K P +LS
Sbjct: 179 LPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD 237
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 265
G+++L+ K+L +P +R+ + G+ W + + P
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-131
Identities = 78/281 (27%), Positives = 140/281 (49%), Gaps = 20/281 (7%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
K+ L +E+GR LG+G FG V A++ S A+K+L K ++ + Q++RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
L+HPN++RL+ +++Y++LEY G ++ ++ + E +L +
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 127 L---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
L EN+LL S G +KI+DFG S R CG+ +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 172 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231
++ R +D D+WS GV+ Y L G PF+ Y++I R +F P +++ GA++
Sbjct: 178 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 232 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 272
L+ ++L+ NP +R + + W + + + ++E
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-130
Identities = 77/312 (24%), Positives = 132/312 (42%), Gaps = 30/312 (9%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---- 59
EG +Y LG G FG V A D + VK ++K +++ +
Sbjct: 14 GLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL 73
Query: 60 -QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE-YVTGGELFDKIASKGRLQEAEGR 117
++ EIA L ++H N++++ ++ ++ +V+E + +G +LF I RL E
Sbjct: 74 GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 118 KLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162
+F+QL+ + ENI++ IK+ DFG +A L +T C
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFC 190
Query: 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 222
G+ Y APEVL Y G ++WS GV LY ++ PF + ++ P
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPP 244
Query: 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 282
+S +L+ +L+P P +R T+ + D W Q A+ +E E+ +
Sbjct: 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLS 304
Query: 283 EVPSDGGRTPGS 294
+ G S
Sbjct: 305 AASLEMGNRSLS 316
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 367 bits (943), Expect = e-126
Identities = 78/292 (26%), Positives = 121/292 (41%), Gaps = 34/292 (11%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--- 60
K Y LG LG+G FG V L L A+K++ +NR++
Sbjct: 21 PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80
Query: 61 IKREIATLKLL----KHPNVVRLHEVLASKSKIYMVLEY-VTGGELFDKIASKGRLQEAE 115
E+A L + HP V+RL + ++ +VLE + +LFD I KG L E
Sbjct: 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 116 GRKLFQQLIDGL---------------ENILLDSK-GNIKISDFGLSALPQHFRDDGLLH 159
R F Q++ + ENIL+D + G K+ DFG AL D
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYT 196
Query: 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 219
G+ Y PE ++ Y + +WS G++LY ++ G +PF+ Q+I +
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAEL 250
Query: 220 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 271
P +SP L+R+ L P P R ++ I D W + + +
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGG 302
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-126
Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 32/291 (10%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IHLKITD 59
+A K++ +Y++G LG G FG V + LP A+K +EK+RI L
Sbjct: 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 91
Query: 60 QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
++ E+ LK + V+RL + ++LE +LFD I +G LQE
Sbjct: 92 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151
Query: 117 RKLFQQLIDGL---------------ENILLDS-KGNIKISDFGLSALPQHFRDDGLLHT 160
R F Q+++ + ENIL+D +G +K+ DFG AL + D +
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 207
Query: 161 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 220
G+ Y PE + Y G ++ +WS G++LY ++ G +PF+ ++I RG
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 261
Query: 221 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 271
+ +S Q+L+R L P R T I+ W + P +
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH 312
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 352 bits (906), Expect = e-120
Identities = 65/324 (20%), Positives = 121/324 (37%), Gaps = 65/324 (20%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------- 56
K++ + Y + RTL +G F K+ + +A+K EK+ + +
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 57 -----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL 111
D K E+ + +K+ + ++ + ++Y++ EY+ + L
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 112 Q--------EAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSA 147
+ + + +++ NIL+D G +K+SDFG S
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDD-R 205
+ D + + G+ ++ PE +N Y+GA DIWS G+ LYV+ +PF
Sbjct: 201 ----YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 206 NLAVLYQKIFRGDFKLP-------------------KWLSPGAQNLLRKILEPNPVKRIT 246
+L L+ I + + P +LS + L+ L NP +RIT
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 247 IAGIKADEWFEQDYTPANPDDDEE 270
EW + +E
Sbjct: 317 SEDALKHEWLADTNIEDLREFSKE 340
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 6e-97
Identities = 89/283 (31%), Positives = 136/283 (48%), Gaps = 34/283 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
Y + +TLG G G+VK A + + A+KI+ K + ++ EI LK
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-- 127
L HP ++++ ++ Y+VLE + GGELFDK+ RL+EA + F Q++ +
Sbjct: 71 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 128 -------------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
EN+LL S+ IKI+DFG S + + L+ T CG+P Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPE 186
Query: 172 VLANRGYDGATS--DIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRG--DFKLPKW-- 224
VL + G G D WS GVIL++ L+GY PF + L +I G +F W
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 267
+S A +L++K+L +P R T W + + D
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 3e-94
Identities = 92/280 (32%), Positives = 144/280 (51%), Gaps = 27/280 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG+G F V+ +GL FA KI+ ++ +++RE + L+HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHP 65
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
N+VRLH+ + +S Y+V + VTGGELF+ I ++ EA+ QQ+++ +
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 128 --------ENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+LL SK +K++DFGL+ D H G+P Y++PEVL
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
Y DIW+CGVILY++L GY PF D + LY +I G D+ P+W ++P A++L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 272
+ +L NP KRIT W A+ ++ +
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 4e-94
Identities = 87/275 (31%), Positives = 144/275 (52%), Gaps = 31/275 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y L T+G G++G+VK A + + A K + K ++ D+ K+EI +K L HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHP 66
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
N++RL+E + IY+V+E TGGELF+++ K +E++ ++ + ++ +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 128 --------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN L + +K+ DFGL+A F+ ++ T G+P YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL-EG 182
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
Y G D WS GV++YV+L GY PF + + KI G F W +SP A++L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 267
+R++L +P +RIT EWF + ++P +
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWF-EKQLSSSPRN 275
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 2e-93
Identities = 89/283 (31%), Positives = 137/283 (48%), Gaps = 34/283 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
Y + +TLG G G+VK A + + A++I+ K + ++ EI LK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-- 127
L HP ++++ ++ Y+VLE + GGELFDK+ RL+EA + F Q++ +
Sbjct: 196 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 128 -------------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
EN+LL S+ IKI+DFG S + + L+ T CG+P Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPE 311
Query: 172 VLANRGYDGATS--DIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW-- 224
VL + G G D WS GVIL++ L+GY PF + R L +I G +F W
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371
Query: 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 267
+S A +L++K+L +P R T W + + D
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 7e-92
Identities = 81/275 (29%), Positives = 132/275 (48%), Gaps = 35/275 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-----IHLKITDQIKREIATLK 69
+Y+ +G G V+ +G FAVKI+E ++ + +RE L+
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 70 LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL- 127
+ HP+++ L + S S +++V + + GELFD + K L E E R + + L++ +
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 128 --------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
ENILLD I++SDFG S H L CG+P Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 174 ------ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW- 224
+ GY G D+W+CGVIL+ +L G PF R ++ + I G F P+W
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 225 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
S ++L+ ++L+ +P R+T +FE+
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-91
Identities = 80/283 (28%), Positives = 127/283 (44%), Gaps = 36/283 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------QIKREIATL 68
YE LG G V+ + +AVKI++ + +E+ L
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 69 KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
+ + HPN+++L + + + ++V + + GELFD + K L E E RK+ + L++ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 128 ---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
ENILLD NIK++DFG S L CG+P+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTPSYLAPEI 194
Query: 173 LA------NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW 224
+ + GY G D+WS GVI+Y +L G PF R ++ + I G F P+W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 225 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 265
S ++L+ + L P KR T A +F+Q
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 2e-91
Identities = 92/278 (33%), Positives = 142/278 (51%), Gaps = 27/278 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG+G F V+ +GL FA KI+ ++ ++RE + L+HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHP 88
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
N+VRLH+ + +S Y+V + VTGGELF+ I ++ EA+ QQ+++ +
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 128 --------ENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+LL SK +K++DFGL+ D H G+P Y++PEVL
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
Y DIW+CGVILY++L GY PF D + LY +I G D+ P+W ++P A++L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 270
+ +L NP KRIT W A+ ++
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 302
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 6e-91
Identities = 86/277 (31%), Positives = 138/277 (49%), Gaps = 30/277 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ LG G F +V + +G FA+K ++K+ ++ EIA LK +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
N+V L ++ S + Y+V++ V+GGELFD+I +G E + + QQ++ +
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 128 --------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+L + I I+DFGLS +G++ T CG+P YVAPEVLA +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
Y D WS GVI Y++L GY PF + + L++KI G +F+ P W +S A++
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 269
+ +LE +P +R T + W + +
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPS 278
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 3e-90
Identities = 64/290 (22%), Positives = 112/290 (38%), Gaps = 51/290 (17%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E LG+G FG+V A++ +A+K + + I E+ L L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQY 63
Query: 76 VVRLHEV-------------LASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
VVR + + KS +++ +EY G L+D I S+ Q E +LF+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLSALPQH------------FRD 154
Q+++ L NI +D N+KI DFGL+
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 214
L + G+ YVA EVL G+ D++S G+I + ++ Y + +K+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241
Query: 215 FRGDFKLPKWL----SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260
+ P + ++R +++ +P KR + W +
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 9e-90
Identities = 88/269 (32%), Positives = 131/269 (48%), Gaps = 32/269 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R LG G FG V ++ SGL +K + K+R +QI+ EI LK L HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGL--- 127
N++++ EV +Y+V+E GGEL ++I S L E +L +Q+++ L
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 128 ------------ENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
ENIL IKI DFGL+ F+ D G+ Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEV 197
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGA 229
R DIWS GV++Y +LTG LPF +L + QK + + L+P A
Sbjct: 198 F-KRDVTFKC-DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 230 QNLLRKILEPNPVKRITIAGIKADEWFEQ 258
+LL+++L +P +R + A + EWF+Q
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 6e-89
Identities = 97/267 (36%), Positives = 146/267 (54%), Gaps = 28/267 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + LG+G+FG+V +D + +AVK++ K + K T I RE+ LK L HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
N+++L E+L S Y+V E TGGELFD+I + R E + ++ +Q+ G+
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 128 --------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
ENILL+SK +IKI DFGLS F+ + + G+ Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEVL-RG 197
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
YD D+WS GVILY++L+G PF +N + +++ G F LP+W +S A++L
Sbjct: 198 TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQD 259
+RK+L +P RIT W ++
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 1e-87
Identities = 60/280 (21%), Positives = 117/280 (41%), Gaps = 34/280 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86
Query: 75 N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
+ ++RL++ + IYMV+E +L + K + E + ++ +++ +
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
N L+ G +K+ DFG++ Q + + G+ NY+ PE + +
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 178 YD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKW 224
SD+WS G ILY + G PF ++ L+ I + + P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 264
Q++L+ L+ +P +RI+I + A + + P N
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 2e-87
Identities = 94/279 (33%), Positives = 146/279 (52%), Gaps = 28/279 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+L LG+G F V+ + +G +A I+ ++ ++RE +LLKHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHP 70
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
N+VRLH+ ++ + Y++ + VTGGELF+ I ++ EA+ QQ+++ +
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 128 --------ENILLDSKGN---IKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLAN 175
EN+LL SK +K++DFGL+ + G+P Y++PEVL
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQN 231
Y G D+W+CGVILY++L GY PF D + LYQ+I G DF P+W ++P A++
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 232 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 270
L+ K+L NP KRIT A W T A+ +E
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQE 285
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 5e-86
Identities = 84/288 (29%), Positives = 136/288 (47%), Gaps = 30/288 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
Y++G LG G F VK ++ +GL +A K ++K + + ++I+RE++ L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
H NV+ LH+V +++ + ++LE V+GGELFD +A K L E E +Q++DG+
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 128 -----------ENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
ENI+L K +IK+ DFGL+ D G+P +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 228
+ D+WS GVI Y++L+G PF I DF + S
Sbjct: 190 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 276
A++ +RK+L KR+TI W E + ++N
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 6e-86
Identities = 80/271 (29%), Positives = 133/271 (49%), Gaps = 30/271 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
YE+G LG G F V+ + +G +A K ++K R+ ++I+RE+ L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
+HPN++ LH++ +K+ + ++LE V+GGELFD +A K L E E + +Q++DG+
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 128 -----------ENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
ENI+L K IK+ DFG++ G+P +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEI 182
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 228
+ D+WS GVI Y++L+G PF I DF + S
Sbjct: 183 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 259
A++ +R++L +P +R+TIA W +
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 9e-86
Identities = 85/288 (29%), Positives = 137/288 (47%), Gaps = 30/288 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
Y++G LG G F VK ++ +GL +A K ++K + ++I+RE++ L+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
HPN++ LH+V +++ + ++LE V+GGELFD +A K L E E +Q++DG+
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 128 -----------ENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
ENI+L K +IK+ DFGL+ D G+P +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 228
+ D+WS GVI Y++L+G PF I DF + S
Sbjct: 190 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 276
A++ +RK+L KR+TI W T E + ++N
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 1e-85
Identities = 68/309 (22%), Positives = 107/309 (34%), Gaps = 65/309 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ L LG+G V + +G FA+K+ L+ D RE LK L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNH 66
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGL- 127
N+V+L + + +++E+ G L+ + L E+E + + ++ G+
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 128 --------------ENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
NI+ D + K++DFG + DD + G+ Y+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLH 183
Query: 170 PEVLANRGYD-------GATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRG- 217
P++ GAT D+WS GV Y TG LPF R + KI G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 218 ------------------DFKLPKW--LSPGAQN----LLRKILEPNPVKRITIAGIKAD 253
+P LS G Q +L ILE + K A+
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 254 EWFEQDYTP 262
Sbjct: 304 TSDILHRGN 312
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 3e-85
Identities = 97/276 (35%), Positives = 147/276 (53%), Gaps = 28/276 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY + LG+G+FG+V +D + +AVK++ K + K T I RE+ LK L HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
N+++L E+L S Y+V E TGGELFD+I + R E + ++ +Q+ G+
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 128 --------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
ENILL+SK +IKI DFGLS F+ + + G+ Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVL-RG 197
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
Y D+WS GVILY++L+G PF +N + +++ G F LP+W +S A++L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 268
+RK+L +P RIT W ++ + D
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISD 292
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 4e-85
Identities = 83/312 (26%), Positives = 127/312 (40%), Gaps = 68/312 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
+Y L +G+G++G V+ A + + A+KI+ KN+I + D IK E+ +K L
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-------------------- 112
HPN+ RL+EV + I +V+E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 113 --------------------EAEGRKLFQQLIDGL---------------ENILLDSKGN 137
E + +Q+ L EN L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 138 --IKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVI 191
IK+ DFGLS + + + T G+P +VAPEVL N Y D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC-DAWSAGVL 265
Query: 192 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 247
L+++L G +PF N A ++ F+ P + LSP A++LL +L N +R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 248 AGIKADEWFEQD 259
W Q
Sbjct: 326 MRALQHPWISQF 337
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 7e-85
Identities = 85/278 (30%), Positives = 136/278 (48%), Gaps = 33/278 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG G V + + P+A+K+L+K ++ EI L L HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLSHP 108
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
N+++L E+ + ++I +VLE VTGGELFD+I KG E + +Q+++ +
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 128 --------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+L + +KI+DFGLS + L+ T CG+P Y APE+L
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLS---KIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 177 GYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW--LSPGAQN 231
Y G D+WS G+I Y++L G+ PF D+R ++++I F P W +S A++
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 232 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 269
L+RK++ +P KR+T W D
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWV-TGKAANFVHMDT 321
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 1e-84
Identities = 81/284 (28%), Positives = 136/284 (47%), Gaps = 33/284 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
YEL +G+G F V+ + ++G FAVKI++ + +KRE + +LK
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ----EAEGRKLFQQLIDGL- 127
HP++V L E +S +YMV E++ G +L +I + EA +Q+++ L
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 128 --------------ENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 170
+LL SK N +K+ FG++ Q + G+P+++AP
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAGGRVGTPHFMAP 202
Query: 171 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LS 226
EV+ Y G D+W CGVIL+++L+G LPF L++ I +G +W +S
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHIS 260
Query: 227 PGAQNLLRKILEPNPVKRITIAGIKADEWF-EQDYTPANPDDDE 269
A++L+R++L +P +RIT+ W E+D E
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPE 304
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 2e-84
Identities = 97/282 (34%), Positives = 149/282 (52%), Gaps = 27/282 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ R LG+G+FG+V +D +G AVK++ K ++ + + RE+ LK L HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
N+++L+E K Y+V E TGGELFD+I S+ R E + ++ +Q++ G+
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 128 --------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+LL+SK NI+I DFGLS HF + G+ Y+APEVL +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVL-HG 202
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
Y D+WS GVILY++L+G PF+ N + +K+ +G F+LP+W +S A++L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFV 274
+RK+L P RI+ EW + D
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 2e-84
Identities = 88/292 (30%), Positives = 144/292 (49%), Gaps = 37/292 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----------DQIKRE 64
Y R LG G +G+V ++ + A+K+++K++ + + ++I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
I+ LK L HPN+++L +V K Y+V E+ GGELF++I ++ + E + + +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 125 DGL---------------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPN 166
G+ ENILL++K NIKI DFGLS F D L G+
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAY 213
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW 224
Y+APEVL + Y D+WSCGVI+Y++L GY PF +N + +K+ +G F W
Sbjct: 214 YIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 225 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFV 274
+S A+ L++ +L + KR T W ++ N D +
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 3e-84
Identities = 82/456 (17%), Positives = 138/456 (30%), Gaps = 76/456 (16%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
G +E+ LG G FG V D+G A+K + K ++ EI +K L
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKL 69
Query: 72 KHPNVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQ 122
HPNVV EV K+ + +EY GG+L + L+E R L
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 123 LIDGL---------------ENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGS 164
+ L ENI+L KI D G + + L G+
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA---KELDQGELCTEFVGT 186
Query: 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---------- 214
Y+APE+L + Y T D WS G + + +TG+ PF V +
Sbjct: 187 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 215 ----------FRGDFKLPKWLSPGAQNL----LRKILEPNPVKRITIAGIKADEWFEQDY 260
F P LS L+ +L + +R T F+
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA-- 303
Query: 261 TPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQ-LIGMSSCLDLSG--FFE 317
+ + +H P + + + + + +
Sbjct: 304 LDSILSLKLLSVMNMVS-GRVHTYPVTENEN------LQNLKSWLQQDTGIPEEEQELLQ 356
Query: 318 KEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVA 377
++ + + + + ++ F + + SV+
Sbjct: 357 ASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAH----PESVS 412
Query: 378 AEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 413
+ + L LR+ +G Q L D
Sbjct: 413 IVLQDPKRPLTYTHLRRVWGQIW---QTIRALKEDC 445
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 5e-84
Identities = 84/288 (29%), Positives = 137/288 (47%), Gaps = 30/288 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
Y+ G LG G F VK ++ +GL +A K ++K R + + I+RE++ LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
+HPNV+ LHEV +K+ + ++LE V GGELFD +A K L E E + +Q+++G+
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 128 -----------ENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
ENI+L + IKI DFGL+ G+P +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 228
+ D+WS GVI Y++L+G PF + +F+ + S
Sbjct: 189 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 276
A++ +R++L +P KR+TI W + T + ++
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 6e-84
Identities = 60/285 (21%), Positives = 117/285 (41%), Gaps = 34/285 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67
Query: 75 N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
+ ++RL++ + IYMV+E +L + K + E + ++ +++ +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
N L+ G +K+ DFG++ Q + + G+ NY+ PE + +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 178 YD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKW 224
SD+WS G ILY + G PF ++ L+ I + + P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 269
Q++L+ L+ +P +RI+I + A + + P N
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 6e-84
Identities = 60/286 (20%), Positives = 117/286 (40%), Gaps = 34/286 (11%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y + + +G G KV + + +A+K + + + D + EIA L L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQ 113
Query: 74 PN--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
+ ++RL++ + IYMV+E +L + K + E + ++ +++ +
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
N L+ G +K+ DFG++ Q + + G+ NY+ PE + +
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 177 GYD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRG-DFKLPK 223
SD+WS G ILY + G PF ++ L+ I + + P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 224 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 269
Q++L+ L+ +P +RI+I + A + + P N
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 3e-83
Identities = 66/312 (21%), Positives = 108/312 (34%), Gaps = 70/312 (22%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+ + L LG+G V + +G FA+K+ L+ D RE
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFE 59
Query: 67 TLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQ 121
LK L H N+V+L + + +++E+ G L+ + L E+E + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 122 QLIDGL---------------ENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTC 162
++ G+ NI+ D + K++DFG + DD +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLY 176
Query: 163 GSPNYVAPEVLANRGYD-------GATSDIWSCGVILYVILTGYLPFDD----RNLAVLY 211
G+ Y+ P++ GAT D+WS GV Y TG LPF R +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 212 QKIFRGDF-------------------------KLPKWLSPGAQNLLRKILEPNPVKRIT 246
KI G L + L +L ILE + K
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 247 IAGIKADEWFEQ 258
D++F +
Sbjct: 297 F-----DQFFAE 303
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 8e-83
Identities = 83/276 (30%), Positives = 144/276 (52%), Gaps = 28/276 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+ + LG G +G+V +D + + A+KI+ K + + + E+A LKLL HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHP 96
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------- 127
N+++L++ K Y+V+E GGELFD+I + + E + + +Q++ G+
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 128 --------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
EN+LL+SK IKI DFGLS F + + G+ Y+APEVL +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPEVL-RK 212
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
Y D+WS GVIL+++L GY PF + + +K+ +G F P+W +S GA++L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 268
++++L+ + +RI+ W ++ + +
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 1e-82
Identities = 85/284 (29%), Positives = 131/284 (46%), Gaps = 37/284 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
YE+ +G G++ K + + FAVKI++K++ EI L + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQH 75
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------ 127
PN++ L +V +Y+V E + GGEL DKI + E E + + +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 128 ---------ENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
NIL + +I+I DFG + Q ++GLL T C + N+VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLE 193
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFD---DRNLAVLYQKIFRG--DFKLPKW--LSP 227
+GYD A DIWS GV+LY +LTGY PF D + +I G W +S
Sbjct: 194 RQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 271
A++L+ K+L +P +R+T A + W + +D
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 2e-81
Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 30/274 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + LG G FG V + S + K ++ +K+EI+ L + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL------ 127
N++ LHE S ++ M+ E+++G ++F++I + L E E Q+ + L
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 128 ---------ENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
ENI+ ++ + IKI +FG + + + +P Y APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
AT D+WS G ++YV+L+G PF + + I F + +S A +
Sbjct: 179 VVSTAT-DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 266
+ ++L R+T + W +Q +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 2e-80
Identities = 91/298 (30%), Positives = 147/298 (49%), Gaps = 43/298 (14%)
Query: 15 RYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
Y+L + LGEG+F + S FAVKI+ K ++EI LKL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62
Query: 72 K-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL--- 127
+ HPN+V+LHEV + ++V+E + GGELF++I K E E + ++L+ +
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 128 ------------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
EN+L + IKI DFG + L D+ L T C + +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIFRG--DFKLPK 223
L GYD + D+WS GVILY +L+G +PF + + +KI +G F+
Sbjct: 181 LNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 224 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEA 278
W +S A++L++ +L +P KR+ ++G++ +EW + +NP + + A
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 2e-79
Identities = 87/282 (30%), Positives = 132/282 (46%), Gaps = 32/282 (11%)
Query: 15 RYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y L + LG G F V+ +G +A K L+K R + I EIA L+L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKS 87
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL--- 127
P V+ LHEV + S+I ++LEY GGE+F + + E + +L +Q+++G+
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 128 ------------ENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
+NILL S G+IKI DFG+S + L G+P Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS---RKIGHACELREIMGTPEYLAPEI 204
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 228
L AT D+W+ G+I Y++LT PF + Y I + D+ + +S
Sbjct: 205 LNYDPITTAT-DMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 270
A + ++ +L NP KR T + W Q + N EE
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWL-QQWDFENLFHPEE 304
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 5e-79
Identities = 74/278 (26%), Positives = 131/278 (47%), Gaps = 29/278 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG G FG V + +G F K + +K EI+ + L HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHP 108
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL------ 127
++ LH+ K ++ ++LE+++GGELFD+IA++ ++ EAE +Q +GL
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 128 ---------ENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
ENI+ ++K +KI DFGL+ D ++ T + + APE++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
T D+W+ GV+ YV+L+G PF + Q + R +F + +SP A++
Sbjct: 226 PVGFYT-DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 270
++ +L+ P KR+T+ W + D++
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 322
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 3e-78
Identities = 84/300 (28%), Positives = 127/300 (42%), Gaps = 54/300 (18%)
Query: 15 RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
Y+L LGEG +V+ +L + +AVKI+EK I ++ RE+ L +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQG 69
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
H NV+ L E + + Y+V E + GG + I + E E + Q + L
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 128 ----------ENILLDSKGN---IKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVA 169
ENIL + +KI DF L + L T CGS Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 170 PEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------- 209
PEV+ YD D+WS GVILY++L+GY PF R +
Sbjct: 190 PEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 210 LYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 265
L++ I G +F W +S A++L+ K+L + +R++ A + W Q P N
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV-QGCAPENT 307
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 1e-77
Identities = 80/269 (29%), Positives = 132/269 (49%), Gaps = 31/269 (11%)
Query: 15 RYELGRT--LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
Y + +T LG G FG+V ++ +GL A KI++ +K +++K EI+ + L
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD 144
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---- 127
H N+++L++ SK+ I +V+EYV GGELFD+I + L E + +Q+ +G+
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 128 -----------ENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
ENIL ++ IKI DFGL+ + ++ L G+P ++APEV+
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQ 230
T D+WS GVI Y++L+G PF N A I D + ++ +S A+
Sbjct: 262 YDFVSFPT-DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 231 NLLRKILEPNPVKRITIAGIKADEWFEQD 259
+ K+L RI+ + W
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDH 349
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 250 bits (639), Expect = 2e-77
Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 29/272 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y++ LG G FG V + +G FA K + + +++EI T+ +L+HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHP 214
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL------ 127
+V LH+ +++ M+ E+++GGELF+K+A + ++ E E + +Q+ GL
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 128 ---------ENILLDSKG--NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
ENI+ +K +K+ DFGL+ H + T G+ + APEV +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 232
T D+WS GV+ Y++L+G PF N + + + + +S ++
Sbjct: 332 PVGYYT-DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPAN 264
+RK+L +P R+TI W P
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 8e-77
Identities = 79/301 (26%), Positives = 133/301 (44%), Gaps = 48/301 (15%)
Query: 15 RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
Y+L + LG G GKV +G A+K+L + + ++E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 73 HPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDG 126
P++V + +V K + +++E + GGELF +I +G E E ++ + +
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 127 L---------------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 168
+ EN+L SK +K++DFG + L T C +P YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYV 196
Query: 169 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRG--DFKLP 222
APEVL YD + D+WS GVI+Y++L G+ PF + ++I G F P
Sbjct: 197 APEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 223 KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 279
+W +S A+ L+R +L+ +P +R+TI W Q P P + D + +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315
Query: 280 S 280
Sbjct: 316 D 316
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-76
Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 22/272 (8%)
Query: 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
+ R ++ G+ LGEG+F V A++L + +A+KILEK II + RE
Sbjct: 23 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82
Query: 67 TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
+ L HP V+L+ K+Y L Y GEL I G E R +++
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 127 L---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
L ENILL+ +I+I+DFG + + ++ G+ YV+PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 172 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231
+L + +SD+W+ G I+Y ++ G PF N +++QKI + ++ P+ P A++
Sbjct: 203 LLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261
Query: 232 LLRKILEPNPVKRITI------AGIKADEWFE 257
L+ K+L + KR+ +KA +FE
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 7e-76
Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 45/300 (15%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHP 74
+ LG G GKV + + FA+K+L+ + +RE+ + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGL- 127
++VR+ +V A + + +V+E + GGELF +I +G E E ++ + + + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 128 --------------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 170
EN+L SK +K++DFG + + L T C +P YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAP 232
Query: 171 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW 224
EVL YD + D+WS GVI+Y++L GY PF + + +I G +F P+W
Sbjct: 233 EVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 225 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 282
+S + L+R +L+ P +R+TI W Q + +++
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 351
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-71
Identities = 54/311 (17%), Positives = 92/311 (29%), Gaps = 68/311 (21%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
+ + G R G LG+ + A D ++G F V + Q+K E+
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 66 ATLKLLK-------------------------HPNVVRLHEVLASKSKIYMVLEY----- 95
L+LL+ ++R+ + Y
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 96 ---VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN 137
G L ++ L +L Q+I L +I+LD +G
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244
Query: 138 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----------YDGATSDIWS 187
+ ++ F DG + S + PE+ A R + D W+
Sbjct: 245 VFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 188 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 247
G+++Y I LP + IFR K + + LL L R+
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLP 354
Query: 248 AGIKADEWFEQ 258
+EQ
Sbjct: 355 LQAMETPEYEQ 365
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 3e-69
Identities = 77/308 (25%), Positives = 125/308 (40%), Gaps = 49/308 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
R + R L EG F V AQD+ SG +A+K L N + I +E+ +K L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGH 85
Query: 74 PNVVRLH-------EVLASKSKIYMVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQL 123
PN+V+ E + +++L + G+L + + S+G L K+F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 124 IDGL-----------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH------- 159
+ EN+LL ++G IK+ DFG + H+ D
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 160 ---TTCGSPNYVAPEV--LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 214
T +P Y PE+ L + G DIW+ G ILY++ PF+D +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LRI 261
Query: 215 FRGDFKLPKWL--SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 272
G + +P +L+R +L+ NP +R++IA + NP ++
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL 321
Query: 273 FVDNEAFS 280
N +
Sbjct: 322 LEQNGGYG 329
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 9e-69
Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R YE+ T+G G++G+ + + G K L+ + + E+ L+ L
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLREL 62
Query: 72 KHPNVVRLHE--VLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLID 125
KHPN+VR ++ + + + +Y+V+EY GG+L I + L E ++ QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 126 GL--------------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
L N+ LD K N+K+ DFGL+ + H D T G+P
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 224
Y++PE + Y+ SDIWS G +LY + PF + L KI G F ++P
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
S ++ ++L R ++ I + +
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-68
Identities = 72/295 (24%), Positives = 109/295 (36%), Gaps = 64/295 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
+ LG G+ G V F G P AVK + + D EI L + H
Sbjct: 16 LVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFC------DIALMEIKLLTESDDH 68
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDG 126
PNV+R + + +Y+ LE L D + SK +E L +Q+ G
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 127 L---------------ENILLDSKG-------------NIKISDFGLSAL--PQHFRDDG 156
+ +NIL+ + I ISDFGL
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 157 LLHTTCGSPNYVAPEVL-------ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 208
L+ G+ + APE+L R + DI+S G + Y IL+ G PF D+
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 209 VLYQKIFRGDFKLP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256
I RG F L + L A +L+ ++++ +P+KR T + F
Sbjct: 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 4e-68
Identities = 58/286 (20%), Positives = 104/286 (36%), Gaps = 38/286 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + LGEG F V + L G +A+K + + + + +RE +L HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE---EAQREADMHRLFNHP 86
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDG 126
N++RL +K + +++L + G L+++I L E + L + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 127 L---------------ENILLDSKGNIKISDFGLSALPQH-------FRDDGLLHTTCGS 164
L NILL +G + D G +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 165 PNYVAPEVLANRGYDGAT--SDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKL 221
+Y APE+ + + + +D+WS G +LY ++ G P+D + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 222 PKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 265
P+ S LL ++ +P +R I + + Q P
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 4e-68
Identities = 85/272 (31%), Positives = 139/272 (51%), Gaps = 26/272 (9%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
Q +L +++ +TLG G+FG+V + +SG +A+KIL+K +++ LK + E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L+ + P +V+L S +YMV+EYV GGE+F + GR E R Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 125 DGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
EN+L+D +G I+++DFG + R G T CG+P +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229
PE++ ++GY+ A D W+ GV++Y + GY PF +Y+KI G + P S
Sbjct: 207 PEIILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 230 QNLLRKILEPNPVKRI-----TIAGIKADEWF 256
++LLR +L+ + KR + IK +WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 3e-67
Identities = 75/262 (28%), Positives = 135/262 (51%), Gaps = 26/262 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ RTLG G+FG+V + +G +A+K+L+K ++ LK + E L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
++R+ +I+M+++Y+ GGELF + R + ++ L
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
ENILLD G+IKI+DFG + + +T CG+P+Y+APEV++ + Y
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY-N 181
Query: 181 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240
+ D WS G+++Y +L GY PF D N Y+KI + + P + + ++LL +++ +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 241 PVKRI-----TIAGIKADEWFE 257
+R+ +K WF+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-66
Identities = 69/264 (26%), Positives = 126/264 (47%), Gaps = 22/264 (8%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ +Y + +GEG+FGK + + G + +K + +R+ K ++ +RE+A L +K
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMK 81
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGLE-- 128
HPN+V+ E +Y+V++Y GG+LF +I QE + F Q+ L+
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 129 -------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 175
NI L G +++ DFG++ + L G+P Y++PE+ N
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICEN 199
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLR 234
+ Y+ SDIW+ G +LY + T F+ ++ L KI G F + S ++L+
Sbjct: 200 KPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258
Query: 235 KILEPNPVKRITIAGIKADEWFEQ 258
++ + NP R ++ I + +
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAK 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-65
Identities = 56/272 (20%), Positives = 88/272 (32%), Gaps = 39/272 (14%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKH 73
+ LG G G + + D AVK + RE+ L+ +H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL----- 127
PNV+R + Y+ +E L + + K E L QQ GL
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 128 ----------ENILLDSKGN-----IKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPE 171
NIL+ ISDFGL L G+ ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 172 VL---ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW--- 224
+L DI+S G + Y +++ G PF +
Sbjct: 197 MLSEDCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256
A+ L+ K++ +P KR + + +F
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-63
Identities = 72/298 (24%), Positives = 123/298 (41%), Gaps = 67/298 (22%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
+ LG G GKV + + FA+K+L+ + +RE+ + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 75 NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGL- 127
++VR+ +V A + + +V+E + GGELF +I +G E E ++ + + + +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 128 --------------ENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 170
EN+L SK +K++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 171 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW 224
E YD + D+WS GVI+Y++L GY PF + + +I G +F P+W
Sbjct: 169 ETTG-EKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 225 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 279
+S + L+R +L+ P +R+TI W Q P P + D E +
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 284
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-62
Identities = 54/277 (19%), Positives = 107/277 (38%), Gaps = 48/277 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ +G G FG+V A+ G + +K ++ N ++ +RE+ L L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64
Query: 75 NVVRLHE----------------VLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEG 116
N+V + + +++ +E+ G L I +L +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 117 RKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 161
+LF+Q+ G+ NI L +KI DFGL ++DG +
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRS 181
Query: 162 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 221
G+ Y++PE ++++ Y D+++ G+IL +L + + + + G +
Sbjct: 182 KGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDG--II 236
Query: 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
+ LL+K+L P R + I +
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 3e-62
Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 25/261 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ LG G++G+V + + G +AVK ++ + K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL------ 127
VRL + +Y+ E G L + G L EA+ + + L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 128 ---------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
NI L +G K+ DFGL G G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232
Query: 179 DGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 237
A +D++S G+ + + LP L Q +F LS +++L +L
Sbjct: 233 GTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289
Query: 238 EPNPVKRITIAGIKADEWFEQ 258
EP+P R T + A Q
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 8e-61
Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 26/262 (9%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L + + + +G G F +V A L G+P A+K ++ ++ K +EI LK L
Sbjct: 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGL 127
HPNV++ + +++ +VLE G+L I K + E K F QL L
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 128 E---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
E N+ + + G +K+ D GL H+ G+P Y++PE
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 207
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFK-LPKW-LSPG 228
+ GY+ SDIWS G +LY + PF D NL L +KI + D+ LP S
Sbjct: 208 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266
Query: 229 AQNLLRKILEPNPVKRITIAGI 250
+ L+ + P+P KR + +
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYV 288
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-60
Identities = 85/259 (32%), Positives = 136/259 (52%), Gaps = 22/259 (8%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
+ E +R +EL R LG+G +GKV + ++G FA+K+L+K I+ + K T
Sbjct: 8 NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
K E L+ +KHP +V L + K+Y++LEY++GGELF ++ +G E
Sbjct: 68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127
Query: 121 QQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
++ L ENI+L+ +G++K++DFGL + D + HT CG+
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTI 185
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 225
Y+APE+L G+ D WS G ++Y +LTG PF N KI + LP +L
Sbjct: 186 EYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244
Query: 226 SPGAQNLLRKILEPNPVKR 244
+ A++LL+K+L+ N R
Sbjct: 245 TQEARDLLKKLLKRNAASR 263
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 5e-60
Identities = 67/262 (25%), Positives = 122/262 (46%), Gaps = 26/262 (9%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E+ R +G+G+FGKV Q D+ +A+K + K + + + +E+ ++ L+HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL--------- 127
V L + ++MV++ + GG+L + +E + +L+ L
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 128 ------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GY 178
+NILLD G++ I+DF ++A + + T G+ Y+APE+ ++R GY
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 179 DGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 235
D WS GV Y +L G P+ R + + P S +LL+K
Sbjct: 195 -SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 236 ILEPNPVKRI-TIAGIKADEWF 256
+LEPNP +R ++ ++ +
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYM 275
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-59
Identities = 81/268 (30%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
Q +++ + L + LG+G+FGKV A+ + FA+K L+K+ ++ + E
Sbjct: 9 SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L +HP + + +K ++ V+EY+ GG+L I S + + ++I
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 125 DGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
GL +NILLD G+IKI+DFG+ ++ D +T CG+P+Y+A
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIA 186
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229
PE+L + Y + D WS GV+LY +L G PF ++ L+ I + P+WL A
Sbjct: 187 PEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 245
Query: 230 QNLLRKILEPNPVKRITIAG-IKADEWF 256
++LL K+ P KR+ + G I+ F
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-58
Identities = 77/244 (31%), Positives = 126/244 (51%), Gaps = 18/244 (7%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
++ + LG+G FGKV ++ +G +A+KIL K II E L+ +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
+ L + ++ V+EY GGELF ++ + E R +++ L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
EN++LD G+IKI+DFGL + D + T CG+P Y+APEVL + Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 181 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240
D W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L+ +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 241 PVKR 244
P +R
Sbjct: 244 PKQR 247
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-58
Identities = 86/274 (31%), Positives = 133/274 (48%), Gaps = 23/274 (8%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
+ + + + +G+G+FGKV A+ + +AVK+L+K I+ K I
Sbjct: 27 LGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM 86
Query: 63 REIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E L K +KHP +V LH + K+Y VL+Y+ GGELF + + E R
Sbjct: 87 SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166
++ L ENILLDS+G+I ++DFGL ++ + T CG+P
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPE 204
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 226
Y+APEVL + Y T D W G +LY +L G PF RN A +Y I +L ++
Sbjct: 205 YLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263
Query: 227 PGAQNLLRKILEPNPVKRITIAG----IKADEWF 256
A++LL +L+ + KR+ IK+ +F
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-58
Identities = 81/259 (31%), Positives = 142/259 (54%), Gaps = 22/259 (8%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
++ E ++EL + LG+G+FGKV K D+ +A+K+L+K + + +
Sbjct: 14 VKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVR 72
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
K E L + HP +V+LH ++ K+Y++L+++ GG+LF +++ + E + +
Sbjct: 73 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 121 QQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
+L L ENILLD +G+IK++DFGLS + + ++ CG+
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTV 190
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 225
Y+APEV+ RG+ ++D WS GV+++ +LTG LPF ++ I + +P++L
Sbjct: 191 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249
Query: 226 SPGAQNLLRKILEPNPVKR 244
SP AQ+LLR + + NP R
Sbjct: 250 SPEAQSLLRMLFKRNPANR 268
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 7e-58
Identities = 77/257 (29%), Positives = 131/257 (50%), Gaps = 19/257 (7%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K + + + +E + LG+G FGKV ++ +G +A+KIL+K I+
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 197
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
E L+ +HP + L + ++ V+EY GGELF ++ + E R ++
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 124 IDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
+ L EN++LD G+IKI+DFGL + +D + T CG+P Y
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 315
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227
+APEVL + Y G D W GV++Y ++ G LPF +++ L++ I + + P+ L P
Sbjct: 316 LAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP 374
Query: 228 GAQNLLRKILEPNPVKR 244
A++LL +L+ +P +R
Sbjct: 375 EAKSLLSGLLKKDPKQR 391
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-57
Identities = 60/293 (20%), Positives = 107/293 (36%), Gaps = 48/293 (16%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +E + LG G FG V A++ +A+K + + +++ RE+ L L+
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61
Query: 73 HPNVVRLHEV------------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--- 117
HP +VR + K +Y+ ++ L D + + ++E E
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 118 KLFQQLIDGLE---------------NILLDSKGNIKISDFGLSAL----------PQHF 152
+F Q+ + +E NI +K+ DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLY 211
G+ Y++PE + Y DI+S G+IL+ +L PF +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237
Query: 212 QKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 263
+ F L P +++ +L P+P++R I + FE P
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-57
Identities = 81/286 (28%), Positives = 132/286 (46%), Gaps = 35/286 (12%)
Query: 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
I + + +E R LG+G+FGKV A+ ++G +AVK+L+K+ I+ +
Sbjct: 12 IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM 71
Query: 63 REIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E L L HP + +L + +++ V+E+V GG+L I R EA R
Sbjct: 72 TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA 131
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166
++I L +N+LLD +G+ K++DFG+ + + T CG+P+
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPD 189
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 226
Y+APE+L Y G D W+ GV+LY +L G+ PF+ N L++ I + P WL
Sbjct: 190 YIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLH 248
Query: 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 272
A +L+ + NP R+ G + E I
Sbjct: 249 EDATGILKSFMTKNPTMRL---G-------------SLTQGGEHAI 278
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-57
Identities = 48/298 (16%), Positives = 97/298 (32%), Gaps = 51/298 (17%)
Query: 6 KKQEGMRLG--RYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKIT 58
K + +LG + LGEG F +V A D + F +K+ + I
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 59 DQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQE 113
Q+ LK ++ + ++ +V E + G L + I + + +
Sbjct: 115 TQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 114 AEGRKLFQQLIDGL---------------ENILL-----------DSKGNIKISDFGLSA 147
+++ + +N +L D + + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRN 206
+ F + C + + E+L+N+ ++ D + +Y +L G Y+ +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEG 290
Query: 207 LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI---KADEWFEQDYT 261
+ +FR L W +L + + K + F+Q YT
Sbjct: 291 GECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-57
Identities = 34/301 (11%), Positives = 76/301 (25%), Gaps = 62/301 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +L L G+ V +D++ FA+K+ +++ L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 75 NVVRLHEVL--------------------------ASKSKIYMVLEYVTG------GELF 102
+ + + + +++ + L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 103 DKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147
+G L QLI +N+ + G + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLPFDDRN 206
+ + Y E L + W G+ +Y + +LPF
Sbjct: 243 -----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 207 LAV--LYQKIFRG-------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 257
+ +++ F L + L+ + L + +R+ F
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 258 Q 258
Q
Sbjct: 358 Q 358
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-57
Identities = 58/346 (16%), Positives = 97/346 (28%), Gaps = 64/346 (18%)
Query: 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
G R G LG+ + A D ++G F V + Q+K E+ L+
Sbjct: 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 70 LL----------------------KHPNVVRLHEVLASKSKIYMVLEYVT---------- 97
LL K P ++ V + ++++ +
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 98 -GGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKIS 141
G L ++ L +L Q+I L +I+LD +G + ++
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 142 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCGVILYVILT 197
F + P A +L + D W+ G+ +Y I
Sbjct: 254 GFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 198 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 257
LP D + IFR +P + LL L R+ +E
Sbjct: 313 ADLPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
Query: 258 Q------DYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPL 297
Q P D E S P + G +
Sbjct: 369 QLRTELSAALPLYQTDGEPTREGGAPP-SGTSQPDEAGAAEAVTAI 413
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 3e-57
Identities = 80/255 (31%), Positives = 133/255 (52%), Gaps = 19/255 (7%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++ M+L + LG+G+FGKV ++ + +AVKIL+K+ +I + E
Sbjct: 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 71
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L K P + +LH + ++Y V+EYV GG+L I GR +E ++
Sbjct: 72 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 125 DGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
GL +N++LDS+G+IKI+DFG+ ++ D T CG+P+Y+A
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 189
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229
PE++A + Y G + D W+ GV+LY +L G PF+ + L+Q I + PK +S A
Sbjct: 190 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248
Query: 230 QNLLRKILEPNPVKR 244
+ + ++ +P KR
Sbjct: 249 VAICKGLMTKHPGKR 263
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 75/290 (25%), Positives = 137/290 (47%), Gaps = 44/290 (15%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
+ + L ++L R +G G++ KV + + +A+K+++K + + D ++ E
Sbjct: 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 68 LKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
+ HP +V LH ++S+++ V+EYV GG+L + + +L E R ++
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 127 L---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
L +N+LLDS+G+IK++D+G+ + R T CG+PNY+APE
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 180
Query: 172 VLANRGYDGATSDIWSCGVILYVILTGYLPF---------DDRNLAVLYQKIFRGDFKLP 222
+L Y G + D W+ GV+++ ++ G PF D L+Q I ++P
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 272
+ LS A ++L+ L +P +R+ G +P DI
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERL---G-------------CHPQTGFADI 273
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 194 bits (493), Expect = 1e-55
Identities = 80/255 (31%), Positives = 133/255 (52%), Gaps = 19/255 (7%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
++ M+L + LG+G+FGKV ++ + +AVKIL+K+ +I + E
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 392
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
L L K P + +LH + ++Y V+EYV GG+L I GR +E ++
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 452
Query: 125 DGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
GL +N++LDS+G+IKI+DFG+ ++ D T CG+P+Y+A
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 510
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229
PE++A + Y G + D W+ GV+LY +L G PF+ + L+Q I + PK +S A
Sbjct: 511 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569
Query: 230 QNLLRKILEPNPVKR 244
+ + ++ +P KR
Sbjct: 570 VAICKGLMTKHPGKR 584
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 3e-55
Identities = 76/267 (28%), Positives = 120/267 (44%), Gaps = 30/267 (11%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ R LG+G FG+V Q +G +A K LEK RI K E L+ +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGL------ 127
VV L +K + +VL + GG+L I G+ E R +F ++ GL
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 128 ---------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
ENILLD G+I+ISD GL+ H + + G+ Y+APEV+ N Y
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 179 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----DFKLPKWLSPGAQNLLR 234
+ D W+ G +LY ++ G PF R + +++ R + + SP A++L
Sbjct: 363 TFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 235 KILEPNPVKRI-----TIAGIKADEWF 256
++L +P +R+ + +K F
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-55
Identities = 75/292 (25%), Positives = 137/292 (46%), Gaps = 44/292 (15%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
K + L ++L R +G G++ KV + + +A+++++K + + D ++ E
Sbjct: 44 KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 66 ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
+ HP +V LH ++S+++ V+EYV GG+L + + +L E R ++
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 125 DGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
L +N+LLDS+G+IK++D+G+ + R T CG+PNY+A
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 221
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF---------DDRNLAVLYQKIFRGDFK 220
PE+L Y G + D W+ GV+++ ++ G PF D L+Q I +
Sbjct: 222 PEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 221 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 272
+P+ LS A ++L+ L +P +R+ G +P DI
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKERL---G-------------CHPQTGFADI 316
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-54
Identities = 77/347 (22%), Positives = 131/347 (37%), Gaps = 57/347 (16%)
Query: 6 KKQEGMRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
K E +G + R LG G FG+V Q +G +A K L K R+ K
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV 234
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE--AEGRKLF- 120
E L + +V L +K+ + +V+ + GG++ I + E R +F
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 121 -QQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164
Q++ GL EN+LLD GN++ISD GL+ + G+
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGT 352
Query: 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFK 220
P ++APE+L YD + D ++ GV LY ++ PF R V L Q++
Sbjct: 353 PGFMAPELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 221 LPKWLSPGAQNLLRKILEPNPVKRITIAG-----IKADEWFEQDYTPANPDDDEEDIFVD 275
P SP +++ +L+ +P KR+ ++ F +
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD---------------IS 456
Query: 276 NEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVS 322
+ PP + + + + D+ F + V+
Sbjct: 457 WRQLEAGMLT---------PPFVPDSRTVYAKNIQDVGAFSTVKGVA 494
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-54
Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 32/283 (11%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
I + + M+ YE+ + +G G FG+V+ + + +A+K+L K +I +
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF 116
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
E + P VV+L +YMV+EY+ GG+L + S + E R
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTA 175
Query: 122 QLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGS 164
+++ L +N+LLD G++K++DFG +G++ T G+
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGT 232
Query: 165 PNYVAPEVLANRGYD---GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDF 219
P+Y++PEVL ++G D G D WS GV LY +L G PF +L Y KI +
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292
Query: 220 KLPK--WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 257
P +S A+NL+ L + R+ G IK +F+
Sbjct: 293 TFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFK 334
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 7e-54
Identities = 81/283 (28%), Positives = 149/283 (52%), Gaps = 33/283 (11%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
E + + +EL + LG G +GKV + D+G +A+K+L+K I+ K T+
Sbjct: 45 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104
Query: 61 IKREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
+ E L+ ++ P +V LH +++K++++L+Y+ GGELF ++ + R E E +
Sbjct: 105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 120 FQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164
+++ L ENILLDS G++ ++DFGLS + + CG+
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 165 PNYVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGD 218
Y+AP+++ + G+D A D WS GV++Y +LTG PF + + A + ++I + +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
Query: 219 FKLPKWLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWF 256
P+ +S A++L++++L +P KR+ IK +F
Sbjct: 283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-53
Identities = 84/395 (21%), Positives = 154/395 (38%), Gaps = 66/395 (16%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE- 64
+ + + + + R +G G FG+V + D+G +A+K L+K RI + E
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 65 --IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
++ + P +V + + K+ +L+ + GG+L ++ G EA+ R +
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300
Query: 123 LIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
+I GL NILLD G+++ISD GL+ H + G+ Y
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHASVGTHGY 356
Query: 168 VAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPK 223
+APEVL YD + D +S G +L+ +L G+ PF + + +LP
Sbjct: 357 MAPEVLQKGVAYDSSA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 224 WLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA 278
SP ++LL +L+ + +R+ +K +F +D +
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS---------------LDWQM 460
Query: 279 FSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKI---------RFT 329
+ + P PPLI + + D+ F++ED K+ F
Sbjct: 461 VFLQKYP---------PPLIPPRGEVNAADAFDIG-SFDEEDTKGIKLLDSDQELYRNFP 510
Query: 330 SNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQE 364
S + E E + + + + K +
Sbjct: 511 LTISERWQQEVAETVFDTINAETDRLEARKKTKNK 545
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-52
Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 36/287 (12%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ KQ + +E+ + +G G FG+V + ++ FA+KIL K ++ T
Sbjct: 62 FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLF 120
+ E L + LH + +Y+V++Y GG+L ++ + RL E R
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181
Query: 121 QQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCG 163
+++ + +NIL+D G+I+++DFG +DG + G
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVG 238
Query: 164 SPNYVAPEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FR 216
+P+Y++PE+L Y G D WS GV +Y +L G PF +L Y KI +
Sbjct: 239 TPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297
Query: 217 GDFKLPKW---LSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 257
F+ P +S A++L+R+++ R+ G K +F
Sbjct: 298 ERFQFPTQVTDVSENAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFS 343
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-51
Identities = 65/288 (22%), Positives = 123/288 (42%), Gaps = 36/288 (12%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
++ K+ ++ +E+ + +G G F +V + +G +A+KI+ K ++
Sbjct: 49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 62 KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLF 120
+ E L + +LH ++ +Y+V+EY GG+L ++ G R+ R
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 121 QQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCG 163
+++ + +NILLD G+I+++DFG R DG + G
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVG 225
Query: 164 SPNYVAPEVLANRGYD------GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 217
+P+Y++PE+L G G D W+ GV Y + G PF + A Y KI
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285
Query: 218 DFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 257
L + + A++ ++++L P R+ G + +F
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 54/274 (19%), Positives = 93/274 (33%), Gaps = 50/274 (18%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +G G FG V G +A+K +K + + ++ A L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGL--- 127
+VVR A + + EY GG L D I +EAE + L Q+ GL
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 128 ------------ENILLDSKGNI-------------------KISDFGLSALPQHFRDDG 156
NI + KI D G
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR------IS 185
Query: 157 LLHTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 215
G ++A EVL N + +DI++ + + + + + +I
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGD---QWHEIR 241
Query: 216 RGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIA 248
+G ++P+ LS LL+ ++ P+P +R +
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAM 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-47
Identities = 56/255 (21%), Positives = 95/255 (37%), Gaps = 33/255 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+G G+FG+V +D +G AVK + + E+ L P
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSP 110
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
+V L+ + + + +E + GG L I G L E Q ++GLE
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 129 ---------NILLDSKGN-IKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLAN 175
N+LL S G+ + DFG + + G+ ++APEV+
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQN 231
+ D DIWS ++ +L G P+ + KI ++P +P
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEPPPIREIPPSCAPLTAQ 288
Query: 232 LLRKILEPNPVKRIT 246
+++ L PV R +
Sbjct: 289 AIQEGLRKEPVHRAS 303
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-47
Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 32/259 (12%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
LG+G +G V +DL + + A+K + + + + + EIA K LK
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLK 77
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEG--RKLFQQLIDGLE- 128
H N+V+ + I + +E V GG L + SK G L++ E +Q+++GL+
Sbjct: 78 HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 129 --------------NILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
N+L+++ G +KISDFG S T G+ Y+APE++
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEII 195
Query: 174 --ANRGYDGATSDIWSCGVILYVILTGYLPFDD--RNLAVLYQKIFRGDF--KLPKWLSP 227
RGY A +DIWS G + + TG PF + A ++ K+ ++P+ +S
Sbjct: 196 DKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSA 253
Query: 228 GAQNLLRKILEPNPVKRIT 246
A+ + K EP+P KR
Sbjct: 254 EAKAFILKCFEPDPDKRAC 272
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-44
Identities = 60/272 (22%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 14 GRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
GR+ +G G+F V D ++ + A L+ ++ + + K E LK L+
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 83
Query: 73 HPNVVRLH----EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE 128
HPN+VR + + K I +V E +T G L + ++ R +Q++ GL+
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 129 -----------------NILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 170
NI + G++KI D GL+ L + G+P ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAP 199
Query: 171 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD--FKLPKWLSP 227
E+ YD + D+++ G+ + + T P+ + +N A +Y+++ G K P
Sbjct: 200 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259
+ ++ + N +R +I + +F+++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 43/246 (17%), Positives = 83/246 (33%), Gaps = 32/246 (13%)
Query: 41 PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE 100
+ + D +I + N V + + K +Y+ ++
Sbjct: 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKEN 147
Query: 101 LFDKIASKGRLQEAEG---RKLFQQLIDGLE---------------NILLDSKGNIKISD 142
L D + + L++ E +F Q+ + +E NI +K+ D
Sbjct: 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 207
Query: 143 FGLSA----------LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 192
FGL + G+ Y++PE + Y DI+S G+IL
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLIL 266
Query: 193 YVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 251
+ +L + +R + + F L P +++ +L P+P +R I
Sbjct: 267 FELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324
Query: 252 ADEWFE 257
+ FE
Sbjct: 325 ENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 17/66 (25%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+E + +G G FG V A++ +A+K + + +++ RE+ L L+HP
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEHPG 65
Query: 76 VVRLHE 81
+VR
Sbjct: 66 IVRYFN 71
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-37
Identities = 79/323 (24%), Positives = 116/323 (35%), Gaps = 91/323 (28%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------R 63
R RYE LGEG F V A+D ++ A+K K I L + K R
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---K---IKLGHRSEAKDGINRTALR 61
Query: 64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
EI L+ L HPN++ L + KS I +V +++ + + L + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYML 119
Query: 122 QLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166
+ GLE N+LLD G +K++DFGL+ + GSPN
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPN 166
Query: 167 -----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQ 212
Y APE+L R Y D+W+ G IL +L +LP D +L L
Sbjct: 167 RAYTHQVVTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRVPFLPGDS-DLDQLT- 223
Query: 213 KIFR-----------GDFKLP-----------------KWLSPGAQNLLRKILEPNPVKR 244
+IF LP +L++ + NP R
Sbjct: 224 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 283
Query: 245 ITIAGIKADEWFEQDYTPANPDD 267
IT ++F P
Sbjct: 284 ITATQALKMKYFSNRPGPTPGCQ 306
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 67/250 (26%), Positives = 115/250 (46%), Gaps = 28/250 (11%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ +G G+FG V A+ G AVKIL + H + ++ RE+A +K L+HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNI 96
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GLE----- 128
V + + +V EY++ G L+ + G ++ + R+ D G+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 129 ------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
N+L+D K +K+ DFGLS L + G+P ++APEVL +
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDE 214
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD-FKLPKWLSPGAQNLLR 234
+ SD++S GVIL+ + T P+ + N V+ F+ ++P+ L+P ++
Sbjct: 215 PSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 235 KILEPNPVKR 244
P KR
Sbjct: 274 GCWTNEPWKR 283
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-36
Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 3/123 (2%)
Query: 293 GSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 351
P ++NAF++I +S L+LS F++ D +R+ RF S +++ IE + MGF+
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 352 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSS 411
+N K + E G L+V E++E++PSL++V++RK+ G+ Y + KL S
Sbjct: 62 SHTRNFKTR--LEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCS 119
Query: 412 DLG 414
L
Sbjct: 120 KLE 122
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-36
Identities = 73/281 (25%), Positives = 111/281 (39%), Gaps = 33/281 (11%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLL 71
+E LG GN G V SGL A K+ IHL+I QI RE+ L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKL------IHLEIKPAIRNQIIRELQVLHEC 88
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE--- 128
P +V + S +I + +E++ GG L + GR+ E K+ +I GL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 129 -------------NILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLA 174
NIL++S+G IK+ DFG+S L D + ++ G+ +Y++PE L
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQ 203
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234
Y SDIWS G+ L + G P + L P + R
Sbjct: 204 GTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 235 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 275
+ + R +A + ++ + P P F D
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 64/305 (20%), Positives = 110/305 (36%), Gaps = 60/305 (19%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
E+ +G G FG V A+ A+K +E E+ L + HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNI 63
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GLE----- 128
V+L A + + +V+EY GG L++ + L + G+
Sbjct: 64 VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 129 -------------NILLDSKGN-IKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVL 173
N+LL + G +KI DFG + D + GS ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAWMAPEVF 175
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPG 228
Y D++S G+IL+ ++T PFD+ + +I L K L
Sbjct: 176 EGSNYSEK-CDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 229 AQNLLRKILEPNPVKR--------------ITIAGIKADEWFEQDYTPANPDDDEEDIFV 274
++L+ + +P +R G + ++ +D + +V
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYV 292
Query: 275 DNEAF 279
D F
Sbjct: 293 DFAEF 297
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 64/255 (25%), Positives = 110/255 (43%), Gaps = 30/255 (11%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY++ LG G V A+D + A+K + + + +RE+ L H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------ 127
N+V + +V Y+V+EY+ G L + I S G L Q++DG+
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 128 ---------ENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTC--GSPNYVAPEVLAN 175
+NIL+DS +KI DFG++ AL + L T G+ Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSPE-QAK 185
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDF-----KLPKWLSPGA 229
+DI+S G++LY +L G PF+ + +++ + I + + K +
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QDSVPNVTTDVRKDIPQSL 244
Query: 230 QNLLRKILEPNPVKR 244
N++ + E + R
Sbjct: 245 SNVILRATEKDKANR 259
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 54/255 (21%), Positives = 111/255 (43%), Gaps = 35/255 (13%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+G+ +G G+FG V K+ D+ AVK+L + K E+ L+ +H
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAP-TPQQLQAFKNEVGVLRKTRH 79
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGLE---- 128
N++ ++ ++ +V ++ G L+ + AS+ + + + + +Q G++
Sbjct: 80 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 129 -----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
NI L +KI DFGL+ + GS ++APEV+ +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 178 YDGAT--SDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-----LPKWLSPGA 229
+ + SD+++ G++LY ++TG LP+ + N + + + RG +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 230 QNLLRKILEPNPVKR 244
+ L+ + L+ +R
Sbjct: 259 KRLMAECLKKKRDER 273
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-34
Identities = 72/314 (22%), Positives = 117/314 (37%), Gaps = 83/314 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
+YE +GEG++G V ++ D+G A+K LE +K REI LK LKH
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL--REIRMLKQLKH 61
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
PN+V L EV K ++++V EY D+ + + E + + Q + +
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-----NYV--- 168
ENIL+ IK+ DFG + R P + V
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA------R-------LLTGPSDYYDDEVATR 166
Query: 169 ---APEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR------ 216
+PE+L + Y D+W+ G + +L+G P ++ LY I +
Sbjct: 167 WYRSPELLVGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKS-DVDQLY-LIRKTLGDLI 223
Query: 217 -------------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIK 251
K+P +S A LL+ L +P +R+T +
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
Query: 252 ADEWFEQDYTPANP 265
+FE +
Sbjct: 284 HHPYFENIREIEDL 297
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-34
Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 5/115 (4%)
Query: 294 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 353
+NAF +I S +LSG F +R RF S +A+ ++ER+E+IV+ V
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVA 61
Query: 354 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 408
KK + K G+ ++ E+ +++ L ++E+RK R L
Sbjct: 62 KKETWGMKIEGQK-----GNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTD 111
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 75/296 (25%), Positives = 118/296 (39%), Gaps = 86/296 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKL 70
+YE +GEG +G V A++ ++ A+K + R+ + REI LK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSS--ALREICLLKE 57
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGLE 128
LKH N+VRLH+VL S K+ +V E+ + FD G L + QL+ GL
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLG 115
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 166
N+L++ G +K+++FGL+ R G P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLA------R-------AFGIPVRCYSAEV 162
Query: 167 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFR--- 216
Y P+VL + Y + D+WS G I + P + L +IFR
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLG 220
Query: 217 --------GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRIT 246
KLP + L+ ++LL+ +L+ NPV+RI+
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 75/312 (24%), Positives = 123/312 (39%), Gaps = 73/312 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
+YE +GEG++G V ++ D+G A+K LE + +K REI LK L+H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI--AMREIKLLKQLRH 83
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
N+V L EV K + Y+V E+V + + L +K Q+I+G+
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCH 141
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------AP 170
ENIL+ G +K+ DFG + + G ++ + V AP
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA---RTLAAPGEVYD-----DEVATRWYRAP 193
Query: 171 EVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR----------- 216
E+L + Y A D+W+ G ++ + G P D ++ LY I
Sbjct: 194 ELLVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDS-DIDQLY-HIMMCLGNLIPRHQE 250
Query: 217 --------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256
+LP+ LS +L +K L +P KR A + ++F
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310
Query: 257 EQDYTPANPDDD 268
+ D +
Sbjct: 311 QMDGFAERFSQE 322
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 61/263 (23%), Positives = 108/263 (41%), Gaps = 36/263 (13%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI-----K 62
+EG + G Y L R +G G G V A+D A+K++ + L +D + +
Sbjct: 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE----TLS-SDPVFRTRMQ 82
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE T L+ P+VV +H+ ++Y+ + + G +L + +G L + +Q
Sbjct: 83 REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQ 142
Query: 123 LIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSP 165
+ L ENIL+ + + DFG++ D+ L T G+
Sbjct: 143 IGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA---SATTDEKLTQLGNTVGTL 199
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 223
Y+APE + +DI++ +LY LTG P+ L+V+ I P
Sbjct: 200 YYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTV 257
Query: 224 --WLSPGAQNLLRKILEPNPVKR 244
+ ++ + + NP R
Sbjct: 258 RPGIPVAFDAVIARGMAKNPEDR 280
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 68/324 (20%), Positives = 112/324 (34%), Gaps = 89/324 (27%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
Y LGEG + V + + A+K + I L+ + RE++ LK
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALK---E---IRLEHEEGAPCTAIREVSLLKD 56
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGLE 128
LKH N+V LH+++ ++ + +V EY+ + D + + QL+ GL
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLA 114
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 166
N+L++ +G +K++DFGL+ R P
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLA------R-------AKSIPTKTYDNEV 161
Query: 167 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR--- 216
Y P++L + Y D+W G I Y + TG P L+ IFR
Sbjct: 162 VTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGST-VEEQLH-FIFRILG 218
Query: 217 ----------------GDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAG 249
+ PK+ L +LL K+L+ RI+
Sbjct: 219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED 278
Query: 250 IKADEWFEQDYTPANPDDDEEDIF 273
+F + D IF
Sbjct: 279 AMKHPFFLSLGERIHKLPDTTSIF 302
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 50/259 (19%), Positives = 94/259 (36%), Gaps = 47/259 (18%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L E + G++ G VK+L K R + + E L++ HPNV
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 77 VRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
+ + S ++ ++ G L++ L E + Q + G
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYN------VLHEGTNFVVDQSQAVKFALDMARG 123
Query: 127 LE-----------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
+ ++++D +IS + +P +VA
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK----FSFQSP---GRMYAPAWVA 176
Query: 170 PEVLANRGYDGAT--SDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWL 225
PE L + D +D+WS V+L+ ++T +PF D N+ + + G +P +
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 226 SPGAQNLLRKILEPNPVKR 244
SP L++ + +P KR
Sbjct: 237 SPHVSKLMKICMNEDPAKR 255
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 26/248 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+ +G+G+FG+V D + A+KI LE+ +I D I++EI L
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIED-IQQEITVLSQCD 78
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
P V + + +K+++++EY+ GG D + G L E + + ++++ GL+
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHS 137
Query: 129 -----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
N+LL G +K++DFG++ Q +T G+P ++APEV+
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236
YD +DIWS G+ + G P + + + VL+ L S + +
Sbjct: 196 YDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254
Query: 237 LEPNPVKR 244
L P R
Sbjct: 255 LNKEPSFR 262
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 74/323 (22%), Positives = 124/323 (38%), Gaps = 94/323 (29%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
+++ LG G + V + +G+ A+K + L + REI+ +K
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIREISLMKE 59
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGG-----ELFDKIASKGRLQEAEGRKLFQQLID 125
LKH N+VRL++V+ +++K+ +V E++ + + L+ + QL+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 126 GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN---- 166
GL N+L++ +G +K+ DFGL+ R G P
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------R-------AFGIPVNTFS 166
Query: 167 -------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR 216
Y AP+VL +R Y + DIWSCG IL ++TG P + + L IF
Sbjct: 167 SEVVTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTN-DEEQLK-LIFD 223
Query: 217 -----------GDFKLPKW-----------------------LSPGAQNLLRKILEPNPV 242
KLPK+ L + L +L+ NP
Sbjct: 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 243 KRITIAGIKADEWFEQDYTPANP 265
R++ WF + Y A+
Sbjct: 284 MRLSAKQALHHPWFAEYYHHASM 306
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 61/263 (23%), Positives = 108/263 (41%), Gaps = 45/263 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
E + +G+G FG V + + A+K L + ++ + +RE+ + L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GLE- 128
HPN+V+L + MV+E+V G+L+ ++ K + + ++D G+E
Sbjct: 82 HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEY 137
Query: 129 ----------------NILLDSKG-----NIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
NI L S K++DFGLS + G+ +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQW 192
Query: 168 VAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGD-FKL 221
+APE + Y +D +S +ILY ILTG PFD+ + + + G +
Sbjct: 193 MAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 222 PKWLSPGAQNLLRKILEPNPVKR 244
P+ P +N++ +P KR
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKR 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 74/269 (27%), Positives = 111/269 (41%), Gaps = 40/269 (14%)
Query: 8 QEGMRL-GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----- 61
L RYELG LG G +V A+DL AVK+L L D
Sbjct: 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA----DLA-RDPSFYLRF 59
Query: 62 KREIATLKLLKHPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
+RE L HP +V +++ + Y+V+EYV G L D + ++G +
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 118 KLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162
++ L NI++ + +K+ DFG+ A + + T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSVTQTAA 178
Query: 163 --GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDF 219
G+ Y++PE A A SD++S G +LY +LTG PF D ++V YQ + R D
Sbjct: 179 VIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDP 236
Query: 220 KLPK----WLSPGAQNLLRKILEPNPVKR 244
P LS ++ K L NP R
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 76/318 (23%), Positives = 125/318 (39%), Gaps = 106/318 (33%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+Y +GEG +G V AQ+ LK +I+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN------------NYGETFALK---KIRLEKEDEGIPSTT 47
Query: 63 -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
REI+ LK LKH N+V+L++V+ +K ++ +V E++ +L D +G L+ +
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSF 105
Query: 120 FQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164
QL++G+ N+L++ +G +KI+DFGL+ R G
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA------R-------AFGI 152
Query: 165 PN-----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 210
P Y AP+VL ++ Y DIWS G I ++ G P L
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVS-EADQL 210
Query: 211 YQKIFR-----------GDFKLPKW------------------LSPGAQNLLRKILEPNP 241
+IFR +LPK+ L +LL K+L+ +P
Sbjct: 211 M-RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 242 VKRITIAGIKADEWFEQD 259
+RIT +F+++
Sbjct: 270 NQRITAKQALEHAYFKEN 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 65/257 (25%), Positives = 104/257 (40%), Gaps = 37/257 (14%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-KITDQIKREIATLKLLKHPN 75
L +G G FGKV A G AVK + + + + +++E +LKHPN
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------- 128
++ L V + + +V+E+ GG L ++ K R+ Q+ G+
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 129 -----------NILLDSKG--------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
NIL+ K +KI+DFGL+ + G+ ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMA 182
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSP 227
PEV+ + SD+WS GV+L+ +LTG +PF LAV Y +P
Sbjct: 183 PEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241
Query: 228 GAQNLLRKILEPNPVKR 244
L+ P+P R
Sbjct: 242 PFAKLMEDCWNPDPHSR 258
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 75/306 (24%), Positives = 122/306 (39%), Gaps = 107/306 (34%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+Y+ +GEG +G V A+D + RI+ LK +I+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD------------SQGRIVALK---RIRLDAEDEGIPSTA 66
Query: 63 -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
REI+ LK L HPN+V L +V+ S+ + +V E++ ++ D+ +K LQ+++ +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIY 124
Query: 120 FQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164
QL+ G+ N+L++S G +K++DFGL+ R G
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------R-------AFGI 171
Query: 165 PN-----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 210
P Y AP+VL ++ Y + DIWS G I ++TG P + L
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVT-DDDQL 229
Query: 211 YQKIFR-----------GDFKLP-------------------KWLSPGAQNLLRKILEPN 240
KIF +LP +LL +L +
Sbjct: 230 P-KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288
Query: 241 PVKRIT 246
P KRI+
Sbjct: 289 PNKRIS 294
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 54/255 (21%), Positives = 100/255 (39%), Gaps = 32/255 (12%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
E +G G G+V + +G AVK + ++ + + +I ++ + K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
+V+ + + +++ +E + K +G + E K+ ++ L
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
NILLD +G IK+ DFG+S DD + G Y+APE +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 179 DGAT----SDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD---FKLPKWLSPGA 229
+D+WS G+ L + TG P+ + VL K+ + + S
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL-TKVLQEEPPLLPGHMGFSGDF 260
Query: 230 QNLLRKILEPNPVKR 244
Q+ ++ L + KR
Sbjct: 261 QSFVKDCLTKDHRKR 275
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-32
Identities = 79/320 (24%), Positives = 120/320 (37%), Gaps = 91/320 (28%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
+ RY LGEG +G+V A D + A+K + R+ H + T I RE++
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGT-AI-REVSL 86
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
LK L+H N++ L V+ +++++ EY +L + + + QLI+G+
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 128 E---------------NILLDS-----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN- 166
N+LL +KI DFGL+ R G P
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------R-------AFGIPIR 192
Query: 167 ----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQK 213
Y PE+L +R Y + DIWS I +L P D + L+ K
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDS-EIDQLF-K 249
Query: 214 IFR--G--------------DFK--------------LPKWLSPGAQNLLRKILEPNPVK 243
IF G D+K L L +LL +LE +PVK
Sbjct: 250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVK 309
Query: 244 RITIAGIKADEWF-EQDYTP 262
RI+ +F D+ P
Sbjct: 310 RISAKNALEHPYFSHNDFDP 329
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 57/262 (21%), Positives = 99/262 (37%), Gaps = 41/262 (15%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
G LG+G FG+ ++G +K L + + +E+ ++ L+HPNV
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID---GLE---- 128
++ VL ++ + EY+ GG L I S + D G+
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW---SQRVSFAKDIASGMAYLHS 126
Query: 129 -----------NILLDSKGNIKISDFGLSALPQH------------FRDDGLLHTTCGSP 165
N L+ N+ ++DFGL+ L D +T G+P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--P 222
++APE++ R YD D++S G++L I+ D + + RG P
Sbjct: 187 YWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 223 KWLSPGAQNLLRKILEPNPVKR 244
P + + + +P KR
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKR 267
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 5e-31
Identities = 80/313 (25%), Positives = 113/313 (36%), Gaps = 87/313 (27%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKL 70
RYE +G G +G V A+D SG A+K + L I+ RE+A L+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIS--TVREVALLRR 67
Query: 71 LK---HPNVVRLHEVLASKS-----KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
L+ HPNVVRL +V A+ K+ +V E+V DK G L + L
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126
Query: 121 QQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
+Q + GL+ NIL+ S G +K++DFGL+ R
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------R-------IYSYQ 173
Query: 166 N----------YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQK 213
Y APEVL Y D+WS G I + + L K
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNS-EADQLG-K 230
Query: 214 IFR-----------GDFKLPKW----------------LSPGAQNLLRKILEPNPVKRIT 246
IF D LP+ + LL ++L NP KRI+
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 247 IAGIKADEWFEQD 259
+ +D
Sbjct: 291 AFRALQHSYLHKD 303
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 66/255 (25%), Positives = 120/255 (47%), Gaps = 32/255 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG+G FGKV A++ ++G A K++E ++ D EI L HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELED-YIVEIEILATCDHP 76
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGLE----- 128
+V+L K+++++E+ GG + + L E + + + +Q+++ L
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-- 176
N+L+ +G+I+++DFG+SA ++ + + G+P ++APEV+
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 177 ---GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGA 229
YD +DIWS G+ L + P + N + VL KI + D P S
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVEF 252
Query: 230 QNLLRKILEPNPVKR 244
++ L+ L+ NP R
Sbjct: 253 RDFLKIALDKNPETR 267
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 64/252 (25%), Positives = 120/252 (47%), Gaps = 29/252 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+++ LGEG++G V A ++G A+K + + +I +EI+ ++ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGLE----- 128
+VV+ + + +++V+EY G + D I L E E + Q + GLE
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
NILL+++G+ K++DFG++ Q +T G+P ++APEV+ GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 179 DGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLR 234
+ +DIWS G+ + G P+ D + + ++ I F+ P+ S + ++
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVK 260
Query: 235 KILEPNPVKRIT 246
+ L +P +R T
Sbjct: 261 QCLVKSPEQRAT 272
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 50/260 (19%), Positives = 99/260 (38%), Gaps = 40/260 (15%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
E+G +G+G FG+V ++ ++ A+++++ R KRE+ + +H
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGEV------AIRLIDIERDNE-DQLKAFKREVMAYRQTRH 88
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGLE---- 128
NVV S + ++ G L+ + K L + R++ Q+++ G+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 129 -----------NILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
N+ D G + I+DFGL + Q R + L G ++APE++
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 175 NRGYDGAT--------SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW 224
D SD+++ G I Y + PF + + ++ G
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG 267
Query: 225 LSPGAQNLLRKILEPNPVKR 244
+ ++L +R
Sbjct: 268 MGKEISDILLFCWAFEQEER 287
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 67/252 (26%), Positives = 120/252 (47%), Gaps = 29/252 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+Y +G+G G V A D+ +G A++ L++ L I EI ++ K
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-----IINEILVMRENK 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
+PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + LE
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 129 -----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
NILL G++K++DFG A Q + T G+P ++APEV+ +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQNLLR 234
Y DIWS G++ ++ G P+ + N L LY G + + P+ LS ++ L
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 235 KILEPNPVKRIT 246
+ LE + KR +
Sbjct: 252 RCLEMDVEKRGS 263
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 64/253 (25%), Positives = 121/253 (47%), Gaps = 31/253 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
+ +GEG+ G V A++ SG AVK+ L K + L + E+ ++ +
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-----LFNEVVIMRDYQ 100
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
H NVV +++ ++++++E++ GG L D I S+ RL E + + + ++ L
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 129 -----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
+ILL G +K+SDFG A Q +D + G+P ++APEV++
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLL 233
Y DIWS G+++ ++ G P+ + + + ++ K +SP ++ L
Sbjct: 218 YA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFL 275
Query: 234 RKILEPNPVKRIT 246
++L +P +R T
Sbjct: 276 ERMLVRDPQERAT 288
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 76/331 (22%), Positives = 126/331 (38%), Gaps = 94/331 (28%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
+ +YE +G+G FG+V A+ +G A+K K + + K IT REI
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL--REIKI 69
Query: 68 LKLLKHPNVVRLHEVLASKS--------KIYMVLEYV----TGGELFDKIASKGRLQEAE 115
L+LLKH NVV L E+ +K+ IY+V ++ G L + + +E
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSE 125
Query: 116 GRKLFQQLIDGLE---------------NILLDSKGNIKISDFGLS-ALPQHFRDDGLLH 159
+++ Q L++GL N+L+ G +K++DFGL+ A +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 160 TTCGSPN------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 210
T N Y PE+L R Y D+W G I+ + T + +
Sbjct: 186 T-----NRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNT----EQ 235
Query: 211 YQ--KIFR-------------------GDFKLPKW-------------LSPGAQNLLRKI 236
+Q I + +L K P A +L+ K+
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 295
Query: 237 LEPNPVKRITIAGIKADEWFEQDYTPANPDD 267
L +P +RI ++F D P++
Sbjct: 296 LVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 70/270 (25%), Positives = 114/270 (42%), Gaps = 46/270 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
YEL +G G V+ A A+K LEK + D++ +EI +
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQCH 71
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------- 124
HPN+V + K ++++V++ ++GG + D I E + L + I
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 125 DGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPN 166
+GLE NILL G+++I+DFG+SA D T G+P
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 167 YVAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLY----------QKI 214
++APEV+ RGYD +DIWS G+ + TG P+ + VL +
Sbjct: 192 WMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 215 FRGDFKLPKWLSPGAQNLLRKILEPNPVKR 244
+ L K+ + ++ L+ +P KR
Sbjct: 251 VQDKEMLKKY-GKSFRKMISLCLQKDPEKR 279
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 58/277 (20%), Positives = 105/277 (37%), Gaps = 47/277 (16%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIA-TLKL 70
E LG G +G V+ + + SG AVK I + ++ ++ +++
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKR------IRATVNSQEQKRLLMDLDISMRT 62
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
+ P V + L + +++ +E + DK + E K+ ++
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 126 GLE----------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
LE N+L+++ G +K+ DFG+S + DD G Y+A
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMA 177
Query: 170 PEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLP- 222
PE + GY SDIWS G+ + + P+D L Q + +LP
Sbjct: 178 PERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236
Query: 223 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
K+ S + + L+ N +R T + +F
Sbjct: 237 DKF-SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-30
Identities = 64/268 (23%), Positives = 103/268 (38%), Gaps = 53/268 (19%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIAT-LKL 70
+ +G G +G V SG AVK I + + Q+ ++ ++
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR------IRSTVDEKEQKQLLMDLDVVMRS 77
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI------ASKGRLQEAEGRKLFQQLI 124
P +V+ + L + ++ +E ++ FDK + E K+ +
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 125 DGLE----------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 168
L NILLD GNIK+ DFG+S D G Y+
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYM 192
Query: 169 APEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD-FKL 221
APE + +GYD SD+WS G+ LY + TG P+ N L ++ +GD +L
Sbjct: 193 APERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQL-TQVVKGDPPQL 250
Query: 222 P-----KWLSPGAQNLLRKILEPNPVKR 244
++ SP N + L + KR
Sbjct: 251 SNSEEREF-SPSFINFVNLCLTKDESKR 277
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 78/309 (25%), Positives = 115/309 (37%), Gaps = 107/309 (34%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
+YE +GEG +GKV A+DL +G R + LK +++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNG----------GRFVALK---RVRVQTGEEGMPLST 58
Query: 63 -REIATLKLLK---HPNVVRLHEVL-----ASKSKIYMVLEYVTG--GELFDKIASKGRL 111
RE+A L+ L+ HPNVVRL +V ++K+ +V E+V DK+ G +
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-V 117
Query: 112 QEAEGRKLFQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDG 156
+ + QL+ GL+ NIL+ S G IK++DFGL+ R
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------R--- 168
Query: 157 LLHTTCGSPN----------YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDD 204
Y APEVL Y D+WS G I +
Sbjct: 169 ----IYSFQMALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSS 223
Query: 205 RNLAVLYQKIFR-----------GDFKLPKW----------------LSPGAQNLLRKIL 237
++ L KI D LP+ + ++LL K L
Sbjct: 224 -DVDQLG-KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281
Query: 238 EPNPVKRIT 246
NP KRI+
Sbjct: 282 TFNPAKRIS 290
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 49/230 (21%), Positives = 94/230 (40%), Gaps = 33/230 (14%)
Query: 14 GRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLK 69
G YEL +G+G + V A+ +G V+ LE + ++ E+ K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV---TFLQGELHVSK 81
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGL 127
L HPN+V + +++++V ++ G D + E + Q ++ L
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 128 E---------------NILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTC----GSPNY 167
+ +IL+ G + +S + + H + ++H +
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 168 VAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKI 214
++PEVL +GYD SDI+S G+ + G++PF D +L +K+
Sbjct: 202 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 33/253 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R +G G+FG V FA+D+ + A+K + + + I +E+ L+ L+HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
N ++ + ++V+EY G K LQE E + + GL
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 129 ---------NILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANR-- 176
NILL G +K+ DFG ++ + ++ G+P ++APEV+
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDE 227
Query: 177 -GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQN 231
YDG D+WS G+ + P + N ++ LY I + + + W S +N
Sbjct: 228 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFRN 284
Query: 232 LLRKILEPNPVKR 244
+ L+ P R
Sbjct: 285 FVDSCLQKIPQDR 297
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L LG+G+FG V ++ + AVK L+ + + + D RE+ + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
N++RL+ V + MV E G L D RL++ +G L L G
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLD------RLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 127 ---LE------------NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV-- 168
LE N+LL ++ +KI DFGL ALPQ +D
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 190
Query: 169 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
APE L R + A SD W GV L+ + T G P+ N + + KI + +LP+
Sbjct: 191 CAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-28
Identities = 68/264 (25%), Positives = 116/264 (43%), Gaps = 42/264 (15%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLK 72
G +EL +G G +G+V + + +G A+K+++ + + + IK+EI LK
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSH 79
Query: 73 HPNVVRLHE------VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
H N+ + ++++V+E+ G + D K L+E + ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 125 DGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
GL N+LL +K+ DFG+SA Q R G +T G+P ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 170 PEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FK 220
PEV+A YD SD+WS G+ + G P D + + L+ I R K
Sbjct: 198 PEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLK 255
Query: 221 LPKWLSPGAQNLLRKILEPNPVKR 244
KW S Q+ + L N +R
Sbjct: 256 SKKW-SKKFQSFIESCLVKNHSQR 278
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 57/265 (21%), Positives = 98/265 (36%), Gaps = 53/265 (20%)
Query: 8 QEGMRL-GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQI---- 61
G + G+YE+ + G G + A D + +G P +K L + D
Sbjct: 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-------DAEAQAM 125
Query: 62 -KREIATLKLLKHPNVVRLHEV-----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAE 115
E L + HP++V++ Y+V+EYV G L +L AE
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183
Query: 116 GRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL-SALPQHFRDDGLLH 159
+++ L ENI+L + +K+ D G S + G L
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVSRINS----FGYL- 237
Query: 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 219
G+P + APE++ R +DI++ G L + + R + L +
Sbjct: 238 --YGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----- 288
Query: 220 KLPKWLSPGAQNLLRKILEPNPVKR 244
LLR+ ++P+P +R
Sbjct: 289 -PVLKTYDSYGRLLRRAIDPDPRQR 312
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 55/237 (23%), Positives = 102/237 (43%), Gaps = 44/237 (18%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG G FG V + +P A+K L + +I E + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
+P+V RL + S + ++ + + G L D ++E + Q L++
Sbjct: 76 NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128
Query: 126 G---LE------------NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NY 167
G LE N+L+ + ++KI+DFGL+ L ++ H G P +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKW 185
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+A E + +R Y SD+WS GV ++ ++T G P+D + + + +G +LP+
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 68/260 (26%), Positives = 107/260 (41%), Gaps = 35/260 (13%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
LG +G GNFG+V + AVK + LK + +E LK HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNI 174
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGLE------- 128
VRL V K IY+V+E V GG+ + ++G + G+E
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 129 --------NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY----VAPEVLA 174
N L+ K +KISDFG+S R+ DG+ + G APE L
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS------REEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 175 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQN 231
Y SD+WS G++L+ + G P+ + + + + +G +L P+
Sbjct: 289 YGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFR 346
Query: 232 LLRKILEPNPVKRITIAGIK 251
L+ + P +R + + I
Sbjct: 347 LMEQCWAYEPGQRPSFSTIY 366
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 29/228 (12%)
Query: 18 LGRTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG GNFG VK Q AVKIL KN + D++ E ++ L +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG---LE---- 128
+VR+ + +V+E G L + +++ +L Q+ G LE
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 129 --------NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS--P-NYVAPEVLANR 176
N+LL ++ KISDFGLS AL D+ P + APE +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA---DENYYKAQTHGKWPVKWYAPECINYY 195
Query: 177 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+ SD+WS GV+++ + G P+ + + + +G ++
Sbjct: 196 KFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGC 241
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 86/371 (23%), Positives = 128/371 (34%), Gaps = 113/371 (30%)
Query: 15 RYE-LGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+E G +G G +G V A+ D +A+K +E I REIA L+ L
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLREL 75
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYV--------TGGELFDKIASKGRLQEAEGRKLFQ 121
KHPNV+ L +V S + K++++ +Y +L + L
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 122 QLIDGLE---------------NILLDS----KGNIKISDFGLSALPQHFRDDGLLHTTC 162
Q++DG+ NIL+ +G +KI+D G + R
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------R-------LF 182
Query: 163 GSPN--------------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF----D 203
SP Y APE+L R Y A DIW+ G I +LT F +
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQE 241
Query: 204 DRNLAVLYQ-----KIFR-----------GDFKLPKW----------------------- 224
D + Y +IF K+P+
Sbjct: 242 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 301
Query: 225 ----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFS 280
A +LL+K+L +P+KRIT D +F +D P + I F
Sbjct: 302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFL 361
Query: 281 MHEVPSDGGRT 291
E P D G
Sbjct: 362 TEEEPDDKGDK 372
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 41/233 (17%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+ LG G +G+V L AVK L+++ + ++ +E A +K +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNL 278
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GLE 128
V+L V + Y++ E++T G L D L+E +++ L+ +E
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSAME 332
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY--VAPE 171
N L+ +K++DFGLS + D APE
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGLS---RLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 172 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
LA + SD+W+ GV+L+ I T G P+ +L+ +Y+ + + +++ +
Sbjct: 390 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 440
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 58/236 (24%), Positives = 100/236 (42%), Gaps = 41/236 (17%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ + +G G+ G+V + +P A+K L+ + E + + H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
PN++RL V+ +V EY+ G L L+ +G+ QL+ G
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT------FLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 168
+ N+L+DS K+SDFGLS + + D +TT G +
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTTTGGKIPIRWT 221
Query: 169 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
APE +A R + A SD+WS GV+++ +L G P+ + + + G ++LP
Sbjct: 222 APEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 45/235 (19%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ LG G +G+V L AVK L+++ + + +E A +K +KHP
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHP 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
N+V+L V + Y++ E++T G L D L+E +++ L+
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSA 123
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVA 169
+E N L+ +K++DFGLS L D P + A
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTA 180
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
PE LA + SD+W+ GV+L+ I T G P+ +L+ +Y+ + + +++ +
Sbjct: 181 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 233
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 58/293 (19%), Positives = 101/293 (34%), Gaps = 67/293 (22%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L +G+G +G+V G AVKI + + + E+ +L+H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
+ S ++++++ Y G L+D + L ++ + GL
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 129 -------------------NILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNY 167
NIL+ G I+D GL+ + + D + G+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 168 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGY----------LPFDDRN------ 206
+APEVL DIW+ G++L+ + PF D
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 207 ----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 251
V + R + +W S L K+++ NP R+T IK
Sbjct: 244 EDMRKVVCVDQQ-RPNIP-NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 47/285 (16%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L LG+G FG+V + A+K L+ + + +E +K L+H +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 324
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GLE 128
V+L+ V S+ IY+V EY++ G L D L+ G+ L QL+D G+
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 171
NIL+ K++DFGL+ + D+ P + APE
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPE 434
Query: 172 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 228
+ SD+WS G++L + T G +P+ + ++ RG +++ P
Sbjct: 435 AALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPES 492
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF 273
+L+ + P +R T ++ + E +T P +
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQ--AFLEDYFTSTEPQYQPGENL 535
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 47/285 (16%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L LG+G FG+V + A+K L+ + + +E +K L+H +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 241
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GLE 128
V+L+ V S+ IY+V EY++ G L D L+ G+ L QL+D G+
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 171
NIL+ K++DFGL+ + D+ P + APE
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPE 351
Query: 172 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 228
+ SD+WS G++L + T G +P+ + ++ RG +++ P
Sbjct: 352 AALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPES 409
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF 273
+L+ + P +R T ++ + E +T P +
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQ--AFLEDYFTSTEPQYQPGENL 452
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 35/260 (13%), Positives = 73/260 (28%), Gaps = 58/260 (22%)
Query: 10 GMRL--GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
G R+ GRY L G + A D A+ ++ ++ + +
Sbjct: 25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLR 84
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
L + P V R+ +V+ +++ +V E++ GG L + + Q L
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAA 142
Query: 128 E---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
+ + + G++ ++ +
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA- 179
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPG 228
DI G LY +L P + LA + G P +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRD 231
Query: 229 A----QNLLRKILEPNPVKR 244
+ + ++ + R
Sbjct: 232 IPFQISAVAARSVQGDGGIR 251
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 59/236 (25%), Positives = 101/236 (42%), Gaps = 42/236 (17%)
Query: 18 LGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ +G G FG+V +P A+K L+ + E + H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSH 105
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
N++RL V++ + ++ EY+ G L L+E +G QL+ G
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDK------FLREKDGEFSVLQLVGMLRGIAAG 159
Query: 127 ---LE------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 168
L NIL++S K+SDFGLS + + D +TT G +
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWT 217
Query: 169 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
APE ++ R + A SD+WS G++++ ++T G P+ + + + + I G F+LP
Sbjct: 218 APEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPT 271
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 48/238 (20%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
ELGR +GEG FG V + + L A+K + ++ ++ +E T++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 75
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L V+ +++ +++++E T GEL LQ + LI
Sbjct: 76 PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKYSLDLASLILYAYQLSTA 128
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-N 166
L N+L+ S +K+ DFGLS R D + P
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS------RYMEDSTYYKASKGKLPIK 182
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
++APE + R + A SD+W GV ++ IL G PF + +I G +LP
Sbjct: 183 WMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 238
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 53/237 (22%), Positives = 99/237 (41%), Gaps = 44/237 (18%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ LG G FG V + +P +K++E + + + + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD 73
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
H ++VRL + S + +V +Y+ G L D +++ G Q L++
Sbjct: 74 HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLD------HVRQHRGALGPQLLLNWGVQIAK 126
Query: 126 GLE---------------NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG-SP-NY 167
G+ N+LL S ++++DFG++ LP DD L + +P +
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP---DDKQLLYSEAKTPIKW 183
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+A E + Y SD+WS GV ++ ++T G P+ LA + + +G +L +
Sbjct: 184 MALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQ 238
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 52/240 (21%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L R LGEG FG+V + + AVK +K+ + K ++ E +K L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDH 72
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L ++ + ++++E GEL L+ + L+
Sbjct: 73 PHIVKLIGII-EEEPTWIIMELYPYGELGH------YLERNKNSLKVLTLVLYSLQICKA 125
Query: 127 ---LE------------NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--PNY 167
LE NIL+ S +K+ DFGLS R D + + P
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLS------RYIEDEDYYKASVTRLP-- 177
Query: 168 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+ +PE + R + A SD+W V ++ IL+ G PF + + +G +LPK
Sbjct: 178 IKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPK 235
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 58/240 (24%), Positives = 105/240 (43%), Gaps = 51/240 (21%)
Query: 18 LGRTLGEGNFGKV---KFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
+ + +G G FG+V + + A+K L EK R L E + +
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-------GEASIMG 101
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
HPN++RL V+ + +V EY+ G L L++ + + QL+
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF------LRKHDAQFTVIQLVGMLRG 155
Query: 126 ---GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 167
G++ NIL++S K+SDFGL + + D +TT G
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGKIP 213
Query: 168 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+ +PE +A R + A SD+WS G++L+ +++ G P+ + + + + + G ++LP
Sbjct: 214 IRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 53/237 (22%), Positives = 101/237 (42%), Gaps = 44/237 (18%)
Query: 17 ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG G FG V + +P A+K L + +I E + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
+P+V RL + S + ++ + + G L D ++E + Q L++
Sbjct: 76 NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128
Query: 126 GLE---------------NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NY 167
G+ N+L+ + ++KI+DFGL+ L ++ H G P +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKW 185
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+A E + +R Y SD+WS GV ++ ++T G P+D + + + +G +LP+
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 60/248 (24%), Positives = 96/248 (38%), Gaps = 47/248 (18%)
Query: 5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK 62
K++ + + ELG GNFG V+ + A+K+L++ +++
Sbjct: 5 FLKRDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMM 58
Query: 63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
RE + L +P +VRL V + +V+E GG L L
Sbjct: 59 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIPVSN 111
Query: 123 LID-------G---LE------------NILLDSKGNIKISDFGLS-ALPQHFRDDGLLH 159
+ + G LE N+LL ++ KISDFGLS AL DD
Sbjct: 112 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYT 168
Query: 160 TTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 215
P + APE + R + SD+WS GV ++ L+ G P+ + I
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
Query: 216 RGDFKLPK 223
+G ++
Sbjct: 228 QG-KRMEC 234
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 51/237 (21%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ +G G FG V + A+K + + + E + L HP
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGA------MSEEDFIEEAEVMMKLSHP 63
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GL 127
+V+L+ V ++ I +V E++ G L D L+ G + L+ G+
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSD------YLRTQRGLFAAETLLGMCLDVCEGM 117
Query: 128 E---------------NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NY 167
N L+ IK+SDFG++ R D ++ G+ P +
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT------RFVLDDQYTSSTGTKFPVKW 171
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+PEV + Y SD+WS GV+++ + + G +P+++R+ + + + I G F+L K
Sbjct: 172 ASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYK 226
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-24
Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 51/237 (21%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
+ LG G FG VK+ + A+K++++ + + E + L H
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEG------SMSEDEFIEEAKVMMNLSHE 79
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G- 126
+V+L+ V + I+++ EY+ G L + L+E R QQL++
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 127 --LE------------NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NY 167
LE N L++ +G +K+SDFGLS R D ++ GS P +
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS------RYVLDDEYTSSVGSKFPVRW 187
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
PEVL + SDIW+ GV+++ I + G +P++ + + I +G +L +
Sbjct: 188 SPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 242
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-24
Identities = 64/279 (22%), Positives = 120/279 (43%), Gaps = 59/279 (21%)
Query: 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHPN 75
L + LG G FG VK + AVK++++ + + +E T+ L HP
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEG------SMSEDEFFQEAQTMMKLSHPK 64
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GLE 128
+V+ + V + + IY+V EY++ G L + L+ QL++ G+
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLN------YLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYV 168
N L+D +K+SDFG++ R D ++ G+ P +
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT------RYVLDDQYVSSVGTKFPVKWS 172
Query: 169 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227
APEV Y SD+W+ G++++ + + G +P+D + + K+ +G +L +
Sbjct: 173 APEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLYR--PH 228
Query: 228 GAQNLLRKIL----EPNPVKRITIAGIKA--DEWFEQDY 260
A + + +I+ P KR T + + + E+D
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-24
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 39/210 (18%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG+GNFG V+ ++G AVK L+ + + +REI LK L+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 69
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ V S + + +++EY+ G L D LQ+ + R +L+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 123
Query: 126 --GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 167
G+E NIL++++ +KI DFGL+ + ++ + SP +
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILT 197
APE L + A SD+WS GV+LY + T
Sbjct: 184 YAPESLTESKFSVA-SDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 50/221 (22%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
+ LG+GNFG V+ ++G AVK L+ + DQ + REI LK
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG------PDQQRDFQREIQILK 79
Query: 70 LLKHPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-- 125
L +V+ V + + +V+EY+ G L D LQ R +L+
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD------FLQRHRARLDASRLLLYS 133
Query: 126 -----GLE---------------NILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG- 163
G+E NIL++S+ ++KI+DFGL+ LP D + G
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREPGQ 191
Query: 164 SP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 202
SP + APE L++ + SD+WS GV+LY + T
Sbjct: 192 SPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSC 231
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 53/236 (22%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L +T+G+G FG V G AVK ++ + E + + L+H N+
Sbjct: 24 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNL 76
Query: 77 VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GL 127
V+L V + K +Y+V EY+ G L D L+ L L+ +
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 128 E---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----V 168
E N+L+ K+SDFGL+ ++ +T +
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEA---SSTQDTGKLPVKWT 181
Query: 169 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
APE L + + SD+WS G++L+ I + G +P+ L + ++ +G +K+
Sbjct: 182 APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 235
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 63/243 (25%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L LG G FG+V + AVK L++ + D E +K L+H +
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRL 70
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GLE 128
VRL+ V ++ IY++ EY+ G L D L+ G KL +L+D G+
Sbjct: 71 VRLYAV-VTQEPIYIITEYMENGSLVD------FLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 168
NIL+ + KI+DFGL+ + D+ Y
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLA---RLIEDN----------EYTAREGA 170
Query: 169 -------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK 220
APE + + SD+WS G++L I+T G +P+ + Q + RG ++
Sbjct: 171 KFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YR 228
Query: 221 LPK 223
+ +
Sbjct: 229 MVR 231
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 42/235 (17%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
ELGR +GEG FG V + + + A+K + ++ ++ +E T++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
P++V+L V+ +++ +++++E T GEL LQ + LI
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKFSLDLASLILYAYQLSTA 503
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SP-NYVA 169
L N+L+ S +K+ DFGLS D + G P ++A
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMA 560
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
PE + R + A SD+W GV ++ IL G PF + +I G +LP
Sbjct: 561 PESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 613
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 39/210 (18%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ + LG+GNFG V+ ++G AVK L+ + + +REI LK L+
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 100
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ V S + + +++EY+ G L D LQ+ + R +L+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 154
Query: 126 --GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 167
G+E NIL++++ +KI DFGL+ + ++ + SP +
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILT 197
APE L + A SD+WS GV+LY + T
Sbjct: 215 YAPESLTESKFSVA-SDVWSFGVVLYELFT 243
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 73/344 (21%), Positives = 120/344 (34%), Gaps = 90/344 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ + +G G G V A D A+K L + H K + RE+ +K +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 82
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + L I + L L Q++ G
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 139
Query: 127 L---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 168
+ NI++ S +KI DFGL+ R G YV
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTP---YVVTR 190
Query: 169 ---APEVLANRGYDGATSDIWSCGVILYVILTG--------------------------- 198
APEV+ GY DIWS G I+ ++ G
Sbjct: 191 YYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249
Query: 199 ----------YL----PFDDRNLAVLYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
Y+ + + L+ +F D + K + A++LL K+L + K
Sbjct: 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309
Query: 244 RITIAGIKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 284
RI++ + Y P+ + I +D ++ E
Sbjct: 310 RISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW 353
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 54/293 (18%), Positives = 92/293 (31%), Gaps = 70/293 (23%)
Query: 17 ELGRTLGEGNFGKV-------KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+LG+G F K+ +K+L+K H ++ + +
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMS 67
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
L H ++V + V + +V E+V G L L++ + ++
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY------LKKNKNCINILWKLEVAKQ 121
Query: 126 ---G---LE------------NILLDSKGN--------IKISDFGLSALPQHFRDDGLLH 159
LE NILL + + IK+SD G+S
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------IT----- 170
Query: 160 TTCGSPNY-------VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 211
+ V PE + N +D WS G L+ I + G P +
Sbjct: 171 --VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 212 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTP 262
Q +LP + NL+ ++ P R + I + F D P
Sbjct: 229 QFYEDR-HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 78/353 (22%), Positives = 120/353 (33%), Gaps = 115/353 (32%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
Y + +G G+FG V A+ DSG A+K +L+ R + RE+ ++ L H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 106
Query: 74 PNVVRLHEVLASKS------KIYMVLEYVTG---GELFDKIASKGRLQEAEGRKLFQQLI 124
N+VRL S + +VL+YV +K L + QL
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 125 DGL---------------ENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN-- 166
L +N+LLD +K+ DFG + G PN
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA-----------KQLVRGEPNVS 215
Query: 167 YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD- 218
Y+ APE++ Y + D+WS G +L +L G Q IF GD
Sbjct: 216 YICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG-------------QPIFPGDS 261
Query: 219 -----------------------------FKLPKW------------LSPGAQNLLRKIL 237
FK P+ P A L ++L
Sbjct: 262 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 321
Query: 238 EPNPVKRITIAGIKADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDG 288
E P R+T A +F++ P P+ + + F+ E+ S+
Sbjct: 322 EYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFN---FTTQELSSNP 371
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 62/251 (24%), Positives = 96/251 (38%), Gaps = 46/251 (18%)
Query: 5 EKKQEGMRLGRYEL---GRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITD 59
E K + + L R L LG GNFG V+ + A+K+L++ +
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--E 381
Query: 60 QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
++ RE + L +P +VRL V + +V+E GG L L
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIP 434
Query: 120 FQQLID-------G---LE------------NILLDSKGNIKISDFGLS-ALPQHFRDDG 156
+ + G LE N+LL ++ KISDFGLS AL DD
Sbjct: 435 VSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA---DDS 491
Query: 157 LLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 212
+ APE + R + SD+WS GV ++ L+ G P+ +
Sbjct: 492 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 550
Query: 213 KIFRGDFKLPK 223
I +G ++
Sbjct: 551 FIEQG-KRMEC 560
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 43/233 (18%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
+L + LG G FG+V A AVK ++ + + E +K L+H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSV----EAFLAEANVMKTLQHDKL 245
Query: 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G-- 126
V+LH V +K IY++ E++ G L D L+ EG K +LID G
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 127 -LE------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 171
+E NIL+ + KI+DFGL+ + D+ P + APE
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLA---RVIEDNEYTAREGAKFPIKWTAPE 355
Query: 172 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
+ + SD+WS G++L I+T G +P+ + + + + RG +++P+
Sbjct: 356 AINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 406
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 69/314 (21%), Positives = 124/314 (39%), Gaps = 65/314 (20%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LGR LG+G FG V + Q+ S + AVK+L+ + I I + RE A +K H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFDH 84
Query: 74 PNVVRL------HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI--- 124
P+V +L ++L ++ G+L + + R+ E Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143
Query: 125 ----DGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
G+E N +L + ++DFGLS R +++
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS------RK---IYSG---- 190
Query: 166 NY-------------VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 211
+Y +A E LA+ Y SD+W+ GV ++ I+T G P+ A +Y
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 212 QKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 270
+ G+ K P +L+ + +P +R + ++ + E + +
Sbjct: 250 NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME--LENILGHLSVLSTSQ 307
Query: 271 D-IFVDNEAFSMHE 283
D ++++ E H
Sbjct: 308 DPLYINIERAHHHH 321
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 71/340 (20%), Positives = 120/340 (35%), Gaps = 78/340 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
++L LGEG +G V A +G A+K K K + REI LK K
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFD-KPLFALRTLREIKILKHFK 67
Query: 73 HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
H N++ + + S +Y++ E + +L ++ S L + + Q + +
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 128 ---------------ENILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGSPNYV-- 168
N+L++S ++K+ DFGL + G +V
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 169 ----APEV-LANRGYDGATSDIWSCGVILYVILTG--------YL------------PFD 203
APEV L + Y A D+WSCG IL + Y P
Sbjct: 186 RWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 204 DRNLAVL-----------YQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGI 250
D +L + + P+ ++P +LL+++L +P KRIT
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 251 KADEWFEQDYTP-----ANPDDDEEDIF-VDNEAFSMHEV 284
+ + + P P F EA + ++
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDL 343
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 17 ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LGEG+FGKV+ + ++G AVK L K I D +K+EI L+ L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIAD-LKKEIEILRNLY 81
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
H N+V+ + I +++E++ G L + L + + + +Q +
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE------YLPKNKNKINLKQQLKYAVQI 135
Query: 126 --GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 167
G++ N+L++S+ +KI DFGL+ + ++ + SP +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILT 197
APE L + A SD+WS GV L+ +LT
Sbjct: 196 YAPECLMQSKFYIA-SDVWSFGVTLHELLT 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 42/211 (19%)
Query: 17 ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ R LGEG+FGKV + +G AVK L+ + + K+EI L+ L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY 91
Query: 73 HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE-- 128
H ++++ + +V+EYV G L D + + + A+ QQ+ +G+
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 129 -------------NILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNYV- 168
N+LLD+ +KI DFGL+ A+P+ R+DG P V
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VF 202
Query: 169 --APEVLANRGYDGATSDIWSCGVILYVILT 197
APE L + A SD+WS GV LY +LT
Sbjct: 203 WYAPECLKEYKFYYA-SDVWSFGVTLYELLT 232
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 52/299 (17%), Positives = 100/299 (33%), Gaps = 69/299 (23%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ +L G FG V AQ AVKI K + Q + E+ +L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGM 75
Query: 72 KHPNVVRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
KH N+++ + ++++ + G L D + + E + + + GL
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGL 134
Query: 128 E-------------------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162
N+LL + I+DFGL+ + + G H
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 163 GSPNYVAPEVLANRGYDGAT----SDIWSCGVILYVILTGYLP----------------- 201
G+ Y+APEVL D+++ G++L+ + +
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 202 ----FDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILE----PNPVKRITIAGIK 251
+D V+++K L W +L + +E + R++ +
Sbjct: 255 QHPSLEDMQEVVVHKKK---RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 49/234 (20%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLKLLKHPN 75
+L +T+G+G FG V G AVK ++ + T Q E + + L+H N
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSN 247
Query: 76 VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
+V+L V + K +Y+V EY+ G L D L+ L L+
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAP 170
+E N+L+ K+SDFGL+ ++ T P + AP
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAP 355
Query: 171 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 223
E L + + SD+WS G++L+ I + G +P+ L + ++ +G +K+
Sbjct: 356 EALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 407
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 64/293 (21%), Positives = 108/293 (36%), Gaps = 67/293 (22%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
L ++G+G FG+V + G AVKI + + + EI +L+H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENI 98
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
+ ++ + +++++V +Y G LFD + + KL GL
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157
Query: 129 -------------------NILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY 167
NIL+ G I+D GL+ D D + G+ Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 168 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGY----------LPFDDRN------ 206
+APEVL + +DI++ G++ + I LP+ D
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 207 ----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 251
V QK+ R + +W S A ++ KI+ N R+T IK
Sbjct: 278 EEMRKVVCEQKL-RPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 75/344 (21%), Positives = 123/344 (35%), Gaps = 90/344 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ + +G G G V A D A+K L + H K + RE+ +K +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 119
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + L I + L L Q++ G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 176
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 168
++ NI++ S +KI DFGL+ R G T+ YV
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG---TSFMMTPYVVTR 227
Query: 169 ---APEVLANRGYDGATSDIWSCGVILYVILTG--------------------------- 198
APEV+ GY DIWS G I+ ++
Sbjct: 228 YYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286
Query: 199 ----------YL----PFDDRNLAVLYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 243
Y+ + L+ +F D + K + A++LL K+L +P K
Sbjct: 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346
Query: 244 RITIAGIKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 284
RI++ + Y PA + I+ +D ++ E
Sbjct: 347 RISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 390
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 67/310 (21%), Positives = 115/310 (37%), Gaps = 89/310 (28%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
Y + +G G+FG V A+ ++S A+K + +K RE+ ++++K
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN---------RELQIMRIVK 90
Query: 73 HPNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----Q 122
HPNVV L S + +VLEYV ++ +L++ L + Q
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 123 LIDGL---------------ENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166
L+ L +N+LLD G +K+ DFG + G PN
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA-----------KILIAGEPN 198
Query: 167 --YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR- 216
Y+ APE++ Y DIWS G ++ ++ G F + +I +
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257
Query: 217 ----------------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIA 248
+ K P+ P A +L+ ++LE P R+T
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317
Query: 249 GIKADEWFEQ 258
+F++
Sbjct: 318 EALCHPFFDE 327
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-22
Identities = 57/246 (23%), Positives = 96/246 (39%), Gaps = 59/246 (23%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLL 71
+G G+FG V + + AVK L + I + + E +K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDF 83
Query: 72 KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI------ 124
HPNV+ L + L S+ +VL Y+ G+L + ++ + LI
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQV 137
Query: 125 -DGLE---------------NILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTT 161
G++ N +LD K +K++DFGL+ H + L
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--- 194
Query: 162 CGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 217
P V A E L + + SD+WS GV+L+ ++T G P+ D N + + +G
Sbjct: 195 ---P--VKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 218 DFKLPK 223
+L +
Sbjct: 249 -RRLLQ 253
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 58/249 (23%), Positives = 97/249 (38%), Gaps = 65/249 (26%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+G G+FG V + + AVK L NRI + Q E +K H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 149
Query: 74 PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------D 125
PNV+ L + L S+ +VL Y+ G+L + ++ + LI
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 126 GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 168
G++ N +LD K +K++DFGL+ RD ++ +
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA------RD---MYDK----EFDSV 250
Query: 169 -------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 214
A E L + + SD+WS GV+L+ ++T G P+ D N + +
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 215 FRGDFKLPK 223
+G +L +
Sbjct: 310 LQG-RRLLQ 317
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 59/293 (20%), Positives = 108/293 (36%), Gaps = 67/293 (22%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
++ + +G+G +G+V + G AVK+ + + + EI L++H N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENI 93
Query: 77 VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
+ + S +++Y++ +Y G L+D + S L KL + GL
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 129 -------------------NILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNY 167
NIL+ G I+D GL+ D +T G+ Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 168 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGYLP--------------------F 202
+ PEVL +D++S G+IL+ + + +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 203 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 251
+D V +K+ R F +W S + K++ NP R+T +K
Sbjct: 273 EDMREIVCIKKL-RPSFP-NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 83/332 (25%), Positives = 129/332 (38%), Gaps = 79/332 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
RY+ +G G +G V A D +GL AVK L + IIH K + RE+ LK +K
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V +Y+V + G +L + + + +L + + L Q++ G
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRG 144
Query: 127 L---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 168
L N+ ++ +KI DFGL+ YV
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----------YVATR 193
Query: 169 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------GD 218
APE+ L Y+ DIWS G I+ +LTG F + + I R +
Sbjct: 194 WYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 219 F--------------KLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKAD 253
L + +P A +LL K+L + KRIT A A
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 254 EWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 284
+F Q + P + P D D +++ + E
Sbjct: 313 AYFAQYHDPDDEPVADPYDQSLESRDLLIDEW 344
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 66/312 (21%), Positives = 116/312 (37%), Gaps = 67/312 (21%)
Query: 17 ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLKLL 71
+ R LG+G+FG V A+ + P A+K + + + +I + E + +K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKL-FQQLI---- 124
+VVRL V++ +++E +T G+L + + ++I
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 125 ---DGLE---------------NILLDSKGNIKISDFGLSALPQHFRD-----------D 155
DG+ N ++ +KI DFG++ RD
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKGGK 199
Query: 156 GLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 211
GLL P V +PE L + + SD+WS GV+L+ I T P+ + +
Sbjct: 200 GLL------P--VRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250
Query: 212 QKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDD 267
+ + G L P L+R + NP R + I + E E + +
Sbjct: 251 RFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 309
Query: 268 DEEDIFVDNEAF 279
EE+ + E
Sbjct: 310 SEENKLPEPEEL 321
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 84/360 (23%), Positives = 128/360 (35%), Gaps = 95/360 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y + +G G +G V A D +G A+K L + + K + RE+ LK ++
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMR 82
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V Y+V+ ++ G +L K+ +L E + L Q++ G
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 127 L---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 168
L N+ ++ +KI DFGL+ R T YV
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTR 189
Query: 169 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 215
APEV L Y DIWS G I+ ++TG F + ++I
Sbjct: 190 WYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248
Query: 216 ---------------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252
+ DF L SP A NLL K+L + +R+T A
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALA 307
Query: 253 DEWFEQDYTPA--------NPDDDEEDIFVD-------NEAFSMHEVPSDGGRTPGSPPL 297
+FE + + D+ D +D E S G R PL
Sbjct: 308 HPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 367
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 73/332 (21%), Positives = 131/332 (39%), Gaps = 74/332 (22%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
RY +GEG +G V A D + + A+K I + + + REI L +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ---RTLREIKILLRFRH 84
Query: 74 PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL- 127
N++ +++++ + + +Y+V + + +L+ + ++ L Q++ GL
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQILRGLK 142
Query: 128 --------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 168
N+LL++ ++KI DFGL+ + D T YV
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWY 197
Query: 169 -APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL-------Y 211
APE+ L ++GY + DIWS G IL +L+ F ++ L +L
Sbjct: 198 RAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 212 QKIF---------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 254
I + + P A +LL K+L NP KRI + A
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 255 WFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 284
+ EQ Y P++ E ++ + ++
Sbjct: 316 YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 347
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-21
Identities = 59/291 (20%), Positives = 110/291 (37%), Gaps = 73/291 (25%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
Y+L R LG G + +V A ++ + VK I+ +IKREI L+ L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGG 90
Query: 74 PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE--- 128
PN++ L +++ +V E+V + + L + + R +++ L+
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH 147
Query: 129 ------------NILLDSK-GNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLA 174
N+++D + +++ D+GL+ F G + S + PE+L
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRYFKGPELLV 203
Query: 175 N-RGYDGATSDIWSCGVILYVILTGYLPF--------------------DDRNLAVLYQK 213
+ + YD + D+WS G +L ++ PF D + Y
Sbjct: 204 DYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 214 IFRGDFK--LPKW----------------LSPGAQNLLRKILEPNPVKRIT 246
F L + +SP A + L K+L + R+T
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 70/325 (21%), Positives = 113/325 (34%), Gaps = 88/325 (27%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
RY + LG G G V A D D A+K +I+ REI ++ L
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLD 66
Query: 73 HPNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRK 118
H N+V++ E+L +Y+V EY+ +L + +G L E R
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARL 124
Query: 119 LFQQLIDGL---------------ENILLDSKG-NIKISDFGLS-ALPQHFRDDGLLHTT 161
QL+ GL N+ ++++ +KI DFGL+ + H+ G L
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL--- 181
Query: 162 CGSPNYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPF------------ 202
+ +P + L+ Y A D+W+ G I +LTG F
Sbjct: 182 ---SEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 203 -------DDRNLAVLYQKIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKR 244
+ + L I +S A + L +IL +P+ R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297
Query: 245 ITIAGIKADEWFEQDYTPANPDDDE 269
+T + + P DE
Sbjct: 298 LTAEEALSHPYMSIYSFP----MDE 318
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 55/244 (22%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
R +G+G+FG V ++ + + A+K L +RI ++ + RE ++ L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH 81
Query: 74 PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
PNV+ L + L + +++L Y+ G+L ++ + + LI
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDL------LQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 126 GLE---------------NILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTTCG 163
G+E N +LD +K++DFGL+ L
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL----- 190
Query: 164 SPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF 219
P V A E L + SD+WS GV+L+ +LT G P+ + L + +G
Sbjct: 191 -P--VKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-R 245
Query: 220 KLPK 223
+LP+
Sbjct: 246 RLPQ 249
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 82/334 (24%), Positives = 129/334 (38%), Gaps = 83/334 (24%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y +G G +G V A D SG A+K L + I K + RE+ LK ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELLLLKHMQ 81
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H NV+ L +V S Y+V+ ++ +L + + E + + L Q++ G
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKG 138
Query: 127 L---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 168
L N+ ++ +KI DFGL+ R T YV
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTR 187
Query: 169 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 215
APEV L+ Y+ DIWS G I+ +LTG F ++ +I
Sbjct: 188 WYRAPEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 216 ---------------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252
R DF P+ SP A +LL K+LE + KR+T A
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLTAAQALT 305
Query: 253 DEWFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 284
+FE P + ++ D +++E ++ E
Sbjct: 306 HPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEW 339
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 60/246 (24%), Positives = 92/246 (37%), Gaps = 62/246 (25%)
Query: 17 ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
LG+ LGEG FG V Q+ + L AVK + K + ++ E A +K H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 74 PNVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI---- 124
PNV+RL K ++L ++ G+L + RL+ Q L+
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154
Query: 125 ---DGLE---------------NILLDSKGNIKISDFGLSALPQHFRD-----------D 155
G+E N +L + ++DFGLS +
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208
Query: 156 GLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 211
+ P V A E LA+R Y SD+W+ GV ++ I T G P+ +Y
Sbjct: 209 AKM------P--VKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 212 QKIFRG 217
+ G
Sbjct: 260 DYLLHG 265
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 63/313 (20%), Positives = 109/313 (34%), Gaps = 79/313 (25%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L R LG G FG+V + S L AVK L + ++ E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI------ 124
H N+VR V ++++E + GG+L + R + ++ L L+
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDI 149
Query: 125 -DGLE---------------NILLDSKGN---IKISDFGLSALPQHFRD----------- 154
G + N LL G KI DFG++ RD
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKGG 203
Query: 155 DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 210
+L P V PE + +D WS GV+L+ I + GY+P+ ++ +
Sbjct: 204 CAML------P--VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 211 YQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA------------DEWF 256
+ + G ++ PK ++ + + P R A I +
Sbjct: 255 LEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
Query: 257 EQDYTPANPDDDE 269
+Y P ++++
Sbjct: 314 PIEYGPLVEEEEK 326
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 56/262 (21%), Positives = 89/262 (33%), Gaps = 77/262 (29%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
LGE FGKV + A+K L+ ++ E
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK------AEGPLREEFRHEAML 65
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
L+HPNVV L V+ + M+ Y + G+L + + S + +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 119 LFQQLI-------DGLE---------------NILLDSKGNIKISDFGLSALPQHFRD-- 154
+ G+E N+L+ K N+KISD GL R+
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVY 179
Query: 155 ---------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 201
+ LL P + APE + + SDIWS GV+L+ + + G P
Sbjct: 180 AADYYKLLGNSLL------P--IRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQP 230
Query: 202 FDDRNLAVLYQKIFRGDFKLPK 223
+ + + + I LP
Sbjct: 231 YCGYSNQDVVEMIRNR-QVLPC 251
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 62/250 (24%), Positives = 98/250 (39%), Gaps = 60/250 (24%)
Query: 18 LGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLK-L 70
+GEGNFG+V A+ + A+K +++ + E+ L L
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY------ASKDDHRDFAGELEVLCKL 82
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQ 121
HPN++ L + +Y+ +EY G L D + + + L Q
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 122 QLID-------GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLH 159
QL+ G++ NIL+ KI+DFGLS R +
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYV 196
Query: 160 TTCGS--PNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 213
P V A E L Y SD+WS GV+L+ I++ G P+ A LY+K
Sbjct: 197 KKTMGRLP--VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 214 IFRGDFKLPK 223
+ +G ++L K
Sbjct: 254 LPQG-YRLEK 262
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 65/317 (20%), Positives = 111/317 (35%), Gaps = 87/317 (27%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L R LG G FG+V + S L AVK L + ++Q + E
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV------CSEQDELDFLMEALI 127
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI-- 124
+ H N+VR V +++LE + GG+L + R + ++ L L+
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHV 186
Query: 125 -----DGLE---------------NILLDSKGN---IKISDFGLSALPQHFRD------- 154
G + N LL G KI DFG++ RD
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYY 240
Query: 155 ----DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 206
+L P V PE + +D WS GV+L+ I + GY+P+ ++
Sbjct: 241 RKGGCAML------P--VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 207 LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA------------ 252
+ + + G ++ PK ++ + + P R A I
Sbjct: 292 NQEVLEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350
Query: 253 DEWFEQDYTPANPDDDE 269
+ +Y P ++++
Sbjct: 351 NTALPIEYGPLVEEEEK 367
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 70/348 (20%), Positives = 128/348 (36%), Gaps = 105/348 (30%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILE----KNRIIHLKITDQIKREIATLK 69
R+++ R G+G FG V+ ++ +G+ A+K +++ +NR + + + L
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL---------QIMQDLA 74
Query: 70 LLKHPNVVRLHEVLASKSK-------IYMVLEYV--TGGELFDKIASKGRLQEAEGRKLF 120
+L HPN+V+L + + + +V+EYV T + K+F
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 121 Q-QLIDGL-----------------ENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTT 161
QLI + N+L++ + G +K+ DFG + + + +
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAYI 192
Query: 162 CGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-- 218
C S Y APE++ + Y A DIWS G I ++ G + IFRGD
Sbjct: 193 C-SRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG-------------EPIFRGDNS 237
Query: 219 ----------------------------FKLPKW---------------LSPGAQNLLRK 235
L + A +LL
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 236 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHE 283
+L+ P +R+ +F++ + PA + +D+ D F +E
Sbjct: 298 LLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNE 345
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 56/275 (20%), Positives = 97/275 (35%), Gaps = 58/275 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
Y + +G G++G V A D ++ A+K + + +I K +I REI L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREITILNRLK 83
Query: 73 HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
++RL++++ +Y+VLE +L + L E + + L+ G
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 128 E---------------NILLDSKGNIKISDFGLS-----------ALPQHFRDDGLLHTT 161
N LL+ ++K+ DFGL+ ++ H
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 162 CGSP---NYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 211
++V APE+ L Y + DIWS G I +L +
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTN--R 259
Query: 212 QKIFRGDFKLPKWLSPGAQNL--------LRKILE 238
+F G P ++ + L I
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 64/339 (18%), Positives = 116/339 (34%), Gaps = 81/339 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITD--QIKREIA 66
Y + R + G++G V D G+P A+K + ++ REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 67 TLKLLKHPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLF 120
L HPN++ L ++ + +Y+V E + +L I + + +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140
Query: 121 QQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
++ GL NILL +I I DF L+ + D
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANK------T 191
Query: 166 NYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL 210
+YV APE+ + +G+ D+WS G ++ + F + V+
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250
Query: 211 ------------------YQKIFRGDFKLPKW------LSPGAQNLLRKILEPNPVKRIT 246
Y + + W P A +L+ K+LE NP +RI+
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
Query: 247 IAGIKADEWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 284
+FE + P + + E D ++++
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDM 349
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 9e-20
Identities = 49/225 (21%), Positives = 78/225 (34%), Gaps = 52/225 (23%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE--IATLKLLKHP 74
+L +G G +G V LD P AVK+ E I + L++H
Sbjct: 16 KLLELIGRGRYGAVYKGS-LD-ERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHD 67
Query: 75 NVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE- 128
N+ R + + +V+EY G L + S +L + GL
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 129 -----------------------NILLDSKGNIKISDFGLS------ALPQHFRDDGLLH 159
N+L+ + G ISDFGLS L + +D
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 160 TTCGSPNYVAPEVL------ANRGYDGATSDIWSCGVILYVILTG 198
+ G+ Y+APEVL + D+++ G+I + I
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 57/233 (24%), Positives = 88/233 (37%), Gaps = 67/233 (28%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------QIKREI 65
RYE+ +G G++G V A D A+K KI +I REI
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK----------KILRVFEDLIDCKRILREI 103
Query: 66 ATLKLLKHPNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
A L L H +VV++ +++ K ++Y+VLE + + L E + L
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL 162
Query: 121 QQLIDGL---------------ENILLDSKGNIKISDFGLS-----------ALPQHFRD 154
L+ G+ N L++ ++K+ DFGL+ LP R+
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 155 DGLLHTTCGSPN--------YV------APEV-LANRGYDGATSDIWSCGVIL 192
D + T +V APE+ L Y A D+WS G I
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIF 274
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 71/331 (21%), Positives = 128/331 (38%), Gaps = 87/331 (26%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD------ATEKDLSDLISEM 125
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 117 RKL-FQQLID-------GLE---------------NILLDSKGNIKISDFGLSALPQHFR 153
+L + L+ G+E N+L+ +KI+DFGL+ R
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------R 239
Query: 154 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 198
D +G L P V APE L +R Y SD+WS GV+L+ I T G
Sbjct: 240 DIHHIDYYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLG 290
Query: 199 YLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256
P+ + L++ + G ++ P + ++R P +R T + E
Sbjct: 291 GSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV--EDL 347
Query: 257 EQDYTPANPDDDEEDIFVDNEAFSMHEVPSD 287
++ ++E + + +++P+
Sbjct: 348 DRIVALT---SNQEMGYYHHHHHHDYDIPTT 375
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 63/265 (23%), Positives = 108/265 (40%), Gaps = 80/265 (30%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 137
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + + +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 117 RKL-FQQLID-------GLE---------------NILLDSKGNIKISDFGLSALPQHFR 153
++ F+ L+ G+E N+L+ +KI+DFGL+ R
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------R 251
Query: 154 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 198
D +G L P V APE L +R Y SD+WS GV+++ I T G
Sbjct: 252 DINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLG 302
Query: 199 YLPFDDRNLAVLYQKIFRGDFKLPK 223
P+ + L++ + G ++ K
Sbjct: 303 GSPYPGIPVEELFKLLKEG-HRMDK 326
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 67/262 (25%), Positives = 100/262 (38%), Gaps = 80/262 (30%)
Query: 17 ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
LG+TLGEG FGKV A L + AVK+L++N + E
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN------ASPSELRDLLSEFNV 79
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
LK + HP+V++L+ + + +++EY G L + L
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 112 QEAEGRKL-FQQLI-------DGLE---------------NILLDSKGNIKISDFGLSAL 148
+ R L LI G++ NIL+ +KISDFGLS
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-- 197
Query: 149 PQHFRDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVIL 196
RD ++ +YV A E L + Y SD+WS GV+L+ I+
Sbjct: 198 ----RD---VYEE---DSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIV 246
Query: 197 T-GYLPFDDRNLAVLYQKIFRG 217
T G P+ L+ + G
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTG 268
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 68/368 (18%), Positives = 122/368 (33%), Gaps = 110/368 (29%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
RY L R LG G+F V A+D+ + A+KI+ ++ T+ + EI L+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74
Query: 73 ----------HPNVVRLHEVLASKSKIY----MVLEYVTGGELFD--KIASKGRLQEAEG 116
++++L + K MV E V G L K +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133
Query: 117 RKLFQQLIDGL----------------ENILLD------SKGNIKISDFGLSALPQHFRD 154
+++ +QL+ GL EN+L++ + IKI+D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188
Query: 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--- 211
D + + Y +PEVL + DIWS +++ ++TG F+
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 212 ------------------------QKIF--RGDFK---------LPKWLSPGAQ------ 230
+ F RG + L L+ +
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 231 ----NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPS 286
+ L +L+ +P KR G+ W ++ + ++ E+
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWL------------KDTLGMEEIRVPDRELYG 355
Query: 287 DGGRTPGS 294
G PG
Sbjct: 356 SGSDIPGW 363
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYE+ +G+G+FG+V A D A+KI+ KN +Q + E+ L+L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNK 109
Query: 74 P------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLID 125
+V L ++ + +V E + L+D + + + RK QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 126 GL-----------------ENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166
L ENILL + IKI DFG S+ R ++ S
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR----IYQYIQSRF 223
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 202
Y +PEVL YD A D+WS G IL + TG F
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLF 258
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 63/265 (23%), Positives = 108/265 (40%), Gaps = 80/265 (30%)
Query: 17 ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
LG+ LGEG FG+V A + AVK+L+ + T++ E+
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 91
Query: 66 ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
+K++ KH N++ L +Y+++EY + G L + + +
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 117 RKL-FQQLI-------DGLE---------------NILLDSKGNIKISDFGLSALPQHFR 153
++ F+ L+ G+E N+L+ +KI+DFGL+ R
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------R 205
Query: 154 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 198
D +G L P V APE L +R Y SD+WS GV+++ I T G
Sbjct: 206 DINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLG 256
Query: 199 YLPFDDRNLAVLYQKIFRGDFKLPK 223
P+ + L++ + G ++ K
Sbjct: 257 GSPYPGIPVEELFKLLKEG-HRMDK 280
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 44/222 (19%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYE+ + +G+G+FG+V A D A+K++ +N + Q EI L+ L+
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RN---EKRFHRQAAEEIRILEHLRK 152
Query: 74 ------PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ 121
NV+ + E ++ I M E + L++ I K + Q G RK
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELI-KKNKFQ---GFSLPLVRKFAH 207
Query: 122 QLIDGL---------------ENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164
++ L ENILL + IK+ DFG S + ++T S
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-----CYEHQRVYTYIQS 262
Query: 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 206
Y APEV+ Y D+WS G IL +LTGY +
Sbjct: 263 RFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGED 303
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 56/264 (21%), Positives = 97/264 (36%), Gaps = 84/264 (31%)
Query: 17 ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
E R +GEG FG+V A L PF AVK+L++ + ++ RE A
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE------ASADMQADFQREAAL 103
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
+ +PN+V+L V A + ++ EY+ G+L ++++ R+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 112 QEAEGRKL-FQQLI-------DGLE---------------NILLDSKGNIKISDFGLSAL 148
L + + G+ N L+ +KI+DFGLS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS-- 221
Query: 149 PQHFRD-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYV 194
R+ + + P + PE + Y SD+W+ GV+L+
Sbjct: 222 ----RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRYTTE-SDVWAYGVVLWE 268
Query: 195 ILT-GYLPFDDRNLAVLYQKIFRG 217
I + G P+ + + G
Sbjct: 269 IFSYGLQPYYGMAHEEVIYYVRDG 292
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 76/360 (21%), Positives = 125/360 (34%), Gaps = 96/360 (26%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
+YEL + LG+G +G V + D +G AVK + + + REI L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELS 66
Query: 73 -HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-- 127
H N+V L VL + + +Y+V +Y+ +L I + L+ + + QLI +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKY 124
Query: 128 -------------ENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPN------- 166
NILL+++ ++K++DFGLS + R + +
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 167 -----YV------APEV-LANRGYDGATSDIWSCGVILYVILTG---------------- 198
YV APE+ L + Y D+WS G IL IL G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 199 ----------------------YL---------PFDDRNLAVLYQKIFRGDFKLPKWLSP 227
+ ++ K +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI---FVDNEAFSMHEV 284
A +LL K+L+ NP KRI+ + + P + + I DN S+ +
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDY 363
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 64/262 (24%), Positives = 98/262 (37%), Gaps = 78/262 (29%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L R LGEG FGKV + AVK L+ T + RE
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-------TLAARKDFQREAEL 70
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
L L+H ++V+ + V + MV EY+ G+L I G+ ++A+G
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 119 LFQQLI-------DGLE---------------NILLDSKGNIKISDFGLSALPQHFRD-- 154
Q++ G+ N L+ + +KI DFG+S RD
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVY 184
Query: 155 ---------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 201
+L P + PE + R + SD+WS GVIL+ I T G P
Sbjct: 185 STDYYRVGGHTML------P--IRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQP 235
Query: 202 FDDRNLAVLYQKIFRGDFKLPK 223
+ + + + I +G L +
Sbjct: 236 WFQLSNTEVIECITQG-RVLER 256
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 63/261 (24%), Positives = 93/261 (35%), Gaps = 77/261 (29%)
Query: 17 ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
L LGEG FGKV + AVK L++ ++ + RE
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-------SESARQDFQREAEL 96
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--------FDKIASKGRLQEAEGRKL 119
L +L+H ++VR V + MV EY+ G+L D G A G
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 120 FQQLI-------DGLE---------------NILLDSKGNIKISDFGLSALPQHFRD--- 154
QL+ G+ N L+ +KI DFG+S RD
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYS 210
Query: 155 --------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 202
+L P + PE + R + SD+WS GV+L+ I T G P+
Sbjct: 211 TDYYRVGGRTML------P--IRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
Query: 203 DDRNLAVLYQKIFRGDFKLPK 223
+ I +G +L +
Sbjct: 262 YQLSNTEAIDCITQG-RELER 281
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 55/233 (23%), Positives = 88/233 (37%), Gaps = 63/233 (27%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ G+TLG G FGKV A D+ L AVK+L+ H + + E+ + L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD------KIASKGRLQEAEGRKL-FQQL 123
+H N+V L + ++ EY G+L + ++ + L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 124 ID-------GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 161
+ G+ N+LL + KI DFGL+ RD +
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD---IMND 217
Query: 162 CGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 201
NY+ APE + + Y SD+WS G++L+ I + G P
Sbjct: 218 ---SNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNP 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 60/237 (25%), Positives = 87/237 (36%), Gaps = 67/237 (28%)
Query: 17 ELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
G+TLG G FGKV A D+ + AVK+L+ + HL + + E+ L L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYL 83
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL-----------FDKIASKGRLQEAEGRKL 119
H N+V L ++ EY G+L S +++ E
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 120 FQQLID-------GLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGL 157
+ L+ G+ NILL KI DFGL+ RD
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA------RD--- 194
Query: 158 LHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 201
+ NYV APE + N Y SD+WS G+ L+ + + G P
Sbjct: 195 IKND---SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSP 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 62/241 (25%), Positives = 93/241 (38%), Gaps = 74/241 (30%)
Query: 17 ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
+LG+ LG G FG+V A +D AVK+L++ T E+
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------ATHSEHRALMSELKI 83
Query: 68 LKLL-KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGR 117
L + H NVV L + +++E+ G L + K ++
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 118 KL-FQQLID-------GLE---------------NILLDSKGNIKISDFGLSALPQHFRD 154
L + LI G+E NILL K +KI DFGL+ RD
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD 197
Query: 155 DGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 201
++ P+YV APE + +R Y SD+WS GV+L+ I + G P
Sbjct: 198 ---IYKD---PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 250
Query: 202 F 202
+
Sbjct: 251 Y 251
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 60/242 (24%), Positives = 90/242 (37%), Gaps = 72/242 (29%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
E G+ LG G FGKV A + AVK+L++ + + E+ + L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQL 105
Query: 72 -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------------FDKIASKGRLQEAE 115
H N+V L IY++ EY G+L + K +E +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 116 GRKL-FQQLI-------DGLE---------------NILLDSKGNIKISDFGLSALPQHF 152
L F+ L+ G+E N+L+ +KI DFGL+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219
Query: 153 RDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GY 199
RD + + NYV APE L Y SD+WS G++L+ I + G
Sbjct: 220 RD---IMSD---SNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGV 272
Query: 200 LP 201
P
Sbjct: 273 NP 274
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 63/343 (18%), Positives = 110/343 (32%), Gaps = 122/343 (35%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLL 71
+Y LG+TLG G+FG V D++SG FA+K K+ + RE+ +K+L
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK----------KVLQDPRYKNRELDIMKVL 57
Query: 72 KHPNVVRLHEVLASKSK--------------------------------------IYMVL 93
H N+++L + + + +++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 94 EYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGL---------------ENILLDS 134
EYV L + S + QL + +N+L++S
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 135 K-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN--YV------APEVLAN-RGYDGATSD 184
K +K+ DFG + + P+ Y+ APE++ Y + D
Sbjct: 177 KDNTLKLCDFGSA------K-----KLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-D 224
Query: 185 IWSCGVILYVILTGYLPFDDRNLAVLYQKIF-----------------RGDFKLPKW--- 224
+WS G + ++ G F +I + + P
Sbjct: 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284
Query: 225 ---------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
A +LL +IL P RI A +F+
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 58/236 (24%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ + R +G+G FG+V Q +D+ +AVK++ +N K T K E LK +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN---IKKYTRSAKIEADILKKIQN 90
Query: 74 -----PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
N+V+ H + ++ E G L++ I + + +++
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 127 L---------------ENILLDS-------------------------KGNIKISDFGLS 146
L ENILLD IK+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-C 208
Query: 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 202
A + + + Y APEV+ N G+D + SD+WS G +L + TG L F
Sbjct: 209 ATFKSDY----HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLF 259
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 59/225 (26%), Positives = 83/225 (36%), Gaps = 67/225 (29%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHPNVV 77
+GEG FG V + ++ AVK L I + ++K+ EI + +H N+V
Sbjct: 39 MGEGGFGVV-YKGYVN-NTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHENLV 93
Query: 78 RL--------HEVLASKSKIYMVLEYVTGG----ELFDKIASKG-----RLQEAEG--RK 118
L L +Y Y+ G L + R + A+G
Sbjct: 94 ELLGFSSDGDDLCL-----VY---VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN- 144
Query: 119 LFQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-- 161
G+ NILLD KISDFGL+ T
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMTSR 194
Query: 162 -CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 205
G+ Y+APE L RG SDI+S GV+L I+TG D+
Sbjct: 195 IVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 5e-15
Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 52/223 (23%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
+G G FGKV + L G A+K ++ + + EI TL +HP++V L
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102
Query: 82 VLASKSKIYMVLEYVTGGE----LFDKIASKG------RLQEAEG--RKLFQQLIDGLE- 128
++++ ++ +Y+ G L+ RL+ G R GL
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--------GLHY 154
Query: 129 --------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAPE 171
NILLD KI+DFG+S + H + G+ Y+ PE
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLSTVVKGTLGYIDPE 211
Query: 172 VLANRGYDGATSDIWSCGVILYVILTG------YLPFDDRNLA 208
+G SD++S GV+L+ +L LP + NLA
Sbjct: 212 -YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 63/238 (26%), Positives = 85/238 (35%), Gaps = 66/238 (27%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPF-AVKILEKNRIIHLKITDQIKREIATLKLLK 72
RYE+ TLGEG FGKV D +G AVKI+ KN + + + EI L+ L
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN---VDRYCEAARSEIQVLEHLN 69
Query: 73 HP------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLI 124
V++ E I +V E + G +D I G + RK+ Q+
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 125 DGL---------------ENILLDSKGN-------------------IKISDFGLSALPQ 150
+ ENIL IK+ DFG SA
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYD 187
Query: 151 HFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVILTGYLPF 202
H+T V APEV+ G+ D+WS G IL G+ F
Sbjct: 188 DEH-----HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVF 234
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 9e-15
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 49/220 (22%)
Query: 22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
LG G FGKV + L G AVK L++ R Q + E+ + + H N++RL
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 82 VLASKSKIYMVLEYVTGG----ELFDKIASKG------RLQEAEG--RKLFQQLIDGLE- 128
+ ++ +V Y+ G L ++ S+ R + A G R GL
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR--------GLAY 146
Query: 129 -----------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYV 168
NILLD + + DFGL+ L D H T G+ ++
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTHVTTAVRGTIGHI 202
Query: 169 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 208
APE + G +D++ GV+L ++TG FD LA
Sbjct: 203 APE-YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 58/238 (24%), Positives = 83/238 (34%), Gaps = 66/238 (27%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
RYE+ LGEG FGKV D A+KI+ +N K + + EI LK +K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN---VGKYREAARLEINVLKKIK 74
Query: 73 HP------NVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
V + + + + E + G F+ K + R + QL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 125 DGL---------------ENILLDS-------------------KGNIKISDFGLSALPQ 150
L ENIL + +I+++DFG SA
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFD 192
Query: 151 HFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVILTGYLPF 202
H HTT V PEV+ G+ D+WS G IL+ G+ F
Sbjct: 193 HEH-----HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 239
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 72/365 (19%), Positives = 103/365 (28%), Gaps = 128/365 (35%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
GRY + R LG G+F V + D+ A+K+++ T+ EI LK ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRN 92
Query: 73 ----HPN---VVRLHEVLASKSK----IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKL 119
PN VV+L + I MV E V G L I L +K+
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 120 FQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL----- 158
QQ++ GL ENILL + Q
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 159 --------------------------------------HTTCGSPN-YVAPEVLANRGYD 179
T Y + EVL GY+
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271
Query: 180 GATSDIWSCGVILYVILTGYLPFDDRNLAVLY---------------------------Q 212
+DIWS + + + TG F+ + +
Sbjct: 272 -TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330
Query: 213 KIF--RGDFKLPKWLSP-------------------GAQNLLRKILEPNPVKRITIAGIK 251
+ F +GD K L P G + L +LE P KR T A
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
Query: 252 ADEWF 256
W
Sbjct: 391 RHPWL 395
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 4e-09
Identities = 20/106 (18%), Positives = 44/106 (41%), Gaps = 8/106 (7%)
Query: 317 EKEDVSERKIRF------TSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKS 370
E +D R +RF TS+ D++ I ++ ++K L ++
Sbjct: 16 EGKDSKPRSLRFTWSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQD 75
Query: 371 LGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLGL 415
+ EV ++ SL V ++ G ++ + +K++++L L
Sbjct: 76 -SLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL 120
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 46/223 (20%), Positives = 84/223 (37%), Gaps = 52/223 (23%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
++ LGR +G G+FG++ ++ + A+K+ E + H Q+ E ++L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKH----PQLLYESKIYRILQG 61
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
+ + +V++ + G L D R L A+ Q+I+
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD------QMIN 114
Query: 126 GLE---------------NILLDSKGN---IKISDFGLSAL------PQH--FRDDGLLH 159
+E N L+ + I DFGL+ QH +R++
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN---K 171
Query: 160 TTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP 201
G+ Y + V + G + D+ S G +L L G LP
Sbjct: 172 NLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 23/94 (24%), Positives = 36/94 (38%), Gaps = 9/94 (9%)
Query: 17 ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+LG+ LG G FG+V A + AVK+L + E+ L +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 82
Query: 72 -KHPNVVRLH-EVLASKSKIYMVLEYVTGGELFD 103
H NVV L + +++E+ G L
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 31/86 (36%), Positives = 40/86 (46%), Gaps = 26/86 (30%)
Query: 129 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------------APEVLANR 176
NILL K +KI DFGL+ RD P+YV APE + +R
Sbjct: 223 NILLSEKNVVKICDFGLA------RD------IYKDPDYVRKGDARLPLKWMAPETIFDR 270
Query: 177 GYDGATSDIWSCGVILYVILT-GYLP 201
Y SD+WS GV+L+ I + G P
Sbjct: 271 VYT-IQSDVWSFGVLLWEIFSLGASP 295
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 54/242 (22%), Positives = 88/242 (36%), Gaps = 59/242 (24%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+ +G+ +G GNFG+++ ++L + A+K LE + Q+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRA----PQLHLEYRFYKQLGS 63
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
+ +++ MVLE G L D L + R + QLI
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLEL-LGPSLED-------LFDLCDRTFSLKTVLMIAIQLI 115
Query: 125 DGLE---------------NILLDSKGN-----IKISDFGLS------ALPQH--FRDDG 156
+E N L+ GN I I DF L+ +H +R+
Sbjct: 116 SRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 157 LLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQ 212
L G+ Y++ + + G + D+ + G + L G LP L YQ
Sbjct: 176 SL---TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230
Query: 213 KI 214
KI
Sbjct: 231 KI 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 2e-06
Identities = 35/192 (18%), Positives = 61/192 (31%), Gaps = 63/192 (32%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
+ + +GEG FG+V F Q + P A+KI+ + H K ++I EI K
Sbjct: 21 KLQRCEKIGEGVFGEV-F-QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 70 LL---------KHPNVVRLHEV------------------------------LASKSKIY 90
L + + L+ V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDS 134
+VLE+ GG +++ +K A + + QL L N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 135 KGNIKISDFGLS 146
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 4e-06
Identities = 75/474 (15%), Positives = 121/474 (25%), Gaps = 165/474 (34%)
Query: 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
E++Q M Y R + D + V L+ +LK+
Sbjct: 100 TEQRQPSMMTRMYIEQRD---------RLYNDNQVFAKYNVSRLQP----YLKLRQ---- 142
Query: 64 EIATLKLLKHPNVVRLH-------EVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEA 114
A L+L NV+ + +A L Y ++ KI +
Sbjct: 143 --ALLELRPAKNVL-IDGVLGSGKTWVALDV----CLSYKVQCKMDFKIFWLNLKNCNSP 195
Query: 115 EGRKLFQQLIDGLENILLDSKGNIKISDFGLSALPQHF-----RDDGLLHTTCGSPNYVA 169
E +++ L+ +L N S + LL S Y
Sbjct: 196 E------TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK----SKPY-- 243
Query: 170 PE---VLANRGYDGATSDIWS----------CGVILYVILTGYLPFDDRNLAVLYQKIFR 216
VL ++ + C ++ + T + D A I
Sbjct: 244 ENCLLVL-----L----NVQNAKAWNAFNLSCKIL---LTTRFKQVTDFLSAATTTHISL 291
Query: 217 GDFK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA------DEWFEQD 259
L K+L Q+L R++L NP ++ I W D
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP---RRLSIIAESIRDGLATW---D 345
Query: 260 YTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKE 319
D I E+ P++ F LS F
Sbjct: 346 NWKHVNCDKLTTII---ESSLNVLEPAE---------YRKMFD--------RLSVF--PP 383
Query: 320 DVSERKIRFTSNHSAKDLLERI---------EDIVTEMGFRVQKKNGKLKATQEHKPQKS 370
I LL I +V ++ HK S
Sbjct: 384 SA---HI------PTI-LLSLIWFDVIKSDVMVVVNKL----------------HK--YS 415
Query: 371 LGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKL-------SSDLGLPP 417
L I PS+Y+ K + ++R + + S DL P
Sbjct: 416 LVEKQPKESTISI-PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 1e-05
Identities = 62/399 (15%), Positives = 115/399 (28%), Gaps = 120/399 (30%)
Query: 2 VIAEKKQEGMRLGRYELGRTLGEGN--FGKV--KFAQDL----DSGLPFAVKILEKNRII 53
++ + L + + T E K QDL + P + I
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI------- 332
Query: 54 HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE 113
I + I+ +AT KH N +L ++ S L L+
Sbjct: 333 ---IAESIRDGLATWDNWKHVNCDKLTTIIESS------LNV---------------LEP 368
Query: 114 AEGRKLFQQLIDGLENILLDSKGNIKISDFGLSAL--------PQHFRDDGLLHTTCGSP 165
AE RK+F +L + + I LS + + LH
Sbjct: 369 AEYRKMFDRLS-----VFPP---SAHIPTILLSLIWFDVIKSDVMVVVNK--LHKYS--- 415
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 225
L + +T I S +Y+ L L N L++ I + +PK
Sbjct: 416 -------LVEKQPKESTISIPS----IYLELKVKL----ENEYALHRSI-VDHYNIPKTF 459
Query: 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ--DYTPANPDDDEED-----IFVDNEA 278
L P + D++F + N + E +F+D
Sbjct: 460 DSDD-------LIPPYL----------DQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR- 501
Query: 279 FSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF----FEKEDVSERKIR----FTS 330
F ++ D S ++N Q L + + + ER + F
Sbjct: 502 FLEQKIRHDSTAWNASGSILNTLQ--------QLKFYKPYICDNDPKYERLVNAILDFLP 553
Query: 331 NHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQK 369
+ + D++ + ++ + + Q+
Sbjct: 554 KIEENLICSKYTDLLR---IALMAEDEAIFEEAHKQVQR 589
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 53/239 (22%), Positives = 86/239 (35%), Gaps = 55/239 (23%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY LGR +G G+FG + D+ +G A+K+ E + H Q+ E K+++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKH----PQLHIESKIYKMMQG 63
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
+ + A MV+E + G L D R L A+ Q+I
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD------QMIS 116
Query: 126 GLE---------------NILLDSKGN---IKISDFGLSALPQHFRDD-GLLHTT----- 161
+E N L+ + I DFGL+ + +RD H
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA---KKYRDARTHQHIPYRENK 173
Query: 162 --CGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQKI 214
G+ Y + + + G + D+ S G +L G LP Y++I
Sbjct: 174 NLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 59/242 (24%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y++GR +GEG+FG + +L + A+K E R Q++ E T KLL
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDA----PQLRDEYRTYKLLAG 64
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
+ ++ +V++ G L D L + GRK +Q++
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDL-LGPSLED-------LLDLCGRKFSVKTVAMAAKQML 116
Query: 125 DGLE---------------NILL----DSKGN-IKISDFGLS------ALPQH--FRDDG 156
++ N L+ N I + DFG+ QH +R+
Sbjct: 117 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK- 175
Query: 157 LLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQ 212
G+ Y++ + + G + D+ + G + L G LP Y+
Sbjct: 176 --KNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231
Query: 213 KI 214
+I
Sbjct: 232 RI 233
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 28/179 (15%), Positives = 64/179 (35%), Gaps = 44/179 (24%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
++ LG+ +G G FG + A + A +++ + + E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN----GPLFSELKFYQRVAK 92
Query: 74 PNVVRLHEVLASKSKI-------------------YMVLEYVTGGELFDKIASKGRLQEA 114
+ ++ + +MV+E + G +L G +++
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 115 EGRKLFQQLIDGLE---------------NILLDSK--GNIKISDFGLSALPQHFRDDG 156
+L +++D LE N+LL K + ++D+GLS + +G
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS---YRYCPNG 207
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 Length = 126 | Back alignment and structure |
|---|
Score = 39.3 bits (91), Expect = 3e-04
Identities = 14/102 (13%), Positives = 37/102 (36%), Gaps = 7/102 (6%)
Query: 324 RKIRFTSNHSAK---DLLERIEDIVTEMGFRVQKKNG-KLKATQEHKPQKSLGSLSVAAE 379
S+ D++ I ++ +++ L ++L + E
Sbjct: 26 TTENLYFQGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENL--VQWEME 83
Query: 380 VFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQE 420
V ++ SL V ++ G ++ + +K++++L L
Sbjct: 84 VCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKLSGPSS 125
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.97 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.52 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.23 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.2 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.87 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.53 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.33 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.19 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.15 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.04 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 97.84 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.5 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.02 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.67 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 94.49 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 92.53 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 90.87 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 88.44 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 87.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 84.43 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 83.36 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-61 Score=466.30 Aligned_cols=248 Identities=31% Similarity=0.562 Sum_probs=229.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
.+.++|++++.||+|+||+||+|++..+++.||||++++....+....+.+.+|+.+|+.++|||||++++++++++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45678999999999999999999999999999999998765544455688999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+|||||+||+|+++|.+.++++|.+++.|+.||+.|| +|||++.+|++||+|||+|+........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999999989999999999999999997 7999999999999999999976544444
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 235 (426)
....+.|||+.|||||++.+..|+ .++|||||||+||+|++|++||.+.+..+++.++..+.+.+|..+|+++++||.+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 556788999999999999998885 9999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCCChHH------HhcCcCCccC
Q 014359 236 ILEPNPVKRITIAG------IKADEWFEQD 259 (426)
Q Consensus 236 ~L~~dP~~R~t~~~------il~h~w~~~~ 259 (426)
||++||++|||++| |++||||+..
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 99999999999988 5899999763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-61 Score=458.94 Aligned_cols=248 Identities=47% Similarity=0.901 Sum_probs=209.5
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
..+.++|+|++++.||+|+||+||+|++..+|+.||||++++...........+.+|+.+|+.++|||||++++++.+++
T Consensus 7 ~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 7 ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp -------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 45678999999999999999999999999999999999998776555555678999999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|+||||| +|+|.+++..++++++.+++.++.||+.|| +|||++.+|++||+|||+|+....
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 999999999 689999999999999999999999999997 799999999999999999985432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 232 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 232 (426)
.....+.|||+.|||||++.+..|++.++||||+||++|+|++|+.||.+.+...++..+..+.+++|.++|+++++|
T Consensus 165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (275)
T 3hyh_A 165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGL 242 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 334567899999999999999998888999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCccC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
|.+||+.||++|||++|+++||||+..
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHHcCcccccC
Confidence 999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=454.40 Aligned_cols=244 Identities=28% Similarity=0.560 Sum_probs=214.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||+||+|++..+|+.||||++++.... ....+.+.+|+.+|++|+|||||++++++.+++.+|+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 467999999999999999999999999999999999876543 3446789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|||||+||+|+++|..+ ..+++..++.|+.||+.|| +||||+.+|++||+|||+|+.... .
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence 99999999999999754 3579999999999999997 799999999999999999996543 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCCCCCHHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL 233 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li 233 (426)
.....+.|||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..+++.++..+.+ +.+..+|+++.+||
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 2234567999999999999998885 899999999999999999999999999999999888765 46677999999999
Q ss_pred HHccccCcCCCCChHHHhcCcCCccC
Q 014359 234 RKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+||+.||++|||++|+++||||.+.
T Consensus 258 ~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHccCChhHCcCHHHHhcCHHhhcC
Confidence 99999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-58 Score=447.55 Aligned_cols=242 Identities=24% Similarity=0.387 Sum_probs=216.4
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
..+|++++.||+|+||+||+|++..+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999998654322 35688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||||+||+|.+++.. +++++.+++.|+.||+.|| +||||+.+|++||+|||+|+.... ....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCc
Confidence 999999999999976 6799999999999999997 799999999999999999986543 2344
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC---CCCCCCHHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLR 234 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~ 234 (426)
..+.|||+.|||||++.+.+|+ .++|||||||++|||++|++||.+.+..+.+..+..+..+ .+..+|+++++||.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 5678999999999999988885 9999999999999999999999999988888888776432 23458999999999
Q ss_pred HccccCcCCCCChHHHhcCcCCccCCC
Q 014359 235 KILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
+||+.||++|||++|+++||||++...
T Consensus 306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 999999999999999999999987543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=445.26 Aligned_cols=243 Identities=34% Similarity=0.647 Sum_probs=213.8
Q ss_pred cccCEEEeceeeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
..++|++++.||+|+||+||+|++. .+++.||||++++....... ...+.+|+.+|++++|||||++++++.+++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3468999999999999999999984 46789999999865443222 3468899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+|+|||||+||+|.++|.+.+++++.+++.|+.||+.|| +|||++.+|++||+|||+|+....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 178 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-- 178 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--
Confidence 999999999999999999989999999999999999997 799999999999999999985432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
......+.|||+.|||||++.+.+|+ .++|||||||+||+|+||++||.+.+..+++.++.++.+++|..+|+++.+||
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 257 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 23445678999999999999998886 89999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCCC-----hHHHhcCcCCcc
Q 014359 234 RKILEPNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 234 ~~~L~~dP~~R~t-----~~~il~h~w~~~ 258 (426)
.+||++||++||| ++|+++||||+.
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 9999999999998 479999999976
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=452.54 Aligned_cols=397 Identities=35% Similarity=0.638 Sum_probs=299.4
Q ss_pred CchhhcccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcccee
Q 014359 1 MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80 (426)
Q Consensus 1 m~~~~~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 80 (426)
|+......+...+++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~ 82 (476)
T 2y94_A 3 MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82 (476)
T ss_dssp ------CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cchhhccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 34455667778899999999999999999999999999999999999865443334467899999999999999999999
Q ss_pred EEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 81 ~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
+++.+.+.+|+||||++||+|.+++...+++++..++.++.||+.|+ +|||++.++++||+|||+
T Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp EEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccc
Confidence 99999999999999999999999999888999999999999999997 799999999999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCC
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 225 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 225 (426)
+..... .....+.|||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+....+.++..+.+..|..+
T Consensus 163 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 239 (476)
T 2y94_A 163 SNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239 (476)
T ss_dssp CEECCT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTC
T ss_pred hhhccc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccC
Confidence 985432 33456789999999999999888877899999999999999999999999998899999999999999999
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCCC----CCCCcc--c------c---cc--Cccccc-cCC-CCC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN----PDDDEE--D------I---FV--DNEAFS-MHE-VPS 286 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~~----~~~~~~--~------~---~~--~~~~~~-~~~-~~~ 286 (426)
++++.+||.+||+.||.+|||+.++++||||........ +..... + . .. ..+... ... .+.
T Consensus 240 s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 319 (476)
T 2y94_A 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQ 319 (476)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC------------------
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCC
Confidence 999999999999999999999999999999987543211 100000 0 0 00 000000 000 000
Q ss_pred -----------CCCCC------------------------CCCCCcccccceeeccCcCCCCCCc--c----cccccccc
Q 014359 287 -----------DGGRT------------------------PGSPPLINAFQLIGMSSCLDLSGFF--E----KEDVSERK 325 (426)
Q Consensus 287 -----------~~~~~------------------------~~~p~~~~~~~~~~~s~~~~~~~~~--~----~~~~~~~~ 325 (426)
+..+. ...|...........+....++... . .....+.+
T Consensus 320 ~~~~~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~ 399 (476)
T 2y94_A 320 DPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWH 399 (476)
T ss_dssp -------------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEE
T ss_pred CHHHHHHHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceee
Confidence 00000 0000000000000000000000000 0 01234567
Q ss_pred eeeEecCCHHHHHHHHHHHHHHcCcEEEe-eCCeeEEEeecCCCCcccceEEEEEEEEEeCceEEEEEEecCCCchHH
Q 014359 326 IRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVY 402 (426)
Q Consensus 326 ~~f~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd~~e~ 402 (426)
.++.|+..|.+|+..+..+++.+|+.|++ ..+.|+++...+... ..+.|.+++|++.++.+||||++..|+.++|
T Consensus 400 lgi~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~--~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 400 LGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp ESEEECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred ecCccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCC--ceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 88889999999999999999999999987 568888886544333 6778999999999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=447.89 Aligned_cols=241 Identities=24% Similarity=0.394 Sum_probs=216.5
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++++.||+|+||+||+|++..+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++.+.+.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 367999999999999999999999999999999998654322 45688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||||+||+|.+++.. +++++.+++.|+.||+.|| +||||+.+|++||+|||+|+.... ....
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 303 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR 303 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCC
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCcc
Confidence 999999999999975 5799999999999999997 799999999999999999986543 2344
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC---CCCCCCCHHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLR 234 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~ 234 (426)
..+.|||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+..+.+..+..+.. ..+..+|+++++||.
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 5678999999999999988885 999999999999999999999999998888888877643 334568999999999
Q ss_pred HccccCcCCCCChHHHhcCcCCccCC
Q 014359 235 KILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+||+.||++|||++|+++||||++..
T Consensus 383 ~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 383 RLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 99999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-56 Score=425.79 Aligned_cols=240 Identities=25% Similarity=0.468 Sum_probs=207.8
Q ss_pred ccCE-EEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe----CC
Q 014359 13 LGRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KS 87 (426)
Q Consensus 13 ~~~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~ 87 (426)
-|+| ++.+.||+|+||+||+|.+..+++.||||++..... .....+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 3676 778899999999999999999999999999986554 33346789999999999999999999999875 35
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------hheeeCC-CCCEEEeccCCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------ENILLDS-KGNIKISDFGLSALP 149 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------eNILld~-~g~lKl~DFGla~~~ 149 (426)
.+|+|||||+||+|.+++.+.+++++..++.|+.||+.|| +||||+. +|++||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 6899999999999999999888999999999999999997 7999985 899999999999853
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc-cHHHHHHHHHhCCC--CCCCCCC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDF--KLPKWLS 226 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s 226 (426)
. .....+.||||.|||||++.+ .|+ .++|||||||+||+|+||+.||.+. +...++..+..+.. .++..++
T Consensus 183 ~----~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 R----ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred C----CCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 2 344567899999999999875 464 8999999999999999999999764 45566777766543 3456689
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+++.+||.+||+.||++|||++|+++||||++.
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=429.36 Aligned_cols=242 Identities=25% Similarity=0.353 Sum_probs=210.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.++.|++.+.||+|+||+||+|++..+|+.||||+++.+.. ..+|+.+|+.++|||||++++++.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45679999999999999999999999999999999986532 2469999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFGla~~~~~~~~~ 155 (426)
|||||+||+|.++|...+++++..++.|+.||+.|| +||||+.+| .+||+|||+|+........
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999888999999999999999997 799999998 6999999999865432211
Q ss_pred C---ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC---CCCCCCCHHH
Q 014359 156 G---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGA 229 (426)
Q Consensus 156 ~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 229 (426)
. ...+.|||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+...++.++..+.+ .+|+.+|+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 1 22356899999999999998886 899999999999999999999998877777777777664 3577899999
Q ss_pred HHHHHHccccCcCCCCChHHH-------------hcCcCCccCCCC
Q 014359 230 QNLLRKILEPNPVKRITIAGI-------------KADEWFEQDYTP 262 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~i-------------l~h~w~~~~~~~ 262 (426)
.+||.+||++||++|||+.|+ ++|||+.+...|
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 999999999999999999997 578998765433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=428.37 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=210.7
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe------CC
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KS 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~ 87 (426)
++|++++.||+|+||+||+|++..+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 479999999999999999999999999999999976543 33445788899999999999999999999764 36
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|+|||||. |+|++++...+++++.+++.|+.||+.|| +|||++.+|.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999995 68999999989999999999999999997 7999999999999999999865332
Q ss_pred --cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCC---------
Q 014359 153 --RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--------- 221 (426)
Q Consensus 153 --~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------- 221 (426)
.......+.|||+.|||||++.+..+++.++||||+|||+|+|++|++||.+.+..+.+..+......+
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 123345678999999999999988777799999999999999999999999998887777765421111
Q ss_pred ----------------------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 222 ----------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 222 ----------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+.+++++.+||.+||..||++|||++|+|+||||++..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 123689999999999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=443.32 Aligned_cols=246 Identities=26% Similarity=0.453 Sum_probs=216.4
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHH---HHHHHHHhcCCCCCccceeEEEEe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~---~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
..+.+++|++++.||+|+||+||+|++..+|+.||||++++...........+ ++++.+++.++|||||++++++.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 46778999999999999999999999999999999999987544322222333 344677788899999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
.+.+|+|||||+||+|+++|...+++++..++.|+.||+.|| +||||+.+|++||+|||+|+...
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999999999989999999999999999997 79999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc---cHHHHHHHHHhCCCCCCCCCCH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSP 227 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~ 227 (426)
. ....+.||||.|||||++.+...++.++|||||||+||+|++|++||.+. +...++..+....+.+|..+|+
T Consensus 344 ~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 344 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp S----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 2 34567899999999999975433359999999999999999999999764 3456777888889999999999
Q ss_pred HHHHHHHHccccCcCCCCC-----hHHHhcCcCCcc
Q 014359 228 GAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t-----~~~il~h~w~~~ 258 (426)
++++||.+||+.||.+|++ ++||++||||+.
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999998 799999999976
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=407.41 Aligned_cols=242 Identities=26% Similarity=0.390 Sum_probs=209.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
....+|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.+|++++|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 44578999999999999999999875 35788999999754 34446789999999999999999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhC-------------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASK-------------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN 137 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~-------------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~ 137 (426)
++.+|+|||||++|+|.++|... .++++.++..++.|++.|| +||||+.+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 99999999999999999999764 3699999999999999997 6999999999
Q ss_pred EEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHh
Q 014359 138 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFR 216 (426)
Q Consensus 138 lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 216 (426)
+||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..++...+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999854332222233446799999999999998885 99999999999999999 9999999998888888888
Q ss_pred CC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 217 GD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 217 ~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
+. ++.|..+|+++.+||.+||+.||++|||+++| |+|+++
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 75 56788999999999999999999999999999 567754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=404.40 Aligned_cols=243 Identities=23% Similarity=0.377 Sum_probs=191.4
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC---
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 87 (426)
..+++|++++.||+|+||+||+|++..+|+.||||+++... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 34678999999999999999999999999999999997653 3344578999999999999999999999987544
Q ss_pred ---------eEEEEEcccCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEE
Q 014359 88 ---------KIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKI 140 (426)
Q Consensus 88 ---------~~~lVmEy~~gg~L~~~i~~~~~---l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl 140 (426)
.+|+|||||+||+|.+++..... .++..++.++.||+.|| +|||++.+|++||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 37999999999999999987665 45567899999999997 7999999999999
Q ss_pred eccCCCCCCCcccCC----------CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HH
Q 014359 141 SDFGLSALPQHFRDD----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AV 209 (426)
Q Consensus 141 ~DFGla~~~~~~~~~----------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~ 209 (426)
+|||+|+........ ....+.|||+.|||||++.+..|+ .++|||||||++|||++ ||.+... ..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999999865432211 123456899999999999998885 89999999999999996 8876432 23
Q ss_pred HHHHHHhCCCC-CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 210 LYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 210 ~~~~i~~~~~~-~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
....+....++ .+...++.+.+||.+||++||++|||+.|+++||||++.
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 34444443322 112356788999999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=432.05 Aligned_cols=248 Identities=29% Similarity=0.592 Sum_probs=222.9
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 345789999999999999999999999999999999997653 33357789999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCC--CCEEEeccCCCCCCCc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSK--GNIKISDFGLSALPQH 151 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~--g~lKl~DFGla~~~~~ 151 (426)
|+|||||+||+|+++|.. .+++++.+++.|+.||+.|| +|||++.+ |.+||+|||+|+...
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~- 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD- 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC-
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc-
Confidence 999999999999999964 46799999999999999997 79999865 899999999998653
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCCH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 227 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 227 (426)
......+.|||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.+..+.+..+..+.+.++ ..+|+
T Consensus 309 --~~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 309 --PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp --TTSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred --CCCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 34456778999999999999998884 999999999999999999999999999999999988876655 45899
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCCC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 264 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~~ 264 (426)
++++||.+||+.||.+|||++|+++||||+....+..
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence 9999999999999999999999999999998765543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=402.94 Aligned_cols=238 Identities=27% Similarity=0.399 Sum_probs=201.1
Q ss_pred cccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
...+|.+.+.||+|+||+||+|++. .+++.||||+++.. +....+.+.+|+.+|++++|||||++++++.+.
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 4468999999999999999999865 36889999999754 344467899999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhC---------------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKG 136 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~---------------~~l~e~~~~~~~~ql~~al---------------eNILld~~g 136 (426)
+.+|+|||||++|+|.+++... +++++.++..++.|++.|| +||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 9999999999999999999753 3599999999999999997 699999999
Q ss_pred CEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHH
Q 014359 137 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 215 (426)
Q Consensus 137 ~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 215 (426)
++||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..+....+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865443333344567899999999999998885 99999999999999999 999999988888888887
Q ss_pred hC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 216 RG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 216 ~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+ .++.|..+++++.+||.+||+.||++|||+.||+++
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 76 467888999999999999999999999999999765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=400.28 Aligned_cols=240 Identities=25% Similarity=0.367 Sum_probs=210.0
Q ss_pred ccccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
..++++++++.||+|+||+||+|... .+++.||||+++... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 45688999999999999999999863 467899999997543 23335789999999999999999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHH---------------hheeeCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGL---------------ENILLDS 134 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~al---------------eNILld~ 134 (426)
++.+|+|||||++|+|.++|..+ ..+++.++..++.||+.|| +||||++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999643 3589999999999999997 6999999
Q ss_pred CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHH
Q 014359 135 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 213 (426)
Q Consensus 135 ~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 213 (426)
++++||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..++...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999865443333445667999999999999988885 99999999999999998 9999999998888888
Q ss_pred HHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 214 IFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 214 i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+..+. ++.|+.+|+++.+|+.+||+.||++|||+.||+++
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87764 56788899999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=392.65 Aligned_cols=249 Identities=41% Similarity=0.809 Sum_probs=228.4
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
.....+++|++++.||+|+||.||+|.+..+|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 345678999999999999999999999999999999999987543 3344678899999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
..|+||||+++|+|.+++...+++++..++.++.|++.|+ +|||++.++++||+|||++....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~-- 165 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-- 165 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS--
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC--
Confidence 9999999999999999999888999999999999999997 79999999999999999998543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 232 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 232 (426)
........+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+.......+..+.+..|..+++++.+|
T Consensus 166 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 166 -VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244 (328)
T ss_dssp -SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 2344667899999999999999988888999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
|++||+.||.+|||++|+++||||....
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999998654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=403.07 Aligned_cols=239 Identities=24% Similarity=0.379 Sum_probs=194.4
Q ss_pred cccCEEEeceeeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
.-++|++++.||+|+||+||+|++. .+++.||||++.+... ..++.+|+.+|+.+ +||||+++++++.+.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3478999999999999999999874 4678999999865431 45688999999998 6999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC-CCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK-GNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~-g~lKl~DFGla~~~~~ 151 (426)
.+|+|||||+||+|.+++. ++++.+++.|+.||+.|| +|||++.+ +.+||+|||+|+....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999999984 599999999999999997 79999987 8999999999975432
Q ss_pred cc--------------------------CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC-
Q 014359 152 FR--------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD- 204 (426)
Q Consensus 152 ~~--------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~- 204 (426)
.. ......+.|||+.|||||++.+..+++.++||||+|||+|+|++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11 012234678999999999998876667999999999999999999999954
Q ss_pred ccHHHHHHHHHh--------------------------------------CCC----------------CCCCCCCHHHH
Q 014359 205 RNLAVLYQKIFR--------------------------------------GDF----------------KLPKWLSPGAQ 230 (426)
Q Consensus 205 ~~~~~~~~~i~~--------------------------------------~~~----------------~~p~~~s~~~~ 230 (426)
.+..+.+..+.. ... .....+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 333333322211 000 01134789999
Q ss_pred HHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 231 NLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
|||++||+.||++|||++|+++||||++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=391.73 Aligned_cols=237 Identities=24% Similarity=0.359 Sum_probs=191.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..+++++++.||+|+||+||+|++. ..||||+++.... .....+.+.+|+.+|++++|||||++++++.. +.+|+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3468899999999999999999853 3599999975433 34456789999999999999999999998854 56899
Q ss_pred EEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|||||+||+|.+++.. ..++++.++..++.|++.|| +||||++++++||+|||+|+........
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999999975 45799999999999999997 6999999999999999999876543334
Q ss_pred CccccccCCCcccchhhhccC---CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHHhCCC-----CCCCCCC
Q 014359 156 GLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDF-----KLPKWLS 226 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~-----~~p~~~s 226 (426)
....+.+||+.|||||++.+. .| +.++|||||||+||||+||+.||.+.+... ....+..+.. ..|..++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y-~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPF-SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred eeecccccCCCccCHHHhhccCCCCC-CcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 455678999999999999643 35 589999999999999999999998866544 3444444321 2345689
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcCc
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKADE 254 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h~ 254 (426)
+++.+||.+||+.||++|||+.||+++-
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999987653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=392.16 Aligned_cols=239 Identities=26% Similarity=0.379 Sum_probs=203.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCccceeEEEEe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~ 85 (426)
..++|++++.||+|+||+||+|.+..+ ++.||||.+.... .....+.+.+|+.+|++++| ||||+++++|..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 347899999999999999999997643 4679999997643 23335779999999999965 999999999866
Q ss_pred C-CeEEEEEcccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHH---------------hheeeC
Q 014359 86 K-SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGL---------------ENILLD 133 (426)
Q Consensus 86 ~-~~~~lVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~al---------------eNILld 133 (426)
. +.+|+|||||++|+|.++|... ..+++.++..|+.||+.|| +|||++
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 4 5789999999999999999753 3489999999999999997 699999
Q ss_pred CCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccH-HHHH
Q 014359 134 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL-AVLY 211 (426)
Q Consensus 134 ~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~-~~~~ 211 (426)
+++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+. ....
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999865443222334567899999999999998885 99999999999999998 9999998654 4455
Q ss_pred HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 212 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 212 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..+..+ .++.|+.+++++.+||.+||+.||++|||+.||++|
T Consensus 299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 555555 567888999999999999999999999999999988
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=389.28 Aligned_cols=247 Identities=32% Similarity=0.608 Sum_probs=217.7
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
....+++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 346789999999999999999999999999999999999876444444467788999999988 7999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|+||||++||+|.+++...+++++..++.++.||+.|| +|||++.+|++||+|||+|+....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 9999999999999999999888999999999999999997 799999999999999999985322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 232 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 232 (426)
......+.|||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+++..+..+...+|.++++++.+|
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 23345677999999999999888775 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCCh------HHHhcCcCCcc
Q 014359 233 LRKILEPNPVKRITI------AGIKADEWFEQ 258 (426)
Q Consensus 233 i~~~L~~dP~~R~t~------~~il~h~w~~~ 258 (426)
|++||+.||.+||++ ++|++||||+.
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 999999999999998 89999999976
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=382.55 Aligned_cols=245 Identities=31% Similarity=0.612 Sum_probs=223.5
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
+.+++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45789999999999999999999999999999999998654333334577899999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+||||++||+|.+++...+.+++..++.++.||+.|| +|||++.+|++||+|||+++.... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 9999999999999999888999999999999999997 799999999999999999985322 23
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 235 (426)
....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+....+..+..+...+|..+++++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 345678999999999999888774 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCC-----ChHHHhcCcCCcc
Q 014359 236 ILEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 236 ~L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
||+.||++|| +++++++||||..
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 8999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=377.04 Aligned_cols=243 Identities=31% Similarity=0.689 Sum_probs=222.8
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+
T Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 45789999999999999999999999999999999999875433333467788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||++||+|.+++...+.+++..++.++.||+.|| +|||++.+|.+||+|||+++...
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~---- 157 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---- 157 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS----
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC----
Confidence 99999999999999999888999999999999999997 79999999999999999998532
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 234 (426)
....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+....+..+..+...+|..+++++.+||.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 158 -DVTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 235 (318)
T ss_dssp -SCBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred -CccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 234567999999999999988775 899999999999999999999999999999999999999999999999999999
Q ss_pred HccccCcCCCC-----ChHHHhcCcCCcc
Q 014359 235 KILEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 235 ~~L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
+||..||++|| +++++++||||+.
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 99999999999 9999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=389.96 Aligned_cols=247 Identities=45% Similarity=0.857 Sum_probs=221.4
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
...+|+|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45789999999999999999999999999999999999865433333346789999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+ +|+|.+++...+++++..++.++.||+.|+ +|||++.++++||+|||++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 9999999 789999998888999999999999999997 799999999999999999986433
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 234 (426)
.....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+....+..+..+.+.+|..+++++.+||+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 33456779999999999999888777899999999999999999999998776666666666777889999999999999
Q ss_pred HccccCcCCCCChHHHhcCcCCccCC
Q 014359 235 KILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+||+.||.+|||++|+++||||+...
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHHhChhhccCC
Confidence 99999999999999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=383.26 Aligned_cols=247 Identities=32% Similarity=0.583 Sum_probs=222.1
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCe
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 88 (426)
...+++|++++.||+|+||+||+|++..+++.||||++++.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 56789999999999999999999999999999999999875433333356788899999877 89999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+|+||||++||+|.+++...+++++..++.++.||+.|| +|||++.+|++||+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-- 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc--
Confidence 999999999999999999888999999999999999997 799999999999999999985322
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
......+.|||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+..+.+.+|.++++++.+||
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 22345678999999999999988874 89999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCCChH-HHhcCcCCccC
Q 014359 234 RKILEPNPVKRITIA-GIKADEWFEQD 259 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~-~il~h~w~~~~ 259 (426)
.+||+.||++||++. +|++||||...
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcCCHhHcCCChHHHHcCccccCC
Confidence 999999999999998 99999999763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=385.46 Aligned_cols=247 Identities=29% Similarity=0.570 Sum_probs=218.0
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
....+++|++++.||+|+||+||+|++..+++.||||++++.........+.+.+|..+++++ +||||+++++++.+.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 456788999999999999999999999999999999999876555444456788999999887 8999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|+||||++||+|.+++...+++++..++.++.||+.|| +|||++.+|++||+|||+|+....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 9999999999999999999888999999999999999997 799999999999999999985322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc---------cHHHHHHHHHhCCCCCCC
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---------NLAVLYQKIFRGDFKLPK 223 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~ 223 (426)
......+.|||+.|+|||++.+..|+ .++|||||||++|+|++|+.||... ....++..+....+.+|.
T Consensus 206 -~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 206 -PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp -TTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred -CCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 23446678999999999999998874 8999999999999999999999632 334577888889999999
Q ss_pred CCCHHHHHHHHHccccCcCCCCCh------HHHhcCcCCcc
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 258 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~------~~il~h~w~~~ 258 (426)
.+++++.+||++||+.||.+||++ ++|++||||+.
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 999999999999999999999995 79999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=379.94 Aligned_cols=250 Identities=33% Similarity=0.593 Sum_probs=221.8
Q ss_pred cccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEE
Q 014359 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 84 (426)
.......+++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|..++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp -------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred CCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 344567889999999999999999999999999999999999875443333457788999999988 7999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
+.+..|+||||++||+|.+++...+++++..++.++.||+.|| +|||++.+|++||+|||+++..
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999999999999888999999999999999997 7999999999999999999853
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHH
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 229 (426)
.. ......+.|||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+...++..+..+.+.+|..+++++
T Consensus 172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 248 (353)
T 2i0e_A 172 IW--DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248 (353)
T ss_dssp CC--TTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cc--CCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 22 23345678999999999999988874 8999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccccCcCCCCC-----hHHHhcCcCCcc
Q 014359 230 QNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t-----~~~il~h~w~~~ 258 (426)
.+||.+||..||.+||+ +++|++||||..
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999999995 699999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=375.03 Aligned_cols=247 Identities=30% Similarity=0.584 Sum_probs=221.6
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
....+++|++++.||+|+||.||+|++..+++.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 345789999999999999999999999999999999999887665666677899999999988 8999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|+||||++||+|.+++...+.+++..++.++.||+.|| +|||++.+|++||+|||+++....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~- 162 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 162 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence 9999999999999999999888999999999999999997 799999999999999999985322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC---------ccHHHHHHHHHhCCCCCCC
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLPK 223 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~ 223 (426)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.. .+....+..+......+|.
T Consensus 163 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 240 (345)
T 3a8x_A 163 -PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT
T ss_pred -CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC
Confidence 2334567799999999999998877 4899999999999999999999975 3345667788888889999
Q ss_pred CCCHHHHHHHHHccccCcCCCCCh------HHHhcCcCCcc
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ 258 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~------~~il~h~w~~~ 258 (426)
.+++++.+||.+||+.||.+||++ +++++||||..
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 999999999999999999999995 89999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=377.62 Aligned_cols=244 Identities=33% Similarity=0.675 Sum_probs=224.3
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
....+++|++++.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34678999999999999999999999999999999999987554333446788999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+|+||||++||+|.+++...+++++..++.++.||+.|| +|||++.+|.+||+|||+++....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence 999999999999999999888999999999999999997 799999999999999999985432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+..+.+.+|..+++++.+||
T Consensus 194 ---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 269 (350)
T 1rdq_E 194 ---RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred ---CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 23467999999999999988875 89999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCCC-----hHHHhcCcCCcc
Q 014359 234 RKILEPNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 234 ~~~L~~dP~~R~t-----~~~il~h~w~~~ 258 (426)
.+||+.||.+||+ +++|++||||..
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 9999999999998 999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=375.24 Aligned_cols=246 Identities=32% Similarity=0.576 Sum_probs=220.1
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
....-++|++++.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 34456789999999999999999999999999999999986543221 124678999999999999999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC----CEEEeccCCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG----NIKISDFGLS 146 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g----~lKl~DFGla 146 (426)
.+.+|+||||++||+|.+++...+.+++..++.++.||+.|+ +|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999999999888999999999999999996 799999887 7999999999
Q ss_pred CCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP---- 222 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---- 222 (426)
..... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+..+.+.++
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eEcCC---CCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 85433 2345567899999999999888774 899999999999999999999999999999999988877765
Q ss_pred CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 223 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
..+++.+.+||.+||..||.+|||+.|+++||||..
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 468999999999999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=375.66 Aligned_cols=247 Identities=35% Similarity=0.608 Sum_probs=214.6
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HhcCCCCCccceeEEEEeCC
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~ 87 (426)
.....++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 35677899999999999999999999999999999999987765544445667778877 57789999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|+||||++||+|.+++...+.+++..++.++.||+.|| +|||++.+|++||+|||+++....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 9999999999999999999888999999999999999997 799999999999999999984322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 232 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 232 (426)
......+.|||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+++..+......+|..+++++.+|
T Consensus 192 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 192 -HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 269 (373)
T ss_dssp -CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHH
T ss_pred -CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Confidence 23345678999999999999988875 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCCh----HHHhcCcCCcc
Q 014359 233 LRKILEPNPVKRITI----AGIKADEWFEQ 258 (426)
Q Consensus 233 i~~~L~~dP~~R~t~----~~il~h~w~~~ 258 (426)
|.+||+.||.+||++ .+|++||||..
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 999999999999997 69999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=368.37 Aligned_cols=248 Identities=38% Similarity=0.662 Sum_probs=211.9
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 578999999999999999999999999999999999755422 224678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||||+++|+|.+++.....+++..++.++.||+.|| +|||++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999999998888899999999999999997 69999999999999999998654333334
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHHhCCCCCC--CCCCHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLL 233 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li 233 (426)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.. ..+..+.......+ ..+++.+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 4557799999999999988887678999999999999999999999876543 33444444433333 44899999999
Q ss_pred HHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 234 RKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
.+||+.||++|||++|+++||||.+...
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhccccc
Confidence 9999999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=374.13 Aligned_cols=248 Identities=27% Similarity=0.514 Sum_probs=221.3
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
.+.+.+++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+|+.++||||+++++++.+.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45567899999999999999999999999999999999998755434444678899999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
..|+||||+.||+|.+++...+.+++..++.++.||+.|| +|||++.+|.+||+|||+|+...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-- 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence 9999999999999999999888999999999999999997 79999999999999999998543
Q ss_pred cCCCccccccCCCcccchhhhccC---CCCCchhhHHHHHHHHHHHhcCCCCCCC---ccHHHHHHHHHhCCCCCCCCCC
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLS 226 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s 226 (426)
......+.+||+.|+|||++.+. +| +.++|||||||++|+|++|+.||.. ......+..+......+|..++
T Consensus 167 -~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 167 -RETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp -TTCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred -CCCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 23445678999999999998742 34 5899999999999999999999974 3456677777788888999999
Q ss_pred HHHHHHHHHccccCcCCCCC-hHHHhcCcCCccC
Q 014359 227 PGAQNLLRKILEPNPVKRIT-IAGIKADEWFEQD 259 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t-~~~il~h~w~~~~ 259 (426)
+.+.+||.+||+.||.+||+ ++++++||||...
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 99999999999999999998 8999999999763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=380.95 Aligned_cols=247 Identities=34% Similarity=0.661 Sum_probs=218.1
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.....++|++++.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 344568999999999999999999999999999999999876532 3335778999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeC---CCCCEEEeccCCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLD---SKGNIKISDFGLSALPQ 150 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld---~~g~lKl~DFGla~~~~ 150 (426)
.|+||||+.||+|.+.+...+.+++..++.++.||+.|| +|||++ .++.+||+|||+|....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999999999989999999999999999997 799998 46789999999998654
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC----CCC
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLS 226 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 226 (426)
. ........+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+....+..+..+.+.+|. .++
T Consensus 165 ~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 241 (444)
T 3soa_A 165 G--EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241 (444)
T ss_dssp T--TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred C--CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence 3 23334567899999999999888774 8999999999999999999999999999999999888766553 489
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+++.+||.+||+.||++|||+.|+++||||...
T Consensus 242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999999999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=382.10 Aligned_cols=246 Identities=31% Similarity=0.609 Sum_probs=213.2
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999865443444456788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+++|+|.+++...+.+++..++.++.||+.|| +|||++.++.+||+|||+|+....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 99999999999999999888999999999999999996 699999999999999999985332
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
........+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+....+..+......+|..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 23345678999999999999888874 89999999999999999999999999999999999999999999999999999
Q ss_pred HHccccCcCCCC-----ChHHHhcCcCCcc
Q 014359 234 RKILEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 234 ~~~L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
.+||+.||.+|| |++|+++||||..
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999 9999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=356.22 Aligned_cols=255 Identities=31% Similarity=0.653 Sum_probs=224.2
Q ss_pred hhhcccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEE
Q 014359 3 IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV 82 (426)
Q Consensus 3 ~~~~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 82 (426)
+++.......+++|++++.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.++||||++++++
T Consensus 3 l~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 82 (284)
T 2vgo_A 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82 (284)
T ss_dssp -------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 45667778899999999999999999999999999999999999976543333335778999999999999999999999
Q ss_pred EEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCC
Q 014359 83 LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 83 ~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~ 147 (426)
+.+.+..|+||||+++|+|.+++...+++++..++.++.|++.|+ +||+++.++.+||+|||++.
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 83 FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence 999999999999999999999999888899999999999999997 69999999999999999987
Q ss_pred CCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCH
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 227 (426)
.... ......+||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+......+|..++.
T Consensus 163 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 2vgo_A 163 HAPS----LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD 237 (284)
T ss_dssp ECSS----SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCH
T ss_pred cCcc----cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCH
Confidence 4332 223456899999999999887774 89999999999999999999999988888888888888889999999
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
.+.+||.+||+.||.+|||+.++++||||+.....
T Consensus 238 ~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence 99999999999999999999999999999875443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=364.23 Aligned_cols=248 Identities=35% Similarity=0.638 Sum_probs=210.7
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCCCccceeEEE
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 83 (426)
......++|++.+.||+|+||.||+|++. .+++.||||++++.... .......+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 44567799999999999999999999985 68999999999865432 222346688999999999999999999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
.+.+..|+||||++||+|.+++...+.+++..++.++.||+.|| +|||++.+|.+||+|||+++.
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999999888899999999999999997 699999999999999999985
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHH
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 228 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 228 (426)
... ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..+......+|..++++
T Consensus 171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 247 (327)
T 3a62_A 171 SIH--DGTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred ccc--CCccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 322 22334567899999999999888774 899999999999999999999999998888999999999999999999
Q ss_pred HHHHHHHccccCcCCCC-----ChHHHhcCcCCcc
Q 014359 229 AQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
+.+||.+||..||++|| ++.++++||||..
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 99999999999999999 8899999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=355.75 Aligned_cols=248 Identities=30% Similarity=0.621 Sum_probs=221.1
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
+..+.+++|++++.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 44678899999999999999999999999999999999997654434444577999999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
..|+||||+++|+|.+++....++++..++.++.||+.|+ +|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 9999999999999999999888899999999999999997 699999999999999999864322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 232 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 232 (426)
......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+....+..+......+|..+++.+.+|
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred ---ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 23345689999999999988776 48999999999999999999999999999999999888999999999999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
|.+||+.||.+|||+.|+++||||....
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCc
Confidence 9999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=368.52 Aligned_cols=242 Identities=36% Similarity=0.678 Sum_probs=217.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34689999999999999999999999999999999986544 33345789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC---CEEEeccCCCCCCCccc
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---NIKISDFGLSALPQHFR 153 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g---~lKl~DFGla~~~~~~~ 153 (426)
||||++||+|.+++.....+++..++.++.||+.|| +|||++.++ .+||+|||++.....
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~-- 183 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 183 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT--
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC--
Confidence 999999999999999888899999999999999997 799998754 599999999986542
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC----CCCHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 229 (426)
.......+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+....+..+..+.+.+|. .+++++
T Consensus 184 -~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 184 -SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp -CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred -CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2334567899999999999888775 8999999999999999999999999988888888888776653 379999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.+||.+||+.||++|||+.++++||||..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=357.58 Aligned_cols=243 Identities=25% Similarity=0.441 Sum_probs=212.4
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
+...++|++.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 445678999999999999999999999999999999997654322 46788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||++||+|.+++... .+++..++.++.|++.|| +|||++.++.+||+|||++..... .
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 169 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--E 169 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--T
T ss_pred EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC--c
Confidence 9999999999999999874 699999999999999997 799999999999999999985433 2
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC---CCCCCCCCCHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQN 231 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ 231 (426)
.......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+.......+... ....|..+++.+.+
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHH
Confidence 2334567899999999999988874 8999999999999999999999988776555444432 23446679999999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
||.+||+.||++|||++|+++||||+..
T Consensus 249 li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=353.86 Aligned_cols=251 Identities=48% Similarity=0.895 Sum_probs=215.9
Q ss_pred ccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..+.+.+++|++++.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 34567789999999999999999999999989999999999765433333457889999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
+..|+||||+++++|.+++...+++++..++.++.|++.|+ +|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999999998888899999999999999997 699999999999999999986433
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 231 (426)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+....+..+..+....|..++..+.+
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 22345668999999999998877766899999999999999999999999888888888888888889999999999
Q ss_pred HHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 232 LLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
||.+||+.||.+|||+.++++||||++..
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=353.41 Aligned_cols=244 Identities=27% Similarity=0.431 Sum_probs=204.8
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 5789999999999999999999999999999999986543 334457888999999999999999999999999999999
Q ss_pred EcccCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+.+ +|.+.+. ..+.+++..++.++.||+.|| +|||++.++.+||+|||++..... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 999976 5655554 467899999999999999997 799999999999999999985432 233
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCC-CCCccHHHHHHHHHhC--CC--------------
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRG--DF-------------- 219 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~P-f~~~~~~~~~~~i~~~--~~-------------- 219 (426)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..| |.+.+.......+... .+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 445678999999999998877556999999999999999987777 5666666655555431 10
Q ss_pred -------------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 220 -------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 220 -------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
..++.+++++.+||.+||+.||++|||++|+++||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 11234789999999999999999999999999999998743
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=361.86 Aligned_cols=241 Identities=26% Similarity=0.481 Sum_probs=216.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 3589999999999999999999999999999999987432 224678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCC--CCCEEEeccCCCCCCCccc
Q 014359 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDS--KGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~--~g~lKl~DFGla~~~~~~~ 153 (426)
||||++||+|.+++... .++++..++.++.||+.|+ +|||++. ++.+||+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 99999999999999765 4799999999999999997 7999997 78999999999985432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 229 (426)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+.+.++ ..+++++
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred -CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 334556789999999999988766 4899999999999999999999999998888899888877765 3689999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+||.+||..||.+|||+.|+++||||.+..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 9999999999999999999999999998643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=359.67 Aligned_cols=244 Identities=34% Similarity=0.604 Sum_probs=216.7
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
...++|++++.||+|+||.||+|.+..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 345789999999999999999999999999999999986543221 12577999999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC----CEEEeccCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG----NIKISDFGLSAL 148 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g----~lKl~DFGla~~ 148 (426)
..|+||||+++|+|.+++...+.+++..++.++.||+.|| +|||++.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999999998888899999999999999997 799999988 899999999985
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CC
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KW 224 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~ 224 (426)
... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+......++ ..
T Consensus 168 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 168 IDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp CCT---TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred CCC---CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 432 2334567899999999999887774 899999999999999999999999888888888877766655 46
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
+++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 8999999999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=375.56 Aligned_cols=247 Identities=27% Similarity=0.502 Sum_probs=212.9
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 45689999999999999999999999999999999998643322222345889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+||||++||+|.+++.. .+.+++..++.++.||+.|| +|||++.+|.+||+|||+|+..... .
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~ 229 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-G 229 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-S
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-C
Confidence 99999999999999987 57899999999999999997 7999999999999999999754321 1
Q ss_pred CCccccccCCCcccchhhhc-----cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCCC---C
Q 014359 155 DGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPK---W 224 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~-----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~---~ 224 (426)
.......+||+.|+|||++. ...| +.++|||||||++|+|++|+.||.+.+..+.+.++... .+.+|. .
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 308 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence 12234579999999999987 3334 58999999999999999999999999988888887653 345554 4
Q ss_pred CCHHHHHHHHHccccCcCC--CCChHHHhcCcCCccC
Q 014359 225 LSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 259 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~--R~t~~~il~h~w~~~~ 259 (426)
+++++++||++||..+|++ |++++++++||||...
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 8999999999999999988 9999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=375.90 Aligned_cols=248 Identities=30% Similarity=0.514 Sum_probs=214.5
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 45678999999999999999999999999999999999764332222234588999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||++||+|.+++.. .++++..++.++.||+.|| +|||++.+|++||+|||+|+..... .
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~-~ 222 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-G 222 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-S
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC-C
Confidence 999999999999999976 5799999999999999997 7999999999999999999854321 1
Q ss_pred CCccccccCCCcccchhhhccCCC---CCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCCC--CCCCH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGY---DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSP 227 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~---~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~ 227 (426)
.....+.+||+.|+|||++.+.+. ++.++|||||||++|+|++|+.||.+.+....+.++..+. +.+| ..+++
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence 112347799999999999987651 3589999999999999999999999999988888887642 4444 46999
Q ss_pred HHHHHHHHccccCcCC--CCChHHHhcCcCCccC
Q 014359 228 GAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 259 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~--R~t~~~il~h~w~~~~ 259 (426)
++++||.+||..+|.+ |+++++|++||||+..
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 9999999999999998 9999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=350.44 Aligned_cols=252 Identities=33% Similarity=0.585 Sum_probs=227.4
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.....++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 89 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 89 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence 34567899999999999999999999999999999999987665555567889999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
.|+||||+++++|.+++.....+++..++.++.|++.|+ +|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~-- 167 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-- 167 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc--
Confidence 999999999999999998888899999999999999997 699999999999999999985432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
........+||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||...+..+.+..+..+....|..+++.+.+||
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 246 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLI 246 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred CccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHH
Confidence 1223445689999999999988776 489999999999999999999999988888888888888889999999999999
Q ss_pred HHccccCcCCCCChHHHhcCcCCccCCCCC
Q 014359 234 RKILEPNPVKRITIAGIKADEWFEQDYTPA 263 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~~~~~~~~ 263 (426)
.+||+.||++|||++++++||||.....+.
T Consensus 247 ~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 247 QKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 999999999999999999999998866543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=365.37 Aligned_cols=243 Identities=38% Similarity=0.746 Sum_probs=203.0
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||.||+|++..+++.||||++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3468999999999999999999999999999999999765432 256889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC--EEEeccCCCCCCCccc
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN--IKISDFGLSALPQHFR 153 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~--lKl~DFGla~~~~~~~ 153 (426)
+||||+++|+|.+++...+++++..++.++.||+.|| +|||++.++. +||+|||+|+...
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~--- 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--- 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence 9999999999999998888999999999999999997 7999998775 9999999998432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc----HHHHHHHHHhCCCCCCC--CCCH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPK--WLSP 227 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s~ 227 (426)
........+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+ .......+......+|. .+++
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 22334566899999999999998887666999999999999999999998743 34555666666666665 4799
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
++.+||.+||+.||++|||+.|+++||||.+..
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 999999999999999999999999999997654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=355.96 Aligned_cols=247 Identities=36% Similarity=0.642 Sum_probs=207.6
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc-----------------------hhHHHHHHHHH
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----------------------LKITDQIKREI 65 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-----------------------~~~~~~~~~Ei 65 (426)
..+.+++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+.+|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 4467899999999999999999999999999999999997654221 11235688999
Q ss_pred HHHhcCCCCCccceeEEEEe--CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------h
Q 014359 66 ATLKLLKHPNVVRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------E 128 (426)
Q Consensus 66 ~il~~l~HpnIv~l~~~~~~--~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------e 128 (426)
.+++.++||||+++++++.+ ....|+||||+++|+|.+++. ..++++..++.++.||+.|| +
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 99999999999999999986 578999999999999988654 46799999999999999997 6
Q ss_pred heeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCC--CCchhhHHHHHHHHHHHhcCCCCCCCcc
Q 014359 129 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRN 206 (426)
Q Consensus 129 NILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~~DIwSlGvil~elltG~~Pf~~~~ 206 (426)
|||++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+.+
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999985433 2233456789999999999976553 3588999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCCC--CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 207 LAVLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 207 ~~~~~~~i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.......+......+| ..+++++.+||.+||+.||++|||+.|+++||||.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 8877777777766555 468999999999999999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=356.39 Aligned_cols=250 Identities=33% Similarity=0.588 Sum_probs=226.7
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 45679999999999999999999999999999999998766555556788999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+||||+.+++|.+++.....+++..++.++.||+.|| +|||++.++.+||+|||++..... ..
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DG 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc--Cc
Confidence 9999999999999998888899999999999999997 699999999999999999985532 12
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 235 (426)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+.+..+..+.+.+|..+++.+.+||.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 23455789999999999988776 48999999999999999999999998888888888888889999999999999999
Q ss_pred ccccCcCCCCChHHHhcCcCCccCCCCC
Q 014359 236 ILEPNPVKRITIAGIKADEWFEQDYTPA 263 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~~~~~~~~ 263 (426)
||+.||++|||++++++||||...+.+.
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HccCChhHCcCHHHHhcCccccCCCccc
Confidence 9999999999999999999999876554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=394.15 Aligned_cols=247 Identities=33% Similarity=0.601 Sum_probs=222.9
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
....+++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 345788999999999999999999999999999999999875443333457788999999988 7999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|+||||++||+|.+++...+++++..++.|+.||+.|| +||||+.+|++||+|||+|+....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 494 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 494 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC-
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc-
Confidence 9999999999999999999888999999999999999997 799999999999999999984322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 232 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L 232 (426)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+++..+..+.+.+|..+++++.+|
T Consensus 495 -~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 572 (674)
T 3pfq_A 495 -DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 572 (674)
T ss_dssp -TTCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHH
T ss_pred -CCcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 23345678999999999999988874 9999999999999999999999999999999999999999999999999999
Q ss_pred HHHccccCcCCCCCh-----HHHhcCcCCcc
Q 014359 233 LRKILEPNPVKRITI-----AGIKADEWFEQ 258 (426)
Q Consensus 233 i~~~L~~dP~~R~t~-----~~il~h~w~~~ 258 (426)
|++||+.||++||++ ++|++||||..
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 999999999999998 99999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=358.77 Aligned_cols=233 Identities=23% Similarity=0.307 Sum_probs=179.9
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC----eE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 89 (426)
.+|.+.+.||+|+||+||+|++ +|+.||||+++... .......+|+..+.+++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4699999999999999999987 68899999997542 11223445677778899999999999997654 58
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------------hheeeCCCCCEEEeccCCC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------------eNILld~~g~lKl~DFGla 146 (426)
|+|||||++|+|.+++.. .++++..+..++.|++.|| +|||||.++++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999986 5699999999999999996 6999999999999999999
Q ss_pred CCCCcccC--CCccccccCCCcccchhhhccCCC-----CCchhhHHHHHHHHHHHhcCCCCCCC---------------
Q 014359 147 ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDD--------------- 204 (426)
Q Consensus 147 ~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~-----~~~~~DIwSlGvil~elltG~~Pf~~--------------- 204 (426)
+....... .......+||+.|||||++.+... ++.++|||||||+||||+||.+||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 85433211 112345689999999999976421 24789999999999999999776532
Q ss_pred ccHHHHHHHHHhCC--CCCCCC-----CCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 205 RNLAVLYQKIFRGD--FKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 205 ~~~~~~~~~i~~~~--~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.....+...+.... +++|.. .+..+.+|+.+||+.||++|||+.||++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12334444444433 334432 23468899999999999999999999764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=378.91 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=219.4
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.....++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 45677999999999999999999999999999999999987654333445778999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
+|+||||++||+|.+++... ..+++..++.|+.||+.|| +|||++.+|++||+|||+++..
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999999763 3699999999999999997 7999999999999999999854
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc----cHHHHHHHHHhCCCCCCCCC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWL 225 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~ 225 (426)
.. ........+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+. +...++..+......+|..+
T Consensus 340 ~~--~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~ 416 (543)
T 3c4z_A 340 KA--GQTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416 (543)
T ss_dssp CT--TCCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cC--CCcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCccc
Confidence 33 12233456999999999999988775 8999999999999999999999875 45677888888888899999
Q ss_pred CHHHHHHHHHccccCcCCCCC-----hHHHhcCcCCcc
Q 014359 226 SPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t-----~~~il~h~w~~~ 258 (426)
++++.+||.+||+.||.+||+ +++|++||||+.
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 999999999999999999996 489999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=361.43 Aligned_cols=243 Identities=32% Similarity=0.613 Sum_probs=209.2
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.-++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3478999999999999999999999999999999997543211 11257789999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC---EEEeccCCCC
Q 014359 90 YMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN---IKISDFGLSA 147 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~al---------------eNILld~~g~---lKl~DFGla~ 147 (426)
|+||||++||+|.+.+... ..+++..++.++.||+.|| +|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999888642 3589999999999999997 7999987665 9999999998
Q ss_pred CCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----C
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----K 223 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~ 223 (426)
.... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+ ...+..+..+.+..+ .
T Consensus 182 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 182 QLGE--SGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp ECCT--TSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHT
T ss_pred EecC--CCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccc
Confidence 5543 22234567899999999999888774 89999999999999999999998854 456677777766554 4
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.+++++.+||.+||+.||++|||+.++++||||..
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 68999999999999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=356.64 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=193.6
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 35789999999999999999999999999999999976542 2224678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 92 VLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
||||++ |+|.+++... ..+++..++.++.||+.|| +|||++.+|.+||+|||++....
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 999997 5999998753 3599999999999999997 79999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CC---------
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF--------- 219 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~--------- 219 (426)
. ........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+... .+
T Consensus 160 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 I--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp S--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred C--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 2 2223456689999999999987554469999999999999999999999988877666555431 00
Q ss_pred -----------------------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCC
Q 014359 220 -----------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 263 (426)
Q Consensus 220 -----------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~ 263 (426)
..+..+++++.+||.+||+.||++|||++|+++||||.+.+.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 01224788999999999999999999999999999999876554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=381.17 Aligned_cols=246 Identities=30% Similarity=0.451 Sum_probs=218.9
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
..+..++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 44677899999999999999999999999999999999987544333345678899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 89 IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
+|+||||++||+|.+++...+ .+++..++.++.||+.|| +|||++.+|++||+|||+|.....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999999998654 499999999999999997 799999999999999999985432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc----cHHHHHHHHHhCCCCCCCCCCH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSP 227 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~ 227 (426)
.......+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+. ....++..+......+|..+++
T Consensus 339 ---~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~ 414 (576)
T 2acx_A 339 ---GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414 (576)
T ss_dssp ---TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred ---CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCH
Confidence 2334567999999999999888775 8999999999999999999999875 3456777777888888899999
Q ss_pred HHHHHHHHccccCcCCCC-----ChHHHhcCcCCcc
Q 014359 228 GAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
++.+||.+||+.||.+|| +++++++||||+.
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 999999999999999999 7899999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=350.65 Aligned_cols=247 Identities=30% Similarity=0.620 Sum_probs=193.1
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
+..+++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 45678999999999999999999999999999999999765433333457899999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+++++|.+++... .++++..++.++.|++.|+ +||+++.++.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP- 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC-
Confidence 9999999999999999865 5799999999999999997 6999999999999999999854321
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 233 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 233 (426)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+.......+....+..|..++.++.+||
T Consensus 166 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 166 -HEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHH
T ss_pred -CCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHH
Confidence 222345689999999999988766 489999999999999999999998877666666666666778888999999999
Q ss_pred HHccccCcCCCCChHHHhcCcCCccC
Q 014359 234 RKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+||+.||++|||++++++||||...
T Consensus 244 ~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHcccCHhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=361.07 Aligned_cols=246 Identities=30% Similarity=0.583 Sum_probs=215.7
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.+...++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+|+.++||||+++++++.+...
T Consensus 46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 3456789999999999999999999999999999999997643 2234678999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCC--CCCEEEeccCCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDS--KGNIKISDFGLSALPQ 150 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~--~g~lKl~DFGla~~~~ 150 (426)
.|+||||++||+|.+++... ..+++..++.++.||+.|| +|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999999999999764 3799999999999999997 7999985 4689999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCC
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 226 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 226 (426)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ ..++
T Consensus 203 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 203 P---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp T---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred C---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence 2 334456789999999999988777 4899999999999999999999999888888888877665443 4589
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
+++.+||.+||+.||.+|||+.++++||||.....
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99999999999999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=370.51 Aligned_cols=247 Identities=24% Similarity=0.447 Sum_probs=211.7
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
....++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|..++..++||||+++++++.+.+..
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999865433333345688999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||++||+|.+++... ..+++..++.|+.||+.|| +|||++.+|++||+|||+++......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999999999874 4799999999999999997 79999999999999999998543211
Q ss_pred CCCccccccCCCcccchhhhcc-------CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCC--
Q 014359 154 DDGLLHTTCGSPNYVAPEVLAN-------RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP-- 222 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~-------~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p-- 222 (426)
.......+||+.|+|||++.. ..| +.++|||||||++|+|++|+.||.+.+..+.+.++... ...+|
T Consensus 217 -~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 217 -TVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp -CEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred -ccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 112345699999999999973 334 58999999999999999999999999988888887653 23334
Q ss_pred -CCCCHHHHHHHHHccccCcCCC---CChHHHhcCcCCccC
Q 014359 223 -KWLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQD 259 (426)
Q Consensus 223 -~~~s~~~~~Li~~~L~~dP~~R---~t~~~il~h~w~~~~ 259 (426)
..+|+++++||++||. +|.+| +++++|++||||...
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 5799999999999999 99998 599999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=342.61 Aligned_cols=244 Identities=36% Similarity=0.671 Sum_probs=217.2
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 45899999999999999999999999999999999986553 33345788999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC---EEEeccCCCCCCCccc
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN---IKISDFGLSALPQHFR 153 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~---lKl~DFGla~~~~~~~ 153 (426)
||||+++|+|.+.+.....+++..++.++.|++.|+ +|||++.++. +||+|||++.....
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~-- 160 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 160 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS--
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc--
Confidence 999999999999998888899999999999999997 6999987765 99999999975432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 229 (426)
.......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+.......+..+....| ..+++++
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 161 -SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp -SCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred -CccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 3334567899999999999888774 899999999999999999999999988888888887766554 3589999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+||.+||+.||++|||++|+++||||....
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999999998743
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=372.90 Aligned_cols=248 Identities=35% Similarity=0.640 Sum_probs=216.2
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch----------hHHHHHHHHHHHHhcCCCCCccc
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----------KITDQIKREIATLKLLKHPNVVR 78 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~HpnIv~ 78 (426)
.+...++|++++.||+|+||+||+|.+..+++.||||++.+...... ...+.+.+|+.+++.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34566899999999999999999999999999999999986543221 23567899999999999999999
Q ss_pred eeEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC---CEEE
Q 014359 79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---NIKI 140 (426)
Q Consensus 79 l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g---~lKl 140 (426)
+++++.+...+|+|||||+||+|.+++...+++++..++.++.||+.|| +|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999999999999888999999999999999996 799999886 6999
Q ss_pred eccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC
Q 014359 141 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 220 (426)
Q Consensus 141 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 220 (426)
+|||+|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|..||.+.+.......+..+.+.
T Consensus 191 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 191 VDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999985433 334566789999999999875 45 58999999999999999999999999999999999988776
Q ss_pred CC----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 221 LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 221 ~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
++ ..+++++.+||++||+.||.+|||++|+++||||+....
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 65 568999999999999999999999999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=349.64 Aligned_cols=245 Identities=32% Similarity=0.566 Sum_probs=217.3
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
....++|++++.||+|+||.||+|.+..+++.||||++........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3456789999999999999999999999999999999986543221 1257799999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC----CEEEeccCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG----NIKISDFGLSA 147 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g----~lKl~DFGla~ 147 (426)
+..|+||||+++++|.+++.....+++..++.++.|++.|| +|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999999888899999999999999997 699999988 89999999998
Q ss_pred CCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----C
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----K 223 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~ 223 (426)
.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+......++ .
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ecCc---cccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 5433 2234566899999999999887774 899999999999999999999999888888888887766655 5
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.+++.+.+||.+||+.||++|||+.++++||||..
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 68999999999999999999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=342.82 Aligned_cols=243 Identities=36% Similarity=0.675 Sum_probs=217.2
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
+...++|++.+.||+|+||.||+|.+..++..||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 345678999999999999999999999999999999998654322 56789999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheee---CCCCCEEEeccCCCCCCCc
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILL---DSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILl---d~~g~lKl~DFGla~~~~~ 151 (426)
|+||||+++++|.+++.....+++..++.++.|++.|+ +|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999999999999888899999999999999997 69999 7889999999999985432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC----CCCH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSP 227 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 227 (426)
.......+||+.|+|||++.+. + +.++|||||||++|+|++|+.||...+.......+..+....|. .+++
T Consensus 162 ---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 162 ---GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ---TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred ---ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 3345567899999999998764 4 58999999999999999999999999888888888888877764 5899
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=360.82 Aligned_cols=248 Identities=21% Similarity=0.361 Sum_probs=205.0
Q ss_pred ccccCEEEeceeeec--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 11 MRLGRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G--~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
...++|++++.||+| +||.||+|++..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456899999999999 999999999999999999999987543 34456788999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
+|+||||+++|+|.+++... ..+++..++.++.||+.|| +|||++.++.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999875 6799999999999999997 799999999999999999864322
Q ss_pred cc-----CCCccccccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC------
Q 014359 152 FR-----DDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------ 218 (426)
Q Consensus 152 ~~-----~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------ 218 (426)
.. ........+||+.|+|||++.+ ..| +.++|||||||++|+|++|+.||.+.+.......+..+.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 11 1122334589999999999987 445 589999999999999999999998755433332222111
Q ss_pred ----------------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 219 ----------------------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 219 ----------------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.+.+..+++.+.+||.+||+.||++|||++|+++||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 1234558899999999999999999999999999999987
Q ss_pred CC
Q 014359 259 DY 260 (426)
Q Consensus 259 ~~ 260 (426)
..
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 54
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=351.72 Aligned_cols=245 Identities=28% Similarity=0.390 Sum_probs=200.5
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
-...++|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++.++||||+++++++.+....
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 346789999999999999999999984 589999999975532 333457788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+++ +|.+.+... .++++..++.++.||+.|| +|||++.++.+||+|||+++....
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-- 171 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-- 171 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC--
Confidence 999999975 888888754 4599999999999999997 799999999999999999985432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh--CCCC-----------
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFK----------- 220 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~----------- 220 (426)
........+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+.. +.+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 223345568999999999998755556999999999999999999999987665544444332 1110
Q ss_pred -----------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 221 -----------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 221 -----------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.++.+++++.+||.+||+.||++|||++|+++||||++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 112367899999999999999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=375.33 Aligned_cols=246 Identities=36% Similarity=0.639 Sum_probs=218.9
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
....++|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34457899999999999999999999999999999999876554444467899999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheee---CCCCCEEEeccCCCCCCCc
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILL---DSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILl---d~~g~lKl~DFGla~~~~~ 151 (426)
|+||||+.+|+|.+++...+++++..++.++.||+.|| +|||+ +.++.+||+|||+|+....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999999999988999999999999999997 79999 5678999999999985432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC--C--CCCH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--K--WLSP 227 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~--~~s~ 227 (426)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+..+....+..+.+.++ . .+++
T Consensus 182 ---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 182 ---SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp ---CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred ---ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 334566789999999999976 45 4899999999999999999999999999889998888865543 3 3899
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
++.+||.+||+.||.+|||+.++++||||+...
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 999999999999999999999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=348.13 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=202.3
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 6899999999999999999999999999999999876532 334457788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|||+++++|.+++...+.+++..++.++.|++.|+ +|||++.++.+||+|||++..... ....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--cccc
Confidence 99999999999998888899999999999999997 699999999999999999985432 2233
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--------------------
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------- 217 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------- 217 (426)
....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 456689999999999987555569999999999999999999999987766554433221
Q ss_pred -CCCCC----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 218 -DFKLP----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 218 -~~~~p----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
..+.| +.+++++.+||.+||+.||.+|||++|+++||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 01111 34788999999999999999999999999999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.04 Aligned_cols=248 Identities=38% Similarity=0.660 Sum_probs=213.1
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 46899999999999999999999999999999999976543 2335789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||||+++++|.+++.....+++..++.++.|++.|| +||+++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999999999998878899999999999999997 69999999999999999998654322223
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHHhCCCCCC--CCCCHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLL 233 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li 233 (426)
.....+||+.|+|||++.+..+.+.++||||+||++|+|++|..||...+.. ..+..+.......+ ..+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 3456789999999999988777668999999999999999999999876543 33444444333333 45899999999
Q ss_pred HHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 234 RKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
.+||+.||++|||++++++||||++...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=360.09 Aligned_cols=238 Identities=35% Similarity=0.628 Sum_probs=208.6
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 89 (426)
...++|++++.||+|+||.||+|.+..+++.||||++.+... ...+|+.++.++ +||||+++++++.+....
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 345789999999999999999999999999999999986542 234688888887 799999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC-C---CEEEeccCCCCCCC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK-G---NIKISDFGLSALPQ 150 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~-g---~lKl~DFGla~~~~ 150 (426)
|+||||++||+|.+++...+.+++..++.++.||+.|| +|||+.++ + .+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999999999888999999999999999997 79998543 3 49999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC---ccHHHHHHHHHhCCCCCC----C
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLP----K 223 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p----~ 223 (426)
. ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+ .+..+++..+..+.+.++ .
T Consensus 172 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 172 A--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp C--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred C--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 3 23345678999999999999887775 899999999999999999999986 456778888888877655 4
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.+++++.+||++||..||++|||+.++++||||..
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 58999999999999999999999999999999965
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=347.72 Aligned_cols=241 Identities=30% Similarity=0.449 Sum_probs=199.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999998 6789999999975532 222246788999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+.+ +|.+++... +++++..++.++.|++.|| +|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--ccc
Confidence 999976 999998764 6799999999999999997 799999999999999999975332 122
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CC---------------
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF--------------- 219 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~--------------- 219 (426)
.....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 3445689999999999987654569999999999999999999999988776655554321 10
Q ss_pred ------------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 220 ------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 220 ------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
..+..+++++.+||.+||+.||++|||++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012347899999999999999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=354.42 Aligned_cols=239 Identities=37% Similarity=0.722 Sum_probs=190.3
Q ss_pred cccCEEEe---ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCC
Q 014359 12 RLGRYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS 87 (426)
Q Consensus 12 ~~~~y~i~---~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 87 (426)
..++|++. +.||+|+||.||+|.+..+++.||||++.+.. ...+.+|+.+++.+. ||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 35778886 78999999999999999999999999997542 467789999999997 999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC---CEEEeccCCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---NIKISDFGLSALP 149 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g---~lKl~DFGla~~~ 149 (426)
..|+||||+++|+|.+++...+++++..++.++.||+.|| +|||++.++ .+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999999988999999999999999997 699998776 7999999999854
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHHHHHhCCCCCC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIFRGDFKLP 222 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~p 222 (426)
.. ........+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+ ..+....+..+.+.++
T Consensus 160 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 160 PP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp CC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred CC--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 33 23345677899999999999888875 89999999999999999999998643 3466777777776665
Q ss_pred C----CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 223 K----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 223 ~----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
. .+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 3 489999999999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=372.45 Aligned_cols=248 Identities=36% Similarity=0.625 Sum_probs=216.0
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
..+...++|++++.||+|+||+||+|.+..+++.||||++.+...... ....+.+|+.+++.++||||+++++++.+..
T Consensus 16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 345567899999999999999999999999999999999976443222 2578899999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeC---CCCCEEEeccCCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLD---SKGNIKISDFGLSALP 149 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld---~~g~lKl~DFGla~~~ 149 (426)
.+|+||||+.+|+|.+.+...+++++..++.++.||+.|| +|||++ .++.+||+|||+|+..
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999999999998888999999999999999996 799995 4567999999999865
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC--C--CC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--K--WL 225 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~--~~ 225 (426)
.. .......+||+.|+|||++.+. | +.++||||+||++|+|++|+.||.+.+..+.+..+..+.+.++ . .+
T Consensus 175 ~~---~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 175 QQ---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp CC---C----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred CC---CCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCC
Confidence 33 3345567899999999999764 5 5899999999999999999999999999888888888765543 3 38
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
|+++.+||.+||+.||.+|||+.++++||||+....
T Consensus 250 s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 999999999999999999999999999999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=361.35 Aligned_cols=247 Identities=29% Similarity=0.362 Sum_probs=196.3
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCC--
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS-- 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-- 87 (426)
..+++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 45689999999999999999999999999999999986543 23444677889999999997 999999999997554
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|+||||+. |+|.+++.. +.+++..++.++.||+.|| +|||++.++.+||+|||+|+.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7899999997 599999976 5799999999999999997 7999999999999999999754321
Q ss_pred -------------------cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH
Q 014359 153 -------------------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 213 (426)
Q Consensus 153 -------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 213 (426)
.........+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0122345578999999999998755456999999999999999999999999887666655
Q ss_pred HHhC--CC---------------------------------------------CCCCCCCHHHHHHHHHccccCcCCCCC
Q 014359 214 IFRG--DF---------------------------------------------KLPKWLSPGAQNLLRKILEPNPVKRIT 246 (426)
Q Consensus 214 i~~~--~~---------------------------------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t 246 (426)
+... .+ ..+..+++++.+||.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 5421 00 011257899999999999999999999
Q ss_pred hHHHhcCcCCccCC
Q 014359 247 IAGIKADEWFEQDY 260 (426)
Q Consensus 247 ~~~il~h~w~~~~~ 260 (426)
++|+++||||....
T Consensus 323 ~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 323 ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHTTSTTTTTTC
T ss_pred HHHHhCCHHHHHhc
Confidence 99999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=341.13 Aligned_cols=245 Identities=36% Similarity=0.611 Sum_probs=207.7
Q ss_pred ccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..++...++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 15 YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp EESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 34566778999999999999999999999999999999999865432 2257899999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheee---CCCCCEEEeccC
Q 014359 87 SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILL---DSKGNIKISDFG 144 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILl---d~~g~lKl~DFG 144 (426)
...|+||||+++|+|.+.+.. ...+++..++.++.||+.|| +|||+ +.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 999999999999999999854 36799999999999999997 69999 456789999999
Q ss_pred CCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC--
Q 014359 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-- 222 (426)
Q Consensus 145 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-- 222 (426)
++..... .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.+...............+
T Consensus 173 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (285)
T 3is5_A 173 LAELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE 247 (285)
T ss_dssp CCCC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-
T ss_pred cceecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc
Confidence 9986433 233456789999999999864 45 5899999999999999999999999888877777666554433
Q ss_pred -CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 223 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 223 -~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
..+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 337899999999999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=353.96 Aligned_cols=240 Identities=33% Similarity=0.636 Sum_probs=194.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 4468999999999999999999999999999999997543 13568899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCC---CCCEEEeccCCCCCCCccc
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDS---KGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~---~g~lKl~DFGla~~~~~~~ 153 (426)
||||+++|+|.+++...+.+++..++.++.||+.|| +|||++. ++.+||+|||+++....
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~-- 203 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-- 203 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc--
Confidence 999999999999999888899999999999999997 6999976 88999999999985432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHHhCCCCCC----CCCCHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP----KWLSPG 228 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~~ 228 (426)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.... ..+..+.......+ ..++.+
T Consensus 204 -~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 204 -QVLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred -ccccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 2334567899999999999887774 8999999999999999999999775543 46677776655433 358999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+.+||.+||+.||++|||+.++++||||....
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999999999999998643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.26 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=198.1
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
.....+++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 456788999999999999999999999999999999999976542 2333467789999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeC-----CCCCEEEeccCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLD-----SKGNIKISDFGLSA 147 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld-----~~g~lKl~DFGla~ 147 (426)
.+|+||||+.+ +|.+++.....+++..++.++.||+.|| +|||++ .++.+||+|||++.
T Consensus 107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99999999975 9999999988999999999999999997 799995 44559999999997
Q ss_pred CCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCC-----
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK----- 220 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~----- 220 (426)
.... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+... .+.
T Consensus 186 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 5432 2233455688999999999987665569999999999999999999999988776665555432 111
Q ss_pred ----CCC-------------------CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 221 ----LPK-------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 221 ----~p~-------------------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+. .+++++.+||.+||+.||++|||++|+++||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 011 167999999999999999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=370.26 Aligned_cols=242 Identities=33% Similarity=0.642 Sum_probs=209.6
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||.||+|++..++..||||++.+...... ....+.+|+.+++.++||||+++++++.+...+|
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 344689999999999999999999999999999999986543222 2467889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC---CCEEEeccCCCCCCCcc
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK---GNIKISDFGLSALPQHF 152 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~---g~lKl~DFGla~~~~~~ 152 (426)
+||||+++|+|.+.+....++++..++.++.||+.|| +|||++.+ +.+||+|||+|.....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~- 191 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN- 191 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT-
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC-
Confidence 9999999999999998888999999999999999997 79999874 4599999999986543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 228 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 228 (426)
.......+||+.|+|||++.+ .| +.++||||+||++|+|++|..||.+.+..+.+..+..+.+.++ ..+++.
T Consensus 192 --~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 192 --QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp --TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred --CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 334556789999999999864 45 5899999999999999999999999999999999988876654 348999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
+.+||.+||+.||.+|||+.++++||||+.
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 999999999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=355.86 Aligned_cols=241 Identities=29% Similarity=0.504 Sum_probs=210.3
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHhcCCCCCccceeEEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 84 (426)
+...++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3456799999999999999999999999999999999986543221 12346778999999999999999999999
Q ss_pred eCCeEEEEEcccCCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 85 SKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg-~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
+.+..|+||||+.+| +|.+++....++++..++.++.||+.|| +|||++.++.+||+|||++..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999999776 9999999888999999999999999997 699999999999999999985
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHH
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 228 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 228 (426)
... .......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..++++
T Consensus 180 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 180 LER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKE 250 (335)
T ss_dssp CCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHH
T ss_pred CCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHH
Confidence 432 33445678999999999999888867899999999999999999999986432 233445667779999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+.+||.+||+.||.+|||++++++||||.+.
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=351.12 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=197.4
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 57899999999999999999999999999999999754321 1122455799999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+. |+|.+++... ..+++..++.++.||+.|| +|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 99997 5999988764 4599999999999999997 699999999999999999985432 223
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCC--------------
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK-------------- 220 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~-------------- 220 (426)
.....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+... .+.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 3455689999999999987555569999999999999999999999998877666555431 110
Q ss_pred --------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 221 --------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 221 --------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
.++.+++++.+||.+||+.||++|||++|+++||||.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 01236889999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=342.80 Aligned_cols=239 Identities=24% Similarity=0.420 Sum_probs=208.6
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48888999999999999999988999999999976532 225678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
|+++|+|.+++.. .++++..+..++.|++.|| +|||++.++.+||+|||++..... ......
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc--Cccccc
Confidence 9999999998865 5799999999999999996 699999999999999999985433 122345
Q ss_pred cccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHc
Q 014359 160 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRKI 236 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~~ 236 (426)
..+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+.....+ .+..+++.+.+||.+|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 67899999999999887764 8999999999999999999999988877777776665432 2335889999999999
Q ss_pred cccCcCCCCChHHHhcCcCCccCC
Q 014359 237 LEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
|+.||++|||+.++++||||.+..
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=367.38 Aligned_cols=242 Identities=27% Similarity=0.421 Sum_probs=198.2
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 86 (426)
..++|++++.||+|+||+||+|.+..+++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4589999999999999999999999999999999998653 2344467889999999999999999999999654
Q ss_pred -CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
..+|+||||+.+ +|.+.+.. .+++..++.++.||+.|| +|||++.++.+||+|||+|+...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 467999999976 67777753 599999999999999997 79999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--C----------
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D---------- 218 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~---------- 218 (426)
. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+... .
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 3345668999999999999998875 8999999999999999999999998877666555431 0
Q ss_pred ----------C-----CCCCC---------------CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 219 ----------F-----KLPKW---------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 219 ----------~-----~~p~~---------------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
+ .+|.. .++++.+||.+||+.||++|||++|+++||||...+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 0 00000 1567999999999999999999999999999986543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=344.69 Aligned_cols=251 Identities=37% Similarity=0.659 Sum_probs=214.3
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc-hhHHHHHHHHHHHHhcCCCCCccceeEEE--EeCC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVL--ASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~ 87 (426)
..+++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 35789999999999999999999999999999999997643221 23457899999999999999999999998 4456
Q ss_pred eEEEEEcccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
..|+||||+.++ |.+.+.. ..++++..++.++.||+.|| +|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 799999999876 7777765 45799999999999999997 69999999999999999998654
Q ss_pred cccCCCccccccCCCcccchhhhccCC-CCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 229 (426)
............||+.|+|||++.+.. +.+.++|||||||++|+|++|+.||.+.+....+..+..+.+.+|..+++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 433334445678999999999987643 3357999999999999999999999999988888999999889999999999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
.+||.+||+.||.+|||+.++++||||.+...+
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 999999999999999999999999999875543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=350.27 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=209.4
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
.+....++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 34566789999999999999999999999999999999998765555566678999999999999999999999987654
Q ss_pred ----eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 88 ----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 88 ----~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
..|+||||++||+|.+++...+++++..++.++.|++.|| +|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 3499999999999999999888999999999999999997 699999999999999999986
Q ss_pred CCcccC-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----C
Q 014359 149 PQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----K 223 (426)
Q Consensus 149 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~ 223 (426)
...... .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...............+ .
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 543221 1223456799999999999888775 899999999999999999999999887777666665544332 4
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+++++.+||.+||+.||.+||++.+++.|+|+...
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 589999999999999999999999999999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=358.55 Aligned_cols=240 Identities=31% Similarity=0.592 Sum_probs=197.1
Q ss_pred CCccccCEEEe-ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-hcCCCCCccceeEEEEe-
Q 014359 9 EGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLAS- 85 (426)
Q Consensus 9 ~~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~- 85 (426)
.+..+++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 34567899997 6899999999999999999999999999642 3567888887 45589999999999876
Q ss_pred ---CCeEEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCC---CCCEEEec
Q 014359 86 ---KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDS---KGNIKISD 142 (426)
Q Consensus 86 ---~~~~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~---~g~lKl~D 142 (426)
...+|+||||++||+|.+++...+ .+++..++.++.||+.|| +|||++. ++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 567999999999999999998753 599999999999999997 6999998 78999999
Q ss_pred cCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH----HHHHHHHhCC
Q 014359 143 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGD 218 (426)
Q Consensus 143 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~ 218 (426)
||+++.... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+.. .....+..+.
T Consensus 208 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 208 FGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp CTTCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred cccccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 999985432 2345678999999999999888775 8999999999999999999999765432 2445566666
Q ss_pred CCCC----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 219 FKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 219 ~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+.+| ..+++++.+||++||+.||.+|||+.++++||||....
T Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 5554 34899999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=350.71 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=206.7
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe----
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS---- 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---- 85 (426)
.-.+++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 34689999999999999999999999999999999999765432 2224567899999999999999999999977
Q ss_pred ----CCeEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 86 ----KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 86 ----~~~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
.+.+|+||||+.+ +|.+.+.. ..++++..++.++.||+.|| +|||++.++.+||+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4568999999975 77777765 35799999999999999997 799999999999999999
Q ss_pred CCCCCccc--CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC
Q 014359 146 SALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK 223 (426)
Q Consensus 146 a~~~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 223 (426)
|....... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......+.
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98654221 2233456789999999999987655569999999999999999999999998877666655432111111
Q ss_pred C--------------------------------CCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 224 W--------------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 224 ~--------------------------------~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
. .++.+.+||.+||+.||++|||++|+++||||.....+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 0 26789999999999999999999999999999875443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.98 Aligned_cols=246 Identities=33% Similarity=0.572 Sum_probs=204.1
Q ss_pred CccccCEEEe-ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 10 GMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 10 ~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
+...++|++. +.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++++ +||||+++++++.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 4456789995 789999999999999999999999999976532 2356789999999985 7999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC---EEEeccCCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN---IKISDFGLSALP 149 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~---lKl~DFGla~~~ 149 (426)
.+|+||||+++|+|.+++.....+++..++.++.||+.|| +|||++.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999999999999888899999999999999997 7999998876 999999999854
Q ss_pred CcccC-----CCccccccCCCcccchhhhcc-----CCCCCchhhHHHHHHHHHHHhcCCCCCCCcc-------------
Q 014359 150 QHFRD-----DGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRN------------- 206 (426)
Q Consensus 150 ~~~~~-----~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~~DIwSlGvil~elltG~~Pf~~~~------------- 206 (426)
..... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 32111 122345679999999999875 334 489999999999999999999997653
Q ss_pred --HHHHHHHHHhCCCCCC----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 207 --LAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 207 --~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
....+..+..+.+.+| ..+++.+.+||.+||+.||++|||++++++||||+..
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2446677777777776 3589999999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=350.57 Aligned_cols=243 Identities=31% Similarity=0.575 Sum_probs=212.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 86 (426)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 36899999999999999999999889999999999764321 122346788999999999 799999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
+..|+||||++|++|.+++.....+++..++.++.||+.|| +|||++.+|.+||+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999999888899999999999999996 699999999999999999985432
Q ss_pred ccCCCccccccCCCcccchhhhccC-----CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP---- 222 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---- 222 (426)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.+.......+..+.+.++
T Consensus 253 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 253 ---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 2334567899999999998642 1235899999999999999999999999888888888887766554
Q ss_pred CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 223 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
..+++.+.+||.+||+.||++|||+.++++||||++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 358899999999999999999999999999999963
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.03 Aligned_cols=244 Identities=32% Similarity=0.611 Sum_probs=212.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
..++|++++.||+|+||.||+|.+..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 34789999999999999999999999999999999986543221 125789999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC----CEEEeccCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG----NIKISDFGLSALP 149 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g----~lKl~DFGla~~~ 149 (426)
.|+||||+++++|.+++.....+++..++.++.|++.|| +||+++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999998888899999999999999997 699999887 8999999999854
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL 225 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 225 (426)
.. .......+||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+.......+.......+ ..+
T Consensus 163 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 163 EA---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp C-----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred cC---CCcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 32 2234456799999999999887764 899999999999999999999999888888887777665554 568
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
++.+.+||.+||..||++|||+.++++||||+..
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.24 Aligned_cols=250 Identities=31% Similarity=0.547 Sum_probs=214.2
Q ss_pred ccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc------chhHHHHHHHHHHHHhcCC-CCCccce
Q 014359 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII------HLKITDQIKREIATLKLLK-HPNVVRL 79 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-HpnIv~l 79 (426)
.......++|++.+.||+|+||.||+|.+..+++.||||+++..... .....+.+.+|+.+++++. ||||+++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 33455679999999999999999999999999999999999754311 1223467889999999995 9999999
Q ss_pred eEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccC
Q 014359 80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFG 144 (426)
Q Consensus 80 ~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFG 144 (426)
++++.+.+..|+||||+++++|.+++.....+++..++.++.||+.|| +||+++.++.+||+|||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999999999999888899999999999999997 69999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCcccchhhhc------cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC
Q 014359 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLA------NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 218 (426)
Q Consensus 145 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~------~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 218 (426)
++..... .......+||+.|+|||++. ...+ +.++|||||||++|+|++|..||.+.+.......+..+.
T Consensus 170 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 170 FSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred chhhcCC---CcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 9985432 23345678999999999985 2334 589999999999999999999999988888888887776
Q ss_pred CCCC----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 219 FKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 219 ~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
...+ ..++..+.+||.+||+.||.+|||+.++++||||++..
T Consensus 246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 5544 24789999999999999999999999999999998643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=343.86 Aligned_cols=245 Identities=31% Similarity=0.392 Sum_probs=199.9
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCC---CCCccceeEEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLK---HPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~ 84 (426)
....++|++.+.||+|+||+||+|++..+++.||||++...... .......+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34568999999999999999999999999999999999754321 1112345677888877765 999999999998
Q ss_pred eCC-----eEEEEEcccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEec
Q 014359 85 SKS-----KIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISD 142 (426)
Q Consensus 85 ~~~-----~~~lVmEy~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~D 142 (426)
... ..|+||||+. |+|.+++..... +++..++.++.||+.|| +|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 765 5899999996 599999987654 99999999999999997 699999999999999
Q ss_pred cCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCC
Q 014359 143 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK 220 (426)
Q Consensus 143 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~ 220 (426)
||+++.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+... .++
T Consensus 164 fg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 164 FGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred CccccccCC---CcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999986532 3344667899999999999888875 8999999999999999999999998877766665432 110
Q ss_pred -------------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 221 -------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 221 -------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
..+.+++.+.+||.+||+.||++|||+.|+++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 013478999999999999999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=340.68 Aligned_cols=241 Identities=35% Similarity=0.655 Sum_probs=212.3
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 345789999999999999999999999999999999986432 12356889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheee---CCCCCEEEeccCCCCCCCcc
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILL---DSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILl---d~~g~lKl~DFGla~~~~~~ 152 (426)
+||||+++++|.+++...+.+++..++.++.|++.|+ +|||+ +.++.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~-- 160 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-- 160 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC--
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC--
Confidence 9999999999999998888899999999999999996 69999 788999999999998532
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 228 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 228 (426)
.......+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+.......+..+.+.++ ..++++
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 161 --NGIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp --CBTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred --CCccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 2234556899999999999887774 899999999999999999999999888888888887765443 458999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+.+||.+||..||.+|||+.++++||||...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=362.50 Aligned_cols=247 Identities=28% Similarity=0.350 Sum_probs=186.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----C
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----S 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 87 (426)
.++|++++.||+|+||+||+|.+..+++.||||++.... ......+.+.+|+.+|+.++||||+++++++... .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999997543 2344467899999999999999999999998443 5
Q ss_pred eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.+|+||||+ +|+|.+++.....+++..++.++.||+.|| +|||++.++.+||+|||+|+.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 799999998 579999999888899999999999999997 7999999999999999999865422
Q ss_pred cCC-------------------------CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc----------
Q 014359 153 RDD-------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT---------- 197 (426)
Q Consensus 153 ~~~-------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt---------- 197 (426)
... ......+||+.|+|||++.....++.++||||||||+|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 110 134556899999999987554444699999999999999999
Q ss_pred -CCCCCCCccH--------------------HHHHHHHHh--CCC-----------------------------CCCCCC
Q 014359 198 -GYLPFDDRNL--------------------AVLYQKIFR--GDF-----------------------------KLPKWL 225 (426)
Q Consensus 198 -G~~Pf~~~~~--------------------~~~~~~i~~--~~~-----------------------------~~p~~~ 225 (426)
|++||.+.+. ...+..+.. +.+ ...+.+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 7777866431 111111110 000 011346
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
++++.+||.+||..||++|||++|+++||||.....
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 899999999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=347.92 Aligned_cols=246 Identities=28% Similarity=0.374 Sum_probs=204.8
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
-..+++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 3567899999999999999999999999999999999876532 334456788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+++++|.+++....++++..++.++.||+.|+ +|||++.++.+||+|||++..... .
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--P 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC--C
Confidence 99999999999999888778899999999999999997 699999999999999999985433 2
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-----------------
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------------- 217 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 217 (426)
.......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 233456789999999999987655568999999999999999999999987765544433211
Q ss_pred --CCCCC------------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 218 --DFKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 218 --~~~~p------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
....| +.+++.+.+||.+||+.||++|||++|+++||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 01111 247899999999999999999999999999999976
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=338.05 Aligned_cols=245 Identities=25% Similarity=0.386 Sum_probs=206.4
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
..-++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 44578999999999999999999999999999999997665555666788999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+||||++||+|.+++...+++++..++.++.|++.|| +|||++.++.+||+|||++...... ..
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SL 166 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-cc
Confidence 9999999999999999888999999999999999997 6999999999999999999865432 11
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-----CCCCCCHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGAQ 230 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~ 230 (426)
......+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+.............+ .+..+++.+.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp --------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred cccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 223456899999999999888774 8999999999999999999999998876655555444322 3456899999
Q ss_pred HHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 231 NLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
++|.+||+.||++||+..+.+.+.|..
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999999777776776643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=356.76 Aligned_cols=249 Identities=26% Similarity=0.340 Sum_probs=197.4
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 86 (426)
..++|++++.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 4579999999999999999999999999999999997543 2344467899999999999999999999999776
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
...|+||||+. |+|.+++.....+++..++.++.||+.|| +|||++.++.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999996 59999999888899999999999999997 799999999999999999986543
Q ss_pred ccCC--------------------CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcC-----------CC
Q 014359 152 FRDD--------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-----------YL 200 (426)
Q Consensus 152 ~~~~--------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG-----------~~ 200 (426)
.... ......+||+.|+|||++.....++.++||||+||++|+|++| .+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2111 2346779999999999975555446999999999999999984 44
Q ss_pred CCCCccH-----------------HHHHHHH------------------------HhCCCCCC-------CCCCHHHHHH
Q 014359 201 PFDDRNL-----------------AVLYQKI------------------------FRGDFKLP-------KWLSPGAQNL 232 (426)
Q Consensus 201 Pf~~~~~-----------------~~~~~~i------------------------~~~~~~~p-------~~~s~~~~~L 232 (426)
+|.+.+. ......+ .......+ +.+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 4444320 1111111 11111111 3489999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
|.+||+.||++|||++|+++||||.....+
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 999999999999999999999999875443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=352.93 Aligned_cols=239 Identities=33% Similarity=0.567 Sum_probs=204.5
Q ss_pred cCEEE--eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 14 GRYEL--GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 14 ~~y~i--~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
+.|++ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45655 678999999999999999999999999998653 2335789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheee--CCCCCEEEeccCCCCCCCccc
Q 014359 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILL--DSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILl--d~~g~lKl~DFGla~~~~~~~ 153 (426)
||||+++|+|.+++... ..+++..++.++.||+.|| +|||+ +.++.+||+|||+++....
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~-- 241 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-- 241 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT--
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC--
Confidence 99999999999998754 4699999999999999997 69999 5678999999999985433
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 229 (426)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......++ ..+++++
T Consensus 242 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 242 -REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp -TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred -ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 233456689999999999987766 4899999999999999999999999988888888887765544 4589999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+||.+||+.||.+|||+.++++||||...
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999999999999763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=350.70 Aligned_cols=241 Identities=28% Similarity=0.373 Sum_probs=198.8
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC------
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 86 (426)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 478999999999999999999999999999999996543 2344467889999999999999999999999765
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..+|+||||+ +++|.+++.. .++++..++.++.||+.|| +|||++.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 3469999999 8899999987 6799999999999999997 699999999999999999985432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CC----------
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF---------- 219 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~---------- 219 (426)
.....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+... .+
T Consensus 181 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 181 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 2445689999999999987444468999999999999999999999988776655554321 10
Q ss_pred -------------------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 220 -------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 220 -------------------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
..+..+++.+.+||.+||+.||.+|||++++++||||.....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 122457899999999999999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=349.60 Aligned_cols=247 Identities=32% Similarity=0.507 Sum_probs=205.9
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
++|++++.||+|+||.||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 6899999999999999999999999999999999765321 23346789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHH----
Q 014359 92 VLEYVTGGELFDKIAS----------------------------------------KGRLQEAEGRKLFQQLIDGL---- 127 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~~~~ql~~al---- 127 (426)
||||++||+|.+++.. ...+++..++.++.||+.||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998852 11246888999999999997
Q ss_pred -----------hheeeCCCC--CEEEeccCCCCCCCcccCC--CccccccCCCcccchhhhccC-CCCCchhhHHHHHHH
Q 014359 128 -----------ENILLDSKG--NIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVI 191 (426)
Q Consensus 128 -----------eNILld~~g--~lKl~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlGvi 191 (426)
+|||++.++ .+||+|||++......... ......+||+.|+|||++.+. ...+.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 699998877 8999999999854332211 124567899999999999752 233589999999999
Q ss_pred HHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 192 LYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 192 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+|+|++|+.||.+.+..+....+......++. .+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999998888888887777654432 3799999999999999999999999999999998743
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=344.89 Aligned_cols=239 Identities=25% Similarity=0.375 Sum_probs=207.1
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++.+.||+|+||.||+|++..+++.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999998655444445678999999999999999999999999999999999
Q ss_pred cccCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||+. |+|.+.+. ...++++..++.++.|++.|| +|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9997 58888875 456799999999999999997 699999999999999999985432
Q ss_pred cccccCCCcccchhhhc---cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC--CCCCCCHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNL 232 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~---~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~L 232 (426)
....+||+.|+|||++. ...+ +.++|||||||++|+|++|+.||.+.+.......+..+..+ .+..+++.+.+|
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 23568999999999985 3444 58999999999999999999999988776666666555432 245689999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
|.+||+.||++|||++++++||||....
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHcccChhhCcCHHHHhhChhhhccC
Confidence 9999999999999999999999997643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=344.84 Aligned_cols=237 Identities=27% Similarity=0.412 Sum_probs=202.2
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----CCCccceeEEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~ 84 (426)
...-++|++++.||+|+||.||+|++..+++.||||++... ........+|+.+++.++ ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 34457999999999999999999999999999999999643 233567788999999996 999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCC-------------
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDS------------- 134 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~------------- 134 (426)
..+..|+||||+ +++|.+++.... ++++..++.++.||+.|| +|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999999 999999998654 599999999999999997 7999986
Q ss_pred ------------CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCC
Q 014359 135 ------------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 202 (426)
Q Consensus 135 ------------~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf 202 (426)
++.+||+|||+|+.... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCC
Confidence 78999999999985322 23467899999999999988875 8999999999999999999999
Q ss_pred CCccHHHHHHHHHhCCCCCCC----------------------------------------------CCCHHHHHHHHHc
Q 014359 203 DDRNLAVLYQKIFRGDFKLPK----------------------------------------------WLSPGAQNLLRKI 236 (426)
Q Consensus 203 ~~~~~~~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~~Li~~~ 236 (426)
.+.+..+....+.....++|. ..++.+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 988776665555433222221 1237788999999
Q ss_pred cccCcCCCCChHHHhcCcCCc
Q 014359 237 LEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h~w~~ 257 (426)
|+.||++|||++|+++||||+
T Consensus 340 L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999995
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=347.18 Aligned_cols=249 Identities=26% Similarity=0.339 Sum_probs=201.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
...++|++++.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 45789999999999999999999999999999999997543221 1122467899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.|+||||+.+ +|.+++... ..+++..++.++.|++.|| +|||++.+|.+||+|||+++....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~- 164 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS- 164 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS-
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC-
Confidence 9999999976 898888764 4699999999999999997 799999999999999999986543
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCC---C------
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK---L------ 221 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~---~------ 221 (426)
........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+..+... .+. +
T Consensus 165 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 -PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp -CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred -CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 2334456789999999999977654568999999999999999999999998877666665432 110 0
Q ss_pred -----------------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 222 -----------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 222 -----------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
...+++++.+||.+||+.||.+|||+.|+++||||.....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 13457899999999999999999999999999999875433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=342.16 Aligned_cols=242 Identities=34% Similarity=0.545 Sum_probs=207.1
Q ss_pred ccCEEEe-ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEE
Q 014359 13 LGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 13 ~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 90 (426)
-++|.+. +.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.+. ||||+++++++.+....|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 3578888 8999999999999999999999999999865432 223577899999999995 699999999999999999
Q ss_pred EEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCC---CCCEEEeccCCCCCCC
Q 014359 91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDS---KGNIKISDFGLSALPQ 150 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~---~g~lKl~DFGla~~~~ 150 (426)
+||||+.+|+|.+++... ..+++..++.++.||+.|| +|||++. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999999998653 6799999999999999997 6999998 7899999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCC
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 226 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 226 (426)
. .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+....+..+.......+ ..++
T Consensus 186 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 186 H---ACELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred C---ccccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence 2 2334567899999999999888775 899999999999999999999999888888777776554433 4589
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+.+.+||.+||+.||.+|||++++++||||+..
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 999999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.63 Aligned_cols=246 Identities=29% Similarity=0.495 Sum_probs=212.8
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--CCe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSK 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~ 88 (426)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 357899999999999999999999999999999999986543 33346789999999999999999999998854 678
Q ss_pred EEEEEcccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHH--------------------hheeeCCCCCEEEeccC
Q 014359 89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGL--------------------ENILLDSKGNIKISDFG 144 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~al--------------------eNILld~~g~lKl~DFG 144 (426)
.|+||||+++|+|.+++... ..+++..++.++.|++.|| +|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999999753 3499999999999999985 69999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCC
Q 014359 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPK 223 (426)
Q Consensus 145 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~ 223 (426)
++..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..+.. .+|.
T Consensus 162 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 238 (279)
T 2w5a_A 162 LARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238 (279)
T ss_dssp HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred hheeecc--ccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence 9975432 11223456899999999999887775 899999999999999999999999888888778777765 5677
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+++++.+||.+||+.||.+|||+.++++|+|+....
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 8999999999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.09 Aligned_cols=241 Identities=22% Similarity=0.303 Sum_probs=202.3
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
.+...++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+..+..+ +||||+++++++.+.+
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 3445689999999999999999999999999999999998654333 3356788999999999 8999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHH---------------hheeeCCCC------------
Q 014359 88 KIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGL---------------ENILLDSKG------------ 136 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~al---------------eNILld~~g------------ 136 (426)
..|+||||+++|+|.+++... ..+++..++.++.||+.|| +|||++.++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999999764 6799999999999999997 699998544
Q ss_pred -------CEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH
Q 014359 137 -------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV 209 (426)
Q Consensus 137 -------~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~ 209 (426)
.+||+|||++..... ....+||+.|+|||++.+....+.++|||||||++|+|++|.+|+...+.
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred cccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 799999999985432 23456999999999998765555899999999999999999988765433
Q ss_pred HHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 210 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 210 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
...+..+ ...+|..+++++.+||.+||+.||++|||+.++++||||...
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 -WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp -HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred -HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 3333444 345677899999999999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=332.51 Aligned_cols=239 Identities=24% Similarity=0.446 Sum_probs=203.8
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe----CCeE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 89 (426)
..|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 358999999999999999999999999999999986543 33446789999999999999999999999875 4568
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------hheeeC-CCCCEEEeccCCCCCCCc
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------ENILLD-SKGNIKISDFGLSALPQH 151 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------eNILld-~~g~lKl~DFGla~~~~~ 151 (426)
|+||||+++|+|.+++.....+++..++.++.||+.|| +|||++ .++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~- 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc-
Confidence 99999999999999999888899999999999999996 699998 78999999999997432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc-cHHHHHHHHHhCCC--CCCCCCCHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDF--KLPKWLSPG 228 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~ 228 (426)
.......+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+. +....+..+..+.. .++...+++
T Consensus 184 ---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 184 ---ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp ---TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ---ccccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 2334567899999999998754 5 58999999999999999999999874 44455555554432 234567899
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+.+||.+||+.||.+|||++++++||||++.
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 9999999999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=346.73 Aligned_cols=244 Identities=29% Similarity=0.424 Sum_probs=206.9
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
+....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 3455689999999999999999999999999999999998653 34446789999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.|+||||+++|+|.+++...+.+++..++.++.|++.|+ +|||++.++.+||+|||++.....
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 999999999999999999888899999999999999986 699999999999999999974322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH--------------------
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ-------------------- 212 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~-------------------- 212 (426)
......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+......
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 223456899999999999888775 89999999999999999999998765543221
Q ss_pred ----------------------HHHhCC-CCCC-CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 213 ----------------------KIFRGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 213 ----------------------~i~~~~-~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+.... ...+ ..++.++.+||.+||+.||++|||++++++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 122222 1222 3478999999999999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=345.42 Aligned_cols=244 Identities=28% Similarity=0.417 Sum_probs=204.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----Ce
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 88 (426)
++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 58999999999999999999999999999999997532 344457889999999999999999999999765 46
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
.|+||||+. |+|.+++.. +++++..++.++.||+.|| +|||++.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 899999997 599999876 5699999999999999997 79999999999999999998654322
Q ss_pred C-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CC-----------
Q 014359 154 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF----------- 219 (426)
Q Consensus 154 ~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~----------- 219 (426)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+... .+
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 223456689999999999776654469999999999999999999999887665554443310 00
Q ss_pred -------------C-----CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 220 -------------K-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 220 -------------~-----~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
. .++.+++++.+||.+||+.||++|||+.|+++||||.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 0 11457899999999999999999999999999999987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=356.24 Aligned_cols=242 Identities=35% Similarity=0.636 Sum_probs=196.1
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----LKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..++|++.+.||+|+||.||+|.+..+++.||||++.+..... ......+.+|+.+|++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3578999999999999999999999999999999998654321 112235889999999999999999999985 4
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC---CEEEeccCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---NIKISDFGLSAL 148 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g---~lKl~DFGla~~ 148 (426)
...|+||||+++|+|.+++...+++++..++.++.|++.|| +|||++.++ .+||+|||+|+.
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 56899999999999999998888999999999999999997 799997655 599999999986
Q ss_pred CCcccCCCccccccCCCcccchhhhcc---CCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHHhCCCCCC--
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLP-- 222 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p-- 222 (426)
... .....+.+||+.|+|||++.+ ..| +.++|||||||++|+|++|+.||.+... ......+..+....+
T Consensus 292 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 292 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp CC--------------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred cCC---CccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 542 334557799999999999864 334 4899999999999999999999986543 344455566655543
Q ss_pred --CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 223 --KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 223 --~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
..+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 458999999999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=348.03 Aligned_cols=248 Identities=31% Similarity=0.582 Sum_probs=211.4
Q ss_pred CccccCEEEeceeeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcC-CCCCccceeEEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 84 (426)
.+.+++|++++.||+|+||.||+|++. .+++.||||++++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 445689999999999999999999985 48999999999754321 112235677899999999 6999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
..+..|+||||+++|+|.+++....++++..++.++.||+.|| +|||++.++.+||+|||+++..
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999999999999888999999999999999997 6999999999999999999854
Q ss_pred CcccCCCccccccCCCcccchhhhccC-CCCCchhhHHHHHHHHHHHhcCCCCCCCc----cHHHHHHHHHhCCCCCCCC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKW 224 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~ 224 (426)
... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||... ....+...+.....++|..
T Consensus 210 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 1vzo_A 210 VAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288 (355)
T ss_dssp CGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence 321 12234456899999999999863 22358999999999999999999999743 3456666777778888899
Q ss_pred CCHHHHHHHHHccccCcCCCC-----ChHHHhcCcCCcc
Q 014359 225 LSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
+++.+.+||.+||..||.+|| |++++++||||..
T Consensus 289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 999999999999999999999 9999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=343.64 Aligned_cols=245 Identities=24% Similarity=0.402 Sum_probs=200.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--CCccceeEEEEeCCeEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIY 90 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~ 90 (426)
-++|++++.||+|+||.||+|.+ .+++.||||++..... .....+.+.+|+.+|+.++| |||+++++++.+....|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 35799999999999999999997 5688999999986543 33445789999999999986 99999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+|||+ .+|+|.+++.....+++..++.++.||+.|| +|||++ ++.+||+|||+++........
T Consensus 86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 99995 5889999999988999999999999999997 799997 688999999999866443223
Q ss_pred CccccccCCCcccchhhhcc-----------CCCCCchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHHHHh--CCCCC
Q 014359 156 GLLHTTCGSPNYVAPEVLAN-----------RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFR--GDFKL 221 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~-----------~~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~--~~~~~ 221 (426)
......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.. .......+.. ....+
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC
Confidence 33456789999999999865 334 589999999999999999999998743 3333444443 34566
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 222 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
|...+.++.+||.+||+.||.+|||+.++++||||+....+
T Consensus 243 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 77888999999999999999999999999999999875443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=349.04 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=202.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC--CCCccceeEEEEeCCeEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~l 91 (426)
.+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++ ||||+++++++...+.+|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 359999999999999999999854 88999999986543 3444678999999999996 5999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||| +.+++|.+++.....+++..++.++.||+.|| +|||++ ++.+||+|||+++.........
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 56889999999888999999999999999997 799995 6899999999998654432223
Q ss_pred ccccccCCCcccchhhhccC----------CCCCchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHHHHhC--CCCCCC
Q 014359 157 LLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPK 223 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~----------~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~p~ 223 (426)
.....+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.. ....+..+... ...+|.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 34567899999999998752 223589999999999999999999998753 33445555543 345678
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
+.+.++.+||.+||+.||.+|||+.|+++||||.....+
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 889999999999999999999999999999999865433
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.34 Aligned_cols=246 Identities=24% Similarity=0.489 Sum_probs=213.6
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchh--------------HHHHHHHHHHHHhcCCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------------ITDQIKREIATLKLLKH 73 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~H 73 (426)
.....+++|++++.||+|+||.||+|.+ +++.||||++......... ..+.+.+|+.+++.++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3456679999999999999999999998 8999999999765432211 12789999999999999
Q ss_pred CCccceeEEEEeCCeEEEEEcccCCCChHHH------HHh--CCCCCHHHHHHHHHHHHHHH----------------hh
Q 014359 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDK------IAS--KGRLQEAEGRKLFQQLIDGL----------------EN 129 (426)
Q Consensus 74 pnIv~l~~~~~~~~~~~lVmEy~~gg~L~~~------i~~--~~~l~e~~~~~~~~ql~~al----------------eN 129 (426)
|||+++++++.+.+..|+||||+++|+|.++ +.. ...+++..++.++.|++.|+ +|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 665 56799999999999999996 69
Q ss_pred eeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccC-CCCCchhhHHHHHHHHHHHhcCCCCCCCccH-
Q 014359 130 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNL- 207 (426)
Q Consensus 130 ILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~- 207 (426)
||++.++.+||+|||++..... ......+||+.|+|||++.+. .+++.++||||+||++|+|++|..||...+.
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 9999999999999999985432 234567899999999999887 4543499999999999999999999998766
Q ss_pred HHHHHHHHhCCCCCC-------------------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 208 AVLYQKIFRGDFKLP-------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 208 ~~~~~~i~~~~~~~p-------------------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
......+..+...+| ..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 777788877777766 5689999999999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=341.69 Aligned_cols=244 Identities=21% Similarity=0.359 Sum_probs=197.5
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC--
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 87 (426)
+..+++|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 345789999999999999999999999999999999997654 3334678999999999999999999999986543
Q ss_pred -------------------------------------------------------eEEEEEcccCCCChHHHHHhCCC--
Q 014359 88 -------------------------------------------------------KIYMVLEYVTGGELFDKIASKGR-- 110 (426)
Q Consensus 88 -------------------------------------------------------~~~lVmEy~~gg~L~~~i~~~~~-- 110 (426)
..|+||||+++|+|.+++.....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 38999999999999999987543
Q ss_pred -CCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC----------CCccccccCC
Q 014359 111 -LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD----------DGLLHTTCGS 164 (426)
Q Consensus 111 -l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~----------~~~~~~~~gt 164 (426)
.++..++.++.||+.|| +|||++.++.+||+|||+++....... .......+||
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 56667899999999997 699999999999999999986543211 1223456899
Q ss_pred CcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHccccCcCC
Q 014359 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-PKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 165 ~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
+.|+|||++.+..++ .++||||+||++|+|++|..|+.. .......+.....+. +...++++.+||.+||+.||++
T Consensus 240 ~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred cCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence 999999999988774 899999999999999999877532 223333333333221 1336788999999999999999
Q ss_pred CCChHHHhcCcCCcc
Q 014359 244 RITIAGIKADEWFEQ 258 (426)
Q Consensus 244 R~t~~~il~h~w~~~ 258 (426)
|||++|+++||||++
T Consensus 317 Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIENAIFEN 331 (332)
T ss_dssp SCCHHHHHHSTTCCC
T ss_pred CCCHHHHhhchhhhc
Confidence 999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=338.43 Aligned_cols=243 Identities=28% Similarity=0.460 Sum_probs=200.5
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
....++|++.+.||+|+||.||+|.+ +++.||||++..... .....+.+.+|+.++++++||||+++++++.+....
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 35568999999999999999999986 688899999976543 334457889999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHH-----------------hheeeCCCCCEEEeccCCCCCC
Q 014359 90 YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGL-----------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~---l~e~~~~~~~~ql~~al-----------------eNILld~~g~lKl~DFGla~~~ 149 (426)
|+||||+++|+|.+++...+. +++..++.++.|++.|| +|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999987553 99999999999999996 6999999999999999999854
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHH--hCCCCCCCCCCH
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKWLSP 227 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 227 (426)
.. ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+. .....+|..+++
T Consensus 190 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 190 AS--TFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp --------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred cc--cccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 32 2223456789999999999988877 489999999999999999999999988777666653 345677888999
Q ss_pred HHHHHHHHccccCcCCCCChHHHhc--CcCCcc
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKA--DEWFEQ 258 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~--h~w~~~ 258 (426)
++.+||.+||+.||.+|||++++++ ++|+..
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999987 455544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=333.70 Aligned_cols=245 Identities=38% Similarity=0.648 Sum_probs=214.3
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.+...++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 455678999999999999999999999989999999999765432 2235788999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC---CEEEeccCCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---NIKISDFGLSALPQ 150 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g---~lKl~DFGla~~~~ 150 (426)
.|+||||+++++|.+.+....++++..++.++.||+.|+ +||+++.++ .+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999999999998888899999999999999997 699997654 69999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCC
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 226 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 226 (426)
. ........||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.+.......+..+....+ ..++
T Consensus 176 ~---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 176 Q---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp C---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred C---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 3 2233455789999999998764 4 5899999999999999999999999888888888877765443 4589
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+++.+||.+||+.||.+|||+.++++||||++.
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=338.66 Aligned_cols=237 Identities=24% Similarity=0.342 Sum_probs=192.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 90 (426)
..++|++.+.||+|+||+||+|.+..+++.||||++........ ......+|+..+..+ +||||+++++++.+.+..|
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 33789999999999999999999999999999999865433222 234455566555554 8999999999999999999
Q ss_pred EEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+||||+ +++|.+++... .++++..++.++.||+.|| +|||++.++.+||+|||++.....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~--- 209 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT--- 209 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---
Confidence 999999 67999988754 4699999999999999997 699999999999999999875432
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC--CCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--KLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~L 232 (426)
.......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+.+.+. ...+..+.. .++..+++++.+|
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHH
Confidence 233456679999999999876 45 5899999999999999999766655332 233333322 2345689999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCcc
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
|.+||+.||++|||++++++||||++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=349.26 Aligned_cols=237 Identities=25% Similarity=0.372 Sum_probs=197.1
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe------
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 85 (426)
..++|++++.||+|+||.||+|.+..+|+.||||++..+.. ...+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45789999999999999999999999999999999875432 23479999999999999999999844
Q ss_pred --------------------------------CCeEEEEEcccCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHH--
Q 014359 86 --------------------------------KSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGL-- 127 (426)
Q Consensus 86 --------------------------------~~~~~lVmEy~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~al-- 127 (426)
....|+||||+++ +|.+.+. ....+++..++.++.||+.||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3348999999975 7776664 457899999999999999997
Q ss_pred -------------hheeeC-CCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHH
Q 014359 128 -------------ENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 193 (426)
Q Consensus 128 -------------eNILld-~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ 193 (426)
+|||++ .++.+||+|||+|+.... .......+||+.|+|||++.+....+.++||||+||++|
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 699998 688999999999985432 233456789999999999987664569999999999999
Q ss_pred HHhcCCCCCCCccHHHHHHHHHhC-----------------CCC------------CCCCCCHHHHHHHHHccccCcCCC
Q 014359 194 VILTGYLPFDDRNLAVLYQKIFRG-----------------DFK------------LPKWLSPGAQNLLRKILEPNPVKR 244 (426)
Q Consensus 194 elltG~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R 244 (426)
+|++|+.||.+.+..+....+... ... +|..+++++.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999988776665554321 001 345588999999999999999999
Q ss_pred CChHHHhcCcCCccC
Q 014359 245 ITIAGIKADEWFEQD 259 (426)
Q Consensus 245 ~t~~~il~h~w~~~~ 259 (426)
||+.|+++||||+..
T Consensus 314 ~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 314 INPYEAMAHPFFDHL 328 (383)
T ss_dssp CCHHHHHTSGGGHHH
T ss_pred CCHHHHhcCHHHHHH
Confidence 999999999999763
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=347.19 Aligned_cols=241 Identities=27% Similarity=0.392 Sum_probs=194.1
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---- 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 87 (426)
..++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 46899999999999999999999999999999999976432 3444678889999999999999999999997654
Q ss_pred --eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 88 --~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
..|+||||+.+ +|.+.+. ..+++..++.++.||+.|| +|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 8888886 4599999999999999997 79999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-----------
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF----------- 219 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 219 (426)
. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2234567899999999999988775 899999999999999999999999887766666543211
Q ss_pred -----------CC--------------CC------CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 220 -----------KL--------------PK------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 220 -----------~~--------------p~------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.. |. ..++++.+||.+||+.||++|||++|+++||||...+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00 00 0156789999999999999999999999999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=330.70 Aligned_cols=241 Identities=24% Similarity=0.418 Sum_probs=211.7
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
.+|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999999865432 23578999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
||+++++|.+++.. +++++..++.++.|++.|+ +|||++.++.+||+|||++...... ....
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 176 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKR 176 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BCCB
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--cccc
Confidence 99999999999875 6799999999999999996 6999999999999999999754331 1223
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHcc
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKIL 237 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L 237 (426)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..+. ...+..++..+.+||.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHc
Confidence 456899999999999887775 89999999999999999999999887776666665543 4456779999999999999
Q ss_pred ccCcCCCCChHHHhcCcCCccCC
Q 014359 238 EPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 238 ~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+.||.+|||+.++++||||....
T Consensus 256 ~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CSSGGGSCCHHHHTTCHHHHHHC
T ss_pred CCChhhCcCHHHHhhChhhhcCC
Confidence 99999999999999999997643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=346.50 Aligned_cols=241 Identities=30% Similarity=0.407 Sum_probs=186.5
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC------
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------ 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 86 (426)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 379999999999999999999999999999999997543 2334467888999999999999999999998654
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
...|+||||+ +++|.+++.. +++++..++.++.||+.|| +|||++.++.+||+|||+++....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 7899998876 6799999999999999997 699999999999999999985432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--C-----------
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D----------- 218 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~----------- 218 (426)
.....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+... .
T Consensus 185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 185 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred -----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2345689999999999987444568999999999999999999999988776655554321 0
Q ss_pred ----------CCC--------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 219 ----------FKL--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 219 ----------~~~--------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
... ...+++.+.+||.+||+.||++|||++++++||||.....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 011 1246889999999999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=343.26 Aligned_cols=241 Identities=25% Similarity=0.439 Sum_probs=207.6
Q ss_pred CccccCEEEeceeeecCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 81 (426)
....++|++++.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345689999999999999999999874 345679999997653 344467899999999999 8999999999
Q ss_pred EEEeCCeEEEEEcccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hhe
Q 014359 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENI 130 (426)
Q Consensus 82 ~~~~~~~~~lVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNI 130 (426)
++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.|| +||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998643 489999999999999997 799
Q ss_pred eeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHH
Q 014359 131 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 209 (426)
Q Consensus 131 Lld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 209 (426)
|++.+|.+||+|||+++...............||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+..+
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999855432222333445678999999999888775 99999999999999999 999999988777
Q ss_pred HHHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 210 LYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 210 ~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+..+..+. ...|..+++++.+||.+||+.||++|||+.+++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777776653 56677899999999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=329.23 Aligned_cols=243 Identities=22% Similarity=0.331 Sum_probs=188.6
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
+..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.++...++.++||||+++++++.+.+..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 456899999999999999999999999999999999976532 2222344555666688899999999999999999999
Q ss_pred EEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 91 MVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
+||||+++ +|.+++.. ...+++..++.++.|++.|+ +|||++.++.+||+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999975 88777653 56799999999999999996 69999999999999999998543
Q ss_pred cccCCCccccccCCCcccchhhh----ccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc-cHHH-HHHHHHhCCCCCC-C
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVL----ANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAV-LYQKIFRGDFKLP-K 223 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l----~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~-~~~~i~~~~~~~p-~ 223 (426)
. .......+||+.|+|||++ .+..+ +.++||||+||++|+|++|+.||... .... ....+.......+ .
T Consensus 162 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 162 D---DVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred c---cccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 3 2233455899999999997 33344 58999999999999999999999863 3333 3333333333333 4
Q ss_pred CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 224 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 224 ~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 689999999999999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=335.37 Aligned_cols=237 Identities=23% Similarity=0.373 Sum_probs=197.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEe--CCe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--KSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~ 88 (426)
..++|++++.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3578999999999999999999999999999999997432 467899999999997 9999999999987 667
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFGla~~~~~~ 152 (426)
.++||||+.+++|.+++.. +++..++.++.||+.|| +|||++.++ .+||+|||+|+....
T Consensus 108 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT-
T ss_pred eEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC-
Confidence 9999999999999998854 99999999999999997 799999777 899999999985432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc-cHHHHH-------------HHHHhCC
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLY-------------QKIFRGD 218 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~-------------~~i~~~~ 218 (426)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +..... ..+....
T Consensus 184 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 233456789999999999987554569999999999999999999999532 222111 1111221
Q ss_pred CCC------------------------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 219 FKL------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 219 ~~~------------------------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
... +..+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 111 122799999999999999999999999999999998743
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=332.42 Aligned_cols=240 Identities=26% Similarity=0.440 Sum_probs=203.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.-++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 45689999999999999999999999999999999976431 3678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
||||+++|+|.+++. ....+++..++.++.|++.|+ +||+++.++.+||+|||++..... ..
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--~~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--TM 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT--TB
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh--hc
Confidence 999999999999997 456799999999999999997 699999999999999999975433 12
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC---CCCCCCCCHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNL 232 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~L 232 (426)
......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.... ...|..++..+.+|
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 233456899999999999888775 89999999999999999999999877665555544442 23355689999999
Q ss_pred HHHccccCcCCCCChHHHhcCcCCccC
Q 014359 233 LRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
|.+||+.||.+|||+.++++||||...
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.25 Aligned_cols=242 Identities=36% Similarity=0.648 Sum_probs=200.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 457899999999999999999999999999999999754321 112234588999999999999999999999766
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC---EEEeccCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN---IKISDFGLSAL 148 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~---lKl~DFGla~~ 148 (426)
. .|+||||+++|+|.+++.....+++..++.++.||+.|| +|||++.++. +||+|||++..
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 5 899999999999999998888999999999999999997 6999998765 99999999985
Q ss_pred CCcccCCCccccccCCCcccchhhhc---cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHHhCCCCCC--
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP-- 222 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p-- 222 (426)
... .......+||+.|+|||++. ...+ +.++|||||||++|+|++|..||...... .....+..+....+
T Consensus 167 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 167 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp CCC---CHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred ccc---ccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 432 22344568999999999974 3344 58999999999999999999999865432 34445555554432
Q ss_pred --CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 223 --KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 223 --~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
..+++.+.+||.+||+.||++|||++++++||||..
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 458999999999999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=347.49 Aligned_cols=239 Identities=28% Similarity=0.394 Sum_probs=199.6
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC------CCCCccceeEEEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL------KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 34568999999999999999999999999999999997542 2346677888888777 5789999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCC--EEEeccCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGN--IKISDFGL 145 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~--lKl~DFGl 145 (426)
..+.+|+||||+. ++|.+++.... .+++..++.++.||+.|| +|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999995 69999998653 599999999999999997 7999999987 99999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CC----
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF---- 219 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~---- 219 (426)
|.... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+..+.+..+... .+
T Consensus 249 a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 249 SCYEH-----QRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CEETT-----CCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ceecC-----CcccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 97432 234567899999999999988874 9999999999999999999999988776655444321 00
Q ss_pred --------------C---------------------------------------CCCCCCHHHHHHHHHccccCcCCCCC
Q 014359 220 --------------K---------------------------------------LPKWLSPGAQNLLRKILEPNPVKRIT 246 (426)
Q Consensus 220 --------------~---------------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t 246 (426)
. ++...++.+.+||.+||+.||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 0 01123788999999999999999999
Q ss_pred hHHHhcCcCCccCC
Q 014359 247 IAGIKADEWFEQDY 260 (426)
Q Consensus 247 ~~~il~h~w~~~~~ 260 (426)
++|+++||||++..
T Consensus 403 a~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 403 PGQALRHPWLRRRL 416 (429)
T ss_dssp HHHHHTSTTTC---
T ss_pred HHHHhCChhhccCC
Confidence 99999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.33 Aligned_cols=243 Identities=26% Similarity=0.404 Sum_probs=203.3
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
-..++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 34578999999999999999999999999999999987543 223578889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+||||+++++|.+++.. ...+++..++.++.||+.|+ +|||++.++.+||+|||++..... .
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~ 170 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--T 170 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--H
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--c
Confidence 99999999999998875 56799999999999999997 699999999999999998753211 1
Q ss_pred CCccccccCCCcccchhhhc-----cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC---CCCCCC
Q 014359 155 DGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLS 226 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~-----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s 226 (426)
.......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.......+.....+ .|..++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred ccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence 11223467999999999984 4444 58999999999999999999999998877777666665432 345689
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
..+.+||.+||+.||++|||+.++++||||...
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=332.30 Aligned_cols=242 Identities=26% Similarity=0.406 Sum_probs=200.1
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe----
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS---- 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~---- 85 (426)
...++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 346899999999999999999999999999999999975432 136788999999999 79999999999977
Q ss_pred --CCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCC
Q 014359 86 --KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 86 --~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla 146 (426)
.+..|+||||+++|+|.+++... ..+++..++.++.||+.|| +|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 56899999999999999999864 5799999999999999996 6999999999999999999
Q ss_pred CCCCcccCCCccccccCCCcccchhhhc-----cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK- 220 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~- 220 (426)
..... ........+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.......+.....+
T Consensus 177 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 177 AQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred eecCc--CccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 86432 122334568999999999987 3344 58999999999999999999999988776666555554332
Q ss_pred -CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 221 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 221 -~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 235689999999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.90 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=201.8
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC----
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK---- 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 86 (426)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 34589999999999999999999999999999999996432 334456788999999999999999999998654
Q ss_pred -CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
...|+||||+. |+|.+++.. +.+++..++.++.|++.|| +|||++.++.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 67999999996 599999876 5799999999999999997 69999999999999999998654
Q ss_pred cccCC--------CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh--CC--
Q 014359 151 HFRDD--------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GD-- 218 (426)
Q Consensus 151 ~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~-- 218 (426)
..... ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.. +.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 32111 1123458999999999987644456999999999999999999999998876554443321 10
Q ss_pred --------------------CC--------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 219 --------------------FK--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 219 --------------------~~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.. .++.+++++.+||.+||+.||++|||++++++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 1135889999999999999999999999999999998744
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=355.04 Aligned_cols=234 Identities=19% Similarity=0.212 Sum_probs=192.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH---HHhcCCCCCcccee-------EE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA---TLKLLKHPNVVRLH-------EV 82 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------~~ 82 (426)
.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999998899999999998665555556788999995 55555799999998 77
Q ss_pred EEeCCe-----------------EEEEEcccCCCChHHHHHhCCCCCH-------HHHHHHHHHHHHHH-----------
Q 014359 83 LASKSK-----------------IYMVLEYVTGGELFDKIASKGRLQE-------AEGRKLFQQLIDGL----------- 127 (426)
Q Consensus 83 ~~~~~~-----------------~~lVmEy~~gg~L~~~i~~~~~l~e-------~~~~~~~~ql~~al----------- 127 (426)
+.+.+. .|+||||+ +|+|.+++...+++++ ..++.++.||+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 766543 89999999 6799999987655666 77888999999997
Q ss_pred ----hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccC-----------CCCCchhhHHHHHHHH
Q 014359 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----------GYDGATSDIWSCGVIL 192 (426)
Q Consensus 128 ----eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----------~~~~~~~DIwSlGvil 192 (426)
+|||++.+|.+||+|||+|+.. .......+| +.|+|||++.+. .| +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 7999999999999999999842 224456788 999999999887 66 4999999999999
Q ss_pred HHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 193 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 193 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
|+|++|+.||.+.+.......+. ..+..+++++.+||.+||+.||++|||+.++++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999998765443333332 233568999999999999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=331.24 Aligned_cols=246 Identities=27% Similarity=0.367 Sum_probs=197.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE-------
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA------- 84 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------- 84 (426)
.-++|++++.||+|+||.||+|.+..+++.||||++... +....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 457999999999999999999999999999999998754 3344678899999999999999999999873
Q ss_pred -------eCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeC-CCCCEEEe
Q 014359 85 -------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLD-SKGNIKIS 141 (426)
Q Consensus 85 -------~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld-~~g~lKl~ 141 (426)
.....|+||||+. |+|.+++.. +++++..++.++.|++.|| +|||++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467999999997 599999865 6799999999999999997 699997 56799999
Q ss_pred ccCCCCCCCccc-CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC
Q 014359 142 DFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 220 (426)
Q Consensus 142 DFGla~~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 220 (426)
|||++....... .........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998654321 1223445678999999999876444469999999999999999999999988776655554432110
Q ss_pred ------------------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 221 ------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 221 ------------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
.++.+++++.+||.+||+.||.+|||++++++||||.....|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 124589999999999999999999999999999999875444
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=330.11 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=196.1
Q ss_pred hhcccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEE
Q 014359 4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (426)
Q Consensus 4 ~~~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 83 (426)
....+.+..+++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.++||||+++++++
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 24 TAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp ----------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 34566788899999999999999999999999999999999999876555555568899999999999999999999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
...+..|+||||+++++|.+++...+++++..++.++.|++.|+ +|||++.++.+||+|||++..
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999999999999888899999999999999997 699999999999999999985
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC---CCCCCC
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWL 225 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~ 225 (426)
.... ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+..... ..++.+
T Consensus 184 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (309)
T 2h34_A 184 TTDE-KLTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGI 261 (309)
T ss_dssp --------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTC
T ss_pred cccc-ccccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCC
Confidence 4331 11223456799999999999887764 899999999999999999999998877655554443322 235678
Q ss_pred CHHHHHHHHHccccCcCCCC-ChHHHhc
Q 014359 226 SPGAQNLLRKILEPNPVKRI-TIAGIKA 252 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~-t~~~il~ 252 (426)
++.+.+||.+||+.||.+|| |++++++
T Consensus 262 ~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 262 PVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999999 7777764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=335.89 Aligned_cols=240 Identities=26% Similarity=0.414 Sum_probs=197.6
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC--
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 87 (426)
...-++|++.+.||+|+||.||+|.+..+++.||||++....... ..+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 345689999999999999999999999999999999997644322 2567889999999999999999999998765
Q ss_pred eEEEEEcccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHH---------------hheee----CCCCCEEEeccCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGL---------------ENILL----DSKGNIKISDFGL 145 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~al---------------eNILl----d~~g~lKl~DFGl 145 (426)
..|+||||+++|+|.+++.... .+++..++.++.||+.|| +|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 7899999999999999998643 399999999999999997 69999 7888899999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhc--------cCCCCCchhhHHHHHHHHHHHhcCCCCCCCc----cHHHHHHH
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLA--------NRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQK 213 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~--------~~~~~~~~~DIwSlGvil~elltG~~Pf~~~----~~~~~~~~ 213 (426)
++.... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|+.||... ........
T Consensus 163 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 163 ARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred ceecCC---CCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 985433 33345678999999999986 3444 58999999999999999999999642 23444455
Q ss_pred HHhCCCC-------------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcC
Q 014359 214 IFRGDFK-------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 214 i~~~~~~-------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w 255 (426)
+..+.+. ++..++..+.+||.+||+.||++|||++|+++||-
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 5443321 11224567889999999999999999999999973
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=333.64 Aligned_cols=248 Identities=24% Similarity=0.341 Sum_probs=187.9
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
....++|++++.||+|+||.||+|.+..++. .||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3455789999999999999999999876665 89999997654333 3367899999999999999999999999877
Q ss_pred CeE------EEEEcccCCCChHHHHHhCC------CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEE
Q 014359 87 SKI------YMVLEYVTGGELFDKIASKG------RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIK 139 (426)
Q Consensus 87 ~~~------~lVmEy~~gg~L~~~i~~~~------~l~e~~~~~~~~ql~~al---------------eNILld~~g~lK 139 (426)
... |+||||+.+|+|.+++.... .+++..++.++.||+.|| +|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 655 99999999999999996432 599999999999999997 799999999999
Q ss_pred EeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-
Q 014359 140 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 217 (426)
Q Consensus 140 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~- 217 (426)
|+|||++................+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+....+..+..+
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999865432222233345678899999999888775 99999999999999999 99999988877777776655
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCC-------hHHHhcCcCCccC
Q 014359 218 DFKLPKWLSPGAQNLLRKILEPNPVKRIT-------IAGIKADEWFEQD 259 (426)
Q Consensus 218 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t-------~~~il~h~w~~~~ 259 (426)
....|..+++++.+||.+||+.||.+||| +++++.|+|+...
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 45667789999999999999999999999 7788999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=346.31 Aligned_cols=246 Identities=30% Similarity=0.433 Sum_probs=182.9
Q ss_pred cccCEEE-eceeeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--C
Q 014359 12 RLGRYEL-GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K 86 (426)
Q Consensus 12 ~~~~y~i-~~~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~ 86 (426)
.-+.|++ +++||+|+||.||+|++. .+++.||||++..... ...+.+|+.+|+.++||||+++++++.. .
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 3467888 568999999999999976 5788999999975432 2467899999999999999999999954 6
Q ss_pred CeEEEEEcccCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHH---------------hheee----CCCCCE
Q 014359 87 SKIYMVLEYVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGL---------------ENILL----DSKGNI 138 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~al---------------eNILl----d~~g~l 138 (426)
..+|+||||+. |+|.+++... ..+++..++.++.||+.|| +|||+ +.++.+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 78999999996 5898888532 2499999999999999997 79999 778899
Q ss_pred EEeccCCCCCCCccc-CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH---------
Q 014359 139 KISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA--------- 208 (426)
Q Consensus 139 Kl~DFGla~~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--------- 208 (426)
||+|||+|+...... ........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999999998654321 1233456789999999999988665569999999999999999999999764431
Q ss_pred HHHHHHHh--CCCCCCC------------------------------------CCCHHHHHHHHHccccCcCCCCChHHH
Q 014359 209 VLYQKIFR--GDFKLPK------------------------------------WLSPGAQNLLRKILEPNPVKRITIAGI 250 (426)
Q Consensus 209 ~~~~~i~~--~~~~~p~------------------------------------~~s~~~~~Li~~~L~~dP~~R~t~~~i 250 (426)
+....+.. +.+.... ..++.+.+||.+||+.||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 22222221 1111111 127789999999999999999999999
Q ss_pred hcCcCCccCCCCC
Q 014359 251 KADEWFEQDYTPA 263 (426)
Q Consensus 251 l~h~w~~~~~~~~ 263 (426)
++||||.....+.
T Consensus 332 L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 332 MQDPYFLEDPLPT 344 (405)
T ss_dssp HTSGGGTSSSCCC
T ss_pred hcChhhccCCCCc
Confidence 9999998865443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.86 Aligned_cols=238 Identities=29% Similarity=0.389 Sum_probs=198.4
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE----
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI---- 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~---- 89 (426)
++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 69999999999999999999999999999999997643 2344467889999999999999999999999877654
Q ss_pred --EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 90 --YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 90 --~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
|+||||+. ++|.+.+. .++++..++.++.||+.|| +|||++.++.+||+|||+++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 99999997 58888774 4599999999999999997 699999999999999999985432
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--C------------
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D------------ 218 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~------------ 218 (426)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+... .
T Consensus 197 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 197 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred ----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 2345689999999999987444468999999999999999999999988776655554321 0
Q ss_pred ---------C--------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 219 ---------F--------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 219 ---------~--------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
. ..++.+++.+.+||.+||+.||++|||++|+++||||....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 0 01234789999999999999999999999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=337.25 Aligned_cols=245 Identities=23% Similarity=0.348 Sum_probs=190.5
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe-
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK- 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 88 (426)
...+++|++.+.||+|+||.||+|.+..+++.||||++...... .....+|+..++.++||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 45678999999999999999999999999999999998654322 2355678888899999999999999966433
Q ss_pred ------EEEEEcccCCCChHHHH----HhCCCCCHHHHHHHHHHHHHHH-----------------hheeeCC-CCCEEE
Q 014359 89 ------IYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGL-----------------ENILLDS-KGNIKI 140 (426)
Q Consensus 89 ------~~lVmEy~~gg~L~~~i----~~~~~l~e~~~~~~~~ql~~al-----------------eNILld~-~g~lKl 140 (426)
.|+||||+.+ +|.+.+ .....+++..++.++.|++.|+ +|||++. ++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 8899999976 554444 3566799999999999999986 6999997 899999
Q ss_pred eccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--
Q 014359 141 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-- 218 (426)
Q Consensus 141 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-- 218 (426)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 174 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 99999986543 2334466899999999999776655699999999999999999999999887766665554310
Q ss_pred ------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 219 ------------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 219 ------------------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
...+...++++.+||.+||+.||.+|||+.|+++||||+....+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 01112256889999999999999999999999999999886543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=335.00 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=183.1
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 4556899999999999999999999888999999999875432 22356788999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHh--------CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCC
Q 014359 90 YMVLEYVTGGELFDKIAS--------KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~--------~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla 146 (426)
|+||||+++|+|.+++.. ...+++..++.++.||+.|+ +|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999999973 45699999999999999997 6999999999999999998
Q ss_pred CCCCccc---CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC----
Q 014359 147 ALPQHFR---DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---- 219 (426)
Q Consensus 147 ~~~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---- 219 (426)
....... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 7543211 112234568999999999987633235899999999999999999999988665544444433322
Q ss_pred ------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 220 ------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 220 ------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
..+..+++++.+||.+||+.||.+|||+.++++||||.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1224578999999999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=346.03 Aligned_cols=239 Identities=27% Similarity=0.358 Sum_probs=194.9
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----- 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 86 (426)
...+|++++.||+|+||.||+|++..+++.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999875431 234799999999999999999998542
Q ss_pred -CeEEEEEcccCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC-CCEEEeccCC
Q 014359 87 -SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK-GNIKISDFGL 145 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~al---------------eNILld~~-g~lKl~DFGl 145 (426)
..+++||||+++ +|.+.+. ....+++..++.++.||+.|| +|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 236799999976 6766654 356799999999999999997 79999965 5689999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--------
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------- 217 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------- 217 (426)
++.... .......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 985432 223445789999999999977644468999999999999999999999988766555444321
Q ss_pred ---------CCC------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 218 ---------DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 218 ---------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
.+. ++..+++++.+||.+||+.||.+|||+.|+++||||.....
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 111 22356899999999999999999999999999999986543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.28 Aligned_cols=245 Identities=23% Similarity=0.294 Sum_probs=209.4
Q ss_pred ccccCEEEeceeeecCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
...++|++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 446789999999999999999999 44578899999996532 33345678899999999999999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCC---CEEE
Q 014359 86 KSKIYMVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKG---NIKI 140 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~-------~~l~e~~~~~~~~ql~~al---------------eNILld~~g---~lKl 140 (426)
....|+||||+++|+|.+++... ..+++..++.++.||+.|| +|||++.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999999764 3599999999999999997 799999665 5999
Q ss_pred eccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-
Q 014359 141 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD- 218 (426)
Q Consensus 141 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~- 218 (426)
+|||+|+..............+||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999754332233344566789999999999888775 89999999999999998 999999998888888877664
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 219 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 219 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
...|..+++.+.+||.+||+.||.+|||+.++++|.|+..
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 5567789999999999999999999999999999988654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=331.15 Aligned_cols=241 Identities=23% Similarity=0.363 Sum_probs=205.0
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
....++|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3556899999999999999999999986555 49999997543 334457899999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
+..|+||||+++|+|.+++... +.+++..++.++.|++.|| +|||++.++.+||+|||+++...
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999999754 5799999999999999997 69999999999999999998654
Q ss_pred cccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCH
Q 014359 151 HFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 227 (426)
Q Consensus 151 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 227 (426)
..... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence 32211 122334568899999999887775 89999999999999999 99999998888887777765 4566778999
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+.+||.+||+.||.+|||+.++++.
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=336.43 Aligned_cols=241 Identities=27% Similarity=0.444 Sum_probs=209.8
Q ss_pred CccccCEEEeceeeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 81 (426)
....++|++++.||+|+||.||+|.+.. .+..||||++.... .......+.+|+.+++++ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 3455899999999999999999999754 33579999997653 344467899999999999 8999999999
Q ss_pred EEEeCCeEEEEEcccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hhe
Q 014359 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENI 130 (426)
Q Consensus 82 ~~~~~~~~~lVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNI 130 (426)
++.+.+..|+||||+++|+|.+++.... .+++..++.++.||+.|| +||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998653 499999999999999997 699
Q ss_pred eeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHH
Q 014359 131 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 209 (426)
Q Consensus 131 Lld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 209 (426)
|++.++.+||+|||+|+...............||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999866543333344556788999999999887774 89999999999999999 999999988888
Q ss_pred HHHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 210 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 210 ~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
....+..+ ....|..+++++.+||.+||+.||++|||+.+++++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88877766 456677899999999999999999999999999886
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.21 Aligned_cols=240 Identities=26% Similarity=0.376 Sum_probs=194.8
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC--
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 87 (426)
....++|++.+.||+|+||.||+|++..+++ ||+|.+..... ...+|+.+++.++||||+++++++...+
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 3455789999999999999999999977666 88888765432 1237999999999999999999996543
Q ss_pred ----eEEEEEcccCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHH---------------hheeeC-CCCCEEEecc
Q 014359 88 ----KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGL---------------ENILLD-SKGNIKISDF 143 (426)
Q Consensus 88 ----~~~lVmEy~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~al---------------eNILld-~~g~lKl~DF 143 (426)
.+|+||||++++ +.+.+. ....+++..++.++.||+.|| +|||++ .++.+||+||
T Consensus 108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 388999999774 444333 356799999999999999997 799999 7999999999
Q ss_pred CCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC------
Q 014359 144 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------ 217 (426)
Q Consensus 144 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------ 217 (426)
|+|+.... .......+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 187 G~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 187 GSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp TTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99985432 233446789999999999987654569999999999999999999999998776655544321
Q ss_pred -----------CCC------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 218 -----------DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 218 -----------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
... ++..+++++.+||.+||+.||.+|||+.++++||||.....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 011 23447899999999999999999999999999999987543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=329.44 Aligned_cols=242 Identities=28% Similarity=0.372 Sum_probs=207.2
Q ss_pred CCccccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEE
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 83 (426)
-....++|++++.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3455689999999999999999999983 456899999997543 344467899999999999999999999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhCCC------------------------CCHHHHHHHHHHHHHHH------------
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASKGR------------------------LQEAEGRKLFQQLIDGL------------ 127 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~~~------------------------l~e~~~~~~~~ql~~al------------ 127 (426)
.+.+..|+||||+++|+|.+++..... +++..++.++.||+.||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999986543 89999999999999997
Q ss_pred ---hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCC
Q 014359 128 ---ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFD 203 (426)
Q Consensus 128 ---eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~ 203 (426)
+|||++.++.+||+|||++................+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCC
Confidence 6999999999999999999854332222223345678999999999887764 89999999999999999 999999
Q ss_pred CccHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 204 DRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 204 ~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+.+.......+..+. ...|..+++++.+||.+||+.||++|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 888777777766653 55677899999999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=330.50 Aligned_cols=241 Identities=29% Similarity=0.409 Sum_probs=200.3
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEE-CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC------cccee
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQD-LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN------VVRLH 80 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~ 80 (426)
.+....++|++.+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+.+++.++|+| |++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3445558999999999999999999998 458899999999643 233577889999999887654 99999
Q ss_pred EEEEeCCeEEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCC---------
Q 014359 81 EVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDS--------- 134 (426)
Q Consensus 81 ~~~~~~~~~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~--------- 134 (426)
+++.+.+..|+||||+ +++|.+++...+ ++++..++.++.||+.|| +|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 889999998765 689999999999999997 6999988
Q ss_pred ----------CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC
Q 014359 135 ----------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 204 (426)
Q Consensus 135 ----------~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~ 204 (426)
++.+||+|||++.... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||..
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCC
Confidence 6789999999998532 223456899999999999988775 899999999999999999999998
Q ss_pred ccHHHHHHHHHhCCCCC--------------------------------------------CCCCCHHHHHHHHHccccC
Q 014359 205 RNLAVLYQKIFRGDFKL--------------------------------------------PKWLSPGAQNLLRKILEPN 240 (426)
Q Consensus 205 ~~~~~~~~~i~~~~~~~--------------------------------------------p~~~s~~~~~Li~~~L~~d 240 (426)
.+..+....+.....++ +...++++.+||.+||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 77655444332211111 1113567899999999999
Q ss_pred cCCCCChHHHhcCcCCccC
Q 014359 241 PVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 241 P~~R~t~~~il~h~w~~~~ 259 (426)
|.+|||++|+++||||+..
T Consensus 317 P~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 317 PAKRITLREALKHPFFDLL 335 (339)
T ss_dssp TTTSCCHHHHTTSGGGGGG
T ss_pred cccccCHHHHhcCHHHHHH
Confidence 9999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=337.14 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=195.0
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc--------chhHHHHHHHHHHHHhcCCCCCccceeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--------HLKITDQIKREIATLKLLKHPNVVRLHEV 82 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 82 (426)
...++|++++.||+|+||.||+|.+. +++.||||++...... .....+.+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 34589999999999999999999985 4899999998653221 22334789999999999999999999999
Q ss_pred EEe-----CCeEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEe
Q 014359 83 LAS-----KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKIS 141 (426)
Q Consensus 83 ~~~-----~~~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~ 141 (426)
+.. ....|+||||+. |+|.+.+... ..+++..++.++.||+.|| +|||++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 854 346899999997 5888888754 4799999999999999997 79999999999999
Q ss_pred ccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--C-
Q 014359 142 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D- 218 (426)
Q Consensus 142 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~- 218 (426)
|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 177 Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 177 DFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp CTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999984332 233456789999999999987444569999999999999999999999988766655554321 0
Q ss_pred ---------------------CC--------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 219 ---------------------FK--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 219 ---------------------~~--------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
.. .++.+++.+.+||.+||+.||++|||+.|+++||||+..+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 01 123468899999999999999999999999999999886543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.28 Aligned_cols=241 Identities=25% Similarity=0.351 Sum_probs=207.7
Q ss_pred CccccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 84 (426)
....++|++++.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456689999999999999999999986 355899999997543 3344678999999999999999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhC------------------------CCCCHHHHHHHHHHHHHHH-------------
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGL------------- 127 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql~~al------------- 127 (426)
+.+..|+||||+++|+|.+++... .++++..++.++.||+.||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999763 5699999999999999997
Q ss_pred --hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCC
Q 014359 128 --ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 204 (426)
Q Consensus 128 --eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~ 204 (426)
+|||++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCC
Confidence 6999999999999999999754332222233456789999999999888775 99999999999999999 9999999
Q ss_pred ccHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 205 RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 205 ~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+.......+..+. ...|..+++.+.+||.+||+.||++|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88888877777765 45678899999999999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=337.87 Aligned_cols=240 Identities=26% Similarity=0.385 Sum_probs=201.8
Q ss_pred ccccCEEEeceeeecCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 456899999999999999999998 45677899999997543 333357799999999999 7999999999998
Q ss_pred eCC-eEEEEEcccCCCChHHHHHhCCC-----------------------------------------------------
Q 014359 85 SKS-KIYMVLEYVTGGELFDKIASKGR----------------------------------------------------- 110 (426)
Q Consensus 85 ~~~-~~~lVmEy~~gg~L~~~i~~~~~----------------------------------------------------- 110 (426)
+.+ ..|+||||+++|+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 48999999999999999986543
Q ss_pred -------------CCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcccccc
Q 014359 111 -------------LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162 (426)
Q Consensus 111 -------------l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~ 162 (426)
+++..++.++.||+.|| +|||++.++.+||+|||++................
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 89999999999999997 79999999999999999998654332233345567
Q ss_pred CCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHH-HHHHHHHhC-CCCCCCCCCHHHHHHHHHcccc
Q 014359 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 163 gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 239 (426)
||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.. .....+..+ ....|..+++++.+||.+||+.
T Consensus 257 ~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp ECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 89999999999888775 99999999999999998 99999886643 333334433 4667788999999999999999
Q ss_pred CcCCCCChHHHhcC
Q 014359 240 NPVKRITIAGIKAD 253 (426)
Q Consensus 240 dP~~R~t~~~il~h 253 (426)
||.+|||+.++++|
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=322.95 Aligned_cols=240 Identities=27% Similarity=0.443 Sum_probs=194.1
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe-------
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------- 85 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------- 85 (426)
.++|++++.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 47899999999999999999999999999999999643 2335788999999999999999999998865
Q ss_pred ------CCeEEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEecc
Q 014359 86 ------KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDF 143 (426)
Q Consensus 86 ------~~~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DF 143 (426)
....|+||||+++|+|.+++.... .+++..++.++.|++.|+ +|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 457899999999999999998543 588999999999999997 6999999999999999
Q ss_pred CCCCCCCccc------------CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC-ccHHHH
Q 014359 144 GLSALPQHFR------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVL 210 (426)
Q Consensus 144 Gla~~~~~~~------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~ 210 (426)
|++....... ........+||+.|+|||++.+.+..+.++||||+||++|+|++ ||.. .+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9998653211 01233456899999999999876545689999999999999998 6653 334455
Q ss_pred HHHHHhCCCCCC----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 211 YQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 211 ~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
...+......+| ...++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 566665554444 3466789999999999999999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=332.33 Aligned_cols=238 Identities=29% Similarity=0.387 Sum_probs=198.0
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe----
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK---- 88 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 88 (426)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 378999999999999999999999999999999997643 234446788999999999999999999999987654
Q ss_pred --EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 89 --IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 89 --~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
+|+||||+. |+|.+++. .++++..++.++.||+.|| +|||++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999997 59988774 3599999999999999997 699999999999999999985432
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--------------
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 217 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------- 217 (426)
.....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 2345689999999999987444468999999999999999999999988766555444321
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 218 -----------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 218 -----------------~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
....++.+++++.+||.+||+.||++|||++++++||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 011234579999999999999999999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=326.24 Aligned_cols=244 Identities=30% Similarity=0.399 Sum_probs=201.7
Q ss_pred ccccCEEEeceeeecCceEEEEEEEC-CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCccceeEEEE--
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA-- 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-- 84 (426)
...++|++.+.||+|+||.||+|.+. .+++.||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34589999999999999999999995 678999999997543221 1123466777777766 8999999999987
Q ss_pred ---eCCeEEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccC
Q 014359 85 ---SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFG 144 (426)
Q Consensus 85 ---~~~~~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFG 144 (426)
.....|+||||+. |+|.+++.... .+++..++.++.|++.|| +|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 5567999999997 69999998643 499999999999999997 69999999999999999
Q ss_pred CCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--C----
Q 014359 145 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D---- 218 (426)
Q Consensus 145 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~---- 218 (426)
++..... .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 166 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 166 LARIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ccccccC---CCCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 9986543 2234567899999999999887774 8999999999999999999999988776666555431 0
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 219 ---------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 219 ---------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
..++..+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 012345789999999999999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=334.99 Aligned_cols=241 Identities=31% Similarity=0.554 Sum_probs=208.8
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCC--CCCccceeEEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLK--HPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~ 84 (426)
....++|++++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456899999999999999999999999999999999986543221 11245678999999996 599999999999
Q ss_pred eCCeEEEEEcccCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeC-CCCCEEEeccCCCC
Q 014359 85 SKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLD-SKGNIKISDFGLSA 147 (426)
Q Consensus 85 ~~~~~~lVmEy~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld-~~g~lKl~DFGla~ 147 (426)
..+..|+||||+.+ ++|.+++...+.+++..++.++.||+.|| +|||++ +++.+||+|||++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999976 89999999888999999999999999997 699999 78999999999998
Q ss_pred CCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCH
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 227 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 227 (426)
.... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...+ .+..+....+..+++
T Consensus 199 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~ 268 (320)
T 3a99_A 199 LLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSS 268 (320)
T ss_dssp ECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCH
T ss_pred cccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCH
Confidence 5432 234456899999999999888776788999999999999999999998643 234566677788999
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
++.+||.+||+.||++|||++++++||||++..
T Consensus 269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 999999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=319.74 Aligned_cols=236 Identities=22% Similarity=0.398 Sum_probs=205.0
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 34579999999999999999999986 5778999999765432 357899999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+||||+++|+|.+++.. ...+++..++.++.|++.|+ +|||++.++.+||+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 160 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 160 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc-
Confidence 99999999999999975 34699999999999999997 69999999999999999998543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........||+.|+|||++.+..++ .++||||+||++|+|++ |..||.+.+.......+..+ ....|..+++.+.+|
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 239 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred cccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHH
Confidence 1123345678899999999888775 89999999999999999 99999999888888887766 455677789999999
Q ss_pred HHHccccCcCCCCChHHHhcC
Q 014359 233 LRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h 253 (426)
|.+||+.||.+|||+.++++|
T Consensus 240 i~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 240 MNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999886
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=322.98 Aligned_cols=243 Identities=28% Similarity=0.445 Sum_probs=198.7
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|.....||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 344444459999999999999999999999999997653 23357789999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHH---------------hheeeCC-CCCEEEeccCCCCCCCccc
Q 014359 93 LEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGL---------------ENILLDS-KGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~al---------------eNILld~-~g~lKl~DFGla~~~~~~~ 153 (426)
|||+++++|.+++... ..+++..++.++.|++.|+ +|||++. ++.+||+|||++......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 9999999999999864 2467999999999999997 6999988 899999999999854331
Q ss_pred CCCccccccCCCcccchhhhccCC-CCCchhhHHHHHHHHHHHhcCCCCCCCccHH--HHHH-HHHhCCCCCCCCCCHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQ-KIFRGDFKLPKWLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--~~~~-~i~~~~~~~p~~~s~~~ 229 (426)
........||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...... .... ........+|..+++++
T Consensus 177 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 177 -NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred -CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence 22334568999999999987643 1358999999999999999999999764322 2222 22334566778899999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+||.+||+.||++|||+.++++||||+...
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=327.10 Aligned_cols=236 Identities=23% Similarity=0.373 Sum_probs=197.8
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4578999999999999999999999999999999988543 3444678999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+||||+++|+|.+++.. ...+++..+..++.|++.|| +|||++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987 56799999999999999997 699999999999999999985433211
Q ss_pred C------------CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH-----HHHHHHhC
Q 014359 155 D------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-----LYQKIFRG 217 (426)
Q Consensus 155 ~------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~-----~~~~i~~~ 217 (426)
. ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||....... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence 1 111256899999999999988775 89999999999999999999986532110 0111111
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 218 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 218 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
...|..+++.+.+||.+||+.||++|||+.++++
T Consensus 242 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 -RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2346778999999999999999999999999976
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.35 Aligned_cols=238 Identities=26% Similarity=0.379 Sum_probs=203.2
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|+.++||||+++++++.+.+..|+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 3468999999999999999999998899999999987542 33345678899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
||||+++|+|.+++... .++++..+..++.|++.|+ +|||++.++.+||+|||+++........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999999764 3699999999999999997 6999999999999999999743221111
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 233 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 233 (426)
.......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+.+||
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 111223457789999999877764 89999999999999998 99999998877777666655 4667788999999999
Q ss_pred HHccccCcCCCCChHHHhc
Q 014359 234 RKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~ 252 (426)
.+||+.||++|||++++++
T Consensus 349 ~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 349 EQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=317.23 Aligned_cols=236 Identities=25% Similarity=0.417 Sum_probs=203.4
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 35689999999999999999999875 6778999999765432 356889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+||||+++++|.+++...+ .+++..++.++.|++.|+ +|||++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 158 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ- 158 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh-
Confidence 9999999999999998654 599999999999999997 69999999999999999998543311
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~L 232 (426)
........+|+.|+|||++.+..++ .++||||+||++|+|++ |..||...+.......+..+. ...|..+++.+.+|
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence 1122344567889999999887775 89999999999999999 999999988887777776664 44567789999999
Q ss_pred HHHccccCcCCCCChHHHhcC
Q 014359 233 LRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h 253 (426)
|.+||+.||++|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=316.60 Aligned_cols=236 Identities=20% Similarity=0.334 Sum_probs=203.7
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK- 86 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~- 86 (426)
.....+++|++.+.||+|+||.||+|.+ .++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 4567889999999999999999999997 488999999986543 333457899999999999999999999999877
Q ss_pred -CeEEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH-----------------hheeeCCCCCEEEeccCCC
Q 014359 87 -SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL-----------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 87 -~~~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al-----------------eNILld~~g~lKl~DFGla 146 (426)
...|+||||+++|+|.+++.... .+++..++.++.|++.|| +|||++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78899999999999999998755 489999999999999996 6999999999999999987
Q ss_pred CCCCcccCCCccccccCCCcccchhhhccCCCCC--chhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCCCC
Q 014359 147 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG--ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP 222 (426)
Q Consensus 147 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~--~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p 222 (426)
.... ....+||+.|+|||++.+..+.. .++|||||||++|+|++|+.||.+.+.......+... ....|
T Consensus 161 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 161 FSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp CTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred eeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 6422 23457899999999998765542 3799999999999999999999988877766665544 45667
Q ss_pred CCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 223 ~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..+++++.+||.+||+.||++|||++++++.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999999999763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=334.88 Aligned_cols=239 Identities=28% Similarity=0.363 Sum_probs=198.5
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CC-----CccceeEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP-----NVVRLHEVL 83 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~ 83 (426)
....++|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++ |+ +|+++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 34568999999999999999999999999999999999743 233567788999988885 44 499999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH-----------------hheeeC--CCCCEEEec
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL-----------------ENILLD--SKGNIKISD 142 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al-----------------eNILld--~~g~lKl~D 142 (426)
...+..|+||||+. |+|.+++... .++++..++.++.|++.|| +|||++ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999996 5999999865 4699999999999999996 699995 477899999
Q ss_pred cCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCC-
Q 014359 143 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL- 221 (426)
Q Consensus 143 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~- 221 (426)
||+|+... ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 205 FG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 205 FGSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp CTTCEETT-----CCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred ccCceecc-----cccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99998542 224467899999999999988875 89999999999999999999999888776665554311000
Q ss_pred ------------------------------------CCC---------------------------CCHHHHHHHHHccc
Q 014359 222 ------------------------------------PKW---------------------------LSPGAQNLLRKILE 238 (426)
Q Consensus 222 ------------------------------------p~~---------------------------~s~~~~~Li~~~L~ 238 (426)
|.+ .++++.+||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 000 01378999999999
Q ss_pred cCcCCCCChHHHhcCcCCccC
Q 014359 239 PNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 239 ~dP~~R~t~~~il~h~w~~~~ 259 (426)
.||++|||++|+++||||++.
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC-
T ss_pred CChhhCCCHHHHhcCcccccC
Confidence 999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=329.95 Aligned_cols=240 Identities=31% Similarity=0.581 Sum_probs=198.7
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcC----CCCCccceeEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLL----KHPNVVRLHEV 82 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~HpnIv~l~~~ 82 (426)
....++|++++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 4456789999999999999999999999999999999976543221 1123466799999998 89999999999
Q ss_pred EEeCCeEEEEEcc-cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeC-CCCCEEEeccCC
Q 014359 83 LASKSKIYMVLEY-VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLD-SKGNIKISDFGL 145 (426)
Q Consensus 83 ~~~~~~~~lVmEy-~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld-~~g~lKl~DFGl 145 (426)
+.+.+..|+|||| +.+++|.+++...+.+++..++.++.||+.|| +|||++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999999888899999999999999997 699999 889999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCC
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 225 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 225 (426)
+..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... .+......+|..+
T Consensus 187 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~ 256 (312)
T 2iwi_A 187 GALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHV 256 (312)
T ss_dssp CEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTS
T ss_pred hhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccC
Confidence 985432 234566799999999999887776668999999999999999999998643 2445667788889
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
++.+.+||.+||+.||++|||++++++||||+..
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 9999999999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=336.52 Aligned_cols=237 Identities=28% Similarity=0.426 Sum_probs=193.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC--------CCCccceeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--------HPNVVRLHEV 82 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~ 82 (426)
...++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++ ||||++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 3457999999999999999999999999999999999743 233577889999999985 7889999999
Q ss_pred EE----eCCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH----------------hheeeCCCC----
Q 014359 83 LA----SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL----------------ENILLDSKG---- 136 (426)
Q Consensus 83 ~~----~~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al----------------eNILld~~g---- 136 (426)
+. ....+|+||||+ +++|.+.+... .++++..++.++.||+.|| +|||++.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence 87 456799999999 66777777654 5699999999999999996 699999876
Q ss_pred ---------------------------------------------CEEEeccCCCCCCCcccCCCccccccCCCcccchh
Q 014359 137 ---------------------------------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171 (426)
Q Consensus 137 ---------------------------------------------~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE 171 (426)
.+||+|||+|..... .....+||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCCh
Confidence 899999999985432 244568999999999
Q ss_pred hhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHHh--CC-------------------------
Q 014359 172 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN------LAVLYQKIFR--GD------------------------- 218 (426)
Q Consensus 172 ~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~------~~~~~~~i~~--~~------------------------- 218 (426)
++.+..++ .++|||||||++|+|++|+.||...+ .......+.. +.
T Consensus 264 ~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 264 VLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 99988875 89999999999999999999997543 1122211111 11
Q ss_pred ---------------CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 219 ---------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 219 ---------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
...+...++.+.+||.+||+.||++|||++|+++||||++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 1112223567889999999999999999999999999963
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=318.11 Aligned_cols=236 Identities=22% Similarity=0.384 Sum_probs=201.9
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...++|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 44569999999999999999999885 6778999999765432 367889999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+||||+++|+|.+++.. ..++++..++.++.|++.|+ +|||++.++.+||+|||++.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 99999999999999976 56799999999999999997 69999999999999999998543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........+|+.|+|||++.+..+ +.++||||+||++|+|++ |+.||...+.......+..+ ....|..+++.+.+|
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 112234457889999999988877 489999999999999998 99999998888887777766 345667789999999
Q ss_pred HHHccccCcCCCCChHHHhcC
Q 014359 233 LRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h 253 (426)
|.+||+.||.+|||+.++++|
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=323.29 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=197.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC--CCCccceeEEEEeCCeE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~ 89 (426)
.-++|++++.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+++.++ ||||+++++++.+.+..
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3457999999999999999999984 588999999976543 3344678999999999997 59999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||| +.+++|.+++.....+++..++.++.|++.|| +|||++ ++.+||+|||++........
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 99999 55889999999888999999999999999997 699996 48999999999986544322
Q ss_pred CCccccccCCCcccchhhhccC----------CCCCchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHHHHhC--CCCC
Q 014359 155 DGLLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKL 221 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~----------~~~~~~~DIwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~--~~~~ 221 (426)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+... ...+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC
Confidence 2234466899999999998752 233589999999999999999999998753 23334444433 3456
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCC
Q 014359 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 263 (426)
Q Consensus 222 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~ 263 (426)
|...+.++.+||.+||+.||.+|||+.++++||||+....+.
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~ 303 (313)
T 3cek_A 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303 (313)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence 777899999999999999999999999999999998755443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=326.35 Aligned_cols=241 Identities=25% Similarity=0.441 Sum_probs=205.6
Q ss_pred CccccCEEEeceeeecCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE 81 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 81 (426)
....++|++++.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++++ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 345589999999999999999999986 356789999997543 334467899999999999 8999999999
Q ss_pred EEEeCCeEEEEEcccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hhe
Q 014359 82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENI 130 (426)
Q Consensus 82 ~~~~~~~~~lVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNI 130 (426)
++.+.+..|+||||+++|+|.+++.... .+++..++.++.||+.|| +||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999998643 389999999999999997 699
Q ss_pred eeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHH
Q 014359 131 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 209 (426)
Q Consensus 131 Lld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~ 209 (426)
|++.++.+||+|||++................+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999999854432221223345678999999999887764 89999999999999999 999999988888
Q ss_pred HHHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 210 LYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 210 ~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
....+..+. ...|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 877776654 55677899999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=321.56 Aligned_cols=233 Identities=22% Similarity=0.293 Sum_probs=198.4
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCC-------ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 83 (426)
...++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45689999999999999999999988776 469999996543 33357899999999999999999999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHH---------------hheeeCCCCC--------EE
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGL---------------ENILLDSKGN--------IK 139 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~al---------------eNILld~~g~--------lK 139 (426)
.+.+..|+||||+++|+|.+++..... +++..++.++.||+.|| +|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987554 99999999999999997 7999999987 99
Q ss_pred EeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC
Q 014359 140 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 218 (426)
Q Consensus 140 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 218 (426)
|+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++ |.+||...+..... ......
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDR 234 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhcc
Confidence 999999974322 2345789999999999874444699999999999999999 55666655544433 344456
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 219 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 219 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
...|...++++.+||.+||+.||++|||+.++++|
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 67777789999999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=317.58 Aligned_cols=242 Identities=29% Similarity=0.473 Sum_probs=194.2
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
+...+++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++...+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 34567899999999999999999999999999999999986554455567789999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
.|+||||+++|+|.+++.. ...+++..++.++.|++.|| +|||++.++.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999999864 45699999999999999997 6999999999999999999854
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc--cHHHHHHHHHhCCCCC--CCCC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRGDFKL--PKWL 225 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~--p~~~ 225 (426)
.. .........||+.|+|||++.+..++ .++|||||||++|+|++|..||.+. +.......+.....+. +..+
T Consensus 187 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 187 SS--KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred cC--CCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence 33 12233456799999999999887774 8999999999999999999999764 3345555555544332 2568
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
++++.+||.+||+.||++|||+.+++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=314.42 Aligned_cols=235 Identities=26% Similarity=0.413 Sum_probs=190.7
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc-hhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
...++|++.+.||+|+||.||+|.+ +++.||||++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4578999999999999999999997 48899999987543322 22357789999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH------------------hheeeCC--------CCCEEEecc
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------------------ENILLDS--------KGNIKISDF 143 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al------------------eNILld~--------~g~lKl~DF 143 (426)
|+||||+++++|.+++.. +++++..++.++.|++.|+ +|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999998864 6799999999999999996 6999986 778999999
Q ss_pred CCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC--CCC
Q 014359 144 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKL 221 (426)
Q Consensus 144 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~ 221 (426)
|++..... .......||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+.......+.... .+.
T Consensus 161 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 161 GLAREWHR----TTKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred Cccccccc----ccccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 99985432 223356899999999999887774 89999999999999999999999988776666665543 456
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 222 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 67899999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=329.54 Aligned_cols=242 Identities=24% Similarity=0.375 Sum_probs=201.1
Q ss_pred ccccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|.+. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34579999999999999999999973 466789999997543 222347899999999999 8999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHH--------------
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKG-----------------------RLQEAEGRKLFQQLIDGL-------------- 127 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~ql~~al-------------- 127 (426)
..+..|+||||+++|+|.+++.... .+++..++.++.||+.||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999998643 379999999999999997
Q ss_pred -hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCc
Q 014359 128 -ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 205 (426)
Q Consensus 128 -eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~ 205 (426)
+|||++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 6999999999999999999865432222233456788999999999887774 99999999999999998 99999887
Q ss_pred cHHHHHHHHHh-C-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcC
Q 014359 206 NLAVLYQKIFR-G-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 206 ~~~~~~~~i~~-~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w 255 (426)
+....+..... + ....|..+++++.+||.+||+.||.+|||+.++++|..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 65444433333 3 34567789999999999999999999999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=329.74 Aligned_cols=239 Identities=31% Similarity=0.563 Sum_probs=170.6
Q ss_pred CCccccCEEEec-eeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--
Q 014359 9 EGMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-- 85 (426)
Q Consensus 9 ~~~~~~~y~i~~-~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-- 85 (426)
.....++|++.+ .||+|+||.||+|.+..+++.||||++.... ....+....++.++||||+++++++..
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 345668999965 6999999999999999999999999996531 122223344677799999999999976
Q ss_pred --CCeEEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCC---CCEEEecc
Q 014359 86 --KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSK---GNIKISDF 143 (426)
Q Consensus 86 --~~~~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~---g~lKl~DF 143 (426)
....|+||||++||+|.+++.... .+++..++.++.||+.|| +|||++.+ +.+||+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 456899999999999999998754 699999999999999997 69999874 45999999
Q ss_pred CCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHH----HHHHHhCCC
Q 014359 144 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDF 219 (426)
Q Consensus 144 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~ 219 (426)
|++.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.... ...+..+..
T Consensus 176 g~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 176 GFAKETT----QNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp TTCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccceecc----ccccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 9998433 2234567899999999999777664 899999999999999999999987654432 222333333
Q ss_pred CCC----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 220 KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 220 ~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
..| ..+++++.+||.+||+.||.+|||++++++||||++.
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 322 4589999999999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.12 Aligned_cols=239 Identities=27% Similarity=0.424 Sum_probs=192.9
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
....++|++++.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 45568999999999999999999998653 4569999986542 3444678999999999999999999999984 5
Q ss_pred CeEEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
+..|+||||+++|+|.+++.... .+++..++.++.|++.|| +|||++.++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 67899999999999999998654 699999999999999997 69999999999999999998654
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 228 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 228 (426)
... ........+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.
T Consensus 168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 168 DST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred ccc-ccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 321 1123345678899999999887775 89999999999999997 99999988777777776665 35677889999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+.+||.+||+.||++|||+.+++++
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=320.71 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=187.1
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
+-...+++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+.++..+++.++||||+++++++.+.+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 344567899999999999999999999999999999999986542 2222344555566788889999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
..|+||||+ ++.+..+... ..++++..++.++.|++.|| +|||++.++.+||+|||++....
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 5555555543 56799999999999999996 69999999999999999997543
Q ss_pred cccCCCccccccCCCcccchhhhc-----cCCCCCchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHHhCCC-CCC-
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDF-KLP- 222 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~-~~p- 222 (426)
. .......+||+.|+|||++. ...+ +.++|||||||++|+|++|+.||.. .+.......+..+.. ..|
T Consensus 177 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (318)
T 2dyl_A 177 D---DKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCS
T ss_pred C---CccccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCc
Confidence 2 22334568999999999985 3334 5899999999999999999999987 344455555555543 233
Q ss_pred -CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 223 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 223 -~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 3489999999999999999999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=326.39 Aligned_cols=239 Identities=26% Similarity=0.400 Sum_probs=197.6
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC------ccceeEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN------VVRLHEV 82 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~ 82 (426)
....++|++.+.||+|+||.||+|.+..++ +.||||++... ....+.+.+|+.+++.++|++ ++.++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 345589999999999999999999998776 78999999643 233567889999999998766 9999999
Q ss_pred EEeCCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheee-------------
Q 014359 83 LASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILL------------- 132 (426)
Q Consensus 83 ~~~~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILl------------- 132 (426)
+...+..|+||||+ +++|.+.+... .++++..++.++.||+.|| +|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 67888888764 3699999999999999997 69999
Q ss_pred ------CCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc
Q 014359 133 ------DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 206 (426)
Q Consensus 133 ------d~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~ 206 (426)
+.++.+||+|||+++... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCC
Confidence 567899999999998532 223456899999999999888775 89999999999999999999999877
Q ss_pred HHHHHHHHHhCCCCCC--------------------------------------------CCCCHHHHHHHHHccccCcC
Q 014359 207 LAVLYQKIFRGDFKLP--------------------------------------------KWLSPGAQNLLRKILEPNPV 242 (426)
Q Consensus 207 ~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~Li~~~L~~dP~ 242 (426)
.......+.....+.| ...++++.+||.+||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 6554433322111111 11245788999999999999
Q ss_pred CCCChHHHhcCcCCccC
Q 014359 243 KRITIAGIKADEWFEQD 259 (426)
Q Consensus 243 ~R~t~~~il~h~w~~~~ 259 (426)
+|||++|+++||||...
T Consensus 324 ~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 324 QRITLAEALLHPFFAGL 340 (355)
T ss_dssp TSCCHHHHTTSGGGGGC
T ss_pred hCcCHHHHhcChhhcCC
Confidence 99999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=323.22 Aligned_cols=240 Identities=27% Similarity=0.410 Sum_probs=202.3
Q ss_pred ccccCEEEeceeeecCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 3457999999999999999999985 4577899999997553 233457899999999999 8999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCC------------------CCCHHHHHHHHHHHHHHH---------------hhee
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGL---------------ENIL 131 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~------------------~l~e~~~~~~~~ql~~al---------------eNIL 131 (426)
+.+..|+||||+++|+|.+++.... ++++..++.++.||+.|| +|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 9999999999999999999998654 489999999999999997 6999
Q ss_pred eCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHH
Q 014359 132 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 210 (426)
Q Consensus 132 ld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~ 210 (426)
++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999865443222233455688999999999887764 99999999999999999 9999988664433
Q ss_pred H-HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 211 Y-QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 211 ~-~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
. ..+..+ ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3 333333 334467799999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=325.40 Aligned_cols=239 Identities=26% Similarity=0.395 Sum_probs=203.5
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceE--EEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF--AVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~v--AvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 85 (426)
+...+++|++.+.||+|+||.||+|.+..++..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 4567789999999999999999999998888865 999887532 223356789999999999 89999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHH---------------hheeeCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGL---------------ENILLDS 134 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~al---------------eNILld~ 134 (426)
.+..|+||||+++|+|.+++.... .+++..++.++.||+.|| +|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 999999999999999999997654 699999999999999997 6999999
Q ss_pred CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHH
Q 014359 135 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 213 (426)
Q Consensus 135 ~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 213 (426)
++.+||+|||+++.... ........+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+....+..
T Consensus 178 ~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp GGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 99999999999974322 1223345678999999999887764 89999999999999998 9999999888888877
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 214 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 214 i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+..+ ....|..+++.+.+||.+||+.||.+|||+++++++
T Consensus 254 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 254 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7665 355677799999999999999999999999999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=326.47 Aligned_cols=239 Identities=21% Similarity=0.315 Sum_probs=194.7
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceE----EEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
...++|++.+.||+|+||.||+|.+..+++.| |+|.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45678999999999999999999998777755 667665332 223357899999999999999999999999876
Q ss_pred CeEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
. .++|+||+.+|+|.+++.. ...+++..++.++.||+.|| +|||++.++++||+|||+|+...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999986 45799999999999999997 69999999999999999998554
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 228 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 228 (426)
............||+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+.......+..+ ..+.|..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 32222233445678899999999988775 99999999999999999 99999988777666666555 35667789999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+.+|+.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=327.85 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=201.4
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 84 (426)
.....++|++++.||+|+||.||+|.+..+++. ||+|++..... ......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 345568999999999999999999999888876 66666643321 112346778999999999999999999986
Q ss_pred eCCeEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
....|+||||+.+|+|.+++... +.+++..+..++.||+.|| +|||++.++.+||+|||+++.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 45689999999999999999864 5799999999999999997 699999999999999999987
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCC
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS 226 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 226 (426)
..............||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ....|..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT 243 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCc
Confidence 6543333344566788999999999888774 99999999999999999 99999988777777776665 456677899
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+++.+||.+||+.||.+|||+.++++|
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 244 IDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.18 Aligned_cols=239 Identities=15% Similarity=0.165 Sum_probs=180.1
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC--CCCCcccee-------EEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLH-------EVL 83 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~-------~~~ 83 (426)
..+|++++.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999886554445567788885544444 699987755 555
Q ss_pred EeC-----------------CeEEEEEcccCCCChHHHHHhCC-CCCHHHH------HHHHHHHHHHH------------
Q 014359 84 ASK-----------------SKIYMVLEYVTGGELFDKIASKG-RLQEAEG------RKLFQQLIDGL------------ 127 (426)
Q Consensus 84 ~~~-----------------~~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~------~~~~~ql~~al------------ 127 (426)
... ..+|+||||++ |+|.+++...+ .+++... ..++.||+.||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 543 33899999998 79999998633 3444444 46669999997
Q ss_pred ---hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCC
Q 014359 128 ---ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPF 202 (426)
Q Consensus 128 ---eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf 202 (426)
+|||++.+|.+||+|||+|+.... ......||+.|+|||++.+ ..| +.++|||||||++|+|++|+.||
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCST
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCC
Confidence 799999999999999999985422 2225567799999999976 556 59999999999999999999999
Q ss_pred CCccHHH--HHHH-----HHhCCCCCC--CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 203 DDRNLAV--LYQK-----IFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 203 ~~~~~~~--~~~~-----i~~~~~~~p--~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.+.+... .+.. .....+.+| ..+++.+.+||.+||+.||++|||+.++++||||.+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 8764321 1100 001122223 468999999999999999999999999999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=318.69 Aligned_cols=242 Identities=24% Similarity=0.377 Sum_probs=195.3
Q ss_pred cCCccccCEEEeceeeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEE
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL 83 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 83 (426)
...+..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345667899999999999999999998 5668999999998754 334457899999999999999999999998
Q ss_pred Ee--CCeEEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 84 AS--KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 84 ~~--~~~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
.. ...+|+||||+++|+|.+++.... ++++..+..++.|++.|| +|||++.++.+||+|||+
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 54 356899999999999999998644 599999999999999997 699999999999999999
Q ss_pred CCCCCcccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH----------------
Q 014359 146 SALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------- 208 (426)
Q Consensus 146 a~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---------------- 208 (426)
+......... .......||+.|+|||++.+..++ .++||||+||++|+|++|..||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9865432211 223344678889999999888775 9999999999999999999998754322
Q ss_pred HHHHHHHh-CCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 209 VLYQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 209 ~~~~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.....+.. ...+.|..+++++.+||.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11222222 3456678899999999999999999999999999763
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=322.30 Aligned_cols=240 Identities=21% Similarity=0.300 Sum_probs=206.4
Q ss_pred ccccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
+..++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 44578999999999999999999876 357889999997543 23335678999999999999999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEE
Q 014359 86 KSKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKI 140 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~----------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl 140 (426)
.+..|+||||+++|+|.+++... .++++..+..++.||+.|| +|||++.++.+||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 99999999999999999999752 4579999999999999997 6999999999999
Q ss_pred eccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-
Q 014359 141 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD- 218 (426)
Q Consensus 141 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~- 218 (426)
+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 999999854332222233445678999999999887774 89999999999999999 999999988888777776654
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 219 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 219 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
...|..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 45677899999999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.18 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=179.9
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHhcCCCCCccceeEEEEeC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~ 86 (426)
.-....++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+. +++.++||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 34566789999999999999999999999999999999997653 2223445566665 77888999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCC
Q 014359 87 SKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~-----~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGl 145 (426)
+..|+||||+.+ +|.+++.. ...+++..++.++.|++.|+ +|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999999975 88888763 56799999999999999996 699999999999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhc----cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHHhCCC-
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDF- 219 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~- 219 (426)
+..... .......+||+.|+|||++. +..+ +.++|||||||++|+|++|+.||.+.+. ......+..+..
T Consensus 173 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 173 SGQLVD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp SCC---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred ceeccc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 985432 22233458999999999983 4445 4899999999999999999999987542 222222222222
Q ss_pred CCC----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 220 KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 220 ~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.++ ..+++.+.+||.+||+.||++|||+.++++||||...
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 222 3589999999999999999999999999999999763
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=310.87 Aligned_cols=235 Identities=22% Similarity=0.383 Sum_probs=203.9
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence 4578999999999999999999985 6778999999865432 3678999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
||||+++++|.+++... ..+++..+..++.|++.|+ +||+++.++.+||+|||++....... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 159 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 159 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence 99999999999999864 5699999999999999997 69999999999999999998543211 1
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 233 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li 233 (426)
.......||+.|+|||++.+..++ .++||||+|+++|+|++ |..||...+.......+..+. ...|..+++.+.+||
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 238 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 238 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred cccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHH
Confidence 122345678899999999887774 89999999999999999 999999988888887777663 455677899999999
Q ss_pred HHccccCcCCCCChHHHhcC
Q 014359 234 RKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h 253 (426)
.+||+.||++|||+.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 239 NHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.92 Aligned_cols=239 Identities=25% Similarity=0.431 Sum_probs=194.0
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----------CCCccce
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVRL 79 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l 79 (426)
...++|++++.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.++++++ ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 45679999999999999999999999999999999997532 23467889999999886 8999999
Q ss_pred eEEEEeCC----eEEEEEcccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH----------------hheeeC----
Q 014359 80 HEVLASKS----KIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL----------------ENILLD---- 133 (426)
Q Consensus 80 ~~~~~~~~----~~~lVmEy~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al----------------eNILld---- 133 (426)
++++...+ .+++||||+ +++|.+++.. ..++++..++.++.||+.|| +|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99997654 789999999 8899999986 34599999999999999996 699994
Q ss_pred --CCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH----
Q 014359 134 --SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---- 207 (426)
Q Consensus 134 --~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---- 207 (426)
.++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 444899999999985432 23456899999999999988774 899999999999999999999986431
Q ss_pred --HHHHHHHH------------------------------------------hCCCCCCCCCCHHHHHHHHHccccCcCC
Q 014359 208 --AVLYQKIF------------------------------------------RGDFKLPKWLSPGAQNLLRKILEPNPVK 243 (426)
Q Consensus 208 --~~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~Li~~~L~~dP~~ 243 (426)
......+. .....+|..+++++.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111111 1122333445678999999999999999
Q ss_pred CCChHHHhcCcCCccCC
Q 014359 244 RITIAGIKADEWFEQDY 260 (426)
Q Consensus 244 R~t~~~il~h~w~~~~~ 260 (426)
|||++|+++||||++..
T Consensus 325 Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CBCHHHHHTCGGGTTCT
T ss_pred cCCHHHHhhChhhhccc
Confidence 99999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=316.50 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=200.5
Q ss_pred CchhhcccCCcc--ccCEEEec-eeeecCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC
Q 014359 1 MVIAEKKQEGMR--LGRYELGR-TLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75 (426)
Q Consensus 1 m~~~~~~~~~~~--~~~y~i~~-~LG~G~fg~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn 75 (426)
|...+..+..+. .++|++.+ .||+|+||.||+|.+ ..+++.||||++..... .....+.+.+|+.+++.++|||
T Consensus 1 m~~~~i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~ 79 (291)
T 1xbb_A 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPY 79 (291)
T ss_dssp ----------CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTT
T ss_pred CcccccCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCC
Confidence 333344444433 46899999 999999999999954 56788999999976532 3334678999999999999999
Q ss_pred ccceeEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEE
Q 014359 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKI 140 (426)
Q Consensus 76 Iv~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl 140 (426)
|+++++++ ..+..|+||||+++++|.+++...+.+++..++.++.|++.|| +|||++.++.+||
T Consensus 80 i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp BCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred EEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEE
Confidence 99999999 5677899999999999999999888899999999999999997 6999999999999
Q ss_pred eccCCCCCCCcccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC
Q 014359 141 SDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 218 (426)
Q Consensus 141 ~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 218 (426)
+|||++......... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+.......+..+.
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 237 (291)
T 1xbb_A 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 237 (291)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred ccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999854332111 112234577899999999887764 89999999999999999 999999988887777776653
Q ss_pred -CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 219 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 219 -~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
...|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5667889999999999999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=325.59 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=203.4
Q ss_pred CccccCEEEeceeeecCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 84 (426)
....++|++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3456899999999999999999999 55678899999997442 3334567899999999999999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHH---------------hheeeCCC---CCEE
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGL---------------ENILLDSK---GNIK 139 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~-------~l~e~~~~~~~~ql~~al---------------eNILld~~---g~lK 139 (426)
+....|+||||+++|+|.+++.... .+++..++.++.||+.|| +|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998653 499999999999999997 69999954 4699
Q ss_pred EeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-
Q 014359 140 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG- 217 (426)
Q Consensus 140 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~- 217 (426)
|+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 9999998743222222233456789999999999887774 89999999999999998 99999998887777777665
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 218 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 218 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
....|..+++.+.+||.+||+.||.+|||+.++++|.|+..
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 45567789999999999999999999999999999988654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=316.39 Aligned_cols=238 Identities=26% Similarity=0.386 Sum_probs=206.9
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 455689999999999999999999999999999999997542 2357789999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 90 YMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
|+||||+++++|.+++... ..+++..++.++.|++.|| +||+++.++.+||+|||++......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999999863 4599999999999999996 7999999999999999999865431
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 230 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 230 (426)
.........+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+... ....|..+++.+.
T Consensus 165 -~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (288)
T 3kfa_A 165 -TYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242 (288)
T ss_dssp -SSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -ccccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHH
Confidence 11223345678899999999888774 89999999999999999 99999988877776666655 4566778999999
Q ss_pred HHHHHccccCcCCCCChHHHhcC
Q 014359 231 NLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+||.+||..||.+|||+.++++.
T Consensus 243 ~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 243 ELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCChhhCcCHHHHHHH
Confidence 99999999999999999999763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.20 Aligned_cols=240 Identities=26% Similarity=0.384 Sum_probs=201.9
Q ss_pred ccccCEEEeceeeecCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|.+ ..+++.||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 4457999999999999999999985 3577899999997653 333456789999999999 6999999999987
Q ss_pred eCC-eEEEEEcccCCCChHHHHHhCCC----------------CCHHHHHHHHHHHHHHH---------------hheee
Q 014359 85 SKS-KIYMVLEYVTGGELFDKIASKGR----------------LQEAEGRKLFQQLIDGL---------------ENILL 132 (426)
Q Consensus 85 ~~~-~~~lVmEy~~gg~L~~~i~~~~~----------------l~e~~~~~~~~ql~~al---------------eNILl 132 (426)
..+ .+|+||||+++|+|.+++..... +++..++.++.||+.|+ +|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 654 59999999999999999987543 89999999999999997 69999
Q ss_pred CCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHH-HH
Q 014359 133 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VL 210 (426)
Q Consensus 133 d~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~-~~ 210 (426)
+.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.. ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 99999999999999865432222233456789999999999888775 99999999999999998 99999876543 33
Q ss_pred HHHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 211 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 211 ~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
...+..+ ....|..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4444444 456678899999999999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=318.18 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=193.4
Q ss_pred ccccCEEEeceeeecCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
...++|++++.||+|+||.||+|.+.. +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 345799999999999999999998765 556899999976543 3334578999999999999999999999997655
Q ss_pred -----eEEEEEcccCCCChHHHHH------hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEe
Q 014359 88 -----KIYMVLEYVTGGELFDKIA------SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKIS 141 (426)
Q Consensus 88 -----~~~lVmEy~~gg~L~~~i~------~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~ 141 (426)
..|+||||+++|+|.+++. ....+++..++.++.||+.|| +|||++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 3599999999999999994 335699999999999999997 69999999999999
Q ss_pred ccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CC
Q 014359 142 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF 219 (426)
Q Consensus 142 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~ 219 (426)
|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence 99999865432222233445678899999999887775 89999999999999999 99999988777777776665 45
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 220 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 220 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6677899999999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=320.40 Aligned_cols=239 Identities=21% Similarity=0.324 Sum_probs=195.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceE----EEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
...++|++++.||+|+||.||+|.+..+++.| |+|.+.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 45689999999999999999999998888766 555554322 223357899999999999999999999999876
Q ss_pred CeEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
. .++||||+.+|+|.+++.. ...+++..++.++.||+.|| +|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 8899999999999999976 45799999999999999997 79999999999999999998654
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 228 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 228 (426)
............||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999988775 89999999999999999 99999988777776666655 35667789999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+.+||.+||+.||.+|||+.++++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=313.86 Aligned_cols=238 Identities=17% Similarity=0.213 Sum_probs=198.4
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
....-++|++++.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.+++.+ +||||+++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 34456789999999999999999999999999999999875432 24578899999999 7999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCC-----EEEeccCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGN-----IKISDFGLS 146 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~-----lKl~DFGla 146 (426)
..|+||||+ +++|.+++...+ ++++..++.++.||+.|| +|||++.++. +||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 999999998654 599999999999999997 6999988776 999999999
Q ss_pred CCCCcccCC-----CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc---cHHHHHHHHHhCC
Q 014359 147 ALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGD 218 (426)
Q Consensus 147 ~~~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~ 218 (426)
......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+. +....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 865432211 12356689999999999988877 49999999999999999999999873 3344444443322
Q ss_pred C-----CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 219 F-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 219 ~-----~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
. ..+..+++++.+||.+||+.||++|||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1 1234689999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.88 Aligned_cols=232 Identities=21% Similarity=0.261 Sum_probs=195.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 91 (426)
-++|++++.||+|+||.||+|.+..+++.||||++..... .+.+.+|+.+++.+ +||||+++++++......|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 3689999999999999999999999999999999875432 23578999999999 89999999999999999999
Q ss_pred EEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC-----EEEeccCCCCCCC
Q 014359 92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN-----IKISDFGLSALPQ 150 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~-----lKl~DFGla~~~~ 150 (426)
||||+ +++|.+++.. .+.+++..++.++.|++.|| +|||++.++. +||+|||+++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 9999999986 46799999999999999997 7999999987 9999999998643
Q ss_pred cccCC-----CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC---ccHHHHHHHHHhCCCCCC
Q 014359 151 HFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLP 222 (426)
Q Consensus 151 ~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p 222 (426)
..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+ .+..+.+..+.......|
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 32211 123467899999999999988774 999999999999999999999987 344455555544433322
Q ss_pred -----CCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 223 -----KWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 223 -----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..++ ++.+||.+||+.||.+||++++|++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2244 9999999999999999999998876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=314.26 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=204.1
Q ss_pred ccccCEEEec-eeeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 11 MRLGRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~-~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
...++|.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 3457898887 9999999999999864 467889999997643 334467899999999999999999999999 556
Q ss_pred eEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..|+||||+++++|.+++... ..+++..++.++.|++.|| +|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 699999999999999999653 5699999999999999997 699999999999999999985533
Q ss_pred ccC-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHH
Q 014359 152 FRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPG 228 (426)
Q Consensus 152 ~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 228 (426)
... ........||+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+..+....+..+. ...|..++++
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 241 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence 211 1122344678999999999877764 89999999999999998 999999888777777776653 5677889999
Q ss_pred HHHHHHHccccCcCCCCChHHHhcCcC
Q 014359 229 AQNLLRKILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 229 ~~~Li~~~L~~dP~~R~t~~~il~h~w 255 (426)
+.+||.+||+.||++|||+.++++|.|
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999998755
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=333.06 Aligned_cols=229 Identities=25% Similarity=0.473 Sum_probs=198.0
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC-eE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~ 89 (426)
...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|++++||||+++++++.... ..
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 45689999999999999999999874 7799999997543 2467899999999999999999999987665 79
Q ss_pred EEEEcccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 90 YMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
|+||||+++|+|.+++...+. +++..+..++.|++.|| +|||++.++.+||+|||+++....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 341 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 341 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-
Confidence 999999999999999987543 79999999999999997 699999999999999999984322
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHH
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 230 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 230 (426)
......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+.
T Consensus 342 ----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 342 ----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 416 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 12334678999999999888775 89999999999999998 99999988777777777665 4667888999999
Q ss_pred HHHHHccccCcCCCCChHHHhc
Q 014359 231 NLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+||.+||+.||++|||+.++++
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=322.82 Aligned_cols=240 Identities=24% Similarity=0.399 Sum_probs=201.4
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA 84 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 84 (426)
...++|++++.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445789999999999999999999876654 79999997543 333467899999999999 8999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhC--------------CCCCHHHHHHHHHHHHHHH---------------hheeeCCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGL---------------ENILLDSK 135 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~--------------~~l~e~~~~~~~~ql~~al---------------eNILld~~ 135 (426)
+.+..|+||||+++|+|.+++... ..+++..++.++.||+.|| +|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 999999999999999999999742 3589999999999999997 69999999
Q ss_pred CCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHH
Q 014359 136 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 214 (426)
Q Consensus 136 g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 214 (426)
+.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.........+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 99999999999865432222223445678899999999887775 99999999999999999 99999886654443333
Q ss_pred Hh-C-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 215 FR-G-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 215 ~~-~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.. + ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 33 2 345567789999999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=310.91 Aligned_cols=238 Identities=25% Similarity=0.380 Sum_probs=196.8
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhH----HHHHHHHHHHHhcCCCCCccceeEEEE
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI----TDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~ 84 (426)
+....++|++.+.||+|+||.||+|.+..+++.||||++.......... .+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 3456689999999999999999999999999999999997654332221 167899999999999999999999997
Q ss_pred eCCeEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH-----------------hheeeCCCCC-----EEEe
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL-----------------ENILLDSKGN-----IKIS 141 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al-----------------eNILld~~g~-----lKl~ 141 (426)
+.. ++||||+++|+|.+.+... .++++..++.++.|++.|+ +|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 665 7999999999999988654 4799999999999999996 6999998886 9999
Q ss_pred ccCCCCCCCcccCCCccccccCCCcccchhhhccC-CCCCchhhHHHHHHHHHHHhcCCCCCCCccHH--HHHHHHHhC-
Q 014359 142 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQKIFRG- 217 (426)
Q Consensus 142 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~- 217 (426)
|||+++... ......+||+.|+|||++.+. ...+.++||||+||++|+|++|+.||...+.. .....+...
T Consensus 172 Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 999998432 234567899999999998432 22358999999999999999999999875432 223333333
Q ss_pred -CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 218 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 218 -~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
....|..+++.+.+||.+||+.||.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 345677899999999999999999999999999763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=327.74 Aligned_cols=240 Identities=20% Similarity=0.347 Sum_probs=193.2
Q ss_pred CccccCEEEeceeeecCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
....++|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 344578999999999999999999876 467789999997543 334467899999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
+..|+||||+++|+|.+++...+ .+++..+..++.||+.|| +|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999998654 699999999999999997 69999999999999999998654
Q ss_pred cccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCH
Q 014359 151 HFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 227 (426)
Q Consensus 151 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 227 (426)
..... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+.......+..+ ..+.|..++.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 32111 111223457899999999888775 89999999999999998 99999988888777777665 3455677899
Q ss_pred HHHHHHHHccccCcCCCCChHHHhc
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.+.+||.+||+.||.+|||+.++++
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=317.68 Aligned_cols=240 Identities=23% Similarity=0.350 Sum_probs=197.9
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
...++|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 44578999999999999999999976543 459999997543 333456789999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
+..|+||||+++|+|.+++... ..+++..++.++.||+.|| +|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999999764 5799999999999999997 69999999999999999998654
Q ss_pred cccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCH
Q 014359 151 HFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP 227 (426)
Q Consensus 151 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~ 227 (426)
..... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 277 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred cccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence 32111 112234568899999999887775 89999999999999999 99999988887777777765 4566777999
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+.+||.+||+.||++|||+.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=319.98 Aligned_cols=236 Identities=21% Similarity=0.250 Sum_probs=187.9
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC---
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--- 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 87 (426)
...++|++++.||+|+||+||+|++. ++.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 44579999999999999999999874 7899999996542 22355667999999999999999999998744
Q ss_pred -eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-------------------------hheeeCCCCCEEEe
Q 014359 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------------------------ENILLDSKGNIKIS 141 (426)
Q Consensus 88 -~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-------------------------eNILld~~g~lKl~ 141 (426)
.+|+||||+++|+|.+++.. .++++..++.++.|++.|| +|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 47999999999999999977 5699999999999999985 59999999999999
Q ss_pred ccCCCCCCCcccCCCccccccCCCcccchhhhccCCC----CCchhhHHHHHHHHHHHhcCCCCCCCcc-----------
Q 014359 142 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY----DGATSDIWSCGVILYVILTGYLPFDDRN----------- 206 (426)
Q Consensus 142 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~----~~~~~DIwSlGvil~elltG~~Pf~~~~----------- 206 (426)
|||+|+..............+||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+..
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999976544333333455789999999999986322 2367899999999999999999997532
Q ss_pred -----HHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 207 -----LAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 207 -----~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.......+..... .++.. .++.+.+||.+||+.||++|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2223333322221 12211 23459999999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.34 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=199.9
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 84 (426)
..+...++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 446677899999999999999999998654 34569999997653 3334678999999999999999999999986
Q ss_pred eCCeEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
+. ..|+||||+++++|.+++... ..+++..++.++.|++.|+ +|||++.++.+||+|||++..
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 54 568999999999999999764 4699999999999999997 699999999999999999986
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCC
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS 226 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 226 (426)
..... ........+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||...+.......+..+ ..+.|..++
T Consensus 163 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (281)
T 3cc6_A 163 IEDED-YYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP 240 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCC
T ss_pred ccccc-ccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCC
Confidence 54321 1123345678899999999887774 89999999999999998 99999876666555555554 456677899
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+.+.+||.+||+.||++|||+.+++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.61 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=195.8
Q ss_pred CccccCEEEeceeeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
.....+|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3445679999999999999999998 56789999999997553 22235788999999999999999999999987
Q ss_pred C--CeEEEEEcccCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCC
Q 014359 86 K--SKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 86 ~--~~~~lVmEy~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~ 147 (426)
. ..+|+||||+++|+|.+++. ...++++..++.++.|++.|| +|||++.++.+||+|||++.
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 67899999999999999995 456799999999999999997 69999999999999999998
Q ss_pred CCCcccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc---------------HHHHH
Q 014359 148 LPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---------------LAVLY 211 (426)
Q Consensus 148 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---------------~~~~~ 211 (426)
........ .......||+.|+|||++.+..++ .++||||+||++|+|++|..|+.... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 65432111 223456789999999999887775 89999999999999999999864321 12223
Q ss_pred HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 212 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 212 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..+..+ ..+.|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 333333 45667889999999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.32 Aligned_cols=232 Identities=23% Similarity=0.388 Sum_probs=198.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe------
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 85 (426)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3478999999999999999999999899999999997542 346789999999999999999999864
Q ss_pred ----------CCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCE
Q 014359 86 ----------KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNI 138 (426)
Q Consensus 86 ----------~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~l 138 (426)
...+|+||||+++|+|.+++... ..+++..++.++.||+.|| +|||++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 45589999999999999999754 5799999999999999997 69999999999
Q ss_pred EEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC
Q 014359 139 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 218 (426)
Q Consensus 139 Kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 218 (426)
||+|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||... ......+..+
T Consensus 162 kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~- 234 (284)
T 2a19_B 162 KIGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG- 234 (284)
T ss_dssp EECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT-
T ss_pred EECcchhheeccc---cccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc-
Confidence 9999999985433 2234456899999999999888774 8999999999999999999987532 2333344333
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 219 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 219 ~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.++..+++.+.+||.+||+.||.+|||+.++++|.|...
T Consensus 235 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 346778999999999999999999999999999988654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.56 Aligned_cols=233 Identities=25% Similarity=0.407 Sum_probs=200.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+. .+..||||+++.... ..+.+.+|+.+|+.++||||+++++++. ....|+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 4468999999999999999999984 577899999976432 2578999999999999999999999986 567899
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
||||+++|+|.+++... ..+++..+..++.||+.|| +|||++.++.+||+|||+++......
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~- 338 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE- 338 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence 99999999999999753 3689999999999999997 69999999999999999998543211
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........+|+.|+|||++....++ .++|||||||++|+|++ |+.||.+.+..+....+..+ ..+.|..+++++.+|
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred eeccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1112234567899999999887775 99999999999999999 99999998888877777665 456678899999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
|.+||+.||++|||+++|++
T Consensus 418 i~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 418 MMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHH
Confidence 99999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=337.72 Aligned_cols=235 Identities=26% Similarity=0.392 Sum_probs=203.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
...+|++.+.||+|+||.||+|.+..++..||||+++.... ..+.+.+|+.+|++++||||+++++++.+...+|+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34689999999999999999999988899999999975432 25678999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
||||+++|+|.+++... ..+++..+..++.||+.|| +|||++.++.+||+|||+++..... .
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 372 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-T 372 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-C
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC-c
Confidence 99999999999999863 4599999999999999997 6999999999999999999865321 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+....+..+..+ ....|..+++.+.+|
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1112334567899999999887774 89999999999999999 99999988877777666654 456678899999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
|.+||+.||++|||+.++++
T Consensus 452 i~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999976
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=306.82 Aligned_cols=237 Identities=23% Similarity=0.354 Sum_probs=198.2
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE-
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI- 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~- 89 (426)
-.|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 367888999999999999999765544 79999987532 344467889999999999999999999999876655
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+.+|+|.+++.. ...+++..++.++.|++.|| +|||++.++.+||+|||++.......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999999986 45699999999999999997 69999999999999999998543321
Q ss_pred --CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHH
Q 014359 154 --DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGA 229 (426)
Q Consensus 154 --~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 229 (426)
.........+|+.|+|||++.+..++ .++||||+||++|+|++ |.+||...+.......+..+. .+.|..+++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence 12233456789999999999888775 89999999999999999 666677766666666665553 55677899999
Q ss_pred HHHHHHccccCcCCCCChHHHhcC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+||.+||+.||.+|||+.++++.
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999998763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=311.28 Aligned_cols=238 Identities=23% Similarity=0.410 Sum_probs=183.5
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.+.-++|++++.||+|+||.||+|.+. ..||||++..... .....+.+.+|+.+++.++||||++++++. .....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 445579999999999999999999853 3599999976543 344467899999999999999999999965 55668
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
++||||+++++|.+++.. ...+++..++.++.|++.|| +|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999999999964 45799999999999999997 69999999999999999998654433
Q ss_pred CCCccccccCCCcccchhhhc---cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHHhCCCC-----CCCC
Q 014359 154 DDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFK-----LPKW 224 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~---~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~-----~p~~ 224 (426)
........+||+.|+|||++. +..+ +.++|||||||++|+|++|+.||.+.+. ......+..+... .+..
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 334445678999999999986 3444 4799999999999999999999987554 3444444444332 2346
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+++.+.+||.+||+.||.+|||+.++++.
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 88999999999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=309.00 Aligned_cols=230 Identities=25% Similarity=0.470 Sum_probs=192.1
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-Ce
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-SK 88 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~ 88 (426)
....++|++.+.||+|+||.||+|.+ +++.||||++.... ..+.+.+|+.+++.++||||+++++++... +.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 35568999999999999999999987 48899999987542 256789999999999999999999997544 57
Q ss_pred EEEEEcccCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 89 IYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
.|+||||+++|+|.+++..... +++..++.++.|++.|+ +||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999999999999976543 89999999999999997 699999999999999999985332
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 229 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 229 (426)
......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+ ....|..+++.+
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 -----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred -----cccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 22345789999999999887774 89999999999999998 99999988777776666555 456677899999
Q ss_pred HHHHHHccccCcCCCCChHHHhc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.++|.+||+.||++|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=315.82 Aligned_cols=240 Identities=26% Similarity=0.388 Sum_probs=199.5
Q ss_pred CccccCEEEeceeeecCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE-
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA- 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~- 84 (426)
-..-++|++.+.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 3455799999999999999999999 4678999999999754 3344577999999999999999999999986
Q ss_pred -eCCeEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCC
Q 014359 85 -SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 85 -~~~~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~ 147 (426)
+....|+||||+++|+|.+++.. ..++++..++.++.|++.|| +|||++.++.+||+|||++.
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 45679999999999999999976 45699999999999999997 69999999999999999998
Q ss_pred CCCcccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH---------------HHH
Q 014359 148 LPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------VLY 211 (426)
Q Consensus 148 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---------------~~~ 211 (426)
........ .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 65332111 12334568899999999988776 48999999999999999999999654432 222
Q ss_pred HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 212 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 212 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..+..+ ..+.|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 233332 355677899999999999999999999999999765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=305.65 Aligned_cols=234 Identities=26% Similarity=0.399 Sum_probs=199.0
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
+..++|++++.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+ +..|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 34579999999999999999999974 667899999975432 14678999999999999999999999864 5589
Q ss_pred EEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+||||+++++|.+++.... .+++..+..++.|++.|| +|||++.++.+||+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999999997543 699999999999999997 69999999999999999998553311
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 231 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 231 (426)
........+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+..+....+..+ ....|..+++++.+
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 241 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -cccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence 1122344678899999999877664 89999999999999999 99999998887777777665 34556779999999
Q ss_pred HHHHccccCcCCCCChHHHhc
Q 014359 232 LLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~ 252 (426)
||.+||+.||++|||+.++++
T Consensus 242 li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 242 LMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=308.03 Aligned_cols=239 Identities=24% Similarity=0.323 Sum_probs=196.6
Q ss_pred cccCEEEeceeeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEE-EeCC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKS 87 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~ 87 (426)
...+|++.+.||+|+||.||+|.+..+ ...||+|.+.... .....+.+.+|+.++++++||||+++++++ ..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 446899999999999999999997543 3468999887532 344467899999999999999999999986 4566
Q ss_pred eEEEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..|+||||+++|+|.+++.. ...+++..++.++.|++.|| +|||++.++.+||+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 88999999999999999976 45689999999999999997 699999999999999999986543
Q ss_pred ccC--CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCH
Q 014359 152 FRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSP 227 (426)
Q Consensus 152 ~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 227 (426)
... ........||+.|+|||++.+..++ .++||||+||++|+|++ |.+||.+.+.......+..+. ...|..+++
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence 221 1223445788999999999888775 89999999999999999 778888777666666665554 445677899
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+.+||.+||+.||.+|||+.++++.
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=314.61 Aligned_cols=239 Identities=23% Similarity=0.339 Sum_probs=191.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe----CCe
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSK 88 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~ 88 (426)
-++|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 46899999999999999999999999999999998654 33446788999999999999999999999863 347
Q ss_pred EEEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
.|+||||+.+|+|.+++.. ...+++..++.++.||+.|| +|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999999999999975 46799999999999999997 6999999999999999998754
Q ss_pred CcccCC-------CccccccCCCcccchhhhccCCC--CCchhhHHHHHHHHHHHhcCCCCCCCccHH--HHHHHHHh-C
Q 014359 150 QHFRDD-------GLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQKIFR-G 217 (426)
Q Consensus 150 ~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~--~~~~~DIwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~-~ 217 (426)
...... .......||+.|+|||++.+... .+.++|||||||++|+|++|+.||...... .....+.. .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 321111 01124568999999999876542 258999999999999999999999642111 11111221 1
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCc
Q 014359 218 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 254 (426)
Q Consensus 218 ~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~ 254 (426)
..+.+..+++.+.+||.+||+.||.+|||+.+++++-
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 2334456899999999999999999999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=326.80 Aligned_cols=233 Identities=24% Similarity=0.370 Sum_probs=195.4
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|+.++||||+++++++.+ ...|+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 34689999999999999999999864 467999999764321 4678999999999999999999999876 67899
Q ss_pred EEcccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
||||+++|+|.+++.. ...+++..+..++.|++.|| +|||++.++.+||+|||+++..... .
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 334 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-E 334 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC-c
Confidence 9999999999999974 35699999999999999997 6999999999999999999865321 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+..+....+..+ ..+.|..+++.+.+|
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1122344578899999999887775 89999999999999999 99999998888877777665 456678899999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
|.+||+.||++|||++++++
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=329.14 Aligned_cols=238 Identities=27% Similarity=0.441 Sum_probs=194.3
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC--
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 87 (426)
...-++|++.+.||+|+||.||+|.+..+++.||||++....... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 345679999999999999999999999999999999997644322 2567889999999999999999999998765
Q ss_pred eEEEEEcccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHH---------------hheee----CCCCCEEEeccCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGL---------------ENILL----DSKGNIKISDFGL 145 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~al---------------eNILl----d~~g~lKl~DFGl 145 (426)
..|+||||+++|+|.+++.... .+++..++.++.||+.|| +|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 7899999999999999997543 399999999999999997 79999 7778899999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhcc--------CCCCCchhhHHHHHHHHHHHhcCCCCCCC----ccHHHHHHH
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLAN--------RGYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQK 213 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~~DIwSlGvil~elltG~~Pf~~----~~~~~~~~~ 213 (426)
++.... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.. ....+....
T Consensus 163 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 163 ARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred ceEccC---CCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 985433 233456789999999999865 333 4789999999999999999999964 223344555
Q ss_pred HHhCCCC-------------------CC------CCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 214 IFRGDFK-------------------LP------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 214 i~~~~~~-------------------~p------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+..+.++ +| ..++..+.+||.+||+.||++|||+.+++++
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 5544321 11 1245678899999999999999999998654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=322.80 Aligned_cols=239 Identities=21% Similarity=0.271 Sum_probs=194.9
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 458999999999999999999996 478899999887543 2335789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 92 VLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
||||+++|+|.+++.... ++++..++.++.|++.|| +|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999986543 599999999999999997 6999999999999999999854433
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH------H-HHHHHhCCC------
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV------L-YQKIFRGDF------ 219 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~------~-~~~i~~~~~------ 219 (426)
.........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+..... . ......+..
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 333334556799999999999887774 89999999999999999999997643211 1 111111111
Q ss_pred C----CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcC
Q 014359 220 K----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 220 ~----~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w 255 (426)
. .+...+..+.+++.+||+.||++|||+.++++|..
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 11224567899999999999999999999998743
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=310.64 Aligned_cols=241 Identities=26% Similarity=0.382 Sum_probs=192.4
Q ss_pred ccccCEEEeceeeecCceEEEEEEECC-CCc--eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
...++|++++.||+|+||.||+|.+.. +++ .||||+++..........+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 345689999999999999999998643 333 69999998665444555688999999999999999999999998765
Q ss_pred eEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
.++||||+++|+|.+++... ..+++..++.++.|++.|| +|||++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 89999999999999999763 5699999999999999997 699999999999999999986533
Q ss_pred ccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC--CCCCCCCCH
Q 014359 152 FRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSP 227 (426)
Q Consensus 152 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~ 227 (426)
.... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+.......+.... .+.+..+++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 2111 122345688899999999887764 89999999999999999 999999988888877776653 445567999
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
++.++|.+||+.||.+|||+.+++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.09 Aligned_cols=239 Identities=17% Similarity=0.174 Sum_probs=186.7
Q ss_pred ccCEEEeceeeecCceEEEEEEECC---CCceEEEEEeecccccchh--------HHHHHHHHHHHHhcCCCCCccceeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLK--------ITDQIKREIATLKLLKHPNVVRLHE 81 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~ 81 (426)
-++|++++.||+|+||.||+|.+.. ++..||||++......... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3589999999999999999999987 7889999999765321100 0124667889999999999999999
Q ss_pred EEEe----CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC--CEEE
Q 014359 82 VLAS----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG--NIKI 140 (426)
Q Consensus 82 ~~~~----~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g--~lKl 140 (426)
++.. ....|+||||+ +++|.+++...+++++..++.++.||+.|| +|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 77899999999 999999998877899999999999999997 699999887 9999
Q ss_pred eccCCCCCCCcccC-----CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc--cHHHHHHH
Q 014359 141 SDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQK 213 (426)
Q Consensus 141 ~DFGla~~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~--~~~~~~~~ 213 (426)
+|||+|+....... .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+. +.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999986543221 1122456899999999999887764 9999999999999999999999652 22222221
Q ss_pred HHhCCCCCC---------CCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 214 IFRGDFKLP---------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 214 i~~~~~~~p---------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.......+| ..+++++.+||.+||..||++|||++++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 111111222 2688999999999999999999999999774
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=307.47 Aligned_cols=234 Identities=20% Similarity=0.228 Sum_probs=192.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEE-EeCCeEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~ 90 (426)
.-++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++|++++..+..+ ......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45799999999999999999999999999999999875432 24588999999999988876666655 6778899
Q ss_pred EEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheee---CCCCCEEEeccCCCCCCCc
Q 014359 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILL---DSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILl---d~~g~lKl~DFGla~~~~~ 151 (426)
+||||+ +++|.+++.. ..++++..++.++.|++.|+ +|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 9999999973 56799999999999999997 69999 4889999999999986543
Q ss_pred ccCC-----CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc---HHHHHHHHHhCCCCC--
Q 014359 152 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKL-- 221 (426)
Q Consensus 152 ~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~-- 221 (426)
.... ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+ ....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 2211 123466899999999999988764 89999999999999999999998632 222333333322222
Q ss_pred ---CCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 222 ---PKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 222 ---p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+..+++++.+||.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 3668999999999999999999999999876
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=310.79 Aligned_cols=239 Identities=27% Similarity=0.358 Sum_probs=194.4
Q ss_pred CccccCE-EEeceeeecCceEEEEEEE----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE
Q 014359 10 GMRLGRY-ELGRTLGEGNFGKVKFAQD----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y-~i~~~LG~G~fg~V~~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 84 (426)
.+.-++| ++++.||+|+||.||++.. ..+++.||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 3344566 9999999999999988754 3578999999997653 3344678999999999999999999999998
Q ss_pred e--CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCC
Q 014359 85 S--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 85 ~--~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~ 147 (426)
+ ...+|+||||+++|+|.+++... ++++..++.++.||+.|| +|||++.++.+||+|||++.
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 7 46799999999999999999764 599999999999999997 69999999999999999998
Q ss_pred CCCcccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH---------------HHH
Q 014359 148 LPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------VLY 211 (426)
Q Consensus 148 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~---------------~~~ 211 (426)
........ .......||+.|+|||++.+..++ .++|||||||++|+|++|..||...... ...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 65432111 123445788999999999887775 8999999999999999999999764322 112
Q ss_pred HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 212 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 212 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..+..+ ..+.|..+++++.+||.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222222 45567789999999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.39 Aligned_cols=228 Identities=26% Similarity=0.423 Sum_probs=185.9
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
...++|++.+.||+|+||.||+|.+ .++.||||++... ...+.+.+|+.++++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 4568999999999999999999997 4788999998643 235778999999999999999999998864 479
Q ss_pred EEEcccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHH------------------hheeeCCCCC-EEEeccCCCCC
Q 014359 91 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGL------------------ENILLDSKGN-IKISDFGLSAL 148 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~al------------------eNILld~~g~-lKl~DFGla~~ 148 (426)
+||||+++|+|.+++.... .+++..+..++.|++.|+ +|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998655 378999999999999986 6999999987 79999999974
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc--HHHHHHHHHhC-CCCCCCCC
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRG-DFKLPKWL 225 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~-~~~~p~~~ 225 (426)
... ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.... .......+..+ ..+.+..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQT-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred ccc-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 332 23345799999999999887774 89999999999999999999998543 22333333333 45566779
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
++.+.+||.+||+.||++|||+++++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=315.14 Aligned_cols=230 Identities=17% Similarity=0.206 Sum_probs=189.0
Q ss_pred cCEEEeceeeecCceEEEEEEECC--------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccc-------
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLD--------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR------- 78 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~------- 78 (426)
++|++.+.||+|+||.||+|.+.. .++.||||++... +.+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 799999999999999999999987 4889999998754 35778999999999999987
Q ss_pred --------eeEEEEe-CCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheee
Q 014359 79 --------LHEVLAS-KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILL 132 (426)
Q Consensus 79 --------l~~~~~~-~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILl 132 (426)
+++++.. ....|+||||+ +++|.+++... ..+++..++.++.||+.|| +|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6777766 78899999999 99999999875 7899999999999999997 69999
Q ss_pred CCCC--CEEEeccCCCCCCCcccCC-----CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc
Q 014359 133 DSKG--NIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 205 (426)
Q Consensus 133 d~~g--~lKl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~ 205 (426)
+.++ .+||+|||+++........ ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 9999999999865432211 122445899999999999887774 8999999999999999999999875
Q ss_pred c--HHHHHHH---HHhCCCCCCC------CCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 206 N--LAVLYQK---IFRGDFKLPK------WLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 206 ~--~~~~~~~---i~~~~~~~p~------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
. ....... +......++. .+++++.+||.+||+.||++|||++++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 3 3322222 2223222222 468999999999999999999999999763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=306.16 Aligned_cols=234 Identities=21% Similarity=0.245 Sum_probs=188.1
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEE-EeCCeEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~ 90 (426)
.-++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+ ...+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 34789999999999999999999999999999998765432 23578899999999988877666655 6778899
Q ss_pred EEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheee---CCCCCEEEeccCCCCCCCc
Q 014359 91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILL---DSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILl---d~~g~lKl~DFGla~~~~~ 151 (426)
+||||+ +++|.+++.. ..++++..++.++.||+.|| +|||+ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 9999999984 46799999999999999997 79999 7889999999999986543
Q ss_pred ccCC-----CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHHHhCCCCCC-
Q 014359 152 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLP- 222 (426)
Q Consensus 152 ~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p- 222 (426)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+. ...+..+.......|
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 2211 12345689999999999998877 4999999999999999999999976332 122333322222222
Q ss_pred ----CCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 223 ----KWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 223 ----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..+++++.+||.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 568999999999999999999999999876
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=319.47 Aligned_cols=237 Identities=24% Similarity=0.327 Sum_probs=188.3
Q ss_pred cCEEEeceeeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEE-eCCeE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~ 89 (426)
.+|++.+.||+|+||.||+|.+..+ +..||||.+.... .....+.+.+|+.+++.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4689999999999999999987543 2468999986532 3344678999999999999999999999875 45688
Q ss_pred EEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+++|+|.+++... ..+++..+..++.||+.|| +|||++.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999864 4589999999999999997 69999999999999999998543221
Q ss_pred C--CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHH
Q 014359 154 D--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGA 229 (426)
Q Consensus 154 ~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 229 (426)
. ........+|+.|+|||++.+..++ .++|||||||++|+|++ |.+||.+.+..+....+..+. ...|..+++.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 1 1122345678899999999888775 99999999999999999 889998876655555555553 45577899999
Q ss_pred HHHHHHccccCcCCCCChHHHhcC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.++|.+||+.||++|||+.+++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.82 Aligned_cols=235 Identities=29% Similarity=0.440 Sum_probs=174.2
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEE--------
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA-------- 84 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~-------- 84 (426)
.+|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3899999999999999999999999999999998654 2334567899999999996 999999999984
Q ss_pred eCCeEEEEEcccCCCChHHHHHh---CCCCCHHHHHHHHHHHHHHH-----------------hheeeCCCCCEEEeccC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGL-----------------ENILLDSKGNIKISDFG 144 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~al-----------------eNILld~~g~lKl~DFG 144 (426)
....+|+||||+. |+|.+++.. .+++++..++.++.||+.|| +|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 3445899999995 699998864 56799999999999999996 69999999999999999
Q ss_pred CCCCCCcccCC----------CccccccCCCcccchhhh---ccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHH
Q 014359 145 LSALPQHFRDD----------GLLHTTCGSPNYVAPEVL---ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 211 (426)
Q Consensus 145 la~~~~~~~~~----------~~~~~~~gt~~Y~APE~l---~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~ 211 (426)
++......... ......+||+.|+|||++ .+..+ +.++|||||||++|+|++|+.||.+.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 99865432111 112256799999999998 34444 58999999999999999999999876544332
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcC
Q 014359 212 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 212 ~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w 255 (426)
... ...+.+...+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 263 ~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 263 NGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 221 123344567889999999999999999999999999855
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.91 Aligned_cols=235 Identities=25% Similarity=0.357 Sum_probs=194.8
Q ss_pred cCEEEec-eeeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 14 GRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 14 ~~y~i~~-~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
+++.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|+.++||||+++++++.. +..|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 4566666 8999999999999875 356679999997653 22336789999999999999999999999976 5699
Q ss_pred EEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+||||+.+|+|.+++... ..+++..+..++.||+.|| +|||++.++.+||+|||+++.......
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999999754 4699999999999999997 699999999999999999986543211
Q ss_pred C-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 014359 155 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 231 (426)
Q Consensus 155 ~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 231 (426)
. .......+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+..+....+..+. ...|..+++++.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1 112233567899999999888775 89999999999999998 999999988888888777664 5677889999999
Q ss_pred HHHHccccCcCCCCChHHHhc
Q 014359 232 LLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~ 252 (426)
||.+||+.||++|||+.++++
T Consensus 571 li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999853
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=316.89 Aligned_cols=237 Identities=16% Similarity=0.184 Sum_probs=185.2
Q ss_pred cCEEEeceeeecCceEEEEEEECCC-----CceEEEEEeecccccchhH--------HHHHHHHHHHHhcCCCCCcccee
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKI--------TDQIKREIATLKLLKHPNVVRLH 80 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~HpnIv~l~ 80 (426)
++|++++.||+|+||.||+|.+..+ ++.||||++.......... ...+.+|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 3899999999999999999998764 5889999987653111000 01244566778888999999999
Q ss_pred EEEEeC----CeEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeC--CCCCE
Q 014359 81 EVLASK----SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLD--SKGNI 138 (426)
Q Consensus 81 ~~~~~~----~~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld--~~g~l 138 (426)
+++... ...|+||||+ |++|.+++... +++++..++.++.||+.|| +|||++ .++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 998764 4589999999 99999999875 6799999999999999997 799999 88999
Q ss_pred EEeccCCCCCCCcccCC-----CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH-
Q 014359 139 KISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ- 212 (426)
Q Consensus 139 Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~- 212 (426)
||+|||+|+........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......+.
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 99999999765432211 12245579999999999998877 499999999999999999999998632211111
Q ss_pred HHH---hCC-------CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 213 KIF---RGD-------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 213 ~i~---~~~-------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
... ... .-.+..+++++.+||.+||..||.+||++.+|++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 110 000 0012567999999999999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.79 Aligned_cols=235 Identities=30% Similarity=0.406 Sum_probs=179.3
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 92 (426)
+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. .+.+.+|+.+++.+ +||||+++++++.+.+..|+|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 456667899999999998764 4679999999987542 35678999999876 899999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCC-------HHHHHHHHHHHHHHH---------------hheeeCCC-------------CC
Q 014359 93 LEYVTGGELFDKIASKGRLQ-------EAEGRKLFQQLIDGL---------------ENILLDSK-------------GN 137 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~-------e~~~~~~~~ql~~al---------------eNILld~~-------------g~ 137 (426)
|||+. |+|.+++....... +..++.++.||+.|| +|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 69999998754332 334567999999997 69999764 48
Q ss_pred EEEeccCCCCCCCcccCC--CccccccCCCcccchhhhcc------CCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHH
Q 014359 138 IKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 208 (426)
Q Consensus 138 lKl~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~------~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~ 208 (426)
+||+|||+++........ ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999865432111 12345689999999999975 1233589999999999999999 99999875443
Q ss_pred HHHHHHHhCCCCCCC-------CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 209 VLYQKIFRGDFKLPK-------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 209 ~~~~~i~~~~~~~p~-------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
. ..+..+....+. .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 3 234444433332 24578999999999999999999999999999964
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=303.64 Aligned_cols=221 Identities=28% Similarity=0.563 Sum_probs=182.0
Q ss_pred ccCCccccCEEEe-ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-hcCCCCCccceeEEEE
Q 014359 7 KQEGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLA 84 (426)
Q Consensus 7 ~~~~~~~~~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~ 84 (426)
...+..+++|.+. +.||+|+||.||+|.+..+++.||||++... ....+|+.++ +.++||||+++++++.
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~ 81 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE 81 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence 3456788999998 7899999999999999999999999998642 4567888888 6669999999999998
Q ss_pred e----CCeEEEEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCC---CCCEEE
Q 014359 85 S----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDS---KGNIKI 140 (426)
Q Consensus 85 ~----~~~~~lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~---~g~lKl 140 (426)
. ....|+||||+++|+|.+++.... ++++..++.++.|++.|| +|||++. ++.+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp EEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred hhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEE
Confidence 7 678999999999999999998754 699999999999999997 6999998 789999
Q ss_pred eccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH----HHHh
Q 014359 141 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ----KIFR 216 (426)
Q Consensus 141 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~ 216 (426)
+|||++.... +..+ +.++||||+||++|+|++|+.||.+.+...... .+..
T Consensus 162 ~Dfg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 216 (299)
T 3m2w_A 162 TDFGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216 (299)
T ss_dssp CCCTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCT
T ss_pred eccccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhh
Confidence 9999987321 1223 478999999999999999999998765443221 1122
Q ss_pred CCCCCC----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 217 GDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 217 ~~~~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+...+| ..+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 233334 46899999999999999999999999999999998643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=300.07 Aligned_cols=235 Identities=23% Similarity=0.338 Sum_probs=183.1
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhc--CCCCCccceeEEEEe--
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLAS-- 85 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~-- 85 (426)
....++|++++.||+|+||.||+|.+ +++.||||++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 44568999999999999999999987 68899999986542 3455566666666 799999999998654
Q ss_pred --CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------------hheeeCCCCCEEE
Q 014359 86 --KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------------ENILLDSKGNIKI 140 (426)
Q Consensus 86 --~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------------eNILld~~g~lKl 140 (426)
....|+||||+++|+|.+++.. .++++..++.++.|++.|| +|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999965 5799999999999999985 5999999999999
Q ss_pred eccCCCCCCCcccCC--CccccccCCCcccchhhhccCCCC-----CchhhHHHHHHHHHHHhcC----------CCCCC
Q 014359 141 SDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG----------YLPFD 203 (426)
Q Consensus 141 ~DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~-----~~~~DIwSlGvil~elltG----------~~Pf~ 203 (426)
+|||+|......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999754321111 112345899999999999876332 2689999999999999999 88986
Q ss_pred Ccc----HHHHHHHHHhC---CCCCCCC-----CCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 204 DRN----LAVLYQKIFRG---DFKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 204 ~~~----~~~~~~~i~~~---~~~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
... ........... ...+|.. +++.+.+||.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 421 12222222221 2222321 45779999999999999999999999763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.95 Aligned_cols=235 Identities=23% Similarity=0.330 Sum_probs=196.3
Q ss_pred CEEEe-ceeeecCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 15 RYELG-RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 15 ~y~i~-~~LG~G~fg~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+.+. +.||+|+||.||+|.+ ..+++.||||+++.... .....+.+.+|+.+|+.++||||+++++++.. ...|+
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999965 45678999999976532 33446789999999999999999999999965 45899
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC-C
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD-D 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~-~ 155 (426)
||||+++|+|.+++.....+++..++.++.||+.|| +|||++.++.+||+|||+|+....... .
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999999999999888899999999999999997 699999999999999999985533211 1
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 233 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li 233 (426)
.......||+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+..+....+..+. ...|..+++++.+||
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 605 (635)
T ss_dssp --------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 122344678899999999888775 89999999999999998 999999988888888777664 567888999999999
Q ss_pred HHccccCcCCCCChHHHhc
Q 014359 234 RKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~ 252 (426)
.+||+.||++|||++++++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.90 Aligned_cols=234 Identities=24% Similarity=0.358 Sum_probs=200.1
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|+.++||||+++++++.+ ...|+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 34689999999999999999999854 467999999764321 4678999999999999999999999866 67899
Q ss_pred EEcccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
||||+.+|+|.+++.. ...+++..+..++.||+.|| +|||++.++.+||+|||+++......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 417 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 417 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence 9999999999999974 35699999999999999997 69999999999999999998653211
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+.+..+....+..+ ..+.|..++..+.+|
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 0112234577899999999887775 89999999999999999 99999998888887777666 456678899999999
Q ss_pred HHHccccCcCCCCChHHHhcC
Q 014359 233 LRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h 253 (426)
|.+||+.||++|||+++|++.
T Consensus 497 i~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=312.59 Aligned_cols=239 Identities=23% Similarity=0.308 Sum_probs=190.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++.+.||+|+||.||+|.+ .+++.||||++........ ...+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 457899999999999999999985 4689999999976542221 2368899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHH------------------hheeeCCCCCEEEeccCCCCCC
Q 014359 92 VLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGL------------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~al------------------eNILld~~g~lKl~DFGla~~~ 149 (426)
||||+++|+|.+++.... ++++..++.++.|++.|| +|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 999999999999998643 499999999999999986 6999999999999999999865
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH----HHHHHHHHhCCC------
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDF------ 219 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~------ 219 (426)
... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .........+..
T Consensus 185 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 185 DYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp CSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred Ccc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 432 2233445679999999999988776 4899999999999999999999963211 001111111100
Q ss_pred ---------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcC
Q 014359 220 ---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW 255 (426)
Q Consensus 220 ---------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w 255 (426)
..+...+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 111123467999999999999999999999999865
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.07 Aligned_cols=230 Identities=14% Similarity=0.157 Sum_probs=186.9
Q ss_pred ccCEEEeceeeecCceEEEEE-----EECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC---CCCccceeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLA 84 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a-----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~ 84 (426)
-++|++.+.||+|+||.||+| .+..+++.||||++.... ...+.+|+.+++.++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 367999999999999999999 466789999999997543 456788888888887 999999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHH---------------hheeeCC----------
Q 014359 85 SKSKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGL---------------ENILLDS---------- 134 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~-----~~~l~e~~~~~~~~ql~~al---------------eNILld~---------- 134 (426)
..+..|+||||+++|+|.+++.. ...+++..++.++.||+.|| +|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999999973 46799999999999999997 7999998
Q ss_pred -CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH
Q 014359 135 -KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 213 (426)
Q Consensus 135 -~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~ 213 (426)
++.+||+|||+|+..............+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 899999999999754433344455678999999999999988875 8999999999999999999999654321000
Q ss_pred HHhCCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 214 IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 214 i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
. ...-...+.++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 295 -~-~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 295 -P-EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp -E-CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred -e-chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0 0111112457789999999999999999765555444
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=307.64 Aligned_cols=242 Identities=24% Similarity=0.373 Sum_probs=196.0
Q ss_pred ccCCccccCEEEeceeeecCceEEEEEEE----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEE
Q 014359 7 KQEGMRLGRYELGRTLGEGNFGKVKFAQD----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV 82 (426)
Q Consensus 7 ~~~~~~~~~y~i~~~LG~G~fg~V~~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 82 (426)
.+.....++|++++.||+|+||.||+|+. ..+++.||||++... .....+.+.+|+.+++.++||||++++++
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 34456678899999999999999999984 568999999999754 33446789999999999999999999999
Q ss_pred EEeCC--eEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccC
Q 014359 83 LASKS--KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFG 144 (426)
Q Consensus 83 ~~~~~--~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFG 144 (426)
+...+ ..|+||||+++|+|.+++... .++++..++.++.|++.|| +|||++.++.+||+|||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence 86543 789999999999999999875 4699999999999999997 69999999999999999
Q ss_pred CCCCCCcccCC-CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH---------------
Q 014359 145 LSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA--------------- 208 (426)
Q Consensus 145 la~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~--------------- 208 (426)
++......... .......+|+.|+|||++.+..++ .++|||||||++|+|++|..||......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 99865432111 112345678889999999887764 8999999999999999999998653211
Q ss_pred -HHHHHHHh-CCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 209 -VLYQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 209 -~~~~~i~~-~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.....+.. ...+.|..+++++.+||.+||+.||++|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11122222 245667789999999999999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=308.25 Aligned_cols=234 Identities=26% Similarity=0.348 Sum_probs=189.4
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
|..++.||+|+||.||+|.+ +++.||||++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44568999999999999985 688999999875432 233446789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh---CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 95 YVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 95 y~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|+++|+|.+++.. ..++++..++.++.|++.|| +|||++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999973 34699999999999999997 69999999999999999998654332222
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH----HHHHHHHhCCC-----------CC
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGDF-----------KL 221 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~-----------~~ 221 (426)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|..||...+.. .....+..... ..
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 33456899999999998764 4 58999999999999999999999865432 22222222111 11
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 222 p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22345778999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=305.03 Aligned_cols=234 Identities=23% Similarity=0.357 Sum_probs=183.0
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC--CCCCccceeEEEEeC--
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLHEVLASK-- 86 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~-- 86 (426)
...++|++++.||+|+||.||+|.+. ++.||||++.... .....+|..++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34579999999999999999999974 8999999986442 23445566666554 899999999999887
Q ss_pred --CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------------hheeeCCCCCEEEe
Q 014359 87 --SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------------ENILLDSKGNIKIS 141 (426)
Q Consensus 87 --~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------------eNILld~~g~lKl~ 141 (426)
...|+||||+++|+|.+++.. .++++..++.++.|++.|| +|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 789999999999999999976 4799999999999999985 69999999999999
Q ss_pred ccCCCCCCCcccCC--CccccccCCCcccchhhhccCCCCCc-----hhhHHHHHHHHHHHhcC----------CCCCCC
Q 014359 142 DFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGA-----TSDIWSCGVILYVILTG----------YLPFDD 204 (426)
Q Consensus 142 DFGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~-----~~DIwSlGvil~elltG----------~~Pf~~ 204 (426)
|||++......... ......+||+.|+|||++.+..+... ++|||||||++|+|++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99999754332111 11235689999999999987766532 49999999999999999 778764
Q ss_pred c-----cHHHHHHHHHhC--CCCCCC-----CCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 205 R-----NLAVLYQKIFRG--DFKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 205 ~-----~~~~~~~~i~~~--~~~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
. ........+... ...+|. .+++++.+||.+||+.||++|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2 122222222222 223332 355679999999999999999999999886
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.05 Aligned_cols=238 Identities=26% Similarity=0.425 Sum_probs=199.8
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
...++|++++.||+|+||.||+|.+..+ +..||||.+.... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4457899999999999999999998653 4579999886532 3444578999999999999999999999984 46
Q ss_pred eEEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..|+||||+++|+|.+++...+ .+++..+..++.|++.|| +|||++.++.+||+|||+++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 6899999999999999998644 699999999999999997 699999999999999999986543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 229 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 229 (426)
.. ........+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+
T Consensus 544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 544 ST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred Cc-ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 21 1122345678899999999888774 89999999999999997 99999998888877777665 456788899999
Q ss_pred HHHHHHccccCcCCCCChHHHhcC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+||.+||+.||++|||+.+++++
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=307.94 Aligned_cols=245 Identities=21% Similarity=0.316 Sum_probs=179.9
Q ss_pred cccCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH--HhcCCCCCccceeEEE
Q 014359 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT--LKLLKHPNVVRLHEVL 83 (426)
Q Consensus 6 ~~~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~ 83 (426)
...+...+++|++++.||+|+||.||+|++ +++.||||++.... ...+..|..+ +..++||||+++++.+
T Consensus 5 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 76 (336)
T 3g2f_A 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGD 76 (336)
T ss_dssp ----CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred ccCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecc
Confidence 455678899999999999999999999986 68999999997543 2333444444 5568999999999865
Q ss_pred Ee-----CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH------------------------hheeeCC
Q 014359 84 AS-----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------------------------ENILLDS 134 (426)
Q Consensus 84 ~~-----~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al------------------------eNILld~ 134 (426)
.. ...+|+||||+++|+|.+++... +.++..++.++.||+.|| +|||++.
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp EEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred cccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 43 33679999999999999999764 469999999999999985 5999999
Q ss_pred CCCEEEeccCCCCCCCccc------CCCccccccCCCcccchhhhccCC------CCCchhhHHHHHHHHHHHhcCCCCC
Q 014359 135 KGNIKISDFGLSALPQHFR------DDGLLHTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILTGYLPF 202 (426)
Q Consensus 135 ~g~lKl~DFGla~~~~~~~------~~~~~~~~~gt~~Y~APE~l~~~~------~~~~~~DIwSlGvil~elltG~~Pf 202 (426)
++.+||+|||++....... ........+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9999999999998543211 122234568999999999997631 2247899999999999999997765
Q ss_pred CC-cc-----------------HHHHHHHHHh--CCCCCCCC------CCHHHHHHHHHccccCcCCCCChHHHh-----
Q 014359 203 DD-RN-----------------LAVLYQKIFR--GDFKLPKW------LSPGAQNLLRKILEPNPVKRITIAGIK----- 251 (426)
Q Consensus 203 ~~-~~-----------------~~~~~~~i~~--~~~~~p~~------~s~~~~~Li~~~L~~dP~~R~t~~~il----- 251 (426)
.. .. .......... ....+|.. +++.+.+||.+||+.||++|||+.|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 32 11 1111111111 12333433 345799999999999999999999994
Q ss_pred -cCcCCccC
Q 014359 252 -ADEWFEQD 259 (426)
Q Consensus 252 -~h~w~~~~ 259 (426)
.++|-++.
T Consensus 316 ll~~~~~~~ 324 (336)
T 3g2f_A 316 LMMIWERNK 324 (336)
T ss_dssp HHHCCCC--
T ss_pred HHHHHHhcc
Confidence 46676553
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=307.25 Aligned_cols=241 Identities=20% Similarity=0.310 Sum_probs=196.4
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
......++|++++.||+|+||.||+|.+.. .||+|++...... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 334567899999999999999999999743 4999999754322 222356778999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..|+||||+++++|.+++...+ .+++..++.++.||+.|+ +|||++ ++.+||+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999999998654 699999999999999997 699998 78999999999875432
Q ss_pred cc---CCCccccccCCCcccchhhhccC--------CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC
Q 014359 152 FR---DDGLLHTTCGSPNYVAPEVLANR--------GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 220 (426)
Q Consensus 152 ~~---~~~~~~~~~gt~~Y~APE~l~~~--------~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 220 (426)
.. .........||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+..+
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 11 12234456799999999998752 22358999999999999999999999998888777777666433
Q ss_pred C--CCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 221 L--PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 221 ~--p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
. +..++.++.+||.+||+.||.+|||+.++++.
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 2 23588999999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.64 Aligned_cols=239 Identities=24% Similarity=0.321 Sum_probs=182.7
Q ss_pred ccccC--EEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 014359 11 MRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~--y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 87 (426)
+.+++ |++.+.||+|+||+|+.. ...+++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+..
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 44554 999999999999997643 346889999999975432 2356899999999 7999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCC-----CCEEEeccCCC
Q 014359 88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSK-----GNIKISDFGLS 146 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~-----g~lKl~DFGla 146 (426)
..|+||||+. |+|.+++.... ..++..+..++.||+.|| +|||++.+ ..+||+|||+|
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999996 59999998643 466677889999999997 69999542 36889999999
Q ss_pred CCCCcccC-CCccccccCCCcccchhhhcc---CCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCCCC-
Q 014359 147 ALPQHFRD-DGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK- 220 (426)
Q Consensus 147 ~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~---~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~- 220 (426)
+....... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++ |..||..................
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 86543211 123455789999999999974 333 479999999999999999 99999765544333222221111
Q ss_pred --CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 221 --LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 221 --~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.+...+..+.+||.+||+.||.+|||+.++++||||..
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 12224567899999999999999999999999999965
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.13 Aligned_cols=245 Identities=28% Similarity=0.380 Sum_probs=193.0
Q ss_pred cCCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--
Q 014359 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-- 85 (426)
Q Consensus 8 ~~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-- 85 (426)
.++..+|+|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 34567899999999999999999999999999999999987542 34446789999999999999999999999755
Q ss_pred ----CCeEEEEEcccCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHH---------------hheeeCCCCC---EEE
Q 014359 86 ----KSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGL---------------ENILLDSKGN---IKI 140 (426)
Q Consensus 86 ----~~~~~lVmEy~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~al---------------eNILld~~g~---lKl 140 (426)
.+..|+||||++||+|.+++.... ++++..++.++.|++.|+ +|||++.++. +||
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 677899999999999999998644 699999999999999997 6999998875 999
Q ss_pred eccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH--------
Q 014359 141 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ-------- 212 (426)
Q Consensus 141 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~-------- 212 (426)
+|||++..... .......+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+......+.
T Consensus 166 ~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 166 IDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred ccccccccccc---ccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 99999986533 3334567899999999999888775 89999999999999999999997643322110
Q ss_pred -H-----HHhCCC------CCC----CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 213 -K-----IFRGDF------KLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 213 -~-----i~~~~~------~~p----~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
. ...+.. +.| ..+++.+.+||.+||..||++|||++++++||||..
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 001111 112 225688999999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=299.19 Aligned_cols=232 Identities=24% Similarity=0.342 Sum_probs=187.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhc--CCCCCccceeEEEEeCC---
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASKS--- 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~--- 87 (426)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 36899999999999999999997 58999999986432 3567788888887 78999999999998776
Q ss_pred -eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------------hheeeCCCCCEEEecc
Q 014359 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------------ENILLDSKGNIKISDF 143 (426)
Q Consensus 88 -~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------------eNILld~~g~lKl~DF 143 (426)
..|+||||+++|+|.+++.. .++++..++.++.|++.|+ +|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 79999999999999999976 5799999999999999985 5999999999999999
Q ss_pred CCCCCCCcccCC--CccccccCCCcccchhhhccCCCC-----CchhhHHHHHHHHHHHhcC----------CCCCCCc-
Q 014359 144 GLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG----------YLPFDDR- 205 (426)
Q Consensus 144 Gla~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~-----~~~~DIwSlGvil~elltG----------~~Pf~~~- 205 (426)
|++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999754321110 023456899999999999775332 1689999999999999999 8899754
Q ss_pred ----cHHHHHHHHHhCC--CCCCC-----CCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 206 ----NLAVLYQKIFRGD--FKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 206 ----~~~~~~~~i~~~~--~~~p~-----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
........+.... ..+|. .++..+.+||.+||+.||++|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2344444444332 22332 133578999999999999999999999876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=313.41 Aligned_cols=235 Identities=18% Similarity=0.237 Sum_probs=193.1
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCccceeEEEEeCCeE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~ 89 (426)
...++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++| ++|..+..++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 456899999999999999999999999999999999875432 2347889999999987 5666666777788899
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheee---CCCCCEEEeccCCCCCCC
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILL---DSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILl---d~~g~lKl~DFGla~~~~ 150 (426)
|+||||+ +++|.+++.. ...+++..++.++.||+.|| +|||+ +.++.+||+|||+++...
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 9999999985 56799999999999999997 79999 688999999999998654
Q ss_pred cccCC-----CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc---HHHHHHHHHhCCC---
Q 014359 151 HFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDF--- 219 (426)
Q Consensus 151 ~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~--- 219 (426)
..... ......+||+.|+|||++.+..+. .++|||||||+||+|++|+.||.+.. ....+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 32211 122367899999999999988774 99999999999999999999998743 3344444333221
Q ss_pred --CCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 220 --KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 220 --~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.++..++.++.+||.+||+.||.+||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223568999999999999999999999998764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.24 Aligned_cols=234 Identities=20% Similarity=0.187 Sum_probs=182.4
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCcc---------ceeEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVV---------RLHEV 82 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv---------~l~~~ 82 (426)
...|.+++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|.. ...+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3468999999999999999999999999999999985443333345789999999999987 3221 11111
Q ss_pred ------------EEe-----CCeEEEEEcccCCCChHHHHHh-------CCCCCHHHHHHHHHHHHHHH-----------
Q 014359 83 ------------LAS-----KSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQQLIDGL----------- 127 (426)
Q Consensus 83 ------------~~~-----~~~~~lVmEy~~gg~L~~~i~~-------~~~l~e~~~~~~~~ql~~al----------- 127 (426)
+.. ...++++|+++ +++|.+++.. ..++++..+..++.||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 111 22467888877 6799999851 23478888899999999997
Q ss_pred ----hheeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhh----------ccCCCCCchhhHHHHHHHHH
Q 014359 128 ----ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL----------ANRGYDGATSDIWSCGVILY 193 (426)
Q Consensus 128 ----eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l----------~~~~~~~~~~DIwSlGvil~ 193 (426)
+|||++.++.+||+|||+++.... ...+.+| +.|+|||++ .+..| +.++|||||||++|
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIY 308 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHH
Confidence 799999999999999999885432 2456788 999999999 33344 48999999999999
Q ss_pred HHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 194 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 194 elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
+|++|+.||.+.+.......+... ...+|+++.+||.+||+.||++|||+.++++||||+.
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGGSS----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHCCCCCCCcchhhhHHHHHhh----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 999999999887654443333322 2357899999999999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=307.64 Aligned_cols=229 Identities=22% Similarity=0.306 Sum_probs=181.2
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHhcCC---------CCCcc
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLK---------HPNVV 77 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------HpnIv 77 (426)
..++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999997 7899999999865421 2223477889999998886 67776
Q ss_pred ceeEEE-----------------Ee-------------CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 014359 78 RLHEVL-----------------AS-------------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127 (426)
Q Consensus 78 ~l~~~~-----------------~~-------------~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al 127 (426)
++.+++ .+ .+..|+||||+++|++.+.+.. +.+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 666654 22 6789999999999987777754 6799999999999999996
Q ss_pred ----------------hheeeCCCC--------------------CEEEeccCCCCCCCcccCCCccccccCCCcccchh
Q 014359 128 ----------------ENILLDSKG--------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171 (426)
Q Consensus 128 ----------------eNILld~~g--------------------~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE 171 (426)
+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 799999987 899999999985432 2458999999999
Q ss_pred hhccCCCCCchhhHHHHHHH-HHHHhcCCCCCCCccH-HHHHHHHHhC-CCC--C----CCCCCHHHHHHHHHccccCcC
Q 014359 172 VLANRGYDGATSDIWSCGVI-LYVILTGYLPFDDRNL-AVLYQKIFRG-DFK--L----PKWLSPGAQNLLRKILEPNPV 242 (426)
Q Consensus 172 ~l~~~~~~~~~~DIwSlGvi-l~elltG~~Pf~~~~~-~~~~~~i~~~-~~~--~----p~~~s~~~~~Li~~~L~~dP~ 242 (426)
++.+.. +.++||||+|++ .+++++|..||.+... ......+... ... . ++.+++++.+||++||+.|
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 998765 589999998777 7888899999965322 2233333322 111 1 1237889999999999987
Q ss_pred CCCChHHHh-cCcCCc
Q 014359 243 KRITIAGIK-ADEWFE 257 (426)
Q Consensus 243 ~R~t~~~il-~h~w~~ 257 (426)
|++|++ +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.28 Aligned_cols=228 Identities=23% Similarity=0.363 Sum_probs=186.6
Q ss_pred ccccCEEEeceeeecCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe-
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK- 88 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 88 (426)
...++|++.+.||+|+||.||+|.+.. +++.||||++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 344899999999999999999999976 78999999986532 33445678999999999999999999999987665
Q ss_pred ----EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 89 ----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 89 ----~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
.|+||||++|++|.+++.. ++++..++.++.||+.|| +|||++.+ .+||+|||+++..
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988765 799999999999999997 69999985 9999999999854
Q ss_pred CcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHH
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 229 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 229 (426)
.. ....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+...... .........++.+
T Consensus 232 ~~------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~~l 297 (681)
T 2pzi_A 232 NS------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDSY 297 (681)
T ss_dssp TC------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCHHH
T ss_pred cc------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc------cccccccccCHHH
Confidence 32 2456899999999998765 3 5899999999999999999999876321100 0000001146789
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
.+||.+||+.||.+||+..+.+.|+|+.
T Consensus 298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 298 GRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=283.52 Aligned_cols=209 Identities=14% Similarity=0.178 Sum_probs=175.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.-|+|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34789999999999999999999999999999999987665555556889999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||||++|++|.+++.. + ..+.++..++.|++.|| +|||++.+|.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999999999954 3 46677899999999997 79999999999998544
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHH---HHHHhCCCC----CCCCCCHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY---QKIFRGDFK----LPKWLSPGA 229 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~---~~i~~~~~~----~p~~~s~~~ 229 (426)
|++| + +.++|||||||++|+|++|+.||.+.+..... .+...+... .+..+++++
T Consensus 175 ----------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ----------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ----------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ----------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 3332 3 58999999999999999999999876542211 011122222 235689999
Q ss_pred HHHHHHccccCcCCCCChHHHhcC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+||.+||+.||++| |+.++++.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999999 99999874
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=216.88 Aligned_cols=124 Identities=31% Similarity=0.580 Sum_probs=116.0
Q ss_pred CCCcccccceeeccCcCCCCCCccccc-ccccceeeEecCCHHHHHHHHHHHHHHcCcEEEeeCCeeEEEeecCCCCccc
Q 014359 294 SPPLINAFQLIGMSSCLDLSGFFEKED-VSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLG 372 (426)
Q Consensus 294 ~p~~~~~~~~~~~s~~~~~~~~~~~~~-~~~~~~~f~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (426)
.|..+|||++|++|+|+|||+||+... ..++++||+|..++++|+++|+++++.+|++|+++++++++++..+|+| |
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grk--G 80 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKA--G 80 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGG--G
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCc--c
Confidence 466799999999999999999997643 2578999999999999999999999999999999989999999999999 9
Q ss_pred ceEEEEEEEEEeCceEEEEEEecCCCchHHHHHHHHHHhhcCCCCcc
Q 014359 373 SLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQ 419 (426)
Q Consensus 373 ~l~~~~~i~~~~~~~~~v~~~~~~gd~~e~~~~~~~~~~~l~~~~~~ 419 (426)
.|++.+|||+++|+++||||+|++||++||++||++|+++|+|++.+
T Consensus 81 ~l~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~ 127 (143)
T 2ehb_D 81 QLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWR 127 (143)
T ss_dssp CCEEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC
T ss_pred eEEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceec
Confidence 99999999999999999999999999999999999999999999865
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=208.25 Aligned_cols=119 Identities=28% Similarity=0.380 Sum_probs=104.0
Q ss_pred CCCcccccceeeccCcCCCCCCcccccccccceeeEecCCHHHHHHHHHHHHHHcCcEEEeeCCeeEEEeecCCCCcccc
Q 014359 294 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGS 373 (426)
Q Consensus 294 ~p~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~f~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (426)
.|..+|||++|++|+|+|||+||+.+...++++||+|+.++++|+++||++|+.+|++|++++++ ++..+|++ |.
T Consensus 2 ~~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~k--G~ 76 (123)
T 2zfd_B 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQK--GN 76 (123)
T ss_dssp --CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGG--GT
T ss_pred CcccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCC--cc
Confidence 35679999999999999999999764334678999999999999999999999999999988775 55668888 99
Q ss_pred eEEEEEEEEEeCceEEEEEEecCCCchHHHHHHH-HHHhhcCCCC
Q 014359 374 LSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCN-KLSSDLGLPP 417 (426)
Q Consensus 374 l~~~~~i~~~~~~~~~v~~~~~~gd~~e~~~~~~-~~~~~l~~~~ 417 (426)
|++.+|||+++|+++||||+|++||++||++||. +|+++|+|++
T Consensus 77 l~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV 121 (123)
T 2zfd_B 77 FAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELV 121 (123)
T ss_dssp EEEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTB
T ss_pred EEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999999775 8999999886
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=257.86 Aligned_cols=218 Identities=14% Similarity=0.103 Sum_probs=147.4
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccc-------hhHHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeEEE
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-------LKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 91 (426)
..++.|+.|.++.++....|+.||+|++.+..... +...+.+.+|+.+|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34677888888887777789999999998653221 22346799999999999 69999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||||++|++|.++|...+++++. .++.||+.|| +|||++.+|++||+|||+|+.... ...
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCS 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCc
Confidence 99999999999999998888875 4889999997 799999999999999999986543 233
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 236 (426)
...+.|||+.|||||++.+.. ..++|+||+|+++++|.+|..|+ +..+... |.. ...+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~-~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVE-RWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHH--------HHHHHTS----CGG-GCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchh--------HHHhhcC----CCC-CCcHHHHHHHH
Confidence 456789999999999998753 36799999999999887665432 1111111 111 11245667777
Q ss_pred cccCcCCCCChHHHhcCcCCc
Q 014359 237 LEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 237 L~~dP~~R~t~~~il~h~w~~ 257 (426)
+..+|..|+.......++|..
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHH
Confidence 778888888777666666653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.3e-23 Score=213.74 Aligned_cols=174 Identities=16% Similarity=0.183 Sum_probs=131.0
Q ss_pred EEeceeeecCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
...+.||+|+||.||+|. ..++.+|+|........... ..+++.+|+.++++++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 345689999999999995 56788999987543332221 23568999999999999999966666667778899
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||||++||+|.+++.. +..++.|++.|| +|||++. ++||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999876 668999999997 6999999 99999999999654321111
Q ss_pred -----ccccccCCCcccchhhhcc--CCCCCchhhHHHHHHHHHHHhcCCCCCC
Q 014359 157 -----LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFD 203 (426)
Q Consensus 157 -----~~~~~~gt~~Y~APE~l~~--~~~~~~~~DIwSlGvil~elltG~~Pf~ 203 (426)
...+.+||+.|||||++.. .+|. ..+|+||..+-..+.+.++-+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 1246789999999999987 5664 77899999888888777766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.4e-19 Score=170.05 Aligned_cols=128 Identities=18% Similarity=0.216 Sum_probs=101.1
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccch---------------hHHHHHHHHHHHHhcCCCCCccceeEEEE
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---------------KITDQIKREIATLKLLKHPNVVRLHEVLA 84 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 84 (426)
+.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|+.++++++ | +++.+++.
T Consensus 96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 9999999999999999 8899999999964322111 13467899999999999 5 66666654
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
. +..|+||||++||+|.+ +.. ..+..++.|++.|+ +|||++ +|.+||+|||+|+
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~-- 240 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV-- 240 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE--
T ss_pred c-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe--
Confidence 4 45699999999999988 421 23557999999996 699999 9999999999986
Q ss_pred CcccCCCccccccCCCcccchhhhcc
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLAN 175 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~ 175 (426)
.+..|+|||++.+
T Consensus 241 -------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 241 -------------EVGEEGWREILER 253 (282)
T ss_dssp -------------ETTSTTHHHHHHH
T ss_pred -------------ECCCCCHHHHHHH
Confidence 3456799998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.8e-14 Score=135.41 Aligned_cols=124 Identities=20% Similarity=0.288 Sum_probs=93.7
Q ss_pred EEEeceeeecCceEEEEEEECCCCce--EEEEEeecccccc---------------------hhHHHHHHHHHHHHhcCC
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIH---------------------LKITDQIKREIATLKLLK 72 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~--vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 72 (426)
|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|+.+|+++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778888 9999975432110 011246889999999999
Q ss_pred CCCc--cceeEEEEeCCeEEEEEcccCC-C----ChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hh
Q 014359 73 HPNV--VRLHEVLASKSKIYMVLEYVTG-G----ELFDKIASKGRLQEAEGRKLFQQLIDGL----------------EN 129 (426)
Q Consensus 73 HpnI--v~l~~~~~~~~~~~lVmEy~~g-g----~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eN 129 (426)
|++| +.++++ ...|+||||+.+ | +|.+.... .++..+..++.|++.|+ +|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8864 444442 356899999932 3 67665432 34567788999999886 69
Q ss_pred eeeCCCCCEEEeccCCCCC
Q 014359 130 ILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 130 ILld~~g~lKl~DFGla~~ 148 (426)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99998 999999999973
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-10 Score=95.68 Aligned_cols=86 Identities=17% Similarity=0.290 Sum_probs=76.3
Q ss_pred eeEecCCHHHHHHHHHHHHHHcCcEEEeeC-CeeEEEeecCCCCcccceEEEEEEEEEe-CceEEEEEEecCCCchHHHH
Q 014359 327 RFTSNHSAKDLLERIEDIVTEMGFRVQKKN-GKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQ 404 (426)
Q Consensus 327 ~f~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~gd~~e~~~ 404 (426)
..+|..+|.+|+..|++++..+|+.|++++ +.+.+.......+ +.+++.+||+++. +++++|+|+|.+||.+.|++
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~--~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~ 109 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQD--SLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN 109 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTT--CCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCC--ccEEEEEEEEEecCCCceeEEEEecCCCHHHHHH
Confidence 346789999999999999999999998765 7888887644445 7899999999996 89999999999999999999
Q ss_pred HHHHHHhhcC
Q 014359 405 LCNKLSSDLG 414 (426)
Q Consensus 405 ~~~~~~~~l~ 414 (426)
+|.+|...|+
T Consensus 110 lc~~il~~L~ 119 (120)
T 3ose_A 110 IASKIANELK 119 (120)
T ss_dssp HHHHHHHHCC
T ss_pred HHHHHHHHhc
Confidence 9999998886
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.5e-11 Score=119.85 Aligned_cols=123 Identities=20% Similarity=0.235 Sum_probs=85.8
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc------------ch---h----HHHHHHHHHHHHhcCCCCCc
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII------------HL---K----ITDQIKREIATLKLLKHPNV 76 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~------------~~---~----~~~~~~~Ei~il~~l~HpnI 76 (426)
|++++.||+|+||.||+|.+ .+|+.||||+++..... .. . ..-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999997 47999999998643211 00 0 00123457777777755554
Q ss_pred cceeEEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCC----
Q 014359 77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGN---- 137 (426)
Q Consensus 77 v~l~~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~---- 137 (426)
....-+.... .++||||+.|++|.++. ....+..++.||+.++ +|||++++|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 3222222222 37999999998886542 2234567889999986 6999998874
Q ss_pred ------EEEeccCCCC
Q 014359 138 ------IKISDFGLSA 147 (426)
Q Consensus 138 ------lKl~DFGla~ 147 (426)
+.|+||+-+.
T Consensus 248 ~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMV 263 (397)
T ss_dssp TSEEEEEEECCCTTCE
T ss_pred cccccceEEEEeCCcc
Confidence 8999999765
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.87 E-value=6.4e-09 Score=85.09 Aligned_cols=85 Identities=16% Similarity=0.268 Sum_probs=73.7
Q ss_pred EecCCHHHHHHHHHHHHHHcCcEEEe-eCCeeEEEeecCCCCcccceEEEEEEEEEe-CceEEEEEEecCCCchHHHHHH
Q 014359 329 TSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLC 406 (426)
Q Consensus 329 ~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~gd~~e~~~~~ 406 (426)
+|..+|.+|+..|.++++.+|+.|+. +.+.+++........ ..++|.+||+++. .+++.|+|+|.+||.+.|+++|
T Consensus 34 TSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~--~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc 111 (126)
T 1v5s_A 34 GSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE--NLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (126)
T ss_dssp CCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTT--TCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHH
T ss_pred ecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCC--ceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHH
Confidence 45789999999999999999999986 557788876543334 7899999999985 7899999999999999999999
Q ss_pred HHHHhhcCC
Q 014359 407 NKLSSDLGL 415 (426)
Q Consensus 407 ~~~~~~l~~ 415 (426)
.+|...|+.
T Consensus 112 ~~IL~eLkL 120 (126)
T 1v5s_A 112 SKIANELKL 120 (126)
T ss_dssp HHHHHHTTC
T ss_pred HHHHHHHhc
Confidence 999998874
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=5.1e-07 Score=71.31 Aligned_cols=87 Identities=9% Similarity=0.279 Sum_probs=74.5
Q ss_pred eeeEecCCHHHHHHHHHHHHHHcCcEEEe-eCCeeEEEeecCCCCcccceEEEEEEEEEeCceEEEEEEecCCC------
Q 014359 326 IRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD------ 398 (426)
Q Consensus 326 ~~f~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd------ 398 (426)
....|...|.+|+..|..+++.+|+.|+. +.+.+++........ ..+.+.+++|++.++.+|+||++..||
T Consensus 10 LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~--~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~ 87 (106)
T 4eai_A 10 LGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGG 87 (106)
T ss_dssp ESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEECCSSCCCSSS
T ss_pred EcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCC--ceeEEEEEEEEecCCcEEEEEEeccCCCCCCCC
Confidence 34567888999999999999999999986 568888886643333 678999999999999999999999995
Q ss_pred --chHHHHHHHHHHhhcC
Q 014359 399 --PTVYRQLCNKLSSDLG 414 (426)
Q Consensus 399 --~~e~~~~~~~~~~~l~ 414 (426)
.++|-++|.++...|.
T Consensus 88 ~~~~~F~d~ca~li~~la 105 (106)
T 4eai_A 88 SHTIEFFEMCANLIKILA 105 (106)
T ss_dssp CHHHHHHHHHHHHHHHCC
T ss_pred cCcEeHHHHHHHHHHHHh
Confidence 9999999999887764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=2.9e-07 Score=85.65 Aligned_cols=89 Identities=11% Similarity=0.031 Sum_probs=73.2
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI 89 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 89 (426)
..++.|++...++.|+.+.||++.. .++.+++|+........ ...+.+|+.+++.+. |.++.+++++..+.+..
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 3578899999999999999999874 46789999987532111 245889999999984 67888999999999999
Q ss_pred EEEEcccCCCChHHH
Q 014359 90 YMVLEYVTGGELFDK 104 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~ 104 (426)
|+||||++|.+|.+.
T Consensus 86 ~lv~e~i~G~~l~~~ 100 (263)
T 3tm0_A 86 NLLMSEADGVLCSEE 100 (263)
T ss_dssp EEEEECCSSEEHHHH
T ss_pred EEEEEecCCeehhhc
Confidence 999999999998764
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.41 E-value=4.6e-06 Score=69.81 Aligned_cols=75 Identities=8% Similarity=0.244 Sum_probs=60.8
Q ss_pred ceeeEecCCHHHHHHHHHHHHHHcCcEEEe-eCCeeEEEeecCCCCcccceEEEEEEEEEeCceEEEEEEecCCCchH
Q 014359 325 KIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 401 (426)
Q Consensus 325 ~~~f~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd~~e 401 (426)
....-|...|.+|+..|..+++.+|+.|++ ..|.|++....+... ..+.+.+++|++.++.+||||++..||+.|
T Consensus 6 hLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~--~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 6 HLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCC--ceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 344567889999999999999999999987 558898887643322 468999999999999999999999998743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.33 E-value=1.2e-06 Score=80.86 Aligned_cols=84 Identities=18% Similarity=0.183 Sum_probs=64.1
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC--ccceeEEEEeCCeE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~ 89 (426)
.+..|.+....+.|..+.||++.. .+|+.+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 356778765555677799999864 567789999875431 245778999999886444 56789988888889
Q ss_pred EEEEcccCCCChH
Q 014359 90 YMVLEYVTGGELF 102 (426)
Q Consensus 90 ~lVmEy~~gg~L~ 102 (426)
|+||||++|.+|.
T Consensus 91 ~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 91 WLLLGEVPGQDLL 103 (264)
T ss_dssp EEEEECCSSEETT
T ss_pred EEEEEecCCcccC
Confidence 9999999998874
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.19 E-value=1.9e-05 Score=63.95 Aligned_cols=72 Identities=6% Similarity=0.217 Sum_probs=57.3
Q ss_pred eEecCCHHHHHHHHHHHHHHcCcEEEe-eCCeeEEEeecCCCCcccceEEEEEEEEEeCceEEEEEEecCCCchH
Q 014359 328 FTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 401 (426)
Q Consensus 328 f~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd~~e 401 (426)
.-|...|.+|+..|..+++.+|+.|+. ..+.+++........ ..+.+.+++|++.++.+|+||++..||..|
T Consensus 12 IrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~--~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~ 84 (130)
T 4eag_A 12 IRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTG--KFSKMSLQLYQVDAKSYLLDFKSLTNDEVE 84 (130)
T ss_dssp BCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEESSSSCEEEEEEECC-----
T ss_pred eecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCC--ceeEEEEEEEEecCCcEEEEeccCCcchhh
Confidence 346778999999999999999999987 468888886644443 578899999999999999999999999543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.19 E-value=7.8e-07 Score=84.82 Aligned_cols=75 Identities=15% Similarity=0.079 Sum_probs=52.5
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCC--ccceeEEEEeCC---eEEEE
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPN--VVRLHEVLASKS---KIYMV 92 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn--Iv~l~~~~~~~~---~~~lV 92 (426)
.+.++.|....||+.. ..+++|+.... .....+.+|+.+|+.+ .+.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3569999999999753 46899985432 2356789999999888 3433 345555443333 45899
Q ss_pred EcccCCCChHH
Q 014359 93 LEYVTGGELFD 103 (426)
Q Consensus 93 mEy~~gg~L~~ 103 (426)
|++++|..|.+
T Consensus 95 m~~i~G~~l~~ 105 (304)
T 3sg8_A 95 FTKIKGVPLTP 105 (304)
T ss_dssp EECCCCEECCH
T ss_pred EcccCCeECCc
Confidence 99999988764
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=1.7e-05 Score=67.26 Aligned_cols=77 Identities=8% Similarity=0.231 Sum_probs=62.1
Q ss_pred ccceeeEecCCHHHHHHHHHHHHHHcCcEEEe-eCCeeEEEeecCCCCcccceEEEEEEEEEeCceEEEEEEecCCCchH
Q 014359 323 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 401 (426)
Q Consensus 323 ~~~~~f~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd~~e 401 (426)
+.....-|...|.+|+..|..+++.+|+.|++ ..|.|++....+... ..+.|.+++|++.++.|||||++..||+.|
T Consensus 18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~--~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCC--eeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 34455668889999999999999999999987 558899887533222 468999999999999999999999999877
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1e-05 Score=67.12 Aligned_cols=91 Identities=12% Similarity=0.175 Sum_probs=71.6
Q ss_pred cceeeEecCCHHHHHHHHHHHHHHcCcEEEee---------C-CeeEEEeecCCC---CcccceEEEEEEEEEeCceEEE
Q 014359 324 RKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK---------N-GKLKATQEHKPQ---KSLGSLSVAAEVFEISPSLYVV 390 (426)
Q Consensus 324 ~~~~f~s~~~~~~~~~~l~~~~~~~~~~~~~~---------~-~~~~~~~~~~~~---~~~~~l~~~~~i~~~~~~~~~v 390 (426)
..-..-|...|.+|+..|..|++.+|+.|+.. + |.|++....+.. .....+.+.+++|++.++.+||
T Consensus 13 WhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YLl 92 (137)
T 2qrd_A 13 WHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFML 92 (137)
T ss_dssp CEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEE
T ss_pred cccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEEE
Confidence 34455678899999999999999999999865 3 668877653221 0014688999999999999999
Q ss_pred EEEecCCC---------------c----hHHHHHHHHHHhhcC
Q 014359 391 ELRKSYGD---------------P----TVYRQLCNKLSSDLG 414 (426)
Q Consensus 391 ~~~~~~gd---------------~----~e~~~~~~~~~~~l~ 414 (426)
||++..|+ . ++|-.+|.+|...|.
T Consensus 93 DFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa 135 (137)
T 2qrd_A 93 DVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 135 (137)
T ss_dssp EEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence 99999999 5 899999998876653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.04 E-value=1.6e-05 Score=77.36 Aligned_cols=81 Identities=15% Similarity=0.310 Sum_probs=58.0
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEee--cccccchhHHHHHHHHHHHHhcCC--CCCccceeEEEEeC---CeEE
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASK---SKIY 90 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~~ 90 (426)
-.+.|+.|.++.||+... .+..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 457889999999999874 34678899775 32211 11357889999999997 45688999988776 4589
Q ss_pred EEEcccCCCChH
Q 014359 91 MVLEYVTGGELF 102 (426)
Q Consensus 91 lVmEy~~gg~L~ 102 (426)
+||||++|..+.
T Consensus 118 ~vme~v~G~~l~ 129 (359)
T 3dxp_A 118 YIMEFVSGRVLW 129 (359)
T ss_dssp EEEECCCCBCCC
T ss_pred EEEEecCCeecC
Confidence 999999997773
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00025 Score=60.67 Aligned_cols=91 Identities=18% Similarity=0.221 Sum_probs=71.0
Q ss_pred cceeeEecCCHHHHHHHHHHHHHHcCcEEEee----CCeeEEEeecCCC-------CcccceEEEEEEEEEeCceEEEEE
Q 014359 324 RKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK----NGKLKATQEHKPQ-------KSLGSLSVAAEVFEISPSLYVVEL 392 (426)
Q Consensus 324 ~~~~f~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~-------~~~~~l~~~~~i~~~~~~~~~v~~ 392 (426)
.....-|...|.+|+..|..+++.+|+.|++. .|.|++....+.. +....+.+.+++|++.++.+||||
T Consensus 51 W~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDf 130 (179)
T 3t4n_A 51 WHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDF 130 (179)
T ss_dssp CEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEEE
T ss_pred eeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEEE
Confidence 34445678999999999999999999999874 5778887542210 101358999999999999999999
Q ss_pred EecCC----------------------CchHHHHHHHHHHhhcCC
Q 014359 393 RKSYG----------------------DPTVYRQLCNKLSSDLGL 415 (426)
Q Consensus 393 ~~~~g----------------------d~~e~~~~~~~~~~~l~~ 415 (426)
+ ..| ....|-.+|.+|.-.|..
T Consensus 131 k-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa~ 174 (179)
T 3t4n_A 131 K-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELAV 174 (179)
T ss_dssp E-EEEEECC----------------CCCCHHHHHHHHHHHHHHHH
T ss_pred E-eccccccccccccccccccccccccCCccHHHHHHHHHHHHHh
Confidence 9 888 778999999988776643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00045 Score=64.00 Aligned_cols=80 Identities=10% Similarity=0.187 Sum_probs=60.8
Q ss_pred eeeecCce-EEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEEEEEcccCC
Q 014359 21 TLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVTG 98 (426)
Q Consensus 21 ~LG~G~fg-~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lVmEy~~g 98 (426)
.+..|..+ .||+......+..+++|+-... ....+.+|..+|+.+. +--+.+++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445544 6898876667778999986533 2467889999998884 33477899999999999999999999
Q ss_pred CChHHHHH
Q 014359 99 GELFDKIA 106 (426)
Q Consensus 99 g~L~~~i~ 106 (426)
.++.+...
T Consensus 105 ~~~~~~~~ 112 (272)
T 4gkh_A 105 KTAFQVLE 112 (272)
T ss_dssp EEHHHHHH
T ss_pred cccccccc
Confidence 88776554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0013 Score=59.04 Aligned_cols=107 Identities=21% Similarity=0.183 Sum_probs=69.9
Q ss_pred CChHHHHHh-CCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCCCccccc
Q 014359 99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 161 (426)
Q Consensus 99 g~L~~~i~~-~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~~ 161 (426)
-+|.+.+.. ..+++|++||.++.|.+.+| ..|++..+|+|-..+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 378888875 56899999999999999987 356666666665542 1110
Q ss_pred cCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcccc
Q 014359 162 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 162 ~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~ 239 (426)
.....+.|||... ...+.+.=|||||+++|.-+-=.+| ...+..+|+++.+||..|..-
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence 1234567888763 2234788999999999998753222 122345999999999999866
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0093 Score=56.47 Aligned_cols=74 Identities=20% Similarity=0.216 Sum_probs=55.6
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC---CccceeEEEE-eCCeEEEEEcc
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLA-SKSKIYMVLEY 95 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lVmEy 95 (426)
+.++.|....||+. +..+++|+-.. ......+.+|..+|+.+.+. .+.+.+.+.. ..+..|+||||
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 45789999999987 56789998422 22356899999999999752 3567777764 45567899999
Q ss_pred cCCCChHH
Q 014359 96 VTGGELFD 103 (426)
Q Consensus 96 ~~gg~L~~ 103 (426)
++|..|.+
T Consensus 95 i~G~~l~~ 102 (306)
T 3tdw_A 95 VQGQILGE 102 (306)
T ss_dssp CCSEECHH
T ss_pred cCCeECch
Confidence 99987765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0076 Score=59.11 Aligned_cols=81 Identities=17% Similarity=0.160 Sum_probs=51.8
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccc-cc---hhHHHHHHHHHHHHhcCCC--C-CccceeEEEEeCCeEEE
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IH---LKITDQIKREIATLKLLKH--P-NVVRLHEVLASKSKIYM 91 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~---~~~~~~~~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~l 91 (426)
.+.||.|.++.||++....+++.|+||....... .. ....+++.+|..+++.+.. | .+.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5689999999999997655678899998653211 00 0113456789999887742 3 34566654 3455689
Q ss_pred EEcccCCCCh
Q 014359 92 VLEYVTGGEL 101 (426)
Q Consensus 92 VmEy~~gg~L 101 (426)
||||++|...
T Consensus 113 vmE~l~g~~~ 122 (397)
T 2olc_A 113 VMEDLSHLKI 122 (397)
T ss_dssp EECCCTTSEE
T ss_pred EEEeCCCcch
Confidence 9999987544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.066 Score=50.85 Aligned_cols=75 Identities=21% Similarity=0.243 Sum_probs=60.9
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC---CCCccceeEEEEeCCeEEEEEcc
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
.+.|+.|....+|+... .+..+++|+..... ...+.+|...|+.|. ...+.+++.+....+..|+||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 46789999999999873 56789999876431 467889999998884 36788999998888899999999
Q ss_pred cCCCCh
Q 014359 96 VTGGEL 101 (426)
Q Consensus 96 ~~gg~L 101 (426)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 999765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=92.53 E-value=1.1 Score=41.30 Aligned_cols=79 Identities=15% Similarity=0.107 Sum_probs=55.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-C--CCccceeEEEEeCCeEEE
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H--PNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~l 91 (426)
+..-.+.+|.|..+.||+... .+|+.|.+|+-....... ...+.+|+..|+.|. . --+.+++.+ +. .++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence 355578899999999999985 578899999865432211 245788999998884 2 234555554 22 478
Q ss_pred EEcccCCCCh
Q 014359 92 VLEYVTGGEL 101 (426)
Q Consensus 92 VmEy~~gg~L 101 (426)
||||+.++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=90.87 E-value=0.13 Score=49.15 Aligned_cols=113 Identities=12% Similarity=0.163 Sum_probs=72.5
Q ss_pred EEecee-eecCceEEEEEEEC---C---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-C--CCccceeEEEEeC
Q 014359 17 ELGRTL-GEGNFGKVKFAQDL---D---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H--PNVVRLHEVLASK 86 (426)
Q Consensus 17 ~i~~~L-G~G~fg~V~~a~~~---~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~ 86 (426)
...+.| +.|....+|+.... . +++.+++|+..............+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88999999987642 0 26678999765432000000135778899888884 3 3577888887655
Q ss_pred ---CeEEEEEcccCCCChHHHHHh---C---CCCCHHHHHHHHHHHHHHHhh
Q 014359 87 ---SKIYMVLEYVTGGELFDKIAS---K---GRLQEAEGRKLFQQLIDGLEN 129 (426)
Q Consensus 87 ---~~~~lVmEy~~gg~L~~~i~~---~---~~l~e~~~~~~~~ql~~aleN 129 (426)
+..|+||||++|..+.+.+.. + ..++..+...++.++...|..
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~ 154 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALAT 154 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHH
T ss_pred CccCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 357899999999877643210 0 135666666677777776643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.44 E-value=0.036 Score=55.77 Aligned_cols=65 Identities=9% Similarity=0.141 Sum_probs=19.5
Q ss_pred EEeceeeecCceEEEEEEECCCCceEEE------EEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 014359 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAV------KILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS 85 (426)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~~~vAv------K~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 85 (426)
.+.+.|| ||.||+|.......+||+ |........ ......+.+|..+++.++|||+++.+.+...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-EKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCcccccccccc-ccccccccccccccccccccccCCCcceEEe
Confidence 4456676 999999988655568898 655432222 2223567789999999999999999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=88.44 E-value=1.8 Score=40.45 Aligned_cols=74 Identities=12% Similarity=0.166 Sum_probs=43.2
Q ss_pred ceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----CCCcccee-E--EEEeCCeEEE
Q 014359 20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLH-E--VLASKSKIYM 91 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-~--~~~~~~~~~l 91 (426)
+.|+.|..+.||+... . +..+++|+.... ...+..|..+++.|. .|.++... + +....+..|+
T Consensus 38 ~~l~gG~~n~~~~v~~-~-~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT-D-SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEE-T-TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEe-C-CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 4566678899999875 2 345899988652 133445555555543 34444311 0 2235678899
Q ss_pred EEcccCCCChH
Q 014359 92 VLEYVTGGELF 102 (426)
Q Consensus 92 VmEy~~gg~L~ 102 (426)
+|+|++|..+.
T Consensus 109 l~~~i~G~~~~ 119 (346)
T 2q83_A 109 VYDWIEGRPFE 119 (346)
T ss_dssp EEECCCCBCCC
T ss_pred EEEeecCccCC
Confidence 99999987663
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=87.39 E-value=1.1 Score=43.57 Aligned_cols=79 Identities=11% Similarity=0.071 Sum_probs=47.5
Q ss_pred cCEEEeceeeecCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEe
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS 85 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 85 (426)
+..++ +.|..|-...+|+..... .++.|.+|+.-.. . .....+.+|..+++.+. +.-..++++++.+
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 34443 567778888999987532 3578999985321 1 11456678999998885 3334677766543
Q ss_pred CCeEEEEEcccCCCCh
Q 014359 86 KSKIYMVLEYVTGGEL 101 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L 101 (426)
.+||||++|..|
T Consensus 126 ----g~v~e~i~G~~l 137 (379)
T 3feg_A 126 ----GRLEQYIPSRPL 137 (379)
T ss_dssp ----EEEEECCSEEEC
T ss_pred ----ccEEEEecCccC
Confidence 389999998554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=84.43 E-value=2.4 Score=39.27 Aligned_cols=71 Identities=15% Similarity=-0.005 Sum_probs=45.6
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-cceeEEEEeCCeEEEEEccc-
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYV- 96 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lVmEy~- 96 (426)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++ .+++.+. .+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 678999999999998 56899987643110 1123568888877743222 4666543 33357899999
Q ss_pred CCCCh
Q 014359 97 TGGEL 101 (426)
Q Consensus 97 ~gg~L 101 (426)
+|.+|
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=83.36 E-value=3.9 Score=39.86 Aligned_cols=77 Identities=13% Similarity=0.056 Sum_probs=46.2
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecccc--cc--h--hHHHHHHHHHHHHh-cCCCCCccceeEEEEeCCeEEE
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IH--L--KITDQIKREIATLK-LLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~--~--~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+.||.|..+.||++. .+++.++||....... .. . .....+..|+..+. ...+..+.+++.+. ....++
T Consensus 39 i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 4678999999999986 3567899994321100 00 0 01223333433322 22335677777765 566799
Q ss_pred EEccc-CCC
Q 014359 92 VLEYV-TGG 99 (426)
Q Consensus 92 VmEy~-~gg 99 (426)
||||+ +|.
T Consensus 115 v~e~l~~g~ 123 (420)
T 2pyw_A 115 GMRYLEPPH 123 (420)
T ss_dssp EECCCCTTC
T ss_pred EEeecCCcc
Confidence 99999 873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 426 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-77 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-74 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-74 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-72 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-71 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-71 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-69 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-68 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-67 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-67 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-66 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-66 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-65 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-63 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-63 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-61 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-61 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-58 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-57 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-57 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-56 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-54 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-54 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-52 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-52 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-52 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-51 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-49 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-47 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-44 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-38 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-33 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 1e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (607), Expect = 7e-77
Identities = 76/262 (29%), Positives = 133/262 (50%), Gaps = 20/262 (7%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L +E+GR LG+G FG V A++ S A+K+L K ++ + Q++RE+ L+
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
HPN++RL+ +++Y++LEY G ++ ++ + E +L + L
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
EN+LL S G +KI+DFG S T CG+ +Y+ PE++ R
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 237
+D D+WS GV+ Y L G PF+ Y++I R +F P +++ GA++L+ ++L
Sbjct: 181 HDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239
Query: 238 EPNPVKRITIAGIKADEWFEQD 259
+ NP +R + + W +
Sbjct: 240 KHNPSQRPMLREVLEHPWITAN 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (594), Expect = 1e-74
Identities = 74/263 (28%), Positives = 125/263 (47%), Gaps = 16/263 (6%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
R ++ G+ LGEG+F V A++L + +A+KILEK II + RE +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL--- 127
L HP V+L+ K+Y L Y GEL I G E R +++ L
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 128 ------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 175
ENILL+ +I+I+DFG + + ++ G+ YV+PE+L
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 235
+ + SD+W+ G I+Y ++ G PF N +++QKI + ++ P+ P A++L+ K
Sbjct: 185 KSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243
Query: 236 ILEPNPVKRITIAGIKADEWFEQ 258
+L + KR+ ++ +
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 3e-74
Identities = 93/266 (34%), Positives = 141/266 (53%), Gaps = 20/266 (7%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++L +TLGEG +G+V+ A + + AVKI++ R + + IK+EI K+L
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
H NVV+ + + Y+ LEY +GGELFD+I + E + ++ F QL+ G+
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
EN+LLD + N+KISDFGL+ + ++ + LL+ CG+ YVAPE+L R
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 178 YDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 234
+ D+WSCG++L +L G LP+D + Y L W + LL
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 235 KILEPNPVKRITIAGIKADEWFEQDY 260
KIL NP RITI IK D W+ +
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPL 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 228 bits (583), Expect = 1e-72
Identities = 89/273 (32%), Positives = 135/273 (49%), Gaps = 28/273 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y+ LG G F +V A+D + A+K + K + ++ EIA L +KHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHP 67
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
N+V L ++ S +Y++++ V+GGELFD+I KG E + +L Q++D ++
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 129 ------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
LD I ISDFGLS + +L T CG+P YVAPEVLA +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNL 232
Y A D WS GVI Y++L GY PF D N A L+++I + +++ +S A++
Sbjct: 185 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANP 265
+R ++E +P KR T W D
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 227 bits (579), Expect = 1e-71
Identities = 74/275 (26%), Positives = 136/275 (49%), Gaps = 29/275 (10%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
++G Y++ LG G FG V + +G F K + + +K EI+
Sbjct: 23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISI 79
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
+ L HP ++ LH+ K ++ ++LE+++GGELFD+IA++ ++ EAE +Q +G
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139
Query: 127 L---------------ENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
L ENI+ ++K ++KI DFGL+ D ++ T + + A
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAA 196
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WL 225
PE++ +D+W+ GV+ YV+L+G PF + Q + R D++ + +
Sbjct: 197 PEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260
SP A++ ++ +L+ P KR+T+ W + D+
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 225 bits (574), Expect = 6e-71
Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 29/280 (10%)
Query: 8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
+ L Y++ LG G FG V + +G FA K + H + +++EI T
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQT 76
Query: 68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDG 126
+ +L+HP +V LH+ +++ M+ E+++GGELF+K+A + ++ E E + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 127 L---------------ENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
L ENI+ +K +K+ DFGL+A H + T G+ + A
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAA 193
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL 225
PEV + +D+WS GV+ Y++L+G PF N + + D+ + +
Sbjct: 194 PEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 265
S ++ +RK+L +P R+TI W P
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (558), Expect = 5e-69
Identities = 59/272 (21%), Positives = 104/272 (38%), Gaps = 25/272 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ R +G G+FG V FA+D+ + A+K + + + I +E+ L+ L+HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
N ++ + ++V+EY G K LQE E + + GL
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 179
NILL G +K+ DFG + ++ G+P ++APEV+
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPEVILAMDEG 189
Query: 180 GAT--SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRK 235
D+WS G+ + P + N I + + + S +N +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 236 ILEPNPVKRITIAGIKADEWFEQDYTPANPDD 267
L+ P R T + + ++ P D
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 5e-68
Identities = 67/269 (24%), Positives = 122/269 (45%), Gaps = 28/269 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+E+ LG+G FGKV AQ+ ++ + A K+++ L+ EI L HP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMVEIDILASCDHP 69
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGL------ 127
N+V+L + ++ +++++E+ GG + + R L E++ + + +Q +D L
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 128 ---------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
NIL G+IK++DFG+SA ++ R + G+P ++APEV+
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 179 D----GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 231
+D+WS G+ L + P + N + KI + + P S ++
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 232 LLRKILEPNPVKRITIAGIKADEWFEQDY 260
L+K LE N R T + + + D
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVTVDS 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-67
Identities = 80/261 (30%), Positives = 133/261 (50%), Gaps = 20/261 (7%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKH 73
+ L + LG+G+FGKV A+ + FA+K L+K+ ++ + E L L +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------ 127
P + + +K ++ V+EY+ GG+L I S + + ++I GL
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 128 ---------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
+NILLD G+IKI+DFG+ ++ D +T CG+P+Y+APE+L + Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 179 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 238
+ + D WS GV+LY +L G PF ++ L+ I + P+WL A++LL K+
Sbjct: 181 NHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239
Query: 239 PNPVKRITIAG-IKADEWFEQ 258
P KR+ + G I+ F +
Sbjct: 240 REPEKRLGVRGDIRQHPLFRE 260
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 213 bits (543), Expect = 3e-67
Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 34/275 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITDQIKREIATL 68
YE LG G V+ + +AVKI++ ++ + +E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 69 KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
+ + HPN+++L + + + ++V + + GELFD + K L E E RK+ + L++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 128 ---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
ENILLD NIK++DFG S L CG+P+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180
Query: 173 LA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW- 224
+ N G D+WS GVI+Y +L G PF R ++ + I G+++ P+W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 225 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
S ++L+ + L P KR T A +F+Q
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 7e-67
Identities = 60/261 (22%), Positives = 118/261 (45%), Gaps = 25/261 (9%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
+Y +G+G G V A D+ +G A++ + + + I EI ++ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----- 128
PN+V + ++++V+EY+ GG L D + ++ + E + + ++ + LE
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
NILL G++K++DFG A + T G+P ++APEV+ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 179 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRK 235
DIWS G++ ++ G P+ + N I + + P+ LS ++ L +
Sbjct: 194 GPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 236 ILEPNPVKRITIAGIKADEWF 256
L+ + KR + + ++
Sbjct: 253 CLDMDVEKRGSAKELLQHQFL 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 2e-66
Identities = 63/274 (22%), Positives = 118/274 (43%), Gaps = 30/274 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y + LG G FG V + S + K ++ +K+EI+ L + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL------ 127
N++ LHE S ++ M+ E+++G ++F++I + L E E Q+ + L
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 128 ---------ENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
ENI+ ++ + IKI +FG + + + +P Y APEV +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 177 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNL 232
A +D+WS G ++YV+L+G PF + + I ++ K +S A +
Sbjct: 179 VVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 266
+ ++L R+T + W +Q +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-66
Identities = 82/270 (30%), Positives = 133/270 (49%), Gaps = 30/270 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLL 71
Y+ G LG G F VK ++ +GL +A K ++K R + + I+RE++ LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
+HPNV+ LHEV +K+ + ++LE V GGELFD +A K L E E + +Q+++G+
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 128 -----------ENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
ENI+L + IKI DFGL+ G+P +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 228
+ +D+WS GVI Y++L+G PF + +++ S
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 229 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
A++ +R++L +P KR+TI W +
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 6e-66
Identities = 75/274 (27%), Positives = 120/274 (43%), Gaps = 32/274 (11%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
+Y++G LG G FG V + LP A+K +EK+RI L ++ E+ LK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 71 LK--HPNVVRLHEVLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGL 127
+ V+RL + ++LE +LFD I +G LQE R F Q+++ +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 128 ---------------ENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
ENIL+D ++G +K+ DFG D + G+ Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVYTDFDGTRVYSPPE 179
Query: 172 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 231
+ Y G ++ +WS G++LY ++ G +PF+ +I RG + +S Q+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 232 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 265
L+R L P R T I+ W + P
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-65
Identities = 70/271 (25%), Positives = 118/271 (43%), Gaps = 31/271 (11%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
R YE+ T+G G++G+ + + G K L+ + + + E+ L+ L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 60
Query: 72 KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLID 125
KHPN+VR ++ + ++ +Y+V+EY GG+L I + L E ++ QL
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 126 GL--------------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
L N+ LD K N+K+ DFGL+ + H D G+P
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 178
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 224
Y++PE + Y+ SDIWS G +LY + PF + L KI G F ++P
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEW 255
S ++ ++L R ++ I +
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 206 bits (524), Expect = 7e-64
Identities = 75/263 (28%), Positives = 137/263 (52%), Gaps = 26/263 (9%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+++ RTLG G+FG+V + +G +A+K+L+K ++ LK + E L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-------- 127
++R+ +I+M+++Y+ GGELF + R + ++ L
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 128 -------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 180
ENILLD G+IKI+DFG + + +T CG+P+Y+APEV++ + Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 181 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 240
+ D WS G+++Y +L GY PF D N Y+KI + + P + + ++LL +++ +
Sbjct: 181 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 241 PVKRI-----TIAGIKADEWFEQ 258
+R+ +K WF++
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-63
Identities = 60/270 (22%), Positives = 116/270 (42%), Gaps = 33/270 (12%)
Query: 14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
GR+ + +G G+F V D ++ + A L+ ++ + K E LK L+
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 66
Query: 73 HPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL- 127
HPN+VR ++ S K I +V E +T G L + ++ R +Q++ GL
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 128 ----------------ENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 170
+NI + G++KI D GL+ + G+P ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAP 182
Query: 171 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG--DFKLPKWLSP 227
E+ YD + D+++ G+ + + T P+ + +N A +Y+++ G K P
Sbjct: 183 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 228 GAQNLLRKILEPNPVKRITIAGIKADEWFE 257
+ ++ + N +R +I + +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-63
Identities = 72/308 (23%), Positives = 116/308 (37%), Gaps = 67/308 (21%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
++ +E LG GN G V SGL A K++ I I +QI RE+ L
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL--- 127
P +V + S +I + +E++ GG L + GR+ E K+ +I GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 128 -------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
NIL++S+G IK+ DFG+S D + ++ G+ +Y++PE L
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQ 176
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKL---------- 221
Y SDIWS G+ L + G P D + L +++ GD
Sbjct: 177 GTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 222 -------------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGI 250
S Q+ + K L NP +R + +
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 251 KADEWFEQ 258
+ ++
Sbjct: 296 MVHAFIKR 303
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 204 bits (521), Expect = 8e-63
Identities = 89/392 (22%), Positives = 160/392 (40%), Gaps = 59/392 (15%)
Query: 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ + + + R +G G FG+V + D+G +A+K L+K RI + E L L
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 71 LK---HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL 127
+ P +V + + K+ +L+ + GG+L ++ G EA+ R ++I GL
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 128 ---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 172
NILLD G+++ISD GL+ H + G+ Y+APEV
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEV 176
Query: 173 LANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLSPGA 229
L +++D +S G +L+ +L G+ PF ++ + + +LP SP
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
Query: 230 QNLLRKILEPNPVKRITIAGIKADE-----WFEQDYTPANPDDDEEDIFVDNEAFSMHEV 284
++LL +L+ + +R+ G A E +F +D + + +
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS---------------LDWQMVFLQKY 281
Query: 285 PSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKD----LLER 340
P PPLI + + D+ F++ED K+ + ++ + ER
Sbjct: 282 P---------PPLIPPRGEVNAADAFDIG-SFDEEDTKGIKLLDSDQELYRNFPLTISER 331
Query: 341 IEDIVTEMGFRVQKKNGKLKATQEHKPQKSLG 372
+ V E F ++ K LG
Sbjct: 332 WQQEVAETVFDTINAETDRLEARKKTKNKQLG 363
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-61
Identities = 80/264 (30%), Positives = 131/264 (49%), Gaps = 23/264 (8%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ ++ + LG+G FGKV ++ +G +A+KIL K II E L+ +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
HP + L + ++ V+EY GGELF ++ + E R +++ L
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
EN++LD G+IKI+DFGL D + T CG+P Y+APEVL +
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDND 181
Query: 178 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 237
Y A D W GV++Y ++ G LPF +++ L++ I + + P+ LSP A++LL +L
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 238 EPNPVKRITIAGIKADE-----WF 256
+ +P +R+ A E +F
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 196 bits (500), Expect = 8e-61
Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 25/266 (9%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RYELG LG G +V A+DL AVK+L + + +RE L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 74 PNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-- 127
P +V +++ +++ Y+V+EYV G L D + ++G + ++ L
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 128 -------------ENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 173
NI++ + +K+ DFG++ + G+ Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 229
D SD++S G +LY +LTG PF + + + R D P + LS
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 230 QNLLRKILEPNPVKRITIAGIKADEW 255
++ K L NP R A +
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 2e-58
Identities = 51/261 (19%), Positives = 107/261 (40%), Gaps = 29/261 (11%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
G+ +G+ +G G+FG V + AVK+L + K E+ L+ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRH 63
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGL----- 127
N++ ++ ++ +V ++ G L+ + + + + + + +Q G+
Sbjct: 64 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
NI L +KI DFGL+ + + GS ++APEV+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 178 YDGAT--SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------KLPKWLSPGA 229
+ + SD+++ G++LY ++TG LP+ + N + + K+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 230 QNLLRKILEPNPVKRITIAGI 250
+ L+ + L+ +R I
Sbjct: 243 KRLMAECLKKKRDERPLFPQI 263
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-57
Identities = 63/311 (20%), Positives = 107/311 (34%), Gaps = 58/311 (18%)
Query: 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+ +YE +G+G FG+V A+ +G A+K + REI L+LL
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLL 66
Query: 72 KHPNVVRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
KH NVV L E+ + K IY+V ++ + +E +++ Q L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 124 IDGL---------------ENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPN 166
++GL N+L+ G +K++DFGL+ +
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--- 223
Y PE+L G D+W G I+ + T I + +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 224 -----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADE 254
P A +L+ K+L +P +RI +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 255 WFEQDYTPANP 265
+F D P++
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (480), Expect = 5e-57
Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
Q +L +++ +TLG G+FG+V + +SG +A+KIL+K +++ LK + E
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
L+ + P +V+L S +YMV+EYV GGE+F + GR E R Q++
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 126 GL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 170
EN+L+D +G I+++DFG + + T CG+P +AP
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAP 207
Query: 171 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 230
E++ ++GY+ A D W+ GV++Y + GY PF +Y+KI G + P S +
Sbjct: 208 EIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 231 NLLRKILEPNPVKRI-----TIAGIKADEWFE 257
+LLR +L+ + KR + IK +WF
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-56
Identities = 64/294 (21%), Positives = 102/294 (34%), Gaps = 47/294 (15%)
Query: 17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKHP 74
E LGEG F V A+D ++ A+K ++ K I REI L+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
N++ L + KS I +V +++ + L + + + GLE
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 179
N+LLD G +K++DFGL+ + + Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 180 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKW------------- 224
G D+W+ G IL +L + +IF G +W
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 225 -------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 265
+L++ + NP RIT ++F P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 7e-56
Identities = 73/301 (24%), Positives = 129/301 (42%), Gaps = 40/301 (13%)
Query: 8 QEGMRLGRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
++ + Y+ + LG G GKV + + FA+K+L+ + +RE+
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVE 56
Query: 67 TL-KLLKHPNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKL 119
+ + P++VR+ +V A + + +V+E + GGELF +I +G E E ++
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 120 FQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164
+ + + + EN+L SK I + L T C +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFK 220
P YVAPEVL YD + D+WS GVI+Y++L GY PF + + +I G ++
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 221 LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 276
P +S + L+R +L+ P +R+TI W Q + ++
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295
Query: 277 E 277
+
Sbjct: 296 K 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-54
Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 33/257 (12%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+L +T+G+G FG V G AVK ++ + E + + L+H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 75 NVVRLHEVLA-SKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL---- 127
N+V+L V+ K +Y+V EY+ G L D + S+GR L K + + +
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 128 -----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 176
N+L+ K+SDFGL+ +D T + APE L +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175
Query: 177 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 234
+ SD+WS G++L+ I + G +P+ L + ++ +G P P +++
Sbjct: 176 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 235 KILEPNPVKRITIAGIK 251
+ R + ++
Sbjct: 235 NCWHLDAAMRPSFLQLR 251
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-54
Identities = 70/315 (22%), Positives = 119/315 (37%), Gaps = 54/315 (17%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY +GEG +G V A D + + A+K + H + REI L +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 74 PNVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE- 128
N++ +++++ + + K ++ ++ G +L+ + L Q++ GL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 129 --------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVL 173
N+LL++ ++KI DFGL+ + D T + Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------------- 219
N + DIWS G IL +L+ F ++ I
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 220 -----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262
+L A +LL K+L NP KRI + A + EQ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 263 ANPDDDEEDIFVDNE 277
++ E D E
Sbjct: 305 SDEPIAEAPFKFDME 319
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 178 bits (453), Expect = 7e-54
Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 48/288 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+Y +GEG +G V AQ+ + G FA+K + + I REI+ LK LKH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE------ 128
N+V+L++V+ +K ++ +V E++ +G L+ + QL++G+
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 179
N+L++ +G +KI+DFGL+ + Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 180 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------------------- 219
T DIWS G I ++ G F + A +IFR
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 220 ---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258
K L +LL K+L+ +P +RIT +F++
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-53
Identities = 58/259 (22%), Positives = 100/259 (38%), Gaps = 23/259 (8%)
Query: 15 RYELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
L LG+G+FG V+ + + AVK L+ + + + D RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL--- 127
H N++RL+ V+ + + MV E G L D++ G + Q+ +G+
Sbjct: 69 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 128 ------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 175
N+LL ++ +KI DFGL D ++ P
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 176 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNL 232
SD W GV L+ + T G P+ N + + KI + +LP+ N+
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 233 LRKILEPNPVKRITIAGIK 251
+ + P R T ++
Sbjct: 248 MVQCWAHKPEDRPTFVALR 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-53
Identities = 55/253 (21%), Positives = 108/253 (42%), Gaps = 29/253 (11%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
+ LG G FG VK+ + A+K++++ + D+ E + L H
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 76 VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGLE------ 128
+V+L+ V + I+++ EY+ G L + + + R Q + ++ + + + +E
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 129 ---------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRG 177
N L++ +G +K+SDFGLS ++ DD + + PEVL
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 178 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 235
+ SDIW+ GV+++ I + G +P++ + + I +G P S ++
Sbjct: 178 FSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236
Query: 236 ILEPNPVKRITIA 248
+R T
Sbjct: 237 CWHEKADERPTFK 249
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-52
Identities = 58/261 (22%), Positives = 101/261 (38%), Gaps = 25/261 (9%)
Query: 20 RTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
+ LG GNFG VK Q AVKIL KN + D++ E ++ L +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------- 127
R+ + +V+E G L + +++ +L Q+ G+
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 128 -----ENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 181
N+LL ++ KISDFGLS AL + APE + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 182 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEP 239
SD+WS GV+++ + G P+ + + + +G+ P +L+
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 240 NPVKRITIAGIKA--DEWFEQ 258
+ R A ++ ++
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-52
Identities = 75/282 (26%), Positives = 136/282 (48%), Gaps = 29/282 (10%)
Query: 6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQI 61
E + + +EL + LG G +GKV + + D+G +A+K+L+K I+ K T+
Sbjct: 16 GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 75
Query: 62 KREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
+ E L+ ++ P +V LH +++K++++L+Y+ GGELF ++ + R E E +
Sbjct: 76 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135
Query: 121 QQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 165
+++ L ENILLDS G++ ++DFGLS +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKL 221
V D WS GV++Y +LTG PF A + ++I + +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255
Query: 222 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADE-----WFEQ 258
P+ +S A++L++++L +P KR+ ADE +F++
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 5e-52
Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 48/293 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
++ +GEG +G V A++ +G A+K + + + REI+ LK L HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 75 NVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGLE----- 128
N+V+L +V+ +++K+Y+V E++ + F ++ + + QL+ GL
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 129 ----------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
N+L++++G IK++DFGL+ + Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLA--RAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 179 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------DFK 220
DIWS G I ++T F + +IFR
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 221 LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262
PKW L ++LL ++L +P KRI+ A +F+ P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 5e-51
Identities = 70/303 (23%), Positives = 114/303 (37%), Gaps = 60/303 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + +G G +G V A D +G A+K L + + RE+ LK ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHE 77
Query: 75 NVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE 128
NV+ L +V L + Y+V+ ++ G K+ +L E + L Q++ GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 129 ---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 173
N+ ++ +KI DFGL+ D + + Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYRAPEVI 190
Query: 174 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--------- 224
N T DIWS G I+ ++TG F + ++I + P
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 225 ----------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262
SP A NLL K+L + +R+T A +FE +
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 263 ANP 265
+
Sbjct: 311 EDE 313
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-51
Identities = 67/296 (22%), Positives = 108/296 (36%), Gaps = 40/296 (13%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
+ +GEGNFG+V A+ GL I E+ L KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGRLQEAEGR 117
PN++ L + +Y+ +EY G L D + ++ L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 118 KLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 162
+ G+ NIL+ KI+DFGLS +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGR 187
Query: 163 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK 220
++A E L N SD+WS GV+L+ I++ G P+ A LY+K+ +G +
Sbjct: 188 LPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 221 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEEDIFV 274
P +L+R+ P +R + A I + E+ T N E+ +
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-50
Identities = 68/295 (23%), Positives = 117/295 (39%), Gaps = 49/295 (16%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
+ +YE +GEG +G V A++ ++ A+K + + + REI LK LK
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59
Query: 73 HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----- 127
H N+VRLH+VL S K+ +V E+ + G L + QL+ GL
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
+N+L++ G +K+++FGL+ + Y P+VL
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 178 YDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDF----------------- 219
+ D+WS G I + P F ++ ++IFR
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 220 ------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262
+ L+ ++LL+ +L+ NPV+RI+ +F D+ P
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCP 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 2e-50
Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 27/275 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ LG G +G+V L AVK L+++ + ++ +E A +K +KHP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHP 73
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL----- 127
N+V+L V + Y++ E++T G L D + R + + Q+ +
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
N L+ +K++DFGLS L + APE LA
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 178 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 235
+ SD+W+ GV+L+ I T G P+ +L+ +Y+ + + + P+ L+R
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 236 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 270
+ NP R + A I + FE + ++ D+ E
Sbjct: 252 CWQWNPSDRPSFAEIH--QAFETMFQESSISDEVE 284
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-50
Identities = 51/252 (20%), Positives = 101/252 (40%), Gaps = 25/252 (9%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+ +G G FG V L+ A+K + + + + E + L HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-EAEGRKLFQQLIDGL------ 127
+V+L+ V ++ I +V E++ G L D + ++ L + + +G+
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 128 ---------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
N L+ IK+SDFG++ T + +PEV + Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 179 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKI 236
SD+WS GV+++ + + G +P+++R+ + + + I G P+ S ++
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 237 LEPNPVKRITIA 248
+ P R +
Sbjct: 239 WKERPEDRPAFS 250
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-50
Identities = 67/260 (25%), Positives = 112/260 (43%), Gaps = 26/260 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
R ELGR +GEG FG V + P AV I + ++ +E T++ H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL----- 127
P++V+L V+ +++ +++++E T GEL + + L A QL L
Sbjct: 68 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLAN 175
N+L+ S +K+ DFGLS ++ D + ++APE +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 176 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 233
R + A SD+W GV ++ IL G PF + +I G+ +P P +L+
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242
Query: 234 RKILEPNPVKRITIAGIKAD 253
K +P +R +KA
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-49
Identities = 60/275 (21%), Positives = 113/275 (41%), Gaps = 29/275 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
L LG+G FG+V + A+K L+ + + +E +K L+H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGL----- 127
+V+L+ V+ S+ IY+V EY++ G L D + + L+ + + Q+ G+
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
NIL+ K++DFGL+ L + + + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 178 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 235
+ SD+WS G++L + T G +P+ + ++ RG P +L+ +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 236 ILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDD 268
P +R T ++A +++F P ++
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-49
Identities = 66/302 (21%), Positives = 110/302 (36%), Gaps = 64/302 (21%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
Y + +G G+FG V A+ DSG A+K + +++ RE+ ++ L H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHC 73
Query: 75 NVVRLHEVLASKSK------IYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLID 125
N+VRL S + + +VL+YV +K L + QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 126 GL---------------ENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
L +N+LLD + K+ DFG + + + S Y A
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRA 190
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------- 216
PE++ ++ D+WS G +L +L G F + +I +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 217 ----GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260
+FK P+ P A L ++LE P R+T A +F++
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
Query: 261 TP 262
P
Sbjct: 311 DP 312
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-49
Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 29/263 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
+L LG G FG+V + AVK L++ + D E +K L+H
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL----- 127
+VRL+ V+ ++ IY++ EY+ G L D + + +L + + Q+ +G+
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 128 ----------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 177
NIL+ + KI+DFGL+ L + + APE + N G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI-NYG 185
Query: 178 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 235
SD+WS G++L I+T G +P+ + Q + RG P L+R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 236 ILEPNPVKRITIAGIKA--DEWF 256
+ P R T +++ +++F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-49
Identities = 60/250 (24%), Positives = 97/250 (38%), Gaps = 25/250 (10%)
Query: 22 LGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
LG GNFG V+ + A+K+L++ T+++ RE + L +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 80 HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL----------- 127
V + +V+E GG L + K + + +L Q+ G+
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 128 ----ENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 182
N+LL ++ KISDFGLS AL + APE + R +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192
Query: 183 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPN 240
SD+WS GV ++ L+ G P+ + I +G + P P L+
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 241 PVKRITIAGI 250
R +
Sbjct: 253 WEDRPDFLTV 262
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-49
Identities = 74/321 (23%), Positives = 119/321 (37%), Gaps = 66/321 (20%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
RY+ +G G +G V A D +GL AVK L + + + RE+ LK +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 75 NVVRLHEVLASKSKI-----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-- 127
NV+ L +V + ++ ++ G + I +L + + L Q++ GL
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 128 -------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 174
N+ ++ +KI DFGL+ + Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIML 191
Query: 175 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--------- 225
N + T DIWS G I+ +LTG F + + I R L
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 226 ----------------------SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 263
+P A +LL K+L + KRIT A A +F Q + P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 264 --------NPDDDEEDIFVDN 276
+ + D+ +D
Sbjct: 312 DEPVADPYDQSFESRDLLIDE 332
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-49
Identities = 59/283 (20%), Positives = 105/283 (37%), Gaps = 50/283 (17%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATL- 68
E G+ LG G FGKV A + AVK+L++ + + E+ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------------- 108
+L H N+V L IY++ EY G+L + + SK
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 109 ---GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150
L + Q+ G+ N+L+ +KI DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 209
+ + ++APE L Y SD+WS G++L+ I + G P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 210 LYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 250
+ K+ + FK+ P + + +++ + KR + +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (414), Expect = 8e-48
Identities = 52/262 (19%), Positives = 100/262 (38%), Gaps = 27/262 (10%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLK 69
+ ++ + +G G FG+V G + A+K L+ K E + +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMG 82
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL- 127
HPNV+ L V+ + + ++ E++ G L + G+ + + + + G+
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 128 --------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAP 170
NIL++S K+SDFGLS + D + + AP
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 171 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 228
E + R + A SD+WS G++++ +++ G P+ D + I + P
Sbjct: 203 EAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261
Query: 229 AQNLLRKILEPNPVKRITIAGI 250
L+ + + R I
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQI 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-47
Identities = 50/285 (17%), Positives = 102/285 (35%), Gaps = 21/285 (7%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
++ + LG G FG V + G + + K K +I E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 74 PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL------ 127
P+V RL + + + + G L K + Q+ G+
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 128 ---------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 178
N+L+ + ++KI+DFGL+ L + ++A E + +R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 179 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKI 236
SD+WS GV ++ ++T G P+D + + + +G+ P + ++ K
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 237 LEPNPVKRITIAGIKAD-EWFEQDYTPANPDDDEEDIFVDNEAFS 280
+ R + + +D +E + + + S
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-47
Identities = 72/295 (24%), Positives = 115/295 (38%), Gaps = 57/295 (19%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
+YE +GEG +GKV A+DL + G A+K + + + + RE+A L+ L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 66
Query: 73 --HPNVVRLHEVLAS-----KSKIYMVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLI 124
HPNVVRL +V ++K+ +V E+V + + + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 125 DGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 169
GL +NIL+ S G IK++DFGL+ + + + Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRA 183
Query: 170 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 217
PEVL Y D+WS G I + F + KI
Sbjct: 184 PEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 218 ---------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 257
K + ++LL K L NP KRI+ + +F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 6e-47
Identities = 60/282 (21%), Positives = 102/282 (36%), Gaps = 49/282 (17%)
Query: 15 RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
E R +GEG FG+V + AVK+L++ ++ +RE A +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMA 71
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR------------------- 110
+PN+V+L V A + ++ EY+ G+L + + S
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 111 -----LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150
L AE + +Q+ G+ N L+ +KI+DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL-PFDDRNLAV 209
++ PE + Y SD+W+ GV+L+ I + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 210 LYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 250
+ + G+ P+ NL+R P R + I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 161 bits (409), Expect = 8e-47
Identities = 57/299 (19%), Positives = 111/299 (37%), Gaps = 69/299 (23%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
Y+L R LG G + +V A ++ + VKIL+ + +IKREI L+ L+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89
Query: 74 PNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---- 127
PN++ L +++ +V E+V + L + + R +++ L
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 128 -----------ENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 175
N+++D + +++ D+GL+ + + + S + PE+L +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 176 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------LYQKIFRGDFKL 221
+ D+WS G +L ++ PF + LY I + + +L
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 222 PKW------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256
+SP A + L K+L + R+T +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 9e-47
Identities = 53/293 (18%), Positives = 91/293 (31%), Gaps = 42/293 (14%)
Query: 11 MRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+R+G RY LGR +G G+FG + D+ +G A+K+ Q+ E K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYK 57
Query: 70 LLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE 128
+++ + + A MV+E + + L Q+I +E
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 129 ---------------NILLDSKG---NIKISDFGLSALPQHFRDDGLLH-----TTCGSP 165
N L+ + I DFGL+ + R + G+
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 166 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----- 220
Y + D+ S G +L G LP+ A QK R K
Sbjct: 178 RYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 221 ---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA---DEWFEQDYTPANPDD 267
L K L + + ++ + + Q ++ D
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-44
Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 33/281 (11%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
+G G+FG V LD+ + AVK L NRI + Q E +K
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85
Query: 72 KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGL-- 127
HPNV+ L + L S+ +VL Y+ G+L + + Q+ G+
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 128 -------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEV 172
N +LD K +K++DFGL+ D + + T ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 173 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 230
L + + SD+WS GV+L+ ++T G P+ D N + + +G P++
Sbjct: 206 LQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264
Query: 231 NLLRKILEPNPVKRITIAGIKA------DEWFEQDYTPANP 265
++ K P R + + + + + + Y N
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 305
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 6e-44
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 44/280 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
R LG+ LGEG FG+V A+ + + AVK+L+ + K + E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 68 LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGR 110
+K + KH N++ L +Y+++EY + G L + + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 111 LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155
L + Q+ G+ N+L+ +KI+DFGL+ H
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 214
++APE L +R Y SD+WS GV+L+ I T G P+ + L++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 215 FRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253
G P + ++R P +R T + D
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-44
Identities = 68/338 (20%), Positives = 120/338 (35%), Gaps = 74/338 (21%)
Query: 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
L RY+ + +G G G V A D A+K L + + + RE+ +K +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 73 HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
H N++ L V + +Y+V+E + + L L Q++ G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131
Query: 127 LE---------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 171
++ NI++ S +KI DFGL+ + ++ + Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPE 188
Query: 172 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 217
V+ GY DIWS G I+ ++ + F R+ + K+
Sbjct: 189 VILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 218 ----------------------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 249
D + K + A++LL K+L +P KRI++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 250 IKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 284
+ Y PA + I+ +D ++ E
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 345
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-43
Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 45/278 (16%)
Query: 15 RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
R G+TLG G FGKV A D+ + AVK+L+ + HL + + E+ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81
Query: 70 LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------------------R 110
L H N+V L ++ EY G+L + + K
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 111 LQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155
L + Q+ G+ NILL KI DFGL+ ++ +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 214
+ ++APE + N SD+WS G+ L+ + + G P+ + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 215 FRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 250
+ F++ P+ ++++ + +P+KR T I
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (383), Expect = 2e-43
Identities = 44/290 (15%), Positives = 85/290 (29%), Gaps = 42/290 (14%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
Y++GR +GEG+FG + +L + A+K + Q++ E T KLL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAG 59
Query: 74 -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGLE---- 128
+ ++ +V++ + + +Q++ ++
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 129 -----------NILLDSK-----GNIKISDFGLSALPQHFRDDGLLH-----TTCGSPNY 167
N L+ I + DFG+ + + G+ Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 168 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------- 220
++ R D+ + G + L G LP+ A QK R K
Sbjct: 180 MSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 221 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 269
L + ++ F + N +DE
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ--GLFSKVLERLNTTEDE 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-42
Identities = 55/259 (21%), Positives = 101/259 (38%), Gaps = 26/259 (10%)
Query: 15 RYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
+ +G G FG+V S +P A+K L+ ++ E +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQ 65
Query: 71 LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL-- 127
H N++RL V++ + ++ EY+ G L + K G + + + + G+
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 128 -------------ENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 173
NIL++S K+SDFGLS L + APE +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 174 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 231
+ R + A SD+WS G++++ ++T G P+ + + + + I G P
Sbjct: 186 SYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244
Query: 232 LLRKILEPNPVKRITIAGI 250
L+ + + +R A I
Sbjct: 245 LMMQCWQQERARRPKFADI 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-42
Identities = 54/291 (18%), Positives = 109/291 (37%), Gaps = 37/291 (12%)
Query: 15 RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
+ + R LG+G+FG V K + A+K + + ++ + E + +K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK 78
Query: 70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----------LQEAEGRKL 119
+VVRL V++ +++E +T G+L + S ++ ++
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 120 FQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 164
++ DG+ N ++ +KI DFG++
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 165 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD-FKLP 222
+++PE L + + + D+WS GV+L+ I T P+ + + + + G P
Sbjct: 199 VRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 223 KWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEED 271
L+R + NP R + I + E E + + EE+
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEEN 308
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-40
Identities = 57/294 (19%), Positives = 102/294 (34%), Gaps = 63/294 (21%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
L ++G+G FG+V + G AVKI + EI +L+H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSW----FREAEIYQTVMLRH 56
Query: 74 PNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-- 127
N++ + +++++V +Y G LFD + ++ + KL GL
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115
Query: 128 ---------------------ENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS 164
+NIL+ G I+D GL+ D D + G+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 165 PNYVAPEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFD---------------D 204
Y+APEVL +DI++ G++ + I D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 205 RNLAVLYQKIFRGDFKLP---KWLSPGA----QNLLRKILEPNPVKRITIAGIK 251
++ + + + + +W S A ++R+ N R+T IK
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-38
Identities = 60/276 (21%), Positives = 101/276 (36%), Gaps = 42/276 (15%)
Query: 15 RYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
R +LG+ LG G FG+V A + AVK+L++ H + + +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIH 72
Query: 70 LLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGR----------------LQ 112
+ H NVV L + +++E+ G L + SK L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 113 EAEGRKLFQQLIDGLE---------------NILLDSKGNIKISDFGLSALPQHFRDDGL 157
Q+ G+E NILL K +KI DFGL+ D
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFR 216
++APE + +R Y SD+WS GV+L+ I + P+ + + + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 217 GD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 250
+ P + +P + P +R T + +
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (317), Expect = 2e-33
Identities = 53/333 (15%), Positives = 108/333 (32%), Gaps = 87/333 (26%)
Query: 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
RY L R LG G+F V A+D+ + A+KI+ +++ T+ + EI L+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVND 68
Query: 74 PNVVRL-------------HEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGR 117
+ + H + +++V+ + G K + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 118 KLFQQLIDGL----------------ENILLDSKGNI-KISDFGLSALPQHFRDDGLLHT 160
++ +QL+ GL EN+L++ + + ++ L D
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 161 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--------- 211
+ + Y +PEVL + +DIWS +++ ++TG F+
Sbjct: 189 SIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 212 ---------------------------------------QKIFRGDFKLPKWLSPGAQNL 232
+ + +K K + +
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 233 LRKILEPNPVKRITIAGIKADEWFEQDYTPANP 265
L +L+ +P KR G+ W +D
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEE 339
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 70.2 bits (172), Expect = 1e-15
Identities = 16/99 (16%), Positives = 38/99 (38%), Gaps = 8/99 (8%)
Query: 324 RKIRF------TSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVA 377
RF TS+ D++ I ++ ++ + H + +
Sbjct: 5 SSGRFTWSMKTTSSMDPSDMMREIRKVLGANNCDY-EQRERFLLFCVHGDGHAENLVQWE 63
Query: 378 AEVFEI-SPSLYVVELRKSYGDPTVYRQLCNKLSSDLGL 415
EV ++ SL V ++ G ++ + +K++++L L
Sbjct: 64 MEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL 102
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.7 bits (162), Expect = 2e-13
Identities = 29/209 (13%), Positives = 60/209 (28%), Gaps = 49/209 (23%)
Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------Q 60
+G+ +GEG V VK + K+ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 61 IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
+ E L+ L+ V +++ +++E + EL+ + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRV-------RVENPDEVL 109
Query: 121 QQLIDGLE--------------NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 166
+++ + +L S+ I I DF S +L +
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNII 169
Query: 167 YVAPEVLANRGYDGATSDIWSCGVILYVI 195
+R Y DI S I ++
Sbjct: 170 T-----YFSRTY-RTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.71 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.41 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.13 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.68 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.5 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.85 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.3 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.65 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-58 Score=434.53 Aligned_cols=244 Identities=31% Similarity=0.643 Sum_probs=225.8
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
+.+++|++++.||+|+||+||+|++..+++.||||++.+....+....+.+.+|+.+++.++|||||++++++.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 45789999999999999999999999999999999998765444445678999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+|||||+||+|.+++...+++++..++.++.||+.|| +|||++.+|++||+|||+|.... .
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~ 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 158 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----C
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----C
Confidence 9999999999999999888999999999999999997 79999999999999999998543 2
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 235 (426)
......+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+.++.+.+|+.+|+++.+||.+
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred CcccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 334567899999999999998875 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCCChHHHhcCcCCccC
Q 014359 236 ILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
||++||++|||++|+++||||...
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCCc
Confidence 999999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=435.57 Aligned_cols=248 Identities=31% Similarity=0.565 Sum_probs=221.4
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
..+-++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|+.+|++++||||+++++++.+++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 34557899999999999999999999999999999999876544444567899999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+|||||+||+|.+++...+++++..++.++.|++.|| +|||++++|.+||+|||+|+.......
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999999999989999999999999999997 799999999999999999987654434
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 234 (426)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+++.++..+.+.+|..+++++++||+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 242 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 4455678999999999999998875 899999999999999999999999999999999999999999999999999999
Q ss_pred HccccCcCCCCChHH------HhcCcCCcc
Q 014359 235 KILEPNPVKRITIAG------IKADEWFEQ 258 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~------il~h~w~~~ 258 (426)
+||+.||++|||++| +++||||+.
T Consensus 243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp TTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 999999999999988 578888865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=432.07 Aligned_cols=247 Identities=38% Similarity=0.664 Sum_probs=213.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||+||+|++..+|+.||||+++..... +..+.+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 368999999999999999999999999999999999865432 234678999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||||+||+|++++...+++++..++.++.||+.|| +|||++.+|++||+|||+|+.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999999998888999999999999999997 79999999999999999999765433344
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHHhCCCCCC--CCCCHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKLP--KWLSPGAQNLL 233 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~Li 233 (426)
...+.+||+.|||||++.+..+++.++|||||||++|+|++|+.||...+.. ..+..+.......+ ..+|+++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 5567899999999999999888778899999999999999999999876543 33444444433333 45899999999
Q ss_pred HHccccCcCCCCChHHHhcCcCCccCC
Q 014359 234 RKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
.+||+.||++|||++|+++||||++..
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 999999999999999999999998654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-56 Score=433.70 Aligned_cols=245 Identities=31% Similarity=0.611 Sum_probs=226.8
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
+.+++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 46889999999999999999999999999999999998765444444678999999999999999999999999999999
Q ss_pred EEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
+|||||+||+|.+++...+.+++..++.|+.||+.|| +|||++.+|++||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 9999999999999999999999999999999999997 799999999999999999985433 23
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 235 (426)
....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+..+++..+..+.+.+|..+|+++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 445678999999999999999885 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCcCCCCC-----hHHHhcCcCCcc
Q 014359 236 ILEPNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 236 ~L~~dP~~R~t-----~~~il~h~w~~~ 258 (426)
||++||++|++ ++|+++||||..
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 899999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-55 Score=422.24 Aligned_cols=241 Identities=32% Similarity=0.697 Sum_probs=224.0
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 57899999999999999999999999999999999987654444456789999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||||+||+|..++.....+++..++.++.||+.|+ +|||++.+|++||+|||+|+....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----- 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 156 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----
Confidence 999999999999999999999999999999999997 799999999999999999985432
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 236 (426)
...+.+||+.|||||++.+..|+ .++|||||||+||+|++|+.||.+.+..+.+.++..+...+|+.+|+++.++|.+|
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 34568999999999999988886 89999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCC-----ChHHHhcCcCCcc
Q 014359 237 LEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 237 L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
|.+||.+|+ |++++++||||++
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhhCHHhccccchhhHHHHHcCccccc
Confidence 999999996 9999999999976
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=418.79 Aligned_cols=238 Identities=25% Similarity=0.443 Sum_probs=211.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++++.||+|+||+||+|++..+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 47999999999999999999999999999999998654322 467999999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcc
Q 014359 94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLL 158 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~ 158 (426)
|||+||+|.+++.. +++++.+++.++.||+.|| +|||++.+|++||+|||+|+.... .....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~ 173 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKR 173 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCB
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccccc
Confidence 99999999998876 5799999999999999997 799999999999999999986543 23345
Q ss_pred ccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-C--CCCCCCCCHHHHHHHHH
Q 014359 159 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-D--FKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 159 ~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~--~~~p~~~s~~~~~Li~~ 235 (426)
...+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+.......+... . +..|..+|+++++||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 677899999999999998875 8999999999999999999999988776655554433 3 34456799999999999
Q ss_pred ccccCcCCCCChHHHhcCcCCcc
Q 014359 236 ILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
||++||++|||++|+++||||+.
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=414.75 Aligned_cols=241 Identities=29% Similarity=0.514 Sum_probs=208.6
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI 89 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 89 (426)
+.++|++++.||+|+||+||+|++..+|+.||||+++.... .....+.+.+|+.+|++++|||||++++++.+ .+.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 46889999999999999999999999999999999987654 33446789999999999999999999999864 4568
Q ss_pred EEEEcccCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHH--------------------hheeeCCCCCEEEeccCC
Q 014359 90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGL--------------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~al--------------------eNILld~~g~lKl~DFGl 145 (426)
|+|||||+||+|.+++.. ...+++..++.++.||+.|| +|||++.+|.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999999863 46799999999999999996 799999999999999999
Q ss_pred CCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC-CCCCC
Q 014359 146 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 224 (426)
Q Consensus 146 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 224 (426)
|+.... ......+.+||+.|||||++.+..|+ .++|||||||++|+|+||+.||.+.+..+++.++..+.+ .+|..
T Consensus 161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 161 ARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred eeeccc--CCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 986543 23345578999999999999988875 999999999999999999999999999999888888765 46778
Q ss_pred CCHHHHHHHHHccccCcCCCCChHHHhcCcCC
Q 014359 225 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 256 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~ 256 (426)
+|+++.+||.+||+.||.+|||++|+++|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-55 Score=420.18 Aligned_cols=241 Identities=37% Similarity=0.693 Sum_probs=199.9
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
-++|++++.||+|+||+||+|++..+++.||||++.+..... ....+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999998765332 245688999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeC---CCCCEEEeccCCCCCCCcccC
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLD---SKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld---~~g~lKl~DFGla~~~~~~~~ 154 (426)
||||+||+|.+++...+++++.+++.++.||+.|| +|||++ ++|.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence 99999999999999988999999999999999997 799995 578999999999985432
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCCHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQ 230 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 230 (426)
.....+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+..+...++ +.+|+++.
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ----------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 3445678999999999999998885 899999999999999999999999998889899888766543 45899999
Q ss_pred HHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 231 NLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+||.+||++||++|||++|+++||||+..
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7e-54 Score=420.56 Aligned_cols=247 Identities=29% Similarity=0.590 Sum_probs=220.4
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||+||+|++..+|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456789999999999999999999999999999999997653 33357889999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCC--CCCEEEeccCCCCCCCc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDS--KGNIKISDFGLSALPQH 151 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~--~g~lKl~DFGla~~~~~ 151 (426)
|+|||||+||+|.+++.. .+++++..++.++.||+.|| +|||++. +|.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~- 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD- 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC-
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc-
Confidence 999999999999999954 56799999999999999997 7999964 5789999999998543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCCH
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP 227 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 227 (426)
......+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+..+...++ ..+|+
T Consensus 178 --~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 178 --PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp --TTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred --cccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 23445678999999999999998885 899999999999999999999999999999999988876655 35899
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCCccCCCCC
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 263 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~~ 263 (426)
++++||.+||+.||++|||++|+++||||.....+.
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 999999999999999999999999999998765443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=418.95 Aligned_cols=243 Identities=32% Similarity=0.585 Sum_probs=220.3
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHh-cCCCCCccceeEEEEeCCeEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~l 91 (426)
+++|++++.||+|+||+||+|++..+++.||||++++.........+.+.+|+.++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 578999999999999999999999999999999998654333333566777777765 6899999999999999999999
Q ss_pred EEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
||||++||+|.+++...+++++.+++.++.||+.|| +|||++++|++||+|||+|+.... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 999999999999999989999999999999999997 799999999999999999985443 233
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 236 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~ 236 (426)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+...++.++..+.+.+|.++|+++.+||++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 45567999999999999998886 89999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCCChH-HHhcCcCCcc
Q 014359 237 LEPNPVKRITIA-GIKADEWFEQ 258 (426)
Q Consensus 237 L~~dP~~R~t~~-~il~h~w~~~ 258 (426)
|+.||++|||+. ++++||||++
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999995 8999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-54 Score=410.70 Aligned_cols=242 Identities=34% Similarity=0.624 Sum_probs=218.3
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
-++|++++.||+|+||+||+|++..+|+.||||++++...... ...+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3679999999999999999999999999999999986543322 2357899999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC----CEEEeccCCCCCCC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG----NIKISDFGLSALPQ 150 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g----~lKl~DFGla~~~~ 150 (426)
|+|||||+||+|.+++...+++++..++.++.|++.|| +|||++.++ .+||+|||+|....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999888999999999999999997 799999887 59999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCC
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 226 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 226 (426)
. .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..+.+..+..+...++ +.+|
T Consensus 169 ~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 169 F---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp T---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred C---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 2 334567789999999999988777 5999999999999999999999999999999999988877655 5689
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
+++.+||++||+.||++|||++|+++||||+.
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=414.36 Aligned_cols=239 Identities=27% Similarity=0.433 Sum_probs=210.5
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
+.|++++.||+|+||+||+|++..+++.||||++++.. ....+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 57999999999999999999999999999999997653 223567889999999999999999999999999999999
Q ss_pred cccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|||+||+|.+++.. .+++++..++.++.||+.|| +|||++.+|++||+|||+|+.... ....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC--Cccc
Confidence 99999999999765 46799999999999999997 799999999999999999975432 1223
Q ss_pred cccccCCCcccchhhhc-----cCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCC---CCCCCCCHHH
Q 014359 158 LHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGA 229 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~-----~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 229 (426)
..+.+||+.|+|||++. +..| +.++|||||||++|+|++|+.||.+.+..+.+.++..+.+ ..|..+|+++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 45678999999999984 3344 4899999999999999999999999888888888877653 3345689999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.+||.+||++||++|||++|+++||||+.
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-54 Score=421.32 Aligned_cols=243 Identities=33% Similarity=0.677 Sum_probs=224.6
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
...+++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+...+
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 34579999999999999999999999999999999999876544444567899999999999999999999999999999
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|+||||+.||+|.+++...+.+++..++.++.||+.|| +|||++.+|++||+|||+|+....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 99999999999999999888999999999999999997 799999999999999999985432
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 234 (426)
...+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+....+.++..+.+.+|..+++++.+||+
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 34567899999999999998885 899999999999999999999999999999999999999999999999999999
Q ss_pred HccccCcCCCC-----ChHHHhcCcCCcc
Q 014359 235 KILEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 235 ~~L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
+||++||.+|+ |++++++||||+.
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhhCHHhccccccccHHHHHcCccccC
Confidence 99999999995 9999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-53 Score=417.80 Aligned_cols=246 Identities=30% Similarity=0.579 Sum_probs=220.1
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.+...++|++++.||+|+||+||+|++..+|+.||||++++.. ......+.+|+.+|++++|||||++++++.+++.
T Consensus 24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3456789999999999999999999999999999999997653 2234678899999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeC--CCCCEEEeccCCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLD--SKGNIKISDFGLSALPQ 150 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld--~~g~lKl~DFGla~~~~ 150 (426)
+|+|||||+||+|++++...+ ++++.+++.++.||+.|| +|||++ .+|.+||+|||+|+...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999999999999886544 699999999999999997 799998 57899999999998654
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCCC
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS 226 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 226 (426)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+..+.+.+| ..+|
T Consensus 181 ---~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 181 ---PDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp ---TTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ---CCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 34456678999999999999998875 999999999999999999999999999999999988876655 4589
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
+++.+||.+||+.||.+|||++|+++||||+....
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 99999999999999999999999999999987543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-54 Score=413.00 Aligned_cols=239 Identities=24% Similarity=0.351 Sum_probs=213.4
Q ss_pred CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEc
Q 014359 15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94 (426)
Q Consensus 15 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmE 94 (426)
+|++++.||+|+||+||+|++..+++.||||+++..........+.+.+|+.+|+.++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999987665555556789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCccc
Q 014359 95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLH 159 (426)
Q Consensus 95 y~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~ 159 (426)
||.+|+|..++...+++++.+++.++.||+.|| +|||++.+|++||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 999999988888888999999999999999997 799999999999999999985432 34
Q ss_pred cccCCCcccchhhhccC---CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCC--CCCCCHHHHHHHH
Q 014359 160 TTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLR 234 (426)
Q Consensus 160 ~~~gt~~Y~APE~l~~~---~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~Li~ 234 (426)
..+||+.|||||++.+. .| +.++|||||||++|+|++|..||.+.+..+.+.++..+..+. +..+|+++.+||.
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y-~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCc-CchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 57899999999998643 34 589999999999999999999999988877777777665432 3458999999999
Q ss_pred HccccCcCCCCChHHHhcCcCCccCC
Q 014359 235 KILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+||+.||++|||++|+++||||....
T Consensus 249 ~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 99999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=401.08 Aligned_cols=237 Identities=25% Similarity=0.467 Sum_probs=205.3
Q ss_pred cCE-EEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe----CCe
Q 014359 14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSK 88 (426)
Q Consensus 14 ~~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~ 88 (426)
|+| ++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+++|++++|||||++++++.+ ...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 566 677899999999999999999999999999986543 33346789999999999999999999999875 356
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------hheeeC-CCCCEEEeccCCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------ENILLD-SKGNIKISDFGLSALPQ 150 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------eNILld-~~g~lKl~DFGla~~~~ 150 (426)
+|+||||+++|+|.+++.+...+++..++.++.||+.|| +|||++ .++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 899999999999999999888999999999999999996 799997 57999999999998532
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCc-cHHHHHHHHHhCCC--CCCCCCCH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDF--KLPKWLSP 227 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~ 227 (426)
.....+.+||+.|||||++.+ .| +.++|||||||++|+|++|+.||.+. +...++..+..+.. .++..+++
T Consensus 167 ----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 167 ----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence 234557799999999999876 46 48999999999999999999999765 45566677766543 23456899
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
++.+||.+||++||++|||++|+++||||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.4e-53 Score=399.74 Aligned_cols=243 Identities=31% Similarity=0.546 Sum_probs=216.1
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccc------hhHHHHHHHHHHHHhcCC-CCCccceeEEEEe
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLK-HPNVVRLHEVLAS 85 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 85 (426)
.++|++++.||+|+||+||+|++..+|+.||||++++..... ....+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 479999999999999999999999999999999998754332 223457889999999997 9999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
++.+|+||||++||+|.++|...+++++..++.++.||+.|| +|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999999999999999889999999999999999997 79999999999999999998654
Q ss_pred cccCCCccccccCCCcccchhhhccC-----CCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC--
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 223 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 223 (426)
. .......+||+.|+|||++.+. ..++.++||||+||+||+|++|+.||.+.+.......+..+...++.
T Consensus 162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 3 3344567899999999998642 23368999999999999999999999999988888888888665442
Q ss_pred --CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 224 --WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 224 --~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
.+|+++++||.+||++||.+|||++|+++||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=415.04 Aligned_cols=240 Identities=30% Similarity=0.433 Sum_probs=204.1
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
-++|++++.||+|+||+||+|++..+|+.||+|+++... .....+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999998653 334457899999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||++||+|.+++.+.+++++..++.++.||+.|| +|||++.+|++||+|||+|+.... .
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----H
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----C
Confidence 99999999999999888999999999999999996 799999999999999999985432 2
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHH--------------------------
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL-------------------------- 210 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~-------------------------- 210 (426)
...+.+||+.|+|||++.+..|+ .++||||+||++|||++|+.||.+.+....
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 34567999999999999998885 899999999999999999999976543211
Q ss_pred ----------------HHHHHhCC-CCCC-CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 211 ----------------YQKIFRGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 211 ----------------~~~i~~~~-~~~p-~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
...+.... +..| ..+|+++.+||.+||+.||.+|||++|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00111111 1122 2268899999999999999999999999999999863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.9e-53 Score=416.22 Aligned_cols=243 Identities=27% Similarity=0.453 Sum_probs=210.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHH---HHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~---~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
.+++|++++.||+|+||+||+|++..+|+.||||++.+...........+. +|+.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 578999999999999999999999999999999999865433222223333 45777888899999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+|+|||||+||+|.++|.....+++..++.++.||+.|| +|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999889999999999999999997 799999999999999999985432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHHHHHhCCCCCCCCCCHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFKLPKWLSPGAQ 230 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~ 230 (426)
......+||+.|+|||++.+...++.++|||||||+||+|+||+.||.+.+. ......+....+.+|..+|+++.
T Consensus 160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 2345679999999999997654446999999999999999999999987543 34455555566777888999999
Q ss_pred HHHHHccccCcCCCCC-----hHHHhcCcCCcc
Q 014359 231 NLLRKILEPNPVKRIT-----IAGIKADEWFEQ 258 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t-----~~~il~h~w~~~ 258 (426)
+||.+||++||++||| ++++++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 799999999976
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=406.77 Aligned_cols=240 Identities=25% Similarity=0.492 Sum_probs=216.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
.+++|++++.||+|+||+||+|.+..+++.||||++++... ....+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999999976532 23568899999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHH---------------hheeeCCC--CCEEEeccCCCCCCCccc
Q 014359 92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGL---------------ENILLDSK--GNIKISDFGLSALPQHFR 153 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~al---------------eNILld~~--g~lKl~DFGla~~~~~~~ 153 (426)
|||||+||+|+++|...+ ++++.+++.++.||+.|+ +|||++.+ +.+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence 999999999999998655 799999999999999997 79999865 489999999998543
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC----CCCHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGA 229 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 229 (426)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+..+.+.+|. .+|+++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 23445677899999999999888775 8999999999999999999999999999999999998877763 689999
Q ss_pred HHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 230 QNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.+||.+||+.||++|||++|+++||||++.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=396.09 Aligned_cols=238 Identities=32% Similarity=0.566 Sum_probs=209.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchh---HHHHHHHHHHHHhcCC--CCCccceeEEEEeCC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK--HPNVVRLHEVLASKS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~ 87 (426)
-++|++++.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 47899999999999999999999999999999999865443221 1234678999999996 899999999999999
Q ss_pred eEEEEEcccCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCC-CCEEEeccCCCCCCC
Q 014359 88 KIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSK-GNIKISDFGLSALPQ 150 (426)
Q Consensus 88 ~~~lVmEy~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~-g~lKl~DFGla~~~~ 150 (426)
..|+||||+.+ +++.+++.....+++.+++.++.||+.|| +|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 68889998888999999999999999997 79999855 799999999998543
Q ss_pred cccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCCCCCHHHH
Q 014359 151 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 230 (426)
Q Consensus 151 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 230 (426)
.....+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+ .+..+...++..+|+++.
T Consensus 163 ----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 163 ----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp ----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred ----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence 2345578999999999999988887788999999999999999999998743 456678888999999999
Q ss_pred HHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 231 NLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
+||.+||+.||++|||++|+++||||++..
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999998643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=396.76 Aligned_cols=243 Identities=24% Similarity=0.306 Sum_probs=202.7
Q ss_pred EeceeeecCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcc
Q 014359 18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY 95 (426)
Q Consensus 18 i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy 95 (426)
.++.||+|+||+||+|++..+|+.||||+++...... ....+.+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999997654322 12235688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCcccc
Q 014359 96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGLLHT 160 (426)
Q Consensus 96 ~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~~~~ 160 (426)
+.++++..++.....+++..++.++.||+.|| +|||++.++.+||+|||+|+.... ......+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccc
Confidence 99988887777777899999999999999997 799999999999999999986543 2334556
Q ss_pred ccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CCC------------------
Q 014359 161 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK------------------ 220 (426)
Q Consensus 161 ~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~------------------ 220 (426)
.+||+.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+..+.+.++.+. .+.
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 789999999999977665579999999999999999999999998887776666531 000
Q ss_pred C--------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 221 L--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 221 ~--------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
. .+.+++++.+||.+||+.||++|||++|+++||||++...|
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 0 12468899999999999999999999999999999875443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=398.83 Aligned_cols=239 Identities=31% Similarity=0.580 Sum_probs=201.7
Q ss_pred CCccccCEEEec-eeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhc-CCCCCccceeEEEEe-
Q 014359 9 EGMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS- 85 (426)
Q Consensus 9 ~~~~~~~y~i~~-~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~- 85 (426)
....+++|++.. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.+ .+|||||++++++.+
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 345589999875 699999999999999999999999998643 457789998755 589999999999976
Q ss_pred ---CCeEEEEEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCC---CCCEEEec
Q 014359 86 ---KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDS---KGNIKISD 142 (426)
Q Consensus 86 ---~~~~~lVmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~---~g~lKl~D 142 (426)
+..+|+|||||+||+|+++|... .++++.+++.++.||+.|+ +|||++. ++.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 46799999999999999999864 3699999999999999997 7999986 45799999
Q ss_pred cCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHH----HHHHHHhCC
Q 014359 143 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGD 218 (426)
Q Consensus 143 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~ 218 (426)
||+|+.... .....+.+||+.|||||++.+..|+ .++|||||||+||+|+||++||.+.+... +...+..+.
T Consensus 158 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 158 FGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred cceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence 999985433 3345678999999999999988885 89999999999999999999998765433 333444455
Q ss_pred CCCCC----CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 219 FKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 219 ~~~p~----~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
+.+|. .+|+++.+||++||+.||++|||+.|+++||||.+.
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 55553 389999999999999999999999999999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=387.55 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=205.2
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||+||+|++..+|+.||||+++.... .....+++.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 5799999999999999999999999999999999976542 223357889999999999999999999999999999999
Q ss_pred EcccCCCChHHHHH--hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 93 LEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 93 mEy~~gg~L~~~i~--~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|||+.+ ++.+++. ...++++..++.++.||+.|| +|||++.++++||+|||+|+.... ..
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~ 156 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV 156 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Cc
Confidence 999976 4444443 345699999999999999997 799999999999999999975432 23
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--C---------------
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D--------------- 218 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~--------------- 218 (426)
......+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+..+....+... .
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 44556789999999999988888889999999999999999999999988876655554321 0
Q ss_pred -CCCC-----------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 219 -FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 219 -~~~p-----------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
...+ ..+++++.+||++||++||++|||++|+++||||++...|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0011 2367899999999999999999999999999999876555
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-49 Score=378.27 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=205.7
Q ss_pred CccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC--
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-- 87 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 87 (426)
...-++|++.+.||+|+||+||+|++..+|+.||||++++....+......+.+|+.+|+.++||||+++++++...+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 344578999999999999999999999999999999998776666666788999999999999999999999997654
Q ss_pred --eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCC
Q 014359 88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQ 150 (426)
Q Consensus 88 --~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~ 150 (426)
.+|+||||++||+|.+++...+++++.+++.++.||+.|| +|||++.++..+|+|||.+....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 4899999999999999999889999999999999999997 79999999999999999987543
Q ss_pred ccc-CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCC----CCC
Q 014359 151 HFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL 225 (426)
Q Consensus 151 ~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 225 (426)
... ......+.+||+.|+|||++.+..|+ +++||||+||++|+|+||++||.+.+..+.+.++....+..| +.+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred cccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 321 22345567899999999999988875 899999999999999999999999888888777776655433 458
Q ss_pred CHHHHHHHHHccccCcCCCCChHHHhcCcCCc
Q 014359 226 SPGAQNLLRKILEPNPVKRITIAGIKADEWFE 257 (426)
Q Consensus 226 s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~ 257 (426)
|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999999555555677753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.5e-50 Score=381.42 Aligned_cols=242 Identities=29% Similarity=0.416 Sum_probs=204.4
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||+||+|++. +|+.||||+++.... .....+.+.+|+.+|++++||||+++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 579999999999999999999985 789999999976543 233357899999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
|||+.++.+..+....+++++..++.++.||+.|| +|||++.++.+||+|||+|..... ....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc--Cccc
Confidence 99999888887777788899999999999999997 799999999999999999985432 2233
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--CC----------------
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF---------------- 219 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~---------------- 219 (426)
.....||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+..+.+.++... .+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 455679999999999988777789999999999999999999999988776665554321 00
Q ss_pred -----------CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCcc
Q 014359 220 -----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 258 (426)
Q Consensus 220 -----------~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~ 258 (426)
..+..+++++.+||++||++||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 122447899999999999999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=381.40 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=203.5
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe------
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------ 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------ 85 (426)
.+++|++++.||+|+||+||+|++..+|+.||||++...... .....++.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 489999999999999999999999999999999999765432 3335678899999999999999999999855
Q ss_pred --CCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCC
Q 014359 86 --KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSAL 148 (426)
Q Consensus 86 --~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~ 148 (426)
.+.+|+||||+.++.+.........+++..++.++.||+.|+ +|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 346899999998877776666677899999999999999997 799999999999999999975
Q ss_pred CCccc--CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCCCCC---
Q 014359 149 PQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--- 223 (426)
Q Consensus 149 ~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--- 223 (426)
..... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+......+++
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 54322 2233456789999999999987755569999999999999999999999988776665554432111110
Q ss_pred -----------------------------CCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 224 -----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 224 -----------------------------~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
..++++.+||.+||++||++|||++|+++||||+..+.|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p 314 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 314 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCC
Confidence 036788999999999999999999999999999875443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=370.82 Aligned_cols=233 Identities=22% Similarity=0.402 Sum_probs=195.0
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL 93 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVm 93 (426)
++|++++.||+|+||+||+|++. +++.||||+++..... .+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 58999999999999999999985 5678999999764322 367899999999999999999999999999999999
Q ss_pred cccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 94 Ey~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||+++|+|.+++... ..+++..+..++.|++.|| +|||+|.++++||+|||+|+...... ...
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-cee
Confidence 999999999998754 5689999999999999997 79999999999999999998654321 222
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 235 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~ 235 (426)
.....||+.|+|||++.+..|+ .++|||||||++|||+| |.+||...+..+++..+..+ ....|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3456799999999999988885 89999999999999999 68888888888888888776 455677899999999999
Q ss_pred ccccCcCCCCChHHHhcC
Q 014359 236 ILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 236 ~L~~dP~~R~t~~~il~h 253 (426)
||+.||++|||+++|++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-48 Score=375.75 Aligned_cols=240 Identities=21% Similarity=0.347 Sum_probs=196.0
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
...++|++.+.||+|+||+||+|.+..+++ .||||.+.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 456899999999999999999999877664 58889886543 3344578999999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..|+|||||++|+|.+++... +.+++.++..++.||+.|| +||||+.++++||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999999988764 5699999999999999997 799999999999999999986543
Q ss_pred ccCCC---ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCC
Q 014359 152 FRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS 226 (426)
Q Consensus 152 ~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 226 (426)
..... ......||+.|||||++.+..|+ .++|||||||++|||+| |+.||.+.+..+....+..+ .++.|..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 22211 11224689999999999888775 89999999999999998 89999998888888888766 456777899
Q ss_pred HHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 227 PGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 227 ~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+++.+||.+||+.||++|||+.||+++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999998875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=383.73 Aligned_cols=238 Identities=24% Similarity=0.373 Sum_probs=200.9
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 86 (426)
.++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++ +|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 4689999999999999999999865543 69999986543 222346789999999998 899999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHH---------------h
Q 014359 87 SKIYMVLEYVTGGELFDKIASKG-----------------------RLQEAEGRKLFQQLIDGL---------------E 128 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~ql~~al---------------e 128 (426)
+.+|+|||||++|+|.++|.... .+++..++.++.|++.|| +
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999997542 489999999999999997 7
Q ss_pred heeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccH
Q 014359 129 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL 207 (426)
Q Consensus 129 NILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~ 207 (426)
|||++.++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||++|||+| |+.||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999865443333334567889999999999988875 99999999999999998 9999998665
Q ss_pred HHHHHHHHhC--CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 208 AVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 208 ~~~~~~i~~~--~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
...+.++... .++.|.++|+++.+||.+||+.||++|||++||++|
T Consensus 273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5544444444 456778899999999999999999999999999886
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=366.71 Aligned_cols=234 Identities=22% Similarity=0.390 Sum_probs=207.8
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
-++|+++++||+|+||+||+|++ .+++.||||++++.... .+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 36899999999999999999998 47889999999875432 46789999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCC
Q 014359 93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDG 156 (426)
Q Consensus 93 mEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~ 156 (426)
|||+++|+|.+++.. ...+++..+.+++.|++.|+ +|||+++++.+||+|||+|+..... ...
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~ 156 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYT 156 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Cce
Confidence 999999999999764 45799999999999999997 6999999999999999999865442 222
Q ss_pred ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHH
Q 014359 157 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 234 (426)
Q Consensus 157 ~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~ 234 (426)
.....+||+.|+|||++.+..|+ .++|||||||++|||+| |+.||.+.+..++..++..+ ....|..+++++.+||.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence 33456799999999999988885 89999999999999998 89999999988888888876 45677889999999999
Q ss_pred HccccCcCCCCChHHHhcC
Q 014359 235 KILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 235 ~~L~~dP~~R~t~~~il~h 253 (426)
+||+.||++|||+++|++|
T Consensus 236 ~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHH
Confidence 9999999999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=373.60 Aligned_cols=238 Identities=23% Similarity=0.364 Sum_probs=192.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||+||+|+. +..||||+++.... +....+.+.+|+.+|++++|||||++++++. .+.+|+
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 357899999999999999999974 33599999976543 3344688999999999999999999999875 456899
Q ss_pred EEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|||||++|+|.+++... .++++..+..++.||+.|| +|||++.++++||+|||+|+........
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999999754 5799999999999999997 7999999999999999999876543334
Q ss_pred CccccccCCCcccchhhhccCC--CCCchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHHhCCC-----CCCCCCCH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDF-----KLPKWLSP 227 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~--~~~~~~DIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~-----~~p~~~s~ 227 (426)
....+.+||+.|||||++.+.. .++.++|||||||++|||+||+.||.+.+.. .....+..+.. ..+..+|+
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence 4556778999999999986532 2358999999999999999999999886644 44444444432 23566899
Q ss_pred HHHHHHHHccccCcCCCCChHHHhcCc
Q 014359 228 GAQNLLRKILEPNPVKRITIAGIKADE 254 (426)
Q Consensus 228 ~~~~Li~~~L~~dP~~R~t~~~il~h~ 254 (426)
++.+||.+||+.||++|||++||+++-
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999999999999873
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=373.79 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=205.8
Q ss_pred ccCEEEece-eeecCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRT-LGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~-LG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
-++|.+.+. ||+|+||+||+|.+.. ++..||||+++... .....+.+.+|+.+|++++|||||++++++.++ .+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 367888885 9999999999998754 45579999997543 344467899999999999999999999998754 58
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+|||||++|+|.+++.. +..+++..+..++.||+.|| +|||++.++.+||+|||+|+......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999999865 45799999999999999997 69999999999999999998654322
Q ss_pred C-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHH
Q 014359 154 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 230 (426)
Q Consensus 154 ~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 230 (426)
. .......+||+.|+|||++.+..|+ .++|||||||++|||+| |+.||.+.+..++...+..+. ++.|+.+|+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 242 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1 1223456799999999999888775 89999999999999998 999999988888888887764 678889999999
Q ss_pred HHHHHccccCcCCCCChHHH---hcCcCCc
Q 014359 231 NLLRKILEPNPVKRITIAGI---KADEWFE 257 (426)
Q Consensus 231 ~Li~~~L~~dP~~R~t~~~i---l~h~w~~ 257 (426)
+||.+||+.||++|||+.+| |+|+|+.
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999888 5677764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-49 Score=374.16 Aligned_cols=235 Identities=26% Similarity=0.371 Sum_probs=203.4
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 91 (426)
..++|++++.||+|+||+||+|.+..+++.||||+++.+.. ..+++.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 34689999999999999999999999999999999976532 24678999999999999999999999999999999
Q ss_pred EEcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 92 VmEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
|||||++|+|.+++... ..+++..+..++.||+.|| +|||++.++++||+|||+|+..... .
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~ 169 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-T 169 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-S
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC-C
Confidence 99999999999999753 5699999999999999997 7999999999999999999865431 1
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCC-CCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~-~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........||+.|+|||++.+..|+ .++|||||||++|||++|. +||.+.+....+..+..+ .++.|..+|+++.+|
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 248 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHH
Confidence 1223344689999999999988885 9999999999999999955 556666777777766655 466778899999999
Q ss_pred HHHccccCcCCCCChHHHhc
Q 014359 233 LRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~ 252 (426)
|.+||+.||++|||+++|++
T Consensus 249 i~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999965
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=374.39 Aligned_cols=234 Identities=23% Similarity=0.341 Sum_probs=197.4
Q ss_pred ceeeecCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEEEcccC
Q 014359 20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97 (426)
Q Consensus 20 ~~LG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lVmEy~~ 97 (426)
+.||+|+||+||+|.+. .+++.||||+++.... +....+.+.+|+.+|++++|||||++++++.++ ..|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999864 4567899999975432 344467899999999999999999999999654 5789999999
Q ss_pred CCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC-Cccccc
Q 014359 98 GGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTT 161 (426)
Q Consensus 98 gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~-~~~~~~ 161 (426)
+|+|.+++....++++..+..++.||+.|| +|||++.++.+||+|||+|+........ ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 999999999988999999999999999997 7999999999999999999865432211 123345
Q ss_pred cCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHcccc
Q 014359 162 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 239 (426)
Q Consensus 162 ~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~~L~~ 239 (426)
.||+.|+|||++.+..|+ .++|||||||++|||+| |+.||.+.+..+....+.++ .++.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 799999999999888775 89999999999999998 99999998888888888776 4677888999999999999999
Q ss_pred CcCCCCChHHHh---cCcCC
Q 014359 240 NPVKRITIAGIK---ADEWF 256 (426)
Q Consensus 240 dP~~R~t~~~il---~h~w~ 256 (426)
||++|||+++|+ +|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 999999999984 56554
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=375.10 Aligned_cols=242 Identities=30% Similarity=0.383 Sum_probs=199.9
Q ss_pred ccCEEEeceeeecCceEEEEEEECCC-CceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCccceeEEEEe---
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS--- 85 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~--- 85 (426)
-++|++++.||+|+||+||+|++..+ ++.||||+++...... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47999999999999999999999765 6779999997654322 1233466788877666 79999999999853
Q ss_pred --CCeEEEEEcccCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCC
Q 014359 86 --KSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSA 147 (426)
Q Consensus 86 --~~~~~lVmEy~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~ 147 (426)
...+|++|||+.++.+..... ....+++..++.++.|++.|| +|||++.+|.+||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 346899999998877754443 345799999999999999997 79999999999999999998
Q ss_pred CCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--C-------
Q 014359 148 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D------- 218 (426)
Q Consensus 148 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~------- 218 (426)
.... .......+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+..+.+..+... .
T Consensus 165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 165 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 5433 3345678999999999999998885 8999999999999999999999998877776665431 0
Q ss_pred ------------------CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 219 ------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 219 ------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
..++..+++.+.+||.+||++||++|||++|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 01234578999999999999999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=370.69 Aligned_cols=238 Identities=26% Similarity=0.410 Sum_probs=203.7
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
.++|++++.||+|+||+||+|.+. +++.||||+++..... .+.+.+|+.+|++++|||||++++++.+ +..|+|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 478999999999999999999974 6788999999754321 4679999999999999999999998754 567999
Q ss_pred EcccCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCC
Q 014359 93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDD 155 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~ 155 (426)
|||+++|+|.+++... .++++..+..++.||+.|| +||||++++.+||+|||+|+..... ..
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~ 164 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EY 164 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC-cc
Confidence 9999999999987543 3699999999999999997 7999999999999999999865431 11
Q ss_pred CccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Q 014359 156 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 233 (426)
Q Consensus 156 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li 233 (426)
.......||+.|+|||++.+..|+ .++|||||||++|||+| |.+||...+..+....+..+ .+..|..+++++.+||
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 243 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHH
Confidence 233456799999999999887775 99999999999999999 56777777777888887765 4667888999999999
Q ss_pred HHccccCcCCCCChHHHhc--CcCCcc
Q 014359 234 RKILEPNPVKRITIAGIKA--DEWFEQ 258 (426)
Q Consensus 234 ~~~L~~dP~~R~t~~~il~--h~w~~~ 258 (426)
.+||+.||++|||+++|++ |+||..
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 9999999999999999988 788753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=365.93 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=210.6
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEEEE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 92 (426)
+++|++++.||+|+||+||+|++..+++.||||+++.... ......++.+|+.+|+.++||||+++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4799999999999999999999999999999999976543 445578899999999999999999999999999999999
Q ss_pred EcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccCCCc
Q 014359 93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRDDGL 157 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~~~~ 157 (426)
||++.+++|..++...+.+++..++.++.|++.|| +|||++.++++||+|||.|+.... ....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~--~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--CCSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC--CCcc
Confidence 99999999999999888999999999999999996 799999999999999999986543 2233
Q ss_pred cccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCC-CCccHHHHHHHHHhC--C----------------
Q 014359 158 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG--D---------------- 218 (426)
Q Consensus 158 ~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~--~---------------- 218 (426)
.....+++.|+|||++.+..+.+.++||||+||++|+|++|+.|| .+.+..+.+..+... .
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 445578899999999988877679999999999999999999885 555555555544321 0
Q ss_pred -----------CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 219 -----------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 219 -----------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
...+..+++.+.+||++||+.||.+|||++|+++||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 112234689999999999999999999999999999998643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=378.98 Aligned_cols=248 Identities=31% Similarity=0.585 Sum_probs=213.1
Q ss_pred CccccCEEEeceeeecCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcCCC-CCccceeEEEE
Q 014359 10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH-PNVVRLHEVLA 84 (426)
Q Consensus 10 ~~~~~~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~ 84 (426)
.+.+++|++++.||+|+||+||+|++. .+|+.||||++++.... +....+.+.+|+.+|++++| |||+++++++.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 456799999999999999999999974 47899999999765432 22234678899999999976 89999999999
Q ss_pred eCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCC
Q 014359 85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALP 149 (426)
Q Consensus 85 ~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~ 149 (426)
+...+|++|||+.+|+|.+++...+.+++..++.++.||+.|+ +|||++.+|.+||+|||+|+.+
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999999999989999999999999999997 7999999999999999999855
Q ss_pred CcccCCCccccccCCCcccchhhhccCC-CCCchhhHHHHHHHHHHHhcCCCCCCCcc----HHHHHHHHHhCCCCCCCC
Q 014359 150 QHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKW 224 (426)
Q Consensus 150 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~DIwSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~ 224 (426)
... ......+.+||+.|+|||.+.+.. +.+.++|||||||+||+|++|+.||.+.+ ...+........+++|..
T Consensus 180 ~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 180 VAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 432 233456778999999999997654 34689999999999999999999997754 334555566677888889
Q ss_pred CCHHHHHHHHHccccCcCCCC-----ChHHHhcCcCCcc
Q 014359 225 LSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ 258 (426)
Q Consensus 225 ~s~~~~~Li~~~L~~dP~~R~-----t~~~il~h~w~~~ 258 (426)
+|+++.+||.+||++||++|| |++|+++||||+.
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 999999999999999999999 5899999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=377.48 Aligned_cols=240 Identities=28% Similarity=0.376 Sum_probs=198.5
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----- 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 87 (426)
-++|++++.||+|+||+||+|.+..+|+.||||++++... +....+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4799999999999999999999999999999999976533 4445678999999999999999999999997654
Q ss_pred -eEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 88 -~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
.+|+||||+ +++|...+.. +++++..++.++.||+.|| +|||++.++.+||+|||+|+...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 6677776654 6899999999999999997 79999999999999999998543
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCC-------------
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------- 218 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------- 218 (426)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+....+..+....
T Consensus 173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 234567899999999999887777799999999999999999999999877655544332210
Q ss_pred ------------------CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 219 ------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 219 ------------------~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
...+..+++++.+||++||..||++|||++|+++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 012345789999999999999999999999999999998643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=362.33 Aligned_cols=241 Identities=24% Similarity=0.387 Sum_probs=200.1
Q ss_pred ccccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeEE
Q 014359 11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 11 ~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 90 (426)
+..++|++++.||+|+||+||+|++..+ +.||||+++..... .+.+.+|+.+|++++|||||++++++.+ +..|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 3458999999999999999999998654 56999999755321 3678999999999999999999999854 5689
Q ss_pred EEEcccCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+||||+++|+|..++.. ...+++.++..++.||+.|| +|||+|.++++||+|||+|+.....
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~- 166 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN- 166 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC-
Confidence 99999999999988854 35799999999999999997 7999999999999999999865432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 231 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 231 (426)
........+||+.|+|||++.+..++ .++|||||||++|||++ |.+||.+.+..+.+..+..+ .++.|..+++++.+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 245 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred CceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence 12233456799999999999988875 99999999999999999 56667777777777777665 46788889999999
Q ss_pred HHHHccccCcCCCCChHHHhc--CcCCccC
Q 014359 232 LLRKILEPNPVKRITIAGIKA--DEWFEQD 259 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~--h~w~~~~ 259 (426)
||.+||+.||++|||+++|++ |+||...
T Consensus 246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999987 8888764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=363.80 Aligned_cols=236 Identities=28% Similarity=0.424 Sum_probs=193.3
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.++|++++.||+|+||.||+|++..++ ..||||.++... .....+.+.+|+.+|++++|||||++++++. .+.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 468999999999999999999987543 468888886432 3444678999999999999999999999985 5678
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+++|+|.+++.. ..++++..++.++.||+.|| +|||++.++.+||+|||+|+.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~- 161 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 161 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-
Confidence 999999999999998765 45799999999999999997 7999999999999999999865432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 231 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 231 (426)
........+||+.|+|||++.+..|+ .++|||||||++|||++ |.+||.+.+..+++.++..+. ++.|+.+|+++.+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 22234456789999999999988875 89999999999999998 999999988888888887764 6778889999999
Q ss_pred HHHHccccCcCCCCChHHHhcC
Q 014359 232 LLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h 253 (426)
||.+||+.||++|||+.||++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=372.39 Aligned_cols=246 Identities=28% Similarity=0.413 Sum_probs=200.1
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC----eE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 89 (426)
.+|++++.||+|+||+||+|++..+|+.||||++++.. .....+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997543 3444678899999999999999999999997653 23
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD 154 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~ 154 (426)
+++|+|+.+|+|++++.. +++++..++.++.||+.|| +|||++.+|.+||+|||+|+.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 444556669999999976 4799999999999999997 799999999999999999986543222
Q ss_pred -CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC--C-------------
Q 014359 155 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D------------- 218 (426)
Q Consensus 155 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~------------- 218 (426)
.......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+........... .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 233566789999999999877666679999999999999999999999987765444332210 0
Q ss_pred -----------C-----CCCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCCC
Q 014359 219 -----------F-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 262 (426)
Q Consensus 219 -----------~-----~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~~ 262 (426)
. ...+.+++++.+||.+||+.||.+|||++|+++||||.....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 0 0123578899999999999999999999999999999875543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=373.04 Aligned_cols=238 Identities=27% Similarity=0.337 Sum_probs=196.6
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC------C
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------S 87 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 87 (426)
-+|+.+++||+|+||+||+|++..+|+.||||++.++.. ...+|+.+|++++||||+++++++... .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 379999999999999999999999999999999976532 234799999999999999999998543 3
Q ss_pred eEEEEEcccCCCChHHH---HHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccCCCCC
Q 014359 88 KIYMVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFGLSAL 148 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~---i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFGla~~ 148 (426)
.+|+||||++++.+... .....++++.+++.++.||+.|| +|||++.++ .+||+|||+|+.
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 58999999977543332 23566799999999999999997 799999876 899999999985
Q ss_pred CCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhC-----------
Q 014359 149 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------- 217 (426)
Q Consensus 149 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------- 217 (426)
... .....+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||...+..+.+..+.+.
T Consensus 173 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 433 334556789999999999887665579999999999999999999999988776665554320
Q ss_pred ------CCC------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 218 ------DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 218 ------~~~------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
... ....+++++.+||.+||..||++|||++|+++||||++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 011 12347899999999999999999999999999999987543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=367.13 Aligned_cols=237 Identities=22% Similarity=0.322 Sum_probs=197.3
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
.+|++++.||+|+||+||+|.+..+|+ .||+|.++... .....+.+.+|+.+|++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988776 57888776432 233467899999999999999999999999865 56
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+++|||+.+|+|.+.+.. ...+++..++.++.||+.|| +|||++.++++||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788899999999998875 45799999999999999997 79999999999999999998654433
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC-CCCCCCCCHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN 231 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 231 (426)
.........||+.|+|||++.+..|+ .++|||||||++|||+| |.+||.+.+..++...+..+. ++.|+.+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 33334455789999999999988875 99999999999999998 899999988777777777764 6778889999999
Q ss_pred HHHHccccCcCCCCChHHHhcCc
Q 014359 232 LLRKILEPNPVKRITIAGIKADE 254 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h~ 254 (426)
||.+||+.||.+|||+.||++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999884
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=356.92 Aligned_cols=237 Identities=23% Similarity=0.356 Sum_probs=194.8
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 88 (426)
-+.|++.+.||+|+||.||+|.+..++ ..||||+++... .......+.+|+.+|++++|||||++++++.+...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 367999999999999999999976554 479999997543 33345678999999999999999999999999999
Q ss_pred EEEEEcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~ 152 (426)
.|+||||+.+|+|.+.+... ..+++..+..++.|++.|+ +||||+.++.+||+|||+|+.....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999999988754 5799999999999999997 6999999999999999999865432
Q ss_pred cC-CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHH
Q 014359 153 RD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA 229 (426)
Q Consensus 153 ~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 229 (426)
.. .......+||+.|||||++.+..|+ .++|||||||++|||++ |.+||.+.+..+.+..+..+ .++.|..++..+
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence 22 1223345789999999999888875 89999999999999999 56666777777777777766 456778899999
Q ss_pred HHHHHHccccCcCCCCChHHHhc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.+||.+||+.||++|||+.+|++
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=372.72 Aligned_cols=241 Identities=29% Similarity=0.368 Sum_probs=201.4
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC-----Ce
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK 88 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 88 (426)
+||++++.||+|+||+||+|++..+|+.||||++.+... +....+.+.+|+.+|+.++|||||++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 689999999999999999999999999999999986543 333457789999999999999999999998643 33
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
.+++|+|+.||+|.+++.. +++++..++.++.||+.|| +|||++.+|.+|++|||+|....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT---
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC---
Confidence 4666777889999998865 5799999999999999997 79999999999999999998543
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHhCCCC-------------
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------- 220 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------- 220 (426)
....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 33456789999999999888877779999999999999999999999988876666555432111
Q ss_pred ----------C--------CCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCCC
Q 014359 221 ----------L--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 261 (426)
Q Consensus 221 ----------~--------p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~~ 261 (426)
. ...+++++.+||++||..||.+|||++|+++||||++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 1 1247899999999999999999999999999999987543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-47 Score=362.84 Aligned_cols=237 Identities=25% Similarity=0.353 Sum_probs=205.4
Q ss_pred ccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS 87 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 87 (426)
.++|++++.||+|+||+||+|++. .+++.||||+++... .....+++.+|+.+|+.++||||+++++++.+.+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 468999999999999999999975 356789999997543 3444678999999999999999999999999999
Q ss_pred eEEEEEcccCCCChHHHHHhCC------------------------CCCHHHHHHHHHHHHHHH---------------h
Q 014359 88 KIYMVLEYVTGGELFDKIASKG------------------------RLQEAEGRKLFQQLIDGL---------------E 128 (426)
Q Consensus 88 ~~~lVmEy~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~ql~~al---------------e 128 (426)
..+++|||+++|+|.+++.... .+++..+..++.|++.|| +
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999996532 389999999999999997 7
Q ss_pred heeeCCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcC-CCCCCCccH
Q 014359 129 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNL 207 (426)
Q Consensus 129 NILld~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~ 207 (426)
|||+|.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|||++| .+||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999855443334445567899999999999998886 999999999999999998 478999888
Q ss_pred HHHHHHHHhCC-CCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 208 AVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 208 ~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.+....+..+. ++.|..+++++.+||.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888888775 4567889999999999999999999999999954
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=356.00 Aligned_cols=229 Identities=25% Similarity=0.462 Sum_probs=193.7
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe-CCeEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~ 90 (426)
..++|++++.||+|+||.||+|.+ .|+.||||+++++. ..+.+.+|+.++++++||||+++++++.+ .+.+|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 467899999999999999999997 47789999997543 24678999999999999999999999854 56689
Q ss_pred EEEcccCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 91 lVmEy~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
+||||+++|+|.+++..++ .+++..+..++.||+.|+ +|||++.+|++||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC--
Confidence 9999999999999997543 599999999999999997 699999999999999999985432
Q ss_pred CCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhC-CCCCCCCCCHHHHH
Q 014359 154 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 231 (426)
Q Consensus 154 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 231 (426)
.....++|+.|+|||++.+..++ .++|||||||++|||+| |++||...+..+....+..+ .+++|..+++++.+
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHH
T ss_pred ---CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 34456789999999999888775 99999999999999998 89999998888888887764 56788889999999
Q ss_pred HHHHccccCcCCCCChHHHhcC
Q 014359 232 LLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 232 Li~~~L~~dP~~R~t~~~il~h 253 (426)
||.+||+.||++|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999774
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=363.92 Aligned_cols=239 Identities=26% Similarity=0.376 Sum_probs=203.5
Q ss_pred CCccccCEEEeceeeecCceEEEEEEECCCCce--EEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe
Q 014359 9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 9 ~~~~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 85 (426)
+-..+++|++.+.||+|+||+||+|.+..++.. ||||.++... .....+.+.+|+.+|+++ +|||||++++++.+
T Consensus 5 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred CccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 345678999999999999999999999888764 6777765432 223356799999999999 79999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHH---------------hheeeCC
Q 014359 86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGL---------------ENILLDS 134 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~al---------------eNILld~ 134 (426)
.+..|+||||+++|+|.++|... ..+++..+..++.||+.|+ +|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence 99999999999999999999653 5699999999999999997 6999999
Q ss_pred CCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcC-CCCCCCccHHHHHHH
Q 014359 135 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQK 213 (426)
Q Consensus 135 ~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~~~~~~ 213 (426)
++.+||+|||+|+.... .......+||+.|+|||.+.+..|+ .++|||||||++|||++| .+||.+.+..+++..
T Consensus 163 ~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp GGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCceEEccccccccccc---cccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999985443 2223456799999999999988875 899999999999999996 578999998898888
Q ss_pred HHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 214 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 214 i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
+..+ .++.|..+++++.+||.+||+.||++|||+.+|++|
T Consensus 239 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8775 567778899999999999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.1e-46 Score=361.59 Aligned_cols=236 Identities=23% Similarity=0.365 Sum_probs=195.6
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeC--Ce
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SK 88 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~ 88 (426)
..++|++++.||+|+||+||+|++..+|+.||||+++... .+++.+|+.+|+.++ ||||+++++++... ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4578999999999999999999999999999999997543 467889999999995 99999999999754 56
Q ss_pred EEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCC-CEEEeccCCCCCCCcc
Q 014359 89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKG-NIKISDFGLSALPQHF 152 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g-~lKl~DFGla~~~~~~ 152 (426)
+|+|||||.+|+|.... +++++..++.++.||+.|| +|||++.++ .+||+|||+|+....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 99999999999997764 4699999999999999997 799999765 599999999985443
Q ss_pred cCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHH-------------hCC
Q 014359 153 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIF-------------RGD 218 (426)
Q Consensus 153 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~-------------~~~ 218 (426)
.......+||+.|+|||++.+...++.++||||+||++|+|++|..||...+. ......+. ...
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 33456778999999999998876657999999999999999999999975432 11111110 000
Q ss_pred CC------------------------CCCCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccC
Q 014359 219 FK------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 259 (426)
Q Consensus 219 ~~------------------------~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~ 259 (426)
.. ....+++++.+||++||..||++|||++|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 00 112378999999999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=357.08 Aligned_cols=238 Identities=26% Similarity=0.442 Sum_probs=204.3
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCC-------ceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL 83 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 83 (426)
..++|++++.||+|+||.||+|++..++ ..||||+++++. .......+.+|+..+.++ +|||||++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3589999999999999999999976544 479999997654 333457788899999888 799999999999
Q ss_pred EeCCeEEEEEcccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHH---------------hheee
Q 014359 84 ASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGL---------------ENILL 132 (426)
Q Consensus 84 ~~~~~~~lVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~al---------------eNILl 132 (426)
.+++..|+||||+++|+|.++|..+ ..+++..+..++.||+.|| +|||+
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 9999999999999999999999754 3589999999999999997 79999
Q ss_pred CCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHH
Q 014359 133 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 211 (426)
Q Consensus 133 d~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~ 211 (426)
+.++.+||+|||+++..............+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+....+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 99999999999999976654444455667899999999999988885 99999999999999998 79999999888888
Q ss_pred HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 212 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 212 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
..+..+ .++.|.++++++.+||.+||+.||++|||+.||++
T Consensus 248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 887766 46778899999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=367.15 Aligned_cols=240 Identities=28% Similarity=0.421 Sum_probs=189.9
Q ss_pred ccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe------C
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------K 86 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~ 86 (426)
+.+|++++.||+|+||+||+|++..+|+.||||++.+... +......+.+|+.+|+.++||||+++++++.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4789999999999999999999999999999999987543 34446789999999999999999999999954 3
Q ss_pred CeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCc
Q 014359 87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQH 151 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~ 151 (426)
..+|+|||||.+ ++.+.+. ..+++..++.++.||+.|+ +|||++.++.+|++|||+++....
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 689999999976 5555553 5699999999999999997 799999999999999999885433
Q ss_pred ccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHHh---------------
Q 014359 152 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--------------- 216 (426)
Q Consensus 152 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------- 216 (426)
.......+||+.|+|||++.+..++ +++||||+||++|+|++|++||.+.+......++..
T Consensus 172 ---~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 ---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ---ccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 3345667899999999999988775 899999999999999999999998776655444321
Q ss_pred -------CCCCC--------------C------CCCCHHHHHHHHHccccCcCCCCChHHHhcCcCCccCC
Q 014359 217 -------GDFKL--------------P------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 260 (426)
Q Consensus 217 -------~~~~~--------------p------~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h~w~~~~~ 260 (426)
..... + ...++++.+||++||..||++|||++|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 11100 0 01367889999999999999999999999999998743
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=357.54 Aligned_cols=238 Identities=21% Similarity=0.289 Sum_probs=207.1
Q ss_pred cccCEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK 86 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 86 (426)
..++|++++.||+|+||+||+|.+.. +++.||||+++... .......+.+|+.++++++||||+++++++..+
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 34899999999999999999998752 45789999997543 333456789999999999999999999999999
Q ss_pred CeEEEEEcccCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEe
Q 014359 87 SKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKIS 141 (426)
Q Consensus 87 ~~~~lVmEy~~gg~L~~~i~~~----------~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~ 141 (426)
...|+||||+++|+|.+++... ..++...+..++.|++.|| +|||++.++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999999998642 2478999999999999997 69999999999999
Q ss_pred ccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcC-CCCCCCccHHHHHHHHHhCC-C
Q 014359 142 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD-F 219 (426)
Q Consensus 142 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~-~ 219 (426)
|||+|+..............+||+.|+|||.+.+..++ .++|||||||++|||+|| .+||.+.+..+.+..+.++. +
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999866543333334556799999999999988775 899999999999999997 68999999888888887764 5
Q ss_pred CCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 220 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 220 ~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
+.|+.+++.+.+||.+||+.||++|||+.+|++
T Consensus 255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 567889999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=354.76 Aligned_cols=238 Identities=26% Similarity=0.396 Sum_probs=192.0
Q ss_pred ccCEEEeceeeecCceEEEEEEECC-CC--ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCCeE
Q 014359 13 LGRYELGRTLGEGNFGKVKFAQDLD-SG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI 89 (426)
Q Consensus 13 ~~~y~i~~~LG~G~fg~V~~a~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 89 (426)
-++|++.+.||+|+||.||+|++.. ++ ..||||++++....+....+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4689999999999999999998643 33 4689999987665556667889999999999999999999999965 467
Q ss_pred EEEEcccCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCccc
Q 014359 90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFR 153 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~ 153 (426)
|+||||+++|+|.+++.. .+.+++..+..++.||+.|| +|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999998765 45699999999999999997 69999999999999999999654432
Q ss_pred CCC-ccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHHHHHHhCC--CCCCCCCCHHH
Q 014359 154 DDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGA 229 (426)
Q Consensus 154 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~ 229 (426)
... .....+||+.|+|||++.+..++ .++|||||||++|||+| |+.||.+.+..+...++.... ++.|+.+|+++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 222 23345688899999999987764 89999999999999998 899999999998888887664 45567799999
Q ss_pred HHHHHHccccCcCCCCChHHHhc
Q 014359 230 QNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 230 ~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.+||.+||+.||++|||+++|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=356.52 Aligned_cols=239 Identities=26% Similarity=0.370 Sum_probs=190.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 85 (426)
..++|++++.||+|+||+||+|.+.. +++.||||+++... .....+.+.+|+.++.++ +||||+.+++++..
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 34789999999999999999999754 45789999997543 233356777888888776 68999999999865
Q ss_pred C-CeEEEEEcccCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHH---------------hheeeC
Q 014359 86 K-SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGL---------------ENILLD 133 (426)
Q Consensus 86 ~-~~~~lVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~al---------------eNILld 133 (426)
. ..+|+|||||++|+|.+++... ..+++.++..++.||+.|| +|||++
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 168 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence 4 5689999999999999999753 2489999999999999997 799999
Q ss_pred CCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcC-CCCCCCccHH-HHH
Q 014359 134 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLA-VLY 211 (426)
Q Consensus 134 ~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG-~~Pf~~~~~~-~~~ 211 (426)
.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|||+|| .+||.+.+.. ...
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999865543333445567899999999999988775 999999999999999986 6788876543 344
Q ss_pred HHHHhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 212 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 212 ~~i~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
..+..+ .++.|..+++++.+||.+||+.||++|||++||++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444444 466788899999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=352.42 Aligned_cols=238 Identities=27% Similarity=0.418 Sum_probs=202.3
Q ss_pred cccCEEEeceeeecCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCccceeEEEEe
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS 85 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 85 (426)
..++|++++.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+++.+ +|||||++++++.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 3479999999999999999999863 467799999997654 333456789999999999 69999999999999
Q ss_pred CCeEEEEEcccCCCChHHHHHhCC------------------CCCHHHHHHHHHHHHHHH---------------hheee
Q 014359 86 KSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGL---------------ENILL 132 (426)
Q Consensus 86 ~~~~~lVmEy~~gg~L~~~i~~~~------------------~l~e~~~~~~~~ql~~al---------------eNILl 132 (426)
....|+|||||++|+|.+++.... .+++..+..++.||+.|+ +|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 999999999999999999997543 599999999999999997 79999
Q ss_pred CCCCCEEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhc-CCCCCCCccHHHHH
Q 014359 133 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 211 (426)
Q Consensus 133 d~~g~lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~ellt-G~~Pf~~~~~~~~~ 211 (426)
+.++++||+|||+++..............+||+.|+|||++.+..+ +.++|||||||++|||+| |.+||.+.+....+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999997655433344456789999999999988776 499999999999999998 77778776655444
Q ss_pred HHH-HhC-CCCCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 212 QKI-FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 212 ~~i-~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.++ ..+ .+..|..+++.+.+||.+||+.||.+|||++||++
T Consensus 258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 443 333 34556779999999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=340.73 Aligned_cols=234 Identities=23% Similarity=0.305 Sum_probs=191.5
Q ss_pred EEeceeeecCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEe-CCeEEEE
Q 014359 17 ELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMV 92 (426)
Q Consensus 17 ~i~~~LG~G~fg~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV 92 (426)
.+.++||+|+||+||+|.+..++ ..||||.+++.. +....+.+.+|+.+|++++||||+++++++.. ++..|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999986543 368999987432 44456889999999999999999999999865 5689999
Q ss_pred EcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCCCCCCCcccC--
Q 014359 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGLSALPQHFRD-- 154 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGla~~~~~~~~-- 154 (426)
||||++|+|.+++... ..+++..+..++.|++.|| +|||+++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999999998754 4588889999999999997 699999999999999999986543221
Q ss_pred CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHHhC-CCCCCCCCCHHHHHH
Q 014359 155 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG-DFKLPKWLSPGAQNL 232 (426)
Q Consensus 155 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~L 232 (426)
........||+.|+|||++.+..++ .++|||||||++|||+||..||.. .+..+....+..+ .+..|+++++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 1223345789999999999888775 999999999999999997666654 4444555666555 456778899999999
Q ss_pred HHHccccCcCCCCChHHHhcC
Q 014359 233 LRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 233 i~~~L~~dP~~R~t~~~il~h 253 (426)
|.+||+.||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-42 Score=329.76 Aligned_cols=245 Identities=21% Similarity=0.242 Sum_probs=191.0
Q ss_pred cccc-CEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-cceeEEEEeCCe
Q 014359 11 MRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSK 88 (426)
Q Consensus 11 ~~~~-~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~ 88 (426)
+++| +|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|+|+ +.+.++..+.+.
T Consensus 3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~ 77 (299)
T d1ckia_ 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 77 (299)
T ss_dssp CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence 3454 79999999999999999999999999999999876432 2357889999999987665 555666678889
Q ss_pred EEEEEcccCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHH---------------hheeeCC---CCCEEEeccCCCCCC
Q 014359 89 IYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGL---------------ENILLDS---KGNIKISDFGLSALP 149 (426)
Q Consensus 89 ~~lVmEy~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~al---------------eNILld~---~g~lKl~DFGla~~~ 149 (426)
.|+||||+ +|+|.+.+. ..+++++..+..++.|++.|| +|||++. +..+||+|||+|+..
T Consensus 78 ~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 78 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99999999 557766664 456899999999999999997 7998764 457999999999865
Q ss_pred CcccC-----CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH---HHHhCC---
Q 014359 150 QHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ---KIFRGD--- 218 (426)
Q Consensus 150 ~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~--- 218 (426)
..... .....+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.......... +.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 43222 1233456899999999999998875 99999999999999999999998755433222 111111
Q ss_pred --CCCCCCCCHHHHHHHHHccccCcCCCCChH---HHhcCcCCccCCCC
Q 014359 219 --FKLPKWLSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQDYTP 262 (426)
Q Consensus 219 --~~~p~~~s~~~~~Li~~~L~~dP~~R~t~~---~il~h~w~~~~~~~ 262 (426)
...+..+|+++.+||.+||+.||++||+++ ++++|+|.+..+..
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 122456899999999999999999999987 45778877655443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=327.07 Aligned_cols=233 Identities=23% Similarity=0.315 Sum_probs=178.8
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCccceeEEEEeCC----eE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI 89 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~ 89 (426)
.+|.+.+.||+|+||.||+|++ +|+.||||+++... .......+|+..++.++|||||++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4799999999999999999986 68899999986542 11222344566667789999999999997654 68
Q ss_pred EEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-----------------------hheeeCCCCCEEEeccCCC
Q 014359 90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL-----------------------ENILLDSKGNIKISDFGLS 146 (426)
Q Consensus 90 ~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al-----------------------eNILld~~g~lKl~DFGla 146 (426)
|+||||+++|+|.+++++ .++++.....++.|++.|+ +||||+.+|++||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999999987 4699999999999999986 6999999999999999999
Q ss_pred CCCCcccC--CCccccccCCCcccchhhhccCCC-----CCchhhHHHHHHHHHHHhcCCCCCCC---------------
Q 014359 147 ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDD--------------- 204 (426)
Q Consensus 147 ~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~-----~~~~~DIwSlGvil~elltG~~Pf~~--------------- 204 (426)
+....... .......+||+.|+|||++.+... .+.++|||||||+||||+||..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 86533221 123345789999999999876431 24689999999999999999887732
Q ss_pred ccHHHHHHHHHhCCC--CCCCC-----CCHHHHHHHHHccccCcCCCCChHHHhcC
Q 014359 205 RNLAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD 253 (426)
Q Consensus 205 ~~~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~~L~~dP~~R~t~~~il~h 253 (426)
.+............. .+|.. .+..+.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 122333333333322 23322 22458899999999999999999999764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.5e-41 Score=321.54 Aligned_cols=232 Identities=17% Similarity=0.211 Sum_probs=191.9
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCccceeEEEEeCCeEEEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKIYMV 92 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV 92 (426)
++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++| +||+.+++++......|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 689999999999999999999999999999999875432 2357789999999975 8999999999999999999
Q ss_pred EcccCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHH---------------hheeeCC-----CCCEEEeccCCCCCCCc
Q 014359 93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGL---------------ENILLDS-----KGNIKISDFGLSALPQH 151 (426)
Q Consensus 93 mEy~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~al---------------eNILld~-----~g~lKl~DFGla~~~~~ 151 (426)
|||+ +++|.+++... ..+++..+..++.|++.|| +|||++. ++.+||+|||+|+....
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 78999998764 4699999999999999996 7999975 57899999999986543
Q ss_pred ccC-----CCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCcc---HHHHHHHHHhCCC----
Q 014359 152 FRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDF---- 219 (426)
Q Consensus 152 ~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~---- 219 (426)
... .....+.+||+.|||||++.+..++ .++|||||||++|+|++|+.||.+.+ ....+.++.....
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 211 1234456899999999999988875 99999999999999999999997543 3333333332211
Q ss_pred -CCCCCCCHHHHHHHHHccccCcCCCCChHHHhc
Q 014359 220 -KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 252 (426)
Q Consensus 220 -~~p~~~s~~~~~Li~~~L~~dP~~R~t~~~il~ 252 (426)
.++..+|+++.+++..|+..+|++||+.+.+.+
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123568999999999999999999999877644
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-39 Score=320.69 Aligned_cols=236 Identities=24% Similarity=0.410 Sum_probs=182.7
Q ss_pred cCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----------CCCccceeEE
Q 014359 14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVRLHEV 82 (426)
Q Consensus 14 ~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~ 82 (426)
|||++++.||+|+||+||+|++..+|+.||||+++++. ...+.+.+|+.+++.++ ||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 57999999999999999999999999999999997653 22467788999888775 5789999998
Q ss_pred EEe--CCeEEEEEcccCCCChHHHH---HhCCCCCHHHHHHHHHHHHHHH----------------hheeeCCCCC----
Q 014359 83 LAS--KSKIYMVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQLIDGL----------------ENILLDSKGN---- 137 (426)
Q Consensus 83 ~~~--~~~~~lVmEy~~gg~L~~~i---~~~~~l~e~~~~~~~~ql~~al----------------eNILld~~g~---- 137 (426)
+.. ....+++|+++..+...... .....+++..++.++.|++.|+ +|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 854 45667777776655543332 2345799999999999999996 7999987764
Q ss_pred --EEEeccCCCCCCCcccCCCccccccCCCcccchhhhccCCCCCchhhHHHHHHHHHHHhcCCCCCCCccHH------H
Q 014359 138 --IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA------V 209 (426)
Q Consensus 138 --lKl~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~DIwSlGvil~elltG~~Pf~~~~~~------~ 209 (426)
+|++|||.|..... .....+||+.|+|||++.+..|+ .++||||+||++++|++|+.||...+.. .
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999984332 33567899999999999988885 8999999999999999999999753321 1
Q ss_pred HHHHH---H---------h------------------------------CCCCCCCCCCHHHHHHHHHccccCcCCCCCh
Q 014359 210 LYQKI---F---------R------------------------------GDFKLPKWLSPGAQNLLRKILEPNPVKRITI 247 (426)
Q Consensus 210 ~~~~i---~---------~------------------------------~~~~~p~~~s~~~~~Li~~~L~~dP~~R~t~ 247 (426)
..... . . .....+...++++.+||.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11100 0 0 0011112246789999999999999999999
Q ss_pred HHHhcCcCCccC
Q 014359 248 AGIKADEWFEQD 259 (426)
Q Consensus 248 ~~il~h~w~~~~ 259 (426)
+|+|+||||++.
T Consensus 323 ~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 323 GGLVNHPWLKDT 334 (362)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhcCcccCCC
Confidence 999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.71 E-value=1.2e-17 Score=147.82 Aligned_cols=121 Identities=19% Similarity=0.255 Sum_probs=93.1
Q ss_pred EEEeceeeecCceEEEEEEECCCCceEEEEEeeccccc---------------chhHHHHHHHHHHHHhcCCCCCcccee
Q 014359 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLKITDQIKREIATLKLLKHPNVVRLH 80 (426)
Q Consensus 16 y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~HpnIv~l~ 80 (426)
|.+++.||+|+||.||+|.+ .+|+.||||+++..... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46899999999999999998 47899999987532111 001123456789999999999999988
Q ss_pred EEEEeCCeEEEEEcccCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH---------------hheeeCCCCCEEEeccCC
Q 014359 81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGL---------------ENILLDSKGNIKISDFGL 145 (426)
Q Consensus 81 ~~~~~~~~~~lVmEy~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~al---------------eNILld~~g~lKl~DFGl 145 (426)
++.. .+++|||++++.+. .+++..+..++.|++.++ +|||+++++ ++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 7632 37999999886653 256666788999999996 799999765 89999999
Q ss_pred CCCC
Q 014359 146 SALP 149 (426)
Q Consensus 146 a~~~ 149 (426)
|...
T Consensus 149 a~~~ 152 (191)
T d1zara2 149 SVEV 152 (191)
T ss_dssp CEET
T ss_pred cccC
Confidence 9743
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.41 E-value=6.5e-13 Score=103.55 Aligned_cols=86 Identities=15% Similarity=0.266 Sum_probs=78.8
Q ss_pred eeEecCCHHHHHHHHHHHHHHcCcEEEee-CCeeEEEeecCCCCcccceEEEEEEEEEe-CceEEEEEEecCCCchHHHH
Q 014359 327 RFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQ 404 (426)
Q Consensus 327 ~f~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~gd~~e~~~ 404 (426)
..+|..+|++|+.+|+++++.+|+.|+++ ++.+++...+++.+ +.++|.+||+++. +++++|+|+|..||+++|++
T Consensus 14 ~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~--~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~ 91 (102)
T d1ul7a_ 14 KTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE--NLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN 91 (102)
T ss_dssp CCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGG--GCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHH
T ss_pred ecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCC--ceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHH
Confidence 44678999999999999999999999775 58899999888888 9999999999996 79999999999999999999
Q ss_pred HHHHHHhhcC
Q 014359 405 LCNKLSSDLG 414 (426)
Q Consensus 405 ~~~~~~~~l~ 414 (426)
+|.+|...|+
T Consensus 92 l~~~il~~l~ 101 (102)
T d1ul7a_ 92 IASKIANELK 101 (102)
T ss_dssp HHHHHHHHCC
T ss_pred HHHHHHHhcc
Confidence 9999998875
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.13 E-value=9.5e-06 Score=65.34 Aligned_cols=72 Identities=8% Similarity=0.243 Sum_probs=60.9
Q ss_pred eEecCCHHHHHHHHHHHHHHcCcEEEe-eCCeeEEEeecCCCCcccceEEEEEEEEEeCceEEEEEEecCCCchH
Q 014359 328 FTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV 401 (426)
Q Consensus 328 f~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~gd~~e 401 (426)
+-|+..|.+|+..+..+++.+|+.|++ +.|.|++........ ..+.+.+++|++.++.|||||++..|+-.|
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~--~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCC--ceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 456789999999999999999999987 568899987755444 788999999999999999999999998765
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.68 E-value=0.00014 Score=57.14 Aligned_cols=87 Identities=14% Similarity=0.292 Sum_probs=65.0
Q ss_pred ceeeEecCCHHHHHHHHHHHHHHcCcEEEeeC----------CeeEEEeecC-----CCCcccceEEEEEEEEEeCceEE
Q 014359 325 KIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----------GKLKATQEHK-----PQKSLGSLSVAAEVFEISPSLYV 389 (426)
Q Consensus 325 ~~~f~s~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~~-----~~~~~~~l~~~~~i~~~~~~~~~ 389 (426)
.-..-|+..|-+|+..|..|++.+|+.|++.+ |.|+++...+ ... ..+.+.+++|++.++.+|
T Consensus 4 hfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~--~~vkm~iQLYqve~~~YL 81 (127)
T d2qrda1 4 HFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKN--TYAYIELQLYEVMPGCFM 81 (127)
T ss_dssp EESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCC--EEEEEEEEEEEEETTEEE
T ss_pred eeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCC--ceEEEEEEEEEEcCCcEE
Confidence 33455789999999999999999999997643 5677774321 112 457889999999999999
Q ss_pred EEEE-----ecCC--------------CchHHHHHHHHHHhhc
Q 014359 390 VELR-----KSYG--------------DPTVYRQLCNKLSSDL 413 (426)
Q Consensus 390 v~~~-----~~~g--------------d~~e~~~~~~~~~~~l 413 (426)
|||+ .+.| .+.+|-.+|.+|.-.|
T Consensus 82 lDFK~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL 124 (127)
T d2qrda1 82 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKL 124 (127)
T ss_dssp EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHH
T ss_pred EEEccCCcccccCCccccccCccccccCCccHHHHHHHHHHHH
Confidence 9998 2222 2467888888776555
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.50 E-value=0.00033 Score=62.34 Aligned_cols=89 Identities=11% Similarity=0.033 Sum_probs=65.8
Q ss_pred cccCEEEeceeeecCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeEE
Q 014359 12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY 90 (426)
Q Consensus 12 ~~~~y~i~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 90 (426)
.+..|++.+..+.++.+.||+.. ..++.+.||+........ ...+.+|...++.+. +--+.+++.+..+++..|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 45788888876666678999876 466678889876543221 235678888888774 434678888888899999
Q ss_pred EEEcccCCCChHHHH
Q 014359 91 MVLEYVTGGELFDKI 105 (426)
Q Consensus 91 lVmEy~~gg~L~~~i 105 (426)
+||++++|..+.+..
T Consensus 87 lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 87 LLMSEADGVLCSEEY 101 (263)
T ss_dssp EEEECCSSEEHHHHT
T ss_pred EEEEecccccccccc
Confidence 999999998876543
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.22 E-value=0.00078 Score=55.55 Aligned_cols=90 Identities=20% Similarity=0.285 Sum_probs=61.1
Q ss_pred cceeeEecCCHHHHHHHHHHHHHHcCcEEEeeC----CeeEEEeecCC-------CCcccceEEEEEEEEEeCceEEEEE
Q 014359 324 RKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----GKLKATQEHKP-------QKSLGSLSVAAEVFEISPSLYVVEL 392 (426)
Q Consensus 324 ~~~~f~s~~~~~~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~-------~~~~~~l~~~~~i~~~~~~~~~v~~ 392 (426)
..-..-|...|-+|+..|..|++.+|+.|++.+ |.|++....+. ......+.+.+++|++.++.+||||
T Consensus 46 WhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlDF 125 (171)
T d2qlva1 46 WHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDF 125 (171)
T ss_dssp CEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEEE
T ss_pred eeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEEE
Confidence 444556899999999999999999999997643 66777743211 1111357889999999999999999
Q ss_pred Ee-----cCC----------------CchHHHHHHHHHHhhc
Q 014359 393 RK-----SYG----------------DPTVYRQLCNKLSSDL 413 (426)
Q Consensus 393 ~~-----~~g----------------d~~e~~~~~~~~~~~l 413 (426)
+- +.| .+.+|-.+|.+|.-.|
T Consensus 126 K~~g~e~~~~~~~~~~~~~~~e~~~~Sp~pFldlca~LI~qL 167 (171)
T d2qlva1 126 KFDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMEL 167 (171)
T ss_dssp EEEEEEC--------------CHHHHTSHHHHHHHHHHHHHH
T ss_pred ecCCccccccccccccccCCCcccCcCCccHHHHHHHHHHHH
Confidence 73 122 2367888888776554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.85 E-value=0.0028 Score=55.66 Aligned_cols=80 Identities=18% Similarity=0.183 Sum_probs=55.3
Q ss_pred CEEEeceeeecC-ceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC--CCCccceeEEEEeCCeEEE
Q 014359 15 RYELGRTLGEGN-FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 15 ~y~i~~~LG~G~-fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~l 91 (426)
.++.. .+..|. -+.||+... ..+..+.+|.-.... ...+.+|...++.+. .-.+.+++.+..+.+..|+
T Consensus 12 g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 12 GYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp TCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 34443 334444 468898874 567778899765432 234677888887774 2346788888888889999
Q ss_pred EEcccCCCChH
Q 014359 92 VLEYVTGGELF 102 (426)
Q Consensus 92 VmEy~~gg~L~ 102 (426)
||++++|.++.
T Consensus 84 v~~~i~G~~~~ 94 (255)
T d1nd4a_ 84 LLGEVPGQDLL 94 (255)
T ss_dssp EEECCSSEETT
T ss_pred EEEeeeccccc
Confidence 99999986653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.30 E-value=0.0096 Score=56.20 Aligned_cols=81 Identities=17% Similarity=0.184 Sum_probs=50.9
Q ss_pred eceeeecCceEEEEEEECCCCceEEEEEeecc-ccc---chhHHHHHHHHHHHHhcCC-C--CCccceeEEEEeCCeEEE
Q 014359 19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RII---HLKITDQIKREIATLKLLK-H--PNVVRLHEVLASKSKIYM 91 (426)
Q Consensus 19 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~---~~~~~~~~~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~l 91 (426)
.+.||.|....||+..+..+++.|+||.-... +.. -.-..++..+|...|+.+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999987777888999965321 100 0111345667888887763 2 346666654 4555689
Q ss_pred EEcccCCCCh
Q 014359 92 VLEYVTGGEL 101 (426)
Q Consensus 92 VmEy~~gg~L 101 (426)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.65 E-value=1.8 Score=38.41 Aligned_cols=69 Identities=25% Similarity=0.254 Sum_probs=45.3
Q ss_pred ceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC-----ccce--eEEEEeCCeEEEEEcccCCC
Q 014359 27 FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-----VVRL--HEVLASKSKIYMVLEYVTGG 99 (426)
Q Consensus 27 fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-----Iv~l--~~~~~~~~~~~lVmEy~~gg 99 (426)
--.||++.. .+|+.|++|+....... .+++..|...+..|...+ .+.. -..+...+..+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 358999875 57888999998654321 456778888887764222 1221 11235577889999999874
Q ss_pred C
Q 014359 100 E 100 (426)
Q Consensus 100 ~ 100 (426)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|